10-K

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-K

(Mark One)

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the fiscal year ended December 31, 2019

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to

Commission file number: 001-37779

FGL HOLDINGS

(Exact name of registrant as specified in its charter)

Cayman Islands	98-1354810
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

4th Floor

Boundary Hall, Cricket Square

Grand Cayman, Cayman Islands KY1-1102

(Address of principal executive offices, including zip code)

(800) 445-6758

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class:	Trading Symbol:	Name of each exchange on which registered:
Ordinary shares, par value $.0001 per share	FG	New York Stock Exchange
Warrants to purchase ordinary shares	FG WS	New York Stock Exchange

Securities registered pursuant to Section 12(g) of the Act: None

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes  ☐       No  ☒

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes  ☐       No  ☒

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒        No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).     Yes ☒        No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer	☒	Accelerated Filer	☐
Non-accelerated Filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes  ☐      No  ☒

The aggregate market value of the ordinary shares held by non-affiliates of the registrant as of the last business day of the registrant's most recently completed second quarter, computed by reference to the closing price reported on the New York Stock Exchange as of June 30, 2019 was approximately $1,214 million.

As of February 24, 2020, there were 221,807,598 ordinary shares, $.0001 par value, issued and outstanding.

FGL HOLDINGS

ANNUAL REPORT ON FORM 10-K

TABLE OF CONTENTS

		Page
	PART I
Item 1.	Business	6
Item 1A.	Risk Factors	28
Item 1B.	Unresolved Staff Comments	51
Item 2.	Properties	51
Item 3.	Legal Proceedings	51
Item 4.	Mine Safety Disclosures	51
	PART II
Item 5.	Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	52
Item 6.	Selected Financial Data	55
Item 7.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	57
	Introduction	57
	Critical Accounting Policies and Estimates	61
	Recent Accounting Pronouncements	66
	Results of Operations	67
	Investment Portfolio	76
	Liquidity and Capital Resources	86
Item 7A.	Quantitative and Qualitative Disclosures about Market Risk	92
Item 8.	Financial Statements and Supplementary Data	97
Item 9.	Changes in and Disagreements with Accountants on Accounting and Financial Disclosure	97
Item 9A.	Controls and Procedures	97
Item 9B.	Other Information	98
	PART III
Item 10.	Directors, Executive Officers and Corporate Governance	100
Item 11.	Executive Compensation	108
Item 12.	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	129
Item 13.	Certain Relationships and Related Transactions, and Director Independence	133
Item 14.	Principal Accounting Fees and Services	135
	PART IV
Item 15.	Exhibits, Financial Statements and Schedules	136
	Exhibit Index	137
Item 16.	Form 10-K Summary	140
	Signatures	141
	Index to Consolidated Financial Statements	F-1

3

PART I

Unless the context otherwise indicates or requires, the terms “we”, “our”, “us”, and the “Company”, as used in this Form 10-K filing, refer for periods prior to the completion of the Business Combination to Fidelity & Guaranty Life ("FGL") and its subsidiaries and, for periods upon or after completion of the Business Combination, to FGL Holdings and its subsidiaries, including FGL and its subsidiaries. The term “FGLH” refers to FGL’s direct subsidiary Fidelity & Guaranty Life Holdings, Inc. FGL Holdings primarily operates through FGL and FGLH’s subsidiary, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”), which is domiciled in Iowa.

Dollar amounts in the accompanying sections are presented in millions, unless otherwise noted.

Special Note Regarding Forward-Looking Statements

This annual report includes forward-looking statements. Some of the forward-looking statements can be identified by the use of terms such as “believes”, “expects”, “may”, “will”, “should”, “could”, “seeks”, “intends”, “plans”, “estimates”, “anticipates” or other comparable terms. However, not all forward-looking statements contain these identifying words. These forward-looking statements include all matters that are not related to present facts or current conditions or that are not historical facts. They appear in a number of places throughout this report and include statements regarding our intentions, beliefs or current expectations concerning, among other things, our consolidated results of operations, financial condition, liquidity, prospects and growth strategies and the industries in which we operate and including, without limitation, statements relating to our future performance.

Forward-looking statements are subject to known and unknown risks and uncertainties, many of which are beyond our control. We caution you that forward-looking statements are not guarantees of future performance and that our actual consolidated results of operations, financial condition and liquidity, and industry development may differ materially from those made in or suggested by the forward-looking statements contained in this report. In addition, even if our consolidated results of operations, financial condition and liquidity, and industry development are consistent with the forward-looking statements contained in this report, those results or developments may not be indicative of results or developments in subsequent periods. A number of important factors could cause actual results to differ materially from those contained in or implied by the forward-looking statements, including the risks and uncertainties discussed in “Risk Factors” (Part I, Item 1A of this Form 10-K). Factors that could cause actual results to differ from those reflected in forward-looking statements relating to our operations and business include:

• general economic conditions and other factors, including prevailing interest and unemployment rate levels and stock and credit market performance;

• concentration in certain states for distribution of our products;

• the impact of interest rate fluctuations;

• equity market volatility;

• credit market volatility or disruption;

• the impact of credit risk of our counterparties;

• volatility or decline in the market price of our ordinary shares could impair our ability to raise necessary capital;

• changes in our assumptions and estimates regarding the amortization of our deferred acquisition costs, deferred sales inducements and value of business acquired balances;

• changes in our methodologies, estimates and assumptions regarding our valuation of investments and the determinations of the amounts of allowances and impairments;

• changes in our valuation allowance against our deferred tax assets, and restrictions on our ability to fully utilize such assets;

• the accuracy of management’s reserving assumptions;

• regulatory changes or actions, including those relating to regulation of financial services affecting (among other things) underwriting of insurance products and regulation of the sale, underwriting and pricing of products, and minimum capitalization and statutory reserve requirements for insurance companies, or the

4

ability of our insurance subsidiaries to make cash distributions to us (including dividends or payments on surplus notes those subsidiaries issue to us);

• the ability to maintain or obtain approval of Iowa Insurance Division ("IID") and other regulatory authorities as required for our operations and those of our insurance subsidiaries

• the impact of the "fiduciary" rule proposals on the Company, its products, distribution and business model;

• changes in the federal income tax laws and regulations which may affect the relative income tax advantages of our products;

• changes in tax laws which affect us and/or our shareholders;

• potential adverse tax consequences if we are treated as a passive foreign investment company;

• the impact on our business of new accounting rules or changes to existing accounting rules;

• our potential need and our insurance subsidiaries’ potential need for additional capital to maintain our and their financial strength and credit ratings and meet other requirements and obligations;

• our ability to successfully acquire new companies or businesses and integrate such acquisitions into our existing framework;

• the impact of potential litigation, including class action litigation;

• our ability to protect our intellectual property;

• our ability to maintain effective internal controls over financial reporting;

• the impact of restrictions in the Company's debt instruments on its ability to operate its business, finance its capital needs or pursue or expand its business strategies;

• our ability and our insurance subsidiaries’ ability to maintain or improve financial strength ratings;

• the performance of third parties including third party administrators, independent distributors, underwriters, actuarial consultants and other outsourcing relationships;

• the loss of key personnel;

• interruption or other operational failures in telecommunication, information technology and other operational systems, or a failure to maintain the security, integrity, confidentiality or privacy of sensitive data residing on such systems;

• our exposure to unidentified or unanticipated risk not adequately addressed by our risk management policies and procedures;

• the impact on our business of natural and man-made catastrophes, pandemics, and malicious and terrorist acts;

• our ability to compete in a highly competitive industry;

• our ability to attract and retain national marketing organizations and independent agents;

• our subsidiaries’ ability to pay dividends to us; and

• the other factors discussed in “Risk Factors”, of (Part I, Item 1A of this Form 10-K).

You should read this report completely and with the understanding that actual future results may be materially different from expectations. All forward-looking statements made in this report are qualified by these cautionary statements. These forward-looking statements are made only as of the date of this report and we do not undertake any obligation, other than as may be required by law, to update or revise any forward-looking statements to reflect future events or developments. Comparisons of results for current and any prior periods are not intended to express any future trends, or indications of future performance, unless expressed as such, and should only be viewed as historical data.

5

Item 1. Business

Overview

FGL Holdings

FGL Holdings (the “Company” or “F&G”), formerly known as CF Corporation (“CF Corp”), a Cayman Islands exempted company, was originally incorporated in the Cayman Islands on February 26, 2016 as a Special Purpose Acquisition Company (“SPAC”). CF Corp formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more target businesses. Prior to November 30, 2017, CF Corp. was a shell company with no operations. On November 30, 2017, CF Corp consummated the acquisition of Fidelity & Guaranty Life ("FGL"), a Delaware corporation, and its subsidiaries, pursuant to the Agreement and Plan of Merger, dated as of May 24, 2017 (the “FGL Merger Agreement”). The transactions contemplated by the FGL Merger Agreement are referred to herein as the “Business Combination.” In connection with the closing of the Business Combination, CF Corp. changed its name to “FGL Holdings” and the Company’s ordinary shares and warrants began trading on the NYSE under the symbols “FG” and “FG WS,” respectively.

F&G Reinsurance Ltd (“F&G Re”), an exempted company incorporated in Bermuda with limited liability has a license to carry on business as an Unrestricted Class "C" reinsurer to provide a platform for non-affiliated offshore reinsurance business. Front Street Re Cayman Ltd, an exempted company incorporated in the Cayman Islands with limited liability (“FSRC”) has a license to carry on business as an Unrestricted Class “B” Insurer that permits FSRC to conduct offshore direct and reinsurance business. F&G Re and FSRC (together herein referred to as the “F&G Reinsurance Companies”), are indirect wholly owned subsidiaries of FGL Holdings and parties to reinsurance transactions.

Our Company

For more than 60 years, our Company has helped middle-income Americans prepare for retirement and for their loved ones' financial security. We partner with leading independent marketing organizations ("IMO") and their agents to serve the needs of the middle-income market and develop competitive products to align with their evolving needs. As of December 31, 2019, we have approximately 650,000 policyholders who count on the safety and protection features our fixed annuity and life insurance products provide.

Through the efforts of our 352 employees, most of whom are located in Des Moines, IA and Baltimore, MD, and through a network of approximately 200 IMOs that represent approximately 37,000 independent agents, we offer various types of fixed annuities and life insurance products. Our fixed annuities serve as a retirement and savings tool for which our customers rely on principal protection and predictable income streams. In addition, our indexed universal life ("IUL") insurance products provide our customers with a complementary product that allows them to build on their savings and provide a payment to their designated beneficiaries upon the policyholder’s death. Our most popular products are fixed indexed annuities (“FIAs”) that tie contractual returns to specific market indices, such as the Standard & Poor's Ratings Services ("S&P") 500 Index. Our customers value our FIAs, which provide a portion of the gains of an underlying market index, while also providing principal protection. We believe this mix of “some upside but limited downside” fills the need for middle-income Americans who must save for retirement but who want to limit the risk of decline in their savings.

For the year ended December 31, 2019, FIAs generated approximately 65% of our total sales. The remaining 35% of sales were primarily generated from fixed rate annuity sales and flow reinsurance during the year. We invest the annuity premiums primarily in fixed income securities, options and futures that hedge our risk and replicate the market index returns to our policyholders. We invest predominantly in call options on the S&P 500 Index. The majority of our products contain provisions that permit us to adjust annually the formula by which we provide index credits in response to changing market conditions. In addition, our annuity contracts generally either cannot be surrendered or include surrender charges that discourage early redemptions.

Pending Transaction with Fidelity National Financial

On February 7, 2020, we announced that we had entered into an Agreement and Plan of Merger (the “FNF Merger Agreement”), by and among the Company, Fidelity National Financial, Inc., a Delaware corporation (“FNF”), F I Corp., a Cayman Islands exempted company and wholly owned subsidiary of FNF (“Merger Sub I”), and F II Corp., a Cayman Islands exempted company and wholly owned subsidiary of FNF (“Merger Sub II” and, together with Merger Sub I, “Merger Subs”). Upon the terms and subject to the conditions set forth in the FNF Merger Agreement, at the time of the closing of the transactions contemplated by the FNF Merger Agreement: (i) Merger Sub I will be merged with and into the Company (the “First Merger”) with the Company surviving the First Merger (the “Surviving Company”) and becoming a wholly owned subsidiary of FNF as a result of the First Merger in accordance with the Companies Law (2018 Revision) of the Cayman Islands (the “CICL”); and (ii) immediately following the First Merger, the Surviving Company will be

6

merged with and into Merger Sub II (the “Second Merger” and, together with the First Merger, the “Mergers”) with Merger Sub II surviving the Second Merger and remaining a wholly owned subsidiary of FNF as a result of the Second Merger in accordance with the CICL. Following the close of the Mergers, the Company will operate as a subsidiary of FNF.

A special committee of our board of directors, comprised solely of independent directors not affiliated with FNF, unanimously determined that it is fair and in the best interests of the Company, and declared it advisable, to enter into the FNF Merger Agreement. Subject to the terms and conditions of the FNF Merger Agreement, each of our ordinary shares issued and outstanding immediately prior to the effective time of the First Merger (other than those owned by FNF, the merger subsidiaries or any other subsidiary of FNF) will be canceled and converted automatically into the right to receive (i) $12.50 in cash or (ii) 0.2558 shares of FNF common stock, at the election of the holder of such ordinary share, subject to the allocation and proration provisions of the FNF Merger Agreement. In addition, subject to the terms and conditions of the Series A Preferred Share Purchase Agreement, FNF will purchase our outstanding Series A Preferred Shares.

The Mergers are expected to occur in the second or third quarter of 2020, subject to shareholder and regulatory approvals and the satisfaction of customary closing conditions. Certain conditions include, among other things, (i) the adoption of the FNF Merger Agreement, the Mergers and the other transactions contemplated thereby by the affirmative vote of the holders of ordinary shares of the Company representing at least two-thirds of the ordinary shares of the Company present and voting in person or by proxy as a single class at the shareholders’ meeting in accordance with the CICL and the Amended and Restated Memorandum and Articles of Association of the Company (as amended and restated), (ii) the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and obtaining any requisite approvals, consents or authorizations from governmental authorities, including insurance regulators in the jurisdictions of domicile of our and FNF’s insurance subsidiaries, (iii) the absence of any injunction or applicable law or order preventing or prohibiting consummation of the Mergers, (iv) a declaration by the Securities and Exchange Commission of the effectiveness of the Form S-4 to be filed with the SEC by FNF relating to the registration under the Securities Act of the shares of FNF’s common stock to be issued in the Mergers, (v) approval for listing by the New York Stock Exchange of the shares of FNF common stock to be issued in the Mergers and (vi) the receipt of an opinion of counsel or an accounting firm to the effect that, for U.S. federal income tax purposes, the Mergers, together with the purchase of the Series A Preferred Shares pursuant to the Series A Preferred Share Purchase Agreement, will constitute a reorganization within the meaning of Section 368(a) of the Code. The FNF Merger Agreement does not contain any financing condition or contingency.

Upon termination of the FNF Merger Agreement, under specified circumstances, we may be required to pay a termination fee to FNF in an aggregate amount of either $40 or $67. The termination fee shall be an amount equal to $40 if such termination fee becomes payable in the event that (i) the Company terminates the FNF Merger Agreement to enter into any Takeover Proposal Documentation regarding a Superior Proposal with an Excluded Party (as such terms are defined in the FNF Merger Agreement) or (ii) FNF terminates the FNF Merger Agreement where the event giving rise to the right of termination is based on the submission of a Takeover Proposal by an Excluded Party (as such terms are defined in the FNF Merger Agreement). The termination fee shall be an amount equal to $67 in all other circumstances that require us to pay a termination fee.

We have filed a Current Report on Form 8-K with the SEC on February 7, 2020 with respect to the proposed Mergers. In addition, please see “Risks relating to the Pending Transaction with Fidelity National Financial, Inc. (FNF)” under “Item 1A. Risk Factors” below for further discussion of the Mergers and risks and uncertainties related thereto.

Our Strategy

At F&G we seek to deliver profitable growth for our shareholders through a number of strategic pillars.

• Serve the growing retirement market needs by collaborating with our existing and new distribution partners to deliver peace of mind solutions. We believe the demand for retirement and principal protection products will continue to grow. As both a direct writer and a reinsurer, we offer valuable products and capabilities tailored to serve this growing demographic need.

• Strengthen our foundation. With our process rigor, we pay close attention to market and profitability trends and fine-tune our actions throughout the year. By partnering with Blackstone Insurance Solutions, we are able to source the breadth and volume of assets that enable us to offer competitive products while we optimize our risk-adjusted returns.

• Enhance the F&G experience. With products that provide downside protection coupled with opportunity for market upside, we are focused on giving our policyholders peace of mind. We partner with agents who help their clients select the best products for their individual needs. Our customer care professionals provide personalized support, and we offer self-serve options through our digital platforms.

• Focus on bottom-line, profit-oriented objectives. In both our organic and inorganic growth plans as a writer and as a reinsurer, we focus on markets and products where we can achieve targeted profit margins.

7

The F&G Reinsurance Companies were formed with the intention of building a flexible and diversified portfolio of life and annuity reinsurance treaties. F&G Re has entered into three reinsurance agreements as of December 31, 2019 and is actively evaluating additional opportunities.

Competition

Our ability to compete is dependent upon many factors which include, among other things, our ability to develop competitive and profitable products, our ability to maintain stable relationships with our contracted IMOs, our ability to maintain low unit costs, our ability to source and secure investments with attractive returns and risk profiles and our ability to maintain adequate financial strength ratings from rating agencies. Principal competitive factors for FIAs are initial crediting rates, reputation for renewal crediting action, product features, brand recognition, customer service, cost, distribution capabilities and financial strength ratings of the provider. Competition may affect, among other matters, both business growth and the pricing of our products and services. Principal competitive factors for IULs are based on service and distribution channel relationships, price, brand recognition, financial strength ratings of our insurance subsidiaries and financial stability.

The reinsurance industry is highly competitive. The F&G Reinsurance Companies compete with major reinsurers, most of which are well established and have significant operating histories, strong financial strength ratings and long-standing client relationships.

For detailed information about revenues, operating income and total assets of our Company, see Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and the consolidated financial statements beginning on page F-1 in this report.

Products

Our experience designing and developing annuities and life insurance products will allow us to continue to introduce innovative products and solutions designed to meet customers’ changing needs. We work hand-in-hand with our distributors to devise the most suitable product solutions for the ever-changing market. We believe that, on a practical basis, we have a unique understanding of the safety, accumulation, protection, and income needs of middle-income Americans.

Annuity Products

Through our insurance subsidiaries, we issue a broad portfolio of deferred annuities (fixed indexed and fixed rate annuities) and immediate annuities. A deferred annuity is a type of contract that accumulates value on a tax deferred basis and typically begins making specified periodic or lump sum payments a certain number of years after the contract has been issued. An immediate annuity is a type of contract that begins making specified payments within one annuity period (e.g., one month or one year) and typically pays principal and earnings in equal payments over some period of time.

Deferred Annuities

FIAs. Our FIAs allow contract owners the possibility of earning returns linked to the performance of a specified market index, predominantly the S&P 500 Index, while providing principal protection. The contracts include a provision for a minimum guaranteed surrender value calculated in accordance with applicable law. A market index tracks the performance of a specific group of stocks representing a particular segment of the market, or in some cases an entire market. For example, the S&P 500 Composite Stock Price Index is an index of 500 stocks intended to be representative of a broad segment of the market. All FIA products allow policyholders to allocate funds once a year among several different crediting strategies, including one or more index-based strategies and a traditional fixed rate strategy. High surrender charges apply for early withdrawal, typically for seven to fourteen years after purchase. For the year ended December 31, 2019, we sold $2,820 of FIAs.

The contractholder account value of a FIA contract is equal to the sum of deposits paid, premium bonuses, if any, (described below), and index credits based on the change in the relevant market index (subject to a cap, spread and/or a participation rate) less any fees for riders and any withdrawals taken to-date. Caps (a maximum rate that may be credited) generally range from 2% to 5% when measured annually and 1% to 3% when measured monthly, spreads (a credited rate determined by deducting a specific rate from the index return) generally range from 1% to 6% when measured annually, and participation rates (a credited rate equal to a percentage of index return) generally range from 100% to 140% of the performance of the applicable market index. The cap, spread and participation rate can typically be reset annually and in some instances every two to five years. Certain riders provide a variety of benefits, such as the ability to increase their cap, lifetime income or additional liquidity for a set fee. As this fee is fixed, the contractholder may lose principal if the index credits received do not exceed the amount of such fee.

8

Approximately 72% of the FIA sales for the year ended December 31, 2019 involved “premium bonuses” or vesting bonuses. Premium bonuses increase the initial annuity deposit by a specified rate of 2% to 5%. The vesting bonuses, which range from 1% to 10%, increase the initial annuity deposit liability but are subject to adjustment for unvested amounts in the event of surrender by the policyholder prior to the end of the vesting period. We made compensating adjustments in the commission paid to the agent or the surrender charges on the policy to offset the premium bonus.

Approximately 66% of our FIA contracts were issued with a guaranteed minimum withdrawal benefit (“GMWB”) rider for the year ended December 31, 2019. With this rider, a contract owner can elect to receive guaranteed payments for life from the FIA contract without requiring the owner to annuitize the FIA contract value. The amount of the income benefit available is determined by the growth in the policy's benefit base value as defined in the FIA contract rider. Typically this accumulates for 10 years based on a guaranteed rate of 3% to 8%. Guaranteed withdrawal payments may be stopped and restarted at the election of the contract owner. Some of the FIA contract riders that we offer include an additional death benefit or an increase in benefit amounts under chronic health conditions. Rider fees range from 0% to 1%.

As of December 31, 2019, the distribution of the FIA account values by cap rate and by strategy was as follows:

	Cap rate
Strategy	0% to 3%		3% to 5%		> 5%		Total
1 year gain trigger	$	612	$	170	$	35	$	817
1-2 year monthly average	890		532		168		1,590
1-3 year monthly point-to-point	5,316		24		—		5,340
1-3 year annual point-to-point	2,174		1,475		704		4,353
3 year step forward	—		23		110		133
Total	$	8,992	$	2,224	$	1,017	$	12,233

As of December 31, 2019, the distribution of the FIA account values by cap rate and by index was as follows:

	Cap rate
Index	0% to 3%		3% to 5%		> 5%		Total
S&P 500	$	8,964	$	2,007	$	987	$	11,958
Dow Jones	—		117		—		117
Nasdaq	28		100		30		158
Total	$	8,992	$	2,224	$	1,017	$	12,233

Fixed Rate Annuities. Fixed rate annuities include annual reset and multi-year rate guaranteed policies. Fixed rate annual reset annuities issued by us have an annual interest rate (the “crediting rate”) that is guaranteed for the first policy year. After the first policy year, we have the discretionary ability to change the crediting rate once annually to any rate at or above a guaranteed minimum rate. Multi-year guaranteed annuities ("MYGA") are similar to fixed rate annual reset annuities except that the initial crediting rate is guaranteed for a specified number of years before it may be changed at our discretion. For the year ended December 31, 2019 we sold $776 of fixed rate MYGA. As of December 31, 2019, crediting rates on outstanding (i) single-year guaranteed annuities generally ranged from 2% to 6% and (ii) MYGA ranged from 1% to 6%. The average crediting rate on all outstanding fixed rate annuities at December 31, 2019 was 3%.

As of December 31, 2019, the distribution of the fixed rate annuity account values by crediting rate was as follows:

Crediting rate	1% to 2%		2% to 3%		3% to 4%		4% to 5%		5% to 6%		Total
Account value (gross)	$	31	$	260	$	2,866	$	423	$	4	$	3,584

9

As of December 31, 2019, the MYGA expiring guaranty account values, net of reinsurance, by year were as follows:

Year of expiry:	Account Value
2020	131
2021	646
2022	764
2023	719
2024	566
Thereafter	467
Total	$	3,293

Withdrawal Options for Deferred Annuities. After the first year following the issuance of a deferred annuity policy, holders of deferred annuities are typically permitted penalty-free withdrawals up to 10% of the prior year’s value, subject to certain limitations. Withdrawals in excess of allowable penalty-free amounts are assessed a surrender charge if such withdrawals are made during the penalty period of the deferred annuity policy. The penalty period typically ranges from seven to fourteen years for FIAs and three to ten years for fixed rate annuities. This surrender charge initially ranges from 0% to 15% of the contract value for FIAs and 0% to 10% of the contract value for fixed rate annuities and generally decreases by approximately one to two percentage points per year during the penalty period. The average surrender charge is 8% for our FIAs and 7% for our fixed rate annuities as of December 31, 2019.

The following table summarizes our deferred annuity account values and surrender charge protection as of December 31, 2019:

	Fixed Rate and Fixed Index Annuities Account Value		Percent of Total		Weighted Average Surrender Charge
SURRENDER CHARGE EXPIRATION BY YEAR
Out of surrender charge	$	2,564	13	%	—	%
2020	588		3	%	3	%
2021 - 2023	3,771		18	%	6	%
2024 - 2025	3,214		16	%	8	%
2026 - 2027	3,608		18	%	9	%
Therafter	6,657		32	%	11	%
Total	$	20,402	100	%	8	%

Subsequent to the penalty period, the policyholder may elect to take the proceeds of the surrender either in a single payment or in a series of payments over the life of the policyholder or for a fixed number of years (or a combination of these payment options). In addition to the foregoing withdrawal rights, policyholders may also elect to have additional withdrawal benefits by purchasing a GMWB.

Immediate Annuities

We also sell single premium immediate annuities (or “SPIAs”), which provide a series of periodic payments for a fixed period of time or for the life of the policyholder, according to the policyholder’s choice at the time of issue. The amounts, frequency and length of time of the payments are fixed at the outset of the annuity contract. SPIAs are often purchased by persons at or near retirement age who desire a steady stream of payments over a future period of years.

10

The following table presents the deposits (also known as “sales”) on annuity policies issued for the period presented as well as reserves required by U.S. generally accepted accounting principles (“U.S. GAAP”) as of the periods presented:

	Year ended December 31, 2019				Year ended December 31, 2018				Period from December 1 to December 31, 2017
	Deposits  on Annuity Policies		U.S. GAAP Reserves		Deposits  on Annuity Policies		U.S. GAAP Reserves		Deposits  on Annuity Policies		U.S. GAAP Reserves
Products (net of reinsurance)
Fixed indexed annuities	$	2,800	$	18,058	$	2,253	$	16,076	$	178	$	15,178
Fixed rate annuities	539		4,477		61		4,462		45		4,022
Single premium immediate annuities	14		3,291		24		3,217		—		3,144
Total	$	3,353	$	25,826	$	2,338	$	23,755	$	223	$	22,344

	Period from October 1 to November 30, 2017				Period from October 1 to December 31, 2016 (Unaudited)				Year ended September 30, 2017
	Predecessor				Predecessor				Predecessor
	Deposits  on Annuity Policies		U.S. GAAP Reserves		Deposits  on Annuity Policies		U.S. GAAP Reserves		Deposits  on Annuity Policies		U.S. GAAP Reserves
Products (net of reinsurance)
Fixed indexed annuities	$	288	$	14,464	$	556	$	13,317	$	1,892	$	14,237
Fixed rate annuities	116		3,993		99		3,627		556		3,910
Single premium immediate annuities	1		2,809		2		2,866		15		2,845
Total	$	405	$	21,266	$	657	$	19,810	$	2,463	$	20,992

Life Insurance

We currently offer IUL insurance policies and have previously sold universal life, term and whole life insurance products. Holders of universal life insurance policies earn returns on their policies which are credited to the policyholder’s cash value account. The insurer periodically deducts its expenses and the cost of life insurance protection from the cash value account. The balance of the cash value account is credited interest at a fixed rate or returns based on the performance of a market index, or both, at the option of the policyholder, using a method similar to that described above for FIAs.

Almost all of the life insurance policies in force, except for the return of premium benefits on term life insurance products and universal life contracts issued after March 1, 2010, are subject to an arrangement with Wilton Reassurance Company (“Wilton Re”). See section titled “Reinsurance-Wilton Re Transaction” in Item 1. Business.

As of December 31, 2019, the distribution of the retained IUL account values by cap rate and by strategy was as follows:

	Cap rate
Strategy	2.5%-5.0%		5.0-7.5%		7.5%-10.0%		10.0-12.5%		12.5+		Total
1 year annual point-to-point, Gold Index	$	—	$	—	$	—	$	—	$	44	$	44
1 year monthly point-to-point, S&P Index	33		—		—		—		—		33
1 year annual point-to-point with 100% par rate, S&P Index	14		2		57		135		168		376
1 year annual point-to-point with 140% par rate, S&P Index	3		4		23		—		—		30
Total	$	50	$	6	$	80	$	135	$	212	$	483

11

Distribution

The sale of our products typically occurs as part of a four-party, three stage sales process between Fidelity & Guaranty Life Insurance Company (“FGL Insurance”), an IMO, the agent and the customer. FGL Insurance designs, manufactures, issues, and services the product. The IMOs will typically sign contracts with multiple insurance carriers to provide their agents with a broad and competitive product portfolio. The IMO provides training and discusses product options with agents in preparation for meetings with clients. The IMO staff also provide assistance to the agent during the selling and application process. The agent may get customer leads from the IMOs. The agent conducts a fact find and presents suitable product choices to the customers. We monitor the business issued by each distribution partner for pricing metrics, mortality, persistency, as well as market conduct and suitability.

We offer our products through a network of approximately 200 IMOs, representing approximately 37,000 agents. We identify "Power Partners" as those we believe have the ability to generate significant production for the Company. We currently have 32 Power Partners, comprised of 21 annuity IMOs and 11 life insurance IMOs. During the year ended December 31, 2019 these Power Partners accounted for approximately 97% of our annual sales volume. We believe that our relationships with these IMOs are strong. The average tenure of the top ten Power Partners is approximately 16 years.

Our Power Partners play an important role in the development of our products by providing feedback integral to the development process and by securing “shelf space” for new products. Over the last ten years, the majority of our best-selling products have been developed with our Power Partners. We intend to continue to involve Power Partners in the development of our products in the future.

The top five states for the distribution of FGL Insurance’s products in the year ended December 31, 2019 were California, Texas, Florida, New Jersey and Arizona, which together accounted for 41% of FGL Insurance’s premiums.

F&G Re provides a platform for non-affiliated offshore reinsurance business. The company’s main product is reinsuring annuity blocks of business. As of December 31, 2019 it had entered into three reinsurance treaties and is actively evaluating additional opportunities.

Investments

We embrace a long-term conservative investment philosophy, investing nearly all the insurance premiums we receive in a wide range of fixed income interest-bearing securities.

FGL Insurance, and certain subsidiaries of the Company, entered into investment management agreements (“IMAs”) with Blackstone ISG-I Advisors LLC (“BISGA”), a wholly-owned subsidiary of Blackstone on December 1, 2017. On December 31, 2019, to be effective as of October 31, 2019, FGL Insurance and certain subsidiaries of the Company entered into amended and restated IMAs (the “Restated IMAs”) with BISGA, pursuant to which BISGA was appointed as investment manager of the company’s general accounts (the “F&G Accounts”). Pursuant to the terms of the IMAs, BISGA may delegate any or all of its discretionary investment, advisory and other rights, powers, functions and obligations under the IMAs to one or more sub-managers, including its affiliates. Pursuant to the Restated IMAs, BISGA delegated certain investment services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors. See "Note 14. Related Party Transactions" to our audited consolidated financial statements for further details. Additionally, three other subsidiaries of the Company entered into Investment Management Agreements with BISGA on substantially the same terms as the FGL Insurance IMA (the “Additional Investment Management Agreements” and collectively with the FGL Insurance IMA, the “Investment Management Agreements”).

BISGA manages the bulk of the investment portfolio. For certain asset classes, we utilize experienced third party companies. As of December 31, 2019, 88% of our $28 billion investment portfolio was managed by Blackstone, with the remaining 12% balance managed by other third parties. BISGA appointed MVB Management, an entity owned by affiliates of the Company’s Co-Executive Chairmen, as Sub-Adviser of the FGL Account pursuant to a sub-advisory agreement (the “Sub-Advisory Agreement”). Under the Sub-Advisory Agreement, MVB Management will provide investment advisory services, portfolio review, and consultation with regard to the FGL Account (and the accounts of the other Company subsidiaries party to Investment Management Agreements) and the asset classes and markets contemplated by the investment guidelines specified in the agreement, including such recommendations as the Investment Manager shall reasonably request. Payment or reimbursement of the subadvisory fee to MVB Management is solely the obligation of BISGA and is not an obligation of FGL Insurance or the Company. Subject to certain conditions, the Sub-Advisory Agreement cannot be terminated by BISGA unless FGL Insurance terminates the FGL Insurance IMA.

The Company and certain subsidiaries entered into amended and restated Investment Management Agreements with BISGA on December 31, 2019, to be effective as of October 1, 2019, pursuant to which BISGA was appointed as investment manager of the company’s general accounts (the “F&G Accounts”). The IMAs amend and restate investment management agreements entered into between November 2017 and March 2018 (the “Restated IMAs”). Pursuant to the terms of the

12

IMAs, BISGA may delegate any or all of its discretionary investment, advisory and other rights, powers, functions and obligations under the IMAs to one or more sub-managers, including its affiliates. BISGA delegated certain investment services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors.

Our investment strategy is designed to (i) achieve strong absolute returns, (ii) provide consistent yield and investment income, and (iii) preserve capital. We base all of our decisions on fundamental, bottom-up research, coupled with a top-down view that respects the cyclicality of certain asset classes. The types of assets in which we may invest are influenced by various state laws, which prescribe qualified investment assets applicable to insurance companies. Additionally, we define risk tolerance across a wide range of factors, including credit risk, liquidity risk, concentration (issuer and sector) risk, and caps on specific asset classes, which in turn establish conservative risk thresholds.

Our investment portfolio consists of high quality fixed maturities, including publicly issued and privately issued corporate bonds, municipal and other government bonds, asset-backed securities ("ABS"), residential mortgage-backed securities ("RMBS"), commercial mortgage-backed securities ("CMBS"), commercial mortgage loans ("CMLs"), residential mortgage loans, limited partnership investments, and fund investments. We also maintain holdings in floating rate, and less rate-sensitive investments, including senior tranches of collateralized loan obligations (“CLOs”), non-agency RMBS, and various types of ABS. It is our expectation that our investment portfolio will broaden in scope and diversity to include other asset classes held by life and annuity insurance writers. We also have a small amount of equity holdings through our funding arrangement with the Federal Home Loan Bank of Atlanta.

Over the last year, we continued to work with BISGA and the other third party asset managers to broaden the portfolio’s exposure to include United States dollar ("USD") denominated emerging market bonds, highly rated preferred stocks and hybrids, and structured securities including ABS. As a result of these portfolio repositionings, we currently maintain:

• a well matched asset/liability profile (asset duration, including cash and cash equivalents, of 6.7 years vs. liability duration of 6.8 years); and

• a large exposure to less rate-sensitive assets (22% of invested assets).

For further discussion of portfolio activity, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations-Investment Portfolio”.

Derivatives

Our FIA contracts permit the holder to elect to receive a return based on an interest rate or the performance of a market index, most typically the S&P 500 Index. We purchase derivatives consisting predominantly of call options and, to a lesser degree, futures contracts on the equity indices underlying the applicable policy. These derivatives are used to fund the index credits due to policyholders under the FIA contracts based upon policyholders' contract elections. The majority of all such call options are one-year options purchased to match the funding requirements underlying the FIA contracts. On the anniversary dates of the FIA contracts, the market index used to compute the annual index credit under the FIA contract is reset. At such time, we purchase new one-, two-, three-, or five-year call options to fund the next index credit. We manage the cost of these purchases through the terms of our FIA contracts, which permit us to change caps or participation rates, subject to certain guaranteed minimums on each contracts anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the equity market related change in the fair value of the FIA contract’s related reserve liability. The call options and futures contracts are marked to fair value with the change in fair value included as a component of "Net investment gains (losses)". The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instruments term or upon early termination and the changes in fair value of open positions.

Outsourcing

We outsource the following functions to third-party service providers:

• new business administration (date entry and policy issue only);

• service of existing policies;

• underwriting administration of life insurance applications;

• life reinsurance administration;

• call centers;

• information technology development and maintenance;

13

• valuation of reinsurance liabilities held at fair value;

• investment accounting and custody; and

• co-located data centers and hosting of financial systems.

We closely manage our outsourcing partners and integrate their services into our operations. We believe that outsourcing such functions allows us to focus capital and our employees on our core business operations and perform differentiating functions, such as investment, actuarial, product development and risk management functions. In addition, we believe an outsourcing model provides predictable pricing, service levels and volume capabilities and allows us to benefit from technological developments that enhance our customer self-service and sales processes. We believe that we have a good relationship with our principal outsource service providers.

We outsource our existing policy administration for annuity and life products to Transaction Applications Group, Inc and Concentrix Insurance Services. Under this arrangement, Transaction Applications Group, Inc. administers most of our new business processing and manages most of our call center and processing requirements. Our current agreement expires on December 31, 2021. Additionally, in August 2017, we partnered with Concentrix Insurance Services to administer a portion of our annuity new business processing and the servicing (administration and call center activities) of these issued annuity contracts.

We have partnered with CRL-Plus (“CRL-Plus”) to implement our life insurance underwriting policies. Under the terms of the arrangement, CRL-Plus has assigned the Company a dedicated team of underwriters with appropriate professional designations and experience. Underwriting guidelines for each product are established by our Chief Underwriter in collaboration with our actuarial department. Our Chief Underwriter and actuarial department work closely with our reinsurance counterparties to establish or change guidelines. Adherence to underwriting guidelines is managed at a case level through monthly underwriting audits conducted by our Chief Underwriter as well as the CRL-Plus lead underwriter. Periodically, underwriting audits are conducted by our reinsurers and an independent third party underwriting firm. Our current agreement with CRL-Plus is reviewed annually.

Ratings

Our access to funding and our related cost of borrowing, the attractiveness of certain of our products to customers and requirements for derivatives collateral posting are affected by our credit ratings and insurance financial strength ratings, which are periodically reviewed by the rating agencies. Financial strength ratings and credit ratings are important factors affecting public confidence in an insurer and its competitive position in marketing products.

As of the date of this filing, A.M. Best Company ("A.M. Best"), Fitch Ratings ("Fitch"), Moody’s Investors Service ("Moody's") and S&P Global Ratings ("S&P") had issued credit ratings, financial strength ratings and/or outlook statements regarding us, as listed below. Credit ratings represent the opinions of rating agencies regarding an entity’s ability to repay its indebtedness. Financial strength ratings represent the opinions of rating agencies regarding the ability of an insurance company to meet its financial obligations under an insurance policy and generally involve quantitative and qualitative evaluations by rating agencies of a company’s financial condition and operating performance. Generally, rating agencies base their financial strength ratings upon information furnished to them by the insurer and upon their own investigations, studies and assumptions. Financial strength ratings are based upon factors of concern to policyholders, agents and intermediaries and are not directed toward the protection of investors. Credit and financial strength ratings are not recommendations to buy, sell or hold securities and they may be revised or revoked at any time at the sole discretion of the rating organization.

In addition to the financial strength ratings, rating agencies use an “outlook statement” to indicate a medium or long term trend which, if continued, may lead to a rating change. A positive outlook indicates a rating may be raised and a negative outlook indicates a rating may be lowered. A stable outlook is assigned when ratings are not likely to be changed. A developing outlook is assigned when a rating may be raised, lowered, or affirmed. Outlooks should not be confused with expected stability of the issuer’s financial or economic performance. A rating may have a "stable" outlook to indicate that the rating is not expected to change, but a "stable" outlook does not preclude a rating agency from changing a rating at any time without notice.

14

The rating organizations may take various actions, positive or negative. Such actions are beyond the Company's control and the Company cannot predict what these actions may be and the timing thereof.

	A.M. Best	Fitch (a)	Moody's (b)	S&P (c)
Holding Company Ratings
FGL Holdings
Issuer Credit / Default Rating	Not Rated	BBB-	Ba3	BB+
Outlook		Positive	Positive	Positive
CF Bermuda Holdings Limited
Issuer Credit / Default Rating	Not Rated	BBB-	Ba2	BB+
Outlook		Positive	Positive	Positive
Fidelity & Guaranty Life Holdings, Inc.
Issuer Credit / Default Rating	bbb-	BBB-	Not Rated	BB+
Outlook	Stable	Positive		Positive
Senior Unsecured Notes	bbb-	BB+	Ba2	BB+
Outlook	Stable		Positive
Operating Subsidiary Ratings
Fidelity & Guaranty Life Insurance Company
Financial Strength Rating	A-	BBB+	Baa2	BBB+
Outlook	Stable	Positive	Positive	Positive
Fidelity & Guaranty Life Insurance Company of New York
Financial Strength Rating	A-	BBB+	Not Rated	BBB+
Outlook	Stable	Positive		Positive
F&G Reinsurance Ltd
Financial Strength Rating	A-	BBB-	Not Rated	Not Rated
Outlook	Stable	Positive
F&G Life Re Ltd
Financial Strength Rating	Not Rated	BBB-	Baa2	BBB+
Outlook		Positive	Positive	Positive
*Reflects current ratings and outlooks as of date of filing

(a) Outlook reflects Rating Watch Positive

(b) Outlook reflects Review for Upgrade

(c) Outlook reflects CreditWatch Positive

A.M. Best, Fitch, Moody’s and S&P review their ratings of insurance companies from time to time. There can be no assurance that any particular rating will continue for any given period of time or that it will not be changed or withdrawn entirely if, in their judgment, circumstances so warrant. While the degree to which ratings adjustments will affect sales and persistency is unknown, we believe if our ratings were to be negatively adjusted for any reason, we could experience a material decline in the sales of our products and the persistency of our existing business. See “Item 1A. Risk Factors”.

Potential Impact of a Ratings Downgrade

The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivatives agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. Please refer to "Note 5. Derivative Financial Instruments" to our audited consolidated financial statements for disclosure around the Company's requirement to maintain minimum ratings.

If the insurance subsidiaries held net short positions against a counterparty, and the subsidiaries’ financial strength ratings were below the levels required in the ISDA agreement with the counterparty, the counterparty would demand immediate further collateralization which could negatively impact overall liquidity. Based on the fair value of our derivatives as of December 31, 2019 and December 31, 2018, we hold no net short positions against a counterparty; therefore, there is currently no potential exposure for us to post collateral.

A downgrade of the financial strength rating of one of our principal insurance subsidiaries could affect our competitive position in the insurance industry and make it more difficult for us to market our products, as potential customers may select companies with higher financial strength ratings. A downgrade of the financial strength rating could also impact the Company's borrowing costs.

15

Risk Management

Risk management is a critical part of our business. We seek to assess risk to our business through a formalized process involving (i) identifying short-term and long-term strategic and operational objectives, (ii) development of risk appetite statements that establish what the company is willing to accept in terms of risks to achieving its goals and objectives, (iii) identifying the levers that control the risk appetite of the company, (iv) establishing the overall limits of risk acceptable for a given risk driver, (v) establishing operational risk limits that are aligned with the tolerances, (vi) assigning risk limit quantification and mitigation responsibilities to individual team members within functional groups, (vii) analyzing the potential qualitative and quantitative impact of individual risks, including but not limited to stress and scenario testing covering over 8 economic and insurance related risks, (viii) mitigating risks by appropriate actions and (ix) identifying, documenting and communicating key business risks in a timely fashion.

The responsibility for monitoring, evaluating and responding to risk is assigned first to our management and employees, second to those occupying specialist functions, such as legal compliance and risk teams, and third to those occupying supervisory functions, such as internal audit and the board of directors.

In compliance with the Risk Management and Own Risk and Solvency Assessment Model Act (ORSA), FGL Insurance submitted an ORSA report to the state regulators in November 2019 to provide risk management transparency and insight in the financial strength and long-term sustainability of the Companies.

 Reinsurance

We both cede reinsurance and assume reinsurance from other insurance companies. We use reinsurance to diversify risks and earnings, to manage loss exposures, to enhance our capital position, and to manage new business volume. The effects of certain reinsurance agreements are not accounted for as reinsurance as they do not transfer the risks of the reinsured policies.

In instances where we are the ceding company, we pay a premium to a reinsurer in exchange for the reinsurer assuming a portion of our liabilities under the policies we issued and collect expense allowances in return for our administration of the ceded policies. Use of reinsurance does not discharge our liability as the ceding company because we remain directly liable to our policyholders and are required to pay the full amount of our policy obligations in the event that our reinsurers fail to satisfy their obligations. We collect reimbursement from our reinsurers when we pay claims on policies that are reinsured. In instances where we assume reinsurance from another insurance company, we accept, in exchange for a reinsurance premium, a portion of the liabilities of the other insurance company under the policies that the ceding company has issued to its policyholders.

We monitor the credit risk related to the ability of our reinsurers to honor their obligations under various agreements. To minimize the risk of credit loss on such contracts, we generally diversify our exposures among many reinsurers and limit the amount of exposure to each based on financial strength ratings, which are reviewed annually. We are able to further manage risk via funds withheld arrangements.

See “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” for further discussion on credit risk and counterparty risk.

See “Item 1A. Risk Factors” for further discussion of credit risk related to reinsurance agreements. A description of significant ceded reinsurance transactions appears below.

Wilton Re Transaction

Pursuant to the agreed upon terms, Wilton Re has reinsured a 100% quota share of certain FGL Insurance policies that are subject to redundant reserves under Regulation XXX and Guideline AXXX, as well as another block of FGL Insurance’s in-force traditional, universal life and IUL insurance policies. The effects of this agreement are accounted for as reinsurance as it satisfies the risk transfer requirements for GAAP.

Hannover Reinsurance Transaction

Effective January 1, 2017, FGL Insurance entered into a reinsurance agreement with Hannover Life Reassurance Company of America (Bermuda) Ltd. ("Hannover Re"), an unaffiliated reinsurer,  to reinsure an inforce block of its FIA and fixed deferred annuity contracts with Guaranteed Minimum Withdraw Benefit (“GMWB”) and Guaranteed Minimum Death Benefit (“GMDB”) guarantees.  In accordance with the terms of this agreement, the Company cedes 70% net retention of secondary guarantee payments in excess of account value for GMWB and GMDB guarantees. FGL Insurance and Hannover Re extended this agreement in subsequent years to include new business issued during 2017, 2018, and 2019. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP.

16

Kubera Reinsurance Transaction

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera Insurance (SAC) Ltd. ("Kubera"), an unaffiliated reinsurer, to cede certain MYGA and deferred annuity statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. The effects of this agreement are accounted for as reinsurance as it satisfies the risk transfer requirements for GAAP. Effective June 30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $185 of MYGA GAAP reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019.

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $4 billion of certain FIA statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes an 80% and 90% quota share percentage of these annuity plans for issue years 2013 through 2014 and 2007 and prior, respectively. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP. Effective June 30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $1 billion of FIA statutory reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019. The effects of the amendment are also not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP.

The CARVM Facility

Life insurance companies operating in the United States must calculate required reserves for life and annuity policies based on statutory principles. These methodologies are governed by “Regulation XXX” (applicable to term life insurance policies), “Guideline AXXX” (applicable to universal life insurance policies with secondary guarantees) and the Commissioners Annuity Reserve Valuation Method, known as “CARVM” (applicable to annuities). Under Regulation XXX, Guideline AXXX and CARVM, insurers are required to establish statutory reserves for such policies that exceed economic reserves. The industry has reduced or eliminated redundancies thereby increasing capital using a variety of techniques including reserve facilities.

Effective October 1, 2012, FGL Insurance entered into a yearly renewable term indemnity reinsurance agreement with Raven Reinsurance Company ("Raven Re"), a wholly-owned subsidiary of FGL Insurance (the “Raven Reinsurance Agreement”), pursuant to which FGL Insurance ceded a 100% quota share of its CARVM liability for annuity benefits where surrender charges are waived. To collateralize its obligations under the Raven Reinsurance Agreement, Raven Re entered into a reimbursement agreement with Nomura Bank International plc (“NBI”), an affiliate of Nomura Securities International, Inc., and FGL (the “Reimbursement Agreement”) whereby a subsidiary of NBI issued trust notes and NBI issued a $295 letter of credit that, in each case, were deposited into a reinsurance trust as collateral for Raven Re’s obligations under the Raven Reinsurance Agreement (the “NBI Facility”). Pursuant to the NBI Facility, FGL Insurance takes full credit on its statutory financial statements for the CARVM reserve ceded to Raven Re.

Effective January 1, 2019, the letter of credit facility was amended to reduce the available amount to $100 and extend the termination date to October 1, 2022, although the facility may terminate earlier, in accordance with the terms of the Reimbursement Agreement. Under the terms of the reimbursement agreement, in the event the letter of credit is drawn upon, Raven Re is required to repay the amounts utilized, and FGLH is obligated to repay the amounts utilized if Raven Re fails to make the required reimbursement. FGLH also is required to make capital contributions to Raven Re in the event that Raven Re’s statutory capital and surplus falls below certain defined levels. As of December 31, 2019 and 2018, Raven Re’s statutory capital and surplus was $33 and $20, respectively, in excess of the minimum level required under the Reimbursement Agreement.

The Front Street Reinsurance Transactions

Effective December 31, 2012, following regulatory approval, FGL Insurance entered into a coinsurance agreement (the “Cayman Reinsurance Agreement”) with FSRC, an indirect wholly-owned subsidiary of the Company. Pursuant to the Cayman Reinsurance Agreement, FSRC reinsured a 10% quota share percentage of certain FGL Insurance annuity liabilities of approximately $1 billion and the funds withheld assets are $1 billion. As of December 31, 2019, ceded reserves are $756.

Effective September 17, 2014, FGL Insurance entered into a second reinsurance treaty with FSRC whereby FGL Insurance ceded 30% of any new business of its MYGA block of business on a funds withheld basis. This treaty was subsequently terminated as to new business effective April 30, 2015, but will remain in effect for policies ceded to FSRC with an effective date between September 17, 2014 and April 30, 2015.

17

F&G Life Re Transaction

F&G Life Re Ltd (“F&G Life Re”) is our licensed reinsurer registered in Bermuda and subject to the Bermuda Insurance Act and the rules and regulations promulgated thereunder. Effective December 1, 2017, F&G Life Re and FGL Insurance entered into a modified coinsurance treaty that effectively ceded 60% of FGL Insurance's inforce to F&G Life Re and provides the ability to cede new business to F&G Life Re. Effective October 1, 2018, FGL Insurance and F&G Life Re mutually agreed to terminate this reinsurance agreement. Upon termination of the reinsurance agreement, F&G Life Re made a $1,094 extraordinary dividend to its sole shareholder, CF Bermuda Holdings Limited (“CF Bermuda”) of which $830 was contributed to FGL Insurance to support the recapture of the insurance liabilities and to allow FGL Insurance to maintain appropriate solvency ratios.  The $1,094 extraordinary dividend included $750 return of capital which was approved by the Bermuda Monetary Authority (“BMA”).

All intercompany balances have been eliminated in the preparation of the Company’s consolidated financial statements. However, these agreements have a material impact on the regulatory capital position of FGL Insurance and the effective tax rate of the Company. See “Note 13. Reinsurance” to our audited consolidated financial statements.

18

Regulation

Overview

FGL Insurance, Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”) and Raven Re are subject to comprehensive regulation and supervision in their domiciles, Iowa, New York and Vermont, respectively, and in each state in which they do business. FGL Insurance does business throughout the United States, except for New York. FGL NY Insurance only does business in New York. Raven Re is a special purpose captive reinsurance company that only provides reinsurance to FGL Insurance under the CARVM Treaty. FGL Insurance’s principal insurance regulatory authority is the IID; however, state insurance departments throughout the United States also monitor FGL Insurance’s insurance operations as a licensed insurer. The New York State Department of Financial Services (“NYDFS”) regulates the operations of FGL NY Insurance,. The purpose of these regulations is primarily to protect policyholders and beneficiaries and not general creditors and shareholders of those insurers. Many of the laws and regulations to which FGL Insurance and FGL NY Insurance are subject are regularly re-examined and existing or future laws and regulations may become more restrictive or otherwise adversely affect their operations.

Generally, insurance products underwritten by and rates used by FGL Insurance and FGL NY Insurance must be approved by the insurance regulators in each state in which they are sold. Those products are also substantially affected by federal and state tax laws. For example, changes in tax law could reduce or eliminate the tax-deferred accumulation of earnings on the deposits paid by the holders of annuities and life insurance products, which could make such products less attractive to potential purchasers. A shift away from life insurance and annuity products could reduce FGL Insurance’s and FGL NY Insurance’s income from the sale of such products, as well as the assets upon which FGL Insurance and FGL NY Insurance earn investment income. In addition, insurance products may also be subject to the Employee Retirement Income Security Act of 1974 ("ERISA").

State insurance authorities have broad administrative powers over FGL Insurance and FGL NY Insurance with respect to all aspects of the insurance business including:

• licensing to transact business;

• licensing agents;

• prescribing which assets and liabilities are to be considered in determining statutory surplus;

• regulating premium rates for certain insurance products;

• approving policy forms and certain related materials;

• determining whether a reasonable basis exists as to the suitability of the annuity purchase recommendations producers make;

• regulating unfair trade and claims practices;

• establishing reserve requirements and solvency standards;

• regulating the amount of dividends that may be paid in any year;

• regulating the availability of reinsurance or other substitute financing solutions, the terms thereof and the ability of an insurer to take credit on its financial statements for insurance ceded to reinsurers or other substitute financing solutions;

•

• fixing maximum interest rates on life insurance policy loans and minimum accumulation or surrender values; and

• regulating the type, amounts, and valuations of investments permitted, transactions with affiliates, and other matters.

Financial Regulation

State insurance laws and regulations require FGL Insurance, FGL NY Insurance and Raven Re to file reports, including financial statements, with state insurance departments in each state in which they do business, and their operations and accounts are subject to examination by those departments at any time. FGL Insurance, FGL NY Insurance and Raven Re prepare statutory financial statements in accordance with accounting practices and procedures prescribed or permitted by these departments.

The National Association of Insurance Commissioners ("NAIC") has approved a series of statutory accounting principles and various model regulations that have been adopted, in some cases with certain modifications, by all state insurance departments. These statutory principles are subject to ongoing change and modification. Moreover, compliance with any particular regulator’s interpretation of a legal or accounting issue may not result in compliance with another regulator’s interpretation of the same issue, particularly when compliance is judged in hindsight. Any particular regulator’s

19

interpretation of a legal or accounting issue may change over time to FGL Insurance’s or FGL NY Insurance’s detriment, or changes to the overall legal or market environment, even absent any change of interpretation by a particular regulator, may cause FGL Insurance and FGL NY Insurance to change their views regarding the actions they need to take from a legal risk management perspective, which could necessitate changes to FGL Insurance’s or FGL NY Insurance’s practices that may, in some cases, limit their ability to grow and improve profitability.

State insurance departments conduct periodic examinations of the books and records, financial reporting, policy and rate filings, market conduct and business practices of insurance companies domiciled in their states, generally once every three to five years. Examinations are generally carried out in cooperation with the insurance departments of other states under guidelines promulgated by the NAIC. State insurance departments also have the authority to conduct examinations of non-domiciliary insurers that are licensed in their states.

The IID completed a routine examination of FGL Insurance for the five year period ending 2017, and found no material deficiencies and proposed no adjustments to the financial statements as filed. The NYDFS completed a routine financial examination of FGL NY Insurance for the three year period ended December 31, 2012, and found no material deficiencies and proposed no adjustments to the financial statements as filed. The Vermont Department of Financial Regulation has completed a routine financial examination of Raven Re for the five year period ending December 31, 2017, and found no material deficiencies and proposed no adjustments to the financial statements as filed.

Dividend and Other Distribution Payment Limitations

The Iowa insurance law and the New York insurance law regulate the amount of dividends that may be paid in any year by FGL Insurance and FGL NY Insurance, respectively. Pursuant to an order issued by the Iowa Commissioner on November 28, 2017 in connection with the approval of the Merger Agreement, FGL Insurance shall not pay any dividend or other distribution to shareholders prior to November 28, 2021 without the prior approval of the Iowa Commissioner. Additionally, F&G Life Re will not, for a period of three (3) years from November 28, 2017, declare, set aside or distribute any dividends or distributions other than solely (a) dividends or distributions that would be permitted in accordance with Section 521A.5(3) of the Iowa Code if F&G Life Re were a life insurance company domesticated in Iowa, upon prior written notice to the Iowa Commissioner, but limited only to the amount necessary to service interest payments on outstanding indebtedness and other obligations of CF Bermuda and FGLH, and (b) dividends or distributions upon written notice to, and with the prior written approval of, the Iowa Commissioner.

Each year, FGL NY Insurance may pay a certain limited amount of ordinary dividends or other distributions without being required to obtain the prior consent of or the NYDFS, respectively. However, to pay any dividends or distributions (including the payment of any dividends or distributions for which prior consent is not required), FGL NY Insurance must provide advance written notice to the NYDFS, respectively.

Pursuant to Iowa insurance law, ordinary dividends are payments, together with all other such payments within the preceding twelve months, that do not exceed the greater of (i) 10% of FGL Insurance’s statutory surplus as regards policyholders as of December 31 of the preceding year; or (ii) the net gain from operations of FGL Insurance (excluding realized capital gains) for the 12-month period ending December 31 of the preceding year.

Dividends in excess of FGL Insurance’s ordinary dividend capacity are referred to as extraordinary and require prior approval of the Iowa Commissioner. In deciding whether to approve a request to pay an extraordinary dividend, Iowa insurance law requires the Iowa Commissioner to consider the effect of the dividend payment on FGL Insurance’s surplus and financial condition generally and whether the payment of the dividend will cause FGL Insurance to fail to meet its required RBC ratio. Dividends may only be paid out of statutory earned surplus.

In 2019, upon approval by the Iowa Commissioner, FGL Insurance declared and paid extraordinary dividends of $100 to its Parent, FGLH.

In recent calendar years, the Company's insurance subsidiaries have had the dividend capacity and paid ordinary dividends to us as set forth in this table:

	2019		2018		2017		2016		2015
FGL Insurance ordinary dividend capacity	$	—	$	—	$	132	$	124	$	121
FGL Insurance ordinary dividends paid	—		—		25		—		—
F&G Life Re dividend capacity	1		1		201		—		—
F&G Re dividend capacity	74		10		—		—		—
FSRC dividend capacity	—		—		—		—		—

Any payment of dividends by FGL Insurance is subject to the regulatory restrictions described above and the approval of such payment by the board of directors of FGL Insurance, which must consider various factors, including general

20

economic and business conditions, tax considerations, FGL Insurance’s strategic plans, financial results and condition, FGL Insurance’s expansion plans, any contractual, legal or regulatory restrictions on the payment of dividends and its effect on RBC and such other factors the board of directors of FGL Insurance considers relevant. For example, payments of dividends could reduce FGL Insurance’s RBC and financial condition and lead to a reduction in FGL Insurance’s financial strength rating. See section titled "Risks Relating to Our Business-A financial strength ratings downgrade, potential downgrade, or any other negative action by a rating agency could make our products less attractive and increase our cost of capital, and thereby adversely affect our financial condition and results of operations” in Item 1A. Risk Factors.

FGL NY Insurance has historically not paid dividends.

See sections titled "Bermuda Regulatory Framework-Restrictions on Dividends and Distributions" and "Cayman Islands Regulation" in Item 1. Business for further discussion on Bermuda and Cayman Island, respectively, dividend limitations that impact F&G Re, F&G Life Re and FSRC.

 Surplus and Capital

FGL Insurance and FGL NY Insurance are subject to the supervision of the regulators in states where they are licensed to transact business. Regulators have discretionary authority in connection with the continuing licensing of these entities to limit or prohibit sales to policyholders if, in their judgment, the regulators determine that such entities have not maintained the minimum surplus or capital or that the further transaction of business will be hazardous to policyholders.

Risk-Based Capital

In order to enhance the regulation of insurers’ solvency, the NAIC adopted a model law to implement RBC requirements for life, health and property and casualty insurance companies. All states have adopted the NAIC’s model law or a substantially similar law. RBC is used to evaluate the adequacy of capital and surplus maintained by an insurance company in relation to risks associated with: (i) asset risk, (ii) insurance risk, (iii) interest rate risk, and (iv) business risk. In general, RBC is calculated by applying factors to various asset, premium and reserve items, taking into account the risk characteristics of the insurer. Within a given risk category, these factors are higher for those items with greater underlying risk and lower for items with lower underlying risk. The RBC formula is used as an early warning regulatory tool to identify possible inadequately capitalized insurers for purposes of initiating regulatory action, and not as a means to rank insurers generally. Insurers that have less statutory capital than the RBC calculation requires are considered to have inadequate capital and are subject to varying degrees of regulatory action depending upon the level of capital inadequacy. As of the most recent annual statutory financial statements filed with insurance regulators, the RBC ratios for FGL Insurance and FGL NY Insurance each exceeded the minimum RBC requirements.

It is desirable to maintain an RBC ratio in excess of the minimum requirements in order to maintain or improve our financial strength ratings. Our historical RBC ratios for FGL Insurance are presented in the table below. See section titled “Risks Relating to Our Business-A financial strength ratings downgrade, potential downgrade, or any other negative action by a rating agency, could make our product offerings less attractive and increase our cost of capital, and thereby adversely affect our financial condition and results of operations” in Item 1A. Risk Factors.

	RBC  Ratio
As of:
December 31, 2019	452	%
December 31, 2018	447	%
December 31, 2017	499	%
December 31, 2016	412	%
December 31, 2015	401	%

See section titled "Bermuda Regulatory Framework-ECR and Bermuda Solvency Capital Requirements" in Item 1. Business for a discussion on Bermuda regulatory requirements that impact F&G Life Re.

Insurance Regulatory Information System Tests

The NAIC has developed a set of financial relationships or tests known as the Insurance Regulatory Information System ("IRIS") to assist state regulators in monitoring the financial condition of U.S. insurance companies and identifying companies that require special attention or action by insurance regulatory authorities. A ratio falling outside the prescribed “usual range” is not considered a failing result. Rather, unusual values are viewed as part of the regulatory early monitoring system. In many cases, it is not unusual for financially sound companies to have one or more ratios that fall outside the usual range. Insurance companies generally submit data annually to the NAIC, which in turn analyzes the data using

21

prescribed financial data ratios, each with defined “usual ranges”. Generally, regulators will begin to investigate or monitor an insurance company if its ratios fall outside the usual ranges for four or more of the ratios. IRIS consists of a statistical phase and an analytical phase whereby financial examiners review insurers’ annual statements and financial ratios. The statistical phase consists of 12 key financial ratios based on year-end data that are generated from the NAIC database annually; each ratio has a “usual range” of results. As of December 31, 2019, FGL Insurance, FGL NY Insurance and Raven Re had two, zero and two ratios outside the usual range, respectively.  The IRIS ratios for total affiliated investments to capital and surplus and change in premium for FGL Insurance were outside the usual range.  The IRIS ratio for change in premium and adequacy of investment income for Raven Re were outside the usual range.

In all instances in prior years, regulators have been satisfied upon follow-up that no regulatory action was required. FGL Insurance, FGL NY Insurance and Raven Re are not currently subject to regulatory restrictions based on these ratios.

Insurance Reserves

State insurance laws require insurers to analyze the adequacy of reserves. The respective appointed actuaries for FGL Insurance, FGL NY Insurance and Raven Re must each submit an opinion on an annual basis that their respective reserves, when considered in light of the respective assets FGL Insurance, FGL NY Insurance and Raven Re hold with respect to those reserves, make adequate provision for the contractual obligations and related expenses of FGL Insurance, FGL NY Insurance and Raven Re. FGL Insurance, FGL NY Insurance and Raven Re have filed all of the required opinions with the insurance departments in the states in which they do business.

Credit for Reinsurance Regulation

States regulate the extent to which insurers are permitted to take credit on their financial statements for the financial obligations that the insurers cede to reinsurers. Where an insurer cedes obligations to a reinsurer which is neither licensed nor accredited by the state insurance department, the ceding insurer is not permitted to take such financial statement credit unless the unlicensed or unaccredited reinsurer secures the liabilities it will owe under the reinsurance contract. Under the laws regulating credit for reinsurance issued by such unlicensed or unaccredited reinsurers, the permissible means of securing such liabilities are (i) the establishment of a trust account by the reinsurer to hold certain qualifying assets in a qualified U.S. financial institution, such as a member of the Federal Reserve, with the ceding insurer as the exclusive beneficiary of such trust account with the unconditional right to demand, without notice to the reinsurer, that the trustee pay over to it the assets in the trust account equal to the liabilities owed by the reinsurer; (ii) the posting of an unconditional and irrevocable letter of credit by a qualified U.S. financial institution in favor of the ceding company allowing the ceding company to draw upon the letter of credit up to the amount of the unpaid liabilities of the reinsurer and (iii) a “funds withheld” arrangement by which the ceding company withholds transfer to the reinsurer of the assets which support the liabilities to be owed by the reinsurer, with the ceding insurer retaining title to and exclusive control over such assets. In addition, on January 1, 2014, the NAIC Model Credit for Reinsurance Act became effective in Iowa, which adds the concept of “certified reinsurer”, whereby a ceding insurer may take financial statement credit for reinsurance provided by an unaccredited and unlicensed reinsurer which has been certified by the Iowa Commissioner. The Iowa Commissioner certifies reinsurers based on several factors, including their financial strength ratings, and imposes collateral requirements based on such factors. FGL Insurance and FGL NY Insurance are subject to such credit for reinsurance rules in Iowa and New York, respectively, insofar as they enter into any reinsurance contracts with reinsurers which are neither licensed nor accredited in Iowa and New York, respectively.

Insurance Holding Company Regulation

As the parent company of FGL Insurance and the indirect parent company of FGL NY Insurance, we and entities affiliated for purposes of insurance regulation are subject to the insurance holding company laws in Iowa and New York. These laws generally require each insurance company directly or indirectly owned by the holding company to register with the insurance department in the insurance company’s state of domicile and to furnish annually financial and other information about the operations of companies within the holding company system. Generally, all transactions between insurers and affiliates within the holding company system are subject to regulation and must be fair and reasonable, and may require prior notice and approval or non-disapproval by its domiciliary insurance regulator.

Most states, including Iowa and New York, have insurance laws that require regulatory approval of a direct or indirect change of control of an insurer or an insurer’s holding company. Such laws prevent any person from acquiring control, directly or indirectly, of FGL Holdings, CF Bermuda, F&G Re, F&G Life Re, FGLH, FGL Insurance or FGL NY Insurance unless that person has filed a statement with specified information with the insurance regulators and has obtained their prior approval. In addition, investors deemed to have a direct or indirect controlling interest are required to make regulatory filings and respond to regulatory inquiries. Under most states’ statutes, including those of Iowa and New York, acquiring 10% or more of the voting stock of an insurance company or its parent company is presumptively considered a change of

22

control, although such presumption may be rebutted. Accordingly, any person who acquires 10% or more of our voting securities or that of FGL Holdings, CF Bermuda, F&G Re, F&G Life Re, FGLH, FGL Insurance or FGL NY Insurance without the prior approval of the insurance regulators of Iowa and New York will be in violation of those states’ laws and may be subject to injunctive action requiring the disposition or seizure of those securities by the relevant insurance regulator or prohibiting the voting of those securities and to other actions determined by the relevant insurance regulator.

Insurance Guaranty Association Assessments

Each state has insurance guaranty association laws under which insurers doing business in the state may be assessed by state insurance guaranty associations for certain obligations of insolvent insurance companies to policyholders and claimants. Typically, states assess each member insurer in an amount related to the member insurer’s proportionate share of the business written by all member insurers in the state. Although no prediction can be made as to the amount and timing of any future assessments under these laws, FGL Insurance and FGL NY Insurance have established reserves that they believe are adequate for assessments relating to insurance companies that are currently subject to insolvency proceedings.

Market Conduct Regulation

State insurance laws and regulations include numerous provisions governing the marketplace activities of insurers, including provisions governing the form and content of disclosure to consumers, illustrations, advertising, sales and complaint process practices. State regulatory authorities generally enforce these provisions through periodic market conduct examinations. In addition, FGL Insurance and FGL NY Insurance must file, and in many jurisdictions and for some lines of business obtain regulatory approval for, rates and forms relating to the insurance written in the jurisdictions in which they operate. FGL Insurance is currently the subject of four ongoing market conduct examinations in various states. Market conduct examinations can result in monetary fines or remediation and generally require FGL Insurance to devote significant resources to the management of such examinations. FGL Insurance does not believe that any of the current market conduct examinations it is subject to will result in any fines or remediation orders that will be material to its business.

Regulation of Investments

FGL Insurance, FGL NY Insurance, and Raven Re are subject to state laws and regulations that require diversification of their investment portfolios and limit the amount of investments in certain asset categories, such as below investment grade fixed income securities, equity, real estate, other equity investments and derivatives. Failure to comply with these laws and regulations would cause investments exceeding regulatory limitations to be treated as either non-admitted assets for purposes of measuring surplus or as not qualified as an asset held for reserve purposes and, in some instances, would require divestiture or replacement of such non-qualifying investments. We believe that the investment portfolios of FGL Insurance, FGL NY Insurance, and Raven Re as of December 31, 2019 complied in all material respects with such regulations.

Bermuda Regulation

F&G Life Re and F&G Re are Bermuda exempted companies incorporated under the Companies Act 1981, as amended (the “Companies Act”) and registered as Class C insurers under the Insurance Act 1978, as amended, and its related regulations (the “Insurance Act”). Each of F&G Life Re and F&G Re are regulated by the BMA.

The Insurance Act provides that no person may carry on an insurance business in or from within Bermuda unless registered as an insurer under the Insurance Act by the BMA. In deciding whether to grant registration, the BMA has broad discretion to act as it thinks fit in the public interest. The BMA is required by the Insurance Act to determine whether the applicant is a fit and proper body to be engaged in the insurance business and, in particular, whether it has, or has available to it, adequate knowledge and expertise. The registration of an applicant as an insurer is subject to the insurer complying with the terms of its registration and such other conditions as the BMA may impose at any time. The Insurance Act also grants to the BMA powers to supervise, investigate and intervene in the affairs of insurance companies. Bermuda has been awarded full equivalence for commercial insurers under Europe’s Solvency II regime applicable to insurance companies, which regime came into effect on January 1, 2016.

All insurers are required to implement corporate governance policies and processes as the BMA considers appropriate given the nature, size, complexity and risk profile of the insurer and all insurers, on an annual basis, are required to deliver a declaration to the BMA confirming whether or not they meet the minimum criteria for registration under the Insurance Act.

All insurers are required to comply with the Bermuda Insurance Code of Conduct (the “Bermuda Insurance Code”), which is a codification of best practices for insurers provided by the BMA, and to submit annually to the BMA with its statutory financial return a declaration of compliance confirming it complies with the Bermuda Insurance Code of Conduct.

23

The BMA utilizes a risk-based approach when it comes to licensing and supervising insurance and reinsurance companies. As part of the BMA’s risk-based system, an assessment of the inherent risks within each particular class of insurer or reinsurer is used to determine the limitations and specific requirements that may be imposed. Thereafter the BMA keeps its analysis of relative risk within individual institutions under review on an ongoing basis, including through the scrutiny of audited financial statements, and, as appropriate, meeting with senior management during onsite visits.

Bermuda Regulatory Framework

The Insurance Act imposes on Bermuda insurance companies solvency and liquidity standards, as well as auditing and reporting requirements. Certain significant aspects of the Bermuda insurance regulatory framework are set forth below.

Minimum Solvency Margin. The Insurance Act provides that the value of the assets of an insurer must exceed the value of its liabilities by an amount greater than its prescribed minimum solvency margin.

The minimum solvency margin that must be maintained by a Class C insurer is the greater of: (i) $500,000; (ii) 1.5% of assets; and (iii) 25% of that insurer’s enhanced capital requirement (“ECR”). An insurer may file an application under the Insurance Act to waive the aforementioned requirements.

ECR and Bermuda Solvency Capital Requirements (“BSCR”). Class C insurers are required to maintain available capital and surplus at a level equal to or in excess of the applicable ECR, which is established by reference to either the applicable BSCR model or an approved internal capital model. Furthermore, to enable the BMA to better assess the quality of the insurer’s capital resources, a Class C insurer is required to disclose the makeup of its capital in accordance with its 3-tiered capital system. An insurer may file an application under the Insurance Act to have the aforementioned ECR requirements waived.

Restrictions on Dividends and Distributions. In addition to the requirements under the Companies Act (as discussed below), the Insurance Act limits the maximum amount of annual dividends and distributions that may be paid or distributed by F&G Life Re and F&G Re without prior regulatory approval.

Each of F&G Life Re and F&G Re is prohibited from declaring or paying a dividend if it fails to meet its minimum solvency margin, or ECR, or if the declaration or payment of such dividend would cause such breach. If F&G Life Re or F&G Re were to fail to meet its minimum solvency margin on the last day of any financial year, it would be prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA.

In addition, as Class C insurers, each of F&G Life Re and F&G Re must: (i) not make any payment from its long-term business fund for any purpose other than a purpose of the insurer’s long-term business, except in so far as such payment can be made out of any surplus certified by the insurer’s approved actuary to be available for distribution otherwise than to policyholders; and (ii) not declare or pay a dividend to any person other than a policyholder unless the value of the assets of its long-term business fund, as certified by the insurer’s approved actuary, exceeds the extent (as to certified) of the liabilities of the insurer’s long-term business. In the event a dividend complies with the above, each of F&G Life Re and F&G Re must ensure the amount of any such dividend does not exceed the aggregate of (i) that excess and (ii) any other funds properly available for the payment of dividend, being funds arising out of business of the insurer other than long-term business.

Furthermore, as Class C insurers, each of F&G Life Re and F&G Re must not declare or pay a dividend to any person other than a policyholder unless the value of the assets of the insurer, as certified by its approved actuary, exceeds its liabilities (as so certified) by the greater of its margin of solvency or its ECR and the amount of any such dividend shall not exceed that excess.

The Companies Act also limits F&G Life Re’s and F&G Re’s ability to pay dividends and make distributions to its shareholders. Each of F&G Life Re and F&G Re is not permitted to declare or pay a dividend, or make a distribution out of its contributed surplus, if it is, or would after the payment be, unable to pay its liabilities as they become due or if the realizable value of its assets would be less than its liabilities.

Reduction of Capital.   Each of F&G Life Re and F&G Re may not reduce its total statutory capital by 15% or more, as set out in its previous year’s financial statements, unless it has received the prior approval of the BMA. Total statutory capital consists of the insurer’s paid in share capital, its contributed surplus (sometimes called additional paid in capital) and any other fixed capital designated by the BMA as statutory capital.

Cayman Islands Regulation

FSRC is licensed as a class B insurer in the Cayman Islands by the Cayman Islands Monetary Authority (“CIMA”). As a regulated insurance company, FSRC is subject to the supervision of CIMA and CIMA may at any time direct FSRC, in relation to a policy, a line of business or the entire business, to cease or refrain from committing an act or pursing a course of conduct and to perform such acts as in the opinion of CIMA are necessary to remedy or ameliorate the situation.

24

The laws and regulations of the Cayman Islands require that, among other things, FSRC maintain minimum levels of statutory capital, surplus and liquidity, meet solvency standards, submit to periodic examinations of its financial condition and restrict payments of dividends and reductions of capital. Statutes, regulations and policies that FSRC is subject to may also restrict the ability of FSRC to write insurance and reinsurance policies, make certain investments and distribute funds. Any failure to meet the applicable requirements or minimum statutory capital requirements could subject it to further examination or corrective action by CIMA, including restrictions on dividend payments, limitations on our writing of additional business or engaging in finance activities, supervision or liquidation.

Privacy Regulation

Our operations are subject to certain federal and state laws and regulations that require financial institutions and other businesses to protect the security and confidentiality of personal information, including health-related and customer information, and to notify customers and other individuals about their policies and practices relating to their collection and disclosure of health-related and customer information and their practices relating to protecting the security and confidentiality of such information. These laws and regulations require notice to affected individuals, law enforcement agencies, regulators and others if there is a breach of the security of certain personal information, including social security numbers, and require holders of certain personal information to protect the security of the data. Our operations are also subject to certain federal regulations that require financial institutions and creditors to implement effective programs to detect, prevent, and mitigate identity theft. In addition, our ability to make telemarketing calls and to send unsolicited e-mail or fax messages to consumers and customers and our uses of certain personal information, including consumer report information, are regulated. Federal and state governments and regulatory bodies may be expected to consider additional or more detailed regulation regarding these subjects and the privacy and security of personal information.

FIAs

In recent years, the U.S. Securities and Exchange Commission (“SEC”) and state securities regulators have questioned whether FIAs, such as those sold by us, should be treated as securities under the federal and state securities laws rather than as insurance products exempted from such laws. Treatment of these products as securities would require additional registration and licensing of these products and the agents selling them, as well as cause us to seek additional marketing relationships for these products, any of which may impose significant restrictions on our ability to conduct operations as currently operated. Under the Dodd-Frank Act, annuities that meet specific requirements, including requirements relating to certain state suitability rules, are specifically exempted from being treated as securities by the SEC. We expect the types of FIAs that FGL Insurance and FGL NY Insurance sell will meet these requirements and therefore are exempt from being treated as securities by the SEC and state securities regulators. However, there can be no assurance that federal or state securities laws or state insurance laws and regulations will not be amended or interpreted to impose further requirements on FIAs.

The Dodd-Frank Act

The Dodd-Frank Act makes sweeping changes to the regulation of financial services entities, products and markets. Certain provisions of the Dodd-Frank Act are or may become applicable to us, our competitors or those entities with which we do business, including, but not limited to:

• the establishment of federal regulatory authority over derivatives;

• the establishment of consolidated federal regulation and resolution authority over systemically important financial services firms;

• the establishment of the Federal Insurance Office;

• changes to the regulation of broker dealers and investment advisors;

• changes to the regulation of reinsurance;

• changes to regulations affecting the rights of shareholders;

• the imposition of additional regulation over credit rating agencies;

•

• the imposition of concentration limits on financial institutions that restrict the amount of credit that may be extended to a single person or entity; and

• the clearing of derivative contracts.

Numerous provisions of the Dodd-Frank Act require the adoption of implementing rules or regulations, some of which have been implemented. In addition, the Dodd-Frank Act mandates multiple studies, which could result in additional legislation or regulation applicable to the insurance industry, us, our competitors or those entities with which we do business.

25

Legislative or regulatory requirements imposed by or promulgated in connection with the Dodd-Frank Act may impact us in many ways, including, but not limited to:

• placing us at a competitive disadvantage relative to our competition or other financial services entities;

• changing the competitive landscape of the financial services sector or the insurance industry;

• making it more expensive for us to conduct our business;

• requiring the reallocation of significant company resources to government affairs;

• increasing our legal and compliance related activities and the costs associated therewith; or

• otherwise having a material adverse effect on the overall business climate as well as our financial condition and results of operations.

Until various studies are completed and final regulations are promulgated pursuant to the Dodd-Frank Act, the full impact of the Dodd-Frank Act on investments, investment activities and insurance and annuity products of FGL Insurance and FGL NY Insurance remains unclear.

ERISA

We may offer certain insurance and annuity products to employee benefit plans governed by ERISA and/or the Code, including group annuity contracts designated to fund tax-qualified retirement plans. ERISA and the Code provide (among other requirements) standards of conduct for employee benefit plan fiduciaries, including investment managers and investment advisers with respect to the assets of such plans, and holds fiduciaries liable if they fail to satisfy fiduciary standards of conduct.

In March 2018, the United States Fifth Circuit Court of Appeals formally vacated the U. S. Department Labor “Fiduciary Rule” which would have imposed fiduciary duties upon insurance agents selling Individual Retirement Account (IRA) annuities and would have potentially had a material impact on the Company, its products, distribution, and business model. Since then, in June 2019, the U.S. Securities and Exchange Commission (SEC) adopted Regulation Best Interest imposing new sales practice standards on securities brokers, which does not directly impact the Company or its distributors, but gives impetus for the National Association of Insurance Commissioners (NAIC) and individual states to consider best interest proposals for insurance sales. The NAIC adopted an amended Suitability in Annuity Transactions Model Regulation in February 2020 incorporating a requirement that agents act in the best interest of consumers without putting their own financial interests or insurer’s interests ahead of consumer interests. It is expected individual states may soon begin to consider and adopt the NAIC model regulation. FGL NY Insurance already modified certain new business processes in response to the New York Department of Financial Services (NYDFS) best interest rule despite relatively low sales in New York. Management is following a legal challenge to nullify the NYDFS rule and will continue to monitor action by other state or federal agencies to implement sales practice rules affecting insurance agents selling fixed insurance or annuity products.

The SECURE Act

New and recently passed legislation may also impact the industry in which we compete. For example, the Setting Every Community Up for Retirement Enhancement Act of 2019, Pub.L. 116-94 (the “SECURE Act”), which took effect January 1, 2020, creates an opportunity for us and our competitors to pursue sales to employer retirement plan sponsors as well as our traditional customers. In addition, we and our competitors may implement operational changes to adapt to the effect of the new legislation. See section titled “The Setting Every Community Up for Retirement Enhancement Act of 2019, may impact our business and the markets in which we compete” in Item 1A. Risk Factors.

26

Employees

As of December 31, 2019, the Company had 352 employees. We believe that we have a good relationship with our employees.

FGL Holdings Available Information

The Company maintains an Internet website at http://www.fglife.bm. The Company’s Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and amendments to those reports filed or furnished pursuant to Sections 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) are made available, free of charge, on or through the “Investor Relations” portion of our Internet website as soon as reasonably practicable after we file them with, or furnish them to, the SEC. The information contained on or connected to our website is not incorporated by reference into this Annual Report on Form 10-K and should not be considered part of this or any other report filed with the SEC. The SEC maintains a website at http://www.sec.gov that contains reports, proxy statements, information statements and other information regarding SEC registrants, including the Company.

27

Item 1A. Risk Factors

In addition to the other information set forth in this Annual Report on Form 10-K, you should carefully consider the following factors which could have a material adverse effect on our business, financial condition, results of operations or stock price. The risks below are not the only risks we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial may also adversely affect our business, financial condition.

Risks relating to economic conditions, market conditions and investments

Conditions in the economy generally could adversely affect our business, results of operations and financial condition.

Our results of operations are materially affected by conditions in the U.S. economy. Adverse economic conditions may result in a decline in revenues and/or erosion of our profit margins. In addition, in the event of extreme prolonged market events and economic downturns we could incur significant losses. Even in the absence of a market downturn we are exposed to substantial risk of loss due to market volatility.

Factors such as consumer spending, business investment, government spending, the volatility and strength of the capital markets, investor and consumer confidence, foreign currency exchange rates and inflation levels all affect the business and economic environment and, ultimately, the amount and profitability of our business. In an economic downturn characterized by higher unemployment, lower family income, negative investor sentiment and lower consumer spending, the demand for our insurance products could be adversely affected. Under such conditions, we may also experience an elevated incidence of policy lapses, policy loans, withdrawals and surrenders. In addition, our investments could be adversely affected as a result of deteriorating financial and business conditions affecting the issuers of the securities in our investment portfolio.

Concentration in certain states for the distribution of our products may subject us to losses attributable to economic downturns or catastrophes in those states.

Our top five states for the distribution of our products are California, Texas, Florida, New Jersey and Arizona. Any adverse economic developments or catastrophes in these states could have an adverse impact on our business.

Interest rate fluctuations could adversely affect our business, financial condition, liquidity, results of operations and cash flows.

Interest rate risk is a significant market risk as our business involves issuing interest rate sensitive obligations backed primarily by investments in fixed income assets. For the past several years interest rates have remained at or near historically low levels. The prolonged period of low rates exposes us to the risk of not achieving returns sufficient to meet our earnings targets and/or our contractual obligations. Furthermore, low or declining interest rates may reduce the rate of policyholder surrenders and withdrawals on our life insurance and annuity products, thus increasing the duration of the liabilities, creating asset and liability duration mismatches and increasing the risk of having to reinvest assets at yields below the amounts required to support our obligations. Lower interest rates may also result in decreased sales of certain insurance products, negatively impacting our profitability from new business.

During periods of increasing interest rates we may offer higher crediting rates on interest-sensitive products, such as universal life insurance and fixed annuities, and we may increase crediting rates on in-force products to keep these products competitive. We may be required to accept lower spread income (the difference between the returns we earn on our investments and the amounts we credit to contractholders) thus reducing our profitability, as returns on our portfolio of invested assets may not increase as quickly as current interest rates. Rapidly rising interest rates may also expose us to the risk of financial disintermediation which is an increase in policy surrenders, withdrawals and requests for policy loans as customers seek to achieve higher returns elsewhere requiring us to liquidate assets in an unrealized loss position. If we experience unexpected withdrawal activity, we could exhaust our liquid assets and be forced to liquidate other less liquid assets such as limited partnership investments. We may have difficulty selling these investments in a timely manner and/or be forced to sell them for less than we otherwise would have been able to realize, which could have a material adverse effect on our business, financial condition and results of operations. We have developed and maintain asset liability management (“ALM”) programs and procedures designed to mitigate interest rate risk by matching asset cash flows to expected liability cash flows. In addition, we assess surrender charges on withdrawals in excess of allowable penalty-free amounts that occur during the surrender charge period. There can be no assurance actual withdrawals, contract benefits, and maturities will

28

match our estimates. Despite our efforts to reduce the impact of rising interest rates, we may be required to sell assets to raise the cash necessary to respond to an increase in surrenders, withdrawals and loans, thereby realizing capital losses on the assets sold.

Fixed maturities that are classified as available-for-sale (‘‘AFS’’) are reported within the audited consolidated financial statements at fair value. Rising interest rates would cause a decrease in the value of financial assets held at fair value on our consolidated balance sheets. Unrealized gains or losses on AFS securities are recognized as a component of accumulated other comprehensive income (‘‘AOCI’’) and are, therefore, excluded from net income. The accumulated change in fair value of the AFS securities is recognized in net income when the gain or loss is realized upon the sale of the asset or in the event that the decline in fair value is determined to be other than temporary (referred to as an other-than-temporary impairment).

We may experience spread income compression, and a loss of anticipated earnings, if credited interest rates are increased on renewing contracts in an effort to decrease or manage withdrawal activity. Our expectation for future spread income is an important component in amortization of deferred acquisition costs (“DAC”), deferred sales inducements ("DSI"), and value of business acquired (“VOBA”) under U.S. GAAP. Significant reductions in spread income may cause us to accelerate DAC, DSI, and VOBA amortization. In addition, certain statutory capital and reserve requirements are based on formulas or models that consider interest rates and a prolonged period of low interest rates may increase the statutory capital we are required to hold as well as the amount of assets we must maintain to support statutory reserves.

Equity market volatility could negatively impact our business.

The estimated cost of providing GMWB associated with our annuity products incorporates various assumptions about the overall performance of equity markets over certain time periods. Periods of significant and sustained downturns in equity markets or increased equity volatility could result in an increase in the valuation of the future policy benefit or policyholder account balance liabilities associated with such products, resulting in a reduction in our revenues and net income. The rate of amortization of DAC and VOBA relating to FIA products could also increase if equity market performance is worse than assumed and have a materially adverse impact on our results of operations and financial condition.

Our investments are subject to market and credit risks. These risks could be heightened during periods of extreme volatility or disruption in financial and credit markets.

Our invested assets and derivative financial instruments are subject to risks of credit defaults and changes in market values. Periods of extreme volatility or disruption in the financial and credit markets could increase these risks. Changes in interest rates and credit spreads could cause market price and cash flow variability in the fixed income instruments in our investment portfolio. Significant volatility and lack of liquidity in the credit markets could cause issuers of the fixed-income securities we own to default on either principal or interest payments. Additionally, market price valuations may not accurately reflect the underlying expected cash flows of securities within our investment portfolio.

The value of our mortgage-backed securities and our commercial and residential mortgage loan investments depends in part on the financial condition of the borrowers and tenants for the properties underlying those investments, as well as general and specific economic trends affecting the overall default rate. We are also subject to the risk that cash flows resulting from the payments on pools of mortgages that serve as collateral underlying the mortgage-backed securities we own may differ from our expectations in timing or size. Any event reducing the estimated fair value of these securities, other than on a temporary basis, could have an adverse effect on our business, results of operations and financial condition.

We are subject to the credit risk of our counterparties, including companies with whom we have reinsurance agreements or we have purchased call options.

Our insurance subsidiaries cede material amounts of insurance and transfer related assets and certain liabilities to other insurance companies through reinsurance. Accordingly, we bear credit risk with respect to our reinsurers. The failure, insolvency, inability or unwillingness of any reinsurer to pay under the terms of reinsurance agreements with us could materially adversely affect our business, financial condition and results of operations. We regularly monitor the credit rating and performance of our reinsurance parties. Wilton Re represents our largest reinsurance counterparty exposure. See section titled “Reinsurance-Wilton Re Transaction” in Item 1. Business.

We are also exposed to credit loss in the event of non-performance by our counterparties on call options. We seek to reduce the risk associated with such agreements by purchasing such options from large, well-established

29

financial institutions. There can be no assurance we will not suffer losses in the event of counterparty non-performance. See "Note 5. Derivative Financial Instruments" to our audited consolidated financial statements for the balances of collateral posted by our counterparties and further discussion of credit risk.

The market price of our ordinary shares may be volatile and could decline impairing our ability to raise capital.

The market price of our ordinary shares may fluctuate significantly in response to various factors, some of which are beyond our control. In addition to the factors discussed in this “Risk Factors” section and elsewhere in this Form 10-K, various factors that could affect our stock price are:

• domestic and international political and economic factors unrelated to our performance;

• actual or anticipated fluctuations in our quarterly operating results;

• changes in or failure to meet publicly disclosed expectations as to our future financial performance;

• changes in securities analysts’ estimates of our financial performance, incomplete research and reports by industry analysts, or misleading or unfavorable research about our business;

• action by institutional shareholders or other large shareholders, including sales of large blocks of ordinary shares;

• speculation in the press or investment community;

• changes in investor perception of us and our industry;

• changes in market valuations or earnings of similar companies;

• announcements by us or our competitors of significant products, contracts, acquisitions or strategic partnerships;

• changes in our capital structure, such as future sales of our ordinary shares or other securities;

• future offerings of debt or equity securities that rank senior to our ordinary shares;

• changes in applicable laws, rules or regulations, regulatory actions affecting us and other dynamics; and

• additions or departures of key personnel.

Risks relating to the Pending Transaction with Fidelity National Financial, Inc. (FNF)

Completion of the Mergers is subject to the satisfaction of certain conditions, including regulatory and shareholder approvals, and there can be no assurances as to whether and when it may be completed.

On February 7, 2020, we announced that we had entered into the FNF Merger Agreement, by and among the Company, FNF, Merger Sub I and Merger Sub II. Upon the terms and subject to the conditions set forth in the FNF Merger Agreement, at the time of the closing of the transactions contemplated by the FNF Merger Agreement: (i) Merger Sub I will be merged with and into the Company with the Company surviving the First Merger and becoming a wholly owned subsidiary of FNF as a result of the First Merger in accordance with the CICL; and (ii) immediately following the First Merger, the Surviving Company will be merged with and into Merger Sub II with Merger Sub II surviving the Second Merger and remaining a wholly owned subsidiary of FNF as a result of the Second Merger in accordance with the CICL. Please see “Pending Transaction with Fidelity National Financial, Inc.” under “Item 1 Business” above for further discussion of the Mergers.

There can be no assurance that the proposed Mergers will be consummated. Consummation of the Mergers is subject to the satisfaction or waiver of customary conditions on or prior to the Closing Date, including, among other things, (i) the adoption of the FNF Merger Agreement, the Mergers and the other transactions contemplated thereby by the affirmative vote of the holders of ordinary shares of the Company representing at least two-thirds of the ordinary shares of the Company present and voting in person or by proxy as a single class at the shareholders’ meeting in accordance with the CICL and the Amended and Restated Memorandum and Articles of Association of the Company (as amended and restated), (ii) the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and obtaining any requisite approvals, consents or authorizations from governmental authorities, including insurance regulators in the jurisdictions of domicile of our and FNF’s insurance subsidiaries, (iii) the absence of any injunction or applicable law or order preventing or prohibiting consummation of the Mergers, (iv) a declaration by the Securities and Exchange Commission (“SEC”) of the effectiveness of the Form S-4 to be filed with the SEC by FNF relating to the registration under the Securities Act of the shares of FNF’s common stock to be issued in the Mergers, (v) approval for listing by the New York Stock Exchange of the shares of FNF common stock to be issued in the Mergers and (vi) the receipt of an opinion of counsel or an accounting firm to the effect that, for U.S. federal income tax purposes, the Mergers, together with the purchase of the Series A Preferred Shares pursuant to the Series A Preferred Share Purchase Agreement, will constitute a reorganization within the meaning of Section 368(a) of the Code.     

30

The FNF Merger Agreement contains certain provisions giving each of FNF and us the right to terminate the FNF Merger Agreement under certain circumstances. Capitalized terms used but not otherwise defined in this paragraph have the meanings set forth in the FNF Merger Agreement, which is included as an exhibit to our Current Report on Form 8-K, filed with the SEC on February 7, 2020. We and FNF may terminate the FNF Merger Agreement by mutual written consent with the approval of the Company Special Committee and the board of directors or special committee of the board of directors of FNF. Subject to certain limitations, we or FNF may terminate the FNF Merger Agreement if (a) any Governmental Authority issues a final and nonappealable Order or a Law is in effect permanently preventing or prohibiting the Mergers, (b) the Company Required Vote has not been obtained at the Company Shareholder Meeting or (c) the Closing does not occur prior to November 7, 2020 (as such date may be extended to February 7, 2021, by FNF or us under certain circumstances in which the requisite regulatory approvals have not been obtained but all of the other closing conditions set forth in the FNF Merger Agreement have been satisfied or waived (other than those conditions that by their nature can only be satisfied at the closing)). Subject to certain limitations, we may terminate the FNF Merger Agreement (i) to enter into any Takeover Proposal Documentation regarding a Superior Proposal if the Company Special Committee determines that failure to take such actions would be inconsistent with the fiduciary duties of the directors under the Laws of the Cayman Islands or (ii) if there has been a breach by FNF, Merger Sub I or Merger Sub II of any representation, warranty, covenant or agreement contained in the FNF Merger Agreement to the extent such breach would result in the failure of a closing condition (subject to a 30-day cure period). Subject to certain limitations, FNF may terminate the FNF Merger Agreement if (A) the Company Special Committee makes an Adverse Recommendation Change, (B) our board of directors recommends to Company Shareholders that they approve or accept a Superior Proposal, (C) the Company enters into or publicly announces its intention to enter into any Takeover Proposal Documentation with respect to a Superior Proposal, (D) we fail to hold the Company Shareholders’ Meeting, (E) we willfully and materially breach any of our obligations concerning the go-shop process or non-solicitation of alternative transactions or (F) we breach any representation, warranty, covenant or agreement in the FNF Merger Agreement (other than if there is a Company Material Adverse Effect) to the extent such breach would result in the failure of a closing condition (subject to a 30-day cure period).

We may experience: the occurrence of an event, change or other circumstance that could give rise to the termination of the FNF Merger Agreement or could otherwise cause the transactions contemplated by the FNF Merger Agreement to fail to close; disruptions to the current plans and operations of the Company and FNF as a result of the announcement of the FNF Merger Agreement; an inability to complete the transactions contemplated by the FNF Merger Agreement, including due to failure to obtain approval of the shareholders of the Company or other conditions to closing in the Merger Agreement; delays in obtaining or the inability to obtain necessary regulatory approvals (including approval from insurance regulators) required to complete the Mergers; the imposition on us by regulators of terms, conditions, requirements, limitations, costs or restrictions that would delay the completion of the Mergers, the imposition of additional material costs on or limitations on the revenues after the Mergers, or limitations on some of the cost savings and other benefits that we expect following completion of the Mergers; changes in applicable laws or regulations; the risk that the transactions contemplated by the FNF Merger Agreement will not qualify for their intended tax treatment; adverse legal and regulatory developments or determinations or adverse changes in, or interpretations of, U.S. or other foreign laws, rules or regulations, including tax laws, rules and regulations, that could delay or prevent completion of the transactions contemplated by the FNF Merger Agreement, cause the terms of such transactions to be modified or change the anticipated tax consequences of such transactions; the possibility that we or FNF may be adversely affected by other economic, business, and/or competitive factors. As a result, we cannot provide any assurance that any such terms, conditions, requirements, limitations, costs, or restrictions will not result in the abandonment of the Mergers.

In addition, we cannot be certain that the other conditions to closing the Mergers will be satisfied (or waived, if applicable) in a timely manner or at all. Failure to, or any delay in, completing the Mergers could cause us to not realize some or all of the benefits that we expect to achieve if the Mergers are successfully completed within the expected timeframe.

Termination of the FNF Merger Agreement could negatively impact our financial condition and the share price of our common stock.

The FNF Merger Agreement provides that in certain specified circumstances, upon termination of the FNF Merger Agreement, we will be required to pay FNF a termination fee of either $40 or $67. Please see “Pending Transaction with Fidelity National Financial, Inc.” under “Item 1 Business” for further discussion of the termination fee. Depending on the circumstances requiring us to make this payment, doing so could materially adversely affect our business, financial condition and results of operations.

31

There can be no assurance that an adequate remedy will be available to us in the event of a breach of the FNF Merger Agreement by FNF or its affiliates, or that we will wholly or partially recover any damages incurred in connection with the proposed Mergers. In particular, a failed transaction may result in negative publicity and a negative impression of our business among our customers or in the investment community or business community generally, all of which could negatively impact our business. Any disruptions to our business resulting from the announcement and pendency of the proposed Mergers, including any adverse changes in our relationships with our customers, IMOs, business partners, and employees, may continue or accelerate in the event of a failed transaction. In addition, if the proposed Mergers are not completed, the share price of our ordinary shares could decline to the extent that the current market price of the our ordinary shares reflects an assumption that the proposed Mergers will be completed. Furthermore, we have incurred, and will continue to incur, significant costs, expenses, and fees for professional services, including legal, accounting, investment banking and advisory fees, and other transaction costs in connection with the proposed Mergers, for which it will have received little or no benefit if the proposed Mergers are not completed. Many of these fees and costs will be payable by us if the proposed Mergers are not completed and may relate to activities that we would not have undertaken other than to complete the proposed Mergers.

The announcement and pendency of the proposed Mergers may adversely affect our business and results of operations.

Uncertainty about the effect of the proposed Mergers on our employees, customers, and other parties with whom we have business relationships may have an adverse effect on our business and results of operations regardless of whether the proposed Mergers are completed. Particularly, these risks to our business include the following: (i) the impairment of our ability to attract, retain, or motivate our employees, or the loss of employees due to office closures; (ii) the diversion of significant management time and attention from ongoing business operations towards the completion of the proposed Mergers and management’s ability to grow and manage growth of our business profitably; (iii) difficulties maintaining relationships with customers, IMOs, and other business partners; (iv) competition; (v) delays or deferments of certain business decisions by our customers, IMOs, and other business partners; (vi) the inability to pursue alternative business opportunities or make appropriate changes to our business because the FNF Merger Agreement requires us to conduct our business in the ordinary course of business and not engage in certain kinds of transactions prior to the completion of the proposed Mergers without the prior written consent of FNF, even if such actions could prove beneficial; (vii) litigation relating to the proposed Mergers and the costs related thereto; and (viii) the incurrence of significant costs, expenses, and fees for professional services and other transaction costs in connection with the proposed Mergers.

Each of the foregoing may be exacerbated by a delay in the completion of the proposed Mergers. Particularly, our management team will have devoted substantial time and resources to matters relating to the Mergers (including integration planning), and would otherwise have devoted their time and resources to other opportunities that may have been beneficial to us as an independent company.

Lawsuits relating to the Mergers could be filed against us and adversely impact our business, financial condition and operating results.

Litigation is common in connection with acquisitions of public companies, regardless of any merits related to the claims. In the event lawsuits are filed against us, the outcome of the lawsuits would be uncertain, and we may not be successful in defending against any such claims. While we will defend against any lawsuits filed against us in connection with the Mergers, the costs of the defense of such actions and other effects of such litigation could have an adverse effect on our business, financial condition and operating results.

Certain of our shareholders have agreed to vote in favor of the Mergers, regardless of how our other shareholders vote.

Concurrently with the execution and delivery of the FNF Merger Agreement, we and FNF entered into Voting Agreements with certain of our shareholders representing, as of February 5, 2020, in the aggregate approximately 32.7% of the issued and outstanding our ordinary shares and all the issued and outstanding Series A Preferred Shares and Series B Preferred Shares. Pursuant to their respective Voting Agreements, these shareholders have agreed (capitalized terms used in the paragraph below but not otherwise defined have the meanings set forth in the applicable Voting Agreement, which are included as exhibits to our Current Report on Form 8-K, filed with the SEC on February 7, 2020):

32

• unless the Company Special Committee has made an Adverse Recommendation Change that has not been rescinded or withdrawn, to vote all Subject Shares owned by them in favor of the approval of the FNF Merger Agreement, the Mergers and the other transactions contemplated thereby;

• against any action or agreement that is recommended against by the Company Special Committee and that would reasonably be expected to impede, frustrate, interfere with, delay, postpone or adversely affect the consummation of the Mergers and the other transactions contemplated by the FNF Merger Agreement; and

• in the event that the Company Special Committee has made an Adverse Recommendation Change that has not been rescinded or otherwise withdrawn, to vote all Subject Shares owned by them in favor of the approval of the FNF Merger Agreement, the Mergers and the other transactions contemplated thereby in the same proportion as the number of Company Ordinary Shares owned by Unaffiliated Shareholders that are voted in favor of the approval of the FNF Merger Agreement, the Mergers and the other transactions contemplated thereby bears to the total number of Shares owned by Unaffiliated Shareholders present (in person or by proxy) and voting at a meeting of the Company’s shareholders.

Accordingly, the Voting Agreements make it more likely that the necessary shareholder approval will be received for the Mergers than would be the case in the absence of the Voting Agreements.

Risks relating to estimates, assumptions and valuations

The pattern of amortizing our DAC, DSI, and VOBA balances relies on assumptions and estimates made by management. Changes in these assumptions and estimates could impact our results of operations and financial condition.

Amortization of our DAC, DSI and VOBA balances depends on the actual and expected profits generated by the respective lines of business that incurred the expenses. Expected profits are dependent on assumptions regarding a number of factors including investment returns, benefit payments, expenses, mortality, and policy lapse. Due to the uncertainty associated with establishing these assumptions, we cannot, with precision, determine the exact pattern of profit emergence. As a result, amortization of these balances will vary from period to period. Any difference in actual experience versus expected results could require us to, among other things, accelerate the amortization of DAC, DSI and VOBA which would reduce profitability for such lines of business in the current period.

For additional information, see “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations-Critical Accounting Policies and Estimates”.

Our valuation of investments and the determinations of the amounts of allowances and impairments taken on our investments may include methodologies, estimates and assumptions which are subject to differing interpretations and, if changed, could materially adversely affect our results of operations or financial condition.

Fixed maturities, equity securities and derivatives represent the majority of total cash and invested assets reported at fair value on our consolidated balance sheets. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date (an exit price). Fair value estimates are made based on available market information and judgments about the financial instrument at a specific point in time. Expectations that our investments will continue to perform in accordance with their contractual terms are based on evidence gathered through our normal credit surveillance process and on assumptions a market participant would use in determining the current fair value.

The determination of other than temporary impairment ("OTTI") varies by investment type and is based upon our periodic evaluation and assessment of known and inherent risks associated with the respective asset class. Our management considers a wide range of factors about the instrument issuer (e.g., operations of the issuer, future earnings potential) and uses their best judgment in evaluating the cause of the decline in the estimated fair value of the instrument and in assessing the prospects for recovery. Such evaluations and assessments require significant judgment and are revised as conditions change and new information becomes available. Additional impairments may need to be taken in the future, and the ultimate loss may exceed management’s current estimate of impairment amounts.

The value and performance of certain of our assets are dependent upon the performance of collateral underlying these investments. It is possible the collateral will not meet performance expectations leading to adverse changes in the cash flows on our holdings of these types of securities.

33

See "Note 4. Investments" to our audited consolidated financial statements for additional information about our investment portfolio.

Change in our evaluation of the recoverability of our deferred tax assets could adversely affect our results of operations and financial condition.

Deferred tax assets and liabilities are attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases using enacted tax rates expected to be in effect during the years in which the basis differences reverse. Deferred tax assets in essence represent future savings of taxes that would otherwise be paid in cash. We are required to evaluate the recoverability of our deferred tax assets each quarter and establish a valuation allowance, if necessary, to reduce our deferred tax assets to an amount that is more-likely-than-not to be realizable. In determining the need for a valuation allowance, we consider many factors, including future reversals of existing taxable temporary differences, future taxable income exclusive of reversing temporary differences and carryforwards, taxable income in prior carryback years and implementation of any feasible and prudent tax planning strategies management would employ to realize the tax benefit. See the “Federal Regulation” section of the risk factor “Our business is highly regulated and subject to numerous legal restrictions and regulations” for further discussion on tax impact.

Based on our current assessment of future taxable income, including available tax planning opportunities, we anticipate it is more-likely-than-not that we will generate sufficient taxable income to realize all of our deferred tax assets as to which we do not have a valuation allowance. If future events differ from our current assumptions, the valuation allowance may need to be increased, which could have a material adverse effect on our results of operation and financial condition.

We may face losses if our actual experience differs significantly from our reserving assumptions.

Our profitability depends significantly upon the extent to which our actual experience is consistent with the assumptions used in setting rates for our products and establishing liabilities for future life insurance and annuity policy benefits and claims. However, due to the nature of the underlying risks and the high degree of uncertainty associated with the determination of the liabilities for unpaid policy benefits and claims, we cannot determine precisely the amounts we will ultimately pay to settle these liabilities. As a result, we may experience volatility in our profitability and our reserves from period to period. To the extent that actual experience is less favorable than our underlying assumptions, we could be required to increase our liabilities, which may reduce our profitability and impact our financial strength.

We have minimal experience to date on policyholder behavior for our GMWB products which we began issuing in 2008. If emerging experience deviates from our assumptions on GMWB utilization, it could have a significant effect on our reserve levels and related results of operations. Based on experience on GMWB utilization, which continues to emerge, we updated our GMWB utilization assumption during 2019, with a favorable impact on reserves. We will continue to monitor the GMWB utilization assumption and update our best estimate as applicable.

See “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations-Critical Accounting Policies and Estimates”.

Legal, regulatory and tax risks

Our business is highly regulated and subject to numerous legal restrictions and regulations.

State insurance regulators, the NAIC and federal regulators continually reexamine existing laws and regulations and may impose changes in the future. New interpretations of existing laws and the passage of new legislation may harm our ability to sell new policies, increase our claims exposure on policies we issued previously and adversely affect our profitability and financial strength. We are also subject to the risk that compliance with any particular regulator’s interpretation of a legal or accounting issue may not result in compliance with another regulator’s interpretation of the same issue, particularly when compliance is judged in hindsight. Regulators and other authorities have the power to bring administrative or judicial proceedings against us, which could result in, among other things, suspension or revocation of our licenses, cease and desist orders, fines, civil penalties, criminal penalties or other disciplinary action, which could materially harm our results of operations and financial condition.

We cannot predict what form any future changes in these or other areas of regulation affecting the insurance industry might take or what effect, if any, such proposals might have on us if enacted into law. In addition, because

34

our activities are relatively concentrated in a small number of lines of business, any change in law or regulation affecting one of those lines of business could have a disproportionate impact on us as compared to other more diversified insurance companies. See section titled “Regulation” in Item 1. Business for further discussion of the impact of regulations on our business.

State Regulation

Our business is subject to government regulation in each of the states in which we conduct business and is concerned primarily with the protection of policyholders and other customers rather than shareholders. Such regulation is vested in state agencies having broad administrative and discretionary authority, which may include, among other things, premium rates and increases thereto, underwriting practices, reserve requirements, marketing practices, advertising, privacy, policy forms, reinsurance reserve requirements, acquisitions, mergers and capital adequacy. At any given time, we and our insurance subsidiaries may be the subject of a number of ongoing financial or market conduct, audits or inquiries. From time to time, regulators raise issues during such examinations or audits that could have a material impact on our business.

We have received inquiries from a number of state regulatory authorities regarding our use of the U.S. Social Security Administration’s Death Master File (“Death Master File”) and compliance with state claims practices regulations and unclaimed property or escheatment laws. We have established procedures to periodically compare our in-force life insurance and annuity policies against the Death Master File or similar databases; investigate any identified potential matches to confirm the death of the insured; determine whether benefits are due; and attempt to locate the beneficiaries of any benefits due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. We believe we have established sufficient reserves with respect to these matters; however, it is possible that third parties could dispute these amounts and additional payments or additional unreported claims or liabilities could be identified which could be significant and could have a material adverse effect on our results of operations.

Under insurance guaranty fund laws in most states, insurance companies doing business therein can be assessed up to prescribed limits for policyholder losses incurred by insolvent companies. We cannot predict the amount or timing of any such future assessments and therefore the liability we have established for these potential assessments may not be adequate. In addition, regulators may change their interpretation or application of existing laws and regulations such as the case with broadening the scope of carriers that must contribute towards Long Term Care insolvencies.

NAIC

Although our business is subject to regulation in each state in which we conduct business, in many instances the state regulatory models emanate from the NAIC. Some of the NAIC pronouncements, particularly as they affect accounting issues, take effect automatically in the various states without affirmative action by the states. Statutes, regulations and interpretations may be applied with retroactive impact, particularly in areas such as accounting and reserve requirements. The NAIC continues to work to reform state regulation in various areas, including comprehensive reforms relating to cyber security regulations, best interest standards, RBC and life insurance reserves.

On June 10, 2016, the NAIC formally approved principle-based reserving for life insurance products with secondary guarantees, with an effective date of January 1, 2017. Effective October 2019, we began replacing our life insurance product portfolio to comply with the new 2017 CSO mortality requirement as well as the principle-based reserve (PBR) requirement.  As of January 1, 2020 all life insurance policies sold by F&G are PBR compliant. 

Our insurance subsidiaries are subject to minimum capitalization requirements based on RBC formulas for life insurance companies that establish capital requirements relating to insurance, business, asset, interest rate and certain other risks. Changes to statutory reserve or risk-based capital requirements may increase the amount of reserves or capital our insurance companies are required to hold and may impact our ability to pay dividends. In addition, changes in statutory reserve or risk-based capital requirements may adversely impact our financial strength ratings. Changes currently under consideration include adding an operational risk component, factors for asset credit risk, and group wide capital calculations. See the risk factor entitled “A financial strength ratings downgrade, potential downgrade, or any other negative action by a rating agency, could make our product offerings less attractive and increase our cost of capital, and thereby adversely affect our financial condition and results of operations” for a discussion of risks relating to our financial strength ratings.

35

“Fiduciary” Rule Proposals

Although the DOL fiduciary rule has been vacated in total, similar rules proposed by state officials or the SEC may have an adverse effect on sales of annuity products to IRA owners particularly in the independent agent distribution channel. Compliance with such rules may require additional supervision of agents, cause changes to compensation practices and product offerings, and increase litigation risk, all of which could have adverse impact our business, results of operations and/or financial condition. Management will continue to monitor for potential action by state officials or the SEC to implement rules similar to the vacated DOL rule.

See section titled “Regulation” in Item 1. Business for further discussion on “fiduciary” rule proposals.

Bermuda and Cayman Islands Regulation

Our business is subject to regulation in Bermuda and the Cayman Islands, including the BMA and the CIMA. These regulations may limit or curtail our activities, including activities that might be profitable, and changes to existing regulations may affect our ability to continue to offer our existing products and services, or new products and services we may wish to offer in the future.

In particular, our reinsurance subsidiaries, F&G Life Re and F&G Re, are registered in Bermuda under the Bermuda Insurance Act and subject to the rules and regulations promulgated thereunder. The BMA has sought regulatory equivalency, which enables Bermuda’s commercial insurers to transact business with the EU on a “level playing field.” In connection with its initial efforts to achieve equivalency under the European Union’s Directive (2009/138/EC) (“Solvency II”), the BMA implemented and imposed additional requirements on the companies it regulates. The European Commission (the “EC”) granted Bermuda’s commercial insurers full equivalence in all areas of Solvency II for an indefinite period of time effective March 24, 2016, and applies from January 1, 2016.

See section titled "Regulation" in Item 1. Business for further discussion of regulations in the Bermuda and Cayman Islands.

Changes in federal or state tax laws may affect sales of our products and profitability.

The annuity and life insurance products that we market generally provide the policyholder with certain federal income or state tax advantages. For example, federal income taxation on any increases in non-qualified annuity contract values (i.e., the “inside build-up”) is deferred until it is received by the policyholder. Non-qualified annuities are annuities that are not sold to a qualified retirement plan or in the form of a qualified contract such as an IRA. With other savings investments, such as certificates of deposit and taxable bonds, the increase in value is generally taxed each year as it is realized. Additionally, life insurance death benefits and the inside build-up under life insurance contracts are generally exempt from income tax or tax deferred.

From time to time, various tax law changes have been proposed that could have an adverse effect on our business, including the elimination of all or a portion of the income tax advantages described above for annuities and life insurance policies. Additionally, insurance products, including the tax favorable features of these products, generally must be approved by the insurance regulators in each state in which they are sold. This review could delay the introduction of new products or impact the features that provide for tax advantages and make such products less attractive to potential purchasers. If legislation were enacted to eliminate the tax deferral for annuities or life insurance policies, such a change would have a material adverse effect on our ability to sell non-qualified annuities or life insurance policies.

36

Changes in tax law may adversely affect us and/or our shareholders.

From time to time, the United States, as well as foreign, state and local governments, consider changes to their tax laws that may affect our future results of operations and financial condition. Also, the Organization for Economic Co-operation and Development has published reports and launched a global dialogue among member and non-member countries on measures to limit harmful tax competition. These measures are largely directed at counteracting the effects of tax havens and preferential tax regimes in countries around the world. Changes to tax laws could increase their complexity and the burden and costs of compliance. Additionally, such changes could also result in significant modifications to the existing transfer pricing rules and could potentially have an impact on our taxable profits as such legislation is adopted by participating countries.

We are incorporated in the Cayman Islands and maintain subsidiaries or offices in the United States, Bermuda and the Cayman Islands. Taxing authorities, such as the IRS, actively audit and otherwise challenge these types of arrangements. We are subject to reviews and audits by the IRS and other taxing authorities from time to time, and the IRS or other taxing authority may challenge our structure. Responding to or defending against challenges from taxing authorities could be expensive and time consuming, and could divert management’s time and focus away from operating our business. We cannot predict whether and when taxing authorities will conduct an audit, challenge our tax structure or the cost involved in responding to any such audit or challenge. If we are unsuccessful, we may be required to pay taxes for prior periods, interest, fines or penalties, and may be obligated to pay increased taxes in the future, all of which could have an adverse effect on our business, financial condition, results of operations or growth prospects.

U.S. Tax Cuts and Jobs Act (“TCJA”)

In 2017, the United States enacted the Tax Cut and Jobs Act (“TCJA”), which amended many provisions of the Internal Revenue Code of 1986 (the “Code”). The TCJA contains provisions affecting the tax treatment of non-U.S. companies that can materially affect us. The TCJA includes provisions that reduce the U.S. corporate tax rate, impose a base erosion minimum tax on income of a U.S. corporation determined without regard to certain otherwise deductible payments made to certain foreign affiliates, and significantly accelerate taxable income and therefore cash tax expense by the imposition of other changes affecting life insurance companies, among others.

The TCJA also includes provisions that could materially affect our shareholders as a result of provisions that broaden the definition of United States shareholder for purposes of the controlled foreign corporation (“CFC”) rules and make it more difficult for a foreign insurance company to not be treated as a passive foreign investment company (“PFIC”). Independent of the TJCA, interpretations of U.S. federal income tax law, including those regarding whether a company is engaged in a trade or business (or has a permanent establishment) within the United States or is a PFIC, or whether U.S. persons are required to include in their gross income “subpart F income” or related person insurance income (“RPII”) of a CFC, are subject to change, possibly on a retroactive basis. Regulations regarding the application of the PFIC rules to insurance companies and regarding RPII are only in proposed form. New regulations or pronouncements interpreting or clarifying the existing proposed Treasury regulations could be forthcoming. In addition to the TCJA, other legislative proposals or administrative or judicial developments could also result in an increase in the amount of U.S. tax payable by us or by an investor in our securities or reduce the attractiveness of our products. If any such developments occur, our business, financial condition and results of operation could be materially and adversely affected and could have a material and adverse effect on your investment in our securities.

The Base Erosion and Anti-Abuse Tax

The TCJA introduced a new tax called the Base Erosion and Anti-Abuse Tax (BEAT). The BEAT is a minimum tax and is calculated as a percentage (10% in 2019-2025, and 12.5% in 2026 and thereafter) of the “modified taxable income” of an “applicable taxpayer.” Modified taxable income is calculated by adding back to a taxpayer’s regular taxable income the amount of certain “base erosion tax benefits” with respect to certain payments made to foreign affiliates (including premium or other consideration paid or accrued to a related foreign reinsurance company for reinsurance) of the taxpayer, as well as the “base erosion percentage” of any net operating loss deductions. The BEAT applies for a taxable year only to the extent it exceeds a taxpayer’s regular corporate income tax liability for such year (determined without regard to certain tax credits).

For the year ended December 31, 2019, we believe that FGL Insurance did not incur tax liability under the BEAT. However, FGL Insurance has incurred BEAT in prior years, and it is possible that tax authorities may disagree with our BEAT calculations, or the interpretations on which those calculations were based, and assess additional taxes, interest and penalties, and the uncertainty regarding the correct interpretation of the BEAT may make such disagreements more likely.

37

Bermuda Tax Exemption

We are subject to the risk that Bermuda tax laws may change and that we may become subject to new Bermuda taxes following the expiration of a current exemption after 2035. The Bermuda Minister of Finance (the “Minister”), under the Exempted Undertakings Tax Protection Act 1966 of Bermuda, as amended, has given our Bermuda subsidiaries an assurance that if any legislation is enacted in Bermuda that would impose tax computed on profits or income, or computed on any capital asset, gain or appreciation, or any tax in the nature of estate duty or inheritance tax, then the imposition of any such tax will not be applicable to our Bermuda subsidiaries or any of our Bermuda subsidiaries’ operations, shares, debentures or other obligations until March 31, 2035, except insofar as such tax applies to persons ordinarily resident in Bermuda or to any taxes payable by our Bermuda subsidiaries in respect of real property owned or leased by our Bermuda subsidiaries in Bermuda. Given the limited duration of the Minister’s assurance, we cannot assure you that our Bermuda subsidiaries will not be subject to any Bermuda tax after March 31, 2035.

We may be subject to U.S. federal income taxation.

The Company is incorporated under the laws of the Cayman Islands and CF Bermuda Holdings Limited (“CF Bermuda”), F&G Re Ltd and F&G Life Re are incorporated under the laws of Bermuda. These companies currently intend to operate so that they will not be treated as being engaged in a trade or business within the U.S. or subject to current U.S. federal income taxation on their net income. However, the determination of whether a foreign corporation is engaged in a trade or business within the United States is highly factual, subject to uncertainty, and must be made annually. There can be no assurance that the IRS will not successfully contend that these companies are engaged in a trade or business in the U.S. If they were considered to be engaged in a U.S. trade or business, they could be subject to U.S. federal income taxation on a net basis on their income that is effectively connected with such U.S. trade or business (including a branch profits tax on the portion of its earnings and profits that is attributable to such income). Any such U.S. federal income taxation could result in substantial tax liabilities and consequently could have a material adverse effect on our financial condition and results of future operations.

U.S. persons who own our shares may be subject to U.S. federal income taxation at ordinary income rates on our undistributed earnings and profits.

Controlled foreign corporations in general. If the Company or any of its non-U.S. subsidiaries is a “controlled foreign corporation” (“CFC”) for the taxable year, each U.S. person treated as a “U.S. Shareholder” with respect to the Company or its non-U.S. subsidiaries that held our shares directly (or indirectly through non-U.S. entities) as of the last day in such taxable year generally is required to include in gross income as ordinary income its pro rata share of such company’s insurance and reinsurance income and certain other investment income, regardless of whether that income was actually distributed to such U.S. person (with certain adjustments).

In general, a non-U.S. corporation is a CFC if its “U.S. Shareholders,” in the aggregate, own (or are treated as owning) stock of the non-U.S. corporation possessing more than 50% of the voting power or value of such corporation’s stock. However, this threshold is lowered to more than 25% for purposes of taking into account the insurance income of a non-U.S. corporation. Special rules apply for purposes of taking into account any related person insurance income (“RPII”) of a non-U.S. corporation, as described below.

U.S. Shareholder status. Prior to the enactment of the TCJA, a “U.S. Shareholder” was defined as any U.S. person that owned, directly or indirectly (or was treated as owning), stock of the non-U.S. corporation possessing 10% or more of the total voting power of such non-U.S. corporation’s stock. However, for taxable years of non-U.S. corporations beginning after December 31, 2017, the TCJA provides that a “U.S. Shareholder” of a non-U.S. corporation generally is any U.S. person that owns (or is treated as owning) stock of the non-U.S. corporation possessing 10% or more of the total voting power or 10% or more of the total value of such non-U.S. corporation’s stock.

In addition, the TCJA expanded the situations in which a U.S. person that does not directly own stock in a non-U.S. corporation will be treated as owning such stock via the application of attribution rules. Specifically, the TCJA eliminated the prohibition on “downward attribution,” one effect of which is that stock of a non-U.S. subsidiary of a foreign parent may be attributed down to a U.S. subsidiary of such parent. Such attribution thus could cause the U.S. subsidiary to become a “U.S. Shareholder” of the non-U.S. subsidiary and thereby cause the latter to become a CFC.

38

CFC status. Our Charter generally limits the voting power attributable to our shares so that no “United States person” (as defined in Section 957 of the Code) holds, directly, indirectly or constructively (within the meaning of Section 958 of the Code), more than 9.5% of the total voting power of our shares. This limitation would not apply to reduce the voting power of shares held by members of (a) the Blackstone Group (as defined in our Charter) without the consent of a majority of the Blackstone Group shareholders (as determined based on their ownership of the common shares) or (b) the FNF Group (as defined in our Charter) without the consent of the applicable member of the FNF Group. This voting power limitation was intended to reduce the likelihood that the Company’s shareholders would be treated as U.S. Shareholders.

By expanding the definition of a U.S. Shareholder, the TCJA reduces the effectiveness of our voting power limitation, because a U.S. person that owns 10% or more by value of our shares will be treated as a U.S. Shareholder, and increases the likelihood that the Company will be treated as a CFC. Thus, there can be no assurance that the Company will not become a CFC. In addition, as a result of the allowance of “downward attribution,” the non-U.S. subsidiaries of CF Bermuda currently are CFCs. U.S. persons should consult with their tax advisors regarding the possible application of the CFC rules to their investment in the Company.

Effect of CFC status on our shareholders. Since CF Bermuda’s non-U.S. subsidiaries are CFCs, a U.S. person that is a U.S. Shareholder with respect to them as of the last day in such taxable year generally is required to include in gross income as ordinary income its pro rata share of such non-U.S. subsidiaries’ insurance and reinsurance income and certain other investment income, regardless of whether that income was actually distributed to such U.S. person (with certain adjustments). This same treatment would apply with respect to the Company or CF Bermuda, if it also becomes a CFC and a U.S. person is similarly treated as a U.S. Shareholder with respect to it.

In addition, if a U.S. Shareholder disposes of shares in a non-U.S. company that was a CFC during the five-year period ending on the date of disposition, any gain from the disposition will generally be treated as a dividend to the extent of the U.S. person’s share of the corporation’s undistributed earnings and profits that were accumulated during the period or periods that the U.S. person owned the shares while the corporation was a CFC (with certain adjustments). Also, a U.S. person may be required to comply with specified reporting requirements, regardless of the number of shares owned.

U.S. persons who own our shares may be subject to U.S. federal income taxation at ordinary income rates on a disproportionate share of our undistributed earnings and profits attributable to RPII.

In general. If either of our non-U.S. insurance subsidiaries is treated as recognizing RPII in a taxable year and is treated as a CFC for purposes of the RPII rules for such taxable year (a “RPII CFC”), each U.S. person that owns, directly or indirectly through non-U.S. entities, any of such non-U.S. insurance subsidiary’s stock as of the last day in such taxable year must generally include in gross income its pro rata share of the RPII of such non-U.S. insurance subsidiary, determined as if the RPII were distributed proportionately only to all such U.S. persons, regardless of whether that income is distributed (with certain adjustments). Each of our non-U.S. insurance subsidiaries generally will be treated as a CFC for purposes of the RPII rules if U.S. persons in the aggregate own (or are treated as owning) 25% or more of the total voting power or value of the Company’s stock on any day of the taxable year. Each of our non-U.S. insurance subsidiaries expects to be treated as a CFC for this purpose based on the ownership of its shares.

RPII of a RPII CFC generally is certain insurance and reinsurance income (including underwriting and investment income) attributable to a policy of insurance or reinsurance with respect to which the person (directly or indirectly) insured is a U.S. person that owns (or is treated as owning) stock of such RPII CFC, or risks of a person that is “related” to such a U.S. person. For this purpose, (1) a person is “related” to another person if such person “controls,” or is “controlled” by, such other person, or if both are “controlled” by the same persons and (2) “control” of a corporation means ownership (or deemed ownership) of stock possessing more than 50% of the total voting power or value of such corporation’s stock and “control” of a partnership, trust or estate for U.S. federal income tax purposes means ownership (or deemed ownership) of more than 50% by value of the beneficial interests in such partnership, trust or estate. Certain attribution rules apply for purposes of determining control.

We do not believe that any of our non-U.S. insurance subsidiaries will earn more than a de minimis amount of RPII from insuring risks of such U.S. shareholders. Our Charter provides that no shareholder or holder (or, to its actual knowledge, any direct or indirect beneficial owner thereof) of our issued and outstanding shares, including any securities exchangeable for our share capital and all options, warrants, and contractual and other rights to purchase our share capital (“Derivative Securities”), that is a “United States person” (as defined in Section 957 of the Code) shall knowingly permit itself to hold (directly, indirectly or constructively within the meaning of Section

39

958 of the Code) 50% or more of the total voting power or of the total value of our issued and outstanding shares, including our Derivative Securities, in order to reduce the likelihood of us recognizing RPII. This limitation would not apply to a shareholder or holder of Derivative Securities that is a member of the Blackstone Group or FNF Group. In the event that any holder of our shares or Derivative Securities to whom this limitation applies contravenes such limitation, our board of directors may require such holder to sell or allow us to repurchase some or all of such holder’s shares or Derivative Securities at fair market value, as the board of directors and such holder agree in good faith, or to take any reasonable action that the board of directors deems appropriate. If a member of the Blackstone Group or FNF Group were to own (directly, indirectly or constructively) more than 50% of the total voting power or total value of our issued and outstanding shares, our subsidiaries may be treated as “related” to a member of the Blackstone Group or FNF Group, as applicable (or one of their affiliates) for these purposes. In such case, income of our non-U.S. insurance subsidiaries allocable to reinsuring risks of our U.S. subsidiaries (if any) would constitute RPII, and might trigger adverse RPII consequences to all U.S. persons that hold our ordinary shares directly or indirectly through non-U.S. entities, as described below.

RPII Exceptions - The RPII rules will not apply with respect to a non-U.S. insurance subsidiary for a taxable year if (1) at all times during its taxable year less than 20% of the total combined voting power of all classes of such non-U.S. insurance subsidiary’s voting stock and less than 20% of the total value of all of its stock is owned (directly or indirectly) by persons who are (directly or indirectly) insured under any policy of insurance or reinsurance issued by such insurance subsidiary, respectively, or who are related persons to any such person or (2) its RPII (determined on a gross basis) is less than 20% of its insurance income (as so determined) for the taxable year, determined with certain adjustments. It is expected that one or both of these exceptions will apply to our non-U.S. insurance subsidiaries but because we cannot be certain of our future ownership or our ability to obtain information about our shareholders to manage such ownership to ensure that our subsidiaries qualify for one or both of these exceptions, there can be no assurance in this regard.

U.S. persons who dispose of our shares may be required to treat any gain as ordinary income for U.S. federal income tax purposes and comply with other specified reporting requirements.

If a U.S. person disposes of shares in a non-U.S. corporation that is an insurance company that had RPII and the 25% threshold described above is met at any time when the U.S. person owned any shares in the corporation during the five-year period ending on the date of disposition, any gain from the disposition will generally be treated as a dividend to the extent of the U.S. person’s share of the corporation’s undistributed earnings and profits that were accumulated during the period that the U.S. person owned the shares (possibly whether or not those earnings and profits are attributable to RPII). In addition, the shareholder will be required to comply with specified reporting requirements, regardless of the amount of shares owned. We believe that these rules should not apply to a disposition of our shares because FGL Holdings is not itself directly engaged in the insurance business. We cannot assure you, however, that the IRS will not successfully assert that these rules apply to a disposition of our ordinary shares.

We may be a PFIC, which could result in adverse United States federal income tax consequences for our shareholders.

If we are a “passive foreign investment company” (“PFIC”) for any taxable year (or portion thereof) that is included in the holding period of U.S. person treated as a “U.S. Shareholder” of our shares or warrants, such U.S. person may be subject to adverse U.S. federal income tax consequences and may be subject to additional reporting requirements.

A foreign corporation will be classified as a PFIC for United States federal income tax purposes if either (i) at least 75% of its gross income in a taxable year, including its pro rata share of the gross income of any corporation in which it is considered to own at least 25% of the shares by value, is passive income or (ii) at least 50% of its assets in a taxable year (ordinarily determined based on fair market value and averaged quarterly over the year), including its pro rata share of the assets of any corporation in which it is considered to own at least 25% of the shares by value, are held for the production of, or produce, passive income (the “look-through rule”). Passive income generally includes dividends, interest, rents and royalties (other than rents or royalties derived from the active conduct of a trade or business) and gains from the disposition of passive assets. Income derived in the active conduct of an insurance business by a qualifying insurance company, however, is not treated as passive income.

Under the look-through rule described above, we are deemed to own all of the assets and to have received all of the income of our wholly-owned subsidiaries, including our Iowa based insurance subsidiary, FGL Insurance, and our non-U.S. insurance subsidiaries. Taking into account the anticipated ratio of passive and non-passive income and assets of our subsidiaries, while not free from doubt, we do not believe that we were a PFIC for the

40

taxable year ending December 31, 2019, and do not currently believe that we will be classified as a PFIC for the 2020 taxable year. Our actual PFIC status for our current taxable year or any subsequent taxable year, however, will not be determinable until after the end of such taxable year.

The determination as to whether we are a PFIC for any taxable year is based on the application of complex U.S. federal income tax rules, which are subject to differing interpretations. The PFIC rules as they relate to insurance companies were amended by the TCJA and there is considerable uncertainty regarding how certain aspects of the new rules will be interpreted. As a result of these uncertainties in the application of the PFIC rules to us and our subsidiaries, there can be no assurance that the IRS will not assert that we are PFIC for any taxable year or that a court will not sustain such assertion.

No final or temporary Treasury regulations currently exist regarding the application of the PFIC rules to an insurance company. However, proposed Treasury regulations were released in July 2019. The proposed Treasury regulations say that whether a company is engaged in the active conduct of an insurance business is a facts and circumstances test, but also introduce a “bright line” test providing that the active conduct requirement is met only if the insurance company’s “active conduct percentage” is at least 50%. In general, a company’s active conduct percentage is determined by dividing the company’s aggregate expenses for certain insurance-related services of its officers and employees (and the officers and employees of certain affiliates) by the company’s aggregate expenses for such insurance-related services (including those paid to unaffiliated persons). In addition, the proposed Treasury regulations modify and limit the application of the look-through rule described above in a manner that may make it more likely for FGL Holdings to be treated as a PFIC. The proposed Treasury regulations would also expand the circumstances in which a shareholder of a foreign corporation is treated as owning shares of a subsidiary that is treated as a PFIC, even if the foreign corporation is not treated as a PFIC. If these rules are finalized in their currently proposed form, there is a risk that we and/or foreign insurance company subsidiaries will be treated as PFICs, and that shareholders will be treated as owning indirectly interests in one or more PFICs.

If we determine we are a PFIC for any taxable year, we will endeavor to provide to a U.S. Holder such information as the Internal Revenue Service (“IRS”) may require, including a PFIC annual information statement, in order to enable the U.S. Holder to make and maintain a qualified electing fund election, but there is no assurance that we will timely provide such required information. There is also no assurance that we will have timely knowledge of our status as a PFIC in the future or of the required information to be provided. We urge U.S. investors to consult their own tax advisors regarding the possible application of the PFIC rules, including the impact of the changes to the PFIC rules contained in the TCJA.

Accounting rules, changes to accounting rules, or the grant of permitted accounting practices to competitors could negatively impact us.    

We are required to comply with U.S. GAAP. A number of organizations are instrumental in the development and interpretation of U.S. GAAP, such as the SEC, the Financial Accounting Standards Board (“FASB”) and the American Institute of Certified Public Accountants. U.S. GAAP is subject to constant review by these organizations and others in an effort to address emerging accounting issues and to interpret existing accounting guidance. See "Note 2. Significant Accounting Policies and Practices" to our audited consolidated financial statements for further discussion on the FASB’s key projects and their impact to our financial condition and profitability.

The amount of statutory capital that our insurance subsidiaries have and the amount of statutory capital that they must hold to maintain their financial strength ratings and meet other requirements can vary significantly from time to time due to a number of factors outside of our control.

The financial strength ratings of our insurance subsidiaries are significantly influenced by their statutory surplus amounts and capital adequacy ratios. In any particular year, statutory surplus amounts and RBC ratios may increase or decrease depending on a variety of factors, most of which are outside of our control, including, but not limited to, the following:

• the amount of statutory income or losses generated by our insurance subsidiaries (which itself is sensitive to equity market and credit market conditions);

• the amount of additional capital our insurance subsidiaries must hold to support business growth and changes to the RBC calculation methodologies;

• changes in statutory accounting or reserve requirements applicable to our insurance subsidiaries;

• our ability to access capital markets to provide reserve relief;

• changes in equity market levels, interest rates, and market volatility;

• the value of certain fixed-income and equity securities in our investment portfolio;

• changes in the credit ratings of investments held in our portfolio; and

41

• the value of certain derivative instruments.

Rating agencies may also implement changes to their internal models, which differ from the RBC capital model and could result in our insurance subsidiaries increasing or decreasing the amount of statutory capital they must hold in order to maintain their current ratings. In addition, rating agencies may downgrade the investments held in our portfolio, which could result in a reduction of our capital and surplus and our RBC ratio. To the extent that an insurance subsidiary’s RBC ratios are deemed to be insufficient, we may take actions either to increase the capitalization of the insurer or to reduce the capitalization requirements. If we are unable to take such actions, the rating agencies may view this as a reason for a ratings downgrade.

The failure of any of our insurance subsidiaries to meet its applicable RBC requirements or minimum capital and surplus requirements could subject it to further examination or corrective action imposed by insurance regulators, including limitations on its ability to write additional business, supervision by regulators or seizure or liquidation. Any corrective action imposed could have a material adverse effect on our business, results of operations and financial condition. A decline in RBC ratios also limits the ability of an insurance subsidiary to make dividends or distributions to us and could be a factor in causing rating agencies to downgrade the insurer’s financial strength ratings, which could have a material adverse effect on our business, results of operations and financial condition.

We may be the target of future litigation, law enforcement investigations or increased scrutiny which may affect our financial strength or reduce profitability.

We, like other financial services companies, are involved in litigation and arbitration in the ordinary course of business. For further discussion on litigation and regulatory investigation risk, see “Note 12. Commitments and Contingencies” to our audited consolidated financial statements.

More generally, we operate in an industry in which various practices are subject to scrutiny and potential litigation, including class actions. In addition, we sell our products through IMOs, whose activities may be difficult to monitor. Civil jury verdicts have been returned against insurers and other financial services companies involving sales, underwriting practices, product design, product disclosure, administration, denial or delay of benefits, charging excessive or impermissible fees, recommending unsuitable products to customers, breaching fiduciary or other duties to customers, refund or claims practices, alleged agent misconduct, failure to properly supervise representatives, relationships with agents or other persons with whom the insurer does business, payment of sales or other contingent commissions and other matters. Such lawsuits can result in substantial judgments and damage to our reputation that is disproportionate to the actual damages, including material amounts of punitive non-economic compensatory damages. In some states, juries, judges and arbitrators have substantial discretion in awarding punitive and non-economic compensatory damages, which creates the potential for unpredictable material adverse judgments or awards in any given lawsuit or arbitration. Arbitration awards are subject to very limited appellate review. In addition, in some class action and other lawsuits, financial services companies have made material settlement payments.

We may not be able to protect our intellectual property and may be subject to infringement claims.

We rely on a combination of contractual rights and copyright, trademark and trade secret laws to establish and protect our intellectual property. Although we use a broad range of measures to protect our intellectual property rights, third parties may infringe or misappropriate our intellectual property. We may have to litigate to enforce and protect our copyrights, trademarks, trade secrets and know-how or to determine their scope, validity or enforceability, which represents a diversion of resources that may be significant in amount and may not prove successful. The loss of intellectual property protection or the inability to secure or enforce the protection of our intellectual property assets could adversely impact our business and its ability to compete effectively.

We may be subject to costly litigation in the event that another party alleges our operations or activities infringe upon that party’s intellectual property rights. Third parties may have, or may eventually be issued, patents or other protections that could be infringed by our products, methods, processes or services or could otherwise limit our ability to offer certain product features. We may also be subject to claims by third parties for breach of copyright, trademark, trade secret or license usage rights. Any such claims and any resulting litigation could result in significant expense and liability for damages or we could be enjoined from providing certain products or services to our customers or utilizing and benefiting from certain methods, processes, copyrights, trademarks, trade secrets or licenses, or alternatively, we could be required to enter into costly licensing arrangements with third parties, all of which could have a material adverse effect on our business, results of operations and financial condition.

42

Because we are incorporated under the laws of the Cayman Islands, shareholders may face difficulties in protecting their interests, and their ability to protect their rights through the U.S. Federal courts may be limited.

We are an exempted company incorporated under the laws of the Cayman Islands. As a result, it may be difficult for investors to effect service of process within the United States upon our directors or executive officers, or enforce judgments obtained in the United States courts against our directors or officers.

Our corporate affairs are governed by our Charter, the Companies Law (2020 Revision) of the Cayman Islands, as amended (the “Companies Law”) (as the same may be supplemented or amended from time to time) and the common law of the Cayman Islands. We are also subject to the federal securities laws of the United States. The rights of shareholders to take action against the directors, actions by minority shareholders and the fiduciary responsibilities of our directors to us under Cayman Islands law are to a large extent governed by the common law of the Cayman Islands. The common law of the Cayman Islands is derived in part from comparatively limited judicial precedent in the Cayman Islands as well as from English common law, the decisions of whose courts are of persuasive authority, but are not binding on a court in the Cayman Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under Cayman Islands law are different from what they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the Cayman Islands has a different body of securities laws as compared to the United States, and certain states may have more fully developed and judicially interpreted bodies of corporate law. In addition, Cayman Islands companies may not have standing to initiate a shareholders derivative action in a Federal court of the United States.

We have been advised by our Cayman Islands legal counsel that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts of the United States predicated upon the civil liability provisions of the federal securities laws of the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.

As a result of all of the above, public shareholders may have more difficulty in protecting their interests in the face of actions taken by management, members of the board of directors or controlling shareholders than they would as public shareholders of a United States company.

Anti-takeover provisions in our Charter discourage, delay or prevent a change in control of the Company and may affect the trading price of our ordinary shares.

Our Charter includes a number of provisions that may discourage, delay or prevent a change in our management or control over us. For example, our Charter includes provisions (i) classifying the Company’s board of directors into three classes with each class to serve for three years with one class being elected annually, (ii) providing that directors may only be removed for cause, (iii) requiring shareholders to comply with advance notice procedures in order to bring business before an annual general meeting or to nominate candidates for election as directors, (iv) providing that only directors may call general meetings, (v) providing that resolutions may only be passed at a duly convened general meeting.

These provisions may prevent our shareholders from receiving the benefit from any premium to the market price of our ordinary shares offered by a bidder in a takeover context. Even in the absence of a takeover attempt, the existence of these provisions may adversely affect the prevailing market price of our ordinary shares if the provisions are viewed as discouraging takeover attempts in the future.

Our Charter may also make it difficult for shareholders to replace or remove our management. These provisions may facilitate management entrenchment that may delay, deter, render more difficult or prevent a change in our control, which may not be in the best interests of our shareholders.

43

Many states, including the jurisdictions where our principal insurance subsidiaries FGL Insurance and FGL NY Insurance are domiciled, have insurance laws and regulations that require advance approval by state agencies of any direct or indirect change in control of an insurance company that is domiciled in or, in some cases, has such substantial business that it is deemed to be commercially domiciled in that state. Therefore, any person seeking to acquire a controlling interest in us would face regulatory obstacles which may delay, deter or prevent an acquisition that shareholders might consider in their best interests.

The consent right of the original holders of our preferred shares over a change of control transaction may discourage, delay or prevent a change in control of our Company and may affect the trading price of our ordinary shares and the preferred shares.

The original holders of the preferred shares each have a consent right over any change of control transaction so long as they hold any preferred shares at the time of such change of control, unless prior to any such change of control transaction, such original holders have received a bona fide, binding offer to purchase all of such original holders’ preferred shares at a price equal to or greater than the then-current liquidation preference, plus any accumulated and unpaid dividends (whether or not declared), from a person not affiliated with any person or group participating in such change of control transaction.

This provision may prevent our shareholders from receiving the benefit from any premium to the market price of our ordinary shares offered by a bidder in a takeover context. Even in the absence of a takeover attempt, the existence of these provisions may adversely affect the prevailing market price of our ordinary shares and our preferred shares if this provision is viewed as discouraging takeover attempts in the future.

If we fail to maintain an effective system of internal controls, we may not be able to accurately report our financial results.

We are required to comply with Section 404 of the Sarbanes-Oxley Act, which requires, among other things, that companies maintain disclosure controls and procedures to ensure timely disclosure of material information, and that management review the effectiveness of those controls on a quarterly basis. Effective internal controls are necessary for us to provide reliable financial reports and to help prevent fraud, and our management and other personnel devote a substantial amount of time to these compliance requirements. Moreover, these rules and regulations increase our legal and financial compliance costs and make some activities more time-consuming and costly. Section 404 of the Sarbanes-Oxley Act also requires us to evaluate annually the effectiveness of our internal controls over financial reporting as of the end of each fiscal year and to include a management report assessing the effectiveness of our internal control over financial reporting in our Annual Report on Form 10-K. If we fail to maintain effective internal controls, we might be subject to sanctions or investigation by regulatory authorities, such as the SEC. Any such action could adversely affect our financial results and may also result in delayed filings with the SEC.

Risks relating to our business

The agreements and instruments governing our debt contain significant operating and financial restrictions, which may prevent us from capitalizing on business opportunities.

The indenture (“the indenture”) governing the 5.50% senior notes due 2025 (the “Senior Notes”) issued by FGLH and the three-year $250 unsecured revolving credit facility (the “Credit Agreement”); each contains various restrictive covenants which limit, among other things, the Company’s ability to:

• incur additional indebtedness;

• pay dividends or certain other distributions on its capital stock other than as allowed under the indenture and the Credit Agreement;

• make certain investments, prepayment of junior indebtedness or other restricted payments;

• engage in transactions with stockholders or affiliates;

• sell certain assets or merge with or into other companies;

• change our accounting policies;

• guarantee indebtedness; and

• create liens or incur liens on the assets of FGLH and its subsidiaries.

In addition, if FGL or FGLH undergoes a “change of control” as defined in the indenture, each holder of Senior Notes will have the right to require us to repurchase their Senior Notes at a price equal to 101% of the principal amount and any accrued but unpaid interest.

44

As a result of these restrictions and their effect on us, we may be limited in how we conduct our business and we may be unable to raise additional debt financing to compete effectively or to take advantage of new business opportunities. The terms of any future indebtedness we or our subsidiaries may incur could include more restrictive covenants. For detailed information about restrictions governing our debt, see the section titled "Debt" in "Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations-Liquidity and Capital Resources" in this report.

A financial strength ratings downgrade, potential downgrade, or any other negative action by a rating agency, could make our product offerings less attractive and increase our cost of capital, and thereby adversely affect our financial condition and results of operations.

Various nationally recognized rating agencies review the financial performance and condition of insurers, including our insurance subsidiaries, and publish their financial strength ratings as indicators of an insurer’s ability to meet policyholder and contractholder obligations. These ratings are important to maintaining public confidence in our products, our ability to market our products and our competitive position. Any downgrade or other negative action by a rating agency could have a materially adverse effect on us in many ways, including the following:

• adversely affecting relationships with distributors, IMOs and sales agents, which could result in reduction of sales;

• increasing the number or amount of policy lapses or surrenders and withdrawals of funds;

• requiring a reduction in prices for our insurance products and services in order to remain competitive;

• adversely affecting our ability to obtain reinsurance at a reasonable price, on reasonable terms or at all;

• adversely affecting our ability to grow offshore reinsurance business; and

• requiring us to collateralize reserves, balances or obligations under reinsurance and derivatives agreements.

See “Item 7A. Quantitative and Qualitative Disclosures About Market Risk” for further discussion on credit risk and counterparty risk.

Our insurance subsidiaries’ ability to grow depends in large part upon the continued availability of capital.

Our insurance subsidiaries’ long-term strategic capital requirements will depend on many factors, including their accumulated statutory earnings and the relationship between their statutory capital and surplus and various elements of required capital. To support long-term capital requirements, we and our insurance subsidiaries may need to increase or maintain statutory capital and surplus through financings, which could include debt, equity, financing arrangements or other surplus relief transactions. Adverse market conditions have affected and continue to affect the availability and cost of capital from external sources. We are not obligated, may choose not, or may not be able to provide financing or make capital contributions to our insurance subsidiaries. Consequently, financings, if available at all, may be available only on terms that are not favorable to us or our insurance subsidiaries. If our insurance subsidiaries cannot maintain adequate capital, they may be required to limit growth in sales of new policies, and such action could materially adversely affect our business, operations and financial condition.

Our business could be interrupted or compromised if we experience difficulties arising from outsourcing relationships.

If we do not maintain an effective outsourcing strategy or third-party providers do not perform as contracted, we may experience operational difficulties, increased costs and a loss of business that could have a material adverse effect on our results of operations. If there is a delay in our third-party providers’ introduction of our new products or if our third-party providers are unable to service our customers appropriately, we may experience a loss of business that could have a material adverse effect on our results of operations. In addition, our reliance on third-party service providers that we do not control does not relieve us of our responsibilities and requirements. Any failure or negligence by such third-party service providers in carrying out their contractual duties may result in us becoming subjected to liability to parties who are harmed and ensuing litigation. Any litigation relating to such matters could be costly, expensive and time-consuming, and the outcome of any such litigation may be uncertain. Moreover, any adverse publicity arising from such litigation, even if the litigation is not successful, could adversely affect our reputation and sales of our products.

See section titled "Outsourcing” in Item 1. Business for functions we outsource to third-party service providers.

45

The loss of key personnel could negatively affect our financial results and impair our ability to implement our business strategy.

Our success depends in large part on our ability to attract and retain qualified employees. Intense competition exists for key employees with demonstrated ability, and we may be unable to hire or retain such employees. Our key employees include senior management, sales and distribution professionals, actuarial and finance professionals and information technology professionals. We do not believe the departure of any particular individual would cause a material adverse effect on our operations; however, the unexpected loss of several of key employees could have a material adverse effect on our operations due to the loss of their skills, knowledge of our business, and their years of industry experience as well as the potential difficulty of promptly finding qualified replacement employees.

Interruption or other operational failures in telecommunication, information technology and other operational systems, or a failure to maintain the security, integrity, confidentiality or privacy of sensitive data residing on such systems, including as a result of human error, could harm our business.

We are highly dependent on automated and information technology systems to record and process our internal transactions and transactions involving our customers, as well as to calculate reserves, value invested assets and complete certain other components of our U.S. GAAP and statutory financial statements. We have policies, procedures, automation, and back-up plans designed to prevent or limit the effect of failure. All of these risks are also applicable where we rely on outside vendors, to provide services to us and our customers. The failure of any one of these systems for any reason could disrupt our operations, result in loss of customer business and adversely impact our business.

We retain confidential information in our information technology systems and those of our business partners, and we rely on industry standard commercial technologies and network security measures to maintain the security of those systems and prevent disruptions from unauthorized tampering with our computer systems. Any compromise of the security of our information technology systems that results in inappropriate access, use or disclosure of personally identifiable customer information could damage our reputation in the marketplace, deter purchases of our products, subject us to heightened regulatory scrutiny or significant civil and criminal liability and require us to incur significant technical, legal and other expenses.

Our risk management policies and procedures could leave us exposed to unidentified or unanticipated risk, which could negatively affect our business or result in losses.

We have developed risk management policies and procedures designed to manage material risks within established risk appetites and risk tolerances. Nonetheless, our policies and procedures may not effectively mitigate the internal and external risks identified or predict future exposures, which could be different or significantly greater than expected. Many of our methods of managing risk and exposures are based upon observed historical data, current market behavior, and certain assumptions made by management. The information may not always be accurate, complete, up-to-date, or properly evaluated. As a result, additional risks and uncertainties not currently known to us, or that we currently deem to be immaterial, may adversely affect our business, financial condition or operating results. See section titled “Risk Management” in Item 1. Business for further discussion of the Company’s risk assessment.

We are exposed to the risks of natural and man-made catastrophes, pandemics and malicious and terrorist acts that could materially adversely affect our business, financial condition and results of operations.

Natural and man-made catastrophes, pandemics and malicious and terrorist acts present risks that could materially adversely affect our results of operations or the mortality or morbidity experience of our business. Claims arising from such events could have a material adverse effect on our business, operations and financial condition, either directly or as a result of their effect on our reinsurers or other counterparties. Such events could also have an adverse effect on lapses and surrenders of existing policies, as well as sales of new policies. While we have taken steps to identify and mitigate these risks, such risks cannot be predicted, nor fully protected against even if anticipated. In addition, such events could result in overall macroeconomic volatility or specifically a decrease or halt in economic activity in large geographic areas, adversely affecting the marketing or administration of our business within such geographic areas or the general economic climate, which in turn could have an adverse effect on our business, operations and financial condition. The possible macroeconomic effects of such events could also adversely affect our asset portfolio.

46

We operate in a highly competitive industry, which could limit our ability to gain or maintain our position in the industry and could materially adversely affect our business, financial condition and results of operations.

We operate in a highly competitive industry. We encounter significant competition in all of our product lines from other insurance companies, many of which have greater financial resources and higher financial strength ratings than us and which may have a greater market share, offer a broader range of products, services or features, assume a greater level of risk, have lower operating or financing costs, or have different profitability expectations than us. Competition could result in, among other things, lower sales or higher lapses of existing products.

Our annuity products compete with fixed indexed, fixed rate and variable annuities sold by other insurance companies and also with mutual fund products, traditional bank investments and other retirement funding alternatives offered by asset managers, banks and broker-dealers. The ability of banks and broker dealers to increase their securities-related business or to affiliate with insurance companies may materially and adversely affect sales of all of our products by substantially increasing the number and financial strength of potential competitors. Our insurance products compete with those of other insurance companies, financial intermediaries and other institutions based on a number of factors, including premium rates, policy terms and conditions, service provided to distribution channels and policyholders, ratings by rating agencies, reputation and commission structures.

Our ability to compete is dependent upon, among other things, our ability to develop competitive and profitable products, our ability to maintain low unit costs, and our maintenance of adequate financial strength ratings from rating agencies. Our ability to compete is also dependent upon, among other things, our ability to attract and retain distribution channels to market our products, the competition for which is vigorous.

The Setting Every Community Up for Retirement Enhancement Act of 2019, may impact our business and the markets in which we compete

The Setting Every Community Up for Retirement Enhancement Act of 2019, Pub.L. 116-94 (the “SECURE Act”), was signed into law on December 20, 2019 as part of the Further Consolidated Appropriations Act, 2020 and takes effect in certain respects as early as January 1, 2020. The SECURE Act contains provisions that may impact our business, including: elimination of the “stretch IRA” (funds from inherited IRAs must now be fully withdrawn by beneficiaries within 10 years of the account owner’s death and, as a result, IRAs may be less desirable to our customers, and our administrative system for handling distributions from IRAs invested in our annuity products may need to be updated to reflect the shortened distribution period for IRA beneficiaries); elimination of age limit for making traditional IRA contributions; raising of the age for required minimum distributions from IRAs from 70½ to 72 (particularly impacting our administrative system for handling distributions from IRAs invested in our annuity products); expansion of 401K plan eligibility for part-time workers; creation of new employer protections for offering annuities, including a fiduciary safe harbor for employer retirement plan sponsors that wish to add in-plan annuity products (particularly impacting how we and our competitors may now sell annuity products to employers or provide certifications necessary to meet the SECURE Act fiduciary safe harbor requirements); and lowering of barriers for offering multiple employer plans. The SECURE Act changes may also affect, to some extent, the length of time that IRA assets remain in our annuity products. While we cannot predict whether, or to what extent, the SECURE Act will ultimately impact us, the SECURE Act may have implications for our business operations and the markets in which we compete. See section titled “The SECURE Act” in Item 1. Business.

If we are unable to attract and retain national marketing organizations and independent agents, sales of our products may be reduced.

We must attract and retain our network of IMOs and independent agents to sell our products. Insurance companies compete vigorously for productive agents. We compete with other life insurance companies for marketers and agents primarily on the basis of our financial position, support services, compensation and product features. Such marketers and agents may promote products offered by other life insurance companies that offer a larger variety of products than we do. If we are unable to attract and retain a sufficient number of marketers and agents to sell our products, our ability to compete and our revenues would suffer.

47

We are a holding company with limited operations of our own. As a consequence, our ability to pay dividends on our stock will depend on the ability of our subsidiaries to pay dividends to us, which may be restricted by law.

We are a holding company with limited business operations of our own. Our primary subsidiaries are insurance subsidiaries that own substantially all of our assets and conduct substantially all of our operations. The Iowa insurance law and the New York insurance law regulate the amount of dividends that may be paid in any year by FGL Insurance and FGL NY Insurance, respectively. Accordingly, our payment of dividends is dependent, to a significant extent, on the generation of cash flow by our subsidiaries and their ability to make such cash available to us, by dividend or otherwise. Our subsidiaries may not be able to, or may not be permitted to, make distributions to enable us to meet our obligations and pay dividends. Each subsidiary is a distinct legal entity and legal and contractual restrictions may also limit our ability to obtain cash from our subsidiaries.

It is possible that in the future our insurance subsidiaries may be unable to pay dividends or distributions to us in an amount sufficient to meet our obligations or to pay dividends due to a lack of sufficient statutory net gain from operations, a diminishing statutory policyholders surplus, changes to the Iowa or New York insurance laws or regulations or for some other reason. In addition, Cayman Islands law may impose requirements that may restrict our ability to pay dividends to holders of our ordinary shares. Further, the covenants in the agreement governing the existing indebtedness of FGLH significantly restrict its ability to pay dividends, which further limits our ability to obtain cash or other assets from our subsidiaries. If our subsidiaries cannot pay sufficient dividends or distributions to us in the future, we would be unable to meet our obligations or to pay dividends. This would negatively affect our business and financial condition as well as the trading price of our ordinary shares. See section titled “Regulation-Dividend and Other Distribution Payment Limitations” in Item 1. Business for further discussion.

Our growth strategy includes selectively acquiring business through acquisitions of other insurance companies and reinsurance of insurance obligations written by unaffiliated insurance companies, and our ability to consummate these acquisitions on economically advantageous terms acceptable to us in the future is unknown.

We intend to grow our business in the future in part by acquisitions of other insurance companies and businesses, and through block reinsurance, which could materially increase the size of our business and could require additional capital, systems development and skilled personnel. Any such acquisitions could be funded through cash from operations, the issuance of equity and/or the incurrence of additional indebtedness, which amount may be material, or a combination thereof. We actively monitor the market for merger and acquisition opportunities; however the timing, structure and size of any such acquisitions are uncertain and any such acquisitions could be material.

Moreover, we may experience challenges identifying, financing, consummating and integrating such acquisitions and block reinsurance transactions. Competition exists in the market for profitable blocks of business and such competition is likely to intensify as insurance businesses become more attractive targets.

It is also possible that merger and acquisition transactions will become less frequent, or be difficult to consummate due to financing or other factors, which could also make it more difficult for us to implement this aspect of our growth strategy. Our acquisition and block reinsurance transaction activities may also divert the attention of our management from our business, which may have an adverse effect on our business and results of operations.

Occasionally we may acquire or seek to acquire an insurance company or business that writes businesses that are not core to our business. The ability of our management to transfer or source sufficient reasonably priced reinsurance for non-core businesses that we may acquire and want to dispose of may be limited. In the event that we were unable to find buyers or purchase adequate reinsurance, we would have to accept an increase in our net risk exposures, revise our pricing to reflect higher reinsurance premiums, or otherwise modify our acquisitions and product offerings, each of which could have a material adverse effect on our business, financial condition, results of operations and cash flows.

In furtherance of our strategy of growth through acquisitions, we may review and conduct investigations of potential acquisitions or block reinsurance transactions, some of which may be material. When we believe a favorable opportunity exists, we may seek to enter into discussions with target companies or sellers regarding the possibility of such transactions. At any given time, we may be in discussions with one or more counterparties. There can be no assurance that any such negotiations will lead to definitive agreements, or if such agreements are reached, that any transactions would be consummated.

48

The founders and Blackstone affiliates own a significant portion of our issued and outstanding voting shares and have nomination rights with respect to our board of directors and have agreed to vote together for nominees selected pursuant to the Nominating and Voting Agreement.

The founders beneficially own approximately 13% of our ordinary shares, and Blackstone affiliates (including GSO) beneficially own approximately 20% of our ordinary shares, in each case excluding warrants held by such parties that are currently exercisable. As long as the founders and Blackstone affiliates own or control a significant percentage of our outstanding voting power, they will have the ability to strongly influence all corporate actions requiring shareholder approval, including the election and removal of directors and the size of our board of directors, any amendment of our Charter, or the approval of any merger or other significant corporate transaction, including a sale of substantially all of our assets.

In addition, we have entered into a nominating and voting agreement (the “Nominating and Voting Agreement”) with Mr. Foley, Mr. Chu and Blackstone Tactical Opportunities Fund II L.P. (“BTO”) (collectively, the “Nominating Parties”), pursuant to which, if the Nominating Parties and their respective affiliates own, in the aggregate, directly or indirectly, at least 20% of our issued and outstanding ordinary shares, the Nominating Parties will have the right to designate one director nominee for election at each general meeting of the Company. If the Nominating Parties and their respective affiliates own, in the aggregate, directly or indirectly, at least 12% but less than 20% of the issued and outstanding ordinary shares (the “Two Director Range”), the Nominating Parties will have the right to designate one director nominee for each of the two director classes (the “Two Director Classes”) to be voted on at the two general meetings of the Company immediately after the aggregate ownership of ordinary shares comes within the Two Director Range and for each subsequent meeting at which one of the Two Director Classes is to be voted on by the shareholders, provided that such aggregate ownership remains within the Two Director Range at the time of each such nomination.

If the Nominating Parties and their respective affiliates own, in the aggregate, directly or indirectly, at least 5% but less than 12% of the issued and outstanding ordinary shares (the “One Director Range”), the Nominating Parties will have the right to designate one director nominee for the class of directors (the “One Director Class”) to be voted on at the general meeting of the Company immediately after the aggregate ownership of ordinary shares comes within the One Director Range and for each subsequent meeting at which the One Director Class is to be voted on by the shareholders, provided that such aggregate ownership remains within the One Director Range at the time of each such nomination.

Director nominees selected under the Nominating and Voting Agreement will be selected by the vote of any two of Mr. Foley, Mr. Chu and BTO. In addition, pursuant to the Nominating and Voting Agreement, each of Mr. Foley, Mr. Chu and BTO agreed to vote their respective ordinary shares for each director so nominated.

The interests of the founders and Blackstone affiliates may not align with the interests of our other shareholders. The founders and Blackstone are in the business of making investments in companies and may acquire and hold interests in businesses that compete directly or indirectly with us. The founders and Blackstone may also pursue acquisition opportunities that may be complementary to our business, and, as a result, those acquisition opportunities may not be available to us.

Warrants, including those issued in connection with the business combination, exercised for our ordinary share would increase the number of shares eligible for future resale in the public market and result in dilution to our shareholders.

We issued warrants to purchase 34,500 ordinary shares as part of our IPO, and we issued an aggregate of 17,300 private placement warrants to CF Capital Growth, LLC ("Sponsor"), each exercisable to purchase one whole ordinary share at $11.50 per whole share. In connection with the business combination, we also issued an aggregate of 19,083 forward purchase warrants to the anchor investors. A total of 65,374 warrants were tendered prior to October 4, 2018, the date of expiration of the Company's offer to exchange. On October 9, 2018, the Company issued 7,191 shares and paid $64 in cash in exchange for the warrants tendered. After completion of the offer to exchange, 5,510 warrants still remain outstanding, which will expire on November 30, 2022, or upon earlier redemption or liquidation.

To the extent the warrants that remain outstanding are exercised, additional ordinary shares will be issued, which will result in dilution to the then existing holders of our ordinary shares and increase the number of shares eligible for resale in the public market. Sales of substantial numbers of such shares in the public market could adversely affect the market price of our ordinary shares. In addition, such dilution could, among other things, limit the ability of our current shareholders to influence management through the election of directors.

49

We may amend the terms of the warrants in a manner that may be adverse to holders with the approval by the holders of at least 65% of the then outstanding public warrants. As a result, the exercise price of the warrants could be increased, the exercise period could be shortened and the number of ordinary shares purchasable upon exercise of a warrant could be decreased, all without the approval of the holders of the warrants.

Our warrants were issued in registered form under a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 65% of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders. Accordingly, we may amend the terms of the public warrants in a manner adverse to a holder if holders of at least 65% of the then outstanding public warrants approve of such amendment. Although our ability to amend the terms of the public warrants with the consent of at least 65% of the then outstanding public warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, shorten the exercise period or decrease the number of ordinary shares purchasable upon exercise of a warrant.

We may redeem unexpired warrants prior to their exercise at a time that is disadvantageous to warrant holders, thereby making their warrants worthless.

We have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of our ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30 trading-day period ending on the third trading day prior to the date we send the notice of redemption to the warrant holders. If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. Redemption of the outstanding warrants could force the warrant holders (i) to exercise their warrants and pay the exercise price therefor at a time when it may be disadvantageous for them to do so, (ii) to sell their warrants at the then-current market price when they might otherwise wish to hold their warrants or (iii) to accept the nominal redemption price which, at the time the outstanding warrants are called for redemption, is likely to be substantially less than the market value of their warrants. None of the warrants will be redeemable by us so long as they are held by our Sponsor or its permitted transferees.

Holders of our Series A Preferred Shares and Series B Preferred Shares will have no voting rights except under limited circumstances.

Except with respect to certain material and adverse changes to the Series A Preferred Shares or Series B Preferred Shares and the right to appoint a director upon certain nonpayment events, holders of the preferred shares do not have voting rights and will not have the right to vote for any members of the board of directors, except as may be required by law.

Upon a successful remarketing of the Series A Preferred Shares or Series B Preferred Shares, the terms of the preferred shares may be modified even if holders are unable to participate in the remarketing.

When we attempt to remarket the Series A Preferred Shares or Series B Preferred Shares, the remarketing agent will agree to use its reasonable best efforts to sell such preferred shares included in the remarketing. In connection with the remarketing, we and the remarketing agent may remarket such preferred shares with different terms prior to the remarketing, including a later earliest redemption date and a different dividend rate. Only the original holders may request or elect to participate in a remarketing. However, if the remarketing is successful, the modified terms will apply to all of the Series A Preferred Shares and Series B Preferred Shares, including those shares that were not included in the remarketing.

The Series A Preferred Shares and Series B Preferred Shares have no maturity or mandatory redemption date.

Each of the Series A Preferred Shares and Series B Preferred Shares is a perpetual equity security. The Series A Preferred Shares and Series B Preferred Shares have no maturity or mandatory redemption date and are not redeemable at the option of the holders. Accordingly, the Series A Preferred Shares and Series B Preferred Shares will remain outstanding indefinitely unless we elect to redeem the Series A Preferred Shares or Series B Preferred Shares or, in the case of an original holder, such original holder decides to convert its preferred shares, subject to the conditions described herein.

50

On or after November 30, 2022, we may redeem any or all of the Series A Preferred Shares or Series B Preferred Shares, and upon any redemption of the Series A Preferred Shares or Series B Preferred Shares, holders will not receive any “make whole” cash or shares or other compensation for future dividends or lost time value of the Series A Preferred Shares or Series B Preferred Shares.

On or after November 30, 2022 (or such later date as is determined in connection with a successful remarketing), we may redeem any or all of the Series A Preferred Shares or Series B Preferred Shares. The redemption price will equal 100% of the liquidation preference of the Series A Preferred Shares and Series B Preferred Shares to be redeemed, plus any accumulated and unpaid dividends (whether or not declared) to, but excluding, the redemption date. Upon any such redemption, we will not be required to pay any “make whole” cash or shares or otherwise compensate holders in any way for any future dividend payments, if any, that holders would have otherwise received or any other lost time value of the Series A Preferred Shares or Series B Preferred Shares.

Holders of the Series A Preferred Shares and Series B Preferred Shares have no right to vote for directors until and unless dividends on of the Series A Preferred Shares or Series B Preferred Shares are in arrears and unpaid for the equivalent of six or more dividend periods.

Until and unless dividends on any of the Series A Preferred Shares or Series B Preferred Shares are in arrears and unpaid for the equivalent of six or more dividend periods, purchasers of the Series A Preferred Shares and Series B Preferred Shares have no voting rights with respect to the election of directors. If dividends on any shares of the Series A Preferred Shares or Series B Preferred Shares are in arrears and unpaid for the equivalent of six or more dividend periods, whether or not consecutive, the holders of our Series A Preferred Shares and Series B Preferred Shares, voting as a single class with all of our other classes or series of preferred shares upon which equivalent voting rights have been conferred and are exercisable, will have the right to elect two additional directors to our board of directors. These voting rights and the terms of the directors so elected will continue until all dividends on the Series A Preferred Shares and Series B Preferred Shares have been paid in full, or declared and a sum or number of preferred shares sufficient for such payment is set aside for payment.

Item 1B. Unresolved Staff Comments

None.

Item 2. Properties

We lease our headquarters at 601 Locust Street, Des Moines, Iowa, and sublease property in Baltimore, Maryland. Such leases expire December 2020 and May 2021, respectively. In December 2019, we entered into a lease for a new headquarters located at 801 Grand Avenue, Des Moines, Iowa. We anticipate occupation of the premises by late 2020. We believe our existing facilities are suitable and adequate for our present purposes. As of January 2020, we believe that our Des Moines, Iowa, and Baltimore, Maryland, properties will be sufficient for us to conduct our operations.

Item 3. Legal Proceedings

See "Note 12. Commitments and Contingencies" to our audited consolidated financial statements.

Item 4. Mine Safety Disclosures

Not applicable.

51

PART II

Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities

Market Information

Our ordinary shares and warrants are listed on the NYSE under the symbols “FG” and “FG WS,” respectively. The Company’s ordinary shares and warrants began trading on the NYSE on December 1, 2017.

As of February 24, 2020, there were approximately 51 holders of record of our ordinary shares. This number does not include the stockholders for whom shares are held in a “nominee” or “street” name.

Dividends on Ordinary Shares

As previously disclosed, in December 2018, the Company's board of directors approved the implementation of a quarterly cash dividend of $0.01 per ordinary share, beginning in the first quarter of fiscal year 2019. The dividend equates to $0.04 per share on a full-year basis. The payment of cash dividends on ordinary shares in the future will be dependent upon the Company’s revenues and earnings, if any, capital requirements and general financial condition. The payment of any dividends on ordinary shares will be within the discretion of the Company’s board of directors at such time. In addition, the terms of the preferred shares and agreements governing the indebtedness of the Company and its subsidiaries contain restrictions on the Company’s ability to declare and pay dividends. For further discussion on dividends and other distribution payment limitations, see “Note 9. Equity” to our audited consolidated financial statements.

52

Performance Graph

The information contained in this Performance Graph section shall not be deemed to be “soliciting material” or “filed” or incorporated by reference in future filings with the SEC, or subject to the liabilities of Section 18 of the Securities Exchange Act of 1934, except to the extent that we specifically incorporate it by reference into a document filed under the Securities Act of 1933 or the Securities Exchange Act of 1934.

The following graph shows a comparison from July 8, 2016 (the date our ordinary shares commenced trading on the Nasdaq) through December 31, 2019 of the cumulative total return for our ordinary shares with the comparable cumulative return of two indices: the Standard & Poor's 500 Stock Index (S&P 500 Index) and the S&P 500 Life & Health Insurance Index. The graph assumes that $100 was invested at the market close on July 8, 2016 in ordinary shares of FGL Holdings and the two indices and assumes reinvestments of dividends. The stock price performance of the following graph is not necessarily indicative of future stock price performance.

Recent Sales of Unregistered Sales of Equity Securities

There were no sales of unregistered securities other than as previously reported by the Company in either its quarterly reports on Form 10-Q or current reports on Form 8-K.

As previously disclosed, on December 21, 2018, we issued a total of 3,813,476 stock options outside our 2017 Omnibus Incentive Plan to Christopher Blunt, our Chief Executive Officer, as an inducement material to Mr. Blunt’s entry into employment with FGL Holdings. For 3,200,000 of such stock options, fifty percent vest in five equal annual installments beginning on December 21, 2019, subject to continued employment, with the remaining fifty percent vesting in five equal installments beginning on December 21, 2019 based on attainment of performance objectives to be established by the board of directors on an annual basis, subject to continued employment. For 613,476 of such stock options, fifty percent vest in three equal annual installments beginning on March 15, 2021 based on attainment of specified return on equity performance metrics, subject to continued employment, with the remaining fifty percent vesting in five equal installments beginning on March 15, 2020 based on attainment of specified minimum stock prices, subject to continued employment.

Also on December 21, 2018, we issued a total of 2,106,738 stock options outside our 2017 Omnibus Incentive Plan to Jonathan Bayer, our Head of Corporate Development & Strategy, as an inducement material to Mr. Bayer’s entry into employment with FGL Holdings. For 1,800,000 of such stock options, fifty percent vest in five equal annual installments beginning on December 21, 2019, subject to continued employment, with the remaining fifty percent vesting in five equal installments beginning on December 21, 2019 based on attainment of performance objectives to be established by the board of directors on an annual basis, subject to continued employment. For 306,738 of such stock options, fifty percent vest in three equal annual installments beginning on March 15, 2021 based on attainment of specified return on equity performance metrics, subject to continued employment, with the remaining fifty percent vesting in five equal installments beginning on March 15, 2020 based on attainment of specified minimum stock prices, subject to continued employment.

53

These awards were granted as an inducement awards pursuant to NYSE Rule 303A.08 and in reliance on Section 4(a)(2) of the Securities Act of 1933, as amended.

Purchases of Equity Securities by the Issuer

On December 19, 2018, the Company's board of directors authorized a share repurchase program of up to $150 of the Company's outstanding common stock. This program will expire on December 15, 2020, and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company.

The following table provides information about our repurchases of our ordinary shares during the quarter ended December 31, 2019:

	Total number of shares purchased	Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs	Approximate dollar value of shares that may yet be purchased under the plans or programs (1)
Period
October 1 to October 31, 2019	2,030	$	8.34	2,030	$	81
November 1 to November 30, 2019	—	—		—	81
December 1 to December 31, 2019	—	—		—	81

(1) On December 19, 2018, the Company’s board of directors authorized and the Company announced a share repurchase program of up to $150 million of the Company’s outstanding ordinary shares. This repurchase program will expire on December 15, 2020, and may be modified at any time.

The company's offer to exchange any and all of its outstanding warrants for 0.11 ordinary shares of the Company, par value $0.0001, and $0.98, in cash, without interest, per warrant expired on October 4, 2018. A total of 65,374 warrants were properly tendered prior to the expiration of the offer to exchange. On October 9, 2018, the Company issued an aggregate of 7,191 ordinary shares and paid $64 million in cash in exchange for the warrants tendered. After completion of the offer to exchange, 5,510 warrants remain outstanding, which will expire on November 30, 2022, or upon earlier redemption or liquidation.

54

Item 6. Selected Financial Data

We have prepared the following selected financial data as of and for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 31, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor years ended September 30, 2017, and 2016.

As a result of the business combination ("Business Combination"), for accounting purposes, FGL Holdings is the acquirer and FGL is the acquired party and accounting predecessor. Our financial statement presentation includes the financial statements of FGL and its subsidiaries as “Predecessor” for the periods prior to the completion of the Business Combination, and FGL Holdings, including the consolidation of FGL and its subsidiaries and F&G Reinsurance Companies, for periods from and after the Closing Date. FGL Holdings is the surviving company organized and existing under the laws of the United States of America, any State of the United States, the District of Columbia or any territory thereof (and in the case of the Company, Bermuda or the Cayman Islands). Prior to the Business Combination, FGL Holdings reported under a fiscal year end of December 31 and the Predecessor companies reported under a fiscal year end of September 30. Subsequent to the Business Combination, FGL Holdings reports under a fiscal year end of December 31.

	FGL Holdings								Fidelity & Guaranty Life
	Year ended					Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017
(In millions, except share data)	December 31, 2019		December 31, 2018
									Predecessor
SUMMARY OF OPERATIONS
Total operating revenues	$	2,113	$	711		$	165		$	362
Total benefits and expenses	1,513		653			144			314
Net income (loss)	$	507	$	13		$	(91	)	$	28
PER SHARE DATA
Net income per common share - basic	$	2.19	$	(0.07	)	$	(0.44	)	$	0.48
Net income per common share - diluted	$	2.19	$	(0.07	)	$	(0.44	)	$	0.47
Cash dividends declared per common share	$	0.04	$	—		$	—		$	0.065
Common shares outstanding (includes treasury shares of 8.7 and 0.6 for the years ended December 31, 2019 and December 31, 2018 respectively)	221.8		221.1			214.4			59.0
BALANCE SHEET DATA
Total investments	$	27,954	$	23,917		$	23,604		$	23,326
Total assets	36,714		30,945			29,923			29,227
Total debt	542		541			412			405
Total liabilities	33,971		30,055			27,960			26,943
Total equity	2,743		890			1,963			2,284
Total equity excluding AOCI	2,262		1,827			1,888			1,729

55

	Fidelity & Guaranty Life
	Period from October 1 to December 31, 2016 (Unaudited)		Year ended
(In millions, except share data)			September 30, 2017		September 30, 2016
	Predecessor		Predecessor		Predecessor
SUMMARY OF OPERATIONS
Total operating revenues	$	340	$	1,530	$	1,139
Total benefits and expenses	171		1,173		964
Net income	$	108	$	223	$	97
PER SHARE DATA
Net income per common share - basic	$	1.85	$	3.83	$	1.67
Net income per common share - diluted	$	1.85	$	3.83	$	1.66
Cash dividends declared per common share	$	0.065	$	0.26	$	0.26
Common shares outstanding	59.0		58.9		59.0
BALANCE SHEET DATA
Total investments	$	21,076	$	23,072	$	21,025
Total assets	26,952		28,965		27,035
Total debt	400		405		400
Total liabilities	25,200		26,718		25,101
Total equity	1,752		2,247		1,934
Total equity excluding AOCI	1,599		1,704		1,495

56

Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Introduction

This “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of FGL Holdings (“FGL Holdings,” “we,” “us,” “our” and, collectively with its subsidiaries, the “Company”) should be read in conjunction with “Item 6. Selected Financial Data,” and our accompanying consolidated financial statements and related notes (the “Consolidated Financial Statements”) referred to in “Item 8. Financial Statements and Supplementary Data” of this Annual Report on Form 10-K (the “Form 10-K”). Certain statements we make under this Item 7 constitute “forward-looking statements” under the Private Securities Litigation Reform Act of 1995. See “Forward-Looking Statements” at the beginning of Part I of this Form 10-K. You should consider our forward-looking statements in light of our Consolidated Financial Statements, related notes, and other financial information appearing elsewhere in this Form 10-K and our other filings with the SEC.

Basis of Presentation

As a result of the completion of the Business Combination on November 30, 2017, our Consolidated Financial Statements included elsewhere in the Annual Report are presented: (i) as of December 31, 2019 and for the year ended December 31, 2019; (ii) as of December 31, 2018 and the year ended December 31, 2018; (iii) for the period December 1, 2017 to December 31, 2017; (iv) for the period October 1, 2017 to November 30, 2017 (Predecessor); (v) for the unaudited period October 1, 2016 to December 31, 2016 (Predecessor); and (vi) for the year ended September 30, 2017 (Predecessor). In this Management’s Discussion and Analysis of Financial Condition and Results of Operations, we present the Predecessor’s year ended September 30, 2017 results. We believe this discussion provides helpful information with respect to performance of our business during those respective periods. In Management’s Discussion and Analysis of Financial Condition and Results of Operations included within this Form 10-K, we discuss consolidated financial results for the year ended December 31, 2019 compared to the year ended December 31, 2018. Discussion for the period December 1, 2017 to December 31, 2017, the period October 1, 2017 to November 30, 2017 (Predecessor), the unaudited period October 1, 2016 to December 31, 2016 (Predecessor), and the year ended September 30, 2017 (Predecessor) is included within our Annual Report on Form 10-K for the year ended December 31, 2018.

Overview

See “Item 1. Business” for a detailed discussion of FGL Holdings company overview, strategy and products, as well as the February 7, 2020 announcement of an agreement to be acquired by Fidelity National Financial, Inc.

Trends and Uncertainties

The following factors represent some of the key trends and uncertainties that have influenced the development of our business and our historical financial performance and that we believe will continue to influence our business and financial performance in the future.

Market Conditions

Market volatility has affected and may continue to affect our business and financial performance in varying ways. Volatility can pressure sales and reduce demand as consumers hesitate to make financial decisions. To enhance the attractiveness and profitability of our products and services, we continually monitor the behavior of our customers, as evidenced by annuitization rates and lapse rates, which vary in response to changes in market conditions.

Interest Rate Environment

Some of our products include guaranteed minimum crediting rates, most notably our fixed rate annuities. As of December 31, 2019, the Company's reserves, net of reinsurance, and average crediting rate on our fixed rate annuities were $4 billion and 3%, respectively. We are required to pay the guaranteed minimum crediting rates even if earnings on our investment portfolio decline, which would negatively impact earnings. In addition, we expect more policyholders to hold policies with comparatively high guaranteed rates for a longer period in a low interest rate environment. Conversely, a rise in average yield on our investment portfolio would increase earnings if the average interest rate we pay on our products does not rise correspondingly. Similarly, we expect that policyholders would be less likely to hold policies with existing guarantees as interest rates rise and the relative value of other new business offerings are increased, which would negatively impact our earnings and cash flows.

57

See “Item 7A. Quantitative and Qualitative Disclosures about Market Risk” for a more detailed discussion of interest rate risk.

Aging of the U.S. Population

We believe that the aging of the U.S. population will increase the demand for our products. As the “baby boomer” generation prepares for retirement, we believe that demand for retirement savings, growth, and income products will grow. The impact of this growth may be offset to some extent by asset outflows as an increasing percentage of the population begins withdrawing assets to convert their savings into income.

Industry Factors and Trends Affecting Our Results of Operations

Demographics and macroeconomic factors are increasing the demand for our FIA and IUL products. Over 10,000 people will turn 65 each day in the United States over the next 15 years, and according to the U.S. Census Bureau, the proportion of the U.S. population over the age of 65 is expected to grow from 15% in 2015 to 20% in 2030.

We operate in the sector of the insurance industry that focuses on the needs of middle-income Americans. The underserved middle-income market represents a major growth opportunity for the Company. As a tool for addressing the unmet need for retirement planning, we believe that many middle-income Americans have grown to appreciate the “sleep at night protection” that annuities such as our FIA products afford. Accordingly, the FIA market grew from nearly $12 billion of sales in 2002 to $68 billion of sales in 2018. Additionally, this market demand has positively impacted the IUL market as it has expanded from $100 million of annual premiums in 2002 to $2 billion of annual premiums in 2018.

Competition

Please refer to the section titled "Competition" in Item 1. Business for discussion on our competition.

Annuity and Life Sales

We regularly monitor and report the production volume metric titled “Sales”. Sales are not derived from any specific GAAP income statement accounts or line items and should not be viewed as a substitute for any financial measure determined in accordance with GAAP. Annuity and IUL sales are recorded as deposit liabilities (i.e. contractholder funds) within the Company's consolidated financial statements in accordance with GAAP. Management believes that presentation of sales, as measured for management purposes, enhances the understanding of our business and helps depict longer term trends that may not be apparent in the results of operations due to the timing of sales and revenue recognition. Sales of annuities and IULs were as follows:

	Annuity Sales						IUL Sales
(Dollars in millions)	2019		2018		2017		2019		2018		2017
First Quarter	$	1,053	$	778	$	732	$	8	$	6	$	14
Second Quarter	1,122		769		582		10		7		9
Third Quarter	797		842		588		9		7		6
Fourth Quarter	921		957		623		11		8		7
Total	$	3,893	$	3,346	$	2,525	$	38	$	28	$	36

58

Key Components of Our Historical Results of Operations

Under U.S. GAAP, premium collections for fixed indexed annuities, fixed rate annuities, and immediate annuities without life contingency are reported in the financial statements as deposit liabilities (i.e., contractholder funds) instead of as sales or revenues. Similarly, cash payments to customers are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income; surrender, cost of insurance, and other charges deducted from contractholder funds; and net realized gains (losses) on investments. Components of expenses for products accounted for as deposit liabilities are interest-sensitive and index product benefits (primarily interest credited to account balances or the cost of providing index credits to the policyholder), amortization of deferred acquisition cost (“DAC”), deferred sales inducements ("DSI"), and value of business acquired (“VOBA”), other operating costs and expenses, and income taxes.

Through our insurance subsidiaries, we issue a broad portfolio of deferred annuities (fixed indexed and fixed rate annuities) and immediate annuities. A deferred annuity is a type of contract that accumulates value on a tax deferred basis and typically begins making specified periodic or lump sum payments a certain number of years after the contract has been issued. An immediate annuity is a type of contract that begins making specified payments within one annuity period (e.g., one month or one year) and typically makes payments of principal and interest earnings over a period of time.

The Company hedges certain portions of its exposure to product related equity market risk by entering into derivative transactions. We purchase derivatives consisting predominantly of call options and, to a lesser degree, futures contracts on the equity indices underlying the applicable policy. These derivatives are used to offset the statutory reserve impact of the index credits due to policyholders under the FIA contracts. The majority of all such call options are one-year options purchased to match the funding requirements underlying the FIA contracts. We attempt to manage the cost of these purchases through the terms of our FIA contracts, which permit us to change caps, spread, or participation rates, subject to certain guaranteed minimums, on each contracts anniversary date. The call options and futures contracts are marked to fair value with the change in fair value included as a component of net investment gains (losses). The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instruments’ terms or upon early termination and the changes in fair value of open positions.

Earnings from products accounted for as deposit liabilities are primarily generated from the excess of net investment income earned over the sum of interest credited to policyholders and the cost of hedging our risk on FIA policies, known as the net investment spread. With respect to FIAs, the cost of hedging our risk includes the expenses incurred to fund the index credits. Proceeds received upon expiration or early termination of call options purchased to fund annual index credits are recorded as part of the change in fair value of derivatives, and are largely offset by an expense for index credits earned on annuity contractholder fund balances.

Our profitability depends in large part upon the amount of assets under management (“AUM”), the net investment spreads earned on our AUM, our ability to manage our operating expenses and the costs of acquiring new business (principally commissions to agents and bonuses credited to policyholders). As we grow AUM, earnings generally increase. AUM increases when cash inflows, which include sales, exceed cash outflows. Managing net investment spreads involves the ability to maximize returns on our AUM and minimize risks such as interest rate changes and defaults or impairment of investments. It also includes our ability to manage interest rates credited to policyholders and costs of the options and futures purchased to fund the annual index credits on the FIAs or IULs. We analyze returns on average assets under management ("AAUM") pre- and post-DAC, DSI, and VOBA as well as pre- and post-tax to measure our profitability in terms of growth and improved earnings.

Non-GAAP Financial Measures

Management believes that certain non-GAAP financial measures may be useful in certain instances to provide additional meaningful comparisons between current results and results in prior operating periods. Our non-GAAP measures may not be comparable to similarly titled measures of other organizations because other organizations may not calculate such non-GAAP measures in the same manner as we do. Reconciliations of such measures to the most comparable GAAP measures are included herein.

Adjusted Operating Income ("AOI") is a non-GAAP economic measure we use to evaluate financial performance each period. AOI is calculated by adjusting net income (loss) to eliminate:

59

(i) the impact of net investment gains/losses, including other than temporary impairment ("OTTI") losses recognized in operations, but excluding realized gains and losses on derivatives hedging our indexed annuity policies,

(ii) the impacts related to changes in the fair values of FIA related derivatives and embedded derivatives, net of hedging cost, and the fair value accounting impacts of assumed reinsurance by our international subsidiaries,

(iii) the tax effect of affiliated reinsurance embedded derivative,

(iv) the effect of change in fair value of the reinsurance related embedded derivative,

(v) the effect of integration, merger related & other non-operating items,

(vi) impact of extinguishment of debt, and

(vii) net impact from Tax Cuts and Jobs Act.

Adjustments to AOI are net of the corresponding impact on amortization of intangibles, as appropriate. The income tax impact related to these adjustments is measured using an effective tax rate, as appropriate by tax jurisdiction. While these adjustments are an integral part of the overall performance of the Company, market conditions and/or the non-operating nature of these items can overshadow the underlying performance of the core business. Accordingly, management considers this to be a useful measure internally and to investors and analysts in analyzing the trends of our operations.

Beginning with the quarter ended March 31, 2018, the Company updated its AOI definition to remove the residual impacts of fair value accounting on its FIA products, including gains and losses on derivatives hedging those policies. Management believes the revised measure enhances the understanding of the business post-merger and is more useful and relevant to investors as compared to the previous definition which eliminated only the effects of changes in the interest rates used to discount the FIA embedded derivative. Periods shown prior to March 31, 2018 have not been adjusted to reflect the new definition.

Beginning with the quarter ended December 31, 2018, the Company updated its AOI definition to remove the incremental change due to the impact of the fair value accounting election for international subsidiaries. Management believes this revision will enhance the understanding of our business as the Company executes its growth strategy through international third party assumed business and is more relevant to investors as the impact of fair value accounting election can create an increase/decrease in the assumed liabilities that does not match the increase/decrease of the corresponding assets. This change will be applied on a prospective basis as the Company executes its growth strategy through international third party assumed reinsurance.

AOI should not be used as a substitute for net income. However, we believe the adjustments made to net income in order to derive AOI provide an understanding of our overall results of operations. For example, we could have strong operating results in a given period, yet report net income that is materially less, if during such period the fair value of our derivative assets hedging the FIA index credit obligations decreased due to general equity market conditions but the embedded derivative liability related to the index credit obligation did not decrease in the same proportion as the derivative assets because of non-equity market factors such as interest rate movements. Similarly, we could also have poor operating results in a given period yet show net income that is materially greater, if during such period the fair value of the derivative assets increases but the embedded derivative liability did not increase in the same proportion as the derivative assets. We hedge our FIA index credits with a combination of static and dynamic strategies, which can result in earnings volatility, the effects of which are generally likely to reverse over time. Our management and board of directors review AOI and net income as part of their examination of our overall financial results. However, these examples illustrate the significant impact derivative and embedded derivative movements can have on our net income. Accordingly, our management and board of directors perform a review and analysis of these items, as part of their review of our hedging results each period.

The adjustments to net income are net of intangibles amortization, as appropriate. Amounts attributable to the fair value accounting for derivatives hedging the FIA index credits and the related embedded derivative liability fluctuate from period to period based upon changes in the fair values of call options purchased to fund the annual index credits for FIAs, changes in the interest rates used to discount the embedded derivative liability, and the fair value assumptions reflected in the embedded derivative liability. The accounting standards for fair value measurement require the discount rates used in the calculation of the embedded derivative liability to be based on risk-free interest rates as of the reporting date. The impact of the change in fair values of FIA related derivatives, embedded derivatives and hedging costs has been removed from net income in calculating AOI.

60

AAUM is a non-GAAP measure we use to assess the rate of return on assets available for reinvestment. AAUM is calculated as the sum of:

(i) total invested assets at amortized cost, excluding derivatives;

(ii) related party loans and investments;

(iii) accrued investment income;

(iv) funds withheld at fair value;

(v) the net payable/receivable for the purchase/sale of investments, and

(iv) cash and cash equivalents, excluding derivative collateral, at the beginning of the period and the end of each month in the period, divided by the total number of months in the period plus one.

Management considers this non-GAAP financial measure to be useful internally and to investors and analysts when assessing the rate of return on assets available for reinvestment.

Critical Accounting Policies and Estimates

General

The preparation of financial statements in conformity with GAAP requires management to make estimates and judgments that affect the reported amounts of certain assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical estimates and assumptions are evaluated on an ongoing basis based on historical developments, market conditions, industry trends and other information that is reasonable under the circumstances. There can be no assurance that actual results will conform to estimates and assumptions and that reported results of operations will not be materially affected by the need to make future accounting adjustments to reflect changes in these estimates and assumptions from time to time.

We have identified the following accounting policies and estimates as critical as they involve a higher degree of judgment and are subject to a significant degree of variability: valuation of available-for sale ("AFS") securities and derivatives, evaluation of OTTI, amortization of DAC, DSI and VOBA, reserves for future policy benefits and product guarantees and recognition of deferred income tax valuation allowances.

In developing these accounting estimates and policies, we make subjective and complex judgments that are inherently uncertain and subject to material changes as facts and circumstances develop. Although variability is inherent in these estimates, we believe the amounts provided are appropriate based upon the facts available upon preparation of our audited consolidated financial statements. We continually update and assess the facts and circumstances regarding all of these critical accounting matters and other significant accounting matters affecting estimates in our financial statements.

The above critical accounting estimates are also described in "Note 2. Significant Accounting Policies and Practices" to our audited consolidated financial statements.

Valuation of AFS Securities, Derivatives and Fund withheld for reinsurance receivables

Our fixed maturity securities classified as AFS are reported at fair value, with unrealized gains and losses included within accumulated other comprehensive income (loss) ("AOCI"), net of associated impact on intangibles adjustments and deferred income taxes. Our equity securities are reported at fair value, with unrealized gains and losses included within net income (loss). Unrealized gains and losses represent the difference between the cost or amortized cost basis and the fair value of these investments. We measure the fair value of our AFS securities based on assumptions used by market participants, which may include inherent risk and restrictions on the sale or use of an asset. The estimate of fair value is the price that would be received to sell an asset in an orderly transaction between market participants (“exit price”) in the principal market, or the most advantageous market in the absence of a principal market, for that asset or liability. We utilize independent pricing services in estimating the fair values of AFS securities. The independent pricing services incorporate a variety of observable market data in their valuation techniques, including: reported trading prices, benchmark yields, broker-dealer quotes, benchmark securities, bids and offers, credit ratings, relative credit information and other reference data.

F&G Re and FSRC have elected to apply the fair value option to account for its funds withheld receivables. F&G Re and FSRC measure fair value of the funds withheld receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. The valuation of AFS securities by F&G Re and FSRC follows the same process as the Company, as outlined above.

61

We categorize our AFS securities into a three-level hierarchy based on the priority of the inputs to the valuation technique. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets (Level 1) and the lowest priority to unobservable inputs (Level 3). If the inputs used to measure fair value fall within different levels of the hierarchy, the category level is based on the lowest priority level input that is significant to the fair value measurement of the instrument. The following table presents the fair value of fixed maturity securities and equity securities by pricing source and hierarchy level as of December 31, 2019 and December 31, 2018.

	As of December 31, 2019
(Dollars in millions)	Quoted Prices in Active Markets for Identical Assets (Level 1)			Significant Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)			Total
Fixed maturity securities available-for-sale and equity securities:
Prices via third party pricing services	$	714		$	21,250		$	1,043		$	23,007
Priced via independent broker quotations	—			—			1,720			1,720
Priced via other methods	—			—			1			1
Total	$	714		$	21,250		$	2,764		$	24,728
Available-for-sale embedded derivative:
Priced via other methods	—			—			21			21
Total	$	714		$	21,250		$	2,785		$	24,749
% of Total	3		%	86		%	11		%	100		%

	As of December 31, 2018
(Dollars in millions)	Quoted Prices in Active Markets for Identical Assets (Level 1)			Significant Observable Inputs (Level 2)			Significant Unobservable Inputs (Level 3)			Total
Fixed maturity securities available-for-sale and equity securities:
Prices via third party pricing services	$	833		$	19,185		$	15		$	20,033
Priced via independent broker quotations	—			—			1,692			1,692
Priced via other methods	—			—			716			716
Total	$	833		$	19,185		$	2,423		$	22,441
Available-for-sale embedded derivative:
Priced via other methods	—			—			14			14
Total	$	833		$	19,185		$	2,437		$	22,455
% of Total	4		%	85		%	10		%	99		%

Management’s assessment of all available data when determining fair value of the AFS securities is necessary to appropriately apply fair value accounting. The independent pricing services also take into account perceived market movements and sector news, as well as a security’s terms and conditions, including any features specific to that issue that may influence risk and marketability. Depending on the security, the priority of the use of observable market inputs may change as some observable market inputs may not be relevant or additional inputs may be necessary. We generally obtain one value from our primary external pricing service. In situations where a price is not available from the independent pricing service, we may obtain broker quotes or prices from additional parties recognized to be market participants. We believe the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. When quoted prices in active markets are not available, the determination of estimated fair value is based on market standard valuation methodologies, including discounted cash flows, matrix pricing, or other similar techniques.

62

We validate external valuations at least quarterly through a combination of procedures that include the evaluation of methodologies used by the pricing services, comparisons to valuations from other independent pricing services, analytical reviews and performance analysis of the prices against trends, and maintenance of a securities watch list. See “Note 4. Investments” and “Note 6. Fair Value of Financial Instruments” to our audited consolidated financial statements for a more complete discussion.

The fair value of derivative assets and liabilities is based upon valuation pricing models and represents what we would expect to receive or pay at the balance sheet date if we canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined internally using a conventional model and market observable inputs, including interest rates, yield curve volatilities and other factors. Credit risk related to the counterparty is considered when estimating the fair values of these derivatives. However, we are largely protected by collateral arrangements with counterparties when individual counterparty exposures exceed certain thresholds. The fair value of futures contracts at the balance sheet date represents the cumulative unsettled variation margin (open trade equity net of cash settlements). The fair values of the embedded derivatives in our FIA contracts are derived using market value of options, use of current and budgeted option cost, swap rates, mortality rates, surrender rates and non-performance spread and are classified as Level 3. The discount rate used to determine the fair value of our FIA embedded derivative liabilities includes an adjustment to reflect the risk that these obligations will not be fulfilled (“non-performance risk”). For the years ended December 31, 2019 and December 31, 2018, our non-performance risk adjustment was based on the expected loss due to default in debt obligations for similarly rated financial companies. See "Note 5. Derivative Financial Instruments” and "Note 6. Fair Value of Financial Instruments” to our audited consolidated financial statements for a more complete discussion.

As discussed in “Item 1. Business”, FGL Insurance entered into a reinsurance agreement with Kubera effective December 31, 2018, to cede certain MYGA and deferred annuity statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. This arrangement creates an obligation for FGL Insurance to pay Kubera at a later date, which results in an embedded derivative. This embedded derivative is considered a total return swap with contractual returns that are attributable to the assets and liabilities associated with this reinsurance arrangement. The fair value of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, were passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. The reinsurance related embedded derivative is reported in “Other assets” if in a net gain position, or “Other liabilities”, if in a net loss position, on the Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains (losses)” on the Consolidated Statements of Operations.

Evaluation of OTTI

We have a policy and process in place to evaluate securities and mortgage loans in our investment portfolio quarterly to assess whether there has been an OTTI. This evaluation process entails considerable judgment and estimation and involves monitoring market events and other items that could impact issuers. See "Note 2. Significant Accounting Policies and Practices" and "Note 4. Investments" to our audited consolidated financial statements for a more complete discussion over the Company's OTTI policy.

Intangibles

Acquisition costs that are incremental, direct costs of successful contract acquisition are capitalized as DAC. DAC consists principally of commissions. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. DSI consists of contract enhancements such as premium and interest bonuses credited to policyholder account balances.

VOBA is an intangible asset that reflects the amount recorded as insurance contract liabilities less the estimated fair value of in-force contracts in a life insurance company acquisition. It represents the portion of the purchase price that is allocated to the value of the rights to receive future cash flows from the business in force at the acquisition date.

DAC, DSI, and VOBA are subject to loss recognition testing on a quarterly basis or when an event occurs that may warrant loss recognition.

For annuity products and IUL, DAC, DSI and VOBA are being amortized in proportion to estimated gross profits from net investment spread margins, surrender charges and other product fees, policy benefits, maintenance expenses, mortality net of reinsurance ceded and expense margins, and recognized gains and losses on investments. Current and future period gross profits for FIA contracts also include the impact of amounts recorded for the change in fair value of derivatives and the change in fair value of embedded derivatives. At each valuation date, the most

63

recent quarter’s estimated gross profits are updated with actual gross profits and the assumptions underlying future estimated gross profits are evaluated for continued reasonableness. If the update of assumptions causes estimated gross profits to increase, DAC, DSI and VOBA amortization will decrease, resulting in lower amortization expense in the period. The opposite result occurs when the assumption update causes estimated gross profits to decrease. Current period amortization is adjusted retrospectively through an unlocking process when estimates of current or future gross profits (including the impact of recognized investment gains and losses) to be realized from a group of products are revised. Our estimates of future gross profits are based on actuarial assumptions related to the underlying policies’ terms, lives of the policies, duration of contract, yield on investments supporting the liabilities, cost to find policy obligations, and level of expenses necessary to maintain the polices over their entire lives.

Changes in assumptions can have a significant impact on DAC, DSI and VOBA, amortization rates and results of operations. Assumptions are management’s best estimate of future outcomes, and require considerable judgment. We periodically review assumptions against actual experience, and update our assumptions based on historical results and our best estimates of future experience when additional information becomes available.

Estimated future gross profits are sensitive to changes in interest rates, which are the most significant component of gross profits. Assumptions related to interest rate spreads and credit losses also impact estimated gross profits for products with credited rates. These assumptions are based on the current investment portfolio yields and credit quality, estimated future crediting rates, capital markets, and estimates of future interest rates and defaults. Significant assumptions also include policyholder behavior assumptions, such as surrender, lapse, and annuitization rates. We use a combination of actual and industry experience when setting and updating our policyholder behavior assumptions.

We perform sensitivity analyses to assess the impact that certain assumptions have on DAC, DSI and VOBA. The following table presents the estimated instantaneous net impact to income before income taxes of various assumption changes on our DAC, DSI and VOBA. The effects, increase or (decrease), presented are not representative of the aggregate impacts that could result if a combination of such changes to interest rates and other assumptions occurred.

(Dollars in millions)	As of December 31, 2019
A change to the long-term interest rate assumption of -50 basis points	$	(26	)
A change to the long-term interest rate assumption of +50 basis points	21
An assumed 10% increase in surrender rate	(1		)

Assumptions regarding shifts in market factors may be overly simplistic and not indicative of actual market behavior in stress scenarios.

Lower assumed interest rates or higher assumed annuity surrender rates tend to decrease the balances of DAC, DSI and VOBA, thus decreasing income before income taxes. Higher assumed interest rates or lower assumed annuity surrender rates tend to increase the balances of DAC, DSI and VOBA, thus increasing income before income taxes.

See “Note 2. Significant Accounting Policies and Practices”, “Note 3. Significant Risks and Uncertainties” and “Note 7. Intangibles” to our audited consolidated financial statements for a more complete discussion.

Reserves for Future Policy Benefits and Product Guarantees

The determination of future policy benefit reserves is dependent on actuarial assumptions. The principal assumptions used to establish liabilities for future policy benefits are based on our experience. These assumptions are established at issue of the contract and include mortality, morbidity, contract full and partial surrenders, investment returns, annuitization rates and expenses. The assumptions used require considerable judgment. We review overall policyholder experience at least annually and update these assumptions when deemed necessary based on additional information that becomes available. For traditional life and immediate annuity products, assumptions used in the reserve calculation can only be changed if the reserve is deemed to be insufficient. For all other insurance products, changes in assumptions will be used to calculate reserves. These changes in assumptions will also incorporate changes in risk free rates and option market values. Changes in, or deviations from, the assumptions previously used can significantly affect our reserve levels and related results of operations.

Mortality is the incidence of death amongst policyholders triggering the payment of underlying insurance coverage by the insurer. In addition, mortality also refers to the ceasing of payments on life-contingent annuities due to the death of the annuitant. We utilize a combination of actual and industry experience when setting our mortality assumptions.

64

A surrender rate is the percentage of account value surrendered by the policyholder. A lapse rate is the percentage of account value canceled by us due to nonpayment of premiums. We make estimates of expected full and partial surrenders of our fixed annuity products. Our surrender rate experience in the years ended December 31, 2019 and December 31, 2018 on the fixed annuity products averaged 4%, which is within our assumed ranges. Management’s best estimate of surrender behavior incorporates actual experience over the entire period, as we believe that, over the duration of the policies, we will experience the full range of policyholder behavior and market conditions. If actual surrender rates are significantly different from those assumed, such differences could have a significant effect on our reserve levels and related results of operations.

The assumptions used to establish the liabilities for our product guarantees require considerable judgment and are established as management’s best estimate of future outcomes. We periodically review these assumptions and, if necessary, update them based on additional information that becomes available. Changes in or deviations from the assumptions used can significantly affect our reserve levels and related results of operations.

At issue, and at each subsequent valuation, we determine the present value of the cost of the GMWB rider benefits in excess of benefits that are funded by the account value. We also calculate the expected value of the future rider charges providing for these benefits. We accumulate a reserve equal to the portion of these fees that would be required to fund the future benefits less benefits paid to date. In making these projections, a number of assumptions are made and we update these assumptions as experience emerges, and determined necessary. We have minimal experience to date on policyholder behavior for our GMWB products which we began issuing in 2008. As a result, future experience could lead to significant changes in our assumptions. If emerging experience deviates from our assumptions on GMWB utilizations, such deviations could have a significant effect on our reserve levels and related results of operations.

Our aggregate reserves for contractholder funds, future policy benefits and product guarantees on a direct and net basis as of December 31, 2019 are summarized as follows:

(Dollars in millions)	Direct		Reinsurance Recoverable			Net
Fixed indexed annuities	$	18,058	$	—		$	18,058
Fixed rate annuities	4,477		(892		)	3,585
Immediate annuities	3,291		(133		)	3,158
Universal life	1,633		(1,017		)	616
Traditional life	2,007		(1,171		)	836
Offshore reinsurance	1,953		—			1,953
Total	$	31,419	$	(3,213	)	$	28,206

Certain FIA products contain an embedded derivative; a feature that permits the holder to elect an interest rate return or an equity-index linked component, where interest credited to the contract is linked to the performance of various equity indices. The FIA embedded derivative is valued at fair value and included in the liability for contractholder funds in our Consolidated Balance Sheets with changes in fair value included as a component of “Benefits and other changes in policy reserves” in our Consolidated Statements of Operations.

See “Note 2. Significant Account Policies and Practices” to our audited consolidated financial statements for a more complete discussion.

Deferred Income Tax Valuation Allowance

Accounting Standards Codification section 740, Income Taxes (ASC 740), provides that deferred income tax assets are recognized for deductible temporary differences and operating loss and tax credit carry-forwards. A valuation allowance is recorded if, based on available information, it is more likely than not that deferred income tax assets will not be realized. Assessing the need for, and the amount of, a valuation allowance for deferred income tax assets requires significant judgment.

Future realization of deferred tax assets ultimately depends on the existence of sufficient taxable income of the appropriate character (i.e., ordinary income or capital gain) in either the carryback or carry-forward period under tax law. The four sources of taxable income that may be considered in determining whether a valuation allowance is required are:

• Future reversals of existing taxable temporary differences (i.e., offset of gross deferred tax assets against gross deferred tax liabilities);

• Taxable income in prior carryback years, if carryback is permitted under tax law;

65

• Tax planning strategies; and

• Future taxable income exclusive of reversing temporary differences and carry-forwards.

At each reporting date, management considers evidence that could impact the future realization of deferred tax assets. As of December 31, 2019, management gathered the following evidence concerning the future realization of deferred tax assets:

Positive Evidence:

• As of December 31, 2019, we were in a cumulative income position based on pre-tax income over the prior 12 quarters;

• We are projecting pre-tax GAAP income from continuing operations or we have tax planning opportunities in which to affect realization;

• We have a history of utilizing all significant tax attributes before they expire;

• For U.S. Life Companies, under new tax laws, net operating losses generated after December 31, 2017 can be carried forward indefinitely; and

• We have net unrealized capital gains as of December 31, 2019.

Negative Evidence:

• §382 limited carry-forwards reduce our ability to utilize tax attributes in future years; and

• Brief carryback/carry-forward period for capital losses.

Based on management’s evaluation of the above positive and negative evidence, management concluded that a valuation allowance continues to be necessary for the deferred tax assets of the non-life insurance companies and FSRC capital deferred tax assets at December 31, 2019. Management also concluded that a valuation allowance is no longer needed for US life insurance companies, as they do not have unrealized deferred tax assets, and for FSRC ordinary deferred tax assets. For the year ended December 31, 2019, the valuation allowance release recorded to the income statement related to the items above was $39.

Recent Accounting Pronouncements

Please refer to "Note 2. Significant Accounting Policies and Practices" to our audited consolidated financial statements for disclosure of recent accounting pronouncements.

66

Results of Operations

(All amounts presented in millions unless otherwise noted)

The following table sets forth the consolidated results of operations for the periods presented:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Revenues:
Premiums	$	40		$	54		$	3		$	7		$	11		$	42
Net investment income	1,229			1,107			92			174			240			1,005
Net investment gains (losses)	674			(629		)	42			146			51			316
Insurance and investment product fees and other	170			179			28			35			38			167
Total revenues	2,113			711			165			362			340			1,530
Benefits and expenses:
Benefits and other changes in policy reserves	1,057			423			124			227			20			843
Acquisition and operating expenses, net of deferrals	330			181			16			51			28			137
Amortization of intangibles	126			49			4			36			123			193
Total benefits and expenses	1,513			653			144			314			171			1,173
Operating income	600			58			21			48			169			357
Interest expense	(32		)	(29		)	(2		)	(4		)	(6		)	(24		)
Income (loss) before income taxes	568			29			19			44			163			333
Income tax (expense) benefit	(61		)	(16		)	(110		)	(16		)	(55		)	(110		)
Net income (loss)	$	507		$	13		$	(91	)	$	28		$	108		$	223
Less Preferred stock dividend	31			29			2			—			—			—
Net income (loss) available to common shareholders	$	476		$	(16	)	$	(93	)	$	28		$	108		$	223

The following table summarizes sales by product type for the periods presented:

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
							Predecessor		Predecessor		Predecessor
Fixed index annuities ("FIA")	$	2,820	$	2,283	$	175	$	287	$	551	$	1,868
Fixed rate annuities ("MYGA")	776		758		47		114		97		546
Institutional spread based	297		305		—		—		—		136
Total annuity	$	3,893	$	3,346	$	222	$	401	$	648	$	2,550
Index universal life ("IUL")	$	38	$	28	$	3	$	4	$	17	$	46
Flow reinsurance	$	394	$	185	$	8	$	—	$	—	$	—

• FIA and MYGA sales during the years ended December 31, 2019 and December 31, 2018 are the result of disciplined pricing to achieve profit and capital targets. Increased FIA sales during the year ended December 31, 2019 compared to December 31, 2018 reflect the Company’s growth strategy.

• Institutional spread based products reflect funding agreements with Federal Home Loan Bank, under an investment strategy that is as subject to fluctuation period to period.

67

• The increase in flow reinsurance during the year ended December 31, 2019 compared to December 31, 2018 reflect F&G Re's assumed third party flow reinsurance which includes the on-boarding of F&G Re's new flow reinsurance partner effective January 1, 2019.

Revenues

Premiums

Premiums primarily reflect insurance premiums for traditional life insurance products which are recognized as revenue when due from the policyholder. FGL Insurance has ceded the majority of its traditional life business to unaffiliated third party reinsurers. While the base contract has been reinsured, we continue to retain the return of premium rider. The traditional life insurance premiums are primarily related to the return of premium riders on traditional life contracts. The following table summarizes premium revenue for the periods presented:

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
							Predecessor		Predecessor		Predecessor
Traditional life insurance	$	26	$	30	$	3	$	6	$	10	$	27
Life-contingent immediate annuity	14		24		—		1		1		15
Premiums	$	40	$	54	$	3	$	7	$	11	$	42

• Traditional life insurance premiums for the year ended December 31, 2019 reflect a decrease compared to December 31, 2018 due to the continuing maturing of the return of premium block of business.

• Immediate annuity premiums for the year ended December 31, 2019 reflect a decrease compared to December 31, 2018 as a result of policyholder behavior for annuitizations as well as FGL Insurance's reinsurance agreements with Kubera Insurance (SAC) Ltd. ("Kubera"), effective December 31, 2018 and June 30, 2019.

68

Net investment income

Below is a summary of net investment income ("NII") for the periods presented:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Fixed maturity securities, available-for-sale	$	1,054		$	1,009		$	80		$	164		$	228		$	953
Equity securities	73			73			6			5			10			41
Funds withheld	65			28			2			—			—			—
Limited partnerships	81			17			1			3			1			5
Mortgage loans, invested cash, and other investments	72			50			4			6			6			28
Gross investment income	1,345			1,177			93			178			245			1,027
Investment expense	(116		)	(70		)	(1		)	(4		)	(5		)	(22		)
Net investment income	$	1,229		$	1,107		$	92		$	174		$	240		$	1,005

Our net investment spread and AAUM for the period is summarized as follows (annualized):

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Yield on AAUM (at amortized cost)	4.49		%	4.32		%	4.48		%	4.93		%	4.85		%	4.95		%
Less: Fixed interest credited and option cost	(2.26		)%	(2.37		)%	(2.47		)%	(2.49		)%	(2.56		)%	(2.53		)%
Net investment spread	2.23		%	1.95		%	2.01		%	2.44		%	2.29		%	2.42		%
AAUM	$	27,358		$	25,619		$	24,722		$	21,167		$	19,768		$	20,324

• The increase in AAUM from December 31, 2018 to December 31, 2019 is primarily the result of $2.1 billion net new business asset flows and an offshore $0.9 billion assumed third-party block reinsurance transaction, partially offset by $0.9 billion reinsurance cession to Kubera.

• NII for the year ended December 31, 2019 compared to December 31, 2018 increased primarily as a result of portfolio reposition uplift and invested asset growth, as described above, partially offset by higher planned for asset management fees. The volume increase period over period resulted in net investment income growth of $75, with the remaining $47 driven by an increase in rate.

69

Net investment gains (losses)

Below is a summary of the major components included in net investment gains (losses) for the periods presented:

	Year ended											Year ended
	December 31, 2019		December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
								Predecessor		Predecessor		Predecessor
Net realized and unrealized gains (losses) on fixed maturity available-for-sale securities, equity securities and other invested assets	$	176	$	(334	)	$	5	$	6	$	—	$	(19	)
Net realized and unrealized gains (losses) on certain derivatives instruments	434		(250		)	37		138		39		348
Change in fair value of funds withheld for reinsurance receivables and reinsurance related embedded derivatives (a)	57		(42		)	—		1		12		(16		)
Change in fair value of other derivatives and embedded derivatives	7		(3		)	—		1		—		3
Net investment gains (losses)	$	674	$	(629	)	$	42	$	146	$	51	$	316

(a) Change in fair value of reinsurance related embedded derivatives starting December 1, 2017 and after is due to F&G Re and FSRC unaffiliated third party business under the fair value option election. Starting January 1, 2019, the balance also includes activity related to the FGL Insurance and Kubera reinsurance treaty. The predecessor periods activity is due to the FGL Insurance and FSRC reinsurance treaty.

• Net investment gains for the year ended December 31, 2019 include realized gains on available-for-sale securities of $69 primarily resulting from the execution of planned portfolio re-positioning strategies, $127 of realized and unrealized gains on equity securities, and $23 of impairment losses.

• Net investment losses for the year ended December 31, 2018 include realized losses on available-for-sale securities of $160 primarily resulting from the execution of planned portfolio re-positioning strategy following the completion of the merger, $142 of realized and unrealized losses on equity securities, and $24 of impairment losses.

• We utilize a combination of static (call options) and dynamic (long futures contracts) instruments in our hedging strategy. A substantial portion of the call options and futures contracts are based upon the S&P 500 Index with the remainder based upon other equity, bond and gold market indices. See the table below for primary drivers of gains (losses) on certain derivatives.

70

The components of the realized and unrealized gains (losses) on certain derivative instruments hedging our indexed annuity and universal life products are as follows for the periods presented:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Call Options:
Gains (losses) on option expiration	$	(41	)	$	3		$	1		$	73		$	—		$	212
Change in unrealized gains (losses)	445			(247		)	33			56			39			126
Futures contracts:
Gains (losses) on futures contracts expiration	23			(7		)	2			7			1			7
Change in unrealized gains (losses)	4			(1		)	1			2			(1		)	3
Foreign currency forward:
Gains (losses) on foreign currency forward	3			2			—			—			—			—
Total net change in fair value	$	434		$	(250	)	$	37		$	138		$	39		$	348
Annual Point-to-Point Change in S&P 500 Index during the period	28		%	(6		)%	1		%	5		%	3		%	16		%

• Realized gains and losses on certain derivative instruments are directly correlated to the performance of the indices upon which the call options and futures contracts are based and the value of the derivatives at the time of expiration compared to the value at the time of purchase. Gains (losses) on option expiration reflect the movement during the years ended December 31, 2019 and 2018 on options settled during the respective period.

• Additionally, the change in unrealized gains and losses due to fair value of call options are primarily driven by the underlying performance of the S&P 500 Index during each respective year relative to the S&P 500 Index on the policyholder buy dates.

The average index credits to policyholders are as follows for the periods presented:

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
							Predecessor		Predecessor		Predecessor
Average Crediting Rate	2	%	4	%	6	%	6	%	2	%	4	%
S&P 500 Index:
Point-to-point strategy	3	%	4	%	4	%	4	%	4	%	4	%
Monthly average strategy	2	%	4	%	4	%	4	%	2	%	3	%
Monthly point-to-point strategy	—	%	4	%	10	%	10	%	1	%	4	%
3 year high water mark	18	%	15	%	13	%	16	%	15	%	13	%

• Actual amounts credited to contractholder fund balances may differ from the index appreciation due to contractual features in the FIA contracts (caps, spreads and participation rates) which allow the Company to manage the cost of the options purchased to fund the annual index credits. Market volatility compared to previous years can impact index credits differently than overall S&P 500 Index appreciation.

• The credits for the periods presented above were based on comparing the S&P 500 Index on each issue date in these respective periods to the same issue date in the respective prior year periods. Favorable S&P 500 Index performance at different points in these periods caused favorable changes in crediting rates for the 3 year high water mark strategy in the year ended December 31, 2019 compared to the year ended December 31, 2018. Unfavorable S&P 500 Index performance at different points in the periods presented caused a decline in crediting rates in the point-to-point, monthly average, and monthly point-to-point

71

strategies due to lower equity returns in the year ended December 31, 2019 compared to December 31, 2018.

Insurance and investment product fees and other

Insurance and investment product fees and other consists primarily of the cost of insurance on IUL policies, policy rider fees primarily on FIA policies and surrender charges assessed against policy withdrawals in excess of the policyholder's allowable penalty-free amounts (up to 10% of the prior year's value, subject to certain limitations). Below is a summary of the major components included in Insurance and investment product fees and other for the periods presented:

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
							Predecessor		Predecessor		Predecessor
Surrender charges	$	30	$	44	$	3	$	10	$	7	$	34
Cost of insurance fees and other income	140		135		25		25		31		133
Total insurance and investment product fees and other	$	170	$	179	$	28	$	35	$	38	$	167

• Surrender charges were higher in the prior year, primarily due to a higher number of universal life policy surrenders.

• Cost of insurance fees and other income changed year over year primarily due to the amortization of the deferred reinsurance gain established at the inception of FGL Insurance's reinsurance agreement with Kubera, effective December 31, 2018 and amended June 30, 2019, and the amortization of unearned revenue liability.

Benefits and expenses

Benefits and other changes in policy reserves

Below is a summary of the major components included in Benefits and other changes in policy reserves for the periods presented:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
FIA embedded derivative impact	$	391		$	(404	)	$	7	$	39	$	(136	)	$	6
Index credits, interest credited & bonuses	477			688			28		151		112			649
Annuity payments	138			150			13		25		40			152
Other policy benefits and reserve movements	73			(12		)	71		12		4			36
Change in fair value of reserve liabilities held at fair value	(22		)	1			5		—		—			—
Total benefits and other changes in policy reserves	$	1,057		$	423		$	124	$	227	$	20		$	843

• The FIA embedded derivative impact on reserve changes for the periods presented above are driven by changes in the equity markets and risk free rates during the respective periods. The change in risk free rates increased the FIA embedded derivative reserves by approximately $164 and reduced the FIA embedded derivative reserves by approximately $36 for the years ended December 31, 2019 and December 31, 2018, respectively. Equity market movements increased reserves by $266 and decreased reserves by $269 for the years ended December 31, 2019 and December 31, 2018, respectively. The change in equity market also impacts the market value of the derivative assets hedging our FIA policies. See table in the net investment gains/losses discussion above for summary and discussion of net unrealized gains (losses) on certain derivative instruments.

72

• Annually, the Company reviews assumptions associated with reserves for policy benefits and product guarantees. The years ended December 31, 2019 and December 31, 2018 included a decrease of $13 and $5 related to the annual surrender assumption update.

• Index credits, interest credited & bonuses changed during the periods presented primarily due to changes in the amount of index credits on FIA policies reflecting the fluctuation in performance of the S&P 500 Index relative to the S&P 500 Index level on the policyholder buy dates and related changes in the options and futures which fund FIA index credits. Increased index credits, interest credited & bonuses for the years ended December 31, 2019 and December 31, 2018 also reflect increased sales volume for FIA products.

• The change in the fair value of reserve liabilities held at fair value for the year ended December 31, 2019 was primarily due to assumption updates on F&G Re and FSRC's assumed business.

Acquisition and operating expenses, net of deferrals

Below is a summary of acquisition and operating expenses, net of deferrals for the periods presented:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
General expenses	$	160		$	150		$	11		$	47		$	25		$	120
Acquisition expenses	541			348			27			44			92			310
Deferred acquisition costs	(371		)	(317		)	(22		)	(40		)	(89		)	(293		)
Total acquisition and operating expenses, net of deferrals	$	330		$	181		$	16		$	51		$	28		$	137

• The increase in acquisition and operating expenses, net of deferrals, during the year ended December 31, 2019 compared to the year ended December 31, 2018 was primarily related to F&G Re closed block reinsurance transaction initial ceding commission (a corresponding offset is recognized in reserves under the fair value option election), ceding commissions on flow reinsurance, and project related costs, partially offset by a decrease in the preferred equity remarketing reimbursement embedded derivative liability.

Amortization of intangibles

Below is a summary of the major components included in amortization of intangibles for the periods presented:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Amortization	$	156		$	64		$	8		$	56		$	136		$	280
Interest	(35		)	(24		)	(2		)	(10		)	(13		)	(57		)
Unlocking	5			9			—			(10		)	—			(30		)
Total amortization of intangibles	$	126		$	49		$	6		$	36		$	123		$	193

• Amortization of intangibles is based on historical, current and future expected gross margins (pre-tax operating income before amortization). The change in amortization year over year is the result of actual gross profits ("AGPs") in each period on the DAC and VOBA lines of business ("LOBs"). The increase in amortization year over year was driven primarily by an increase in net investment gains.

• Annually, the Company reviews assumptions associated with the amortization of intangibles. For the year ended December 31, 2019, this resulted in a decrease in future expected margins and an increase of $3 amortization expense reported as a component of “unlocking”. In 2018, this assumption review process resulted in an increase in future expected margins and a corresponding decrease of $2 amortization expense.

73

Other items affecting net income

Interest expense

The interest expense and amortization of debt issuance costs of the Company's debt for the periods presented:

	Year ended											Year ended
	December 31, 2019		December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
								Predecessor		Predecessor		Predecessor
Debt	$	32	$	29		$	2	$	3	$	5	$	19
Revolving credit facility	—		2			—		1		1		5
Gain on extinguishment of debt	—		(2		)	—		—		—		—
Total interest expense	$	32	$	29		$	2	$	4	$	6	$	24

• On April 20, 2018, the Company completed a debt offering of $550 aggregate principal amount of 5.50% senior notes due 2025. The Company used the net proceeds of the offering (i) to repay $135 of borrowings under its revolving credit facility and related expenses and (ii) to redeem in full and satisfy and discharge all of the outstanding $300 aggregate principal amount of FGLH's outstanding 6.375% Senior Notes due 2021.

• The year ended December 31, 2018 reflects a $2 gain on extinguishment of the $300 debt, and interest on the 5.50% senior notes beginning April 20, 2018. The year ended December 31, 2019 reflects a full year of interest on the 5.50% senior notes.

Income tax (expense) benefit

Below is a summary of the major components included in Income tax expense for the periods presented:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Income before taxes	$	568		$	29		$	19		$	44		$	163		$	333
Income tax before valuation allowance and tax law impact	100			(22		)	(8		)	14			55			111
Change in tax law impact	—			—			131			—			—			—
Change in valuation allowance	(39		)	38			(13		)	2			—			(1		)
Income tax expense	$	61		$	16		$	110		$	16		$	55		$	110
Effective rate	11		%	55		%	579		%	37		%	34		%	33		%

• Income tax expense for the year ended December 31, 2019 was affected by the impact of the valuation allowance release, the benefit of low taxed international income in excess of the withholdings taxes, and favorable permanent adjustments, including low income housing credits and the dividends received deduction.

• Income tax expense for the year ended December 31, 2018 was affected by the impact of the valuation allowance expense, partially offset by the benefit of low taxed international income in excess of the BEAT, and favorable permanent adjustments, including low income housing credits and the dividends received deduction.

In assessing the recoverability of our deferred tax assets, we regularly consider the guidance outlined within Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes”. The guidance requires an assessment of both positive and negative evidence in determining the realizability of deferred tax assets. See "Note 11. Income Taxes" to our audited consolidated financial statements for additional information regarding deferred tax assets and our analysis for recoverability.

74

AOI

The table below shows the adjustments made to reconcile net income to AOI and AOI available to common shareholders for the periods presented:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Net income (loss)	$	507		$	13		$	(91	)	$	28		$	108		$	223
Adjustments to arrive at AOI:
Effect of investment losses (gains), net of offsets (a)	(170		)	288			—			(6		)	(1		)	13
Impacts related to changes in the fair values of FIA related derivatives and embedded derivatives, net of hedging cost, and the fair value accounting impacts of assumed reinsurance by our international subsidiaries (a) (b)	(19		)	(25		)	(8		)	(10		)	(92		)	(95		)
Effect of change in fair value of reinsurance related embedded derivative, net of offsets (a)	27			—			—			(1		)	(10		)	11
Effects of integration, merger related & other non-operating items	(1		)	40			(8		)	29			—			—
Effects of extinguishment of debt	—			(2		)	—			—			—			—
Tax effect of affiliated reinsurance embedded derivative	—			—			(20		)	—			—			—
Net impact of Tax Cuts and Jobs Act (c)	—			3			131			—			—			—
Tax impact of adjusting items	7			(31		)	(1		)	(4		)	36			25
AOI	$	351		$	286		$	3		$	36		$	41		$	177
Less Preferred stock dividend	$	31		$	29		$	2		$	—		$	—		$	—
AOI available to common shareholders	$	320		$	257		$	1		$	36		$	41		$	177

(a) Amounts are net of offsets related to value of business acquired ("VOBA"), deferred acquisition cost ("DAC"), deferred sale inducement ("DSI"), unearned revenue ("UREV") and cost of reinsurance amortization, as applicable.

(b) The updated definition of AOI removes the impact of fair value accounting of FIA products for periods after December 31, 2017 and the fair value accounting impacts of assumed reinsurance by our international subsidiaries for periods after September 30, 2018. Included in the one-month period ended December 31, 2017 is the impact of the immaterial error resulting from the model code error, net of VOBA amortization.

(c) For the year ended December 31, 2018, the Company recorded an immaterial out of period adjustment related to the December 1, 2017 fair value of the deferred income tax valuation allowance acquired from the Business Combination.  See "Note 2. Significant Accounting Policies and Practices" for additional information.

• AOI increased for the year ended December 31, 2019 primarily due to increased investment spread as a result of portfolio repositioning activity, disciplined crediting rate strategy, and invested asset growth. Included in these results were $30 net favorable actual to expected mortality within the single premium immediate annuity (“SPIA”) product line, $21 favorable market movement on the futures and options contracts held to economically hedge our indexed products, $18 tax benefit due to the release of the FSRC valuation allowance, and $11 net favorable adjustments resulting from the annual review of DAC, VOBA, and our international subsidiaries assumptions, partially offset by $23 project expenses.

• AOI increased for the year ended December 31, 2018, primary as a result of an increase in net investment income. Included in these results were favorable items related to $24 net tax benefit realized upon recapture of affiliated reinsurance (pursuant to a tax reform strategy), $22 net favorable actual to expected mortality within the SPIA product line and other reserve adjustments, $5 bond prepay income and other; partially offset by $9 unfavorable market movement on futures and options contracts held to economically hedge our indexed products and $5 project expenses.

75

Investment Portfolio

(All dollar amounts presented in millions unless otherwise noted)

The types of assets in which we may invest are influenced by various state laws, which prescribe qualified investment assets applicable to insurance companies. Within the parameters of these laws, we invest in assets giving consideration to four primary investment objectives: (i) maintain robust absolute returns; (ii) provide reliable yield and investment income; (iii) preserve capital and (iv) provide liquidity to meet policyholder and other corporate obligations.

Our investment portfolio is designed to contribute stable earnings and balance risk across diverse asset classes and is primarily invested in high quality fixed income securities.

As of December 31, 2019 and December 31, 2018, the fair value of our investment portfolio was approximately $28 billion and $24 billion, respectively, and was divided among the following asset class and sectors:

	December 31, 2019				December 31, 2018
	Fair Value		Percent		Fair Value		Percent
Fixed maturity securities, available for sale:
United States Government full faith and credit	$	34	—	%	$	119	—	%
United States Government sponsored entities	134		—	%	106		—	%
United States municipalities, states and territories	1,343		5	%	1,187		5	%
Foreign Governments	155		1	%	121		1	%
Corporate securities:
Finance, insurance and real estate	4,234		15	%	4,113		17	%
Manufacturing, construction and mining	771		3	%	574		2	%
Utilities, energy and related sectors	2,452		9	%	2,281		10	%
Wholesale/retail trade	1,617		6	%	1,376		6	%
Services, media and other	2,523		9	%	2,037		9	%
Hybrid securities	1,027		4	%	901		4	%
Non-agency residential mortgage-backed securities	820		3	%	925		4	%
Commercial mortgage-backed securities	2,922		10	%	2,537		10	%
Asset-backed securities	5,694		20	%	4,832		20	%
Total fixed maturity available for sale securities	23,726		85	%	21,109		88	%
Equity securities (a)	1,071		4	%	1,382		6	%
Commercial mortgage loans	435		1	%	483		2	%
Residential mortgage loans	848		3	%	187		1	%
Other (primarily derivatives and limited partnerships)	1,875		7	%	748		3	%
Total Investments	$	27,955	100	%	$	23,909	100	%

(a) Includes investment grade non-redeemable preferred stocks ($887 and $1,208, respectively).

Insurance statutes regulate the type of investments that our life insurance subsidiaries are permitted to make and limit the amount of funds that may be used for any one type of investment. In light of these statutes and regulations, and our business and investment strategy, we generally seek to invest in (i) corporate securities rated investment grade by established nationally recognized statistical rating organizations (each, an “NRSRO”), (ii) U.S. Government and government-sponsored agency securities, or (iii) securities of comparable investment quality, if not rated.

76

The following table summarizes the credit quality, by Nationally Recognized Statistical Ratings Organization ("NRSRO") rating, of our fixed income portfolio:

	December 31, 2019				December 31, 2018
Rating	Fair Value		Percent		Fair Value		Percent
AAA	$	496	2	%	$	627	3	%
AA	1,520		6	%	1,415		7	%
A	6,601		28	%	5,354		25	%
BBB	8,800		37	%	8,328		39	%
Not rated (c)	4,304		18	%	3,612		17	%
Total investment grade	21,721		91	%	19,336		91	%
BB (a)	1,353		6	%	1,307		6	%
B and below (b)	519		2	%	351		2	%
Not rated (c)	133		1	%	115		1	%
Total below investment grade	2,005		9	%	1,773		9	%
Total	$	23,726	100	%	$	21,109	100	%

(a) Includes $13 and $17 at December 31, 2019 and December 31, 2018, respectively, of non-agency residential mortgage-backed securities ("RMBS") that carry a National Association of Insurance Commissioners ("NAIC") 1 designation.

(b) Includes $138 and $175 at December 31, 2019 and December 31, 2018, respectively, of non-agency RMBS that carry a NAIC 1 designation.

(c) Securities denoted as not-rated by an NRSRO were classified as investment or non-investment grade according to the securities' respective NAIC designation.

The NAIC’s Securities Valuation Office ("SVO") is responsible for the day-to-day credit quality assessment and valuation of securities owned by state regulated insurance companies. Insurance companies report ownership of securities to the SVO when such securities are eligible for regulatory filings. The SVO conducts credit analysis on these securities for the purpose of assigning an NAIC designation or unit price. Typically, if a security has been rated by an NRSRO, the SVO utilizes that rating and assigns an NAIC designation based upon the following system:

NAIC Designation	NRSRO Equivalent Rating
1	AAA/AA/A
2	BBB
3	BB
4	B
5	CCC and lower
6	In or near default

The NAIC has adopted revised designation methodologies for non-agency RMBS, including RMBS backed by subprime mortgage loans and for commercial mortgage-backed securities ("CMBS"). The NAIC’s objective with the revised designation methodologies for these structured securities was to increase accuracy in assessing expected losses and to use the improved assessment to determine a more appropriate capital requirement for such structured securities. The NAIC designations for structured securities, including subprime and Alternative A-paper ("Alt-A") RMBS, are based upon a comparison of the bond’s amortized cost to the NAIC’s loss expectation for each security. Securities where modeling does not generate an expected loss in all scenarios are given the highest designation of NAIC 1. A number of our RMBS securities carry a NAIC 1 designation while the NRSRO rating indicates below investment grade. The revised methodologies reduce regulatory reliance on rating agencies and allow for greater regulatory input into the assumptions used to estimate expected losses from such structured securities. In the tables below, we present the rating of structured securities based on ratings from the revised NAIC rating methodologies described above (which in some cases do not correspond to rating agency designations). All NAIC designations (e.g., NAIC 1-6) are based on the revised NAIC methodologies.

77

The tables below present our fixed maturity securities by NAIC designation as of December 31, 2019 and December 31, 2018:

	December 31, 2019
NAIC Designation	Amortized Cost		Fair Value		Percent of Total Fair Value
1	$	12,326	$	12,829	54	%
2	9,046		9,350		39	%
3	1,112		1,108		5	%
4	273		280		1	%
5	157		159		1	%
6	—		—		—	%
Total	$	22,914	$	23,726	100	%
	December 31, 2018
NAIC Designation	Amortized Cost		Fair Value		Percent of Total Fair Value
1	$	11,245	$	10,928	52	%
2	9,677		9,003		43	%
3	1,064		967		4	%
4	155		139		1	%
5	71		65		—	%
6	7		7		—	%
Total	$	22,219	$	21,109	100	%

78

Investment Industry Concentration

The tables below presents the fair value of the top ten industry categories of our fixed maturity, equity securities, and FHLB common stock, and percent of total fixed maturity, equity securities, and FHLB common stock fair value as of December 31, 2019 and December 31, 2018:

	December 31, 2019
Top 10 Industry Concentration	Fair Value		Percent of Total Fair Value
ABS collateralized loan obligation ("CLO")	$	3,881	10	%
Whole loan collateralized mortgage obligation ("CMO")	2,479		16	%
Banking	2,414		6	%
ABS Other	1,779		5	%
Life insurance	1,610		7	%
Municipal	1,343		10	%
Electric	1,261		5	%
CMBS	887		3	%
Technology	694		3	%
Pipelines	648		4	%
Total	$	16,996	68	%

	December 31, 2018
Top 10 Industry Concentration	Fair Value		Percent of Total Fair Value
ABS collateralized loan obligation ("CLO")	$	3,283	15	%
Banking	2,491		11	%
Whole loan collateralized mortgage obligation ("CMO")	2,234		10	%
ABS Other	1,545		7	%
Life insurance	1,376		6	%
Municipal	1,187		5	%
Electric	939		4	%
CMBS	874		4	%
Pipelines	812		4	%
Property and casualty insurance	542		2	%
Total	$	15,283	68	%

79

The amortized cost and fair value of fixed maturity AFS securities by contractual maturities as of December 31, 2019 and December 31, 2018, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or prepay obligations.

	December 31, 2019				December 31, 2018
	Amortized Cost		Fair Value		Amortized Cost		Fair Value
Corporate, Non-structured Hybrids, Municipal and U.S. Government securities:
Due in one year or less	$	85	$	85	$	191	$	191
Due after one year through five years	888		914		817		794
Due after five years through ten years	2,020		2,082		2,219		2,137
Due after ten years	10,496		11,075		10,443		9,587
Subtotal	$	13,489	$	14,156	$	13,670	$	12,709
Other securities which provide for periodic payments:
Asset-backed securities	$	5,720	$	5,694	$	4,954	$	4,832
Commercial mortgage-backed securities	2,788		2,922		2,568		2,537
Residential mortgage-backed securities	917		954		1,027		1,031
Subtotal	$	9,425	$	9,570	$	8,549	$	8,400
Total fixed maturity available-for-sale securities	$	22,914	$	23,726	$	22,219	$	21,109

80

Non-Agency RMBS Exposure    

Our investment in non-agency RMBS securities is predicated on the conservative and adequate cushion between purchase price and NAIC 1 rating, general lack of sensitivity to interest rates, positive convexity to prepayment rates and correlation between the price of the securities and the unfolding recovery of the housing market.

The fair value of our investments in subprime and Alt-A RMBS securities was $81 and $130 as of December 31, 2019, respectively, and $104 and $163 as of December 31, 2018, respectively.

The following tables summarize our exposure to subprime and Alt-A RMBS by credit quality using NAIC designations, NRSRO ratings and vintage year as of December 31, 2019 and December 31, 2018:

	December 31, 2019				December 31, 2018
NAIC Designation:	Fair Value		Percent of Total		Fair Value		Percent of Total
1	$	193	92	%	$	245	92	%
2	6		3	%	18		7	%
3	1		—	%	—		—	%
4	11		5	%	4		1	%
5	—		—	%	—		—	%
6	—		—	%	—		—	%
Total	$	211	100	%	$	267	100	%
NRSRO:
AAA	$	1	—	%	$	1	—	%
AA	7		3	%	11		4	%
A	21		10	%	25		9	%
BBB	5		2	%	8		3	%
Not rated - Above investment grade (a)	34		16	%	46		17	%
BB and below	143		69	%	176		66	%
Total	$	211	100	%	$	267	100	%
Vintage:
2017	$	13	6	%	$	12	4	%
2016	—		—	%	15		6	%
2007	44		21	%	51		19	%
2006	55		26	%	63		24	%
2005 and prior	99		47	%	126		47	%
Total	$	211	100	%	$	267	100	%

(a) Securities denoted as not-rated by an NRSRO were classified as investment or non-investment grade according to the securities' respective NAIC designation.

81

ABS Exposure

As of December 31, 2019 and December 31, 2018, our ABS exposure was largely composed of CLOs, which comprised 68% and 68%, respectively, of all ABS holdings. These exposures are generally senior tranches of CLOs which have leveraged loans as their underlying collateral. The remainder of our ABS exposure was largely diversified by underlying collateral and issuer type, including automobile and home equity receivables.

As of December 31, 2019, the non-CLO exposure represents 32% of total ABS assets, or 6% of total invested assets, and the CLO and non-CLO positions were trading at a net unrealized gain (loss) position of $(65) and $38, respectively. As of December 31, 2018, the non-CLO exposure represented 32% of total ABS assets, or 6% of total invested assets, and the CLO and non-CLO positions were trading at a net unrealized gain (loss) position of $(128) and $6, respectively. The following tables summarize our ABS exposure.

	December 31, 2019				December 31, 2018
Asset Class	Fair Value		Percent		Fair Value		Percent
ABS CLO	$	3,881	68	%	$	3,283	68	%
ABS auto	34		1	%	1		—	%
ABS credit card	—		—	%	3		—	%
ABS other	1,779		31	%	1,545		32	%
Total ABS	$	5,694	100	%	$	4,832	100	%

Mortgage Loans

We rate all CMLs to quantify the level of risk. We place those loans with higher risk on a watch list and closely monitor them for collateral deficiency or other credit events that may lead to a potential loss of principal and/or interest. If we determine the value of any CML to be impaired (i.e., when it is probable that we will be unable to collect on amounts due according to the contractual terms of the loan agreement), the carrying value of the CML is reduced to either the present value of expected cash flows from the loan, discounted at the loan’s effective interest rate, or fair value of the collateral. For those mortgage loans that are determined to require foreclosure, the carrying value is reduced to the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. The carrying value of the impaired loans is reduced by establishing a specific write-down recorded in "Net realized capital gains (losses)" in the Consolidated Statements of Operations.

Loan-to-value (“LTV”) and debt service coverage (“DSC”) ratios are utilized as part of the review process described above. As of December 31, 2019, our mortgage loans on real estate portfolio had a weighted average DSC ratio of 2.21 , and a weighted average LTV ratio of 44%. See "Note 4. Investments" to our audited consolidated financial statements for additional information regarding our LTV and DSC ratios.

The Company's residential mortgage loans (“RML”) are closed end, amortizing loans and 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to reduce concentration risk. Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due and/or in nonaccrual status which is assessed monthly.

82

Unrealized Losses

The amortized cost and fair value of the fixed maturity securities and the equity securities that were in an unrealized loss position as of December 31, 2019 and December 31, 2018, were as follows:

	December 31, 2019
	Number of securities	Amortized Cost		Unrealized Losses			Fair Value
Fixed maturity securities, available for sale:
United States Government full faith and credit	2	$	6	$	—		$	6
United States Government sponsored agencies	33	36		—			36
United States municipalities, states and territories	23	188		(5		)	183
Corporate securities:
Finance, insurance and real estate	41	413		(14		)	399
Manufacturing, construction and mining	20	132		(2		)	130
Utilities, energy and related sectors	54	502		(30		)	472
Wholesale/retail trade	45	508		(19		)	489
Services, media and other	39	351		(7		)	344
Hybrid securities	10	87		(4		)	83
Non-agency residential mortgage backed securities	62	115		(3		)	112
Commercial mortgage backed securities	43	254		(6		)	248
Asset backed securities	364	3,249		(77		)	3,172
Total fixed maturity available for sale securities	736	5,841		(167		)	5,674
Equity securities	33	505		(17		)	488
Total investments	769	$	6,346	$	(184	)	$	6,162

	December 31, 2018
	Number of securities	Amortized Cost		Unrealized Losses			Fair Value
Fixed maturity securities, available for sale:
United States Government full faith and credit	15	$	120	$	(1	)	$	119
United States Government sponsored agencies	72	88		(2		)	86
United States municipalities, states and territories	103	1,054		(32		)	1,022
Foreign Governments	16	123		(8		)	115
Corporate securities:
Finance, insurance and real estate	300	3,721		(230		)	3,491
Manufacturing, construction and mining	86	613		(57		)	556
Utilities, energy and related sectors	237	2,347		(222		)	2,125
Wholesale/retail trade	211	1,469		(144		)	1,325
Services, media and other	266	2,179		(195		)	1,984
Hybrid securities	67	956		(91		)	865
Non-agency residential mortgage backed securities	110	249		(6		)	243
Commercial mortgage backed securities	205	1,768		(40		)	1,728
Asset backed securities	419	3,704		(137		)	3,567
Total fixed maturity available for sale securities	2,107	18,391		(1,165		)	17,226
Equity securities	95	1,523		(145		)	1,378
Total investments	2,202	$	19,914	$	(1,310	)	$	18,604

The gross unrealized loss position on the available-for-sale fixed maturity security and equity portfolio as of December 31, 2019 and December 31, 2018 was $184 and $1,310, respectively. The gross unrealized loss position decreased $1,126 from December 31, 2018 to December 31, 2019 as most components of the portfolio exhibited price appreciation due to interest rates and credit spreads narrowing during the year. Floating rate notes experienced some stress as LIBOR declined through the year in response to interest rate cuts from the US Federal Reserve Bank, however, some of this was mitigated by tightening spreads. The total book value of all securities in an unrealized loss position was $6,346 and $19,914 as of December 31, 2019 and December 31, 2018, respectively.

83

The total book value of all securities in an unrealized loss position decreased 68% from December 31, 2018 to December 31, 2019. The average market value/book value of the investment category with the largest unrealized loss position was 98% for asset backed securities and 92% for corporate bonds as of December 31, 2019 and December 31, 2018, respectively. In aggregate, asset backed securities represented 42% and corporate bonds represented 65% of the total unrealized loss position as of December 31, 2019 and December 31, 2018, respectively.

Our municipal bond exposure is a combination of general obligation bonds (fair value of $228 and an amortized cost of $215 as of December 31, 2019) and special revenue bonds (fair value of $1,115 and amortized cost of $1,069 as of December 31, 2019).

Across all municipal bonds, the largest issuer represented 9% of the category, less than 1% of the entire portfolio, and is rated NAIC 1. Our focus within municipal bonds is on NAIC 1 rated instruments, and 90% of our municipal bond exposure is rated NAIC 1.

The amortized cost and fair value of fixed maturity securities and equity securities (excluding U.S. Government and U.S. Government-sponsored agency securities) in an unrealized loss position greater than 20% and the number of months in an unrealized loss position with fixed maturity investment grade securities (NRSRO rating of BBB/Baa or higher) as of December 31, 2019 and December 31, 2018, were as follows:

	December 31, 2019
	Number of securities	Amortized Cost		Fair Value		Gross Unrealized Losses
Investment grade:
Less than six months	—	$	—	$	—	$	—
Six months or more and less than twelve months	—	—		—		—
Twelve months or greater	1	—		—		—
Total investment grade	1	—		—		—
Below investment grade:
Less than six months	1	3		2		(1		)
Six months or more and less than twelve months	—	—		—		—
Twelve months or greater	3	42		33		(9		)
Total below investment grade	4	45		35		(10		)
Total	5	$	45	$	35	$	(10	)

	December 31, 2018
	Number of securities	Amortized Cost		Fair Value		Gross Unrealized Losses
Investment grade:
Less than six months	3	$	23	$	18	$	(5	)
Six months or more and less than twelve months	10	72		55		(17		)
Twelve months or greater	4	25		19		(6		)
Total investment grade	17	120		92		(28		)
Below investment grade:
Less than six months	3	11		9		(2		)
Six months or more and less than twelve months	9	31		22		(9		)
Twelve months or greater	5	12		9		(3		)
Total below investment grade	17	54		40		(14		)
Total	34	$	174	$	132	$	(42	)

84

OTTI and Watch List

At December 31, 2019 and December 31, 2018, our watch list included 8 and 34 securities, respectively, in an unrealized loss position with an amortized cost of $45 and $174, unrealized losses of $10 and $42, and a fair value of $35 and $132, respectively. As part of the OTTI analysis, we evaluated each of these securities to assess the following:

•whether the issuer is currently meeting its financial obligations;

•its ability to continue to meet these obligations;

•its existing cash available;

•its access to additional available capital;

•any expense management actions the issuer has taken; and

•whether the issuer has the ability and willingness to sell non-core assets to generate liquidity.

Based on our analysis, these securities demonstrated that the December 31, 2019 and December 31, 2018 carrying values were fully recoverable.

There were 4 and 4 structured securities with a fair value of $0 and $6 on the watch list to which we had potential credit exposure as of December 31, 2019 and December 31, 2018, respectively. Our analysis of these structured securities, which included cash flow testing results, demonstrated the December 31, 2019 and December 31, 2018 values were fully recoverable.

Exposure to Sovereign Debt

Our investment portfolio had no direct exposure to European sovereign debt as of December 31, 2019 and December 31, 2018.

As of December 31, 2019 and December 31, 2018, the Company also had no material exposure risk related to financial investments in Puerto Rico.

Net Investment Income and Net Investment Gains (Losses)

For discussion regarding our net investment income and net investment gains (losses) refer to "Note 4. Investments" to our audited consolidated financial statements.

Available-For-Sale Securities

For additional information regarding our AFS securities, including the amortized cost, gross unrealized gains (losses), and fair value as well as the amortized cost and fair value of fixed maturity AFS securities by contractual maturities as of December 31, 2019, refer to "Note 4. Investments" to our audited consolidated financial statements.

Concentrations of Financial Instruments

For detail regarding our concentration of financial instruments refer to "Note 3. Significant Risks and Uncertainties" to our audited consolidated financial statements.

Derivatives

We are exposed to credit loss in the event of nonperformance by our counterparties on call options. We attempt to reduce this credit risk by purchasing such options from large, well-established financial institutions.

We also hold cash and cash equivalents received from counterparties for call option collateral, as well as U.S. Government securities pledged as call option collateral, if our counterparty’s net exposures exceed pre-determined thresholds.

The Company is required to pay counterparties the effective federal funds rate each day for cash collateral posted to FGL for daily mark to market margin changes. The Company reduces the negative interest cost associated with cash collateral posted from counterparties under various ISDA agreements by reinvesting derivative cash collateral. This program permits collateral cash received to be invested in short term Treasury securities, bank deposits and commercial paper rated A1/P1 which are included in "Cash and cash equivalents" in the accompanying Consolidated Balance Sheets.

See "Note 5. Derivative Financial Instruments" to our audited consolidated financial statements for additional information regarding our derivatives and our exposure to credit loss on call options.

85

Liquidity and Capital Resources

Liquidity and Cash Flow

Liquidity refers to the ability of an enterprise to generate adequate amounts of cash from its normal operations to meet cash requirements with a prudent margin of safety. Our principal sources of cash flow from operating activities are insurance premiums, and fees and investment income, however, sources of cash flows from investing activities also result from maturities and sales of invested assets. Our operating activities provided cash of $675 in the year ended December 31, 2019. When considering our liquidity and cash flow, it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company, FGL Holdings. As a holding company with no operations of its own, FGL Holdings derives its cash primarily from its insurance subsidiaries and CF Bermuda Holdings Limited ("CF Bermuda"), a Bermuda exempted limited liability company and a wholly owned direct subsidiary of the Company, a downstream holding company that provides additional sources of liquidity. Dividends from our insurance subsidiaries flow through CF Bermuda to FGL Holdings.

The sources of liquidity of the holding company are principally comprised of dividends from subsidiaries, bank lines of credit (at FGLH level) and the ability to raise long-term public financing under an SEC-filed registration statement or private placement offering. These sources of liquidity and cash flow support the general corporate needs of the holding company, including common stock dividends, interest and debt service, funding acquisitions, and investment in core businesses.

Our cash flows associated with collateral received from and posted with counterparties change as the market value of the underlying derivative contract changes. As the value of a derivative asset declines (or increases), the collateral required to be posted by our counterparties would also decline (or increase). Likewise, when the value of a derivative liability declines (or increases), the collateral we are required to post to our counterparties would also decline (or increase).

Discussion of Consolidated Cash Flows

Presented below is a table that summarizes the cash provided or used in our activities and the amount of the respective increases or decreases in cash provided or used from those activities for the periods presented:

(Dollars in millions)	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
Cash provided by (used in):										Predecessor			Predecessor			Predecessor
Operating activities	$	675		$	897		$	85		$	79		$	72		$	237
Investing activities	(1,568		)	(2,280		)	(22		)	(175		)	(594		)	(1,217		)
Financing activities	1,291			739			45			135			290			1,001
Net increase (decrease) in cash and cash equivalents	$	398		$	(644	)	$	108		$	39		$	(232	)	$	21

Operating Activities

Cash provided by operating activities for the years ended December 31, 2019 and December 31, 2018 were principally due to investment income and deferred acquisition costs. For the year ended December 31, 2019, net investment income receipts of $1,280 were partially offset by deferred acquisition costs of $468.

Investing Activities

Cash used in investing activities for the years ended December 31, 2019 and December 31, 2018 was principally due to the purchases of fixed maturity securities and other investments, net of cash proceeds from sales, maturities and repayments, as a result of the Company's portfolio repositioning.

86

Financing Activities

Cash provided by financing activities for the years ended December 31, 2019 and December 31, 2018 was related to the issuance of investment contracts and pending new production, including annuity and universal life insurance contracts, net of redemptions and benefit payments.

Sources of Cash Flow

Dividends from Insurance Subsidiaries, Statutory Capital and Risk-Based Capital

The Company’s insurance subsidiaries domiciled in the U.S. are restricted by state laws and regulations as to the amount of dividends they may pay to their parent without regulatory approval in any year, the purpose of which is to protect affected insurance policyholders, depositors or investors. Any dividends in excess of limits are deemed “extraordinary” and require regulatory approval. Based on statutory results as of December 31, 2019, in accordance with applicable dividend restrictions, the Company’s subsidiaries may pay “ordinary” dividends to FGLH in 2020 of $175. However, pursuant to an order issued in connection with the approval of the Merger Agreement by the Iowa Commissioner on November 28, 2017, FGL Insurance shall not pay any dividend or other distribution to shareholders prior to November 28, 2021 without the prior approval of the Iowa Commissioner. In 2019, upon approval by the Iowa Commissioner, FGL Insurance declared and paid extraordinary dividends of $100 to its Parent, FGLH.

FGL Insurance and FGL NY Insurance are subject to minimum RBC requirements established by the insurance departments of their applicable state of domicile. The formulas for determining the amount of RBC specify various weighting factors that are applied to financial balances and levels of premium activity based on the perceived degree of risk. Regulatory compliance is determined by a ratio of TAC, as defined by the NAIC, to RBC requirements, as defined by the NAIC. FGL Insurance and FGL NY Insurance exceeded the minimum RBC requirements that would require regulatory or corrective action for all periods presented herein. RBC is an important factor in the determination of the financial strength ratings of FGL Insurance.

FGL Insurance and FGL NY Insurance are required to prepare statutory financial statements in accordance with statutory accounting practices prescribed or permitted by the insurance department of the state of domicile of the respective insurance subsidiary. Statutory accounting practices primarily differ from GAAP by charging policy acquisition costs to expense as incurred, establishing future policy benefit liabilities using different actuarial assumptions as well as valuing investments and certain assets and accounting for deferred taxes on a different basis. Certain assets that are not admitted under statutory accounting principles are charged directly to surplus.

For non-U.S. companies, Class C insurers are required to maintain available capital and surplus at a level equal to or in excess of the applicable ECR, which is established by reference to either the applicable BSCR model or an approved internal capital model. Furthermore, to enable the BMA to better assess the quality of the insurer’s capital resources, a Class C insurer is required to disclose the makeup of its capital in accordance with its 3-tiered capital system. An insurer may file an application under the Insurance Act to have the aforementioned ECR requirements waived.

Statutory capital and surplus of FGL Insurance and our other insurance subsidiaries is as follows for the periods presented:

(Dollars in millions)	As of December 31, 2019		As of December 31, 2018
Subsidiary Name:
F&G Life Re Ltd	$	2	$	2
FSRC	73		73
F&G Reinsurance Ltd	295		38
Fidelity & Guaranty Life Insurance Company	1,513		1,545
Fidelity & Guaranty Life Insurance Company of New York	95		85
Raven Reinsurance Company	87		94

87

We monitor the ratio of our insurance subsidiaries’ TAC to company action level risk-based capital (“CAL”). A ratio in excess of either (i) 100% or (ii) 150% if there is a negative trend, indicates that the insurance subsidiary is not required to take any corrective actions to increase capital levels at the direction of the applicable state of domicile.

The ratio of TAC to CAL for FGL Insurance and FGL NY Insurance is set out below for the periods presented:

	As of December 31, 2019						As of December 31, 2018
(Dollars in millions)	CAL		TAC		Ratio		CAL		TAC		Ratio
Fidelity & Guaranty Life Insurance Company	$	393	$	1,776	452	%	$	380	$	1,699	447	%
Fidelity & Guaranty Life Insurance Company of New York	14		99		709	%	10		88		903	%

Debt

During the year ended December 31, 2018, FGLH completed a debt offering of $550 aggregate principal amount of 5.50% senior notes due 2025, issued at 99.5% for proceeds of $547. The Company also has a credit agreement with certain financial institutions party thereto, as lenders, and Royal Bank of Canada, as administrative agent and letter of credit issuer, which provides for a $250 senior unsecured revolving credit facility with a maturity of three years. Refer to "Note 8. Debt" to our audited consolidated financial statements for further details regarding the Company's Senior Notes and revolving credit agreement.

The 5.50% Senior Notes were issued pursuant to an indenture, dated as of April 20, 2018 (the “Base Indenture”), among FGLH, the guarantors from time to time party thereto and Wells Fargo Bank, National Association, as trustee (the “Trustee”), and a supplemental indenture thereto (the “Supplemental Indenture” and, together with the Base Indenture, the “Indenture”). FGLH pays interest on the 5.50% Senior Notes in cash on May 1 and November 1 of each year at a rate of 5.50% per annum. The 5.50% Senior Notes will mature on May 1, 2025. The 5.50% Senior Notes are fully and unconditionally guaranteed by FGLH’s direct parent, FGL US Holdings Inc., a Delaware corporation, FGL’s indirect parent, CF Bermuda, and certain existing and future wholly-owned domestic restricted subsidiaries of the CF Bermuda, other than its insurance subsidiaries.

The Indenture contains covenants that restrict the CF Bermuda’s and its restricted subsidiaries’ ability to, among other things, pay dividends on or make other distributions in respect of equity interests or make other restricted payments, make certain investments, incur or guarantee additional indebtedness, create liens on certain assets to secure debt, sell certain assets, consummate certain mergers or consolidations or sell all or substantially all assets, or enter into transactions with affiliates.

Debt Covenants

The Credit Agreement contains a number of covenants that, among other things, limit or restrict the ability of FGLH, CF Bermuda and their subsidiaries to incur additional indebtedness, incur or become subject to liens, dispose of assets, make investments, dividends or distributions or repurchases of certain equity interests or prepayments of certain indebtedness, enter into certain transactions with affiliates, undergo fundamental changes, enter into certain restrictive agreements, and change certain accounting policies or reporting practices. The Credit Agreement also contains certain affirmative covenants, including financial and other reporting requirements. In addition, the Credit Agreement includes the following financial maintenance covenants: (a) minimum total shareholders’ equity of CF Bermuda and its consolidated subsidiaries at the end of each fiscal quarter of the sum of (i) the greater of (x) 70% of the total shareholders’ equity of CF Bermuda as of the Closing Date and (y) $1.19 billion plus (ii) 50% of the consolidated net income (loss) of CF Bermuda and its consolidated subsidiaries since the first day of the first fiscal quarter after November 30, 2017 plus (iii) 50% of all equity issuances of CF Bermuda after November 30, 2017; (b) maximum debt to total capitalization ratio of CF Bermuda at the end of each fiscal quarter of 0.35 to 1.00 for CF Bermuda and its consolidated subsidiaries; and (c) a minimum aggregate risk-based capital ratio of FGL Insurance, at the end of each fiscal quarter, of 300%. As of the date of this filing, FGLH and CF Bermuda are in compliance with all such covenants.

The Indenture contains a number of covenants that, among other things, limit or restrict FGLH’s ability and the ability of FGLH’s restricted subsidiaries to incur debt, incur liens, make certain asset dispositions or dispositions of subsidiary stock, enter into transactions with affiliates, enter into mergers, consolidations or transfers of all or substantially all assets, declare or pay dividends, redeem stock or prepay certain indebtedness, make investments

88

or enter into restrictive agreements. The Indenture also contains certain affirmative covenants, including financial and other reporting requirements. Most of these covenants will cease to apply for so long as the Senior Notes have investment grade ratings from both Moody’s and S&P. As of the date of this filing, FGLH is in compliance with all such covenants.

Credit Ratings

The indicative credit ratings published by the primary rating agencies are set forth below. Securities are rated at the time of issuance so actual ratings may differ from the indicative ratings. There may be other rating agencies that also provide credit ratings, which we do not disclose in our reports. Our current financial strength ratings of our principal insurance subsidiaries are described in section titled “Ratings” in Item 1. Business.

The long-term credit rating scales of A.M. Best, Fitch, Moody’s and S&P are as follows:

	Financial Strength Rating Scale	Senior Unsecured Notes Credit Rating Scale
Rating Agency
A.M. Best(1)	“A++” to “S”	“aaa to rs”
S&P(2)	“AAA” to “R”	“AAA to D”
Moody's(3)	“Aaa” to “C”	“Aaa to C”
Fitch(4)	“AAA” to “C”	“AAA to D”

(1) A.M. Best’s financial strength rating is an independent opinion of an insurer’s financial strength and ability to meet its ongoing insurance policy and contract obligations. It is based on a comprehensive quantitative and qualitative evaluation of a company’s balance sheet strength, operating performance and business profile. A.M. Best’s long-term credit ratings reflect its assessment of the ability of an obligor to pay interest and principal in accordance with the terms of the obligation. Ratings from “aa” to “ccc” may be enhanced with a “+” (plus) or “-” (minus) to indicate whether credit quality is near the top or bottom of a category. A.M. Best’s short-term credit rating is an opinion to the ability of the rated entity to meet its senior financial commitments on obligations maturing in generally less than one year.

(2) S&P’s insurer financial strength rating is a forward-looking opinion about the financial security characteristics of an insurance organization with respect to its ability to pay under its insurance policies and contracts in accordance with their terms. A “+” or “-” indicates relative standing within a category. An S&P credit rating is an assessment of default risk, but may incorporate an assessment of relative seniority or ultimate recovery in the event of default. Short-term issuer credit ratings reflect the obligor’s creditworthiness over a short-term time horizon.

(3) Moody’s financial strength ratings are opinions of the ability of insurance companies to repay punctually senior policyholder claims and obligations. Moody’s appends numerical modifiers 1, 2, and 3 to each generic rating classification from Aa through Caa. The modifier 1 indicates that the obligation ranks in the higher end of its generic rating category; the modifier 2 indicates a mid-range ranking; and the modifier 3 indicates a ranking in the lower end of that generic rating category. Moody’s long-term credit ratings are opinions of the relative credit risk of fixed-income obligations with an original maturity of one year or more. They address the possibility that a financial obligation will not be honored as promised. Moody’s short-term ratings are opinions of the ability of issuers to honor short-term financial obligations.

(4) Fitch’s financial strength ratings provide an assessment of the financial strength of an insurance organization. The IFS Rating is assigned to the insurance company’s policyholder obligations, including assumed reinsurance obligations and contract holder obligations, such as guaranteed investment contracts. Within long-term and short-term ratings, a “+” or a “-” may be appended to a rating to denote relative position within major rating categories.

A downgrade of our debt ratings could affect our ability to raise additional debt with terms and conditions similar to our current debt, and accordingly, likely increase our cost of capital. In addition, a downgrade of these ratings could make it more difficult to raise capital to refinance any maturing debt obligations, to support business growth at our insurance subsidiaries and to maintain or improve the current financial strength ratings of our principal insurance subsidiaries described in section titled “Ratings” in Item 1. Business. All of our ratings are subject to

89

revision or withdrawal at any time by the rating agencies, and therefore, no assurance can be given that we can maintain these ratings. Each rating should be evaluated independently of any other rating.

Preferred Stock

Our amended and restated memorandum of association and articles of association provide that we have the authority to issue 100,000,000 preferred shares, including the 275,000 shares of Series A Preferred Shares and the 100,000 Series B Preferred Shares issued on November 30, 2017. Subject to certain consent rights of the holders of the Series A Preferred Shares and the Series B Preferred Shares, we may issue additional series of preferred shares that would rank on parity with the Series A Preferred Shares and the Series B Preferred Shares as to liquidation preference. Under our amended and restated articles of association, our board of directors has the authority, subject to the provisions, if any, in our amended and restated memorandum of association and any rights attached to any existing shares, to issue preferred shares and to fix the preferred, deferred or other rights or restrictions, whether in regard to dividends or other distributions, voting, return of capital or otherwise, including varying such rights at such times and on such other terms as the board of directors thinks proper.

The Series A Preferred Shares and the Series B Preferred Shares (together, the “preferred shares”) do not have a maturity date and are non-callable for the first five years. The dividend rate of the preferred shares is 7.5% per annum, payable quarterly in cash or additional preferred shares, at the Company’s option, subject to increase beginning 10 years after issuance based on the then-current three-month LIBOR rate plus 5.5%. In addition, commencing 10 years after issuance of the preferred shares, and following a failed remarketing event, GSO and FNF will have the right to convert their preferred shares into a number of ordinary shares of the Company as determined by dividing (i) the aggregate par value (including dividends paid in kind and unpaid accrued dividends) of the preferred shares that GSO or FNF, as applicable, wishes to convert by (ii) the higher of (a) a 5% discount to the 30-day volume weighted average of the ordinary shares following the conversion notice, and (b) the then-current Floor Price. The “Floor Price” will be $8.00 per share during the 11th year post-funding, $7.00 per share during the 12th year post-funding, and $6.00 during the 13th year post-funding and thereafter.

Because the board of directors has the power to establish the preferences and rights of the shares of preferred shares, it may afford holders of any preferred shares preferences, powers and rights, including voting and dividend rights, senior to the rights of holders of our ordinary stock, which could adversely affect the holders of the ordinary shares and could delay, discourage or prevent a takeover of us even if a change of control of our company would be beneficial to the interests of our shareholders.

FHLB

We are currently a member of the Federal Home Loan Bank of Atlanta (“FHLB”) and are required to maintain a collateral deposit that backs any funding agreements issued. We use these funding agreements as part of a spread enhancement strategy. We have the ability to obtain funding from the FHLB based on a percentage of the value of our assets, subject to the availability of eligible collateral. Collateral is pledged based on the outstanding balances of FHLB funding agreements. The amount of funding varies based on the type, rating and maturity of the collateral posted to the FHLB. Generally, U.S. government agency notes and mortgage-backed securities are pledged to the FHLB as collateral. Market value fluctuations resulting from changes in interest rates, spreads and other risk factors for each type of asset are monitored and additional collateral is either pledged or released as needed.

Our borrowing capacity under these credit facilities does not have an expiration date as long as we maintain a satisfactory level of creditworthiness based on the FHLB’s credit assessment. As of December 31, 2019 and December 31, 2018, we had $1,096 and $878 in non-putable funding agreements, respectively, included under contract owner account balances on our consolidated balance sheet. As of December 31, 2019 and December 31, 2018, we had assets with a fair value of approximately $1,521 and $1,414, respectively, which collateralized the FHLB funding agreements. Assets pledged to the FHLB are included in fixed maturities, AFS, on our consolidated balance sheets.

Collateral-Derivative Contracts

Under the terms of our ISDA agreements, we may receive from, or deliver to, counterparties collateral to assure that all terms of the ISDA agreements will be met with regard to the Credit Support Annex (“CSA”). The terms of the CSA call for us to pay interest on any cash received equal to the federal funds rate. As of December 31, 2019 and December 31, 2018, $489 and $59 collateral was posted by our counterparties as they did not meet the net exposure thresholds. Collateral requirements are monitored on a daily basis and incorporate changes in market

90

values of both the derivatives contract as well as the collateral pledged. Market value fluctuations are due to changes in interest rates, spreads and other risk factors.

Uses of Cash Flow

Contractual Obligations

The following table summarizes, as of December 31, 2019, our contractual obligations that were fixed and determinable and the payments due under those obligations in the following periods.

	Payment Due by Period
(Dollars in millions)	Total		Less than 1 year		1-3 years		3-5 years		More than 5 years
Annuity and universal life products (a)	$	36,628	$	2,125	$	5,540	$	4,948	$	24,015
Operating leases	16		2		3		3		8
Debt	550		—		—		—		550
Interest expense	166		30		60		61		15
Total	$	37,360	$	2,157	$	5,603	$	5,012	$	24,588

(a) Amounts shown in this table are projected payments through the year 2030 which we are contractually obligated to pay our annuity and IUL policyholders. The payments are derived from actuarial models which assume a level interest rate scenario and incorporate assumptions regarding mortality and persistency, when applicable. These assumptions are based on our historical experience, but actual amounts will differ.

Return of Capital to Common Stockholders

One of the Company’s primary goals is to provide a return to our common stockholders through share price accretion, dividends and stock repurchases. In determining dividends, the board of directors takes into consideration items such as current and expected earnings, capital needs, rating agency considerations and requirements for financial flexibility. The amount and timing of share repurchase depends on key capital ratios, rating agency expectations, the generation of free cash flow and an evaluation of the costs and benefits associated with alternative uses of capital.

In December 2018, the Company's board of directors authorized a share repurchase program of up to $150 of the Company's outstanding ordinary shares. This program will expire on December 15, 2020, and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Exchange Act. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company. As of December 31, 2019, the Company has repurchased 8,652 thousand shares for a total cost of $69.

In December 2018, the Company’s board of directors approved the implementation of a quarterly cash dividend of $0.01 per ordinary share, beginning in the first quarter of fiscal year 2019. The dividend equates to $0.04 per share on a full-year basis.

Off-Balance Sheet Arrangements

Throughout our history, we have entered into indemnifications in the ordinary course of business with our customers, suppliers, service providers, business partners and in certain instances, when we sold businesses. Additionally, we have indemnified our directors and officers who are, or were, serving at our request in such capacities. Although the specific terms or number of such arrangements is not precisely known due to the extensive history of our past operations, costs incurred to settle claims related to these indemnifications have not been material to our financial statements. We have no reason to believe that future costs to settle claims related to our former operations will have a material impact on our financial position, results of operations or cash flows.

On November 30, 2017, FGLH and CF Bermuda, together as borrowers and each as a borrower, entered into the Credit Agreement with certain financial institutions party thereto, as lenders, and Royal Bank of Canada, as administrative agent and letter of credit issuer, which provides for a $250 senior unsecured revolving credit facility with a maturity of three years. The Credit Agreement provides a letter of credit sub-facility in a maximum amount

91

of $20. The borrowers are permitted to use the proceeds of the loans under the Credit Agreement for working capital, growth initiatives and general corporate purposes, as well as to pay fees, commissions and expenses incurred in connection with the Credit Agreement and the transactions contemplated thereby. Amounts borrowed under the Credit Agreement may be reborrowed until the maturity date or termination of commitments under the Credit Agreement. The borrowers may increase the maximum amount of availability under the Credit Agreement from time to time by up to an aggregate amount not to exceed $50, subject to certain conditions, including the consent of the lenders participating in each such increase. As of December 31, 2019, the Company had not drawn on the revolver.

The Company has unfunded investment commitments as of December 31, 2019 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. Please refer to "Note 4. Investments" and "Note 12. Commitments and Contingencies" to our audited consolidated financial statements for additional details on unfunded investment commitments.

Item 7A. Quantitative and Qualitative Disclosures about Market Risk

Market Risk Factors

Market risk is the risk of the loss of fair value resulting from adverse changes in market rates and prices, such as interest rates, foreign currency exchange rates, commodity prices and equity prices. Market risk is directly influenced by the volatility and liquidity in the markets in which the related underlying financial instruments are traded. We have significant holdings in financial instruments and are naturally exposed to a variety of market risks. We are primarily exposed to interest rate risk, credit risk and equity price risk and have some exposure to counterparty risk, which affect the fair value of financial instruments subject to market risk.

Enterprise Risk Management

We place a high priority to risk management and risk control. As part of our effort to ensure measured risk taking, management has integrated risk management in our daily business activities and strategic planning. We have comprehensive risk management, governance and control procedures in place and have established a dedicated risk management function with responsibility for the formulation of our risk appetite, strategies, policies and limits. The risk management function is also responsible for monitoring our overall market risk exposures and provides review, oversight and support functions on risk-related issues. Our risk appetite is aligned with how our businesses are managed and how we anticipate future regulatory developments.

Our risk governance and control systems enable us to identify, control, monitor and aggregate risks and provide assurance that risks are being measured, monitored and reported adequately and effectively in accordance with the following three principles:

• Management of the business has primary responsibility for the day-to-day management of risk.

• The risk management function has the primary responsibility to align risk taking with strategic planning through risk tolerance and limit setting.

• The internal audit function provides an ongoing independent and objective assessment of the effectiveness of internal controls, including financial and operational risk management.

The Chief Risk Officer (“CRO”) heads our risk management process and reports directly to our Chief Executive Officer (“CEO”). Our Enterprise Risk Committee discusses and approves all risk policies and reviews and approves risks associated with our activities. This includes volatility (affecting earnings and value), exposure (required capital and market risk) and insurance risks.

We have implemented several limit structures to manage risk. Examples include, but are not limited to, the following:

• At-risk limits on sensitivities of regulatory capital to the capital markets provide the fundamental framework to manage capital markets risks including the risk of asset / liability mismatch;

• Duration and convexity mismatch limits;

• Credit risk concentration limits; and

• Investment and derivative guidelines.

92

We manage our risk appetite based on two key risk metrics:

• Regulatory Capital Sensitivities: the potential reduction, under a range of moderate to extreme capital markets stress scenarios, of the excess of available statutory capital above the minimum required under the NAIC regulatory RBC methodology; and

• Earnings Sensitivities: the potential reduction in results of operations over a 30 year time horizon under the same moderate to extreme capital markets stress scenario. Maintaining a consistent level of earnings helps us to finance our operations, support our capital requirements and provide funds to pay dividends to stockholders.

Our risk metrics cover the most important aspects in terms of performance measures where risk can materialize and are representative of the regulatory constraints to which our business is subject. The sensitivities for earnings and statutory capital are important metrics since they provide insight into the level of risk we take under stress scenarios. They also are the basis for internal risk management.

We are also subject to cash flow stress testing pursuant to regulatory requirements. This analysis measures the effect of changes in interest rate assumptions on asset and liability cash flows. The analysis includes the effects of:    

• The timing and amount of redemptions and prepayments in our asset portfolio;

• Our derivative portfolio;

• Death benefits and other claims payable under the terms of our insurance products;

• Lapses and surrenders in our insurance products;

• Minimum interest guarantees in our insurance products; and

• Book value guarantees in our insurance products.

Interest Rate Risk

Interest rate risk is our primary market risk exposure. We define interest rate risk as the risk of an economic loss due to adverse changes in interest rates. This risk arises from our holdings in interest sensitive assets and liabilities, primarily as a result of investing life insurance premiums and fixed annuity deposits received in interest-sensitive assets and carrying these funds as interest-sensitive liabilities. Substantial and sustained increases or decreases in market interest rates can affect the profitability of the insurance products and the fair value of our investments, as the majority of our insurance liabilities are backed by fixed maturity securities.

The profitability of most of our products depends on the spreads between interest yield on investments and rates credited on insurance liabilities. We have the ability to adjust the rates credited, primarily caps and credit rates, on the majority of the annuity liabilities at least annually, subject to minimum guaranteed values. In addition, the majority of the annuity products have surrender and withdrawal penalty provisions designed to encourage persistency and to help ensure targeted spreads are earned. However, competitive factors, including the impact of the level of surrenders and withdrawals, may limit our ability to adjust or maintain crediting rates at the levels necessary to avoid a narrowing of spreads under certain market conditions.

In order to meet our policy and contractual obligations, we must earn a sufficient return on our invested assets. Significant changes in interest rates exposes us to the risk of not earning the anticipated spreads between the interest rate earned on our investments and the credited interest rates paid on outstanding policies and contracts. Both rising and declining interest rates can negatively affect interest earnings, spread income and the attractiveness of certain of our products.

During periods of increasing interest rates, we may offer higher crediting rates on interest-sensitive products, such as IUL insurance and fixed annuities, and we may increase crediting rates on in-force products to keep these products competitive. A rise in interest rates, in the absence of other countervailing changes, will result in a decline in the market value of our investment portfolio.

As part of our asset liability management (“ALM”) program, we have made a significant effort to identify the assets appropriate to different product lines and ensure investing strategies match the profile of these liabilities. Our ALM strategy is designed to align the expected cash flows from the investment portfolio with the expected liability cash flows. As such, a major component of our effort to manage interest rate risk has been to structure the investment portfolio with cash flow characteristics that are consistent with the cash flow characteristics of the insurance liabilities. We use actuarial models to simulate the cash flows expected from the existing business under various interest rate scenarios. These simulations enable us to measure the potential gain or loss in the fair value

93

of interest rate-sensitive financial instruments, to evaluate the adequacy of expected cash flows from assets to meet the expected cash requirements of the liabilities and to determine if it is necessary to lengthen or shorten the average life and duration of our investment portfolio. Duration measures the price sensitivity of a security to a small change in interest rates. When the durations of assets and liabilities are similar, exposure to interest rate risk is minimized because a change in the value of assets could be expected to be largely offset by a change in the value of liabilities.

The duration of the investment portfolio, excluding cash and cash equivalents, derivatives, policy loans, and common stocks as of December 31, 2019, is summarized as follows:

(Dollars in millions)
Duration	Amortized Cost		% of Total
0-4	$	11,195	43	%
5-9	6,406		24	%
10-14	5,854		22	%
15-19	2,959		11	%
20-25	36		—	%
Total	$	26,450	100	%

Credit Risk and Counterparty Risk

We are exposed to the risk that a counterparty will default on its contractual obligation resulting in financial loss. The major source of credit risk arises predominantly in our insurance operations’ portfolios of debt and similar securities. The fair value of our fixed maturity portfolio totaled $24 billion and $21 billion at December 31, 2019 and December 31, 2018, respectively. Our credit risk materializes primarily as impairment losses. We are exposed to occasional cyclical economic downturns, during which impairment losses may be significantly higher than the long-term historical average. This is offset by years where we expect the actual impairment losses to be substantially lower than the long-term average. Credit risk in the portfolio can also materialize as increased capital requirements as assets migrate into lower credit qualities over time. The effect of rating migration on our capital requirements is also dependent on the economic cycle and increased asset impairment levels may go hand in hand with increased asset related capital requirements.

We attempt to manage the risk of default and rating migration by applying disciplined credit evaluation and underwriting standards and limiting allocations to lower quality, higher risk investments. In addition, we diversify our exposure by issuer and country, using rating based issuer and country limits. We also set investment constraints that limit our exposure by industry segment. To limit the impact that credit risk can have on earnings and capital adequacy levels, we have portfolio-level credit risk constraints in place. Limit compliance is monitored on a monthly or, in some cases, daily basis.

In connection with the use of call options, we are exposed to counterparty credit risk-the risk that a counterparty fails to perform under the terms of the derivative contract. We have adopted a policy of only dealing with credit worthy counterparties and obtaining sufficient collateral where appropriate, as a means of attempting to mitigate the financial loss from defaults. The exposure and credit rating of the counterparties are continuously monitored and the aggregate value of transactions concluded is spread amongst different approved counterparties to limit the concentration in one counterparty. Our policy allows for the purchase of derivative instruments from counterparties and/or clearinghouses that meet the required qualifications under the Iowa Code. The Company reviews the ratings of all the counterparties periodically. Collateral support documents are negotiated to further reduce the exposure when deemed necessary. See "Note 5. Derivative Financial Instruments" to our audited consolidated financial statements for additional information regarding our exposure to credit loss.

94

We also have credit risk related to the ability of reinsurance counterparties to honor their obligations to pay the contract amounts under various agreements. To minimize the risk of credit loss on such contracts, we diversify our exposures among many reinsurers and limit the amount of exposure to each based on credit rating. We also generally limit our selection of counterparties with which we do new transactions to those with an “A-” credit rating or above and/or that are appropriately collateralized and provide credit for reinsurance. When exceptions are made to that principle, we ensure that we obtain collateral to mitigate our risk of loss. The following table presents our reinsurance recoverable balances and financial strength ratings for our five largest reinsurance recoverable balances as of December 31, 2019:

(Dollars in millions)		Financial Strength Rating
Parent Company/Principal Reinsurers	Reinsurance Recoverable	AM Best	S&P	Fitch	Moody's
Wilton Re	1,496	A+	Not Rated	A+	Not Rated
Kubera Insurance (SAC) Ltd	842	Not Rated	Not Rated	Not Rated	Not Rated
Security Life of Denver	156	Not Rated	A+	A	A3
Hannover Re	131	A+	AA-	Not Rated	Not Rated
London Life	107	A+	Not Rated	Not Rated	Not Rated

In the normal course of business, certain reinsurance recoverables are subject to reviews by the reinsurers. We are not aware of any material disputes arising from these reviews or other communications with the counterparties as of December 31, 2019 that would require an allowance for uncollectible amounts.

Through FSRC and F&G Re, the Company is exposed to insurance counterparty risk, which is the potential for FSRC and F&G Re to incur losses due to a client or partner becoming distressed or insolvent. This includes run-on-the-bank risk and collection risk. The run-on-the-bank risk is that a client’s in force block incurs substantial surrenders and/or lapses due to credit impairment, reputation damage or other market changes affecting the counterparty. Substantially higher than expected surrenders and/or lapses could result in inadequate in force business to recover cash paid out for acquisition costs. The collection risk for clients includes their inability to satisfy a reinsurance agreement because the right of offset is disallowed by the receivership court; the reinsurance contract is rejected by the receiver, resulting in a premature termination of the contract; and/or the security supporting the transaction becomes unavailable to FSRC and F&G Re.

FSRC and F&G Re are exposed to the risk that a counterparty will default on its contractual obligation resulting in financial loss. The major source of credit risk arises predominantly in FSRC and F&G Re’s funds withheld receivables portfolio that consists primarily of debt and equity securities. FSRC and F&G Re’s credit risk materializes primarily as impairment losses. FSRC and F&G Re are exposed to occasional cyclical economic downturns, during which impairment losses may be significantly higher than the long-term historical average. This is offset by years where FSRC and F&G Re expect the actual impairment losses to be substantially lower than the long-term average. Credit risk in the portfolio can also materialize as increased capital requirements as assets migrate into lower credit qualities over time. The effect of rating migration on FSRC and F&G Re’s capital requirements is also dependent on the economic cycle and increased asset impairment levels may go hand in hand with increased asset related capital requirements.

FSRC and F&G Re assume reinsurance business from counterparties that seek to manage the risk of default and rating migration by applying credit evaluation and underwriting standards and limiting allocations to lower quality, higher risk investments. In addition, FSRC and F&G Re’s reinsurance counterparties diversify their exposure by issuer and country, using rating based issuer and country limits and set investment constraints that limit its exposure by industry segment. To limit the impact that credit risk can have on earnings and capital adequacy levels, FSRC and F&G Re have portfolio-level credit risk constraints in place. Limit compliance is monitored on a daily or, in some cases, monthly basis.

95

Equity Price Risk

We are primarily exposed to equity price risk through certain insurance products, specifically those products with GMWB. We offer a variety of FIA contracts with crediting strategies linked to the performance of indices such as the S&P 500 Index, Dow Jones Industrials or the NASDAQ 100 Index. The estimated cost of providing GMWB incorporates various assumptions about the overall performance of equity markets over certain time periods. Periods of significant and sustained downturns in equity markets, increased equity volatility or reduced interest rates could result in an increase in the valuation of the future policy benefit or policyholder account balance liabilities associated with such products, resulting in a reduction in our net income (loss). The rate of amortization of intangibles related to FIA products and the cost of providing GMWB could also increase if equity market performance is worse than assumed.

To economically hedge the equity returns on these products, we purchase derivatives to hedge the FIA equity exposure. The primary way we hedge FIA equity exposure is to purchase over the counter equity index call options from broker-dealer derivative counterparties approved by the Company. The second way to hedge FIA equity exposure is by purchasing exchange traded equity index futures contracts. Our hedging strategy enables us to reduce our overall hedging costs and achieve a high correlation of returns on the call options purchased relative to the index credits earned by the FIA contractholders. The majority of the call options are one-year options purchased to match the funding requirements underlying the FIA contracts. These hedge programs are limited to the current policy term of the FIA contracts, based on current participation rates. Future returns, which may be reflected in FIA contracts’ credited rates beyond the current policy term, are not hedged. We attempt to manage the costs of these purchases through the terms of our FIA contracts, which permit us to change caps or participation rates, subject to certain guaranteed minimums that must be maintained.

The derivatives are used to fund the FIA contract index credits and the cost of the call options purchased is treated as a component of spread earnings. While the FIA hedging program does not explicitly hedge GAAP income volatility, the FIA hedging program tends to mitigate a significant portion of the GAAP reserve changes associated with movements in the equity market and risk-free rates. This is due to the fact that a key component in the calculation of GAAP reserves is the market valuation of the current term embedded derivative. Due to the alignment of the embedded derivative reserve component with hedging of this same embedded derivative, there should be a reasonable match between changes in this component of the reserve and changes in the assets backing this component of the reserve. However, there may be an interim mismatch due to the fact that the hedges which are put in place are only intended to cover exposures expected to remain until the end of an indexing term. To the extent index credits earned by the contractholder exceed the proceeds from option expirations and futures income, we incur a raw hedging loss.

See "Note 5. Derivative Financial Instruments" to our audited consolidated financial statements for additional details on the derivatives portfolio.

Fair value changes associated with these investments are intended to, but do not always, substantially offset the increase or decrease in the amounts added to policyholder account balances for index products. When index credits to policyholders exceed option proceeds received at expiration related to such credits, any shortfall is funded by our net investment spread earnings and futures income. For the years ended December 31, 2019 and December 31, 2018, the annual index credits to policyholders on their anniversaries were $196 and $379, respectively. Proceeds received at expiration on options related to such credits were $214 and $384, respectively.

Other market exposures are hedged periodically depending on market conditions and our risk tolerance. The FIA hedging strategy economically hedges the equity returns and exposes us to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. We use a variety of techniques including direct estimation of market sensitivities and value-at-risk to monitor this risk daily. We intend to continue to adjust the hedging strategy as market conditions and risk tolerance change.

Sensitivity Analysis

The analysis below is hypothetical and should not be considered a projection of future risks. Earnings projections are before tax and non-controlling interest.

Interest Rate Risk

We assess interest rate exposures for financial assets, liabilities and derivatives using hypothetical test scenarios that assume either increasing or decreasing 100 basis point parallel shifts in the yield curve, reflecting changes in either credit spreads or risk-free rates.

96

If interest rates were to increase 100 basis points from levels at December 31, 2019, the estimated fair value of our fixed maturity securities would decrease by approximately $1,697. The impact on shareholders’ equity of such decrease, net of income taxes (assumes a 21% tax rate) and intangibles adjustments, and the change in reinsurance related derivative would be a decrease of $1,093 in AOCI and in total shareholders’ equity. If interest rates were to decrease by 100 basis points from levels at December 31, 2019, the estimated impact on the FIA embedded derivative liability of such a decrease would be an increase of $284.

The actuarial models used to estimate the impact of a one percentage point change in market interest rates incorporate numerous assumptions, require significant estimates and assume an immediate and parallel change in interest rates without any management of the investment portfolio in reaction to such change. Consequently, potential changes in value of financial instruments indicated by these simulations will likely be different from the actual changes experienced under given interest rate scenarios, and the differences may be material. Because we actively manage our investments and liabilities, the net exposure to interest rates can vary over time. However, any such decreases in the fair value of fixed maturity securities, unless related to credit concerns of the issuer requiring recognition of an OTTI, would generally be realized only if we were required to sell such securities at losses prior to their maturity to meet liquidity needs. Our liquidity needs are managed using the surrender and withdrawal provisions of the annuity contracts and through other means.

Equity Price Risk

Assuming all other factors are constant, we estimate that a decline in equity market prices of 10% would cause the market value of our equity investments to decrease by approximately $107, our call option investments to decrease by approximately $20 based on equity positions and our FIA embedded derivative liability to decrease by approximately $49 as of December 31, 2019. Due to the adoption of ASU 2016-01, the 10% decline in market value of our equity securities would affect current earnings. These scenarios consider only the direct effect on fair value of declines in equity market levels and not changes in asset-based fees recognized as revenue, or changes in our estimates of total gross profits used as a basis for amortizing intangibles.

Item 8. Financial Statements and Supplementary Data

The Reports of the Independent Registered Public Accounting Firm, the Company’s consolidated financial statements and notes to the Company’s consolidated financial statements appear in a separate section of this Form 10-K (beginning on Page F-2 following Part IV). The index to the Company’s consolidated financial statements appears on Page F-1.

Item 9. Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

None.

Item 9A. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

An evaluation was performed under the supervision and participation of the Company’s management, including the Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the "Exchange Act")), as of the end of the period covered by this report. Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that, as of December 31, 2019, the Company’s disclosure controls and procedures were effective to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and is accumulated and communicated to the Company’s management, including the Company’s CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Notwithstanding the foregoing, there can be no assurance that the Company’s disclosure controls and procedures will detect or uncover all failures of persons within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of the controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable, not absolute, assurance of achieving their control objectives.

97

Management’s Report on Internal Control Over Financial Reporting

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting for the Company, as such term is defined in Exchange Act Rules 13a-15(f) and 15d-15(f). Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of the financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures are being made only with proper authorizations; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of the Company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. These inherent limitations are an intrinsic part of the financial reporting process. Therefore, although the Company’s management is unable to eliminate this risk, it is possible to develop safeguards to reduce it. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

The Company's management, under the supervision of and with the participation of the CEO and CFO, assessed the effectiveness of the Company's internal control over financial reporting as of December 31, 2019 based on criteria for effective control over financial reporting described in Internal Control - Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission ("COSO") in 2013. Based on this assessment the Company's management concluded that its internal control over financial reporting was effective as of December 31, 2019 in accordance with the COSO criteria. The Company's independent registered public accounting firm, KPMG LLP, has issued an attestation report on the effectiveness of the Company's internal control over financial reporting, which is included herein.

Changes in Internal Control Over Financial Reporting

An evaluation was performed under the supervision of the Company's management, including the CEO and CFO, of whether any change in the Company's internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) occurred during the quarter ended December 31, 2019.

Based on that evaluation, the Company’s management, including the CEO and CFO, concluded that no change in the Company’s internal control over financial reporting occurred during the quarter ended December 31, 2019 that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting.

Limitations on the Effectiveness of Controls

A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

Item 9B. Other Information

Disclosure pursuant to Item 5.02(e) of Form 8-K

On February 25, 2020, the Compensation Committee approved Transaction Bonus Letter Agreements with each of our named executive officers to reward them for the critical role they are performing in working towards the closing of the FNF Merger.

Under the Transaction Bonus Letter Agreements, each executive is eligible to receive a specified cash transaction bonus, as set forth below, subject to the occurrence of the closing of the FNF Merger and the executive’s continued employment through the date of the closing. Such bonuses would be paid out within 30 days following the date of closing. Executives will no longer be eligible to receive a Transaction Bonus if their employment is

98

terminated for any reason prior to the closing date, or if the Merger Agreement with FNF is terminated prior to closing.

	Potential Transaction Bonus
Christopher Blunt	$	400,000
John Fleurant	$	250,000
Raj Krishnan	$	200,000
Bonnie Wasgatt	$	200,000
Alex Castillo	$	200,000

The foregoing description is qualified in its entirety by the form of Transaction Bonus Letter Agreement, which is filed as an exhibit to this Form 10-K.

99

PART III

Item 10. Directors, Executive Officers and Corporate Governance

Our Directors

Name	Age (a)	Director Since	Class (b)	Position	Pursuant to Nominating Agreement (c)
William P. Foley, II	75	2016	A	Co-Chairman and Director	*
Keith W. Abell	62	2017	A	Director
Richard M. Massey	64	2016	A	Director
Chinh E. Chu	53	2016	B	Co-Chairman and Director	*
Patrick S. Baird	66	2017	B	Director
James A. Quella	70	2016	B	Director
Christopher O. Blunt	57	2019	C	Chief Executive Officer, President and Director
Menes O. Chee	42	2017	C	Director	*
Timothy M. Walsh	57	2017	C	Director

a. The respective age of each individual is as of February 15, 2020.

b. Our Board is divided into three classes of as nearly equal number of directors as possible. Any additional directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. The term of each class of directors is three years, with the term for one class expiring each year in rotation. As a result, one class of directors is elected at each annual shareholders meeting for a term of three years, to hold office until their successors are elected and qualified or until their earlier death, removal or resignation. The term of the current Class A directors will expires at our 2020 annual meeting.

c. The company is a party to a nominating and voting agreement (the “Nominating and Voting Agreement”) with Messrs. Foley and Chu, and BTO (the “Nominating Parties”). The Nominating and Voting Agreement is intended to preserve continuity of leadership of the founding sponsors and lead investor to preserve the F&G investment thesis and long-term perspective upon which the company was founded. Pursuant to the Nominating and Voting Agreement, if the Nominating Parties and their respective affiliates own, in the aggregate, directly or indirectly, at least 20% of the issued and outstanding ordinary shares, the Nominating Parties will have the right to designate one director nominee for election at each general meeting of the company. If the Nominating Parties and their respective affiliates own, in the aggregate, directly or indirectly, at least 12% but less than 20% of the issued and outstanding ordinary shares (the “Two Director Range”), the Nominating Parties will have the right to designate one director nominee for each of the two director classes (the “Two Director Classes”) to be voted on at the two general meetings of the company immediately after the aggregate ownership of ordinary shares comes within the Two Director Range and for each subsequent meeting at which one of the Two Director Classes is to be voted on by the shareholders, provided that such aggregate ownership remains within the Two Director Range at the time of each such nomination. If the Nominating Parties and their respective affiliates own, in the aggregate, directly or indirectly, at least 5% but less than 12% of the issued and outstanding ordinary shares (the “One Director Range”), the Nominating Parties will have the right to designate one director nominee for the class of directors (the “One Director Class”) to be voted on at the general meeting of the company immediately after the aggregate ownership of ordinary shares comes within the One Director Range and for each subsequent meeting at which the One Director Class is to be voted on by the shareholders, provided that such aggregate ownership remains within the One Director Range at the time of each such nomination. Director nominees selected under the Nominating and Voting Agreement will be selected by the vote of any two of Mr. Chu, Mr. Foley and BTO. In addition, pursuant to the Nominating and Voting Agreement, each of Mr. Foley, Mr. Chu and BTO agreed to vote for each director so nominated. Our Nominating and Corporate Governance Committee and our Board recommend each nominee for director to our shareholders to be elected at our annual meetings.

Class A Directors - Terms Expiring in 2020

Keith W. Abell joined our Board in May 2017. Mr. Abell is the co-founder of Sungate Properties, LLC, a real estate investment company, which he co-founded in 2010, and is the founder of Snowridge Investments, which establishes strategic partnerships between U.S. fund managers and Chinese financial institutions, which he founded in 2015. From 1994 to 2007, Mr. Abell was a co-founder of, and served in a variety of senior management roles at, GSC Group (and its predecessor, Greenwich Street Capital Partners, L.P.), an alternative asset manager. From 1990 to 1994, Mr. Abell was a managing director at Blackstone where he, among other things, founded the firm’s first Hong Kong office. From 1986 to 1990, Mr. Abell was a vice president at Goldman, Sachs & Co. where he worked in the global finance, corporate finance and mergers and acquisitions departments. Mr. Abell serves as the treasurer and as a director of the National Committee on United States-China Relations. Mr. Abell serves as a director of Graf Industrial Corp. Throughout his career, Mr. Abell has served as a director of a number of public, private and not-for-profit entities.

100

Mr. Abell’s qualifications to serve on our Board include: his extensive experience in corporate finance, private equity and mergers and acquisitions.

William P. Foley, II has served as Co-Executive Chairman of FGL Holdings since 2016. Mr. Foley is a founder of FNF and has served as Chairman of FNF’s board of directors since 1984. He served as Chief Executive Officer of FNF until May 2007 and as President of FNF until December 1994. Mr. Foley also serves as Chairman of the board of directors of Black Knight, Inc. since December 2014, and as Chairman of Cannae Holdings, Inc. since July 2017. Mr. Foley also serves as Chairman of The Dun & Bradstreet Corporation, which is privately held. Mr. Foley serves on the boards of directors of The Foley Family Charitable Foundation and the Cummer Museum of Arts and Gardens. He is a founder, trustee and director of The Folded Flag Foundation. Mr. Foley is also Executive Chairman and Chief Executive Officer of Black Knight Sports and Entertainment LLC, which is the private company that owns the Vegas Golden Knights, a National Hockey League team. Within the past five years, Mr. Foley served as Vice Chairman of Fidelity National Information Services, Inc. (FIS), and as a director of Ceridian HCM Holding Inc. After receiving his B.S. degree in engineering from the United States Military Academy at West Point, Mr. Foley served in the U.S. Air Force, where he attained the rank of captain.

Mr. Foley’s qualifications to serve on our Board include more than 30 years as a director and executive officer of FNF, his long and deep knowledge of our business and industry, his strategic vision, his experience as a board member and executive officer of public and private companies in a wide variety of industries, and his strong track record of building and maintaining shareholder value and successfully negotiating and implementing mergers and acquisitions. Mr. Foley provides high value-added services ot the Company and has sufficient time to focus on FGL Holdings.

Richard N. Massey joined our Board in May 2016. Since 2009, Mr. Massey has been a partner of Westrock Capital, LLC, a private investment partnership. Mr. Massey was Chief Strategy Officer and General Counsel of Alltel Corporation, or Alltel, from 2006 to 2009. Alltel, the fifth-largest wireless carrier in the United States as of 2009, was acquired by its management and a consortium of private equity investors in 2007 and sold to Verizon Communications, Inc. in 2009 for approximately $29 billion. Since 2006, Mr. Massey has served as a director of FNF. Mr. Massey also serves as a director of Black Knight and ServiceLink Holdings, LLC, as Chairman of the board of directors of Bear State Financial, Inc., as a director of Oxford American Literary Project, a non-profit literary publication, and as Chairman of the board of directors of the Arkansas Razorback Foundation. Mr. Massey served as a director of Fidelity National Information Services, Inc. (“FIS”) until May 2017 and has also served as a director of various other private companies. Mr. Massey received a B.A. and a J.D., with high honors, from the University of Arkansas.

Mr. Massey’s qualifications to serve on the board of directors include his experience in corporate finance and investment banking and as a financial and legal advisor to public and private businesses, as well as his expertise in identifying, negotiating and consummating mergers and acquisitions.

Class B Directors - Terms Expiring in 2021

Chinh E. Chu joined our Board as Co-Chairman in April 2016. Mr. Chu is the Founder and Managing Partner at CC Capital, a private investment firm which he founded in 2015. Before founding CC Capital, Mr. Chu worked at Blackstone from 1990 to 2015. Blackstone is a leading global alternative asset manager, with total assets under management of $366.6 billion as of December 31, 2016. Mr. Chu was a Senior Managing Director at Blackstone since 2000, and previously served as Co-Chair of Blackstone’s Private Equity Executive Committee and was a member of Blackstone’s Executive Committee. Mr. Chu currently serves as a Director of Catalent, Inc., Stearns Mortgage, and NCR Corporation. Mr. Chu previously served as a Director of Kronos Incorporated, SunGard Data Systems, Inc., Stiefel Laboratories, Freescale Semiconductor, Ltd. Biomet, Inc., Alliant, Celanese Corporation, Nalco Company, DJO Global, Inc., HealthMarkets, Inc., Nycomed, Alliant Insurance Services, Inc., the London International Financial Futures and Options Exchange, or LIFFE, Graham Packaging, and AlliedBarton Security Services. Before joining Blackstone in 1990, Mr. Chu worked at Salomon Brothers in the Mergers & Acquisitions Department. Mr. Chu received a B.S. in Finance from the University of Buffalo.

Mr. Chu’s qualifications to serve on our Board include: his substantial experience in mergers and acquisitions, corporate finance and strategic business planning; his track record at Blackstone and in advising and managing multi-national companies; and his experience serving as a director for various public and private companies.

Patrick S. Baird joined our Board in November 2017. From March 2002 until his retirement in January 2010, Mr. Baird served as the President and Chief Executive Officer of AEGON USA, LLC, the U.S. subsidiary of AEGON

101

N.V., a leading multinational insurance organization (“AEGON”). He continues to serve AEGON with certain projects and is currently assisting AEGON with its expansion activities in Latin America. Mr. Baird joined the AEGON USA companies in 1976, and during his career also served as Executive Vice President and Chief Operating Officer, Chief Financial Officer and Chief Tax Officer. Mr. Baird currently serves as Chairman of QCR Holdings, Inc., a publicly traded community bank holding company in Moline, Illinois, and two of its subsidiaries, Cedar Rapids Bank and Trust Company and m2 Lease Funds. He is also a director of Lombard International, a specialty life insurance company based in Luxembourg and Philadelphia, Pennsylvania. Mr. Baird is a Commissioner for the Eastern Iowa Airport, a founding board member and Treasurer of the Zach Johnson Foundation and a member of the board of directors of the Creative Corridor Economic Development Partnership. He also served as a director of National Financial Partners Corp. until its sale in 2013. Mr. Baird holds a Bachelor of Business Administration from the University of Iowa and is a Certified Public Accountant (inactive).

Mr. Baird’s qualifications to serve on our Board include: his wide-ranging experience in the insurance industry; his extensive financial and accounting knowledge; his strong track record as an executive officer of AEGON; and his experience as a board member of various companies.

James A. Quella joined our Board in May 2016. Since 2013, Mr. Quella has served as a Senior Advisor at Blackstone. On June 30, 2013, Mr. Quella retired as a Senior Managing Director and Senior Operating Partner at Blackstone, where he worked since 2004. Mr. Quella was responsible for monitoring the strategy and operational performance of Blackstone’s portfolio companies and providing direct assistance in the oversight of large investments. Mr. Quella has been a Director of Michaels Stores, Inc. since 2006 and has been an Independent Director of The Michaels Companies, Inc. since 2013. Mr. Quella has been a Director of Catalent, Inc. since 2009 and a Director of DJO Finance LLC and DJO Global Inc. since 2012. While at Blackstone, Mr. Quella also served as a Director at The Columbia House Company from 2004 to 2005. Mr. Quella served as a Director of Celanese Emulsions GmbH and Celanese Corporation from 2004 to 2007. He served as a Director of Houghton Mifflin Harcourt Publishing Company from 2005 to 2006. Mr. Quella served as a Director of Allied Waste Industries, Inc. from 2005 to 2008. He served as a Director and Vice President, Assistant Secretary and Assistant Treasurer Graham Packaging Holdings Company from 2005 to 2010. Mr. Quella served as Member of Supervisory Board at Nielsen Holdings plc (also known as Nielsen Holdings N.V.) from 2006 to 2009. He served as a Director of Intelenet Global Services from 2007 to 2011, a Director of Vanguard Health Systems Inc. from 2007 to 2011, a Director of Freescale Semiconductor, Ltd. from 2008 to February 2011 and from August, 2011 to 2015. Independently, Mr. Quella was a Director of Lionbridge Technologies Inc. from 2015-2017.

Previous to his experience at Blackstone, Mr. Quella held various positions at Donaldson, Lufkin & Jenrette Merchant Banking Partners-CSFB Private Equity. Mr. Quella served as Managing Director and Senior Operating Partner at Credit Suisse Private Equity, LLC (formerly, CSFB Private Equity) from 2000 to 2004. While at DLJ Merchant Banking Partners-CSFB Private Equity, Mr. Quella served as a member of various private equity company Boards including as a Director of Merrill Corporation from 2000 to 2004. He served as a Director of Von Hoffmann Holdings Inc. and Von Hoffmann Corporation from 2000 to 2004. Mr. Quella served as a Director of Advanstar Holdings Inc., from 2000 to 2004, a Director of DeCrane Aerospace, Inc. (formerly Decrane Aircraft Holdings Inc.) and DeCrane Holdings Co. from 2003 to 2004, and a Director of Jostens, Inc. from 2003 to 2004.

From 1981 to 2000, Mr. Quella worked at Oliver Wyman, Inc., (Mercer Management Consulting and Strategic Planning Associates) where he served as a Senior Consultant to Chief Executive Officers and senior management teams and served as a Co-Vice Chairman from 1997 to 2000 with shared responsibility for overall management of the global firm. In 1992, he founded the Financial Services Practice Group and also managed it until 1995.

Mr. Quella is a co-author of Profit Patterns: 30 Ways to Anticipate and Profit from the Strategic Forces Reshaping Your Business. Mr. Quella received his Masters of Business Administration, with Dean’s honors, from the University of Chicago Graduate School of Business, and a B.A. in International Studies from the University of Chicago and University of Wisconsin-Madison.

Mr. Quella’s qualifications to serve on our Board include: his substantial experience in managing businesses; his experience in mergers and acquisitions; his familiarity with corporate finance and strategic business planning activities; and his extensive experience serving as a director for various public and private companies.

102

Class C Directors - Terms Expiring in 2022

Christopher O. Blunt joined our company as President and Chief Executive Officer and joined our Board in January 2019. Mr. Blunt previously served as a Senior Managing Director and Chief Executive Officer of Blackstone Insurance Solutions, beginning in January 2018. Before joining Blackstone Insurance Solutions, Mr. Blunt served in a variety of senior leadership positions with New York Life from 2004 to 2017. During his tenure at New York Life, Mr. Blunt served as the President of New York Life’s Investment Group and prior to that, as Co-President of the Insurance and Agency Group, which included the company’s U.S. Life Operations, Seguros Monterrey New York Life Mexico and AARP Operations. Prior to joining New York Life, Mr. Blunt was Chairman and Chief Executive Officer of Giving Capital, Inc., a wealth management solutions provider serving the financial institutions marketplace, from 2001 to 2004. Mr. Blunt served in a variety of senior marketing and distribution roles in the investment management industry. Mr. Blunt was the Chief Marketing Officer - Americas for Merrill Lynch Investment Managers and President of Mercury Funds Distributors from 1999 to 2001. Before working with Merrill Lynch, Mr. Blunt was a Managing Director with Goldman Sachs & Co., as well as the National Sales Manager for Goldman Sachs Funds, from 1996 to 1999. He currently serves as Chair of the Board of Directors of the YMCA of Greater New York. Mr. Blunt received a B.A. in History from the University of Michigan and an MBA in Finance from The Wharton School at the University of Pennsylvania.

Menes O. Chee joined our Board in November 2017. Mr. Chee is a Senior Managing Director and founding member of Blackstone’s Tactical Opportunities Group. He is responsible for sourcing, evaluating and executing investments in private opportunities and capital markets. Mr. Chee is a member of the investment committees of Tactical Opportunities. Mr. Chee joined Blackstone in 2009 as a Managing Director of GSO and transferred to Tactical Opportunities in 2012. Before joining Blackstone, Mr. Chee was a Principal in TPG-Axon Capital, where he invested globally in equity and credit public markets and private transactions. Prior to that, he was a private equity investment professional with Texas Pacific Group. Before TPG, Mr. Chee worked at Credit Suisse First Boston in the Merchant Banking Group and at Donald Lufkin & Jenrette in the Leveraged Finance Group.

Mr. Chee currently serves on the boards of Lombard International, Philadelphia Financial Group, Finance of America, DRB Capital, Viva Capital, and Ellington Residential Mortgage REIT. He graduated magna cum laude from the University of Pennsylvania with a B.S. in Economics from the Wharton School and a B.A. from the College of Arts and Sciences, where he was elected Phi Beta Kappa.

Mr. Chee’s qualifications to serve on our Board include: his strong track record as Senior Managing Director of Blackstone’s Tactical Opportunities Group and his extensive experience in corporate finance and private equity.

Timothy M. Walsh joined our Board in November 2017. He is currently a Director of Strategic Relationships for Owl Rock Capital Partners, a direct lending business development corporation. In addition, he is an investment advisor to the $55 billion Alaska Permanent Fund Corporation and an independent trustee to Blackstone Mortgage Trust, Inc. From 2013 to 2015, he served as President of Gaw Capital USA, a California-based private equity real estate firm. He served as Chief Investment Officer for the State of New Jersey’s Division of Investment from 2010 to 2013, where he served as the chief fiduciary for the approximately $70 billion New Jersey pension fund as well as approximately $15 billion in money market funds, deferred compensation plans and college savings plans. Prior to joining the State of New Jersey, he was the Chief Investment Officer managing the $8 billion Indiana State Teachers’ Retirement Fund. Before joining the Indiana State Teachers’ Retirement Fund, he was head of investor relations for a global macro hedge fund, VARA Capital Management, and a vice president and senior trader in fixed income securities and foreign currencies for several large money center banks in Chicago, Illinois. Mr. Walsh founded an investment advisory firm, Walsh Financial Services that provided wealth management services for individuals, private trusts and corporate clients. He served on the board of directors of Ambassadors Corp. from 2012 to 2014 and has also been a board member of various privately held companies, a trustee of the Indiana State Teachers’ Retirement Fund and a Commissioner of the Indiana Gaming Commission. Mr. Walsh holds a B.S. from Merrimack College and an MBA from the Kellogg School of Management at Northwestern University.

Mr. Walsh’s qualifications to serve on our Board include: his over 30 years in the investment business, with extensive experience in fixed income, equities, private equity and real estate, and his substantial experience on the boards of directors of various companies.

103

Information About Our Executive Officers

The following sets forth certain information with respect to our executive officers. We deem certain employees of our subsidiaries Fidelity & Guaranty Life Holdings, Inc. (“FGLH”) and F&G Life Re Ltd. (“F&G Life Re”) to be our executive officers. All officers of our company serve at the discretion of our Board.

Name	Age	Position
Christopher O. Blunt	57	President, Chief Executive Officer and Director
John T. Fleurant	57	Executive Vice President, Chief Financial Officer
Eric L. Marhoun	57	Executive Vice President, General Counsel and Secretary
Rajesh Krishnan	48	Executive Vice President, Chief Investment Officer
John D. Currier	49	Executive Vice President, Chief Actuary & Chief Product Officer
Wendy J.B. Young	56	Executive Vice President, Chief Risk Officer
Jonathan Bayer	43	Head of Corporate Development & Strategy
John A. Phelps, II	60	Executive Vice President, Chief Distribution Officer
Bonnie Wasgatt	62	Executive Vice President, Chief Operations Officer
Alex Castillo	41	Senior Vice President, Chief Human Resources Officer

Christopher O. Blunt joined our company as President and Chief Executive Officer and joined our Board in January 2019. Mr. Blunt previously served as a Senior Managing Director and Chief Executive Officer of Blackstone Insurance Solutions, beginning in January 2018. Before joining Blackstone Insurance Solutions, Mr. Blunt served in a variety of senior leadership positions with New York Life from 2004 to 2017. During his tenure at New York Life, Mr. Blunt served as the President of New York Life’s Investment Group and prior to that, as Co-President of the Insurance and Agency Group, which included the company’s U.S. Life Operations, Seguros Monterrey New York Life Mexico and AARP Operations. Prior to joining New York Life, Mr. Blunt was Chairman and Chief Executive Officer of Giving Capital, Inc., a wealth management solutions provider serving the financial institutions marketplace, from 2001 to 2004. Mr. Blunt served in a variety of senior marketing and distribution roles in the investment management industry. Mr. Blunt was the Chief Marketing Officer - Americas for Merrill Lynch Investment Managers and President of Mercury Funds Distributors from 1999 to 2001. Before working with Merrill Lynch, Mr. Blunt was a Managing Director with Goldman Sachs & Co., as well as the National Sales Manager for Goldman Sachs Funds, from 1996 to 1999. He currently serves as Chair of the Board of Directors of the YMCA of Greater New York. Mr. Blunt received a B.A. in History from the University of Michigan and an MBA in Finance from The Wharton School at the University of Pennsylvania.

John T. Fleurant joined our company as Chief Financial Officer in November 2019. Mr. Fleurant served in a number of senior leadership positions with New York Life Insurance Co. from November 2010 to April 2019, including Senior Vice President of Finance and Controller from 2010 to 2013, and Executive Vice President and Chief Financial Officer from 2013 to 2019. Prior to joining New York Life Insurance Co., Mr. Fleurant was the Financial Controller and Chief Financial Officer, U.S. Businesses of Prudential Financial. Mr. Fleurant received a B.A. in accounting from Widener University.

Rajesh Krishnan joined our company as Chief Investment Officer in January 2019. He is responsible for all aspects of the company’s investment portfolio. Before to joining F&G, Mr. Krishnan was Executive Vice President at Blackstone ISG-I Advisors L.L.C. from November 2017 to December 2018. Prior to his position there, Mr. Krishnan worked as Executive Vice President and Chief Investment Officer of Fidelity & Guaranty Life starting in 2009. During his tenure at Fidelity & Guaranty Life, Mr. Krishnan led the restructuring of the company’s fixed income portfolio and the development of in-house asset management capabilities, including the establishment of the company’s Baltimore-based trading desk, and was promoted from Senior to Executive Vice President in August 2012. Prior to joining Fidelity & Guaranty Life, Mr. Krishnan was with Wellington Management Company, an investment management company, in Boston, Massachusetts, from 1994 to 2008. While employed there, he was a Fixed Income Portfolio Manager and Associate Partner focusing on managing bond portfolios for a wide range of insurance clients. Mr. Krishnan is a Chartered Financial Analyst and a member of the Boston Security Analysts Society. He holds a Bachelor of Arts degree from Harvard College.

104

Eric L. Marhoun joined our company as General Counsel and Secretary in November 2017. Mr. Marhoun previously served as Executive Vice President, General Counsel and Secretary of FGL until its acquisition by CF Corp in November 2017. Mr. Marhoun joined FGL in 2007 as Senior Vice President and General Counsel. Mr. Marhoun was promoted to Executive Vice President of FGL in November 2013. In his current position, Mr. Marhoun oversees Legal and Compliance matters for the U.S. life and annuity businesses of our company. Mr. Marhoun has over 35 years of legal experience in U.S. and non-U.S. insurance markets. Mr. Marhoun was previously Senior Vice President and General Counsel to Old Mutual US Life and managed the Legal and Compliance departments for the U.S. and Bermuda life and annuity businesses of Old Mutual plc of the United Kingdom from 2007 to 2011. Prior to joining Old Mutual US Life, Mr. Marhoun was Vice President, Lead Group Counsel and Secretary of American Express Financial Advisors, Inc., a financial services company, from 1995 to 2006 where he oversaw the legal operations of the insurance division of American Express. He was also Of Counsel with Lord, Bissell & Brook in 2006 and an Associate with the firm at the beginning of his career. Mr. Marhoun received his J.D., cum laude, from DePaul University College of Law and is admitted to practice law in the states of Illinois, Minnesota, Wisconsin and Georgia as well as various federal courts.

Wendy J.B. Young joined our company as Chief Risk Officer in November 2017. Ms. Young previously served as Senior Vice President, Chief Risk Officer of FGL until CF Corp’s acquisition of FGL in November 2017. Ms. Young joined FGL in 2000 as Actuary. During her tenure with FGL, she was promoted to Senior Vice President and assumed increasing responsibilities, including leading the Financial Planning & Analysis area. In February 2014, Ms. Young was appointed Senior Vice President, Chief Risk Officer of FGL where she was responsible for risk management across the organization, which included ERM, internal controls, and internal audit. Ms. Young has over 28 years of experience as an actuary in the insurance industry. Prior to joining FGL, Ms. Young served for 10 years at the Acacia Group, a life and annuity company holding various actuarial roles, ending as 2nd Vice President and Associate Actuary responsible for statutory reporting and projections for regulatory filings. Ms. Young began her career in Ernst & Young’s insurance practice performing auditing and consulting functions. She holds a Bachelor of Science in Insurance with a concentration in Actuarial Science from The Pennsylvania State University. Ms. Young is a Member of the American Academy of Actuaries as well as a Fellow in the Society of Actuaries.

Bonnie Wasgatt joined our company as Chief Operating Officer in May 2019. Ms. Wasgatt most recently served as a Senior Advisor at The Blackstone Group L.P. since January 2019, where she worked in insurance vertical growth opportunities. Prior to joining Blackstone, Ms. Wasgatt served as the Chief Information Officer at Jackson National Life Insurance Company from 2013 to 2018, where she was responsible for all aspects of systems development, production support, vendor management, project management and execution as well as firmwide organizational and transformational change, and also served as Executive IT Strategist from 2012 to 2013. Before joining Jackson National Life Insurance Company, she worked in a variety of roles for both insurance carriers and software firms, including as President of Insurance Solutions at DST Corporation from 2010 to 2012, as a Senior Vice President of Swiss Re - Global Admin Re from 2002 to 2010, as an Executive Vice President at Computer Sciences Corporation (now DXC Technology Company) and as a Project Director at Vantage Computer Systems. Ms. Wasgatt brings over 35 years of experience in the life insurance and annuity product manufacturing and software development arenas.

John D. Currier Jr. joined FGLH as Deputy Chief Actuary in May 2015 and was named Chief Actuary in October 2016. Mr. Currier has more than 25 years of experience in the insurance industry. Prior to joining FGLH, he served briefly as Chief Operating Officer and Chief Actuary of the Life Companies of Farm Bureau Financial Services. He served with Aviva USA, a provider of indexed universal life and indexed annuity products, as Executive Vice President and Chief Actuary of Aviva USA (formerly AmerUs Group) from March 2010 to June 2013, Chief Product Officer from February 2008 to February 2010, and Senior Vice President of Annuity Product Development from August 2005 to February 2010. Prior to Aviva USA, he served in a variety of product development and management positions with INF US Financial Services and Conseco, Inc. Mr. Currier began his insurance career as a consulting actuary with Beckley & Associates on a wide range of actuarial projects. Mr. Currier holds a bachelor’s degree Cum Laude from Butler University, is a Fellow of the Society of Actuaries and a Member of the American Academy of Actuaries.

John A. Phelps, II is FGLH’s Senior Vice President and Chief Distribution Officer. In 2000, Mr. Phelps joined FGLH as National Life Sales Director and in 2002 was promoted to Vice President, Brokerage Life Sales. In 2003, Mr. Phelps was promoted to Vice President, Life Distribution. In 2006, Mr. Phelps was promoted to the position of Senior Vice President, Sales & Marketing, overseeing all life & annuity product development and distribution

105

channels. In 2009, Mr. Phelps was named Chief Distribution Officer and continues to function in this role today. During his 32-year career in the industry, Mr. Phelps has served as a personal producer and general agent and has held executive sales and marketing positions with home office insurance companies as well as having served on the ACLI Life Insurance Committee, the LIMRA Distribution Leaders Round Table Committee and LIMRA Brokerage Committee. Mr. Phelps obtained his Masters of Science Management degree from The American College and holds a Bachelor of Science degree in Economics from Manchester College.

Jonathan Bayer joined our company as Head of Corporate Development and Strategy in December 2018. Mr. Bayer is responsible for directing the company's M&A, corporate strategy, and overseeing the execution of acquisitions. He has more than 20 years of experience in insurance investment banking, where he has focused on M&A advisory and capital raising transactions. Over his career, Mr. Bayer has advised a number of leading Annuity and Life insurers, including F&G. Mr. Bayer joins F&G from RBC Capital Markets, where he was Managing Director and Head of U.S. Insurance Investment Banking since September 2011. Prior to his tenure there, Mr. Bayer worked on the FIG team at UBS AG and focused on the life and property and casualty insurance industries. Before UBS, he covered insurance while working at Deutsche Bank AG. Mr. Bayer holds a Bachelor of Arts degree in Economics from Washington and Lee University.

Rubén Alejandro (“Alex”) Castillo joined FGLH as Senior Vice President, Chief Human Resources Officer in May 2019. Mr. Castillo previously served as Vice President of Global Human Resources at Kemin Industries from September 2016 to May 2019.  Prior to Kemin, Mr. Castillo was Vice President of Human Resources at ATI Physical Therapy from March 2014 to September 2016. He also served in a number of Human Resources leadership roles at Collins Aerospace from July 2005 to February 2014. Mr. Castillo earned his B.S. in International Business and Economics from St. Ambrose University and his MBA from the Kellogg School of Management at Northwestern University.

106

CORPORATE GOVERNANCE

Audit Committee of the Board

Our Board maintains an Audit Committee, which is currently composed of Messrs. Abell, Baird and Walsh. Each member of the Audit Committee has been determined by the Board to be independent within the meaning of the federal securities laws and NYSE Corporate Governance Standards and meets the financial literacy requirements under NYSE Corporate Governance Standards, and our Board has determined that Messrs. Abell, Baird and Walsh are each an “audit committee financial expert,” as that term is defined by the applicable rules of the SEC.

Code of Ethics and Business Conduct

Our Board has adopted a Code of Business Conduct and Ethics that applies to directors and all of our employees, including our senior executive and financial officers, which include our principal executive officer, principal financial officer, principal accounting officer, and persons performing similar functions. A copy of the Code of Business Conduct and Ethics is available on our website. We will promptly disclose any future amendments to this code on our website as well as any waivers from this code for executive officers and directors. Copies of this code also are available in print from our corporate secretary upon request.

Governance Documents Availability

We have posted our Corporate Governance Guidelines, Code of Business Conduct and Ethics, Audit Committee charter, Compensation Committee charter, Nominating and Corporate Governance Committee charter and Transactions Committee charter on our website under the heading “Corporate Governance” at investors.fglife.bm. We intend to disclose any amendments to, and, if applicable, any waivers of, these governance documents on that section of our website. These governance documents are also available in print without charge to any shareholder of record that makes a written request to our company. Inquiries should be directed to the Investor Relations Department at FGL Holdings, 4th Floor, Boundary Hall, Cricket Square, Grand Cayman, Cayman Islands KY1-1102.

Communications with Board Members

We believe that communications between our Board, our shareholders and other interested parties are an important part of our corporate governance. Shareholders and other interested parties may communicate with the Board as a whole, the independent directors, or any individual member of the Board or any committee of the Board. All such communications should be submitted:

By email at:                    By mail at the following address:

Legalgovernance@fglife.com            FGL Holdings

c/o General Counsel and Secretary

4th Floor, Boundary Hall, Cricket Square

Grand Cayman, Cayman Islands KY1-1102

The Board has designated our General Counsel as its agent to receive and review written communications addressed to the Board, any of its committees, or any board member or group of members. As an initial matter, the General Counsel will determine whether the communication is a proper communication for the Board. The General Counsel will promptly forward to the chairman of the Audit Committee any communication alleging legal, ethical or compliance issues by management or any other matter deemed by the General Counsel to be potentially material to our company. The General Counsel will not forward communications of a personal nature or not related to the duties and responsibilities of the Board, including junk mail and mass mailings, business solicitations, routine customer service complaints, new product or service suggestions, opinion survey polls or any other communications deemed by the General Counsel to be immaterial to the company.

107

Delinquent Section 16(a) Reports

Section 16(a) of the Exchange Act requires our directors, executive officers, and any persons who beneficially own more than 10% of our ordinary shares to file with the SEC initial reports of ownership and reports of changes in ownership of our ordinary shares. Such reporting persons are also required by the SEC’s regulations to furnish us with copies of all forms they file with the SEC pursuant to Section 16(a) of the Exchange Act. Based solely on the reports received by us and on the representations of the reporting persons, we believe that the reporting persons have complied with all applicable filing requirements during the fiscal 2019, except for a Form 4 for Patrick S. Baird which was triggered on August 14, 2019, and filed on August 22, 2019.

Item 11. Executive Compensation

COMPENSATION DISCUSSION AND ANALYSIS

In this compensation discussion and analysis section, we provide an overview and analysis of our executive compensation program, including a discussion of our compensation philosophy. The discussion below is intended to help provide an understanding of the detailed information in the compensation tables and related narrative disclosure below. We discuss the material elements of our compensation program and the material factors considered by the Compensation Committee in making compensation decisions. The following table identifies our named executive officers (“NEOs”) as of December 31, 2019, as defined by SEC regulations:

Named Executive Officers (NEO's)	Position
Christopher O. Blunt	President, Chief Executive Officer and Director
John T. Fleurant	Chief Financial Officer
Rajesh Krishnan	Chief Investment Officer
Bonnie Wasgatt	Executive Vice President, Chief Operations Officer
R. Alex Castillo	Senior Vice President, Chief Human Resources Officer
Dennis R. Vigneau (a)	Former Chief Financial Officer

a. Mr. Vigneau transitioned to a non-executive advisor role in November 2019 in connection with the appointment of Mr. Fleurant as our CFO, and retired December 31, 2019.

Executive Summary

Our Business

We are an insurance holding company that helps middle-income Americans prepare for retirement and for their loved ones' financial security. Through our subsidiaries, we are a leading provider of annuity and life insurance products. We acquired Fidelity & Guaranty Life, a Delaware corporation (“FGL”), on November 30, 2017 (the “Business Combination”). For more information about our business, please see the “Business” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included within this report.

Executive Compensation Highlights

The Compensation Committee has designed our executive compensation programs to align with evolving competitive and governance practices and respond to feedback from our shareholders. We tie executive compensation closely to financial performance through the use of performance metrics in our short-term incentives as well as the use of options and stock-price incentives to directly align executive incentives with long-term shareholder interests.

108

In 2018, we made substantial grants of equity to our then-NEOs intended to provide equity compensation for a five-year period, leveraging a mix of time-based and performance-based stock options to ensure alignment with shareholder interests. During 2019, we granted equity with a similar five-year design to our new NEOs upon joining our Company.

2019 Appointment of CEO

Christopher O. Blunt joined our company as President and Chief Executive Officer effective January 2, 2019. In, developing our compensatory arrangement with Mr. Blunt, the Board considered Mr. Blunt’s then current compensation, including his current equity, the compensation of our former President and Chief Executive Officer, and the compensation of chief executive officers of other similarly sized insurance companies. In designing a compensation package for Mr. Blunt, the Board determined to provide him the following:

• annual base salary of $800,000,

• target bonus opportunity equal to 200% of his base salary, and

• sign-on bonus in the amount of $2,250,000.

Upon a termination without “cause” or by Mr. Blunt for “good reason,” he will be entitled to receive severance benefits equal to three times his base salary, acceleration of certain unvested options and 18 months of benefit continuation. In addition, Mr. Blunt will be subject to certain restrictive covenants that apply both during his employment with the company and for certain durations afterwards.

The Board also determined to grant a one-time award of stock options covering a five-year period to Mr. Blunt for 3.2 million shares, subject to a combination of time and performance-based vesting, as well as a stretch award of stock options for 613,476 shares, subject to performance-based vesting, as inducements to his employment by us. The stock options were issued outside of our 2017 Omnibus Incentive Plan as employment inducement awards pursuant to NYSE rules. The Board determined that the overall compensation package would be sufficient to encourage Mr. Blunt to join our company, yet would help support the creation of shareholder value and be in the best interests of our shareholders.

Compensation Philosophy and Practices

Compensation Philosophy and Objectives

Our compensation programs are based on the following objectives:

• Attract and retain highly qualified executives and employees;

• Align our incentives with shareholder interests;

• Drive performance and results; and

• Support our culture.

Compensation Practices

Market and industry practices are taken into account when developing compensation programs. Third-party market industry surveys and compensation data from other public companies are utilized when reviewing compensation. We consider our peer group to be companies in our industry that are similar in size to us, that have business models similar to ours and that compete with us for customers, labor and capital.

Our goal is to align total compensation to the competitive market within our peer group while being mindful of internal equity. Salaries are reviewed annually in a process correlated to our performance management program and a competitive base salary market review. Incentives are the primary motivators to achieve business goals and strong business or individual performance can result in above-market incentives.

The Committee leverages the following best practices in designing, administering and governing our executive compensation programs:

109

What We Do	What We Do Not Do
Target executive compensation to be competitive at the median	"Single trigger" change-in-control cash severance payments, or change-in-control cash severance payments exceeding three times base salary and annual incentives
Tie the majority of compensation to stock price targets and performance based incentives	Stock option discounts or repricings
Use equity to create long-term incentives aligned with shareholders' interests	Change-in-control tax gross-ups to our named executive officers
Promote stock ownership with equity-based compensation	Executives or director hedging or pledging company stock unless approved in advance
Reflect shareholder preferences in our compensation program and policies, including double trigger protections
Periodically review our compensation program to ensure it does not encourage excessive risk taking
Consider market and industry practices when developing compensation programs

Our Process for Making Compensation Decisions

Our Compensation Committee

Our Compensation Committee is responsible for reviewing and approving the compensation and benefits strategy for our employees, including our NEOs, authorizing and ratifying equity grants and other incentive arrangements, and authorizing employment and related agreements. The Compensation Committee has the full authority of the Board to make compensation decisions relating to our NEOs.

The Compensation Committee has the authority to delegate any of its responsibilities to sub-committees as the Compensation Committee may deem appropriate, provided that the sub-committees are composed entirely of directors satisfying the independence standards then applicable to the Compensation Committee generally. The Compensation Committee has the authority to delegate responsibilities regarding some activities that are below certain thresholds to management, provided that no member of management is delegated authority of his or her own compensation.

Role of our Executive Officers

Although our Compensation Committee has the authority to make final decisions with respect to executive compensation, our Senior Vice President, Human Resources in partnership with our Chief Executive Officer, drive the design and implementation of all executive compensation programs. The goal is to ensure that the design of our compensation programs supports our overall strategy. Except for his own compensation, the Chief Executive Officer has final management-level review of any compensation program or individual element of compensation for our NEOs before they are reviewed by the Compensation Committee. The Chief Executive Officer and our other NEOs do not participate in discussions regarding their own compensation.

Role of the Compensation Consultant

Prior to establishing our executive compensation program for fiscal 2019, our Compensation Committee and management reviewed our executive compensation policies and practices. The Compensation Committee also conducted on-going assessments of our compensation structure. The committee has retained FW Cook to serve as our compensation consultant and to assist and advise the Compensation Committee in connection with compensation policies and practices, including the design and setup of our long-term incentive program.

FW Cook reviewed the structure and mechanics of the various components of our compensation programs and practices in preparation for fiscal 2019. In order to obtain a complete view of the competitive market for talent, FW Cook considered data from publicly available peer company proxy statements, and, as a secondary view of the market, considered data from published survey sources, which includes industry peers from privately held and publicly traded organizations. In particular, FW Cook analyzed two key elements: pay magnitude and pay practices. Pay magnitude relates to overall base pay delivery, base salaries, annual and long-term incentive targets and payouts. Pay practices is the assessment of the design attributes of other organizations’ incentive plans that provide

110

perspectives on performance measurement, the mix of long-term incentive vehicles, vesting and shareholding requirements.

FW Cook completed an assessment in 2019 indicating that the current compensation structure is sound and well-balanced, and demonstrates alignment between company performance and executive compensation.

Compensation Peer Group

The Compensation Committee reviewed recommendations from FW Cook based on a peer group of insurance companies. FW Cook conducted a market analysis that included several data points using peer group comparators and relevant survey data to develop a clear assessment of current compensation practices in our industry. In order to provide peer comparison data, FW Cook utilized data from multiple sources. The primary survey source is the LOMA insurance and financial services industry survey.  FW Cook utilizes a comparison of survey participants with total assets in the category of $10 billion to $40 billion.

Competitive pay data from a selected peer group’s proxy data is also used as a data source. The selected peer group consisted of companies with total assets from $10.1 billion to $144.2 billion, revenue ranging from $625 million to $11.8 billion and market capitalization ranging from $1.1 billion to $11.4 billion at the time of the analysis. There were 14 companies included in the peer group, and the list was the same as our 2018 peer group except that Globe Life Inc. changed its name in the interim, becoming Torchmark Corp.

American Equity Investment Life Holding Company	Horace Mann Educators Corporation
American Financial Group, Inc.	Kemper Corporation
American National Insurance Company	National General Holdings Corp.
Assurant, Inc.	National Western Life Group, Inc.
Athene Holding Ltd.	Primerica, Inc.
CNO Financial Group, Inc.	Globe Life Inc.
FBL Financial Group, Inc.	Unum Group

Shareholder Approval of our Executive Compensation Program

In deciding on the structure of the executive compensation program for fiscal 2019, the Compensation Committee took into account the perspectives of our shareholders, in particular the results of the shareholder advisory vote on executive compensation (the “say on pay” vote). At our 2018 Annual General Meeting, our proposal regarding the “say on pay” vote was approved by approximately 99.90% of the votes cast on the proposal in support of the compensation of our NEOs. We continue to consider the perspectives of our shareholders in the design and administration of our executive compensation programs.

In addition, at our 2018 Annual General Meeting, our shareholders also voted on the frequency of future “say on pay” votes, with approximately 64.97% of the votes cast supporting a frequency of every three years. Our Board also reviewed these results and determined that, consistent with the preference of our shareholders as reflected in the shareholder advisory vote, we will hold a “say on pay” vote every three years. Accordingly, the next scheduled “say on pay” advisory vote would take place at the 2021 Annual General Meeting.

Other Related Considerations

Relationship of Compensation Policies and Practices to Risk Management

We believe that our compensation policies and practices are designed to promote a strong risk management culture. We have reviewed our compensation programs and employee policies and practices and have determined that they do not encourage excessive risk taking and are not reasonably likely to have a material adverse effect on the company.

111

Components of Our Executive Compensation Program

For fiscal 2019, our compensation program consisted of the following key components:

Component	Purpose	Key Features
Base Salary	Provide a fixed level of compensation Compensate executive officers fairly for the responsibility of the position held and reflect competitive practices	Salary levels set based on an assessment of: Level of responsibility Experience and time in position Individual performance Future potential Competitiveness Internal pay equity considerations Salary levels are reviewed annually by the committee and adjusted as appropriate
Short-Term Incentives	Provide executive officers with incentives to achieve objectives to drive short- and long-term business performance Support attracting and retaining the best available talent	Awards based on achievement of financial and corporate objectives Awards determined on annual basis
Long-Term Incentives
Time Based Options	Provide opportunities for equity ownership Support leadership retention objectives	5-year ratable vesting 7-year expiration
Stock Price Options	Encourage sustained shareholder value creation via stock price increases Align executive officers’ interests with the interests of our shareholders	Vesting subject to stock performance objectives Target awards subject to multi-year ratable vesting Stretch awards subject to 1-year performance periods
Performance Options	Provide executive officers with incentives to achieve long-term success Align executive officers’ interests with the interests of our shareholders	Vesting subject to performance objectives 3-, 4- and 5-year performance periods

Set forth below is a discussion of each component of compensation, the rationale for each component, and how each component fits into our overall compensation philosophy.

Base Salary

We provide a base salary to compensate our executives for their services rendered on a day-to-day basis during the year. Base salaries are set to attract and retain executives with qualities necessary to ensure our short-term and long-term financial success. Base salary levels are set to be competitive with the salaries of executives in similar positions with similar responsibilities at comparable companies. The determination of an executive’s base salary is based on market compensation rates and individual factors, including personal performance and contribution, experience in the role, scope of responsibility and overall impact on the business. Base salaries are reviewed annually and adjusted when necessary to reflect market conditions as well as individual roles and performance.

The table below shows base salaries for fiscal 2019, on an annualized basis:

Name	Fiscal 2019 Base Salary
Christopher O. Blunt	$800,000
John T. Fleurant	$500,000
Rajesh Krishnan	$350,000
Bonnie Wasgatt	$335,000
R. Alex Castillo	$275,000
Dennis R. Vigneau	$440,000

112

Short-Term Incentives

In order to promote our “pay for performance” culture, we pay annual cash incentives to our executives for achieving performance targets that support financial and corporate goals. The short-term incentives made pursuant to our Employee Incentive Plan (the “EIP”), which allows for annual cash-based bonus awards intended to attract and retain the best available executive officers to be responsible for the management, growth, and success of our business and to provide an incentive for such individuals to exert their best efforts on behalf of our company and shareholders. Our Chief Executive Officer and executive team develop an annual business plan that includes objectives to drive short- and long-term business performance. The Compensation Committee reviews these objectives and establishes performance targets. Performance against plan objectives are reviewed and approved by the Compensation Committee to establish the bonus pool for each performance period. Short-term incentive payouts require that minimum targets be satisfied and allow for recognition of individual performance and contribution toward those goals.

The EIP includes a financial performance component based on the annual business plan weighted at 85% and a corporate initiatives component weighted at 15%. For fiscal 2019, the performance metrics for the EIP were:

Metrics	Weighting
Achieve the Financial Plan	85%
Sales
Adjusted Operating Income
Risk-based Capital
New Business Internal Rate of Return
Corporate Initiatives	15%
Enhance our control environment and strengthen our risk management process
Diversify the business through new products, distribution operating plans and channel growth
Further optimize capital usage
Simplify our Investor Relations story
Win the war for talent

The Compensation Committee approved the percentage of base salary paid for performance at the target levels depicted below. If a minimum performance measure is satisfied, depending on actual performance, bonus payments under the EIP could range from 50% to 150% of target. As a result of the corporate performance against our goals for fiscal 2019, the bonus pool for determining individual executive incentive awards was 137% of target.

Name	2019 Target Bonus		Actual Bonus Earned
	(% of base salary earnings)	($)	(% of base salary earnings)	($)
Christopher O. Blunt	200%	1,587,693	271%	2,150,000
John T. Fleurant (a)	100%	N/A	N/A	N/A
Rajesh Krishnan	100%	348,654	143%	500,000
Bonnie Wasgatt	50%	103,077	82%	170,000
R. Alex Castillo	40%	67,692	59%	100,000
Dennis R. Vigneau	60%	264,000	114%	500,000 (b)

a. Mr. Fleurant was not eligible for a 2019 bonus due to his hire date.

b. Pursuant to his transition agreement, Mr. Vigneau received $500,000 with respect to payments under the EIP, irrespective of company performance. Therefore this amount is classified as a bonus and reported in the Summary Compensation Table as a bonus.

Long-Term Incentives

We provide long-term incentive opportunities to motivate and reward our executive officers for their contributions toward achieving our business objectives and the interests of our shareholders. We believe that equity-based awards link compensation levels with performance results and ensure sustained alignment with shareholder interests. Additionally, we believe equity awards provide an important retention tool, because the awards are subject

113

to multi-year vesting. In furtherance of these objectives, we adopted the FGL Holdings 2017 Omnibus Incentive Plan, under which we grant such equity awards.

In 2018, the Compensation Committee established a new program for long-term award opportunities for our executives. We made substantial equity grants to each of the then-NEOs through a five-year incentive program that provides for a one-time award of stock options. The Compensation Committee approved these one-time grants covering long-term award targets for the five-year period in lieu of annual awards. In establishing these awards, the Compensation Committee considered its desire to strategically align the long term incentives to the long-term success of our business. In addition, a stretch award was granted to drive extraordinary performance of the stock price over the five-year period of the grant. These grants were made in March 2018.

Our long-term incentives for NEOs consist of three forms of stock option awards that incentivize long-term value creation: time-vesting options that reward increases in the market value of our shares and continued service with our company; stock price options that reward the achievement of our long-term goals for increasing the market price of our shares; and performance options that reward the achievement of our long-term performance goals as determined by Adjusted Operating ROE. The mix of long-term incentives granted to our NEOs is as follows:

Time-Vesting Options	1/3
Stock Price Options	1/3
Performance Options	1/3

Time-Vesting Options

Time-vesting options provide value based solely on stock price appreciation. The time-vesting options vest in four or five equal annual installments beginning on the anniversary of the date grant, based on continued service.

Stock Price Options

Stock price options align our long-term incentives to the appreciation of our share price. Stock price options vest based on achievement of both stock price goals and continued service requirements.

We awarded our NEOs two one-time grants of stock price options: target stock price options that vest in four or five equal installments upon the later of the achievement of annual stock price goals or the applicable continued service requirement; and stretch stock price options that vest in four or five equal installments based on both continued service during the performance period and achievement of the stock price goal for the applicable one-year performance period.

Performance Options

Performance options align our long-term incentives to the achievement of our Adjusted Operating ROE objectives. Performance options vest in equal installments based on continued service and achievement of separate three-year, four-year and five-year Adjusted Operating ROE goals established at the start of the five-year period.

Of our 2019 NEOs, only Mr. Vigneau was employed by the Company in March 2018 when the original five-year grants were made. He received the following grants in 2018, and no additional grants in 2019.

			Stock Price Options (c)		Performance Options (d)
		Time-Vesting Options	Target	Stretch	Target	Stretch	Total Value at Grant (a)
Name	Date of Grant	(#)	(#)	(#)	(#)	(#)	($)
Dennis R. Vigneau (b)	May 15, 2018	605,693	605,693	153,369	605,693	153,369 (d)	4,462,790

a. Represents the grant date fair value computed in accordance with Financial Accounting Standards Board Accounting Standards Clarification (“FASB ASC”) Topic 718.

b. Mr. Vigneau’s options were subsequently accelerated in part, and cancelled in part, on December 31, 2019, in connection with his transition agreement from the company. See “Potential Payments Upon Termination or Change in Control” for more detail.

114

c. The stock price objectives for our ordinary shares for the applicable installment period and performance period for the target stock price options and stretch period stock price options granted to our NEOs in fiscal 2018 were:

	2019	2020	2021	2022	2023
Target	$11.00	$12.75	$14.75	$17.00	$20.00
Stretch	$12.00	$14.50	$17.00	$21.00	$25.00

d.    Included the following terms:

Performance Option Award	Performance Periods	Adjusted Operating ROE Performance Targets (a)
Stretch Performance Options	March 15, 2021 March 15, 2022 March 15, 2023	16.50% 17.50% 18.50%

a. “Adjusted Operating ROE” is a non-GAAP measure and is calculated by dividing adjusted operating income (“AOI”) available to common shareholders by total average common shareholders’ equity excluding accumulated other comprehensive income. AOI available to common shareholders is a non-GAAP measure and is calculated by adjusting net income (loss) available to common shareholders to eliminate certain items including the impact of net investment gains/losses, the effect of changes in fair values of FIA derivatives and embedded derivatives, the tax effect of change in fair value of affiliated reinsurance embedded derivatives, the effect of integration, merger related and other non-operating items and the impact of extinguishment of debt. Management considers this non-GAAP financial measure to provide useful supplemental information internally and to investors and analysts assessing the level of adjusted earned return on common equity.

Mr. Blunt’s appointment as President and CEO was announced on December 21, 2018, and he joined our Company on January 2, 2019. He received similar but not identical equity awards that were designed to mirror the awards received by the then-NEOs in March 2018 but to also reflect the passage of time, including Company’s stock price at the date of grant, and his key role as our Chief Executive Officer:

				Performance Options (d)
		Time-Vesting Options (b)	Stock Price Options (c)	Target (d)	Stretch (e)	Total Value at Grant (a)
Name	Date of Grant	(#)	(#)	(#)	(#)	($)
Christopher O. Blunt	December 21, 2018	1,600,000	306,738	1,600,000	306,738	4,075,971

a. Represents the grant date fair value computed in accordance with Financial Accounting Standards Board Accounting Standards Clarification (“FASB ASC”) Topic 718.

b. These options vest equally across five years on the anniversaries of the date of grant; One-half of the target options have an exercise price of $7.04, and one-half $10.00.

c. The stock price options vest in five annual installments beginning on March 15, 2020 based upon continued service and the achievement of stock price objectives:

	2019	2020	2021	2022	2023
Target	$11.00	$12.75	$14.75	$17.00	$20.00
Stretch	$12.00	$14.50	$17.00	$21.00	$25.00

d. These options vest in five annual installments, beginning on December 21, 2019, based upon continued service and the achievement of performance objectives to be established by the Board on an annual basis.

e. These options vest in five annual installments, beginning on December 21, 2019, based upon continued service and the achievement of the following objectives, were:

Performance Option Award	Vesting Date	Adjusted Operating ROE Performance Targets (a)
Stretch Performance Options	March 15, 2021 March 15, 2022 March 15, 2023	16.50% 17.50% 18.50%

a. ROE measured as of December 31 of each year. “Adjusted Operating ROE” is a non-GAAP measure and is calculated by dividing adjusted operating income (“AOI”) available to common shareholders by total average common shareholders’ equity excluding accumulated other comprehensive income. AOI available to common shareholders is a non-GAAP measure and is calculated by adjusting net income (loss) available to common shareholders to eliminate certain items including the impact of net investment gains/losses, the effect of changes in fair values of FIA derivatives and embedded derivatives, the tax effect of change in fair value

115

of affiliated reinsurance embedded derivatives, the effect of integration, merger related and other non-operating items and the impact of extinguishment of debt. Management considers this non-GAAP financial measure to provide useful supplemental information internally and to investors and analysts assessing the level of adjusted earned return on common equity.

Our other NEOs received substantially similar grants as sign-on awards as they joined our Company, with stock price objectives and performance targets that generally mirror the older awards except for adjustments based on the passage of time, including shortening time horizons to four rather than five years. Specific information about these grants is provided in the “Grants of Plan-Based Awards” table below.

Stock Option Awards

In August 2019, upon Mr. Blunt’s recommendation, our Compensation Committee determined to make additional stock option awards to our executive team other than Mr. Blunt and Mr. Fleurant. They did so in order to align goals and incentives across the team and retain executive talent.

Like our sign-on awards, these awards were split evenly between time-based vesting, stock price vesting, and vesting based on performance goals.

Time-Vesting Options	1/3
Stock Price Options	1/3
Performance Options	1/3

Transaction Bonus Letter Agreements

As discussed in Item 1 of this Annual Report on Form 10-K, we announced on February 7, 2020 that we had entered into the FNF Merger Agreement, upon closing of which our company would become a fully-owned subsidiary of Fidelity National Financial, Inc. (FNF).

In order to reward our NEOs for the critical role they are performing in working towards the closing of the FNF Merger, the Compensation Committee approved Transaction Bonus Letter Agreements with each of our NEOs on February 25, 2020.

Under the Transaction Bonus Letter Agreements, each executive is eligible to receive a specified cash transaction bonus, as set forth below, subject to the occurrence of the closing of the FNF Merger and the executive’s continued employment through the date of the closing. Such bonuses would be paid out within 30 days following the date of closing. Executives will no longer be eligible to receive a Transaction Bonus if their employment is terminated for any reason prior to the closing date, or if the Merger Agreement with FNF is terminated prior to closing.

	Potential Transaction Bonus
Christopher Blunt	$	400,000
John Fleurant	$	250,000
Raj Krishnan	$	200,000
Bonnie Wasgatt	$	200,000
Alex Castillo	$	200,000

116

Employment and Other Severance, Change-in-Control and Related Agreements

Employment Agreements

We believe that having employment agreements with our NEOs is beneficial to us because they provide retentive value, subject the executives to key restrictive covenants, and generally provide us with a competitive advantage in the recruiting process over companies that do not offer employment agreements. We have entered into employment agreements with our NEOs as follows:

NEOs	Date of Agreement
Christopher O. Blunt	December 2018
John T. Fleurant	November 2019
Rajesh Krishnan	January 2019
Bonnie Wasgatt	N/A
R. Alex Castillo	N/A
Dennis R. Vigneau	January 2014, amended and restated March 2019

These employment agreements include the specific terms set forth in greater detail below in “Summary Compensation Table-Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table ‒ Employment Agreements and Leadership Transition Agreement.”

Other Agreements with Mr. Vigneau

Leadership Transition Agreement

On March 29, 2019, we entered into a prospective leadership transition agreement with then-Chief Financial Officer Dennis Vigneau, in connection with his planned retirement on December 31, 2019, which technically amended and restated the existing employment agreement between Mr. Vigneau and the Company, dated January 27, 2014. This agreement is detailed below under “Summary Compensation Table-Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table ‒ Employment Agreements and Leadership Transition Agreement.”

2017 Incentive Awards

FGL entered into an incentive award letters with Mr. Vigneau and certain other executives dated February 1, 2017. The incentive award letters provided for the grant of a cash award in lieu of the December 2015 and December 2016 ordinary course discretionary long-term equity incentive awards that FGL was not permitted to make to its executive officers under the terms of its merger agreement with Anbang Insurance Group Co., Ltd. and its affiliates, which was terminated on April 17, 2017. The 2017 incentive awards were granted in recognition of the continued commitment and contributions of FGL’s executives during this period. These incentive awards vested in installments on December 1, 2017, December 3, 2018 and December 2, 2019, subject to the executive’s continued employment through the applicable vesting date. They would have also vested in full if the executive’s employment had been terminated by without “cause” prior to December 2, 2019 or if the executive’s position had been eliminated and the executive was not offered “comparable employment” before November 30, 2018, the first anniversary of the completion of the 2017 Business Combination. The amount of each incentive award installment to the NEOs is set forth in the following table:

Name	December 2017	December 2018	December 2019	Total
Dennis R. Vigneau	$146,667	$146,667	$ 73,333	$366,667

Other Executive Compensation Arrangements, Policies and Practices

Our executives are eligible to participate in our tax-qualified 401(k) defined contribution plan and our health and welfare plans on the same basis as our other salaried employees. Our executives also participate in a limited number of perquisite programs.

117

401(k) Plan

Under the 401(k) Plan, our company will match 100% of a participant’s contributions up to five percent of compensation, subject to the limits specified in the Internal Revenue Code (the “Code”). The employer match vests immediately. The 401(k) plan also allows for annual discretionary profit sharing contributions, which historically have been two percent of earnings, subject to limits under the Code. Any profit sharing contributions are immediately vested.

Nonqualified Deferred Compensation Arrangements

We permit our executives to defer on an elective basis a specified portion of their base salaries and performance-based bonus compensation, if any. See the narrative description following the table entitled “Nonqualified Deferred Compensation” below for more information surrounding the terms of the nonqualified deferred compensation plan.

Health and Welfare Benefits

We also offer a package of insurance benefits to all salaried employees, including our executives, including health, vision and dental insurance, basic life insurance, accidental death and dismemberment insurance and short- and long-term disability insurance.

Limited Executive Perquisites

All of our executives are eligible to participate in the Executive Life Insurance Plan. Under this plan, the beneficiary of a participant who dies while employed by us is entitled to a lump sum payment equal to three times his or her annual base salary at the time of hire. Our executives are also offered physical examinations at our cost once biannually. The value of these executive perquisites is reflected in the “All Other Compensation” column of the Summary Compensation Table below. We maintain no defined benefit pension plans or retiree medical plans.

Prohibition of Short Sales, Derivatives Trading, Hedging and Pledging of Our Securities

Our Board has adopted a policy prohibiting designated employees, including the NEOs, and directors from engaging in any short sales of our securities, or transactions in puts, calls or other derivative securities with respect to any of our equity securities. Unless first pre-cleared by our General Counsel, the policy also prohibits all employees, including the NEOs, and directors from entering into hedging transactions with respect to our securities or pledging our securities as collateral for any loan, including margin accounts.

Policy on Rule 10b5-1 Trading Plans

We have adopted a policy for Rule 10b5-1 trading plans for designated employees, including the NEOs, and directors, which allow for transactions in our securities pursuant to a pre-established written plan meeting certain requirements. Any Rule 10b5-1 plan must (a) be in writing and in a form acceptable to the company; (b) be acknowledged in writing by the General Counsel of the company prior to the plan becoming effective; (c) contain such terms and conditions as may be required by Rule 10b5-1; and (d) not be entered into, amended or terminated during a blackout period or when the person is in possession of material nonpublic information.

Compensation Committee Report

Our Compensation Committee has reviewed and discussed the “Compensation Discussion and Analysis” contained in this report with our management. Based on such review and discussions, the committee recommended to our Board that the “Compensation Discussion and Analysis” be included in Annual Report on Form 10-K filed with the SEC for fiscal 2019.

COMPENSATION COMMITTEE

/s/ Keith W. Abell

/s/ Richard M. Massey

118

/s/ James A. Quella

Compensation Committee Interlocks and Insider Participation

No member of the Compensation Committee has served as an officer or employee of the company or any of its subsidiaries during fiscal 2019 or any prior year. In addition, during fiscal 2019, no executive officer of our company served as a director or as a member of the compensation committee of a company (i) one of whose executive officers served as a director or as a member of the Compensation Committee of our company or (ii) which employed a director of our company.

CEO Pay Ratio

As required by the “pay ratio” rules under the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and Item 402(u) of Regulation S-K, we determined the annual total compensation of the estimated median of the annual total compensation of all employees, except our current President and Chief Executive Officer (our “non-CEO median employee”) and present a comparison of that annual total compensation to the annual total compensation of our President and Chief Executive Officer (our “CEO”). In accordance with SEC rules, for 2019, we have calculated:

• The annual total compensation of our non-CEO median employee was $103,823

• The annual total compensation of our CEO was $9,344,988

• The estimated pay ratio of the annual total compensation of our CEO to the annual total compensation of our non-CEO median employee was 90:1

As permitted by Securities and Exchange Commission rules, to identify our non-CEO median employee we used a commonly accepted compensation measure, “total cash compensation,” which includes annual base pay plus all commissions and bonuses paid during the fiscal year. We used October 1, 2019, as our determination day, and included all 344 full-time, part-time, seasonal, and temporary employees of F&G and its subsidiaries globally, other than our CEO. We annualized pay for those who commenced work during the fiscal year. After we identified our non-CEO median employee based on total cash compensation, we calculated annual total compensation for both our CEO and our non-CEO median employee, using the same definition for total compensation set forth in this proxy statement’s Summary Compensation Table plus the value of benefits and employer retirement contributions not reported therein. These benefits include company contributions to the medical, dental and basic life insurance plans.

Mr. Blunt served as our CEO beginning Jan. 2, 2019. As allowed when a CEO does not serve for the entire fiscal year, we annualized his compensation for purposes of the pay ratio estimation. Mr. Blunt’s annualized total compensation for our fiscal year was $9,344,988.

This pay ratio is a reasonable estimate calculated in a manner consistent with Item 402(u) of Regulation S-K. Given the different methodologies that various public companies use to determine an estimate of their pay ratios and our unique situation in including the inducement equity grants made to our CEO, the estimated pay ratio reported above should not be used as a basis for comparison between companies.

119

SUMMARY COMPENSATION TABLE

The following table summarizes the total compensation paid to our NEOs for the fiscal year ended December 31, 2019, the fiscal year ended December 31, 2018, the three month transition period ended December 31, 2017 (“TP 2017”), and the fiscal year ended September 30, 2017.

Name	Year	Salary ($)	Bonus ($)(a)	Stock Awards ($)(b)(c)	Option Awards ($)(b)	Non-Equity Incentive Plan Compensation ($)(d)	Change in Pension Value and Nonqualified Deferred Compensation Earnings ($)	All Other Compensation ($)(e)	Total ($)
Christopher O. Blunt, President and Chief Executive Officer (f)	FY 2019	793,846	2,250,000	-	4,075,971	2,150,000	-	75,170	9,344,988
John T. Fleurant, Chief Financial Officer (g)	FY 2019	67,308	-	-	3,727,065	-	-	6,050	3,800,424
Rajesh Krishnan, Chief Investment Officer (h)	FY 2019	348,654	-	-	2,882,609	500,000	-	15,759	3,747,022
Bonnie Wasgatt, EVP and Chief Operations Officer (i)	FY 2019	206,154	-	-	875,546	170,000	-	10,799	1,262,498
R. Alex Castillo, SVP and Chief Human Resources Officer (j)	FY 2019	169,231	60,000	-	614,808	100,000	-	8,466	952,505
Dennis R. Vigneau, Former Chief Financial Officer (k)	FY 2019	440,000	573,340	-	-	-	-	1,171,258	2,184,598
	FY 2018	440,000	586,667	-	4,462,790	500,000	-	22,292	6,011,749
	TP 2017	118,462	446,667	-	-	120,000	-	10,337	695,465
	FY 2017	440,000	73,333	1,626,484	-	500,000	-	24,508	2,664,325

a. For fiscal 2019, represents sign-on bonus paid to Mr. Blunt and bonuses paid to Mr. Vigneau pursuant to his transition agreement, including related to his EIP award. For fiscal 2018, represents cash payments under the 2017 Incentive Awards and the Retention Awards paid in December 2018 to Mr. Vigneau.

b. Represents the grant date fair value computed in accordance with Financial Accounting Standards Board Accounting Standards Clarification (“FASB ASC”) Topic 718.

c. Represents cash amounts paid by FGL to settle Performance RSUs granted to Mr. Vigneau in fiscal 2017 in connection with the Business Combination.

d. For fiscal 2019 and 2018, the amounts reported in this column reflect amounts earned under the EIP for all NEOs in such fiscal year. The amounts reported for periods prior to fiscal 2018 reflect the amounts paid out to Mr. Vigneau under FGL’s Employee Incentive Compensation Plan.

e. All other compensation for fiscal year 2019 was as follows:

Name	401(k) Match		Profit Sharing	Life Insurance Premiums	Long-Term Disability Insurance Premium		Relocation Subsidy		Paid-Time Off	Separation Payments (k)	Other		Total
Blunt	$	14,000	-	-	$	945	$	58,761	-	-	$	1,464	$	75,170
Fleurant	-		-	-	145		5,905		-	-	-		6,050
Krishnan	14,000		-	814	945		-		-	-	-		15,759
Wasgatt	7,087		-	3,130	582		-		-	-	-		10,799
Castillo	7,933		-	-	533		-		-	-	-		8,466
Vigneau	14,000		5,500	2,197	945		-		18,615	1,130,000	-		1,171,258

f. Mr. Blunt was appointed as President, Chief Executive Officer and Director effective as of January 2, 2019.

g. Mr. Fleurant joined our company effective November 11, 2019.

h. Mr. Krishnan joined our company effective January 1, 2019.

i. Ms. Wasgatt joined our company effective May 20, 2019.

j. Mr. Castillo joined our company effective May 20, 2019.

k. Mr. Vigneau transitioned to a non-executive role upon the appointment of Mr. Fleurant pursuant to a transition agreement, which is described in more detail below under “Leadership Transition Agreement”.

120

Grants of Plan-Based Awards

The following table sets forth information concerning estimated possible payouts under non-equity incentive plan awards for fiscal 2019 performance and equity incentive plan awards granted in fiscal 2019 to our named executive officers. The terms and conditions applicable to these awards are described in “Compensation Discussion and Analysis” and “Outstanding Equity Awards at Fiscal Year-End.”

	Grant Date	Estimated future payouts under non-equity incentive plan awards ($)(a)			Estimated future payouts under equity incentive plan awards ($)			All other stock awards: Number of shares of stock or units (#)	All other option awards: Number of securities underlying options (#)(b)	Exercise or base price of option awards ($/Sh)	Grant date fair value of stock and option awards ($)
		Threshold	Target	Maximum	Threshold	Target	Maximum
Christopher O. Blunt	2/26/2019	800,000	1,600,000	2,400,000	-	-	-	-	-	-	-
	12/21/2018	-	-	-	-	-	-	-	878,400	1.42	1,247,328
	12/21/2018	-	-	-	-	-	-	-	721,600	0.89	642,224
	12/21/2018	-	-	-	-	-	-	-	87,840	1.56	137,030
	12/21/2018	-	-	-	-	-	-	-	87,840	1.28	112,435
	12/21/2018	-	-	-	-	-	-	-	87,840	0.98	86,083
	12/21/2018	-	-	-	-	-	-	-	87,840	0.7	61,488
	12/21/2018	-	-	-	-	-	-	-	87,840	0.44	38,650
	12/21/2018	-	-	-	-	-	-	-	72,160	1.01	72,882
	12/21/2018	-	-	-	-	-	-	-	72,160	0.88	63,501
	12/21/2018	-	-	-	-	-	-	-	72,160	0.71	51,234
	12/21/2018	-	-	-	-	-	-	-	72,160	0.54	38,966
	12/21/2018	-	-	-	-	-	-	-	72,160	0.35	25,256
	12/21/2018	-	-	-	-	-	-	-	439,200	1.74	764,208
	12/21/2018	-	-	-	-	-	-	-	360,800	1.13	407,704
	12/21/2018	-	-	-	-	-	-	-	306,738	0.89	272,997
	12/21/2018	-	-	-	-	-	-	-	61,348	0.12	7,362
	12/21/2018	-	-	-	-	-	-	-	61,348	0.18	11,043
	12/21/2018	-	-	-	-	-	-	-	61,348	0.21	12,883
	12/21/2018	-	-	-	-	-	-	-	61,347	0.18	11,042
	12/21/2018	-	-	-	-	-	-	-	61,347	0.19	11,656
	12/21/2018	-	-	-	-	-	-	-	306,738	0.89	272,997
	12/21/2018	-	-	-	-	-	-	-	61,348	0.12	7,362
	12/21/2018	-	-	-	-	-	-	-	61,348	0.18	11,043
	12/21/2018	-	-	-	-	-	-	-	61,348	0.21	12,883
	12/21/2018	-	-	-	-	-	-	-	61,347	0.18	11,042
	12/21/2018	-	-	-	-	-	-	-	61,347	0.19	11,656
John Fleurant (c)	11/11/2019	250,000	500,000	750,000	-	-	-	-	-	-	-
	11/11/2019	-	-	-	-	-	-	-	30,000	0.61	18,300
	11/11/2019	-	-	-	-	-	-	-	500,000	2.22	1,110,000
	11/11/2019	-	-	-	-	-	-	-	30,000	0.32	9,600
	11/11/2019	-	-	-	-	-	-	-	30,000	0.27	8,100
	11/11/2019	-	-	-	-	-	-	-	30,000	0.19	5,700
	11/11/2019	-	-	-	-	-	-	-	13,334	1.05	14,001
	11/11/2019	-	-	-	-	-	-	-	13,334	1.26	16,801
	11/11/2019	-	-	-	-	-	-	-	13,333	1.51	20,133
	11/11/2019	-	-	-	-	-	-	-	13,333	1.92	25,599
	11/11/2019	-	-	-	-	-	-	-	13,333	2.23	29,733
	11/11/2019	-	-	-	-	-	-	-	100,000	1	100,000
	11/11/2019	-	-	-	-	-	-	-	100,000	1.2	120,000
	11/11/2019	-	-	-	-	-	-	-	100,000	1.43	143,000
	11/11/2019	-	-	-	-	-	-	-	100,000	1.81	181,000
	11/11/2019	-	-	-	-	-	-	-	100,000	2.08	208,000
	11/11/2019	-	-	-	-	-	-	-	150,000	2.22	333,000
	11/11/2019	-	-	-	-	-	-	-	66,666	2.34	155,998
	11/11/2019	-	-	-	-	-	-	-	500,000	2.1	1,050,000
	11/11/2019	-	-	-	-	-	-	-	66,667	2.46	164,001
	11/11/2019	-	-	-	-	-	-	-	30,000	0.47	14,100
Raj Krishnan	2/26/2019	175,000	350,000	525,000	-	-	-	-	-	-	-
	3/15/2019	-	-	-	-	-	-	-	24,539	1.74	42,698

121

	3/15/2019	-	-	-	-	-	-	-	96,910	1.79	173,469
	3/15/2019	-	-	-	-	-	-	-	24,539	0.64	15,705
	3/15/2019	-	-	-	-	-	-	-	96,911	0.68	65,899
	3/15/2019	-	-	-	-	-	-	-	24,539	0.98	24,048
	3/15/2019	-	-	-	-	-	-	-	96,911	0.99	95,942
	3/15/2019	-	-	-	-	-	-	-	24,539	1.27	31,165
	3/15/2019	-	-	-	-	-	-	-	96,911	1.28	124,046
	3/15/2019	-	-	-	-	-	-	-	24,539	1.52	37,299
	3/15/2019	-	-	-	-	-	-	-	96,911	1.57	152,150
	3/15/2019	-	-	-	-	-	-	-	122,695	1.74	213,489
	3/15/2019	-	-	-	-	-	-	-	484,554	1.74	843,124
	3/15/2019	-	-	-	-	-	-	-	484,555	1.68	814,052
	8/6/2019	-	-	-	-	-	-	-	62,225	1.73	107,649
	8/6/2019	-	-	-	-	-	-	-	62,225	1.64	102,049
	8/6/2019	-	-	-	-	-	-	-	15,557	0.26	4,045
	8/6/2019	-	-	-	-	-	-	-	15,556	0.48	7,467
	8/6/2019	-	-	-	-	-	-	-	15,556	0.75	11,667
	8/6/2019	-	-	-	-	-	-	-	15,556	1.07	16,645
Bonnie Wasgatt	5/20/2019	83,750	167,500	251,250	-	-	-	-	-	-	-
	8/6/2019	-	-	-	-	-	-	-	18,192	1.73	31,472
	8/6/2019	-	-	-	-	-	-	-	18,193	1.64	29,837
	8/6/2019	-	-	-	-	-	-	-	4,548	0.26	1,182
	8/6/2019	-	-	-	-	-	-	-	4,548	0.48	2,183
	8/6/2019	-	-	-	-	-	-	-	4,548	0.75	3,411
	8/6/2019	-	-	-	-	-	-	-	4,548	1.07	4,866
	5/20/2019	-	-	-	-	-	-	-	9,375	0.36	3,375
	5/20/2019	-	-	-	-	-	-	-	35,416	0.78	27,624
	5/20/2019	-	-	-	-	-	-	-	9,375	0.33	3,094
	5/20/2019	-	-	-	-	-	-	-	35,417	1.15	40,730
	5/20/2019	-	-	-	-	-	-	-	9,375	0.3	2,813
	5/20/2019	-	-	-	-	-	-	-	35,417	1.49	52,771
	5/20/2019	-	-	-	-	-	-	-	9,375	0.1	938
	5/20/2019	-	-	-	-	-	-	-	35,417	1.8	63,751
	5/20/2019	-	-	-	-	-	-	-	141,667	1.86	263,501
	5/20/2019	-	-	-	-	-	-	-	37,500	1.92	72,000
	5/20/2019	-	-	-	-	-	-	-	141,666	1.92	271,999
Alex Castillo	5/20/2019	55,000	110,000	165,000	-	-	-	-	-	-	-
	8/6/2019	-	-	-	-	-	-	-	12,842	1.73	22,217
	8/6/2019	-	-	-	-	-	-	-	12,842	1.64	21,061
	8/6/2019	-	-	-	-	-	-	-	3,211	0.26	835
	8/6/2019	-	-	-	-	-	-	-	3,210	0.48	1,541
	8/6/2019	-	-	-	-	-	-	-	3,210	0.75	2,408
	8/6/2019	-	-	-	-	-	-	-	3,210	1.07	3,435
	5/20/2019	-	-	-	-	-	-	-	6,250	0.36	2,250
	5/20/2019	-	-	-	-	-	-	-	25,000	0.78	19,500
	5/20/2019	-	-	-	-	-	-	-	6,250	0.33	2,063
	5/20/2019	-	-	-	-	-	-	-	25,000	1.15	28,750
	5/20/2019	-	-	-	-	-	-	-	6,250	0.3	1,875
	5/20/2019	-	-	-	-	-	-	-	25,000	1.49	37,250
	5/20/2019	-	-	-	-	-	-	-	6,250	0.1	625
	5/20/2019	-	-	-	-	-	-	-	25,000	1.8	45,000
	5/20/2019	-	-	-	-	-	-	-	100,000	1.86	186,000
	5/20/2019	-	-	-	-	-	-	-	25,000	1.92	48,000
	5/20/2019	-	-	-	-	-	-	-	100,000	1.92	192,000
Dennis R. Vigneau (d)	2/26/2019	132,000	264,000	396,000	-	-	-	-	-	-	-
	5/15/2018	-	-	-	-	-	-	-	30,673	0.69	21,164
	5/15/2018	-	-	-	-	-	-	-	30,674	0.83	25,459
	5/15/2018	-	-	-	-	-	-	-	30,674	0.87	26,686
	5/15/2018	-	-	-	-	-	-	-	30,674	0.77	23,619
	5/15/2018	-	-	-	-	-	-	-	30,674	0.77	23,619
	5/15/2018	-	-	-	-	-	-	-	121,138	2.53	306,479
	5/15/2018	-	-	-	-	-	-	-	121,138	2.36	285,886
	5/15/2018	-	-	-	-	-	-	-	121,139	2.10	254,392
	5/15/2018	-	-	-	-	-	-	-	121,139	1.77	214,416
	5/15/2018	-	-	-	-	-	-	-	121,139	1.36	164,749
	5/15/2018	-	-	-	-	-	-	-	153,369	2.35	360,417
	5/15/2018	-	-	-	-	-	-	-	605,693	2.35	1,423,379
	5/15/2018	-	-	-	-	-	-	-	605,693	2.20	1,332,525

122

a. Represents the potential amounts for annual EIP incentives for fiscal 2019. Actual amounts earned by the NEOs are reflected in the Summary Compensation Table.

b. Represents stock option awards granted under our 2017 Omnibus Incentive Plan which vest, if at all, subject to a combination of time and/or performance based vesting over a four or five year period from the date of grant. Time-based stock options vest one-fifth or one-fourth each year on the anniversary of the grant date. Stock price options vest based on the achievement of stock price goals, ranging from $10 to $25, applicable to each period. Performance based options vest based on three-year, four-year and five-year Adjusted Operating ROE goals, ranging from 15.50% to 18.50%, applicable to each period. These stock options expire seven years from their respective grant date.

c. Mr. Fleurant was not eligible for the 2019 EIP grant, as he joined our company in November 2019.

d. Pursuant to his transition agreement, we agreed to amend the vesting of certain options held by Mr.Vigneau.

Narrative Disclosure to Summary Compensation Table and Grants of Plan-Based Awards Table

Employment Agreements and Related Agreements with Named Executive Officers

Employment Agreement with Christopher O. Blunt

On December 19, 2018, we announced that Christopher O. Blunt had been appointed as President, Chief Executive Officer, and member of the Board of Directors, effective January 2, 2019. In connection with this appointment we entered into an employment agreement with Mr. Blunt, pursuant to which Mr. Blunt is entitled to receive a base salary of $800,000 and a target bonus opportunity equal to 200% of his base salary, subject to the achievement of criteria to be established by the Board of Directors. The agreement also provided for a signing bonus of $2,250,000 upon Mr. Blunt’s continued employment through March 15, 2019.

Upon a termination without “cause” or by Mr. Blunt for “good reason,” each as defined in the agreement, he will be entitled to receive severance benefits equal to three times his base salary, acceleration of the stock options awarded December 21, 2018, and eighteen months of benefit continuation. He is also entitled to acceleration of certain options upon termination without cause or for good reason within 12 months following a change in control of the Company. In addition, Mr. Blunt will be subject to certain restrictive covenants that apply both during his employment with the Company and for certain durations afterwards.

Other Employment Agreements

On November 6, 2019, we announced that John T. Fleurant would join the Company as its Chief Financial Officer, effective November 11, 2019. In connection with this appointment we entered into an employment agreement with Mr. Fleurant, pursuant to which Mr. Fleurant is entitled to receive an annual base salary of $500,000 and a target bonus opportunity equal to 100% of his base salary, subject to the achievement of criteria to be established by the Company. Upon a termination without “cause”, Mr. Fleurant will be entitled to receive severance benefits equal to six months of his base salary and six months of Company-paid COBRA. Mr. Fleurant will be subject to certain restrictive covenants that apply both during his employment with the Company and for certain durations afterwards.

We have also entered into an employment agreement with Mr. Krishnan dated January 1, 2019. Pursuant to this agreement, Mr. Krishnan’s compensation is determined by the Company and he is entitled to certain severance amounts if terminated without cause, the amount of which is based on his tenure with the Company but range from 26 to 52 weeks of base salary, subject to execution of a release. Mr. Krishnan will be subject to certain restrictive covenants that apply both during his employment with the Company and for certain durations afterwards.

Leadership Transition Agreement with Dennis Vigneau

On March 29, 2019, we entered into a prospective leadership transition agreement with Chief Financial Officer Dennis Vigneau, in connection with his planned retirement on December 31, 2019, which technically amended and restated the existing employment agreement between Mr. Vigneau and the Company, dated January 27, 2014.

Under this agreement, Mr. Vigneau agreed to continue as the Company’s CFO until a new CFO was identified by the Company, at which time, Mr. Vigneau would assume a non-executive advisor role until his retirement. In return, Mr. Vigneau was entitled to the following payments pursuant to the terms of this agreement: (i) continued base salary through 2019; (ii) a 2019 fixed performance bonus of $500,000; (iii) a $500,000 bonus

123

upon the Company’s hiring of a permanent CFO; (iv) two bonuses equal to $200,000 each contingent upon the completion of certain strategic initiatives; (v) full severance benefits under Mr. Vigneau’s employment agreement equal to $330,000; (vi) an amount no greater than $40,000 for reasonable attorneys’ fees for the negotiation of the transition agreement; and (vii) accelerated vesting of certain options held by Mr. Vigneau.

2017 Business Combination

At the effective time of the Business Combination on November 30, 2017, each (i) option to purchase shares of FGL’s common stock (“FGL Stock Option”), (ii) restricted share of FGL’s common stock and (iii) Performance RSU, in each case whether vested or unvested, became fully vested and automatically converted into the right to receive a cash payment equal to the product of (1) the number of shares subject to the award (for Performance RSUs, determined at the target performance level) multiplied by (2) the merger consideration of $31.10 (less the exercise price per share in the case of FGL Stock Options). In addition, at the effective time of the Merger, each stock option (“FGLH Stock Option”) and restricted stock unit relating to shares of Fidelity & Guaranty Life Holdings, Inc., a Delaware corporation and wholly owned subsidiary of the company (“FGLH”), whether vested or unvested, became fully vested and automatically converted into the right to receive a cash payment equal to the product of (A) the number of shares of FGLH stock subject to the award multiplied by (B) $176.32 (less the exercise price in the case of such FGLH Stock Options).

Outstanding Equity Awards at Fiscal Year-End

The following table sets forth information concerning outstanding equity awards held by our named executive officers at the end of fiscal 2019.

	Option Awards				Stock Awards
Name	Number of securities underlying unexercised options (#) exercisable	Number of securities underlying unexercised options (#) unexercisable	Option exercise price ($)	Option Expiration Date	Number of shares or units of stock that have not vested (#)	Market value of shares or units of stock that have not vested (#)	Equity incentive plan awards: number of unearned shares, units or other rights that have not vested (#)	Equity incentive plan awards: market or payout value of unearned shares, units or other rights that have not vested ($)
Christopher O. Blunt	144,320	1,912,356	10.00	12/21/2025	-	-	-	-
	175,680	1,581,120	7.04	12/21/2025	-	-	-	-
John Fleurant	-	1,800,000	10.00	11/11/2026	-	-	-	-
	-	200,000	9.18	11/11/2026	-	-	-	-
Raj Krishnan	-	1,674,514	10.00	3/15/2026	-	-	-	-
	-	186,675	7.16	8/6/2026	-	-	-	-
Bonnie Wasgatt	-	500,000	10.00	5/20/2026	-	-	-	-
	-	54,577	7.16	8/6/2026	-	-	-	-
Alex Castillo	-	350,000	10.00	5/20/2026	-	-	-	-
	-	38,525	7.16	8/6/2026	-	-	-	-
Dennis R. Vigneau (a)	242,277	-	10.00	5/15/2025	-	-	-	-

a. Reflects the amendment of a portion of Mr. Vigneau’s options effective December 31, 2019, pursuant to his transition agreement with the company.

124

Option Exercises and Stock Vested

	Option Awards		Stock Awards
Name	Number of shares acquired on exercise (#)	Option exercise price	Number of shares acquired on vesting (#)	Value realized on vesting
Christopher O. Blunt	-	-	-	-
John T. Fleurant	-	-	-	-
Rajesh Krishnan	-	-	-	-
Bonnie Wasgatt	-	-	-	-
R. Alex Castillo	-	-	-	-
Dennis R. Vigneau	-	-	-	-

Pension Benefits

We do not provide any defined benefit plans to our NEOs.

125

Nonqualified Deferred Compensation

The following table provides information concerning the nonqualified deferred compensation of each of the participating NEOs in the Executive Nonqualified Deferred Compensation Plan of FGLH (the “Deferred Compensation Plan”) as of December 31, 2019.

Name	Aggregate Balance at Beginning of Last Fiscal Year		Executive Contributions in Last Fiscal Year (a)		Registrant Contributions in Last Fiscal Year (b)		Aggregate Earnings in Last Fiscal Year (c)		Aggregate Withdrawals/Distributions		Aggregate Balance at Last Fiscal Year End (d)
Christopher O. Blunt	$	—	$	—	$	—	$	—	$	—	$	—
John T. Fleurant	—		—		—		—		—		—
Rajesh Krishnan	1,247,008		—		—		170,411		—		1,417,419
Bonnie Wasgatt	—		30,923		—		1,412		—		32,335
R. Alex Castillo	—		—		—		—		—		—
Dennis R. Vigneau	1,028,079		686,364		—		238,463		—		1,952,906

a. Amounts reported in this column are included in the Summary Compensation Table in the “Salary” and “Non-Equity Incentive Plan Compensation” columns for fiscal 2019.

b. Contributions were not made by FGL after fiscal 2013.

c. Amounts reported in this column are not reported as compensation in the Summary Compensation Table.

d. Amounts reported in this column were not reported as compensation in the Summary Compensation tables for previous years.

The Deferred Compensation Plan permits our participating NEOs and certain other employees to elect to defer up to 50% of their base salary and up to 100% of any performance-based non-equity incentive plan compensation. Any deferral elections are made under the Deferred Compensation Plan pursuant to a participation agreement with the NEO. We have eliminated the annual discretionary grant to each active participating NEO effective January 2013. Past employer contributions vest 20% for each year of service and are fully vested after five years of service. Deferred amounts and employer contributions are contributed to individual accounts in the FGLH Executive Deferred Compensation Plan Trust. The participants self-direct the notional investment of deferred contribution accounts in investment funds from a selection made available by our retirement committee.

The vested balance of the deferred compensation accounts will be distributed to each participating NEO upon his or her death, disability or separation from service (including retirement). Participants may elect upon initial enrollment to have accounts distributed upon a change in control event, although none of our NEOs have so elected. In-service hardship and education account withdrawals are permitted under the plan with respect to participant deferrals and employer credits.

Potential Payments upon Termination or Change in Control

The following table sets forth the estimated amount of compensation each of our NEOs would receive under the termination or change in control provisions contained in the agreements and plans discussed above, assuming that such termination or change in control event occurred on December 31, 2019. However, for Mr. Vigneau, the table includes only the actual amounts paid in connection with the transition agreement related to his retirement from the company on December 31, 2019.

The table excludes (i) amounts accrued through the termination date that would be paid in the normal course of continued employment, such as accrued but unpaid salary, (ii) vested account balances under our 401(k) plan that are generally available to all of our employees and (iii) except as indicated in the footnotes below, any post-employment benefit that is available to all of our employees and does not discriminate in favor of our NEOs. In the case of a change in control situation, we assume that the vesting of all options and restricted stock will be accelerated, even though our Compensation Committee has the discretion to provide for alternative treatment of the awards upon a change in control.

126

Name	Termination Trigger	Severance (Salary)(a)		Severance (Bonus)(b)		Equity Vesting (c)		Nonqualified Deferred Compensation (d)		Other Benefits (e)		Total
Christopher O. Blunt	Involuntary termination w/o cause	$	2,400,000	$	—	$	1,116,019	$	—	$	16,950	$	3,532,969
	Voluntary termination	—		—		1,116,019		—		15,385		1,131,404
	Retirement (f)	—		—		—		—		—		—
	Death	—		1,600,000		1,116,019		—		15,385		2,731,404
	Disability	—		1,600,000		1,116,019		—		15,385		2,731,404
	Change in control	2,400,000		—		1,116,019		—		16,950		3,532,969
John T. Fleurant	Involuntary termination w/o cause	250,000		500,000		—		—		13,969		763,969
	Voluntary termination	—		—		—		—		5,923		5,923
	Retirement (f)	—		—		—		—		—		—
	Death	—		500,000		—		—		—		500,000
	Disability	—		500,000		—		—		5,923		505,923
	Change in control	500,000		1,000,000		—		—		22,014		1,522,014
Rajesh Krishnan	Involuntary termination w/o cause	175,000		350,000		—		1,417,419		16,413		1,958,832
	Voluntary termination	—		—		—		1,417,419		6,731		1,424,150
	Retirement (f)	—		—		—		—		—		—
	Death	—		350,000		—		1,417,419		—		1,767,419
	Disability	—		350,000		—		1,417,419		6,731		1,774,150
	Change in control	350,000		700,000		—		-		26,095		1,076,095
Bonnie Wasgatt	Involuntary termination w/o cause	167,500		—		—		32,335		16,156		215,991
	Voluntary termination	—		—		—		32,335		6,442		38,777
	Retirement (f)	—		—		—		—		—		—
	Death	—		—		—		32,335		—		32,335
	Disability	—		—		—		32,335		6,442		38,777
	Change in control	335,000		335,000		—		—		25,869		695,869
R. Alex Castillo	Involuntary termination w/o cause	137,500		—		—		—		14,970		152,470
	Voluntary termination	—		—		—		—		5,288		5,288
	Retirement (f)	—		—		—		—		—		—
	Death	—		—		—		—		—		—
	Disability	—		—		—		—		5,288		5,288
	Change in control	275,000		220,000		—		—		24,652		519,652
Dennis R. Vigneau (g)	Transition and Retirement	330,000		500,000		169,594		1,952,906		—		2,952,500

a. Under the terms of the employment agreements and severance plan, severance pays out in a lump sum. Amounts payable in this column may be subject to the NEO executing and not revoking a release of claims against the company. See “Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table-Employment Agreements with Named Executive Officers.”

b. Amounts in this column include, if provided in an employment agreement with the NEO, a pro rata bonus for the year of termination upon certain types of terminations

c. As of December 31, 2019, the exercise price of the stock options held by the NEOs subject to potential vesting exceeded the market price of the underlying ordinary shares.

d. For any participating NEO, the vested balance of the deferred compensation accounts will be distributed upon death, disability or separation from service.

e. Amounts include any accrued vacation as of December 31, 2019, which would be paid out upon a termination.

f. As of December 31, 2019, none of our continuing NEOs were retirement eligible.

g. Represents the amounts paid pursuant to Mr. Vigneau’s transition agreement from the company, which include amounts payable under his employment agreement as if he were terminated without cause. For a description of Mr. Vigneau’s transition agreement, see “Summary Compensation Table-Narrative to Summary Compensation Table and Grants of Plan-Based Awards Table ‒ Leadership Transition Agreement.”

127

NON-EMPLOYEE DIRECTOR COMPENSATION

Our Nominating and Corporate Governance Committee is responsible for reviewing the compensation of our non-employee directors and making recommendations to the Board. In recommending compensation, the committee takes into consideration the following: (i) compensation should be competitive and fairly compensate directors for the time and effort required of Board and committee members, taking into consideration compensation paid to directors of comparable companies; (ii) compensation should align directors' interests with the long-term interests of shareholders; and (iii) the structure of the compensation should be simple, transparent and easy for shareholders to understand.

In 2018, Frederic W. Cook & Co., Inc. (“FW Cook”) conducted a competitive analysis of our company’s compensation peer group with respect to board compensation. Based on the recommendations of FW Cook, the Nominating and Corporate Governance Committee recommended, and the Board approved, adjusting non-employee director compensation, including adding an equity component, which placed the compensation levels between the median and 75th percentile of the peer group.

The following are the components of our non-employee directors’ compensation:

Compensation Component	Description
Annual Cash Retainer	$100,000
Annual Equity Retainer	$125,000 in restricted stock shares that vest after one year
Board and Committee Fees	None
Chair Fees	$20,000 for Audit Committee $10,000 for Compensation and Nominating and Corporate Governance Committees
Other	Directors are reimbursed for out-of-pocket expenses in connection with their service on the Board, including meetings and other Board duties

Director Compensation Table

The following table provides summary information concerning compensation paid or accrued by us to our non-employee directors for services rendered to us during fiscal 2019.

Name	Fees Earned or Paid in Cash		Stock Awards (a)	Option Awards	Non-Equity Incentive Plan Compensation	Change in Pension Value and Non-qualified Deferred Compensation Earnings	All Other Compensation	Total
Chinh E. Chu	$	100,000	124,997	-	-	-	-	$	224,997
William P. Foley, II	100,000		124,997	-	-	-	-	224,997
Keith W. Abell	110,000		124,997	-	-	-	-	234,997
Patrick S. Baird	100,000		124,997	-	-	-	-	224,997
Menes O. Chee	100,000		124,997	-	-	-	-	224,997
Richard M. Massey	100,000		124,997	-	-	-	-	224,997
James A. Quella	110,000		124,997	-	-	-	-	234,997
Timothy M. Walsh	120,000		124,997	-	-	-	-	244,997

a. Represents the grant date fair value of restricted stock, computed in accordance with Financial Accounting Standards Board Accounting Standards Clarification (“FASB ASC”) Topic 718.

128

Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

SECURITIES AUTHORIZED FOR ISSUANCE UNDER EQUITY COMPENSATION PLANS

The following table presents information as of December 31, 2019, regarding our securities authorized for issuance under equity compensation plans:

Plan category	Number of securities to be issued upon exercise of outstanding options, warrants and rights (1)	Weighted-average exercise price of outstanding options, warrants and rights (2)		Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (1)) (3)
Equity compensation plans approved by security holders (a)	9,293,745	$	9.77	5,712,155
Equity compensation plans not approved by security holders (b)	5,920,214	$	8.57	—
Total	15,213,959	$	9.30	5,712,155

a. Represents securities issued or issuable under our 2017 Omnibus Incentive Plan.

b. Represents shares reserved for issuance in connection with stock options granted outside of the 2017 Omnibus Incentive Plan as an “employment inducement award” under NYSE Listing Rule 303A.08. The inducement awards are subject to the terms and conditions of the 2017 Omnibus Incentive Plan. Includes:

For Mr. Blunt, stock options for a total of 3,813,476 shares were issued as inducement awards and vest as follows:

• Stock options for 3,200,000 shares vest as follows: fifty percent in five equal annual installments beginning on December 21, 2019, subject to continued employment, and fifty percent in five equal installments beginning on December 21, 2019, based on attainment of performance objectives to be established by the board of directors on an annual basis, subject to continued employment.

• Stock options for 613,476 shares vest as follows: fifty percent in three equal annual installments beginning on March 15, 2021, based on attainment of specified return on equity performance metrics, subject to continued employment, and fifty percent vesting in five equal installments beginning on March 15, 2020, based on attainment of specified minimum stock prices, subject to continued employment.

For Mr. Bayer, stock options for a total of 2,106,738 shares were issued as inducement awards and vest as follows:

• Stock options for 1,800,000 shares vest as follows: fifty percent in five equal annual installments beginning on December 21, 2019, subject to continued employment, and fifty percent in five equal installments beginning on December 21, 2019, based on attainment of performance objectives to be established by the board of directors on an annual basis, subject to continued employment.

• Stock options for 306,738 shares vest as follows: fifty percent in three equal annual installments beginning on March 15, 2021, based on attainment of specified return on equity performance metrics, subject to continued employment, and fifty percent in five equal installments beginning on March 15, 2020, based on attainment of specified minimum stock prices, subject to continued employment.

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

The following table sets forth certain information regarding beneficial ownership of our ordinary shares as of February 24, 2020, unless otherwise noted, by (a) each person who is known to us to own beneficially more than 5% of our common stock, (b) each director and nominee for director, (c) each named executive officer and (d) the directors and executive officers as a group. The table lists voting securities, including restricted stock held

129

by our directors and executive officers over which they have sole voting power but no investment power. Otherwise, except to the extent noted below, each person identified below has sole voting and investment power over the shares reported. Except as otherwise noted below, we know of no agreements among our shareholders which related to voting or investment power with respect to our common stock and none of the stated shares have been pledged as a security.

Name and Address of Beneficial Owner (a)	Number of Shares Beneficially Owned (a)		Percent of Outstanding Ordinary Shares (b)
Greater than 5% Shareholders:
Blackstone	45,301,593	(c)(d)	20.4%
Fidelity National Financial, Inc.	16,897,000	(e)	7.6%
The Vanguard Group	15,289,000	(f)	6.9%
Coral Blue Investment Pte. Ltd.	12,691,278	(g)	5.7%
BlackRock, Inc.	21,669,453	(h)	9.7%
Directors and Officers:
Chinh E. Chu	14,935,466	(i)(d)	6.7%
William P. Foley, II	14,935,466	(j)(d)	6.7%
Keith W. Abell	234,046		*
Patrick S. Baird	49,743		*
Menes O. Chee	42,743	(k)	*
Richard N. Massey	1,985,782	(l)	*
James A. Quella	979,262		*
Timothy M. Walsh	52,743		*
Christopher O. Blunt	821,348	(m)	*
John T. Fleurant	-		*
Rajesh Krishnan	273,700	(n)	*
Bonnie Wasgatt	89,304	(n)	*
R. Alex Castillo	62,670	(n)	*
Dennis Vigneau	242,277	(n)	*
All directors and executive officers as a group (19 persons)	36,150,298	(o)	16.3%

*    Indicates less than 1% of our outstanding ordinary shares.

a. Except as described in the footnotes below and subject to applicable community property laws and similar laws, the company believes that each person listed above has sole voting and investment power with respect to all ordinary shares beneficially owned by them. Unless otherwise indicated, the business address of each of the entities, directors and executives in this table is 4th Floor, Boundary Hall, Cricket Square, Grand Cayman, Cayman Islands KY1-1102.

b. Percentage of beneficial ownership is based on 221,807,598 shares outstanding as of February 24, 2020. Shares issuable pursuant to options and warrants that are currently exercisable or exercisable within 60 days are deemed outstanding for computing the percentage of the person holding such options or warrants but are not deemed outstanding for computing the percentage of any other person.

c. Based solely on a Schedule 13D/A filed with the SEC on February 10, 2020 by CFS Holdings (Cayman), L.P. (“CFS 1”), CFS Holdings II (Cayman), L.P. (“CFS 2” and together with CFS 2, the “Blackstone Funds”), CFS Holdings (Cayman) Manager L.L.C. (“CFS Cayman Manager”), Blackstone Tactical Opportunities LR Associates-B (Cayman) Ltd. (“BTO Cayman”), Blackstone Holdings III L.P. (“Blackstone Holdings III”), Blackstone Holding III GP L.P. (“Blackstone Holdings III GP”), Blackstone Holdings III GP Management L.L.C.(“(“Blackstone Holdings III LLC”), GSO Aiguille des Grands Montets Fund II LP (“Aiguille Fund”), GSO COF III AIV-5 LP (“GSO AIV-5”), GSO COF III Co-Investment AIV-5 LP (“GSO COF AIV-5”), GSO Co-Investment Fund-D LP (“GSO D”), GSO Credit Alpha Fund LP (“GSO Alpha”), GSO Churchill Partners LP (“GSO Churchill”), GSO Credit-A Partners LP (“GSO Credit-A”), GSO Harrington Credit Alpha Fund (Cayman) L.P. (“GSO Harrington” and collectively with Aiguille Fund, GSO AIV-5, GSO COF AIV-5, GSO D, GSO Alpha, GSO Churchill and GSO Credit-A, the “GSO Funds”). GSO Capital Partners LP (“GSO Partners”), GSO Advisor Holdings L.L.C. (“GSO Holdings”), GSO Capital Opportunities Associates III LLC (“GSO III LLC”), GSO COF III Co-Investment Associates LLC (“GSO COF AIV-5 LLC”), GSO Co-Investment Fund-D Associates LLC (“GSO D LLC”), GSO Credit Alpha Associates LLC (“GSO Alpha LLC”), GSO Churchill Associates LLC (“GSO Churchill LLC”), GSO Credit-A Associates LLC (“GSO Credit-A LLC”), GSO Harrington Credit Alpha Associates L.L.C. (“GSO Harrington LLC”), GSO Holdings I L.L.C. (“GSO Holdings I”), Blackstone Holdings I L.P. (“Blackstone Holdings I”), Blackstone Holdings II L.P. (“Blackstone Holdings II”), Blackstone Holdings I/II GP Inc. (“Blackstone Holdings I/II GP”), The Blackstone Group L.P., Blackstone Group Management L.L.C. (“Blackstone Management”), Stephen A. Schwarzman, Bennett J. Goodman, and J. Albert Smith III.

130

Includes 16,620,850 held by CFS 1, and 22,500,000 ordinary shares held by CFS 2, 142,111 ordinary shares held by Aiguille Fund; 4,147,302 ordinary shares held by GSO AIV-5; 1,442,118 ordinary shares held by GSO COF AIV-5; 50,912 ordinary shares held by GSO D; 165,079 ordinary shares held by GSO Alpha; 52,541 ordinary shares held by GSO Churchill; 113,921 ordinary shares held by GSO Credit-A; and 24,016 ordinary shares held by GSO Harrington. Additionally, includes 42,743 shares held by Mr. Chee, one of our directors and an employee of Blackstone and/or one of its affiliates. Pursuant to arrangements between Mr. Chee and Blackstone, Mr. Chee is required to transfer to Blackstone any and all compensation received in connection with his directorship for any company Blackstone invests in or advises. Blackstone has designated Blackstone Tactical Opportunities Advisors L.L.C. (“BTOA”) as the entity to receive the securities described herein. BTOA is an indirect subsidiary of Blackstone. As such, each of Blackstone, Blackstone Group Management L.L.C. and Stephen A. Schwarzman may be deemed to beneficially own the shares beneficially owned by BTOA.

CFS Cayman Manager is the general partner of CFS 1 and CFS 2. The Managing Member of CFS Cayman Manager is BTO Cayman. The controlling shareholder of BTO Cayman is Blackstone Holdings III. The general partner of Blackstone Holdings III is Blackstone Holding III GP. The general partner of Blackstone Holdings III GP is Blackstone Holdings III LLC The sole member of Blackstone Holdings III LLC is Blackstone.

GSO Partners is the investment manager of Aiguille Fund. GSO Holdings is the special limited partner of GSO Partners with the investment and voting power over the securities beneficially owned by GSO Partners. Blackstone Holdings I is the sole member of GSO Holdings.

GSO III LLC is the general partner of GSO AIV-5. GSO COF AIV-5 LLC is the general partner of GSO COF AIV-5. GSO D LLC is the general partner of GSO D. GSO Alpha LLC is the general partner of GSO Alpha. GSO Churchill LLC is the general partner of GSO Churchill. GSO Credit-A LLC is the general partner of GSO Credit-A. GSO Harrington LLC is the general partner of GSO Harrington. GSO Holdings I is the managing member of each of GSO III LLC, GSO COF AIV-5 LLC, GSO D LLC, GSO Alpha LLC, GSO Churchill LLC, GSO Credit-A LLC and GSO Harrington LLC. Blackstone Holdings II is the managing member of GSO Holdings I with respect to securities beneficially owned by the GSO Funds. Blackstone Holdings I/II GP is the general partner of each of Blackstone Holdings I and Blackstone Holdings II. Blackstone is the controlling shareholder of Blackstone Holdings I/II GP.

The general partner of Blackstone is Blackstone Management. Blackstone Management is wholly owned by Blackstone’s senior managing directors and controlled by its founder, Stephen A. Schwarzman. In addition, each of Bennett J. Goodman may be deemed to have shared voting power and/or investment power with respect to the securities held by the GSO Funds. Each of the foregoing entities and individuals disclaims beneficial ownership of the securities held directly by the GSO Funds (other than the GSO Funds to the extent of their direct holdings).

Each of such Blackstone entities, Mr. Schwarzman and Mr. Goodman may be deemed to beneficially own the shares beneficially owned by the Blackstone Funds and/or the GSO Funds directly or indirectly controlled by it or him, but each (other than the Blackstone Funds and GSO Funds to the extent they directly hold such securities) disclaims beneficial ownership of such shares.

The address for the GSO Funds, each entity listed in the third through fifth paragraphs of this footnote (other than Blackstone, Blackstone Holdings I, Blackstone Holdings II and Blackstone Holdings I/II GP), and Mr. Goodman is c/o GSO Capital Partners LP, 345 Park Avenue. The address for each other entity and person listed in this footnote is c/o The Blackstone Group L.P., 345 Park Avenue, New York, NY 10154.

d. Pursuant to the Nominating and Voting Agreement, Mr. Chu, Mr. Foley and BTO have the right to designate one director nominee for election at each general meeting of the company, which nominee will be selected by a vote of any two of Mr. Chu, Mr. Foley and BTO. Mr. Chu, Mr. Foley and BTO have agreed to vote all of their shares in favor of such nominee. As such, each of Mr. Chu, Mr. Foley and BTO may be deemed to be members of a “group” within the meaning of Section 13(d)(3) of the Exchange Act, and each of the members may be deemed to beneficially own the shares of the other members. Each of Mr. Chu, Mr. Foley and BTO expressly disclaims any beneficial ownership of any securities owned by each of the other parties and their affiliates.

e. Includes (i) 125,000 ordinary shares held by Fidelity National Financial, Inc. and (ii) 4,335,680 ordinary shares held by Fidelity National Title Insurance Company, 9,163,920 ordinary shares held by Chicago Title Insurance Company and 3,272,400 ordinary shares held by Commonwealth Land Title Insurance Company, each a wholly owned subsidiary of FNF (collectively, the “FNF Investors”). Each of the FNF Investors shares the power to vote and the power to dispose of the securities of the company held by it with FNF, and as such, FNF may be deemed to beneficially own the securities held by each of the FNF Investors. William P. Foley, II, our Co-Executive Chairman, is the non-executive Chairman of the Board of FNF. The address for FNF and the FNF Investors is 601 Riverside Ave., Jacksonville, FL 32204.

f. Based solely on a Schedule 13G filed with the SEC on February 12, 2020 by The Vanguard Group. The Schedule 13G indicates that The Vanguard Group has sole voting power with respect to 144,811 of the shares, shared voting power with respect to 13,774 of the shares, sole dispositive power with respect to 15,157,775 of the shares, and shared dispositive power with respect to 131,725 of the shares. The business address of The Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355.

g. Based solely on a Schedule 13G/A filed with the SEC on February 14, 2019 by GIC Private Limited (“GIC”) and Coral Blue Investment Pte. Ltd.. Coral Blue Investment Pte. Ltd. shares the power to vote and the power to dispose of these securities with GIC Private Limited (“GIC”), a private limited company incorporated in Singapore. GIC is wholly owned by the Government of Singapore and was set up with the sole purpose of managing Singapore’s foreign reserves. The Government of Singapore disclaims beneficial ownership of these securities. GIC and Coral Blue Investment Pte. Ltd. disclaim membership in a group. The business address of GIC and Coral Blue Investment Ltd. is 168 Robinson Road, #37-101, Capital Tower, Singapore, 068913.

h. Based solely on a Schedule 13G filed with the SEC on February 5, 2020 by BlackRock, Inc. The Schedule 13G indicates that BlackRock, Inc. has sole dispositive power with respect to 21,669,453 of the ordinary shares and sole voting power with respect to 21,198,761 of the ordinary shares. The business address of BlackRock, Inc. is 55 East 52nd Street, New York, NY 10055.

131

i. Includes 14,892,723 ordinary shares held by CC Capital Management LLC (“CCCM”). Mr. Chu is the managing member of CCCM and as such may be deemed to beneficially own all of the securities held directly by CCCM. Mr. Chu disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

j. Includes 14,892,723 ordinary shares held by BilCar, LLC (“BilCar”). Mr. Foley is a manager of BilCar and as such may be deemed to beneficially own all of the securities held directly by BilCar. Mr. Foley disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

k. Mr. Chee holds these shares for the benefit of Blackstone Tactical Opportunities Advisors L.L.C. Mr. Chee disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

l. Includes 1,843,039 ordinary shares held by CFC 2016-A, LLC (“CFC”).  Mr. Massey is the managing member of CFC and as such may be deemed to beneficially own all of the securities held by CFC. Mr. Massey disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.

m. Includes 701,348 ordinary shares subject to stock options, which are currently exercisable or are exercisable within 60 days.

n. Comprised entirely of ordinary shares subject to stock options, which are currently exercisable or are exercisable within 60 days.

o. Includes 1,445,748 ordinary shares subject to stock options, which are currently exercisable or are exercisable within 60 days.

132

Item 13. Certain Relationships and Related Transactions, and Director Independence

CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS

Policies and Procedures for Related Person Transactions

Our Transactions Committee is responsible for reviewing any transaction with a related party pursuant to the policy and procedures in the committee’s charter. The Transactions Committee charter provides procedures for the approval of transactions with related persons as set forth in the rules and regulations of the SEC as well as “affiliate transactions” that require approval pursuant to the covenants set forth in any indenture, credit agreement or similar agreement of the company. These procedures provide that the Transactions Committee is responsible for reviewing and approving or disapproving all affiliate transactions, which include: any transaction between our company or its subsidiaries and our affiliates; any transaction, arrangement or relationship in which the amount involved may be expected to exceed $120,000 in any fiscal year, our company or its subsidiaries will be a participant, and a related person has a direct or indirect material interest; and any transaction described as an affiliate transaction in any indenture, credit agreement or similar agreement of our company. The Transactions Committee considers relevant facts and circumstances in determining whether or not to approve or ratify an affiliate transaction, and will approve or ratify only those transactions that are, in the committee’s judgment, fair to the company under the circumstances. In addition, Board approval is required for affiliate transactions required to comply with covenants set forth in any indenture, credit agreement or similar agreement of the company.

Related Person Transactions

In addition to the compensation arrangements with directors and executive officers described above in the section entitled “Executive Compensation,” the following is a description of each transaction since January 1, 2019 and each currently proposed transaction in which (i) we have been or are to be a participant, (ii) the amount involved exceeded or will exceed $120,000 and (iii) any of our directors, nominees for director, executive officers, holders of more than 5% of our ordinary shares, or any member of their immediate families or person sharing their household had or will have a direct or indirect material interest.

Investment Management Agreements

We, and certain subsidiaries of ours, entered into amended and restated investment management agreements (the “IMAs”) with Blackstone ISG-I Advisors LLC (“BISGA”), a wholly owned subsidiary of The Blackstone Group LP (“Blackstone”) on December 31, 2019, to be effective as of October 1, 2019, pursuant to which BISGA was appointed as investment manager of the Company’s general accounts (the “F&G Accounts”). The IMAs amend and restate investment management agreements entered into between November 2017 and March 2018 (the “Restated IMAs”). Pursuant to the terms of the IMAs, BISGA may delegate any or all of its discretionary investment, advisory and other rights, powers, functions and obligations under the IMAs to one or more sub-managers, including its affiliates. Pursuant to the Restated IMAs, BISGA delegated certain investment services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors. For the year ended December 31, 2019, the fees paid to BISGA under the Restated IMAs and the IMAs were approximately $95 million. As of December 31, 2019, the Company had a net liability of $47 million for the services provided under the Restated IMAs, the IMAs and related sub-management agreements, partially offset by fees received and expense reimbursements from BISGA. During fiscal 2019, we received expense reimbursements from BISGA for the services consumed under the agreements. The fees received for these services were $10 million for fiscal 2019.

Director Independence

Our Board has affirmatively determined that Messrs. Abell, Baird, Massey, Quella and Walsh are independent directors under NYSE Corporate Governance Standards. Under NYSE Corporate Governance Standards, no director qualifies as independent unless our Board affirmatively determines that the director has no material relationship with our company. Based upon information requested from and provided by each director concerning their background, employment and affiliations, including commercial, industrial, banking, consulting,

133

legal, accounting, charitable and familial relationships, our Board has determined that each of the independent directors named above has no material relationship with our company and is independent within the meaning of NYSE Corporate Governance Standards.

Our Audit, Compensation, Nominating and Corporate Governance Committee are entirely composed of such independent directors In addition, the Board has determined that members of the Audit Committee and Compensation Committee meet the additional independence requirements applicable to those committees under the NYSE Corporate Governance Standards and Rule 10A-3 under the Exchange Act, as applicable.

134

Item 14. Principal Accounting Fees and Services

Principal Accountant Fees and Services

In accordance with Sarbanes-Oxley, our Audit Committee charter provides that our Audit Committee has the sole authority and responsibility to pre-approve all audit services, audit-related tax services and other permitted services to be performed for our company by our independent registered public accounting firm and the related fees. Pursuant to its charter and in compliance with rules of the SEC and the PCAOB, our Audit Committee has established a pre-approval policy and procedures that require the pre-approval of all services to be performed by our independent registered public accounting firm. The independent registered public accounting firm may be considered for other services not specifically approved as audit services or audit-related services and tax services so long as the services are not prohibited by SEC or PCAOB rules and would not otherwise impair the independence of our independent registered public accounting firm.

The table below sets forth the professional fees billed or expected to be billed to our company by KPMG for professional services rendered during fiscal 2019 and fiscal 2018.

	Fiscal 2019		Fiscal 2018
Audit fees	$	4,701,000	$	3,696,000
Audit-related fees	220,070		187,855
Tax fees	786,724		679,175
All other fees	48,000		—
Total fees	$	5,755,794	$	4,563,030

• Audit Fees are fees for professional services for the audit of the consolidated financial statements included in Form 10-K and the review of the consolidated financial statements included in Form 10-Qs or services that are provided in connection with statutory and regulatory filings or engagements, such as statutory audits required for certain U.S. and foreign subsidiaries. These fees also include services provided in connection with review of registration statements, comfort letters and consents.

• Audit-Related Fees are fees for assurance and related services that are reasonably related to the performance of the audit or review of the consolidated financial statements.

• Tax Fees are fees for tax compliance, tax advice and tax planning.

• All Other Fees are fees, if any, for any services not included in the first three categories.

135

PART IV

Item 15.     Exhibits, Financial Statements and Schedules

List of Documents Filed

1) Financial Statements

See Index to Consolidated Financial Statements on Page F-1 following this Part IV.

2) Financial Statement Schedules

Schedule I - Summary of Investments - Other than Investments in Related Parties

Schedule II - Condensed Financial Information of Parent Only

Schedule III - Supplementary Insurance Information

Schedule IV - Reinsurance

All other schedules have been omitted since they are either not applicable or the information is contained within the accompanying consolidated financial statements.

136

List of Exhibits  

The following is a list of exhibits filed or incorporated by reference as a part of this Annual Report on Form 10-K.

Exhibit No.	Description of Exhibits
2.1	Agreement and Plan of Merger, dated as of May 24, 2017, by and between CF Corporation, FGL US Holdings Inc., FGL Merger Sub Inc. and Fidelity & Guaranty Life (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed by CF Corporation on May 31, 2017).
2.2	Amendment No. 1 to Agreement and Plan of Merger, dated as of June 30, 2017, by and between CF Corporation, FGL US Holdings Inc., FGL Merger Sub Inc. and Fidelity & Guaranty Life (incorporated by reference to Exhibit 2.2 of the Quarterly Report on Form 10-Q filed by CF Corporation on August 14, 2017).
2.3	Voting Agreement, dated as of May 24, 2017, by and among Fidelity & Guaranty Life, CF Capital Growth, LLC, Fidelity National Financial, Inc., CFS Holdings (Cayman), L.P., CC Capital Management, LLC, BilCar, LLC, Richard N. Massey and James A. Quella (incorporated by reference to Exhibit 2.3 to our Form 8-K, filed on May 24, 2017 (File No. 001-36227)).
2.4	Agreement and Plan of Merger, dated as of February 7, 2020, by and among the Company, Parent, Merger Sub I and Merger Sub II. (incorporated by reference to Exhibit 2.1 of the Current Report on Form 8-K filed with the SEC on February 7, 2020)(File No. 001-37779).
2.5	Voting Agreement, dated as of February 7, 2020, by and among the Company, Parent, Chicago Title Insurance Company, Fidelity National Title Insurance Company and Commonwealth Land Title Insurance Company. (incorporated by reference to Exhibit 2.2 of the Current Report on Form 8-K filed with the SEC on February 7, 2020)(File No. 001-37779).
2.6	Voting Agreement, dated as of February 7, 2020, by and among the Company, Parent and BilCar, LLC. (incorporated by reference to Exhibit 2.3 of the Current Report on Form 8-K filed with the SEC on February 7, 2020)(File No. 001-37779).
2.7	Voting Agreement, dated as of February 7, 2020, by and among the Company, Parent and CFS Holdings (Cayman) L.P. and CFS Holdings II (Cayman) L.P. (incorporated by reference to Exhibit 2.4 of the Current Report on Form 8-K filed with the SEC on February 7, 2020)(File No. 001-37779).
2.8	Voting Agreement, dated as of February 7, 2020, by and among the Company, Parent, William P. Foley, II and GSO. (incorporated by reference to Exhibit 2.5 of the Current Report on Form 8-K filed with the SEC on February 7, 2020)(File No. 001-37779).
2.9	Letter Agreement, dated as of February 7, 2020, by and among the Company, Parent and Blackstone ISG-I Advisors LLC. (incorporated by reference to Exhibit 2.6 of the Current Report on Form 8-K filed with the SEC on February 7, 2020)(File No. 001-37779).
3.1	Amended and Restated Memorandum and Articles of Association (incorporated by reference to Exhibit 3.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 11, 2018 (File No. 001-37779)).
3.2	Certificate of Designations of Series A Cumulative Convertible Preferred Shares (incorporated by reference to Exhibit 3.2 of the Registrant’s Current Report on Form 8-K filed with the SEC on December 1, 2017).
3.3	Certificate of Designations of Series B Cumulative Convertible Preferred Shares (incorporated by reference to Exhibit 3.3 of the Registrant’s Registration Statement on Form S-3 filed on December 21, 2017 (File No. 333-222232).
4.1	Description of Securities.
4.2	Specimen Ordinary Share Certificate (incorporated by reference to Exhibit 4.1 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 1, 2017).
4.3	Specimen Warrant Certificate (incorporated by reference to Exhibit 4.2 to the Registrant's Current Report on Form 8-K filed with the SEC on December 1, 2017).
4.4	Warrant Agreement, dated May 19, 2016, by and between CF Corporation and Continental Stock Transfer & Trust Company, as warrant agent (incorporated by reference to Exhibit 4.4 of the Current Report on Form 8-K, filed by CF Corporation on May 25, 2016 (File No. 001-37779)).

137

4.5	Amended and Restated Indenture, dated November 20, 2017, among Fidelity & Guaranty Life Holdings, Inc., as issuer, the Subsidiary Guarantors from time to time parties thereto and Wells Fargo Bank, National Association, as trustee, relating to the 6.375% Senior Notes due 2021 (incorporated by reference to Exhibit 4.4 to the Registrant’s Current Report on Form 8-K filed with the SEC on December 1, 2017).
4.6	Indenture, dated April 20, 2018, among Fidelity Guaranty & Life Holdings, Inc., the guarantors party thereto and Wells Fargo Bank, National Association, as trustee (incorporated by reference to Exhibit 4.1 to the Registrant's Current Report on Form 8-K filed with the SEC on April 25, 2018 (File No. 001-37779)).
4.7	Supplemental Indenture, dated April 20, 2018, among Fidelity & Guaranty Life Holdings, Inc., the guarantors party thereto and Wells Fargo Bank, National Association, as trustee (incorporated by reference to Exhibit 4.2 to the Registrant's Current Report on Form 8-K filed with the SEC on April 25, 2018 (File No. 001-37779)).
4.8	Form of 5.50% Note due 2025 (incorporated by reference to Exhibit 4.8 to the Registrant’s Current Report on Form 8-K filed with the SEC on April 25, 2018 (File No. 001-37779)).
10.1	Registration Rights Agreement, dated May 19, 2016, by and among CF Corporation, CF Capital Growth, LLC and the Holders signatory thereto (incorporated by reference to Exhibit 10.3 of the Current Report on Form 8-K, filed by CF Corporation on May 25, 2016 (File No. 001-37779)).
10.2	Indemnity Agreement, dated May 19, 2016, between the Registrant and Chinh E. Chu (incorporated by reference to Exhibit 10.6 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 25, 2016 (File No. 001-37779)).
10.3	Indemnity Agreement, dated May 19, 2016, between the Registrant and William P. Foley, II (incorporated by reference to Exhibit 10.7 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 25, 2016 (File No. 001-37779) ).
10.4	Indemnity Agreement, dated May 19, 2016, between the Registrant and James A. Quella (incorporated by reference to Exhibit 10.9 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 25, 2016 (File No. 001-37779)).
10.5	Indemnity Agreement, dated May 19, 2016, between the Registrant and Richard N. Massey (incorporated by reference to Exhibit 10.10 to the Registrant’s Current Report on Form 8-K filed with the SEC on May 25, 2016 (File No. 001-37779)).
10.6	Letter Agreement, dated as of November 30, 2017, by and between CF Corporation, Blackstone Tactical Opportunities Advisors LLC and Fidelity National Financial, Inc. (incorporated by reference to Exhibit 10.41 of the Registrant’s Current Report on Form 8-K filed with the SEC on December 1, 2017 (File No. 001-37779)).
10.7	Letter Amendment No. 1 to Letter Agreement, dated as of November 2, 2018, by and between FGL Holdings, Blackstone Tactical Opportunities Advisors LLC and Fidelity National Financial, Inc. (incorporated by reference to Exhibit 10.46 of the Registrant's Annual Report on Form 10-K, filed with the SEC on March 1, 2019)(File No. 001-37779).
10.8	Nominating and Voting Agreement, dated as of November 30, 2017, by and among Blackstone Tactical Opportunities Fund II L.P., Chinh E. Chu, William P. Foley, II and CF Corporation (incorporated by reference to Exhibit 10.42 of the Registrant’s Current Report on Form 8-K filed with the SEC on December 1, 2017 (File No. 001-37779)).
10.9	Credit Agreement, dated as of November 30, 2017, by and among CF Bermuda Holdings Limited, Fidelity & Guaranty Life Holdings, Inc., the financial institutions party thereto, as lenders, and Royal Bank of Canada, as administrative agent (incorporated by reference to Exhibit 10.43 of the Registrant’s Current Report on Form 8-K filed with the SEC on December 1, 2017 (File No. 001-37779)).
10.10	Guarantee Agreement, dated as of November 30, 2017, by and among Fidelity & Guaranty Life, FGL US Holdings Inc., Fidelity & Guaranty Life Business Services, Inc. and Royal Bank of Canada, as administrative agent (incorporated by reference to Exhibit 10.44 of the Registrant’s Current Report on Form 8-K filed with the SEC on December 1, 2017 (File No. 001-37779)).
10.11	FGL Holdings 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.1 of the Registrant’s Registration Statement on Form S-8 filed with the SEC on February 16, 2018 (File No. 333-23085)). +
10.12	Form of Non-Statutory Stock Option Agreement (Initial Grant) under the FGL Holdings 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.52 of the Registrant's Annual Report on Form 10-K, filed with the SEC on March 1, 2019)(File No. 001-37779).  +
10.13	Form of Non-Statutory Stock Option Agreement (Stretch Grant) under the FGL Holdings 2017 Omnibus Incentive Plan (incorporated by reference to Exhibit 10.53 of the Registrant's Annual Report on Form 10-K, filed with the SEC on March 1, 2019)(File No. 001-37779).  +

138

10.14	Employment Agreement, dated November 14, 2013, between Fidelity & Guaranty Life Business Services, Inc. and John Phelps (incorporated by reference to Exhibit 10.39 of Fidelity & Guaranty Life’s Registration Statement on Form S-1/A, filed on November 22, 2013 (File No. 333-190880)). +
10.15	Employment Agreement, dated November 14, 2013, between Fidelity & Guaranty Life Business Services, Inc. and Wendy J.B. Young (incorporated by reference to Exhibit 10.41 of Fidelity & Guaranty Life’s Registration Statement on Form S-1/A, filed on November 22, 2013 (File No. 333-190880)).
10.16	Form of Director and Officer Indemnification Agreement (incorporated by reference to Exhibit 10.58 of the Registrant's Annual Report on Form 10-K, filed with the SEC on March 1, 2019)(File No. 001-37779).  +
10.17	Credit Agreement between Fidelity & Guaranty Life Holdings, Inc. as borrower, the Company as guarantor, and RBC Capital Markets and Credit Suisse Securities (USA) LLC together as joint lead arrangers for the lenders, dated as of August 26, 2014 (incorporated by reference to Exhibit 10.1 of Fidelity & Guaranty Life’s Current Report on Form 8-K, filed on August 26, 2014 (File No. 001-36227)).
10.18	Second Amendment to Credit Agreement dated as of July 17, 2017 by and among Fidelity & Guaranty Life Holdings, Inc., each of the lenders from time to time party thereto and Royal Bank of Canada (incorporated by reference to Exhibit 10.1 of Fidelity & Guaranty Life’s Form 8-K, filed on July 21, 2017 (File No. 001-36227)).
10.19	Revolving Loan Note, dated August 26, 2014 (incorporated by reference to Exhibit 10.2 of Fidelity & Guaranty Life’s Current Report on Form 8-K, filed on August 26, 2014 (File No. 001-36227)).
10.20	Guarantee Agreement, dated as of August 26, 2014, among Fidelity & Guaranty Life, other Guarantors, and Royal Bank of Canada, as Administrative Agent (incorporated by reference to Exhibit 10.3 of Fidelity & Guaranty Life’s Current Report on Form 8-K, filed on August 26, 2014 (File No. 001-36227)).
10.21	Employment Agreement between FGL Holdings and Christopher Blunt, dated as of February 6, 2019 (incorporated by reference to Exhibit 10.69 of the Registrant's Annual Report on Form 10-K, filed with the SEC on March 1, 2019)(File No. 001-37779).  +
10.22	Non-Statutory Stock Option Grant Agreement (Initial Award) between FGL Holdings and Christopher Blunt, dated as of December 21, 2018 (incorporated by reference to Exhibit 10.70 of the Registrant's Annual Report on Form 10-K, filed with the SEC on March 1, 2019)(File No. 001-37779).  +
10.23	Non-Statutory Stock Option Grant Agreement (Stretch Award) between FGL Holdings and Christopher Blunt, dated as of December 21, 2018 (incorporated by reference to Exhibit 10.71 of the Registrant's Annual Report on Form 10-K, filed with the SEC on March 1, 2019)(File No. 001-37779).
10.24	Non-Statutory Stock Option Grant Agreement (Initial Award) between FGL Holdings and Jonathan Bayer, dated as of December 21, 2018 (incorporated by reference to Exhibit 10.72 of the Registrant's Annual Report on Form 10-K, filed with the SEC on March 1, 2019)(File No. 001-37779).  +
10.25	Non-Statutory Stock Option Grant Agreement (Stretch Award) between FGL Holdings and Jonathan Bayer, dated as of December 21, 2018 (incorporated by reference to Exhibit 10.73 of the Registrant's Annual Report on Form 10-K, filed with the SEC on March 1, 2019)(File No. 001-37779).  +
10.26	Amended and Restated Investment Management Agreement dated as of December 31, 2019 and effective as of October 1, 2019 by and between FGL Holdings and Blackstone ISG-I Advisors L.L.C. (incorporated by reference to Exhibit 10.1 of the Registrant’s Current Report on Form 8-K filed on January 3, 2020 (File No. 001-37779))
10.27	Amended and Restated Investment Management Agreement dated as of December 31, 2019 and effective as of October 1, 2019 by and between Fidelity & Guaranty Life Insurance Company and Blackstone ISG-I Advisors L.L.C (incorporated by reference to Exhibit 10.2 of the Registrant’s Current Report on Form 8-K filed on January 3, 2020 (File No. 001-37779))
10.28	Amended and Restated Investment Management Agreement dated as of December 31, 2019 and effective as of October 1, 2019 by and between FGL US Holdings Inc. and Blackstone ISG-I Advisors L.L.C. (incorporated by reference to Exhibit 10.3 of the Registrant’s Current Report on Form 8-K filed on January 3, 2020 (File No. 001-37779))
10.29	Amended and Restated Investment Management Agreement dated as of December 31, 2019 and effective as of October 1, 2019 by and between Fidelity & Guaranty Life Holdings, Inc. and Blackstone ISG-I Advisors L.L.C. (incorporated by reference to Exhibit 10.4 of the Registrant’s Current Report on Form 8-K filed on January 3, 2020 (File No. 001-37779))

139

10.30	Amended and Restated Investment Management Agreement dated as of December 31, 2019 and effective as of October 1, 2019 by and between CF Bermuda Holdings Limited and Blackstone ISG-I Advisors L.L.C. (incorporated by reference to Exhibit 10.5 of the Registrant’s Current Report on Form 8-K filed on January 3, 2020 (File No. 001-37779))
10.31	Amended and Restated Investment Management Agreement dated as of December 31, 2019 and effective as of October 1, 2019 by and between Front Street Re (Cayman) Ltd and Blackstone ISG-I Advisors L.L.C. (incorporated by reference to Exhibit 10.6 of the Registrant’s Current Report on Form 8-K filed on January 3, 2020 (File No. 001-37779))
10.32	Amended and Restated Investment Management Agreement dated as of December 31, 2019 and effective as of October 1, 2019 by and between F & G Life Re Ltd and Blackstone ISG-I Advisors L.L.C. (incorporated by reference to Exhibit 10.7 of the Registrant’s Current Report on Form 8-K filed on January 3, 2020 (File No. 001-37779))
10.33	Amended and Restated Investment Management Agreement dated as of December 31, 2019 and effective as of October 1, 2019 by and between F & G Reinsurance Ltd and Blackstone ISG-I Advisors L.L.C. (incorporated by reference to Exhibit 10.8 of the Registrant’s Current Report on Form 8-K filed on January 3, 2020 (File No. 001-37779))
10.36*	Employment Agreement between Fidelity & Guaranty Life Business Services and Rajesh Krishnan, dated as of January 1, 2019.
10.37*	Amended and Restated Employment Agreement between Fidelity & Guaranty Life Business Services and Dennis Vigneau, dated as of March 29, 2019.
10.38*	Employment Agreement between FGL Holdings and John Fleurant, dated as of November 11, 2019.
10.50*	Form of Transaction Bonus Letter Agreement, dated February 25, 2020.
21*	Subsidiaries of the Company.
23*	Consent of Independent Registered Public Accounting Firm.
24*	Power of Attorney (set forth on the signature page).
31.1 *	Certification of Chief Executive Officer, pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2 *	Certification of Chief Financial Officer, pursuant to Exchange Act Rule 13a-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1 *	Certification of Chief Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 *	Certification of Chief Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101 *	The following financial information from FGL Holdings' Quarterly Report on Form 10-Q for the period ended December 31, 2019 is formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets as of December 31, 2019 (unaudited) and December 31, 2018, (ii) the Condensed Consolidated Statements of Operations (unaudited), (iii) the Condensed Consolidated Statements of Comprehensive Income (Loss) (unaudited), (iv) the Condensed Consolidated Statements of Changes in Stockholders Equity (unaudited), (v) the Condensed Consolidated Statements of Cash Flows (unaudited), and (vi) Notes to the Condensed Consolidated Financial Statements.
104 *	The cover page from FGL Holdings' Quarterly Report on Form 10-Q for the period ended December 31, 2019 is formatted in Inline XBRL (Extensible Business Reporting Language).

* Filed herewith

+ Indicates management contract or compensatory plan or agreement.

Item 16. Form 10-K Summary

None.

140

SIGNATURES

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		FGL HOLDINGS (Registrant)
Date:	March 2, 2020	By:	/s/ John Fleurant
			Chief Financial Officer
			(on behalf of the Registrant and as Principal Financial Officer)

POWERS OF ATTORNEY

KNOW ALL BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Christopher O. Blunt and John Fleurant, and each of them, acting individually, as his true and lawful attorney-in-fact and agent, each with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

141

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signature	Title	Date
/s/ Christopher O. Blunt
Christopher O. Blunt	President, Chief Executive Officer and Director (Principal Executive Officer)	March 2, 2020
/s/ John Fleurant
John Fleurant	Chief Financial Officer (Principal Financial Officer and Principal Accounting Officer)	March 2, 2020
/s/ Chinh E. Chu
Chinh E. Chu	Co-Chairman	March 2, 2020
/s/ William P. Foley, II
William P. Foley, II	Co-Chairman	March 2, 2020
/s/ Keith W. Abell
Keith W. Abell	Director	March 2, 2020
/s/ Patrick S. Baird
Patrick S. Baird	Director	March 2, 2020
/s/ Menes O. Chee
Menes O. Chee	Director	March 2, 2020
/s/ Richard N. Massey
Richard N. Massey	Director	March 2, 2020
/s/ James A. Ouella
James A. Ouella	Director	March 2, 2020
/s/ Timothy M. Walsh
Timothy M. Walsh	Director	March 2, 2020

142

FGL HOLDINGS

INDEX OF CONSOLIDATED FINANCIAL STATEMENTS

	Page
Report of Independent Registered Public Accounting Firm	F-2
Report of Independent Registered Public Accounting Firm	F-5
Consolidated Balance Sheets	F-7
Consolidated Statements of Operations	F-8
Consolidated Statements of Comprehensive Income (Loss)	F-9
Consolidated Statements of Changes in Shareholders' Equity	F-10
Consolidated Statements of Cash Flows	F-11
Notes to Consolidated Financial Statements	F-12
(1) Basis of Presentation and Nature of Business	F-12
(2) Significant Accounting Policies and Practices	F-14
(3) Significant Risks and Uncertainties	F-27
(4) Investments	F-30
(5) Derivative Financial Instruments	F-39
(6) Fair Value of Financial Instruments	F-44
(7) Intangibles	F-61
(8) Debt	F-63
(9) Equity	F-63
(10) Stock Compensation	F-67
(11) Income Taxes	F-68
(12) Commitments and Contingencies	F-74
(13) Reinsurance	F-75
(14) Related Party Transactions	F-78
(15) Earnings Per Share	F-80
(16) Insurance Subsidiary Financial Information and Regulatory Matters	F-81
(17) Other Liabilities	F-84
(18) Quarterly Results	F-84
(19) Subsequent Events	F-85
Schedule I - Summary of Investments-Other than Investments in Related Parties	F-86
Schedule II - Condensed Financial Information of Parent Only	F-87
Schedule III - Supplementary Insurance Information	F-90
Schedule IV - Reinsurance	F-91

 

F-1

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors

FGL Holdings and subsidiaries:

Opinion on the Consolidated Financial Statements

We have audited the accompanying consolidated balance sheets of FGL Holdings and subsidiaries (the Company) as of December 31, 2019 and 2018, the related consolidated statements of operations, comprehensive income (loss), changes in shareholders’ equity, and cash flows for each of the years in the two year period ended December 31, 2019 and the period from December 1, 2017 to December 31, 2017 (Successor Company operations), the consolidated statements of operations, comprehensive income (loss), changes in shareholders’ equity, and cash flows of Fidelity & Guaranty Life and subsidiaries for the period from October 1, 2017 to November 30, 2017, and for the year ended September 30, 2017 (Predecessor Company operations) and the related notes and financial statement schedules I to IV (collectively, the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2019 and 2018, and the results of its operations and its cash flows for each of the years in the two year period ended December 31, 2019 and the period from December 1, 2017 to December 31, 2017, in conformity with U.S. generally accepted accounting principles. Further, in our opinion, the consolidated financial statements present fairly, in all material respects, the results of the Predecessor Company operations and its cash flows for the period from October 1, 2017 to November 30, 2017, and for the year ended September 30, 2017, in conformity with U.S. generally accepted accounting principles.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company’s internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission, and our report dated March 2, 2020 expressed an unqualified opinion on the effectiveness of the Company’s internal control over financial reporting.

Basis for Opinion

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

Critical Audit Matters

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

F-2

Assessment of the fair value measurement of fixed maturity securities, available for sale, classified as level 3 in the fair value hierarchy

As discussed in Note 2, 4 and 6 to the consolidated financial statements, the Company’s investments in fixed maturity securities classified as level 3 within the fair value hierarchy have been designated as available for sale and are reported at fair value which was $2.8 billion as of December 31, 2019. To estimate the fair value of fixed maturity securities classified as level 3 in the fair value hierarchy the Company employs a market approach which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services and independent broker quotations.

We identified the assessment of the fair value measurement of fixed maturity securities, available for sale, classified as level 3 in the fair value hierarchy as a critical audit matter. Due to the significant measurement uncertainty, this assessment involved subjective auditor judgment and required specialized skills and knowledge in identifying and applying comparable market information that is relevant and reliable.

The primary procedures we performed to address this critical audit matter included the following. We tested certain internal controls over the Company’s evaluation of quotations obtained from third-party pricing services and independent brokers, including the assessment of the valuation methodologies, and a comparison to portfolio and market trends.

We involved financial instrument valuation professionals with specialized skills and knowledge, who assisted in:

• testing the Company’s methodology to produce fair value estimates compliant with U.S. generally accepted accounting principles, and

• developing an independent estimate of fair value for securities selected for testing using key assumptions and market data sources, and comparing those fair value estimates to the Company’s value.

Assessment of certain assumptions used in the valuation of insurance intangible assets

As discussed in Notes 2 and 7 to the consolidated financial statements, the Company amortizes insurance intangible assets reflecting the value of insurance and reinsurance contracts acquired, deferred acquisition costs, and deferred sales inducements over the lives of the respective policies in relation to the expected emergence of estimated gross profits (EGP’s). EGP’s are derived from the estimates of future investment income, surrender charges and other product fees, less the cost of amounts credited to policyholders, maintenance expenses, mortality, net of reinsurance ceded, and expense margins. The determination of EGP’s requires the Company to use certain assumptions, including (1) surrender rates, (2) the earned rate, which represents the long term assumptions of the Company’s expected earnings on investments, and

(3) budgeted option costs, which represents the expected cost to purchase call options in future periods to fund the equity indexed linked feature related to the Company’s fixed indexed annuity contracts. The value of insurance and reinsurance contracts acquired, deferred acquisition costs, and deferred sales inducements were $0.6 billion, $0.6 billion and $0.2 billion, respectively as of December 31, 2019.

We identified the assessment of certain assumptions used in the valuation of insurance intangible assets as a critical audit matter. Due to the significant measurement uncertainty, this assessment involved subjective auditor judgment and required specialized skills and knowledge to evaluate the assumptions listed above used to determine the EGP estimates.

The primary procedures we performed to address this critical audit matter included the following. We tested certain internal controls over the Company’s development, review, and approval of the EGP assumptions listed above. We involved actuarial professionals with specialized skills and industry knowledge, who assisted in:

• evaluating the Company’s methodology used to produce EGP estimates compliant with U.S. generally accepted accounting principles,

• comparing estimated gross profits for the current year to actual gross profits for the current year,

F-3

• comparing the Company’s actual historical experience to expected experience for surrender rates,

• comparing the earned rates and budgeted option costs to historic and current experience, and

• performing an analysis to evaluate the application of the earned rate and budgeted option cost assumptions used in the projection of EGP’s.

We also involved financial instrument valuation professionals with specialized skills and knowledge, who assisted in:

• comparing the earned rate assumptions to actual Company projections and observable market information, and

• re-performing calculations of projected cash flows for a selection of securities used in determining the earned rate assumptions.

Assessment of certain assumptions used in the fair value measurement of the fixed indexed annuity embedded derivative liability

As discussed in Notes 2, 5, and 6 to the consolidated financial statements, the Company permits the holder of a fixed indexed annuity contract to elect an equity index linked feature, where amounts credited to the contract are linked to the performance of the equity indices selected by the contract holder. This feature is accounted for as an embedded derivative liability and reported at fair value which was $3.2 billion as of December 31, 2019. The embedded derivative liability was classified as level 3 in the fair value hierarchy, and the fair value measurement uses inputs deemed unobservable, including the mortality multiplier, surrender rates, non-performance spread and budgeted option cost.

We identified the assessment of certain assumptions used in the fair value measurement of the fixed index annuity embedded derivative liability as a critical audit matter. Due to the significant measurement uncertainty, this assessment involved subjective auditor judgment and required specialized skills and knowledge to evaluate the assumptions related to the (1) surrender rates, and (2) budgeted option costs, which represent the expected cost to purchase call options in future periods to fund the equity indexed linked feature.

The primary procedures we performed to address the critical audit matter included the following. We tested certain internal controls over the Company’s development, review, and approval of the assumptions. We involved actuarial professionals with specialized skills and industry knowledge, who assisted in:

• evaluating the Company’s methodology to produce a fair value estimate compliant with U.S. generally accepted accounting principles,

• comparing the Company’s actual historical experience to expected experience for surrender rates,

• comparing the budgeted option cost to the historic and current experience, and

• testing the application of the Company’s methodology and assumptions by developing independent estimates for a selection of policies and comparing the results to the Company’s estimates.

/s/ KPMG LLP

We have served as the Company’s auditor since 1998.

Des Moines, Iowa

March 2, 2020

F-4

Report of Independent Registered Public Accounting Firm

To the Shareholders and Board of Directors

FGL Holdings and subsidiaries:

Opinion on Internal Control Over Financial Reporting

We have audited FGL Holdings and subsidiaries (the Company) internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission. In our opinion, the Company maintained, in all material respects, effective internal control over financial reporting as of December 31, 2019, based on criteria established in Internal Control - Integrated Framework (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission.

We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December 31, 2019 and 2018, the related consolidated statements of operations, comprehensive income (loss), changes in shareholders’ equity, and cash flows for each of the years in the two-year period ended December 31, 2019 and the period from December 1, 2017 to December 31, 2017 (Successor Company operations), the consolidated statements of operations, comprehensive income (loss), changes in shareholders’ equity, and cash flows of Fidelity & Guaranty Life and subsidiaries for the period from October 1, 2017 to November 30, 2017, and for the year ended September 30, 2017 (Predecessor Company operations) and the related notes and financial statement schedules I to IV (collectively, the consolidated financial statements), and our report dated March 2, 2020 expressed an unqualified opinion on those consolidated financial statements.

Basis for Opinion

The Company’s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting, included in the accompanying Management’s Report on Internal Control Over Financial Reporting. Our responsibility is to express an opinion on the Company’s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects. Our audit of internal control over financial reporting included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, and testing and evaluating the design and operating effectiveness of internal control based on the assessed risk. Our audit also included performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control Over Financial Reporting

A company’s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company’s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made

F-5

only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company’s assets that could have a material effect on the financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

/s/ KPMG LLP

Des Moines, Iowa

March 2, 2020

F-6

FGL HOLDINGS

CONSOLIDATED BALANCE SHEETS

(In millions, except share data)

	December 31, 2019			December 31, 2018
ASSETS
Investments:
Fixed maturity securities, available-for-sale, at fair value (amortized cost: December 31, 2019 - $22,914; December 31, 2018 - $22,219)	$	23,726		$	21,109
Equity securities, at fair value (cost: December 31, 2019 - $1,069; December 31, 2018 - $1,526)	1,071			1,382
Derivative investments	587			97
Mortgage loans	1,267			667
Other invested assets	1,303			662
Total investments	27,954			23,917
Cash and cash equivalents	969			571
Accrued investment income	228			216
Funds withheld for reinsurance receivables, at fair value	2,172			757
Reinsurance recoverable	3,213			3,190
Intangibles, net	1,455			1,359
Deferred tax assets, net	61			343
Goodwill	467			467
Other assets	195			125
Total assets	$	36,714		$	30,945
LIABILITIES AND SHAREHOLDERS' EQUITY
Contractholder funds	$	25,684		$	23,387
Future policy benefits, including $1,953 and $725 at fair value at December 31, 2019 and December 31, 2018, respectively	5,735			4,641
Funds withheld for reinsurance liabilities	831			722
Liability for policy and contract claims	71			64
Debt	542			541
Other liabilities	1,108			700
Total liabilities	33,971			30,055
Commitments and contingencies ("Note 12")
Shareholders' equity:
Preferred stock ($.0001 par value, 100,000,000 shares authorized, 429,789 and 399,033 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively)	—			—
Common stock ($.0001 par value, 800,000,000 shares authorized, 221,807,598 and 221,660,974 issued and outstanding at December 31, 2019 and December 31, 2018, respectively	—			—
Additional paid-in capital	2,031			1,998
Retained earnings (Accumulated deficit)	300			(167		)
Accumulated other comprehensive income (loss)	481			(937		)
Treasury stock, at cost (8,652,400 shares at December 31, 2019; 600,000 shares at December 31, 2018)	(69		)	(4		)
Total shareholders' equity	2,743			890
Total liabilities and shareholders' equity	$	36,714		$	30,945

See accompanying notes to consolidated financial statements.

F-7

FGL HOLDINGS

CONSOLIDATED STATEMENTS OF OPERATIONS

(In millions, except share data)

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Revenues:
Premiums	$	40		$	54		$	3		$	7		$	11		$	42
Net investment income	1,229			1,107			92			174			240			1,005
Net investment gains (losses)	674			(629		)	42			146			51			316
Insurance and investment product fees and other	170			179			28			35			38			167
Total revenues	2,113			711			165			362			340			1,530
Benefits and expenses:
Benefits and other changes in policy reserves	1,057			423			124			227			20			843
Acquisition and operating expenses, net of deferrals	330			181			16			51			28			137
Amortization of intangibles	126			49			4			36			123			193
Total benefits and expenses	1,513			653			144			314			171			1,173
Operating income	600			58			21			48			169			357
Interest expense	(32		)	(29		)	(2		)	(4		)	(6		)	(24		)
Income (loss) before income taxes	568			29			19			44			163			333
Income tax (expense) benefit	(61		)	(16		)	(110		)	(16		)	(55		)	(110		)
Net income (loss)	$	507		$	13		$	(91	)	$	28		$	108		$	223
Less Preferred stock dividend	31			29			2			—			—			—
Net income (loss) available to common shareholders	$	476		$	(16	)	$	(93	)	$	28		$	108		$	223
Net income (loss) per common share
Basic	$	2.19		$	(0.07	)	$	(0.44	)	$	0.48		$	1.85		$	3.83
Diluted	$	2.19		$	(0.07	)	$	(0.44	)	$	0.47		$	1.85		$	3.83
Weighted average common shares used in computing net income (loss) per common share:
Basic	216,591,908			216,018,629			214,370,000			58,341,112			58,280,532			58,319,517
Diluted	216,737,602			216,018,629			214,370,000			58,494,043			58,366,009			58,415,187
Cash dividend per common share	$	0.04		$	—		$	—		$	0.07		$	0.07		$	0.26
Supplemental disclosures
Other-than-temporary impairments	$	(23	)	$	(24	)	$	—		$	—		$	(1	)	$	(22	)
Gains (losses) on derivatives and embedded derivatives	498			(295		)	37			140			51			335
Other investment gains (losses)	199			(310		)	5			6			1			3
Total net investment gains (losses)	$	674		$	(629	)	$	42		$	146		$	51		$	316

See accompanying notes to consolidated financial statements.

F-8

FGL HOLDINGS

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In millions)

	Year ended														Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (unaudited)			September 30, 2017
										Predecessor		Predecessor			Predecessor
Net income (loss)	$	507		$	13		$	(91	)	$	28	$	108		$	223
Other comprehensive income (loss):
Net change in unrealized gains/losses on investments (net of intangibles and deferred tax asset)	1,433			(1,020		)	75			12		(286		)	104
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	(15		)	4			—			—		—			—
Net changes to derive comprehensive income (loss) for the period	1,418			(1,016		)	75			12		(286		)	104
Comprehensive income (loss), net of tax	$	1,925		$	(1,003	)	$	(16	)	$	40	$	(178	)	$	327

See accompanying notes to consolidated financial statements.

F-9

FGL HOLDINGS

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

(In millions)

	Preferred Stock		Common Stock		Additional Paid-in Capital			Retained Earnings (Accumulated Deficit)			Accumulated Other Comprehensive Income (Loss)			Treasury Stock			Total Shareholders' Equity
Balance, September 30, 2016	$	—	$	1	$	714		$	792		$	439		$	(12	)	$	1,934
Treasury shares purchased	—		—		—			—			—			(1		)	(1		)
Common stock dividends	—		—		—			(15		)	—			—			(15		)
Net income	—		—		—			223			—			—			223
Unrealized investment gains, net	—		—		—			—			104			—			104
Stock-based compensation	—		—		2			—			—			—			2
Balance, September 30, 2017	$	—	$	1	$	716		$	1,000		$	543		$	(13	)	$	2,247
Balance, October 1, 2016 (unaudited)	$	—	$	1	$	714		$	792		$	439		$	(12	)	$	1,934
Treasury shares purchased	—		—		—			—			—			(1		)	(1		)
Common stock dividends	—		—		—			(4		)	—			—			(4		)
Net income	—		—		—			108			—			—			108
Unrealized investment (losses), net	—		—		—			—			(286		)	—			(286		)
Stock-based compensation	—		—		1			—			—			—			1
Balance, December 31, 2016 (unaudited)	$	—	$	1	$	715		$	896		$	153		$	(13	)	$	1,752
Balance, October 1, 2017	$	—	$	1	$	716		$	1,000		$	543		$	(13	)	$	2,247
Common stock dividends	—		—		—			(4		)	—			—			(4		)
Net income	—		—		—			28			—			—			28
Unrealized investment gains, net	—		—		—			—			12			—			12
Stock-based compensation	—		—		1			—			—			—			1
Balance, November 30, 2017	$	—	$	1	$	717		$	1,024		$	555		$	(13	)	$	2,284
Balance, December 1, 2017	$	—	$	—	$	2,037		$	(56	)	$	—		$	—		$	1,981
Preferred stock dividends (paid in-kind)	—		—		—			(2		)	—			—			(2		)
Net income	—		—		—			(91		)	—			—			(91		)
Unrealized investment gains, net	—		—		—			—			75			—			75
Balance, December 31, 2017	$	—	$	—	$	2,037		$	(149	)	$	75		$	—		$	1,963
Treasury shares purchased	—		—		—			—			—			(4		)	(4		)
Preferred stock dividends (paid in kind)	—		—		23			(29		)	—			—			(6		)
Net income	—		—		—			13			—			—			13
Unrealized investment gains (losses), net	—		—		—			—			(1,020		)	—			(1,020		)
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	—		—		—			—			4			—			4
Stock-based compensation	—		—		4			—			—			—			4
Cash paid upon warrant tender and capitalized warrant tender costs	—		—		(66		)	—			—			—			(66		)
Cumulative effect of changes in accounting principles and other	—		—		—			(2		)	4			—			2
Balance, December 31, 2018	$	—	$	—	$	1,998		$	(167	)	$	(937	)	$	(4	)	$	890
Treasury shares purchased	—		—		—			—			—			(65		)	(65		)
Dividends
Preferred stock (paid in kind)	—		—		29			(31		)	—			—			(2		)
Common stock ($0.04/share)	—		—		—			(9		)	—			—			(9		)
Net income	—		—		—			507			—			—			507
Unrealized investment gains (losses), net	—		—		—			—			1,433			—			1,433
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	—		—		—			—			(15		)	—			(15		)
Stock-based compensation	—		—		4			—			—			—			4
Balance, December 31, 2019	$	—	$	—	$	2,031		$	300		$	481		$	(69	)	$	2,743

See accompanying notes to consolidated financial statements.

F-10

FGL HOLDINGS

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Cash flows from operating activities:
Net income (loss)	$	507		$	13		$	(91	)	$	28		$	108		$	223
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock based compensation	5			4			(1		)	4			1			6
Amortization	39			43			6			(4		)	(6		)	(42		)
Deferred income taxes	41			(30		)	104			(7		)	76			(4		)
Interest credited/index credits to contractholder account balances	985			347			124			206			(13		)	701
Net recognized losses (gains) on investments and derivatives	(682		)	629			(42		)	(137		)	(51		)	(305		)
Charges assessed to contractholders for mortality and administration	(124		)	(136		)	(13		)	(25		)	(32		)	(131		)
Intangibles, net	(336		)	(390		)	(29		)	(12		)	23			(144		)
Changes in operating assets and liabilities:
Reinsurance recoverable	13			24			17			3			(8		)	(18		)
Future policy benefits reflected in net income (loss)	1,079			(110		)	4			(11		)	(14		)	(55		)
Funds withheld for reinsurers	(1,220		)	679			(2		)	(16		)	(26		)	(105		)
Collateral (returned) posted	387			(291		)	17			56			40			158
Other assets and other liabilities	(19		)	115			(9		)	(6		)	(26		)	(47		)
Net cash provided by (used in) operating activities	675			897			85			79			72			237
Cash flows from investing activities:
Proceeds from available-for-sale investments sold, matured or repaid	4,506			8,265			313			626			733			2,755
Proceeds from derivatives instruments and other invested assets	338			499			169			117			71			458
Proceeds from mortgage loans	100			65			1			2			13			48
Costs of available-for-sale investments	(4,733		)	(10,079		)	(348		)	(874		)	(1,355		)	(4,123		)
Costs of derivatives instruments and other invested assets	(1,067		)	(781		)	(156		)	(45		)	(54		)	(351		)
Costs of mortgage loans	(701		)	(185		)	—			—			—			—
Capital expenditures	(11		)	(7		)	(1		)	(1		)	(2		)	(4		)
Contingent purchase price payment	—			(57		)	—			—			—			—
Net cash provided by (used in) investing activities	(1,568		)	(2,280		)	(22		)	(175		)	(594		)	(1,217		)
Cash flows from financing activities:
Treasury stock	(65		)	(4		)	—			—			(1		)	(1		)
Debt issuance costs	—			(6		)	—			—			—			—
Proceeds from issuance of new debt	—			547			—			—			—			—
Retirement and paydown on debt and revolving credit facility	(27		)	(440		)	(105		)	—			—			—
Draw on revolving credit facility	27			30			105			—			—			5
Common stock dividends paid	(9		)	—			—			(4		)	(4		)	(15		)
Cash paid upon warrant tender and capitalized warrant tender costs	—			(66		)	—			—			—			—
Contractholder account deposits	4,124			3,352			217			443			698			2,890
Contractholder account withdrawals	(2,759		)	(2,674		)	(172		)	(304		)	(403		)	(1,878		)
Net cash provided by (used in) financing activities	1,291			739			45			135			290			1,001
Change in cash & cash equivalents	398			(644		)	108			39			(232		)	21
Cash & cash equivalents, beginning of period	571			1,215			1,107			885			864			864
Cash & cash equivalents, end of period	$	969		$	571		$	1,215		$	924		$	632		$	885
Supplemental disclosures:
Interest paid	$	30		$	30		$	—		$	10		$	10		$	23
Income taxes (refunded) paid	$	(1	)	$	41		$	(21	)	$	—		$	—		$	114
Deferred sales inducements	$	130		$	138		$	10		$	3		$	—		$	20

See accompanying notes to consolidated financial statements.

F-11

FGL HOLDINGS

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(1) Basis of Presentation and Nature of Business

FGL Holdings (the "Company"), formerly known as CF Corporation ("CF Corp"), a Cayman Islands exempted company, was originally incorporated in the Cayman Islands on February 26, 2016 as a Special Purpose Acquisition Company ("SPAC"). The Company’s primary business is the sale of individual life insurance products and annuities through independent agents, managing general agents, and specialty brokerage firms and in selected institutional markets. The Company’s principal products are deferred annuities (including fixed indexed annuity (“FIA”) contracts and fixed rate annuity contracts), immediate annuities and life insurance products. The Company markets products through its wholly-owned insurance subsidiaries, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) and Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”), which together are licensed in all fifty states and the District of Columbia.

F&G Reinsurance Ltd (“F&G Re”), an exempted company incorporated in Bermuda with limited liability, provides a platform for non-affiliated reinsurance business. Front Street Re Cayman Ltd (“FSRC”), an exempted company incorporated in the Cayman Islands with limited liability, has a license to carry on business as an Unrestricted Class “B” Insurer that permits FSRC to conduct offshore direct and reinsurance business. F&G Re and FSRC (together herein referred to as the “F&G Reinsurance Companies”), are indirect wholly owned subsidiaries of the Company and parties to reinsurance transactions.

Prior to November 30, 2017, CF Corp. was a shell company with no operations. On November 30, 2017, CF Corp. consummated the acquisition of Fidelity & Guaranty Life ("FGL"), a Delaware corporation, and its subsidiaries, pursuant to the Agreement and Plan of Merger, dated as of May 24, 2017 (the “FGL Merger Agreement”). The transactions contemplated by the FGL Merger Agreement are referred to herein as the “Business Combination.” In addition to the Business Combination, on November 30, 2017, CF Corp bought all of the issued and outstanding shares of FSRC and F&G Re (formerly known as Front Street Re Ltd).

As a result of the Business Combination, for accounting purposes, FGL Holdings is the acquirer and FGL is the acquired party and accounting predecessor. Our financial statement presentation includes the financial statements of FGL and its subsidiaries as “Predecessor” for the periods prior to the completion of the Business Combination, and FGL Holdings, including the consolidation of FGL and its subsidiaries and the F&G Reinsurance Companies, for periods from and after the Closing Date. FGL Holdings is the surviving company organized and existing under the laws of the United States of America, any State of the United States, the District of Columbia or any territory thereof (and in the case of the Company, Bermuda or the Cayman Islands). Prior to the acquisition, FGL Holdings reported under a fiscal year end of December 31, and the Predecessor companies reported under a fiscal year end of September 30. Subsequent to the acquisition, FGL Holdings reports under a fiscal year end of December 31.

On February 7, 2020, FGL Holdings and Fidelity National Financial, Inc. (NYSE: FNF) (“FNF”) entered into a merger agreement pursuant to which FNF will acquire FGL Holdings for $12.50 per share, representing an equity value of approximately $2.7 billion. The transaction was approved by a Special Committee of FGL Holdings Directors, a Special Committee of FNF Directors and the FNF Board of Directors. FNF currently owns 7.9% of FGL Holdings outstanding ordinary shares and all of FGL Holdings Series B Preferred shares. In connection with and immediately prior to the closing of the proposed acquisition, FNF will acquire all outstanding FGL Holdings Series A preferred shares, with a face value of approximately $321 million as of December 31, 2019, and assume the $550 million of senior notes due 2025.

Under the terms of the merger agreement, holders of FGL Holdings' ordinary shares (other than FNF and its subsidiaries) may elect to receive either (i) $12.50 per share in cash or (ii) 0.2558 of a share of FNF common stock for each ordinary share of F&G they own. This is subject to an election and proration mechanism such that the aggregate consideration paid to such holders of FGL Holdings' ordinary shares will consist of approximately 60% cash and 40% FNF common stock.  

The transaction is expected to close in the second or third quarter of 2020, subject to the satisfaction of customary closing conditions, including the receipt of regulatory clearances and approval by FGL Holdings shareholders.

F-12

The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Dollar amounts in the accompanying sections are presented in millions, unless otherwise noted.

We have one reporting segment, which is consistent with and reflects the manner by which our chief operating decision maker views and manages the business. We currently distribute and service primarily fixed rate annuities, including FIAs. Premiums and annuity deposits (net of reinsurance), which are not included as revenues (except for traditional premiums) in the accompanying Consolidated Statements of Operations, collected by product type were as follows:

 

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
Product Type							Predecessor		Predecessor		Predecessor
Fixed indexed annuities	$	2,800	$	2,253	$	178	$	288	$	556	$	1,892
Fixed rate annuities	539		61		45		116		99		556
Single premium immediate annuities	14		24		—		1		2		15
Life insurance (a)	203		182		16		29		50		176
Total	$	3,556	$	2,520	$	239	$	434	$	707	$	2,639

(a) Life insurance includes Universal Life (“UL”) and traditional life insurance products for FGL Insurance and FGL NY Insurance.

F-13

(2) Significant Accounting Policies and Practices

Principles of Consolidation

The accompanying audited consolidated financial statements include the accounts of the Company and all other entities in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.

We are involved in certain entities that are considered variable interest entities ("VIEs") as defined under U.S. GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control, to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our audited consolidated financial statements. See "Note 4. Investments" for additional information on the Company’s investments in VIEs.

Revenue Recognition

Insurance Premiums

The Company’s insurance premiums for traditional life insurance products are recognized as revenue when due from the contractholder. The Company’s traditional life insurance products include those products with fixed and guaranteed premiums and benefits and consist primarily of term life insurance and certain annuities with life contingencies, net of premiums ceded under reinsurance.

Premium collections for fixed indexed and fixed rate annuities, indexed universal life (“IUL”) policies and immediate annuities without life contingency are reported as an increase to deposit liabilities (i.e., contractholder funds) instead of as revenues. Similarly, cash payments to policyholders are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Surrender charges are earned when a policyholder withdraws funds from the contract early or cancels the contract. Other income related to riders is earned when elected by the policyholder.

See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts as described under "Reinsurance".

Net Investment Income

Dividends and interest income are recorded in “Net investment income” and recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities are recognized in "Net investment income". Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in “Net investment income” based on the earliest call date of the investments in a manner that produces a constant effective yield.

FSRC and F&G Re's dividends and interest income are recorded in "Net investment income" in the consolidated financial statements and are recognized on an accrual basis. Amortization of premiums and accretion of discounts on investment in debt securities are reflected in "Net investment income" over the contractual terms of the investments in a manner that produces a constant effective yield.

For mortgage-backed and asset-backed securities, included in the fixed maturity available-for-sale (“AFS”) securities portfolios, the Company recognizes income using a constant effective yield based on anticipated cash flows and the estimated economic life of the securities. When actual prepayments differ significantly from originally anticipated prepayments, the effective yield is generally recalculated prospectively to reflect actual payments to date plus anticipated future payments. Any adjustments resulting from changes in effective yield are reflected in “Net investment income’’.

"Net investment income" is presented net of earned investment management fees.

Net Investment Gains (Losses)

Net investment gains (losses) include realized gains and losses from the sale of investments, unrealized gains and losses on equity securities at fair value, write-downs for other-than-temporary impairments (“OTTI”) of AFS investments, and realized and unrealized gains and losses on derivatives and embedded derivatives. FSRC and F&G Re's net investment gains (losses) include realized losses and gains from the sale of investments, changes in

F-14

the fair value of funds withheld receivables and realized and unrealized gains and losses on derivative investments. Realized gains and losses on the sale of investments are determined using the specific identification method on the trade date.

Insurance and Investment Product Fees and Other

Product fee revenue from IUL products and annuities is comprised of policy and contract fees charged for the cost of insurance, policy administration and rider fees. Fees are assessed on a monthly basis and recognized as revenue when earned. Product fee revenue also includes surrender charges which are collected and recognized as revenue when the policy is surrendered. Some of the product fee revenue is not level by policy year.  The unearned portion of the revenues are deferred and brought into income relative to the gross profits of the business.

Benefits and Other Changes in Policy Reserves

Benefit expenses for deferred annuity, FIA and IUL policies include index credits and interest credited to contractholder account balances and benefit claims in excess of contract account balances, net of reinsurance recoveries, are charged to expense in the period that they are earned by the policyholder based on their selected strategy. Interest crediting rates associated with funds invested in the general account of our insurance subsidiaries during 2017 through 2019 ranged from 0.5% to 6.0% for deferred annuities and FIA's, combined, and 3.0% to 4.8% for IUL's. Other changes in policy reserves include the change in the fair value of the FIA embedded derivative and the change in the reserve for secondary guarantee benefit payments.

Other changes in policy reserves also include the change in reserves for life insurance products. For traditional life and immediate annuities, policy benefit claims are charged to expense in the period that the claims are incurred, net of reinsurance recoveries.

See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts as described under "Future Policy Benefits" in Note 2.

Stock-Based Compensation

We expense the fair value of stock awards included in our incentive compensation plans. The Company issues stock options with three different types of vesting conditions. As of the date that there is a mutual understanding between the Company and the grantee of key terms of the awards, the fair value of stock options that vest based on service or non-market based performance conditions are determined using a Black-Scholes options valuation methodology. The Company uses a Monte Carlo simulation to determine the fair value of stock awards that vest based upon market conditions. The fair value of the awards is expensed over the performance or service period, which generally corresponds to the vesting period, and is recognized as an increase to “Additional paid-in capital” in “Shareholders’ equity”. We classify certain stock awards settled in cash as liabilities. For these awards, the fair value is classified as a liability on our Consolidated Balance Sheets, and the liability is marked-to-market through net income (loss) at the end of each reporting period. Stock-based compensation expense is reflected in “Acquisition and operating expenses, net of deferrals” on our Consolidated Statements of Operations.

Interest Expense

Interest expense on our debt is recognized as due and any associated premiums, discounts, and issuance costs are amortized (accreted) over the term of the related borrowing utilizing the straight line method. Interest expense also includes non-use fees on the revolving line of credit facility.

Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the average common shares outstanding. Diluted EPS is computed assuming the conversion or exercise of nonvested stock, stock options, warrants and performance share units outstanding during the year. The effect of a potential conversion of outstanding preferred shares to common shares is not considered in the diluted EPS calculation as the preferred shareholders do not yet have the right to convert. Stock options and warrants are excluded from the computation of diluted EPS, based on the application of the treasury stock method, if they are anti-dilutive.

Cash Equivalents

The Company considers money market funds and highly liquid debt instruments purchased with original maturities of three months or less to be cash equivalents. As of December 31, 2019 and December 31, 2018, the Company held cash equivalents of $38 and $84 respectively.

F-15

Investments

Investment Securities

The Company’s investments in fixed maturity securities have been designated as AFS and are carried at fair value with unrealized gains and losses included in “Accumulated other comprehensive income” (“AOCI”), net of associated intangible asset and unearned revenue ("UREV") “shadow adjustments” (discussed in "Note 7. Intangibles") and deferred income taxes. The Company's investments in equity securities are carried at fair value with unrealized gains and losses included in “Realized gains (losses)”. Prior to the adoption of ASU 2016-01, effective January 1, 2018, unrealized gains and losses on equity securities were included in AOCI.

Available-for-Sale Securities' Other-Than-Temporary Impairments

The Company regularly reviews AFS securities for declines in fair value that it determines to be other-than-temporary. Prior to the adoption of ASU 2016-01, for an equity security, if the Company did not have the ability and intent to hold the security for a sufficient and reasonable period of time to allow for a recovery in value, it concluded that an OTTI had occurred and the amortized cost of the security was written down to the current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. Following the adoption of ASU 2016-01, equity securities are no longer reviewed for OTTI. When assessing its ability and intent to hold a security to recovery, the Company considers, among other things, the severity and duration of the decline in fair value of the security as well as the cause of the decline, business prospects and the overall financial condition of the issuer. When evaluating redeemable preferred stocks for OTTI the Company applies the accounting policy described above for fixed maturity securities (including an anticipated recovery period), provided there has been no evidence of a deterioration in credit of the issuer.

For its fixed maturity AFS securities, the Company generally considers the following in determining whether its unrealized losses are other-than-temporary:

• The estimated period until recovery;

• The extent and the duration of the decline;

• The reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening);

• The financial condition of and near-term prospects of the issuer (including issuer’s current credit rating and the probability of full recovery of principal based upon the issuer’s financial strength);

• Current delinquencies and nonperforming assets of underlying collateral;

• Expected future default rates;

• Collateral value by vintage, geographic region, industry concentration or property type;

• Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and

• Contractual and regulatory cash obligations and the issuer's plans to meet such obligations.

The Company recognizes OTTI on fixed maturity securities in an unrealized loss position when one of the following circumstances exists:

• The Company does not expect full recovery of its amortized cost based on the present value of cash flows expected to be collected;

• The Company intends to sell a security; or

• It is more likely than not that the Company will be required to sell a security prior to recovery.

If the Company intends to sell a fixed maturity AFS security or it is more likely than not the Company will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, the Company will conclude that an OTTI has occurred and the amortized cost is written down to current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. If the Company does not intend to sell a fixed maturity security or it is more likely than not the Company will not be required to sell a fixed maturity security before recovery of its amortized cost basis and the present value of the cash flows expected to be collected is less than the amortized cost of the security (referred to as the credit loss), an OTTI has occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations, as this amount is deemed the credit loss portion of the OTTI. The remainder of the

F-16

decline to fair value is recorded in AOCI as an unrealized loss on AFS securities, as this amount is considered a non-credit impairment.

When assessing the Company’s intent to sell a fixed maturity security or if it is more likely than not the Company will be required to sell a fixed maturity security before recovery of its cost basis, the Company evaluates facts and circumstances at the individual security level based on facts and circumstances relevant to that security. Management also consider decisions to reposition the Company’s security portfolio, sale of securities to meet cash flow needs and sales of securities to capitalize on favorable pricing and tax planning strategies.

When evaluating mortgage-backed securities and asset-backed securities, the Company considers a number of pool-specific factors as well as market level factors when determining whether or not the impairment on the security is temporary or other-than-temporary. The most important factor is the performance of the underlying collateral in the security and the trends of that performance. The Company uses this information about the collateral to forecast the timing and rate of mortgage loan defaults, including making projections for loans that are already delinquent and for those loans that are currently performing but may become delinquent in the future. Other factors used in this analysis include type of underlying collateral (e.g., prime, Alternative A-paper (“Alt-A”), or subprime), geographic distribution of underlying loans and timing of liquidations by state. Once default rates and timing assumptions are determined, the Company then makes assumptions regarding the severity of a default if it were to occur. Factors that impact the severity assumption include expectations for future home price appreciation or depreciation, loan size, first lien versus second lien, existence of loan level private mortgage insurance, type of occupancy and geographic distribution of loans. Once default and severity assumptions are determined for the security in question, cash flows for the underlying collateral are projected, including expected defaults and prepayments. These cash flows on the collateral are then translated to cash flows on the Company’s tranche based on the cash flow waterfall of the entire capital security structure. If this analysis indicates the entire principal on a particular security will not be returned, the security is reviewed for OTTI by comparing the present value of expected future cash flows to amortized cost. To the extent that the security has already been impaired or was purchased at a discount, such that the amortized cost of the security is less than or equal to the present value of cash flows expected to be collected, no impairment is required. The Company also considers the ability of monoline insurers to meet their contractual guarantees on wrapped mortgage-backed securities. Otherwise, if the amortized cost of the security is greater than the present value of the cash flows expected to be collected, then an OTTI is recognized.

The Company includes the total OTTI recognized in "Net investment gains (losses)" in the Consolidated Statements of Operations, with an offset for the amount of non-credit impairments recognized in AOCI. See "Note 4. Investments" for additional disclosures related to OTTI, including the amount of OTTI recognized in AOCI.

Mortgage Loans on Real Estate

The Company’s investment in mortgage loans consists of commercial and residential mortgage loans on real estate, which are reported at amortized cost, less impairment write-downs and allowance for losses. If a mortgage loan is determined to be impaired (i.e., when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement or the loan is modified in a troubled debt restructuring), the carrying value of the mortgage loan is reduced to the lower of either the present value of expected cash flows from the loan, discounted at the loan’s original purchase yield, or fair value of the collateral. For those mortgages that are determined to require foreclosure, the carrying value is reduced to the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. The carrying value of the impaired loans is reduced by establishing an allowance with the offset recorded in "Net investment gains (losses)" in the Consolidated Statements of Operations.

Commercial mortgage loans are continuously monitored by reviewing appraisals, operating statements, rent revenues, annual inspection reports, loan specific credit quality, property characteristics, market trends and other factors.

Commercial mortgage loans are rated for the purpose of quantifying the level of risk. Loans are placed on a watch list when the debt service coverage ("DSC") ratio falls below and the loan-to-value ("LTV") ratios exceeds certain thresholds. Loans on the watchlist are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. The Company defines delinquent mortgage loans as 30 days past due, consistent with industry practice.

Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines nonperforming residential mortgage loans as those that are 90 or more days past due

F-17

and/or in nonaccrual status which is assessed monthly. Generally, nonperforming residential mortgage loans have a higher risk of experiencing a credit loss.

Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan.

We establish mortgage loan valuation allowances both on a loan specific basis for those loans considered impaired where a property specific or market specific risk has been identified that could likely result in a future loss, as well as for pools of loans with similar risk characteristics where a property specific or market specific risk has not been identified, but for which we expect to incur a loss. Accordingly, a valuation allowance is provided to absorb these estimated probable credit losses. As of December 31, 2019 and 2018, the Company did not identify any specific loans that were impaired.

The determination of the amount of valuation allowances is based upon our periodic evaluation and assessment of inherent risks associated with our loan portfolios. Such evaluations and assessments are based upon several factors, including our experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. We evaluate and monitor LTV ratios and DSC ratios of our loans as indicators of potential risk of default in establishing our valuation allowance.

Derivative Financial Instruments

The Company hedges certain portions of its exposure to product related equity market risk by entering into derivative transactions (primarily call options). All such derivative instruments are recognized as either assets or liabilities in the accompanying Consolidated Balance Sheets at fair value. The changes in fair value are reported within “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations.

The Company purchases financial instruments and issues products that may contain embedded derivative instruments. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract for measurement purposes. The embedded derivative is carried at fair value, which is determined through a combination of market observable inputs such as market value of option and interest swap rates and unobservable inputs such as the mortality multiplier, surrender and withdrawal rates and non-performance spread. The changes in fair value are reported within “Benefits and other changes in policy reserves” in the accompanying Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments".

Reinsurance Related Embedded Derivatives

As discussed in “Note 13. Reinsurance”, FGL Insurance entered into a reinsurance agreement with Kubera effective December 31, 2018, to cede certain MYGA and deferred annuity statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. Funds withheld arrangements allow the Company to retain legal ownership of assets backing reinsurance arrangements until they are earned by the reinsurer while passing credit risk associated with the assets in the funds withheld account to the reinsurer. These arrangements create embedded derivatives considered total return swaps with contractual returns that are attributable to the assets and liabilities associated with the reinsurance arrangement. The fair value of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, are passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. These total return swaps are not clearly and closely related to the underlying reinsurance contract and thus require bifurcation. The reinsurance related embedded derivative is reported in “Other assets” if in a net gain position, or “Other liabilities”, if in a net loss position on the Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains (losses)” on the Consolidated Statements of Operations.

FGL Insurance has a funds withheld coinsurance arrangement with FSRC, which creates an embedded derivative similar to the embedded derivative described above related to the Kubera reinsurance agreement. Due to the acquisition of FSRC, the reinsurance related embedded derivative is eliminated in consolidation in the periods after December 1, 2017.

F-18

Preferred Equity Remarketing Reimbursement Embedded Derivative Liability

On November 30, 2017 the Company issued 275,000 Series A cumulative preferred shares and 100,000 Series B cumulative preferred shares (together the “Preferred Shares”). The Preferred Shares do not have a maturity date and are non-callable for the first five years. From and after November 30, 2022, the original holders of the Preferred Shares may request and thus require, the Company (subject to customary blackout provisions) to remarket the Preferred Shares on their existing terms. If the remarketing is successful and the original holders elect to sell their preferred shares at the remarketed price and proceeds from such sale are less than the outstanding balance of the applicable shares (including dividends paid in kind and accumulated but unpaid dividends), the Company will be required to reimburse the sellers, up to a maximum of 10% of the par value of the originally issued preferred shares (including dividends paid in kind and accumulated but unpaid dividends) with such amount payable either in cash, ordinary shares, or any combination thereof, at the Company's option (the “Reimbursement Feature”). The Reimbursement Feature represents an embedded derivative that is not clearly and closely related to the preferred stock host and must be bifurcated. The Reimbursement Feature liability is reported at fair value within “Other liabilities” in the accompanying Consolidated Balance Sheets using a Black Derman Toy model incorporating among other things the paid in kind dividend coupon rate and the Company’s call option.

Funds withheld Receivable

FSRC and F&G Re have entered into various reinsurance agreements on a funds withheld basis, meaning that the funds are withheld by the ceding company from the coinsurance premium owed to FSRC and F&G Re as collateral for FSRC's and F&G Re's payment obligations. Accordingly, the collateral assets remain under the ultimate ownership of the ceding company. FSRC and F&G Re manage the assets supporting the reserves in accordance with the internal investments policies of the ceding companies and applicable law.

Limited Partnership Investments

Our investments in limited partnerships are included in other invested assets on our Consolidated Balance Sheets. We account for our investments in limited partnerships using the equity method and use net asset value ("NAV") as a practical expedient to determine the carrying value. Income from the limited partnership is included within "Net investment income" in the accompanying Consolidated Statements of Operations. Recognition of income is delayed due to the availability of the related financial statements, which are obtained from the partnership’s general partner generally on a one to three-month delay. Management meets quarterly with the general partner to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter valuation and investment income. In addition, the impact of audit adjustments related to completion of calendar-year financial statement audits of the limited partnership are typically received during the second quarter of each calendar year. Accordingly, our investment income from the limited partnership investment for any calendar-year period may not include the complete impact of the change in the underlying net assets for the partnership for that calendar-year period.

Intangible Assets

The Company’s intangible assets include an intangible asset reflecting the value of insurance and reinsurance contracts acquired (hereafter referred to as “the value of business acquired” or (“VOBA”), deferred acquisition costs (“DAC”), deferred sales inducements (“DSI”), and trademarks and state licenses.

VOBA is an intangible asset that reflects the amount recorded as insurance contract liabilities less the estimated fair value of in-force contracts in a life insurance company acquisition. It represents the portion of the purchase price allocated to the value of the rights to receive future cash flows from the business in force at the acquisition date. DAC consists principally of commissions that are related directly to the successful sale of new or recoverable insurance contracts, which may be deferred to the extent recoverable. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. DSI represents up front bonus credits and vesting bonuses to policyholder account values which may be deferred to the extent recoverable.

The methodology for determining the amortization of DAC, DSI and VOBA varies by product type. For all insurance contracts accounted for under long-duration contract deposit accounting, amortization is based on assumptions consistent with those used in the development of the underlying contract liabilities adjusted for emerging experience and expected trends. Amortization is reported within “Amortization of intangibles” in the accompanying Consolidated Statements of Operations.

For all of the insurance intangibles (DAC, DSI and VOBA), the balances are generally amortized over the lives of the policies in relation to the expected emergence of estimated gross profits (“EGPs”) from investment

F-19

income, surrender charges and other product fees, less policy benefits, maintenance expenses, mortality net of reinsurance ceded, and expense margins. Recognized gains (losses) on investments and changes in fair value of the funds withheld coinsurance embedded derivative are included in actual gross profits in the period realized as described further below.

Changes in assumptions, including the Company’s earned rate, (i.e., long term assumptions of the Company’s expected earnings on related investments), budgeted option costs (i.e., the expected cost to purchase call options in future periods to fund the equity indexed linked feature) and surrender rates can have a significant impact on VOBA, DAC and DSI balances and amortization rates. Due to the relative size and sensitivity to minor changes in underlying assumptions of those intangible balances, the Company performs quarterly and annual analysis of the VOBA, DAC and DSI balances for recoverability to ensure that the unamortized portion does not exceed the expected recoverable amounts. At each evaluation date, actual historical gross profits are reflected with the impact on the intangibles reported as “unlocking” as a component of amortization expense, and estimated future gross profits and related assumptions are evaluated for continued reasonableness. Any adjustment in estimated future gross profits requires that the amortization rate be revised (“unlocking”) retroactively to the date of the policy or contract issuance. The cumulative unlocking adjustment is recognized as a component of current period amortization.

The carrying amounts of VOBA, DAC and DSI are adjusted for the effects of unrealized gains and losses on fixed maturity securities classified as AFS. For investment-type products, the VOBA, DAC and DSI assets are adjusted for the impact of unrealized gains (losses) on investments as if these gains (losses) had been realized, with corresponding credits or charges included in AOCI.

Amortization expense of VOBA, DAC and DSI reflects an assumption for an expected level of credit-related investment losses. When actual credit-related investment losses are realized, the Company performs a retrospective unlocking of amortization for those intangibles as actual margins vary from expected margins. This unlocking is reflected in the accompanying Consolidated Statements of Operations.

Reinsurance

The Company’s insurance subsidiaries enter into reinsurance agreements with other companies in the normal course of business. The assets, liabilities, premiums and benefits of certain reinsurance contracts are presented on a net basis in the accompanying Consolidated Balance Sheets and Consolidated Statements of Operations, respectively, when there is a right of offset explicit in the reinsurance agreement. All other reinsurance agreements are reported on a gross basis in the Company’s Consolidated Balance Sheets as an asset for amounts recoverable from reinsurers or as a component of other liabilities for amounts, such as premiums, owed to the reinsurers, with the exception of amounts for which the right of offset also exists. Premiums and benefits are reported net of insurance ceded. The effects of certain reinsurance agreements are not accounted for as reinsurance as they do not satisfy the risk transfer requirements for GAAP. See "Note 13. Reinsurance" for details.

Income Taxes

The Company’s life insurance subsidiaries file a consolidated life insurance income tax return. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company assesses the recoverability of its deferred tax assets in each reporting period under the guidance outlined within Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes”. The guidance requires an assessment of both positive and negative evidence in determining the realizability of deferred tax assets. A valuation allowance is required to reduce the Company’s deferred tax asset to an amount that is more likely than not to be realized. In determining the net deferred tax asset and valuation allowance, management is required to make judgments and estimates related to projections of future profitability.  These judgments include the following: the timing and extent of the utilization of net operating loss carry-forwards, the reversals of temporary differences, and tax planning strategies.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company has the ability and intent to recover in a tax-free manner assets (or liabilities) with book/tax basis differences for which no deferred taxes have been provided, in accordance with ASC 740.

The Company applies the accounting guidance for uncertain tax positions which prescribes a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. The

F-20

guidance also provides information on de-recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Accrued interest expense and penalties related to uncertain tax positions are recorded in “Income tax (expense) benefit” in the Company’s Consolidated Statements of Operations. The Company had no unrecognized tax benefits related to uncertain tax positions as of December 31, 2019.

For discussion on the impact of tax reform and the 338(h)(10) election, see “Note 11. Income Taxes”.

Contractholder Funds

The liabilities for contractholder funds for deferred annuities, IUL and UL policies consist of contract account balances that accrue to the benefit of the contractholders. The liabilities for FIA policies consist of the value of the host contract plus the fair value of the embedded derivative. The embedded derivative is carried at fair value in “Contractholder funds” in the accompanying Consolidated Balance Sheets with changes in fair value reported in "Benefits and other changes in policy reserves" in the accompanying Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments". Liabilities for immediate annuities with life contingencies are recorded at the present value of future benefits.

Liabilities for the secondary guarantees on UL-type products or Investment-type contracts are calculated by multiplying the benefit ratio by the cumulative assessments recorded from contract inception through the balance sheet date less the cumulative secondary guarantee benefit payments plus interest. The benefit ratio is the ratio of the present value of future secondary guarantees to the present value of the assessments used to provide the secondary guarantees using the same assumptions as the Company uses for its intangible assets. If experience or assumption changes result in a new benefit ratio, the reserves are adjusted to reflect the changes in a manner similar to the unlocking of DAC, DSI and VOBA. The accounting for secondary guarantee benefits impact EGPs used to calculate amortization of DAC, DSI and VOBA.

Future Policy Benefits

The liabilities for future policy benefits and claim reserves for traditional life policies and life contingent pay-out annuity policies are computed using assumptions for investment yields, mortality and withdrawals based on generally accepted actuarial methods and assumptions at the time of contract issue. Investment yield assumption for traditional direct life reserves for all contracts is 5.7%. The investment yield assumptions for life contingent pay-out annuities range from 0.1% to 5.5%.

FSRC and F&G Re elected to apply the fair value option to account for its funds withheld receivables, non-funds withheld assets and insurance reserves related to its assumed third party reinsurance at the inception date of the reinsurance transactions. FSRC and F&G Re measure fair value of the funds withheld receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. The non-funds withheld assets held by FSRC, backing the insurance reserves, are measured at fair value.

FSRC and F&G Re use a discounted cash flows approach to measure the fair value of the insurance reserves. The cash flows associated with future policy premiums and benefits are generated using best estimate assumptions (plus a risk margin, where applicable). Risk margins are typically applied to non-observable, non-hedgeable market inputs such as mortality, morbidity, lapse, discount rate for non-performance risk, discount rate for risk margin, surrenders, etc. Mortality relates to the occurrence of death and morbidity relates to health risks. Mortality and morbidity assumptions are based upon the experience of the cedant as well as past and emerging industry experience, when available. Mortality and morbidity assumptions may be different by sex, underwriting class and policy type. Assumptions are also made for future mortality and morbidity improvements.

Policies are terminated through surrenders and maturities, where surrenders represent the voluntary terminations of policies by policyholders and maturities are determined by policy contract terms. Surrender assumptions are based upon cedant experience adjusted for expected future conditions. FSRC and F&G Re use market value weighting in the development of the discount rate. FSRC and F&G Re discount the liability cash flows using the market yields on the underlying assets backing the liabilities less a risk margin to reflect uncertainty and an adjustment to reflect the credit risk of FSRC and F&G Re, respectively. The Company adopted ASU 2016-01 effective January 1, 2018, which requires FSRC and F&G Re to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific

F-21

credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. See "Note 13. Reinsurance" for further information.

Federal Home Loan Bank of Atlanta Agreements

Contractholder funds include funds related to funding agreements that have been issued by the Company to the Federal Home Loan Bank of Atlanta (“FHLB”) as a funding medium for single premium funding agreements. The funding agreements (i.e., immediate annuity contracts without life contingencies) provide a guaranteed stream of payments or provide for a bullet payment with renewal provisions. Single premiums were received at the initiation of the funding agreements and were in the form of advances from the FHLB. Payments under the funding agreements extend through 2022. The reserves for the funding agreements totaled $1,096 and $878 at December 31, 2019 and December 31, 2018, respectively, and are included in “Contractholder funds” in the accompanying Consolidated Balance Sheets.

In accordance with the agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to settle the general obligations of the Company. The collateral investments had a fair value of $1,521 and $1,414 at December 31, 2019 and December 31, 2018, respectively.

Commitments and Contingencies

Contingencies arising from environmental remediation costs, regulatory judgments, claims, assessments, guarantees, litigation, recourse reserves, fines, penalties and other sources are recorded when deemed probable and reasonably estimable. The Company also has unfunded investment commitments based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. See "Note 12. Commitments and Contingencies" for further information.

Business Combinations

In accordance with ASC Topic 805, Business Combinations (“ASC 805”), the Company accounts for acquisitions by applying the acquisition method of accounting. The acquisition method of accounting requires, among other things, that the assets acquired and liabilities assumed in a business combination be measured at their fair values as of the closing date of the acquisition. The fair values assigned to the assets acquired and liabilities assumed are based on valuations using market participant assumptions and are preliminary pending the completion of the valuation analysis of selected assets and liabilities. During the measurement period (which is not to exceed one year from the acquisition date), the Company is required to retrospectively adjust the provisional assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets or liabilities as of that date. As of December 31, 2018, the measurement period is closed with respect to the Business Combination.

Reclassifications and Retrospective Adjustments

The Company identified an immaterial error, as described below, during the period ended September 30, 2018. Management has reviewed the impact of this error on prior periods in accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” (SAB 99) and determined this was not material to the prior periods impacted.

Effective December 1, 2017, the Company measured the identifiable assets acquired and liabilities assumed from the Business Combination at acquisition-date fair value in accordance with ASC 805. This required significant model changes for the re-bifurcation of the host contract and embedded derivative components of the fixed income annuity ("FIA") liability. During the quarter ended September 30, 2018, the Company identified an immaterial error resulting from the model code used in the calculation of the FIA embedded derivative liability. In issuing the September 30, 2018 Form 10-Q, the Company recorded an immaterial correction to the Consolidated Balance Sheet as of December 31, 2017 by decreasing the contractholder funds liability by $17 as well as a resulting decrease to the intangibles and deferred tax assets of $3 and $3, respectively. In addition, the Company recorded immaterial corrections to the Consolidated Statement of Operations for the one month ended December 31, 2017 by decreasing the benefits and other changes in policy reserves by $17, as well as increasing the amortization of intangibles by $3, and income tax expense by $3.

F-22

Certain prior year amounts have been reclassified or combined to conform to the current year presentation. These reclassifications and combinations had no effect on previously reported results of operations.

Adoption of New Accounting Pronouncements

Revenue from Contracts with Customers

In May 2014, the Financial Accounting Standards Board (FASB) issued new guidance on revenue recognition (ASU 2014-09, Revenue from Contracts with Customers (Topic 606)), effective for fiscal years beginning after December 15, 2016 and interim periods within those years. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606) - Deferral of the Effective Date, which deferred the effective date of ASU 2014-09 by one year. The FASB also issued the following ASUs which clarify the guidance in ASU 2014-09:

•ASU 2016-08 - Revenue from Contracts with Customers (Topic 606) - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) issued in March 2016

•ASU 2016-10 - Revenue from Contracts with Customers (Topic 606) - Identifying Performance Obligations and Licensing issued in April 2016

•ASU 2016-11 - Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815) - Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting issued in May 2016

•ASU 2016-12 - Revenue from Contracts with Customers (Topic 606) - Narrow-Scope Improvements and Practical Expedients issued in May 2016

The guidance in ASU 2014-09 and the related ASUs supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance unless the contracts are within the scope of other standards (for example, financial instruments, insurance contracts or lease contracts). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance establishes a five-step process to achieve this core principle.

The Company adopted these standards effective January 1, 2018. The adoption of these standards has had no impact on the Company's consolidated financial statements as the Company’s primary sources of revenue, insurance contracts and financial instruments, are excluded from the scope of these standards.

Statement of Cash Flows Classification of Certain Cash Receipts and Cash Payments

In August 2016, the FASB issued new guidance (ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments), effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years. Notable amendments in this update change the classification of certain cash receipts and cash payments in the Statement of Cash Flows in the following ways:

• cash payments for debt prepayment or debt extinguishment costs should be classified as cash outflows for financing activities

• the settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing should be classified as follows: the portion of the cash payment attributable to the accreted interest related to the debt discount as cash outflows for operating activities, and the portion of the cash payment attributable to the principal as cash outflows for financing activities

• a reporting entity must make an accounting policy election to classify distributions received from equity method investees using either:

◦ the cumulative earnings approach, which considers distributions received as returns on the investment and are classified as cash inflows from operating activities (with an exception when cumulative distributions received less distributions received in prior periods that were classified as returns of investment exceeds cumulative equity in earnings, in which case the current period distribution up to this excess amount will be considered a return of investment and classified as cash inflows from investing activities); or

◦ the nature of the distribution approach, which classifies distributions received based on the nature of the activity or activities of the investee that generated the distribution (would be considered

F-23

either a return on investment and classified as cash inflows from operating activities or a return of investment and classified as cash inflows from investing activities)

• in the absence of specific GAAP guidance, an entity should classify cash receipts and payments that have aspects of more than one class of cash flows by determining and appropriately classifying each separately identifiable source or use within the cash receipts and cash payments on the basis of the underlying cash flows. If cash receipts and payments have aspects of more than one class of cash flows and cannot be separated by source or use, the activity that is likely to be the predominant source or use of cash flows for the item will determine the classification.

The amendments in this ASU were adopted by the Company effective January 1, 2018 as required, using a retrospective transition method to each period presented (except where impracticable to apply retrospectively; those specific amendments will be applied prospectively as of the earliest date practicable). The Company has elected to use the nature of distribution approach to classify distributions received from equity method investees. The adoption of this standard had an immaterial impact on the Company's Consolidated Statements of Cash Flows.

Amendments to Recognition and Measurement of Financial Assets and Financial Liabilities

In March 2018, February 2018 and January 2016, the FASB issued amended guidance on the measurement of financial assets and financial liabilities (ASU 2018-04, Investments-Debt Securities (Topic 320) and Regulated Operations (Topic 980) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 117 and SEC Release No. 33-9273; ASU 2018-03, Technical Corrections and Improvements to Financial Instruments-Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities; and ASU 2016-01, Financial Instruments- Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities, respectively), effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Notable amendments in these updates:

• require all equity securities (other than equity investments accounted for under the equity method of accounting or requiring the consolidation of the investee) to be measured at fair value with changes in fair value recognized through net income. Equity securities that do not have readily determinable fair values may be measured at cost minus impairment

• require qualitative assessment for impairment of equity investments without readily determinable fair values at each reporting period and, if the qualitative assessment indicates that impairment exists, to measure the investment at fair value

• eliminate the requirement to disclose the methods and significant assumptions used to estimate fair value (which is currently required to be disclosed, for financial instruments measured at amortized cost on the balance sheet)

• require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments

The amendments in these ASUs were applied via a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption, and the amendments related to equity securities without readily determinable fair values were applied prospectively to equity investments that exist as of the date of adoption. The Company adopted ASUs 2016-01, 2018-03, and 2018-04 effective January 1, 2018, with a cumulative-effect adjustment to decrease retained earnings and increase AOCI by $4.

Premium Amortization on Purchased Callable Debt Securities

In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date. The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update were to be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its consolidated financial statements.

F-24

Amendments to Lease Accounting

In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842)), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update:

• require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less

• create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance

• not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02

• provide additional guidance on separating the lease components from the nonlease components of a contract

• require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases

• include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements

The amendments were required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its consolidated financial statements.

Derivatives and Hedging

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815), Targeted Improvements to the Accounting for Hedging Activities, effective for fiscal years beginning after December 15, 2018 including interim periods within those fiscal years. Under this update:

• removes previous limitations on designation of hedged risk in certain cash flow and fair value hedging relationships

• permits different measurements when accounting for hedged items in fair value hedges of interest rate risk

• the entity must present the hedging instrument earnings and hedged item earnings in the same income statement line

• in addition to exclusion of option premiums and forward points, also permits exclusion of the cross-currency basis spread portion of the change in fair value of a currency swap in assessment of hedge effectiveness

The Company adopted this standard effective January 1, 2019, as required, and it did not impact its consolidated financial statements.

Future Adoption of Accounting Pronouncements

New Credit Loss Standard

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Since its release, certain targeted improvements and transition relief amendments have been made to ASU 2016-13 and have been published in ASU 2018-19, ASU 2019-04, ASU 2019-05 and ASU 2019-11. Collectively, these ASUs will change the accounting for impairment of most financial assets and certain other instruments in the following ways:

• financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset. The measurement of expected credit losses is based on relevant information about past

F-25

events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount.

• credit losses relating to AFS fixed maturity securities generally will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses for AFS fixed maturity securities will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value

• the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount

• disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due

The Company has identified the material asset classes (e.g. available for sale securities, mortgage loans, reinsurance recoverable, other miscellaneous assets) affected by the new guidance. We will adopt this standard on January 1, 2020 and expect the total adoption date impact to be between $29 and $39 with $20 to $24 relating to our reinsurance recoverable, $7 to $14 related to mortgages and $1 related to other miscellaneous assets. The adoption of this guidance will significantly impact the operation of our existing processes around assessing the aforementioned asset classes for impairment.

Test for Goodwill Impairment

In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update:

• the subsequent measurement of goodwill is simplified by the elimination of step 2 from the goodwill impairment test, which required an entity to determine the implied fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination

• the entity should perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, not to exceed the total amount of goodwill allocated to that reporting unit

• the entity is no longer required to perform a qualitative assessment for any reporting unit with a zero or negative carrying amount

The Company will adopt this standard on January 1, 2020, and does not expect this new accounting standard to have a significant impact on its consolidated financial statements.

Long-Duration Contracts

In August 2018, the FASB issued ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts, effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Under this update:

• assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations

• the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income

F-26

• market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income

• deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts

• deferred acquisition costs must be written off for unexpected contract terminations

• disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed

The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements.

Fair Value Measurement

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update:

• for investments in certain entities that calculate net asset value, investors are required to disclose the timing of liquidation of an investee's assets and the date when restrictions from redemption might lapse if the investee has communicated timing to the entity or announced timing publicly

• entities should use the measurement uncertainty disclosure to communicate information about the uncertainty in measurement as of the reporting date

• entities must disclose changes in unrealized gains and losses included in other comprehensive income for recurring Level 3 fair value measurements, as well as the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, or other quantitative information in lieu of weighted average if the entity determines such information would be more reasonable and rational

• entities are no longer required to disclose the amounts and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements

The Company will adopt this standard on January 1, 2020, and does not expect this new accounting standard to have a significant impact on its consolidated financial statements.

Consolidation

In October 2018, the FASB issued ASU 2018-17, Consolidation (Topic 810), Targeted Improvements to Related Party Guidance for Variable Interest Entities, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update, entities must consider indirect interests held through related parties under common control on a proportional basis to determine whether a decision-making fee is a variable interest.

The Company will adopt this standard on January 1, 2020, and does not expect this new accounting standard to have a significant impact on its consolidated financial statements.

(3) Significant Risks and Uncertainties

Best Interest Regulation    

In March 2018, the United States Fifth Circuit Court of Appeals formally vacated the U. S. Department Labor “Fiduciary Rule” which would have imposed fiduciary duties upon insurance agents selling Individual Retirement Account (IRA) annuities and would have potentially had a material impact on the Company, its products,

F-27

distribution, and business model. Since then, in June 2019, the U.S. Securities and Exchange Commission (SEC) adopted Regulation Best Interest imposing new sales practice standards on securities brokers, which does not directly impact the Company or its distributors, but gives impetus for the National Association of Insurance Commissioners (NAIC) and individual states to consider best interest proposals for insurance sales. The NAIC adopted an amended Suitability in Annuity Transactions Model Regulation in February 2020 incorporating a requirement that agents act in the best interest of consumers without putting their own financial interests or insurer’s interests ahead of consumer interests. It is expected individual states may soon begin to consider and adopt the NAIC model regulation. FGL NY Insurance already modified certain new business processes in response to the New York Department of Financial Services (NYDFS) best interest rule despite relatively low sales in New York. Management is following a legal challenge to nullify the NYDFS rule and will continue to monitor action by other state or federal agencies to implement sales practice rules affecting insurance agents selling fixed insurance or annuity products.

Use of Estimates and Assumptions

The preparation of the Company's consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used.

The Company periodically, and at least annually, reviews the assumptions associated with reserves for policy benefits, product guarantees, and amortization of intangibles. As a result of the assumption review process that occurred in the year ended December 31, 2019, the surrender rates, guaranteed minimum withdrawal benefit (“GMWB”) utilization, IUL premium persistency, maintenance expenses, and earned rate assumptions were updated to reflect the Company's current and expected future experience. These changes in assumptions resulted in a net decrease in future expected margins and a corresponding increase in amortization expense reported as a component of “unlocking” for the period ended December 31, 2019. This resulted in a decrease to intangible assets of $3.  These assumptions are used in the SOP 03-1 liability for GMWB benefits and resulted in a decrease in liability of $13 for the period ended December 31, 2019.  The surrender rate assumptions are also used in the reserve calculation and resulted in an increase in embedded derivative liability of $1 for the period ended December 31, 2019. The change in assumptions as of December 31, 2018 resulted in a net increase in future expected margins and a corresponding decrease in amortization expense reported as a component of “unlocking”. This resulted in a decrease to intangible assets of $2.  These assumptions are also used in the reserve calculation and resulted in a decrease of $5 in the year ended December 31, 2018.

As a result of the assumption review process at FSRC that occurred in the year ended December 31, 2019, the premium rate, claim factor and IBNR assumptions were updated. This resulted in an increase to the future policy benefits of $10. F&G Re periodically, and at least annually, reviews the assumptions associated with reserves for future policy benefits. As a result of the assumption review process that occurred in the year ended December 31, 2019, the duration discount weighting and model demographics assumptions were updated to reflect the Company's current and expected future experience. This resulted in a decrease to future policy benefits of $14.

Concentrations of Financial Instruments

As of December 31, 2019 and December 31, 2018, the Company’s most significant investment in one industry, excluding United States ("U.S.") Government securities, was its investment securities in the Banking industry with a fair value of $2,414 or 9% and $2,491 or 10%, respectively, of the invested assets portfolio and an amortized cost of $2,325 and $2,691, respectively. As of December 31, 2019, the Company’s holdings in this industry include investments in 98 different issuers with the top ten investments accounting for 39% of the total holdings in this industry. As of December 31, 2019, the Company had no investments in issuers that exceeded 10% of shareholders' equity. As of December 31, 2018, the Company had sixteen investments in issuers that exceeded 10% of shareholders' equity, with a total fair value of $1,634 or 7% of the invested assets portfolio: JP Morgan Chase & Co, Metropolitan Transportation Authority (NY), AT&T Inc, HSBC Holdings, Wells Fargo & Company, General Motors Co, Nationwide Mutual Insurance Company, Goldman Sachs Group Inc, United Mexican States, Energy Transfer Partners, Prudential Financial Inc, Citigroup Inc, HP Enterprise Co, Viacom Inc, Kinder Morgan Energy Partners, and Fuel Trust. The Company's largest concentration in any single issuer as of December 31, 2019 and December 31, 2018 was HSBC Holdings with a total fair value of $132 or 1%, and JP Morgan Chase & Co, with a total fair value of $115 or 1% of the invested assets portfolio, respectively.

F-28

Concentrations of Financial and Capital Markets Risk

The Company is exposed to financial and capital markets risk, including changes in interest rates and credit spreads which can have an adverse effect on the Company’s results of operations, financial condition and liquidity. The Company’s exposure to such financial and capital markets risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will increase the net unrealized loss position of the Company’s investment portfolio and, if long-term interest rates rise dramatically within a six to twelve month time period, certain of the Company’s products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders surrender their contracts in a rising interest rate environment, requiring the Company to liquidate assets in an unrealized loss position. The Company attempts to mitigate the risk, including changes in interest rates by investing in less rate-sensitive investments, including senior tranches of collateralized loan obligations, non-agency residential mortgage-backed securities, and various types of asset backed securities. Management believes this risk is also mitigated to some extent by surrender charge protection provided by the Company’s products. The Company expects to continue to face these challenges and uncertainties that could adversely affect its results of operations and financial condition.

Concentration of Reinsurance Risk

The Company has a significant concentration of reinsurance risk with third party reinsurers, Wilton Reassurance Company (“Wilton Re”) and Kubera Insurance (SAC) Ltd. ("Kubera") that could have a material impact on the Company’s financial position in the event that either Wilton Re or Kubera fail to perform their obligations under the various reinsurance treaties. Wilton Re is a wholly-owned subsidiary of Canada Pension Plan Investment Board ("CPPIB"). CPPIB has an AAA issuer credit rating from Standard & Poor's Ratings Services ("S&P") as of December 31, 2019. Kubera is not rated, however, management has attempted to mitigate the risk of non-performance through the funds withheld arrangement. As of December 31, 2019, the net amount recoverable from Wilton Re was $1,496 and the net amount recoverable from Kubera was $842. The Company monitors both the financial condition of individual reinsurers and risk concentration arising from similar activities and economic characteristics of reinsurers to attempt to reduce the risk of default by such reinsurers. The Company believes that all amounts due from Wilton Re and Kubera for periodic treaty settlements are collectible as of December 31, 2019.

On March 6, 2019, Scottish Re (U.S.), Inc. (“SRUS”), a Delaware domestic life and health reinsurer of FGL Insurance, was ordered into receivership for purposes of rehabilitation. As of December 31, 2019, the net amount recoverable from SRUS was $47. The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business.

On July 9, 2019, Pavonia Life Insurance Company of Michigan ("Pavonia"), a Michigan domiciled life, accident, and health insurance company, was placed into rehabilitation.  While the court order indicated that Pavonia had a stable financial condition and lack of non-insurance affiliated investments, the Director of the Michigan Department of Insurance and Financial Services ("MDIFS") has concerns relating to Pavonia's parent company. To insulate Pavonia from its parent until a pending acquisition transaction could be consummated, MDIFS placed Pavonia under supervision and rehabilitation. As of December 31, 2019, the net amount recoverable from Pavonia was $85.  The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business.

F-29

(4) Investments

The Company’s fixed maturity securities investments have been designated as available-for-sale and are carried at fair value with unrealized gains and losses included in AOCI, net of associated adjustments for DAC, VOBA, DSI, UREV, and deferred income taxes. The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income. The Company’s consolidated investments at December 31, 2019 and December 31, 2018 are summarized as follows:

         

	December 31, 2019
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	5,720	$	51	$	(77	)	$	5,694	$	5,694
Commercial mortgage-backed securities	2,788		140		(6		)	2,922		2,922
Corporates	11,051		618		(72		)	11,597		11,597
Hybrids	983		48		(4		)	1,027		1,027
Municipals	1,284		64		(5		)	1,343		1,343
Residential mortgage-backed securities	917		40		(3		)	954		954
U.S. Government	33		1		—			34		34
Foreign Governments	138		17		—			155		155
Total available-for-sale securities	22,914		979		(167		)	23,726		23,726
Equity securities	1,069		19		(17		)	1,071		1,071
Derivative investments	336		261		(10		)	587		587
Commercial mortgage loans	422		—		—			435		422
Residential mortgage loans	845		—		—			848		845
Other invested assets	1,306		—		(3		)	1,288		1,303
Total investments	$	26,892	$	1,259	$	(197	)	$	27,955	$	27,954

	December 31, 2018
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	4,954	$	15	$	(137	)	$	4,832	$	4,832
Commercial mortgage-backed securities	2,568		9		(40		)	2,537		2,537
Corporates	11,213		16		(848		)	10,381		10,381
Hybrids	992		—		(91		)	901		901
Municipals	1,216		3		(32		)	1,187		1,187
Residential mortgage-backed securities	1,027		12		(8		)	1,031		1,031
U.S. Government	120		—		(1		)	119		119
Foreign Governments	129		—		(8		)	121		121
Total available-for-sale securities	22,219		55		(1,165		)	21,109		21,109
Equity securities	1,526		1		(145		)	1,382		1,382
Derivative investments	330		2		(235		)	97		97
Commercial mortgage loans	482		—		—			483		482
Residential mortgage loans	185		—		—			187		185
Other invested assets	662		—		—			651		662
Total investments	$	25,404	$	58	$	(1,545	)	$	23,909	$	23,917

F-30

Included in AOCI were cumulative gross unrealized gains of $0 and gross unrealized losses of $0 related to the non-credit portion of other-than-temporary-impairments ("OTTI") on non-agency residential mortgage backed securities ("RMBS") for both December 31, 2019 and December 31, 2018.

Securities held on deposit with various state regulatory authorities had a fair value of $17,591 and $19,930 at December 31, 2019 and December 31, 2018, respectively. Under Iowa regulations, insurance companies are required to hold securities on deposit in an amount no less than the legal reserve.

At December 31, 2019 and December 31, 2018, the Company held no material investments that were non-income producing for a period greater than twelve months.

In accordance with the Company's FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to the Company for general purposes. The collateral investments had a fair value of $1,472 and $1,401 at December 31, 2019 and December 31, 2018, respectively.

The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.

	December 31, 2019
	Amortized Cost		Fair Value
Corporates, Non-structured Hybrids, Municipal and Government securities:
Due in one year or less	$	85	$	85
Due after one year through five years	888		914
Due after five years through ten years	2,020		2,082
Due after ten years	10,496		11,075
Subtotal	13,489		14,156
Other securities which provide for periodic payments:
Asset-backed securities	5,720		5,694
Commercial mortgage-backed securities	2,788		2,922
Residential mortgage-backed securities	917		954
Subtotal	9,425		9,570
Total fixed maturity available-for-sale securities	$	22,914	$	23,726

The Company's available-for-sale securities with unrealized losses are reviewed for potential OTTI. For factors considered in evaluating whether a decline in value is other-than-temporary, please refer to “Note 2. Significant Accounting Policies and Practices". Based on the results of our process for evaluating available-for-sale securities in unrealized loss positions for OTTI as discussed above, the Company determined the unrealized losses as of December 31, 2019 decreased due to lower interest rates during the year in conjunction with tighter credit spreads over Treasuries.

F-31

The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows:

	December 31, 2019
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	719	$	(12	)	$	2,453	$	(65	)	$	3,172	$	(77	)
Commercial mortgage-backed securities	232		(4		)	16		(2		)	248		(6		)
Corporates	1,030		(25		)	804		(47		)	1,834		(72		)
Hybrids	23		(1		)	60		(3		)	83		(4		)
Municipals	123		(2		)	60		(3		)	183		(5		)
Residential mortgage-backed securities	41		—			107		(3		)	148		(3		)
U.S. Government	6		—			—		—			6		—
Total available-for-sale securities	$	2,174	$	(44	)	$	3,500	$	(123	)	$	5,674	$	(167	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													290
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													446
Total number of available-for-sale securities in an unrealized loss position													736

	December 31, 2018
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	2,924	$	(116	)	$	643	$	(21	)	$	3,567	$	(137	)
Commercial mortgage-backed securities	1,466		(34		)	262		(6		)	1,728		(40		)
Corporates	8,016		(772		)	1,465		(76		)	9,481		(848		)
Hybrids	858		(90		)	7		(1		)	865		(91		)
Municipals	850		(27		)	172		(5		)	1,022		(32		)
Residential mortgage-backed securities	139		(3		)	190		(5		)	329		(8		)
U.S. Government	69		—			50		(1		)	119		(1		)
Foreign Government	47		(3		)	68		(5		)	115		(8		)
Total available-for-sale securities	$	14,369	$	(1,045	)	$	2,857	$	(120	)	$	17,226	$	(1,165	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													556
Total number of available-for-sale securities in an unrealized loss position													2,107

At December 31, 2019 and December 31, 2018, securities with a fair value of $35 and $132, respectively, had an unrealized loss greater than 20% of amortized cost (excluding U.S. Government and U.S. Government sponsored agency securities), which were insignificant to the carrying value of all investments, respectively.

F-32

The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the periods presented, for which a portion of the OTTI was recognized in AOCI:

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
							Predecessor		Predecessor		Predecessor
Beginning balance	$	—	$	—	$	—	$	3	$	3	$	3
Increases attributable to credit losses on securities:
OTTI was previously recognized	—		—		—		—		—		—
OTTI was not previously recognized	—		—		—		—		—		—
Ending balance	$	—	$	—	$	—	$	3	$	3	$	3

The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the periods presented:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Credit impairment losses in operations	$	(21	)	$	(24	)	$	—	$	—	$	(1	)	$	(22	)
Change-of-intent losses in operations	(2		)	—			—		—		—			—
Amortized cost	37			64			—		—		19			—
Fair value	37			64			—		—		19			—
Non-credit losses in other comprehensive income for investments which experienced OTTI	—			—			—		—		(1		)	—

Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Asset-backed securities	$	—		$	—		$	—	$	—	$	(1	)	$	(2	)
Corporates	(21		)	(24		)	—		—		—			(20		)
Equity security	(2		)	—			—		—		—			—
Total	$	(23	)	$	(24	)	$	—	$	—	$	(1	)	$	(22	)

F-33

Mortgage Loans

The Company's mortgage loans are collateralized by commercial and residential properties.

Commercial Mortgage Loans

Commercial mortgage loans ("CMLs") represented approximately 2% of the Company’s total investments as of December 31, 2019 and December 31, 2018, respectively. The Company primarily invests in mortgage loans on income producing properties including hotels, industrial properties, retail buildings, multifamily properties and office buildings. The Company diversifies its CML portfolio by geographic region and property type to reduce concentration risk. The Company continuously evaluates CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables:

	December 31, 2019				December 31, 2018
	Gross Carrying Value		% of Total		Gross Carrying Value		% of Total
Property Type:
Hotel	21		5	%	21		4	%
Industrial - General	37		9	%	37		8	%
Industrial - Warehouse	20		4	%	20		4	%
Multifamily	54		13	%	56		12	%
Office	143		34	%	147		30	%
Retail	147		35	%	201		42	%
Total commercial mortgage loans, gross of valuation allowance	$	422	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	422			$	482
U.S. Region:
East North Central	$	64	15	%	$	98	20	%
East South Central	19		5	%	19		4	%
Middle Atlantic	77		18	%	79		17	%
Mountain	51		12	%	65		13	%
New England	4		1	%	10		2	%
Pacific	113		27	%	116		24	%
South Atlantic	56		13	%	57		12	%
West North Central	13		3	%	13		3	%
West South Central	25		6	%	25		5	%
Total commercial mortgage loans, gross of valuation allowance	$	422	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	422			$	482

All of the Company's investments in CMLs had a loan-to-value ("LTV") ratio of less than 75% at December 31, 2019 and December 31, 2018, as measured at inception of the loans unless otherwise updated. As of December 31, 2019, all CMLs are current and have not experienced credit or other events which would require the recording of an impairment loss.

LTV and DSC ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation.

F-34

The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at December 31, 2019 and December 31, 2018:

	Debt-Service Coverage Ratios				Total Amount		% of Total		Estimated Fair Value		% of Total
	>1.25		1.00 - 1.25
December 31, 2019
LTV Ratios:
Less than 50%	$	346	$	6	$	352	83	%	$	363	83	%
50% to 60%	70		—		70		17	%	72		17	%
Commercial mortgage loans	$	416	$	6	$	422	100	%	$	435	100	%
December 31, 2018
LTV Ratios:
Less than 50%	$	296	$	6	$	302	63	%	$	302	63	%
50% to 60%	169		—		169		35	%	170		35	%
60% to 75%	11		—		11		2	%	11		2	%
Commercial mortgage loans	$	476	$	6	$	482	100	%	$	483	100	%

The Company establishes a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using the DSC ratio and LTV ratio. The Company believes that the LTV ratio is an indicator of the principal recovery risk for loans that default. A higher LTV ratio will result in a higher allowance. The Company believes that the DSC ratio is an indicator of default risk on loans. A higher DSC ratio will result in a lower allowance.

The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At December 31, 2019 and December 31, 2018, the Company had no CMLs that were delinquent in principal or interest payments.

Mortgage loan workouts, refinances or restructures that are classified as debt restructurings ("TDRs") are individually evaluated and measured for impairment. As of December 31, 2019 and December 31, 2018, our CML portfolio had no impairments, modifications or TDRs.

Residential Mortgage Loans

Residential mortgage loans ("RMLs") represented approximately 3% and 1% of the Company’s total investments as of December 31, 2019 and December 31, 2018, respectively. The Company's residential mortgage loans are closed end, amortizing loans and 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration is reflected in the following tables at December 31, 2019 and December 31, 2018:

	December 31, 2019
US State:	Unpaid Principal Balance		% of Total
California	$	167	20	%
Florida	141		17	%
New Jersey	76		9	%
All Other States (a)	447		54	%
Total mortgage loans	$	831	100	%

(a) The individual concentration of each state is less than 9%.

F-35

	December 31, 2018
US State:		Unpaid Principal Balance		% of Total
Florida		$	25	14	%
Illinois		24		13	%
New Jersey		17		9	%
All Other States (a)		114		64	%
Total mortgage loans		$	180	100	%

(a) The individual concentration of each state is less than 9%.

Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at December 31, 2019 and December 31, 2018 were as follows:

	December 31, 2019				December 31, 2018
Performance indicator:	Carrying Value		% of Total		Carrying Value		% of Total
Performing	$	843	100	%	$	185	100	%
Non-performing	2		—	%	—		—	%
Total residential mortgage loans, gross of valuation allowance	$	845	100	%	$	185	100	%
Allowance for loan loss	—		—	%	—		—	%
Total residential mortgage loans	$	845	100	%	$	185	100	%

Net Investment Income

The major sources of “Net investment income” on the accompanying Consolidated Statements of Operations were as follows:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Fixed maturity securities, available-for-sale	$	1,054		$	1,009		$	80		$	164		$	228		$	953
Equity securities	73			73			6			5			10			41
Mortgage loans	42			24			2			4			6			23
Invested cash and short-term investments	18			16			1			1			—			3
Funds withheld	65			28			2			—			—			—
Limited partnerships	81			17			1			3			1			5
Other investments	12			10			1			1			—			2
Gross investment income	1,345			1,177			93			178			245			1,027
Investment expense	(116		)	(70		)	(1		)	(4		)	(5		)	(22		)
Net investment income	$	1,229		$	1,107		$	92		$	174		$	240		$	1,005

F-36

Net Investment Gains (Losses)

Details underlying “Net investment gains (losses)” reported on the accompanying Consolidated Statements of Operations were as follows:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Net realized gains (losses) on fixed maturity available-for-sale securities	$	46		$	(187	)	$	5	$	5	$	2		$	(20	)
Net realized/unrealized gains (losses) on equity securities	127			(142		)	—		1		—			3
Realized gains (losses) on other invested assets	3			(5		)	—		—		(2		)	(2		)
Derivatives and embedded derivatives:
Realized gains (losses) on certain derivative instruments	(15		)	(2		)	3		80		1			219
Unrealized gains (losses) on certain derivative instruments	449			(248		)	34		58		38			129
Change in fair value of funds withheld for reinsurance receivables and reinsurance related embedded derivatives (a)	57			(42		)	—		1		12			(16		)
Change in fair value of other derivatives and embedded derivatives	7			(3		)	—		1		—			3
Realized gains (losses) on derivatives and embedded derivatives	498			(295		)	37		140		51			335
Net investment gains (losses)	$	674		$	(629	)	$	42	$	146	$	51		$	316

(a) Change in fair value of reinsurance related embedded derivatives starting December 1, 2017 and after is due to F&G Re and FSRC unaffiliated third party business under the fair value option election. Starting January 1, 2019, the balance also includes activity related to the FGL Insurance and Kubera reinsurance treaty. The predecessor periods activity is due to the FGL Insurance and FSRC reinsurance treaty. See "Note 13. Reinsurance".

The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Proceeds	$	2,848		$	6,260		$	125	$	151	$	97		$	703
Gross gains	91			12			—		6		2			25
Gross losses	(27		)	(171		)	—		—		(2		)	(20		)

Variable Interest Entities

FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements, and one investment in a VIE that is consolidated within the Company’s financial statements.  VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. VIE’s are consolidated by their ‘primary beneficiary’, a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While FGL Insurance participates in the benefits from VIEs in which it invests, but does not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under common control with FGL Insurance. It is for this reason that FGL Insurance is not considered the primary beneficiary for the VIE investments that are not consolidated.

The Company has concluded it is the primary beneficiary of BISA Co-Invest Fund II L.P (“Co-Invest II”). The primary beneficiary conclusion was drawn given the fact that substantially all of Co-Invest II’s activities are

F-37

conducted on behalf of the Company, its sole investor and limited partner. As the Company is considered the primary beneficiary, Co-Invest II is consolidated within the Company’s financial statements. As of December 31, 2019, the Company has $22 of net assets recorded related to Co-Invest II.

The Company previously executed a commitment of $83 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power.  The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund June 2020. The Company has funded $69 as of December 31, 2019.

The Company invests in various limited partnerships as a passive investor. These investments are in credit funds with a bias towards current income, real assets, or private equity. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s consolidated balance sheet. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's consolidated balance sheet in addition to any required unfunded commitments. As of December 31, 2019 and December 31, 2018, the Company's maximum exposure to loss was $1,010 and $510 in recorded carrying value, respectively, and $1,202 and $1,132 in unfunded commitments, respectively.

F-38

(5) Derivative Financial Instruments

The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows:

	December 31, 2019		December 31, 2018
Assets:
Derivative investments:
Call options	$	587	$	97
Futures contracts	—		—
Other invested assets:
Other derivatives and embedded derivatives	21		14
Funds withheld:
Call options	3		—
	$	611	$	111

Liabilities:
Contractholder funds:
FIA embedded derivative	$	3,235	$	2,476
Other liabilities:
Reinsurance related embedded derivative	33		—
Preferred shares reimbursement feature embedded derivative	16		29
	$	3,284	$	2,505

 

The change in fair value of derivative instruments included in the accompanying Consolidated Statements of Operations is as follows:

	Year ended														Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor		Predecessor			Predecessor
Net investment gains (losses):
Call options	$	404		$	(244	)	$	34		$	129	$	39		$	338
Futures contracts	27			(8		)	3			9		—			10
Foreign currency forward	3			2			—			—		—			—
Other derivatives and embedded derivatives	7			(3		)	—			1		—			3
Reinsurance related embedded derivatives (a)	57			(42		)	—			1		12			(16		)
Total net investment gains (losses)	$	498		$	(295	)	$	37		$	140	$	51		$	335
Benefits and other changes in policy reserves:
FIA embedded derivatives	$	759		$	199		$	(54	)	$	123	$	(133	)	$	244
Acquisition and operating expenses, net of deferrals:
Preferred shares reimbursement feature embedded derivative (b)	$	(13	)	$	6		$	—		$	—	$	—		$	—

(a) Change in fair value of reinsurance related embedded derivatives starting December 1, 2017 and after is due to F&G Re and FSRC unaffiliated third party business under the fair value option election. Starting January 1, 2019, the balance also includes activity related to the FGL Insurance and Kubera reinsurance treaty. The predecessor periods activity is due to the FGL Insurance and FSRC reinsurance treaty. See "Note 13. Reinsurance".

(b) Only applicable to periods after December 1, 2017.

F-39

Additional Disclosures

Other Derivatives and Embedded Derivatives

The Company holds a fund-linked note issued by Nomura International Funding Pte. Ltd with a face value of $35. The note provides for an additional payment at maturity based on the value of an embedded derivative in AnchorPath Dedicated Return Fund (the "AnchorPath Fund") which was based on the actual return of the fund. At December 31, 2019, the fair value of the fund-linked note and embedded derivative were $29 and $21, respectively. At December 31, 2018, the fair value of the fund-linked note and embedded derivative were $26 and $14, respectively. At maturity of the fund-linked note, FGL Insurance will receive the $35 face value of the note plus the value of the embedded derivative in the AnchorPath Fund. The additional payment at maturity is an embedded derivative reported in "Other invested assets", while the host is an available-for-sale security reported in "Fixed maturities, available-for-sale".

Fixed Index Annuity ("FIA") Embedded Derivative, and Call Options and Futures

The Company has FIA Contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, primarily the S&P 500 Index. This feature represents an embedded derivative under GAAP. The FIA embedded derivative is valued at fair value and included in the liability for contractholder funds in the accompanying Consolidated Balance Sheets with changes in fair value included as a component of “Benefits and other changes in policy reserves” in the Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments".

The Company purchases derivatives consisting of a combination of call options and futures contracts on the applicable market indices to fund the index credits due to FIA contractholders. The call options are one, two, three, and five year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the index policies, the index used to compute the interest credit is reset and the Company purchases new one, two, three, or five year call options to fund the next index credit. The Company manages the cost of these purchases through the terms of its FIA contracts, which permit the Company to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the portion of the change in the fair value of the FIA embedded derivative related to index performance through the current credit period. The call options and futures contracts are marked to fair value with the change in fair value included as a component of “Net investment gains (losses).” The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instrument's term or upon early termination and the changes in fair value of open positions.

Other market exposures are hedged periodically depending on market conditions and the Company’s risk tolerance. The Company’s FIA hedging strategy economically hedges the equity returns and exposes the Company to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. The Company uses a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. The Company intends to continue to adjust the hedging strategy as market conditions and the Company’s risk tolerance change.

F-40

Credit Risk

The Company is exposed to credit loss in the event of non-performance by its counterparties on the call options and assumptions regarding this non-performance risk are reflected in the fair value of the call options. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. The Company maintains a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement.

Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table:

		December 31, 2019
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	2,718	$	88	$	43	$	45
Deutsche Bank	BBB/A3/BBB+	157		7		7		—
Morgan Stanley	*/A1/A+	2,053		66		65		1
Barclay's Bank	A+/A2/A	4,290		211		193		18
Canadian Imperial Bank of Commerce	*/Aa2/A+	2,691		106		74		32
Wells Fargo	A+/A2/A-	2,165		81		80		1
Goldman Sachs	A/A3/BBB+	1,065		31		27		4
Total		$	15,139	$	590	$	489	$	101

		December 31, 2018
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	3,952	$	25	$	—	$	25
Deutsche Bank	A-/A3/BBB+	1,327		5		6		(1		)
Morgan Stanley	*/A1/A+	1,648		9		6		3
Barclay's Bank	A+/A2/A	2,205		27		20		7
Canadian Imperial Bank of Commerce	*/Aa2/A+	1,716		11		8		3
Wells Fargo	A+/A2/A-	1,635		17		16		1
Goldman Sachs	A/A3/BBB+	647		3		3		—
Total		$	13,130	$	97	$	59	$	38

(a) An * represents credit ratings that were not available.

F-41

Collateral Agreements

The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open option contracts between the parties, at which time any amounts payable by the Company or the counterparty would be dependent on the market value of the underlying option contracts. The Company’s current rating doesn't allow any counterparty the right to terminate ISDA agreements. In certain transactions, the Company and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, this threshold is set to zero. As of December 31, 2019 and December 31, 2018, counterparties posted $489 and $59 of collateral, respectively, of which $446 and $59, respectively, is included in "Cash and cash equivalents" with an associated payable for this collateral included in "Other liabilities" on the Consolidated Balance Sheets. The remaining $43 and $0, respectively, of non-cash collateral was held by a third-party custodian and may not be sold or re-pledged, except in the event of default, and, therefore, is not included in the Company's Consolidated Balance Sheets at December 31, 2019 and December 31, 2018, respectively. This collateral generally consists of U.S. treasury bonds and agency mortgage-backed securities ("Agency MBS"). Accordingly, the maximum amount of loss due to credit risk that the Company would incur if parties to the call options failed completely to perform according to the terms of the contracts was $101 and $38 at December 31, 2019 and December 31, 2018, respectively.

The Company is required to pay counterparties the effective federal funds rate each day for cash collateral posted to FGL for daily mark to market margin changes.  The Company reinvests derivative cash collateral to reduce the interest cost. Cash collateral is invested in overnight investment sweep products which are included in "Cash and cash equivalents" in the Consolidated Balance Sheets.

The Company held 879 and 664 futures contracts at December 31, 2019 and December 31, 2018, respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). The Company provides cash collateral to the counterparties for the initial and variation margin on the futures contracts which is included in "Cash and cash equivalents" in the Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $5 and $3 at December 31, 2019 and December 31, 2018, respectively.

Preferred Equity Remarketing Reimbursement Embedded Derivative Liability

On November 30, 2017 the Company issued 275,000 Series A cumulative preferred shares and 100,000 Series B cumulative preferred shares (together the “Preferred Shares”). The Preferred Shares do not have a maturity date and are non-callable for the first five years. From and after November 30, 2022, the original holders of the Preferred Shares may request and thus require, the Company (subject to customary blackout provisions) to remarket the Preferred Shares on their existing terms. If the remarketing is successful and the original holders elect to sell their preferred shares at the remarketed price and proceeds from such sale are less than the outstanding balance of the applicable shares (including dividends paid in kind and accumulated but unpaid dividends), the Company will be required to reimburse the sellers, up to a maximum of 10% of the par value of the originally issued preferred shares (including dividends paid in kind and accumulated but unpaid dividends) with such amount payable either in cash, ordinary shares, or any combination thereof, at the Company's option (the “Reimbursement Feature”). The Reimbursement Feature represents an embedded derivative that is not clearly and closely related to the preferred stock host and must be bifurcated. The Reimbursement Feature liability is held at fair value within “Other liabilities” in the accompanying Consolidated Balance Sheets and it is determined using a Black Derman Toy model incorporating among other things the paid in kind dividend coupon rate and the Company’s call option. Changes in fair value of this derivative are recognized within “Acquisition and operating expenses, net of deferrals” in the accompanying Consolidated Statements of Operations.

Reinsurance Related Embedded Derivatives

FGL Insurance entered into a reinsurance agreement with Kubera effective December 31, 2018, to cede certain MYGA and deferred annuity statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. This arrangement creates an obligation for FGL Insurance to pay Kubera at a later date, which results in an embedded derivative. This embedded derivative is considered a total return swap with contractual returns that are attributable to the assets and liabilities associated with this reinsurance arrangement. The fair value

F-42

of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, were passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. The reinsurance related embedded derivative is reported in “Other assets” if in a net gain position, or “Other liabilities”, if in a net loss position, on the Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains (losses)” on the Consolidated Statements of Operations.

In the predecessor periods, FGL Insurance had a funds withheld coinsurance arrangement with FSRC, meaning that funds were withheld by FGL Insurance. This arrangement resulted in an embedded derivative in predecessor periods, similar to the embedded derivative described above related to the Kubera agreement. Due to the acquisition of FSRC, the reinsurance related embedded derivative is eliminated in consolidation in the periods after December 1, 2017.

F-43

(6) Fair Value of Financial Instruments

The Company’s measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include the Company’s own credit risk. The Company’s estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). The Company categorizes financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows:

Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date.

Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves.

Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources.

F-44

The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows:

	December 31, 2019
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	969	$	—	$	—	$	969	$	969
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,866		828		5,694		5,694
Commercial mortgage-backed securities	—		2,895		27		2,922		2,922
Corporates	—		10,305		1,292		11,597		11,597
Hybrids	299		718		10		1,027		1,027
Municipals	—		1,301		42		1,343		1,343
Residential mortgage-backed securities	—		408		546		954		954
U.S. Government	28		6		—		34		34
Foreign Governments	—		137		18		155		155
Equity securities	387		614		1		1,002		1,002
Derivative investments	—		587		—		587		587
Other invested assets	—		—		46		46		46
Funds withheld for reinsurance receivables, at fair value	314		1,856		1		2,171		2,171
Total financial assets at fair value	$	1,997	$	23,693	$	2,811	$	28,501	$	28,501
Liabilities
Fair value of future policy benefits	—		—		1,953		1,953		1,953
Derivatives:
FIA embedded derivatives, included in contractholder funds	$	—	$	—	$	3,235	$	3,235	$	3,235
Reinsurance related embedded derivative, included in other liabilities	—		33		—		33		33
Preferred shares reimbursement feature embedded derivative	—		—		16		16		16
Total financial liabilities at fair value	$	—	$	33	$	5,204	$	5,237	$	5,237

F-45

	December 31, 2018
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	571	$	—	$	—	$	571	$	571
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,388		444		4,832		4,832
Commercial mortgage-backed securities	—		2,470		67		2,537		2,537
Corporates	—		9,150		1,231		10,381		10,381
Hybrids	265		626		10		901		901
Municipals	—		1,150		37		1,187		1,187
Residential mortgage-backed securities	—		417		614		1,031		1,031
U.S. Government	114		5		—		119		119
Foreign Governments	—		105		16		121		121
Equity securities	454		874		4		1,332		1,332
Derivative investments	—		97		—		97		97
Other invested assets	—		—		39		39		39
Funds withheld for reinsurance receivables, at fair value	177		576		4		757		757
Total financial assets at fair value	$	1,581	$	19,858	$	2,466	$	23,905	$	23,905
Liabilities
Fair value of future policy benefits	—		—		725		725		725
Derivatives:
FIA embedded derivatives, included in contractholder funds	—		—		2,476		2,476		2,476
Preferred shares reimbursement feature embedded derivative	—		—		29		29		29
Total financial liabilities at fair value	$	—	$	—	$	3,230	$	3,230	$	3,230

Valuation Methodologies

Fixed Maturity Securities & Equity Securities

The Company measures the fair value of its securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity or equity security, and the Company will then consistently apply the valuation methodology to measure the security’s fair value. The Company's fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. The Company uses observable and unobservable inputs in its valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met.

For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. To estimate the fair value of fixed maturity securities classified as level 3 in the fair value hierarchy the Company primarily uses prices from independent broker quotes. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. Management believes the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. The Company does analyze the third-party valuation methodologies and related inputs to perform assessments and to determine the appropriate level within the fair value hierarchy. The Company did not adjust prices received from third parties as of December 31, 2019 or December 31, 2018.

The Company has an equity investment in a private business development company which is not traded on an exchange or valued by other sources such as analytics or brokers. The Company based the fair value of this investment on an estimated net asset value provided by the investee. Management did not make any adjustments to this valuation.

F-46

Derivative Financial Instruments

The fair value of call option assets represents what the Company would expect to receive or pay at the balance sheet date if it canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined internally, based on industry accepted valuation pricing models which use market-observable inputs, including interest rates, yield curve volatilities, and other factors.

The fair value of futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements) which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the contracts or entered into offsetting positions. These contracts are classified as Level 1.

The fair value measurement of the FIA embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs using the option budget method. The market observable inputs are the market value of option and interest swap rates. The significant unobservable inputs are the budgeted option cost (i.e., the expected cost to purchase call options in future periods to fund the equity indexed linked feature), surrender rates, mortality multiplier, and non-performance spread. The mortality multiplier at December 31, 2019 and December 31, 2018 was applied to the Annuity 2000 mortality tables. Increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Increases or decreases in interest swap rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input.

The fair value of the reinsurance-related embedded derivative in the funds withheld reinsurance agreement with Kubera is estimated based upon the fair value of the assets supporting the funds withheld from reinsurance liabilities. The fair value of the assets is based on a quoted market price of similar assets (Level 2), and therfore the fair value of the embedded derivative is based on market-observable inputs and classified as Level 2.

The fair value of the Reimbursement Feature is determined using a Black Derman Toy model, incorporating the paid in kind dividend coupon, the Company's redemption option and the preferred shareholder's remarketing feature. The remarketing feature allows the shareholder to put the preferred shares to the Company for a value of par after five years and, if after a successful remarketing event the amount is less than 90% par, up to a maximum of 10% of liquidation price defined. Fair value of this derivative liability decreased $13 during the year ended December 31, 2019 and increased $6 during the year ended December 31, 2018, due primarily to changes in the credit spread applied in the discount rate.

Other Invested Assets

Fair value of the AnchorPath embedded derivative is based on an unobservable input, the net asset value of the AnchorPath fund at the balance sheet date.  The embedded derivative is similar to a call option on the net asset value of the AnchorPath fund with a strike price of zero since FGL Insurance will not be required to make any additional payments at maturity of the fund-linked note in order to receive the net asset value of the AnchorPath fund on the maturity date.  A Black-Scholes model determines the net asset value of the AnchorPath fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model.  The net asset value of the AnchorPath fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the AnchorPath fund. As the value of the AnchorPath fund increases or decreases, the fair value of the embedded derivative will increase or decrease.

FSRC and F&G Re Funds Withheld for Reinsurance Receivables and Future Policy Benefits

FSRC and F&G Re elected to apply the Fair Value Option to account for its funds withheld receivables and future policy benefits liability related to its assumed reinsurance. FSRC and F&G Re measures the fair value of the Funds Withheld for Reinsurance Receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. FSRC and F&G Re use a discounted cash flows approach to measure the fair value of the Future Policy Benefits Reserve. The cash flows associated with future policy premiums and benefits are generated using best estimate assumptions. Included in the cash flows within the fair value for the reinsurance liabilities is a risk premium, which represents compensation a market participant would demand for uncertainty.

The significant unobservable inputs used in the fair value measurement of the FSRC and F&G Re future policy benefit liability are undiscounted cash flows (which are determined using actuarial assumptions related to lapses, surrenders, mortality, partial withdrawals and morbidity), non-performance risk spread and risk margin to reflect uncertainty. Undiscounted cash flows used in our December 31, 2019 and December 31, 2018 discounted cash flow models equaled $2,569 and $1,199, respectively. Increases or decreases in non-performance risk spread and risk margin to reflect uncertainty would result in a lower or higher fair value measurement, respectively.

F-47

Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of December 31, 2019 and December 31, 2018 are as follows: 

	Fair Value at				Range (Weighted average)
	December 31, 2019		Valuation Technique	Unobservable Input(s)	December 31, 2019
Assets
Asset-backed securities	$	801	Broker-quoted	Offered quotes	98.65% - 119.35% (102.02%)
Asset-backed securities	27		Third-Party Valuation	Offered quotes	0.00% - 99.43% (35.96%)
Commercial mortgage-backed securities	27		Broker-quoted	Offered quotes	100.15% - 127.60% (126.82%)
Corporates	346		Broker-quoted	Offered quotes	83.51% - 106.73% (99.56%)
Corporates	946		Third-Party Valuation	Offered quotes	98.58% - 119.44% (105.06%)
Hybrids	10		Third-Party Valuation	Offered quotes	104.72% - 104.72% (104.72%)
Municipals	42		Third-Party Valuation	Offered quotes	127.68% - 127.68% (127.68%)
Residential mortgage-backed securities	546		Broker-quoted	Offered quotes	0.00% - 106.50% (106.28%)
Foreign governments	18		Third-Party Valuation	Offered quotes	110.12% - 118.09% (112.61%)
Equity securities (Salus preferred equity)	1		Income-Approach	Yield	2.47%
Other invested assets:
Available-for-sale embedded derivative (AnchorPath)	21		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit linked note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables at fair value	1		Broker-quoted	Offered quotes	100.00%
Total	$	2,811
Liabilities
Future policy benefits	$	1,953	Discounted cash flow	Market value of option	0.00% - 11.20% (2.50%)
				Mortality multiplier	80.00% - 120.00% (95.46%)
				Surrender rates	0.00% - 55.00% (21.18%)
				Partial withdrawals	0.00% - 4.00% (2.28%)
				Non-performance spread	0.00% - 0.08% (0.03%)
				Option cost	0.00% - 5.02% (1.28%)
				Risk margin to reflect uncertainty	0.23% - 0.96% (0.34%)
				Morbidity risk margin	0.00% - 2.00% (0.07%)
Derivatives:
FIA embedded derivatives included in contractholder funds	3,235		Discounted cash flow	Market value of option	0.00% - 32.54% (3.64%)
				SWAP rates	1.73% - 1.90% (1.81%)
				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.64%)

F-48

				Partial withdrawals	2.00% - 3.50% (2.53%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.18% - 16.61% (2.12%)
Preferred shares reimbursement feature embedded derivative	16		Black Derman Toy model	Credit Spread	3.81%
				Yield Volatility	20.00%
Total liabilities at fair value	$	5,204

F-49

	Fair Value at				Range (Weighted average)
	December 31, 2018		Valuation Technique	Unobservable Input(s)	December 31, 2018
Assets
Asset-backed securities	$	405	Broker-quoted	Offered quotes	97.00% - 102.00% (99.77%)
Asset-backed securities	24		Matrix Pricing	Quoted prices	96.07% - 96.07% (96.07%)
Asset-backed securities	15		Third-Party Valuation	Offered quotes	0.00% - 99.29% (23.05%)
Commercial mortgage-backed securities	43		Broker-quoted	Offered quotes	77.12% - 100.08% (85.46%)
Commercial mortgage-backed securities	24		Matrix Pricing	Quoted prices	117.72% - 117.72% (117.72%)
Corporates	577		Broker-quoted	Offered quotes	74.63% - 104.62% (97.80%)
Corporates	654		Matrix Pricing	Quoted prices	91.74% - 113.25% (98.86%)
Hybrids	10		Matrix Pricing	Quoted prices	96.60% - 96.60% (96.60%)
Municipals	37		Broker-quoted	Offered quotes	111.23% - 111.23% (111.23%)
Residential mortgage-backed securities	614		Broker-quoted	Offered quotes	89.80% - 100.99% (100.73%)
Foreign governments	16		Broker-quoted	Offered quotes	98.38% - 99.01% (98.58%)
Equity securities (Salus preferred equity)	4		Income-Approach	Yield	7.15%
Other invested assets:
Available-for-sale embedded derivative (AnchorPath)	14		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit linked note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables, at fair value	4		Matrix pricing	Calculated prices	100.00%
Total	$	2,466
Liabilities
Future policy benefits	$	725	Discounted cash flow	Non-Performance risk spread	0.00% - 0.22% (0.18%)
				Risk margin to reflect uncertainty	0.35% - 0.71% (0.68%)
Derivatives:
FIA embedded derivatives included in contractholder funds	$	2,476	Discounted cash flow	Market value of option	0.00% - 31.06% (0.94%)
				SWAP rates	2.57% - 2.71% (2.63%)
				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.90%)
				Partial withdrawals	1.00% - 2.50% (2.00%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.11% - 16.61% (2.18%)
Preferred shares reimbursement feature embedded derivative	$	29	Black Derman Toy model	Credit Spread	5.14%
				Yield Volatility	20.00%
Total liabilities at fair value	$	3,230

F-50

The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, Predecessor period from October 1, 2017 to November 30, 3017, Predecessor period from October 1, 2016 to December 31, 2016, and the Predecessor year ended September 30, 2017, respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.

	Year ended December 31, 2019
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	444	$	—		$	19		$	675	$	—		$	(128	)	$	(182	)	$	828
Commercial mortgage-backed securities	67		—			5			1		—			(10		)	(36		)	27
Corporates	1,231		—			69			221		(106		)	(133		)	10			1,292
Hybrids	10		—			—			—		—			—			—			10
Municipals	37		—			5			—		—			—			—			42
Residential mortgage-backed securities	614		—			27			25		—			(91		)	(29		)	546
Foreign governments	16		—			2			—		—			—			—			18
Equity securities	4		(2		)	(1		)	—		—			—			—			1
Other invested assets:
Available-for-sale embedded derivative	14		7			—			—		—			—			—			21
Credit linked note	25		—			—			—		—			—			—			25
Funds withheld for reinsurance receivables, at fair value	4		—			—			20		(1		)	—			(22		)	1
Total assets at Level 3 fair value	$	2,466	$	5		$	126		$	942	$	(107	)	$	(362	)	$	(259	)	$	2,811
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,476	$	759		$	—		$	—	$	—		$	—		$	—		$	3,235
Future policy benefits (F&G Re and FSRC)	725		123			15			—		—			1,090			—			1,953
Preferred shares reimbursement feature embedded derivative	29		(13		)	—			—		—			—			—			16
Total liabilities at Level 3 fair value	$	3,230	$	869		$	15		$	—	$	—		$	1,090		$	—		$	5,204

(a) The net transfers out of Level 3 during the year ended December 31, 2019 were exclusively to Level 2.

F-51

	Year ended December 31, 2018
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	412	$	—		$	(4	)	$	476	$	—		$	(28	)	$	(412	)	$	444
Commercial mortgage-backed securities	49		—			(3		)	46		—			(6		)	(19		)	67
Corporates	1,169		—			(29		)	288		—			(126		)	(71		)	1,231
Hybrids	10		—			—			—		—			—			—			10
Municipals	38		—			(1		)	—		—			—			—			37
Residential mortgage-backed securities	66		—			5			560		(1		)	(15		)	(1		)	614
Foreign governments	17		—			(1		)	—		—			—			—			16
Equity securities	3		1			—			—		—			—			—			4
Other invested assets:
Available-for-sale embedded derivative	17		(3		)	—			—		—			—			—			14
Credit linked note	—		—			—			25		—			—			—			25
Funds withheld for reinsurance receivables, at fair value	4		—			—			6		—			(4		)	(2		)	4
Total assets at Level 3 fair value	$	1,785	$	(2	)	$	(33	)	$	1,401	$	(1	)	$	(179	)	$	(505	)	$	2,466
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,277	$	199		$	—		$	—	$	—		$	—		$	—		$	2,476
Future policy benefits (F&G Re and FSRC)	728		(45		)	(4		)	—		—			46			—			725
Preferred shares reimbursement feature embedded derivative	23		6			—			—		—			—			—			29
Total liabilities at Level 3 fair value	$	3,028	$	160		$	(4	)	$	—	$	—		$	46		$	—		$	3,230

(a) The net transfers out of Level 3 during the year ended December 31, 2018 were exclusively to Level 2.

F-52

	Period from December 1 to December 31, 2017
	Balance at Beginning of Period		Total Gains (Losses)					Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	225	$	—		$	—	$	143	$	—		$	(1	)	$	45		$	412
Commercial mortgage-backed securities	49		—			—		—		—			—			—			49
Corporates	1,163		—			2		30		(10		)	(16		)	—			1,169
Hybrids	10		—			—		—		—			—			—			10
Municipals	38		—			—		—		—			—			—			38
Residential mortgage-backed securities	67		—			—		—		—			(1		)	—			66
Foreign governments	17		—			—		—		—			—			—			17
Equity securities	38		—			—		—		—			—			(35		)	3
Other invested assets:
Available-for-sale embedded derivative	17		—			—		—		—			—			—			17
HGI Energy Note	20		—			—		—		(20		)	—			—			—
Funds withheld for reinsurance receivables, at fair value	4		—			—		—		—			—			—			4
Total assets at Level 3 fair value	$	1,648	$	—		$	2	$	173	$	(30	)	$	(18	)	$	10		$	1,785
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,331	$	(54	)	$	—	$	—	$	—		$	—		$	—		$	2,277
Future policy benefits (FSRC)	723		9			—		—		—			(4		)	—			728
Preferred shares reimbursement feature embedded derivative	23		—			—		—		—			—			—			23
Total liabilities at Level 3 fair value	$	3,077	$	(45	)	$	—	$	—	$	—		$	(4	)	$	—		$	3,028

(a) The net transfers out of Level 3 during the period from December 1 to December 31, 2017 were exclusively to Level 2.

F-53

	Period from October 1 to November 30, 2017
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales		Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	159	$	—		$	—		$	95	$	—	$	—		$	(29	)	$	225
Commercial mortgage-backed securities	95		—			(1		)	—		—		—			(45		)	49
Corporates	1,097		—			—			67		—		(19		)	18			1,163
Hybrids	10		—			—			—		—		—			—			10
Municipals	38		—			—			—		—		—			—			38
Residential mortgage-backed securities	15		—			1			51		—		—			—			67
Foreign governments	17		—			—			—		—		—			—			17
Equity securities	2		—			—			—		—		—			35			37
Other invested assets:
Available-for-sale embedded derivative	16		1			—			—		—		—			—			17
Total assets at Level 3 fair value	$	1,449	$	1		$	—		$	213	$	—	$	(19	)	$	(21	)	$	1,623
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,627	$	(296	)	$	—		$	—	$	—	$	—		$	—		$	2,331
Total liabilities at Level 3 fair value	$	2,627	$	(296	)	$	—		$	—	$	—	$	—		$	—		$	2,331

(a) The net transfers out of Level 3 during the Predecessor period from October 1 to November 30, 2017 were exclusively to Level 2.

F-54

	Period from October 1 to December 31, 2016 (Unaudited)
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	172	$	(1	)	$	(1	)	$	63	$	—		$	(7	)	$	(29	)	$	197
Commercial mortgage-backed securities	79		—			(2		)	8		—			—			—			85
Corporates	1,104		(1		)	(41		)	51		(5		)	(48		)	1			1,061
Hybrids	—		—			—			10		—			—			—			10
Municipals	41		—			(3		)	—		—			(1		)	—			37
Foreign governments	17		—			—			—		—			—			—			17
Equity securities	3		(2		)	—			—		—			—			—			1
Other invested assets:
Available-for-sale embedded derivative	13		—			—			—		—			—			—			13
Loan participations	21		(1		)	—			—		—			(14		)	—			6
Total assets at Level 3 fair value	$	1,450	$	(5	)	$	(47	)	$	132	$	(5	)	$	(70	)	$	(28	)	$	1,427
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,383	$	(133	)	$	—		$	—	$	—		$	—		$	—		$	2,250
Total liabilities at Level 3 fair value	$	2,383	$	(133	)	$	—		$	—	$	—		$	—		$	—		$	2,250

(a) The net transfers out of Level 3 during the Predecessor period from October 1 to December 30, 2016 (unaudited) were exclusively to Level 2.

F-55

	Year ended September 30, 2017
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	172	$	(2	)	$	2		$	152	$	—		$	(40	)	$	(125	)	$	159
Commercial mortgage-backed securities	79		—			1			18		—			(1		)	(2		)	95
Corporates	1,104		(1		)	(29		)	189		(20		)	(109		)	(37		)	1,097
Hybrids	—		—			—			10		—			—			—			10
Municipals	41		—			(2		)	—		—			(1		)	—			38
Residential mortgage-backed securities	—		—			1			—		—			—			14			15
Foreign governments	17		—			—			—		—			—			—			17
Equity securities	3		(2		)	1			—		—			—			—			2
Other invested assets:
Available-for-sale embedded derivative	13		3			—			—		—			—			—			16
Loan participations	21		(2		)	1			—		—			(20		)	—			—
Total assets at Level 3 fair value	$	1,450	$	(4	)	$	(25	)	$	369	$	(20	)	$	(171	)	$	(150	)	$	1,449
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,383	$	244		$	—		$	—	$	—		$	—		$	—		$	2,627
Total liabilities at Level 3 fair value	$	2,383	$	244		$	—		$	—	$	—		$	—		$	—		$	2,627

(a) The net transfers out of Level 3 during the Predecessor year ended September 30, 2017 were exclusively to Level 2.

Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value

The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange.

FHLB Common Stock

The fair value of FHLB common stock is based on cost.

Mortgage Loans

The fair value of mortgage loans is established using a discounted cash flow method based on credit rating, maturity and contractual cash flows. This yield-based approach is sourced from our third-party vendor. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. In the event of an impairment, the carrying value is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price, or the fair value of the collateral if the loan is collateral-dependent. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy.

Policy Loans (included within Other Invested Assets)

Fair values for policy loans are estimated from a discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk.  Loans with similar characteristics are aggregated for purposes of the calculations.

F-56

Company Owned Life Insurance

Company owned life insurance (COLI) is a life insurance program used to finance certain employee benefit expenses. The fair value of COLI is based on net realizable value, which is generally cash surrender value.

Affiliated Bank Loan

The fair value of the affiliated bank loan is estimated using a discounted cash flow method based on the weighted average cost of capital ("WACC"). This yield-based approach is sourced from a third-party vendor and the WACC establishes a market participant discount rate by determining the hypothetical capital structure for the asset should it be underwritten as of each period end.

Investment Contracts

Investment contracts include deferred annuities, FIAs, indexed universal life policies ("IULs") and immediate annuities. The fair value of deferred annuity, FIA, and IUL contracts is based on their cash surrender value (i.e. the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of immediate annuities contracts is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. At December 31, 2019 and December 31, 2018, this resulted in lower fair value reserves relative to the carrying value. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value.

Debt

The fair value of debt is based on quoted market prices. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy. Our revolving credit facility debt is classified as Level 3 within the fair value hierarchy, and the estimated fair value reflects the carrying value as the revolver has no maturity date.

F-57

The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described.

	December 31, 2019
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	62	$	—	$	62	$	62
Commercial mortgage loans	—		—		435		435		422
Residential mortgage loans	—		—		848		848		845
Policy loans, included in other invested assets	—		—		14		14		28
Company-owned life insurance	—		—		129		129		129
Affiliated bank loan	—		—		28		28		28
Funds withheld for reinsurance receivables, at fair value	—		—		1		1		1
Total	$	—	$	62	$	1,455	$	1,517	$	1,515
Liabilities
Investment contracts, included in contractholder funds	$	—	$	—	$	19,285	$	19,285	$	22,449
Debt	—		578		—		578		542
Total	$	—	$	578	$	19,285	$	19,863	$	22,991

	December 31, 2018
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	52	$	—	$	52	$	52
Commercial mortgage loans	—		—		483		483		482
Residential mortgage loans	—		—		187		187		185
Policy loans, included in other invested assets	—		—		11		11		22
Affiliated other invested assets	—		—		39		39		39
Total	$	—	$	52	$	720	$	772	$	780
Liabilities
Investment contracts, included in contractholder funds	$	—	$	—	$	18,358	$	18,358	$	20,911
Debt	—		520		—		520		541
Total	$	—	$	520	$	18,358	$	18,878	$	21,452

The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments is measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices”.

	Carrying Value After Measurement
	December 31, 2019		December 31, 2018
Equity securities available-for-sale	$	69	$	50
Limited partnership investment, included in other invested assets	1,010		510

For investments for which NAV is used as a practical expedient for fair value, the Company does not have any significant restrictions in their ability to liquidate their positions in these investments, other than obtaining general partner approval, nor does the Company believe it is probable a price less than NAV would be received in the event of a liquidation.

F-58

The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. The transfers into and out of Level 3 were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value.

F-59

The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, are as follows: 

	Transfers Between Fair Value Levels
	Level 1				Level 2				Level 3
	In		Out		In		Out		In		Out
Year ended December 31, 2019
Asset-backed securities	$	—	$	—	$	233	$	51	$	51	$	233
Commercial mortgage-backed securities	—		—		37		1		1		37
Corporates	—		—		1		11		11		1
Residential mortgage-backed securities	—		—		29		—		—		29
Equity securities	7		29		29		7		16		16
Funds withheld for reinsurance receivables	—		—		22		—		—		22
Total transfers	$	7	$	29	$	351	$	70	$	79	$	338
Year ended December 31, 2018
Asset-backed securities	$	—	$	—	$	425	$	13	$	13	$	425
Commercial mortgage-backed securities	—		—		28		9		9		28
Corporates	—		—		75		4		4		75
Hybrids	20		—		—		20		—		—
Residential mortgage-backed securities	—		—		36		35		35		36
Equity securities	25		30		30		25		—		—
Funds withheld for reinsurance receivables	—		—		2		—		—		2
Total transfers	$	45	$	30	$	596	$	106	$	61	$	566
Period from December 1 to December 31, 2017
Asset-backed securities	$	—	$	—	$	1	$	46	$	46	$	1
Commercial mortgage-backed securities	—		—		1		—		—		1
Hybrids	27		15		15		27		—		—
Equity securities	53		26		61		53		—		35
Total transfers	$	80	$	41	$	78	$	126	$	46	$	37
Predecessor
Period from October 1 to November 30, 2017
Asset-backed securities	$	—	$	—	$	29	$	—	$	—	$	29
Commercial mortgage-backed securities	—		—		46		1		1		46
Corporates	—		—		—		18		18		—
Hybrids	244		—		—		244		—		—
Equity securities	374		—		—		409		35		—
Total transfers	$	618	$	—	$	75	$	672	$	54	$	75
Predecessor
Period from October 1 to December 31, 2016 (Unaudited)
Asset-backed securities	$	—	$	—	$	68	$	39	$	39	$	68
Corporates	—		—		4		5		5		4
Total transfers	$	—	$	—	$	72	$	44	$	44	$	72
Predecessor
Year ended September 30, 2017
Asset-backed securities	$	—	$	—	$	222	$	112	$	112	$	222
Commercial mortgage-backed securities	—		—		7		6		6		7
Corporates	—		—		49		10		10		49
Total transfers	$	—	$	—	$	278	$	128	$	128	$	278

F-60

(7) Intangibles

A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows:

	VOBA			DAC			DSI			Total
Balance at December 31, 2018	$	866		$	344		$	149		$	1,359
Deferrals	—			379			130			509
Amortization	(106		)	(30		)	(20		)	(156		)
Interest	18			13			4			35
Unlocking	(2		)	(2		)	(1		)	(5		)
Adjustment for net unrealized investment (gains) losses	(183		)	(74		)	(30		)	(287		)
Balance at December 31, 2019	$	593		$	630		$	232		$	1,455

	VOBA			DAC			DSI			Total
Balance at December 31, 2017	$	821		$	22		$	10		$	853
Deferrals	—			317			138			455
Amortization	(58		)	(4		)	(2		)	(64		)
Interest	19			4			1			24
Unlocking	(9		)	—			—			(9		)
Adjustment for net unrealized investment (gains) losses	93			5			2			100
Balance at December 31, 2018	$	866		$	344		$	149		$	1,359

	VOBA			DAC			DSI		Total
Balance at December 1, 2017	$	844		$	—		$	—	$	844
Deferrals	—			23			10		33
Amortization	(7		)	(1		)	—		(8		)
Interest	2			—			—		2
Unlocking	—			—			—		—
Adjustment for net unrealized investment (gains) losses	(18		)	—			—		(18		)
Balance at December 31, 2017	$	821		$	22		$	10	$	853

Predecessor	VOBA			DAC			DSI			Total
Balance at October 1, 2017	$	—		$	1,023		$	106		$	1,129
Deferrals	—			40			8			48
Amortization	(12		)	(39		)	(5		)	(56		)
Interest	2			7			1			10
Unlocking	7			4			(1		)	10
Adjustment for net unrealized investment (gains) losses	3			(4		)	—			(1		)
Balance at November 30, 2017	$	—		$	1,031		$	109		$	1,140

	VOBA			DAC			DSI			Total
Balance at October 1, 2016	$	19		$	921		$	86		$	1,026
Deferrals	—			88			12			100
Amortization	(31		)	(103		)	(2		)	(136		)
Interest	2			22			(11		)	13
Unlocking	6			(7		)	1			—
Adjustment for unrealized investment losses (gains)	122			103			—			225
Balance at December 31, 2016	$	118		$	1,024		$	86		$	1,228

F-61

Predecessor	VOBA			DAC			DSI			Total
Balance at September 30, 2016	$	19		$	921		$	86		$	1,026
Deferrals	—			293			43			336
Amortization	(65		)	(192		)	(23		)	(280		)
Interest	11			42			4			57
Unlocking	32			2			(4		)	30
Adjustment for net unrealized investment (gains) losses	3			(43		)	—			(40		)
Balance at September 30, 2017	$	—		$	1,023		$	106		$	1,129

Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01%. The adjustment for net unrealized investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the Consolidated Statements of Operations. As of December 31, 2019 and 2018, the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $(108), and $75, respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $(70) and $5, respectively, and the DSI balances included net unrealized investment (gains) losses of $(28) and $2 respectively.

Estimated amortization expense for VOBA in future fiscal periods is as follows:

	Estimated Amortization Expense
Fiscal Year
2020	62
2021	85
2022	80
2023	72
2024	65
Thereafter	337

The Company had an unearned revenue balance of $(43) as of December 31, 2019, including deferrals of $(41), amortization of $(4), interest of $(2), unlocking of $1, and adjustment for net unrealized investment gains (losses) of $44. The Company had an unearned revenue balance of $(41) as of December 31, 2018, including deferrals of $(37), amortization of $18, unlocking of $4, and adjustment for net unrealized investment gains (losses) of $(26).

Definite and Indefinite Lived Intangible Assets

On November 30, 2017, $467 of goodwill was recognized as a result of the FGL and FSR acquisitions. These transactions were accounted for separately using the acquisition method under which the Company recorded the identifiable assets acquired, including indefinite-lived and definite-lived intangible assets, and liabilities assumed, at their acquisition date fair values.

Other identifiable intangible assets as of December 31, 2019 consist of the following:

	December 31, 2019
	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
Trade marks / trade names	$	16	$	4	$	12	10
State insurance licenses	6		N/A		6		Indefinite
Total					$	18

F-62

(8) Debt

On November 30, 2017, FGLH and CF Bermuda, together as borrowers and each as a borrower, entered into a credit agreement with certain financial institutions party thereto, as lenders, and Royal Bank of Canada, as administrative agent and letter of credit issuer, which provides for a $250 senior unsecured revolving credit facility with a maturity of three years (the “Credit Agreement”). Various financing options are available within the Credit Agreement, including overnight and term based borrowing.  In each case, a margin is ascribed based on the Debt to Capitalization ratio of CF Bermuda. The loan proceeds from the Credit Agreement may be used for working capital and general corporate purposes.

On April 20, 2018, FGLH completed a debt offering of $550 aggregate principal amount of 5.50% senior notes due 2025, issued at 99.5% for proceeds of $547. The Company used the net proceeds of the offering (i) to repay $135 of borrowings under its revolving credit facility and related expenses and (ii) to redeem in full and satisfy and discharge all of the outstanding $300 aggregate principal amount of FGLH's outstanding 6.375% Senior Notes due 2021. The remaining proceeds of the offering were used for general corporate purposes, including additional capital contributions to the Company's insurance subsidiaries. This exchange of debt instruments constituted an extinguishment. As a result, the Company recognized a $2 gain on the extinguishment of the 6.375% Senior Notes.

The Company capitalized $7 of debt issuance costs in connection with the 5.50% Senior Notes offering, which are classified as an offset within the "Debt" line on the Company's Consolidated Balance Sheets, and are being amortized from the date of issue to the redemption date using the straight-line method.

The carrying amount of the Company's outstanding debt as of December 31, 2019 and December 31, 2018 is as follows:

	December 31, 2019		December 31, 2018
Debt	$	542	$	541
Revolving credit facility	—		—

Interest rates on the revolving credit facility were equal to 4.55% and 5.27% as of December 31, 2019 and December 31, 2018, respectively. As of December 31, 2019 and December 31, 2018, the amount available to be drawn on the revolver was $250.

The interest expense and amortization of debt issuance costs for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, were as follows:

	Year ended									Period from December 1 to December 31, 2017
	December 31, 2019				December 31, 2018
	Interest Expense		Amortization		Interest Expense			Amortization		Interest Expense		Amortization
Debt	$	30	$	2	$	28		$	1	$	2	$	—
Revolving credit facility	—		—		2			—		—		—
Gain on extinguishment of debt	—		—		(2		)	—		—		—

The interest expense and amortization of debt issuance costs for the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, were not material.

(9) Equity

General

The Company is a Cayman Islands exempted company and our affairs are governed by the Companies Law, the common law of the Cayman Islands and our Charter. Pursuant to our Charter, our authorized share capital is $90 thousand divided into 800,000 thousand ordinary shares and 100,000 thousand preferred shares, par value $0.0001 per share.

F-63

Common Stock

Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in our Charter, or as required by applicable provisions of the Companies Law or applicable stock exchange rules, the affirmative vote of a majority of ordinary shares that are voted is required to approve any matter voted on by our shareholders. Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least two-thirds of ordinary shares that are voted and, pursuant to our Charter, such actions include amending our Charter and approving a statutory merger or consolidation with another company.

The Company consummated the initial public offering ("IPO") of 60,000 thousand ordinary shares for $10.00 per share on May 25, 2016. On June 29, 2016, the Company consummated the closing of the sale of 9,000 thousand ordinary shares pursuant to the exercise in full of the underwriter’s over-allotment option. An additional 145,370 thousand ordinary shares were issued for $10.00 per share on November 30, 2017 in advance of the Business Combination.

In accordance with the Merger Agreement, FGL’s common stock outstanding as of the date of the business combination were retired and ceased to exist upon conversion.

Preferred Stock

On November 30, 2017, the Company issued 275 thousand shares of Series A Cumulative Preferred Shares ("Series A Preferred Shares"), $1,000 liquidation preference per share for $275, and 100 thousand Series B Cumulative Convertible Preferred Shares ("Series B Preferred Shares"), $1,000 liquidation per share for $100. In connection with offering of the Series A Preferred Shares and Series B Preferred Shares, the Company incurred $12 of issuance costs which have been recorded as a reduction of additional paid-in-capital.

The Series A Preferred Shares and the Series B Preferred Shares (together, the "preferred shares") do not have a maturity date and are non-callable for the first five years. The dividend rate of the preferred shares is 7.5% per annum, payable quarterly in cash or additional preferred shares, at the Company's option, subject to increase beginning 10 years after issuance based on the then-current three-month LIBOR rate plus 5.5%. In addition, commencing 10 years after issuance of the preferred shares, and following a failed remarketing event, the holders of the preferred shares will have the right to convert their preferred shares into ordinary shares of the Company as determined by dividing (i) the aggregate par value (including dividends paid in kind and unpaid accrued dividends) of the preferred shares that the holders of the preferred shares wish to convert by (ii) the higher of (a) 5% discount to the 30-day volume weighted average of the ordinary shares following the conversion notice, and (b) the then-current floor price. The floor price will be $8.00 per share during the 11th year post-funding, $7.00 per share during the 12th year post funding, and $6.00 during the 13th year post-funding and thereafter.

Warrants

The Company issued 34,500 thousand warrants as part of the units sold in the IPO. The Company issued 15,800 thousand and 1,500 thousand warrants to CF Capital Growth, LLC, at $1.00 per private placement warrant in a private placement consummated simultaneously with the closing of the IPO and upon conversion of working capital loans at the time of the business combination, respectively. In connection with forward purchase agreements, at the closing of the business combination the Company issued 19,083 thousand forward purchase warrants to the anchor investors. The forward purchase warrants have identical terms as the public warrants.

Each whole warrant entitles the holder thereof to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as described below, at any time commencing December 30, 2017, provided that the Company has an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or we permit holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the warrants (the “warrant agreement”)) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of ordinary shares. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued and only whole warrants trade. The warrants will expire on November 30, 2022, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

We have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of our ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30 trading-day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by us, the Company may exercise our redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

F-64

The Company conducted an offer to exchange its outstanding warrants for 0.11 ordinary shares of the Company, par value $0.0001 (the "Exchange Shares") and $0.98, in cash without interest, per warrant, which expired on October 4, 2018. A total of 65,374 thousand warrants were properly tendered prior to the expiration of the offer to exchange. On October 9, 2018 the Company issued 7,191 thousand shares and paid $64 in cash in exchange for the warrants tendered. After completion of the Offer to Exchange, 5,510 thousand warrants still remain outstanding, which will expire on November 30, 2022, or upon earlier redemption or liquidation.

Share Repurchases

On December 19, 2018, the Company's Board of Directors authorized a share repurchase program of up to $150 of the Company's outstanding common stock. This program will expire on December 15, 2020, and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company.

During the years ended December 31, 2019 and December 31, 2018, the Company purchased 8,052 and 600 thousand shares, respectively, for a total cost of $65 and $4, respectively. As of December 31, 2019, the Company had repurchased 8,652 thousand shares for a total cost of $69.

Dividends

The Company declared the following cash dividends to its common shareholders during the year ended December 31, 2019:

Date Declared	Date Paid	Date Shareholders of record	Shareholders of record (in thousands)	Cash Dividend declared (per share)	Total cash paid
February 27, 2019	April 1, 2019	March 18, 2019	221,661	$0.01	$2
May 7, 2019	June 10, 2019	May 28, 2019	221,661	$0.01	$2
August 7, 2019	September 9, 2019	August 26, 2019	221,661	$0.01	$2
November 6, 2019	December 9, 2019	November 25, 2019	221,661	$0.01	$2

On February 26, 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on March 30, 2020 to shareholders of record as of the close of business on March 16, 2020.

F-65

The Company declared the following dividends to its preferred shareholders during the years ended December 31, 2019 and December 31, 2018:

Type of Preferred Share	Date Declared	Date Paid	Date Shareholders of record	Shareholders of record (in thousands)	Method of Payment	Total cash paid	Total shares paid in kind (in thousands)
Series A Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	277	Paid in kind	$—	5
Series B Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	101	Paid in kind	$—	1
Series A Preferred Shares	June 29, 2018	July 1, 2018	June 15, 2018	282	Paid in kind	$—	5
Series B Preferred Shares	June 29, 2018	July 1, 2018	June 15, 2018	102	Paid in kind	$—	2
Series A Preferred Shares	September 28, 2018	October 1, 2018	September 15, 2018	287	Paid in kind	$—	5
Series B Preferred Shares	September 28, 2018	October 1, 2018	September 15, 2018	104	Paid in kind	$—	2
Series A Preferred Shares	December 31, 2018	January 1, 2019	December 15, 2018	293	Paid in kind	$—	6
Series B Preferred Shares	December 31, 2018	January 1, 2019	December 15, 2018	106	Paid in kind	$—	2
Series A Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	298	Paid in kind	$—	6
Series B Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	108	Paid in kind	$—	2
Series A Preferred Shares	June 28, 2019	July 1, 2019	June 15, 2019	304	Paid in kind	$—	6
Series B Preferred Shares	June 28, 2019	July 1, 2019	June 15, 2019	110	Paid in kind	$—	2
Series A Preferred Shares	September 30, 2019	October 1, 2019	September 15, 2019	310	Paid in kind	$—	6
Series B Preferred Shares	September 30, 2019	October 1, 2019	September 15, 2019	112	Paid in kind	$—	2
Series A Preferred Shares	December 31, 2019	January 1, 2020	December 15, 2019	316	Paid in kind	$—	5
Series B Preferred Shares	December 31, 2019	January 1, 2020	December 15, 2019	114	Paid in kind	$—	3

Restricted Net Assets of Subsidiaries

CF Bermuda’s equity in restricted net assets of consolidated subsidiaries was approximately $2,501 as of December 31, 2019 representing 91% of CF Bermuda’s consolidated stockholder’s equity as of December 31, 2019 and consisted of net assets of CF Bermuda which were restricted as to transfer to the Company in the form of cash dividends, loans or advances under regulatory restrictions.

F-66

(10) Stock Compensation

On August 8, 2017, the Company adopted a stock-based incentive plan (the “FGL Incentive Plan”) that permits the granting of awards in the form of qualified stock options, non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, unrestricted stock, performance-based awards, dividend equivalents, cash awards and any combination of the foregoing. The Company’s Compensation Committee is authorized to grant up to 15,006 thousand equity awards under the Incentive Plan. At December 31, 2019, 5,712 thousand equity awards are available for future issuance.

FGL Incentive Plan

The Company granted 7,749 thousand and 17,255 thousand stock options to certain officers during the twelve months ended December 31, 2019 and 2018 that vest based on continued service with the Company or a combination of continued service and Company performance (adjusted operating income return on equity or stock price performance). The total fair value of the awards granted during twelve months ended December 31, 2019 and 2018 was $12 and $32, respectively.

The fair value of the options is expensed over the requisite service period, which generally corresponds to the vesting period. To value the options granted with service and adjusted operating income return on equity performance vesting conditions, a Black Scholes valuation model was used. To value the options granted with stock price performance vesting conditions, a Monte Carlo simulation was used. A summary of the Company’s outstanding stock options as of December 31, 2019, and related activity during the twelve months ended December 31, 2019, is as follows (share amount in thousands):

Stock Option Awards	Options		Weighted Average Exercise Price
Stock options outstanding at December 31, 2018	13,007		$	9.68
Granted	7,749		9.18
Exercised	—		—
Forfeited or expired	(5,542	)	10.00
Stock options outstanding at December 31, 2019	15,214		9.30
Exercisable at December 31, 2019	1,009		9.16
Vested or projected to vest at December 31, 2019	15,214		$	9.30

The Company granted 147 thousand and 112 thousand restricted shares to directors in the twelve months ended December 31, 2019 and 2018, which vested on December 31, 2019 and 2018, respectively. The total fair value of the restricted shares granted in the twelve months ended December 31, 2019 and 2018 was $1 and $1, respectively.

A summary of the Company’s nonvested restricted shares outstanding as of December 31, 2019, and related activity during the twelve months ended, is as follows (share amount in thousands):

Restricted Stock Awards	Shares		Weighted Average Grant Date Fair Value
Restricted shares outstanding at December 31, 2018	—		$	—
Granted	147		6.82
Vested	(147	)	6.82
Vested or expected to vest at December 31, 2019	—		—

Management Incentive Plan

In the twelve months ended December 31, 2019 and 2018, the Company granted 541 thousand and 374 thousand phantom units to members of management under a management incentive plan (the "Management Incentive Plan"). The phantom units are settled in cash, and therefore the Management Incentive Plan is classified as a liability plan. The value of this plan is classified within "Other liabilities" on the Consolidated Balance Sheets and is adjusted each period, with a corresponding adjustment to “Acquisition and operating expenses, net of deferrals”, to reflect changes in the Company’s stock price. See "Note 2. Significant Accounting Policies and Practices" for a more detailed discussion of stock-based compensation. The total fair value of the phantom units granted in the twelve months ended December 31, 2019 and 2018 was $5 and $3, respectively.

F-67

One half of the phantom units vest in three equal installments on each March 15^th from 2019 to 2021, subject to awardees continued service with the Company. The other half will begin vesting on March 15, 2020 and cliff vest on March 15, 2021 based on continued service and attainment of a performance metric: adjusted operating income return on equity for the fiscal year 2020.

At December 31, 2019, the liability for phantom units of $1 was based on the number of units granted, the elapsed portion of the service period and the fair value of the Company’s common stock on that date which was $10.65.

A summary of the Management Incentive Plan nonvested phantom units outstanding as of December 31, 2019, and related activity during the twelve months ended is as follows (share amount in thousands):

Phantom units	Shares		Weighted Average Grant Date Fair Value
Phantom units outstanding at December 31, 2018	356		$	8.95
Granted	541		8.54
Vested	(59	)	10.00
Forfeited or expired	(93	)	9.33
Phantom units outstanding at December 31, 2019	745		$	9.02

The Company recognized total stock compensation expense related to the FGL Incentive Plan and Management Incentive Plan is as follows:

	Year ended
	December 31, 2019		December 31, 2018
Total stock compensation expense	5		4
Related tax benefit	1		1
Net stock compensation expense	$	4	$	3

The stock compensation expense is included in "Acquisition and operating expenses, net of deferrals" in the Company's Consolidated Statements of Operations.

Total compensation expense related to the FGL Incentive Plan and Management Incentive Plan not yet recognized as of December 31, 2019 and the weighted-average period over which this expense will be recognized are as follows:

	Unrecognized Compensation Expense		Weighted Average Recognition Period in Years
FGL Incentive Plan	$	18	3
Management Incentive Plan	4		2
Total unrecognized stock compensation expense	$	22	3

(11) Income Taxes

The Company is a Cayman-domiciled corporation that has operations in Bermuda and the U.S. Neither the Cayman Islands nor Bermuda impose a corporate income tax. The Company’s U.S. non-life subsidiaries file a consolidated non-life U.S. Federal income tax return. For tax years prior to December 1, 2017, the non-life members were included in the consolidated U.S. Federal income tax return of HRG, the majority owner of FGL prior to the execution of the FGL Merger Agreement on November 30, 2017. The income tax liabilities of the Company as former members of the consolidated HRG return were calculated using the separate return method as prescribed in ASC 740. The Company’s US life insurance subsidiaries file a separate life subgroup consolidated U.S. Federal income tax return. The life insurance companies will be eligible to join in a consolidated filing with the U.S. non-life companies in 2022.

On May 24, 2017, the Company, HRG Group, Inc. ("HRG"), the majority owner of FGL prior to the execution of the FGL merger agreement on November 30, 2017, and CF Corp executed a letter agreement (the “side letter”)

F-68

which set forth the settlement provisions between the parties related to the Section 338(h)(10) transaction. The Section 338(h)(10) election treated the merger as an asset acquisition for U.S. tax purposes resulting in stub period tax yearends for both the life and non-life subsidiaries within the target group acquired as part of the acquisition. The side letter agreement between the parties specified that the purchase price would be adjusted for incremental tax costs attributable to the election. As such, the Company made two payments to HRG totaling $57 in March and May of 2018. The target 338(h)(10) group did not include FSRC, a 953(d) election U.S. tax payer. Any tax liability of the non-life entities’ arising from the deemed asset sale were reflected on HRG’s consolidated return, with the Companies’ non-life entities retaining successor liability. The life entities filed a separate final short-period return reflecting gain (or loss) from the deemed asset sale.

The Company’s U.S. subsidiaries are taxed at corporate rates on taxable income based on existing U.S. tax laws. Current income taxes are charged or credited to net income based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year.

Deferred income taxes are provided for the tax effect of temporary differences in the financial reporting and income tax bases of assets and liabilities, net operating loss carryforwards and tax credit carryforwards using enacted income tax rates and laws. The effect on deferred income tax assets and deferred income tax liabilities of a change in tax rates is recognized in net income in the period in which the change is enacted. A valuation allowance is required if it is more likely than not that a deferred tax asset will not be realized. In assessing the need for a valuation allowance, we considered the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxable income from prior years available for recovery and tax planning strategies. Based on the available positive and negative evidence regarding future sources of taxable income, we have determined that the establishment of a valuation allowance was necessary for the U.S. non-life companies at December 31, 2019. The valuation allowance reflects a history of cumulative losses for the US nonlife subgroup. In addition, due to the debt structure of the US non-life entities, particularly at the holding company level, it is unlikely the US non-life subgroup will be in a net cumulative taxable income position in a near term projection window. During the quarter ended September 30, 2019, Management determined that a valuation allowance was no longer needed for the ordinary deferred tax assets of FSRC based on positive evidence including: cumulative three-year income, future projected earnings, and management’s ability to implement a future tax planning strategy if needed. Therefore, the valuation allowance against the FSRC deferred tax assets at that date was released and the Company recorded an $18 million gain in operating income during that quarter related to the release. The Company still maintains a valuation allowance against FSRC’s capital deferred tax assets due to lack of sufficient sources of income in which to recognize them. All other deferred tax assets were more likely than not to be realized based on expectations regarding future taxable income and considering all other available evidence, both positive and negative.

The Tax Cut and Jobs Act (“TCJA”) was enacted on December 22, 2017, and it amended many provisions of the Internal Revenue Code that have effects on the Company. Because the TCJA reduced the statutory tax rate from 35% to 21%, the Company was required to remeasure its deferred tax assets and liabilities using the lower rate at the December 22, 2017, date of enactment. This remeasurement resulted in a reduction of net deferred tax assets of $131, which includes a $0 benefit related to deferred taxes previously recognized in accumulated other comprehensive income. The Company evaluated whether or not to make a Section 953(d) election with respect to F&G Life Re Ltd. which would have resulted in F&G Life Re Ltd. being treated as if it were a US Tax Payer. Ultimately, the Company chose to be subject to the Base Erosion and Anti-Abuse Tax ("BEAT") through September 30, 2018 and then recapture the business that was subject to the Modco Agreement. The Modco Agreement was terminated effective September 30, 2018.

The SEC’s Staff Accounting Bulletin No. 118 (“SAB 118”) provides guidance on accounting for the effects of U.S. tax reform in circumstances in which an exact calculation cannot be made, but for which a reasonable estimate can be determined. December 22, 2018 marked the end of the measurement period for purposes of SAB 118. As such, we have completed our analysis based on the legislative updates relating to TCJA currently available. The only provision amount utilized in the preparation of the Company's December 31, 2017 financial statements was tax reserves. There are no provisional amounts utilized in the preparation of the Company’s December 31, 2018 or 2019 financial statements.

F-69

Income tax (expense) benefit is calculated based upon the following components of income before income taxes:

	Year ended												Year ended
	December 31, 2019		December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
									Predecessor		Predecessor		Predecessor
Pretax income (loss):
United States	$	467	$	(271	)	$	(55	)	$	44	$	163	$	333
Outside the United States	101		300			74			—		—		—
Total pretax income	$	568	$	29		$	19		$	44	$	163	$	333

The components of income tax (expense) benefit are as follows:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Current:
Federal	$	(22	)	$	(42	)	$	(5	)	$	(23	)	$	21		$	(114	)
State	—			—			—			—			—			—
Total current	$	(22	)	$	(42	)	$	(5	)	$	(23	)	$	21		$	(114	)
Deferred:
Federal	$	(39	)	$	26		$	(105	)	$	7		$	(76	)	$	4
State	—			—			—			—			—			—
Total deferred	$	(39	)	$	26		$	(105	)	$	7		$	(76	)	$	4
Income tax (expense)/benefit	$	(61	)	$	(16	)	$	(110	)	$	(16	)	$	(55	)	$	(110	)

F-70

The difference between income taxes expected at the U.S. Federal statutory income tax rate of 21% and reported income tax (expense) benefit is summarized as follows:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Expected income tax (expense)/benefit at Federal statutory rate	$	(119	)	$	(6	)	$	(7	)	$	(15	)	$	(57	)	$	(117	)
Valuation allowance for deferred tax assets	39			(38		)	13			(2		)	—			1
Amortization of low income housing tax credits	(8		)	(4		)	(1		)	(1		)	—			(4		)
Benefit on LIHTC under proportional amortization method	9			5			—			1			—			5
Write off of expired capital loss carryforward	—			—			—			—			—			—
Remeasurement of deferred taxes under U.S. tax reform	—			—			(131		)	—			—			—
Dividends received deduction	4			5			—			1			—			4
Benefit on Outside of United States Income taxed at 0%	21			63			26			—			—			—
Withholding Tax on 0% Taxed Jurisdictions	(5		)	—			—			—			—			—
Write off of 382 Limited NOL	—			—			(12		)	—			—			—
Base Erosion & Antiabuse Tax "BEAT"	—			(44		)	—			—			—			—
Other	(2		)	3			2			—			2			1
Reported income tax (expense)/benefit	$	(61	)	$	(16	)	$	(110	)	$	(16	)	$	(55	)	$	(110	)
Effective tax rate	11		%	55		%	579		%	37		%	34		%	33		%

For the year ended December 31, 2019, the Company’s effective tax rate was 11%. The effective tax rate was positively impacted by the valuation allowance release on the US life companies’ prior year unrealized capital losses and the FSRC ordinary deferred tax assets, as well as the benefit of low taxed international income in excess of withholding taxes, and favorable permanent adjustments, including low income housing tax credits ("LIHTC") and the dividends received deduction ("DRD").

For the year ended December 31, 2018, the Company’s effective tax rate was 55%. The effective tax rate was negatively impacted by the valuation allowance expense on the US life companies’ unrealized capital losses and the FSRC and non-life insurance companies’ deferred tax assets. The negative impacts of the valuation allowance were partially offset by the benefit of low taxed international income in excess of the BEAT, and favorable permanent adjustments, including LIHTC and the DRD.

For the period December 1, 2017 to December 31, 2017, the Company’s effective tax rate includes the effects of rate change from 35% to 21% in connection with TCJA as well as certain reinsurance effects between the Companies' onshore and offshore insurance entities. Reversing out the effects of the tax reform rate change and impacts of FAS 133/DIGB36, (i.e. Embedded Derivatives impacts under Modified Coinsurance Arrangements) in regards to US/offshore reinsurance treatment of unrealized gains on funds withheld assets, results in an adjusted effective rate for the period of approximately 34% and is a more useful comparative to prior period rates reflected in the schedule above. The effective tax rate was impacted by tax expense recorded related to the remeasurement of deferred tax assets and liabilities as a result of tax reform. Additionally, the tax rate was positively impacted by income earned by foreign companies that is taxed at 0%.

For the Predecessor period October 1, 2017 to November 30, 2017, the Company’s effective tax rate was 37% (for Predecessor periods, references to “the Company” are to its predecessor). The negative impact of the valuation allowance expense of the non-life companies was partially offset by the net impact of positive permanent adjustments, including LIHTC and the DRD.

For the Predecessor period October 1, 2016 to December 31, 2016 (unaudited), the Company’s effective tax rate was 34%. The effective tax rate was impacted by favorable permanent adjustments, including LIHTC.

F-71

For the Predecessor year ended September 30, 2017, the Company’s effective tax rate was 33%. The effective tax rate was positively impacted by a valuation allowance release within the non-life companies and favorable permanent adjustments, including LIHTC and the DRD.

For the year ended December 31, 2019, the Company recorded a net valuation allowance release of $39 (comprised of a full year valuation allowance release of $14 related to the U.S. life insurance companies' unrealized capital losses on equity securities that are recorded through net income and $31 related to FSRC ordinary deferred tax assets, partially offset by a net increase to valuation allowance of $6 related to the Company's non-life companies).

For the year ended December 31, 2018, the company recorded a net valuation allowance expense of $38 (comprised of a net increase to valuation allowance of $3 related to the Company’s non-life companies, a net increase to valuation allowance of $21 related to FSRC, and a net increase to valuation allowance of $14 related to the US life insurance companies unrealized capital losses on equity securities that are recorded through net income).

For the period from December 1, 2017 to December 31, 2017, the Company recorded a net valuation allowance release of $13 primarily related to the DTA write off of the Net Operating Loss ("NOL") on FSRC that would not be able to be utilized as a result of the Section 382 limitation created by the merger with CF Corporation. For the Predecessor period from October 1, 2017 to November 30, 2017, the Company recorded a net valuation allowance expense of $2 related to the Company’s non-life companies. For the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), the Company recorded a net valuation allowance release of $0.

For the Predecessor year ended September 30, 2017, the Company recorded a net valuation allowance release of $1 related to the Company's non-life companies.

The Company records tax expense (benefit) that results from a change in Other Comprehensive Income (“OCI”) directly to OCI. Tax expense recorded directly to OCI includes deferred tax expense arising from a change in unrealized gain (loss) on available-for-sale securities and the tax-effects of other income items that are recorded to OCI. Changes in valuation allowance that are solely due to a deferred tax asset related to the unrealized gain on an available-for-sale security are allocated to other comprehensive income in accordance with ASC 740-10-45-20, "Income Taxes: Other Presentation Matters".

The Company recorded the following deferred tax expense to OCI:

	Year ended													Year ended
	December 31, 2019			December 31, 2018		Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
									Predecessor			Predecessor		Predecessor
Deferred Tax Expense in OCI	$	(242	)	$	132	$	(19	)	$	(7	)	$	154	$	(56	)

An excess tax benefit is the realized tax benefit related to the amount of deductible compensation cost reported on an employer’s tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes. The Company adopted ASU-2016-09 (Stock Compensation) effective October 1, 2015. ASU-2016-09 eliminates the requirement for excess tax benefits to be recorded as additional paid-in capital when realized. For the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, the Company recorded all excess tax benefits in the Consolidated Statements of Operations as a component of current income tax expense in accordance with the newly adopted guidance.

The following table is a summary of the components of deferred income tax assets and liabilities:

F-72

	December 31, 2019			December 31, 2018
Deferred tax assets:
Net operating loss, credit and capital loss carryforwards	$	35		$	94
Insurance reserves and claim related adjustments	716			620
Unrealized Investment Losses	—			201
Derivatives	—			36
Deferred acquisition costs	—			—
Funds held under Reinsurance Agreements	11			—
Other	37			30
Valuation allowance	(14		)	(154		)
Total deferred tax assets	$	785		$	827
Deferred tax liabilities:
Value of business acquired	$	(124	)	$	(181	)
Unrealized Investment Gains	(221		)	—
Investments	(121		)	(133		)
Derivatives	(45		)	—
Deferred acquisition costs	(139		)	(76		)
Transition reserve on new reserve method	(63		)	(75		)
Funds held under Reinsurance Agreements	—			(11		)
Other	(11		)	(8		)
Total deferred tax liabilities	$	(724	)	$	(484	)
Net deferred tax assets and (liabilities)	$	61		$	343

For the year ended December 31, 2019, the Company's valuation allowance of $14 consisted of a full valuation allowance on the Company's non-life insurance net deferred taxes, and a full valuation allowance on FSRC's capital net deferred taxes.

For the year ended December 31, 2018, the Company's valuation allowance of $154 consisted of a valuation allowance of $115 on US life company unrealized capital loss deferred tax assets, a full valuation allowance on the Company's non-life insurance net deferred taxes, and a full valuation allowance on FSRC's net deferred taxes.

For the period from December 1, 2017 to December 31, 2017, the Company’s valuation allowance of $15 consisted of a valuation allowance of $0 on US life company deferred tax assets, a full valuation allowance on the Company’s non-life insurance net deferred taxes, and a full valuation allowance on FSRC's net deferred taxes.

As of December 31, 2019, the Company has NOL carryforwards of $165, consisting of NOL carryforwards of $113 on the US life companies and $52 on FSRC. A portion of the FSRC losses existed prior to the November 30, 2017 acquisition and are therefore subject to Section 382 limitations. The FSRC NOL carryforwards that existed prior to January 1, 2018 of $31 will expire in years 2031 - 2032, if unused. The remaining NOLs are not subject to any limitation and have an indefinite carryforward period.

The U.S. Federal income tax returns of the Company for years prior to 2016 are no longer subject to examination by the taxing authorities. With limited exception, the Company is no longer subject to state and local income tax audits for years prior to 2014. The Company does not have any unrecognized tax benefits (“UTBs”) at December 31, 2019, December 31, 2018, December 31, 2017, and September 30, 2017 (Predecessor). In the event the Company has UTBs, interest and penalties related to uncertain tax positions would be recorded as part of income tax expense in the financial statements. The Company regularly assesses the likelihood of additional tax assessments by jurisdiction and, if necessary, adjusts its tax reserves based on new information or developments.

F-73

(12) Commitments and Contingencies

Commitments

The Company has unfunded investment commitments as of December 31, 2019 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. A summary of unfunded commitments by invested asset class are included below:

	December 31, 2019
Asset Type
Other invested assets	$	1,202
Equity securities	14
Fixed maturity securities, available-for-sale	48
Other assets	78
Residential mortgage loans	16
Total	$	1,358

As of December 31, 2019, the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information.

Lease Commitments

The Company leases office space under non-cancelable operating leases that expire in May 2021 and January 2031. Rent expense and minimum rental commitments under non-cancelable leases are immaterial.

Contingencies

Regulatory and Litigation Matters

The Company is involved in various pending or threatened legal proceedings, including purported class actions, arising in the ordinary course of business. In some instances, these proceedings include claims for unspecified or substantial punitive damages and similar types of relief in addition to amounts for alleged contractual liability or requests for equitable relief. In the opinion of the Company's management and in light of existing insurance and other potential indemnification, reinsurance and established accruals, such litigation is not expected to have a material adverse effect on the Company's financial position, although it is possible that the results of operations and cash flows could be materially affected by an unfavorable outcome in any one period.

The Company is assessed amounts by state guaranty funds to cover losses to policyholders of insolvent or rehabilitated insurance companies. Those mandatory assessments may be partially recovered through a reduction in future premium taxes in certain states. At December 31, 2019, the Company has accrued $2 for guaranty fund assessments that is expected to be offset by estimated future premium tax deductions of $2.

The Company has received inquiries from a number of state regulatory authorities regarding our use of the U.S. Social Security Administration’s Death Master File (“Death Master File”) and compliance with state claims practices regulations and unclaimed property or escheatment laws. We have established procedures to periodically compare our in-force life insurance and annuity policies against the Death Master File or similar databases; investigate any identified potential matches to confirm the death of the insured; determine whether benefits are due, and attempt to locate the beneficiaries of any benefits due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. We believe we have established sufficient reserves with respect to these matters; however, it is possible that third parties could dispute these amounts and additional payments or additional unreported claims or liabilities could be identified which could be significant and could have a material adverse effect on our results of operations.

F-74

On June 30, 2017, a putative class action complaint was filed against FGL Insurance, FGL, and FS Holdco II Ltd in the United States District Court for the District of Maryland, captioned Brokerage Insurance Partners v. Fidelity & Guaranty Life Insurance Company, Fidelity & Guaranty Life, FS Holdco II Ltd, and John Doe, No. 17-cv-1815. The complaint alleges that FGL Insurance breached the terms of its agency agreement with Brokerage Insurance Partners (“BIP”) and other agents by changing certain compensation terms. The complaint asserts, among other causes of action, breach of contract, defamation, tortious interference with contract, negligent misrepresentation, and violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”).  The complaint seeks to certify a class composed of all persons who entered into an agreement with FGL Insurance to sell life insurance and who sold at least one life insurance policy between January 1, 2015 and January 1, 2017.  The complaint seeks unspecified compensatory, consequential, and punitive damages in an amount not presently determinable, among other forms of relief.

On September 1, 2017, FGL Insurance filed a counterclaim against BIP and John and Jane Does 1-10, asserting, among other causes of action, breach of contract, fraud, civil conspiracy and violations of RICO. On September 22, 2017, Plaintiff filed an Amended Complaint, and on October 16, 2017, FGL Insurance filed an Amended Counterclaim against BIP, Agent Does 1-10, and Other Person Does 1-10. The parties also filed cross-Motions to Dismiss in Part.

On August 17, 2018, the Court in the BIP Litigation denied all pending Motions to Dismiss filed by all parties without prejudice, pending a decision as to whether the BIP Litigation will be consolidated into related litigation, captioned Fidelity & Guaranty Life Insurance Company v. Network Partners, et al., Case No. 17-cv-1508. On August 31, 2018, FGL Insurance filed its Answer to BIP’s Amended Complaint. Also on that date, FGL Insurance filed its Answer to Amended Complaint, Affirmative Defenses, and Counterclaim, Filed Pursuant to Fed. R. Civ. P. 12(a)(4)(A).

On October 15, 2019, BIP filed with the Court an Unopposed Motion for Preliminary Approval of Settlement and Class Certification, along with a copy of the Class Action Settlement Agreement signed by all parties. A Fairness Hearing on Plaintiff’s Motion for Preliminary Approval of Class Settlement was held on Monday, January 13, 2020.

On January 15, 2020, the Court issued the Modified Findings and Order Preliminarily Approving Class Settlement Between Plaintiff and Defendants, Granting Conditional Certification of Settlement Class, Directing Issuance of Notice to the Class, and Setting of Final Approval Hearing. In preliminarily approving the Class Settlement, the Court also approved the Settlement Schedule that had been filed by Class Counsel on January 10, 2020.

Final settlement is subject to, among other requirements, satisfactory completion of confirmatory discovery by the Defendants and the Class Representative and final approval by the Court after Court-approved Notice has been provided to the absent members of the putative class.

As of the date of this report, the Company does not have sufficient information to determine whether it has exposure to any losses that would be either probable or reasonably estimable.

(13) Reinsurance

The Company reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured. The Company primarily seeks reinsurance coverage in order to limit its exposure to mortality losses and enhance capital management. The Company follows reinsurance accounting when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. The Company also assumes policy risks from other insurance companies.

F-75

The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017 were as follows:

	Year ended												Period from December 1 to December 31, 2017
	December 31, 2019						December 31, 2018
	Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred
Direct	$	204		$	1,277		$	223		$	646		$	17		$	142
Assumed	—			(19		)	—			(13		)	—			7
Ceded	(164		)	(201		)	(169		)	(210		)	(14		)	(25		)
Net	$	40		$	1,057		$	54		$	423		$	3		$	124

	Period from October 1 to November 30, 2017						Period from October 1 to December 31, 2016 (Unaudited)						Year ended
													September 30, 2017
	Predecessor						Predecessor						Predecessor
	Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred
Direct	$	36		$	267		$	57		$	69		$	233		$	1,097
Assumed	—			—			—			—			—			—
Ceded	(29		)	(40		)	(46		)	(49		)	(191		)	(254		)
Net	$	7		$	227		$	11		$	20		$	42		$	843

Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. The Company did not write off any significant reinsurance balances during the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, or the Predecessor year ended September 30, 2017. The Company did not commute any ceded reinsurance during the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, or the Predecessor year ended September 30, 2017.

No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance.

The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues.

Effective January 1, 2017, FGL Insurance entered into an indemnity reinsurance agreement with Hannover Re, a third party reinsurer, to reinsure an inforce block of its FIA and fixed deferred annuity contracts with GMWB and Guaranteed Minimum Death Benefit (“GMDB”) guarantees.  In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of the net retention of guarantee payments in excess of account value for GMWB and GMDB guarantees. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective July 1, 2017, FGL Insurance extended this agreement to include new business issued during 2017. Effective January 1, 2018, FGL Insurance extended this agreement to include new business issued during 2018 and extended the recapture period from 8 to 12 years. Effective January 1, 2019, FGL Insurance extended this agreement to include new business issued during 2019. FGL Insurance incurred risk charge fees of $17, $11, $2, $2 and $4 during the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, and the Predecessor year ended September 30, 2017, respectively, in relation to this reinsurance agreement.

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $758 of certain MYGA and deferred annuity GAAP reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of MYGA and deferred annuity policies for certain issue years to Kubera. Effective June

F-76

30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $185 of MYGA GAAP reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019.

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $4 billion of certain FIA statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of FIA policies for certain issue years to Kubera. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective June 30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $1 billion of FIA statutory reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019. The effects of the amendment are also not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP.

Intercompany Reinsurance Agreements

A description of significant intercompany reinsurance agreements appears below. All intercompany balances have been eliminated in the preparation of the Company’s consolidated financial statements. However, these agreements have a material impact on the regulatory capital position of FGL Insurance and the effective tax rate of the Company.

Effective December 31, 2012, FGL Insurance entered into a reinsurance treaty with FSRC, an affiliated reinsurer, whereby FGL Insurance ceded 10% of its June 30, 2012 in-force annuity block of business not already reinsured on a funds withheld basis. Effective September 17, 2014, FGL Insurance entered into a second reinsurance treaty with FSRC whereby FGL Insurance ceded 30% of any new business of its MYGA issued effective September 17, 2014 and later on a funds withheld basis. The September 17, 2014 treaty was subsequently terminated as to new business effective April 30, 2015, but will remain in effect for policies ceded to FSRC with an effective date between September 17, 2014 and April 30, 2015. Accordingly, MYGA policies issued with an effective date of May 1, 2015 and later will not be ceded to FSRC.

In anticipation of the merger of CF Corp. and FGL, a new Bermuda based reinsurance entity, F&G Life Re Ltd. (“F&G Life Re”) was formed as an indirect wholly owned subsidiary of the Company. Effective December 1, 2017, FGL Insurance entered into an indemnity modified coinsurance agreement with F&G Life Re to reinsure up to 80% of its in-force FIA business and 40% of its in-force deferred annuity business on a net retained basis. Effective October 1, 2018, FGL Insurance and F&G Life Re mutually agreed to terminate this reinsurance agreement. Upon termination of the reinsurance agreement, F&G Life Re made a $1,094 extraordinary dividend to its sole shareholder, CF Bermuda of which $830 was contributed to FGL Insurance to support the recapture of the insurance liabilities and to allow FGL Insurance to maintain appropriate solvency ratios.  The $1,094 extraordinary dividend included $750 return of capital which was approved by the Bermuda Monetary Authority (“BMA”).

Effective October 1, 2012, FGL Insurance entered into a reinsurance treaty with Raven Reinsurance Company ("Raven Re"), its wholly-owned captive reinsurance company, to cede the Commissioners Annuity Reserve Valuation Method (CARVM) liability for annuity benefits where surrender charges are waived. In connection with the CARVM reinsurance agreement, FGL Insurance and Raven Re entered into an agreement with Nomura Bank International plc (“NBI”) to establish a $295 reserve financing facility in the form of a letter of credit issued by NBI.

Effective January 1, 2019, the letter of credit facility was amended to reduce the available amount to $100 and extend the termination date to October 1, 2022, although the facility may terminate earlier, in accordance with the terms of the Reimbursement Agreement. Under the terms of the reimbursement agreement, in the event the letter of credit is drawn upon, Raven Re is required to repay the amounts utilized, and FGLH is obligated to repay the amounts utilized if Raven Re fails to make the required reimbursement. FGLH also is required to make capital contributions to Raven Re in the event that Raven Re’s statutory capital and surplus falls below certain defined levels. As of December 31, 2019 and 2018, Raven Re’s statutory capital and surplus was $33 and $20, respectively, in excess of the minimum level required under the Reimbursement Agreement.

As this letter of credit is provided by an unaffiliated financial institution, Raven Re is permitted to carry the letter of credit as an admitted asset on the Raven Re statutory balance sheet.

F-77

F&G Reinsurance Companies

FSRC has entered into various reinsurance agreements on a funds withheld basis, meaning that funds are withheld by the ceding company from the coinsurance premium owed to FSRC as collateral for FSRC's payment obligations. Accordingly, the collateral assets remain under the ultimate ownership of the ceding company. FSRC manages the assets supporting the reserves assumed in accordance with the internal investment policy of the ceding companies and applicable law.

At December 31, 2019 and 2018, FSRC had $307 and $275 of funds withheld receivables and $285 and $254 of insurance reserves related to these reinsurance treaties, respectively.

F&G Re has entered into multiple reinsurance agreements on a funds withheld basis with unaffiliated parties. At December 31, 2019 and December 31, 2018, F&G Re had $1,865 and $482 of funds withheld receivables, respectively, and $1,668 and $471, respectively, of insurance reserves related to these reinsurance treaties. Effective April 1, 2019, F&G Re entered into a reinsurance agreement with an unaffiliated company to reinsure an inforce block of fixed deferred annuity contracts on a 100% coinsurance funds withheld basis. In accordance with the terms of this agreement, F&G Re established a fair value of funds withheld asset and future policy benefits liability of $983 and $896, respectively.

See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts as described under the section titled "Reinsurance" in Note 2. Significant Accounting Policies and Practices.

(14) Related Party Transactions

Affiliated Investments

The Company has determined that related parties would fall into the following categories; (i) affiliates of the entity, (ii) entities for which investments in their equity securities would be required to be accounted for by the equity method by the investing entity, (iii) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management, (iv) principal owners (>10% equity stake) of the entity and members of their immediate families, (v) management (including BOD, CEO, and other persons responsible for achieving the objectives of the entity and who have the authority to establish policies and make decisions) of the entity and other members of their immediate families, (vi) other parties with which the entity may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests (vii) other parties that can significantly influence management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate business, (viii) attorney in fact of a reciprocal reporting entity or any affiliate of the attorney in fact, and (ix) a U.S. manager of a U.S. branch or any affiliate of the U.S. manager of a U.S. branch. The Company has determined that for the years ended December 31, 2019 and December 31, 2018, the Blackstone Group LP ("Blackstone") and its affiliates as well as the FGL Holdings’ directors and officers (along with their immediate family members) are FGL Holdings' related parties.

FGL Insurance, and certain subsidiaries of the Company, entered into investment management agreements (“IMAs”) with Blackstone ISG-I Advisors LLC (“BISGA”), a wholly-owned subsidiary of Blackstone on December 1, 2017. On December 31, 2019, to be effective as of October 31, 2019, FGL Insurance and certain subsidiaries of the Company entered into amended and restated IMAs (the “Restated IMAs”) with BISGA, pursuant to which BISGA was appointed as investment manager of the Company’s general accounts (the “F&G Accounts”). Pursuant to the terms of the IMAs, BISGA may delegate any or all of its discretionary investment, advisory and other rights, powers, functions and obligations under the IMAs to one or more sub-managers, including its affiliates. BISGA delegated certain investment services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors. For the year ended December 31, 2019, the fees paid to BISGA under the Restated IMAs and the IMAs were approximately $95. As of December 31, 2019 and 2018, the Company has a net liability of $47 and $20, respectively, for the services consumed under the Restated IMAs, the IMAs and related sub-management agreements, partially offset by fees received and expense reimbursements from BISGA.

F-78

During the years ended December 31, 2019 and December 31, 2018, the Company received expense reimbursements from BISGA for the services consumed under these agreements. Fees received for these types of services are $10 and $9 for years ended December 31, 2019 and December 31, 2018.

The Company holds certain fixed income security interests, limited partnerships and bank loans issued by portfolio companies that are affiliates of Blackstone Tactical Opportunities, an affiliate of Blackstone Tactical Opportunities LR Associates-B (Cayman) Ltd (the “Blackstone Fixed Income Securities”) both on a direct and indirect basis.  Indirect investments include an investment made in an affiliates’ asset backed fund while direct investments are an investment in affiliates' equity or debt securities.  As of December 31, 2019 and December 31, 2018, the Company held $2,001 and $1,461 in affiliated investments, respectively, which includes foreign exchange unrealized loss of $(3) and $(2), respectively. As of December 31, 2019 and December 31, 2018, the Company had unfunded commitments relating to affiliated investments of $993 and $990, respectively.

The Company purchased $89 and $185 of residential loans from Finance of America Holdings LLC, a Blackstone affiliate, during the year ended December 31, 2019 and on December 17, 2018, respectively. 

The Company earned $112, $33 and $1 net investment income for the years ended December 31, 2019 and December 31, 2018, and the period from December 1, 2017 to December 31, 2017, respectively, on affiliated investments. The Company had no gross realized gains (losses) and realized impairment losses on related party investments during the years ended December 31, 2019 and December 31, 2018 and the period from December 1, 2017 to December 31, 2017.

F-79

(15) Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands):

	Year Ended												Year ended
	December 31, 2019		December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
									Predecessor		Predecessor		Predecessor
Net income (loss)	$	507	$	13		$	(91	)	$	28	$	108	$	223
Less Preferred stock dividend	31		29			2			—		—		—
Net income (loss) available to common shares	476		(16		)	(93		)	28		108		223
Weighted-average common shares outstanding - basic	216,592		216,019			214,370			58,341		58,281		58,320
Dilutive effect of unvested restricted stock & PRSU	86		—			—			61		57		43
Dilutive effect of stock options	59		—			—			92		28		52
Weighted-average shares outstanding - diluted	216,738		216,019			214,370			58,494		58,366		58,415
Net income (loss) per common share:
Basic	$	2.19	$	(0.07	)	$	(0.44	)	$	0.48	$	1.85	$	3.83
Diluted	$	2.19	$	(0.07	)	$	(0.44	)	$	0.47	$	1.85	$	3.83

The number of shares of common stock outstanding used in calculating the weighted average thereof reflects the actual number of FGL Holdings shares of common stock outstanding, excluding unvested restricted stock and shares held in treasury.

The calculation of diluted earnings per share excludes the incremental effect of warrants, preferred shares and options due to their anti-dilutive effect for the following periods:

	Year Ended					Year ended
	December 31, 2019	December 31, 2018	Period from December 1 to December 31, 2017	Period from October 1 to November 30, 2017	Period from October 1 to December 31, 2016 (Unaudited)	September 30, 2017
(in thousands)				Predecessor	Predecessor	Predecessor
Warrants	5,510	55,838	70,883	—	—	—
Preferred shares	430	399	375	—	—	—
Options and restricted shares	1,346	863	—	—	31	—

Under applicable accounting guidance, companies in a loss position are required to use basic weighted average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our net loss for the year ended December 31, 2018, we were required to use basic weighted-average common shares outstanding in the calculation of the year ended December 31, 2018 diluted loss per share, as the inclusion of shares for restricted stock of 35 thousand would have been antidilutive to the calculation. If we had not incurred a net loss in the year ended December 31, 2018, dilutive potential common shares would have been 216 million.

The preferred stock shares outstanding as of December 31, 2019 and December 31, 2018 are anti-dilutive as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met.    

F-80

(16) Insurance Subsidiary Financial Information and Regulatory Matters

The Company’s U.S. insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect DAC, DSI and VOBA, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items.

FSRC (Cayman), F&G Re (Bermuda) and F&G Life Re (Bermuda) file financial statements based on U.S. GAAP with their respective regulators.

The Company’s principal insurance subsidiaries’ statutory (SAP and GAAP) financial statements are based on a December 31 year end. Statutory net income and statutory capital and surplus of the Company’s wholly-owned insurance subsidiaries were as follows:

	Subsidiary (state/country of domicile) (a)
	FGL Insurance (IA)			FGL NY Insurance (NY)			F&G Life Re (Bermuda)
Statutory Net Income (loss):
Year ended December 31, 2019	$	152		$	(1	)	$	3
Year ended December 31, 2018	(151		)	(3		)	319
Statutory Capital and Surplus:
December 31, 2019	$	1,513		$	95		$	2
December 31, 2018	1,545			85			2

(a) FGL NY Insurance is a subsidiary of FGL Insurance, and the columns should not be added together.

	Subsidiary (state/country of domicile)
	FSR (Cayman)			F&G Re (Bermuda)
Statutory Net Income (loss):
Year ended December 31, 2019	$	(29	)	$	69
Year ended December 31, 2018	(29		)	(14		)
Statutory Capital and Surplus:
December 31, 2019	$	73		$	295
December 31, 2018	73			38

Capital Requirements and Restrictions on Dividends and Distribution

U.S. Companies

The amount of statutory capital and surplus necessary to satisfy the applicable regulatory requirements is less than FGL Insurance’s and FGL NY Insurance’s respective statutory capital and surplus.

Life insurance companies domiciled in the U.S. are subject to certain Risk-Based Capital (“RBC”) requirements as specified by the NAIC. The RBC is used to evaluate the adequacy of capital and surplus maintained by an insurance company in relation to risks associated with: (i) asset risk, (ii) insurance risk, (iii) interest rate risk and (iv) business risk. The Company monitors the RBC of FGLH’s insurance subsidiaries. As of December 31, 2019 and December 31, 2018, each of FGLH's insurance subsidiaries had exceeded the minimum RBC requirements.

The Company’s insurance subsidiaries domiciled in the U.S. are restricted by state laws and regulations as to the amount of dividends they may pay to their parent without regulatory approval in any year, the purpose of which is to protect affected insurance policyholders, depositors or investors. Any dividends in excess of limits are deemed “extraordinary” and require regulatory approval. In addition, and pursuant to an order issued in connection with the approval of the Merger Agreement by the Iowa Commissioner on November 28, 2017, FGL Insurance shall not pay any dividend or other distribution to shareholders prior to November 28, 2021 without the prior

F-81

approval of the Iowa Commissioner. In September 2019 and December 2019, upon approval by the Iowa Commissioner, FGL Insurance declared and paid, respectively, extraordinary dividends of $100 to its Parent, FGLH.

FGL Insurance applies Iowa-prescribed accounting practices that permit Iowa-domiciled insurers to report equity call options used to economically hedge FIA index credits at amortized cost for statutory accounting purposes and to calculate FIA statutory reserves such that index credit returns will be included in the reserve only after crediting to the annuity contract. This resulted in a $110 decrease and $30 increase to statutory capital and surplus at December 31, 2019 and December 31, 2018, respectively.

Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance which increased Raven Re’s statutory capital and surplus by $6 and $0 at December 31, 2019 and December 31, 2018, respectively. Without such permitted statutory accounting practices Raven Re’s statutory capital and (deficit) surplus would be $(19) and $(16) at December 31, 2019 and December 31, 2018, respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent. FGL Insurance’s statutory carrying value of Raven Re at December 31, 2019 and December 31, 2018 was $87 and $94, respectively.

Effective April 1, 2019, Raven Re and FGL Insurance executed the third amended and restated Reinsurance Agreement (the "CARVM treaty"). The amendment allowed Raven Re to declare and pay a one-time dividend of up to $30 to FGL Insurance provided that the dividend was paid on or before June 30, 2020 and subject to other provisions outlined in the amendment. The Vermont Department of Financial Regulation approved the amendment on April 15, 2019. Pursuant to the provisions of the amended CARVM treaty, Raven Re paid a $20 dividend to FGL Insurance in June 2019.

FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset which increased Raven Re’s statutory capital and surplus by $100 and $110 at December 31, 2019 and December 31, 2018, respectively.

Pursuant to an order issued in connection with the Merger agreements, F&G Life Re will not, for a period of three (3) years from November 28, 2017, declare, set aside or distribute any dividends or distributions other than solely (a) dividends or distributions that would be permitted in accordance with Section 521A.5(3) of the Iowa Code if F&G Life Re were a life insurance company domesticated in Iowa, upon prior written notice to the Iowa Commissioner, but limited only to the amount necessary to service interest payments on outstanding indebtedness and other obligations of CF Bermuda and FGLH, and (b) dividends or distributions upon written notice to, and with the prior written approval of, the Iowa Commissioner.

The prescribed and permitted statutory accounting practices have no impact on the Company’s unaudited condensed consolidated financial statements which are prepared in accordance with GAAP.

As of December 31, 2019, FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices.

On May 14, 2018, FGLH made a dividend payment of $27 to FGL US Holdings, Inc. ("FGL US Holdings"). On June 28, 2018, FGL US Holdings issued a $65 intercompany note to F&G Life Re and subsequently approved a $65 capital contribution to its wholly owned subsidiary, FGLH. On June 28, 2018, FGLH made a capital contribution for $125 to FGL Insurance. On July 3, 2018, CF Bermuda issued a $50 intercompany note to F&G Life Re and subsequently approved a $50 capital contribution to its wholly owned subsidiary, F&G Re. On April 3, 2019, CF Bermuda made a capital contribution of $2 to Freestone. In 2019, CF Bermuda made capital contributions of $198 to F&G Re.

Non-U.S. companies

As licensed class C insurers in Bermuda, F&G Life Re and F&G Re are required to maintain available capital and surplus at a level equal to or in excess of the applicable enhanced capital requirement ("ECR"), which is established by reference to either the applicable Bermuda Solvency Capital Requirements ("BSCR") model or an approved internal capital model. Furthermore, to enable the Bermuda Monetary Authority ("BMA") to better assess the quality of the insurer’s capital resources, a Class C insurer is required to disclose the makeup of its capital in accordance with its 3-tiered capital system. An insurer may file an application under the Insurance Act to have the aforementioned ECR requirements waived.

In addition to the requirements under the Companies Act (as discussed below), the Insurance Act limits the maximum amount of annual dividends and distributions that may be paid or distributed by F&G Life Re and F&G Re without prior regulatory approval.

F-82

F&G Life Re and F&G Re are prohibited from declaring or paying a dividend if it fails to meet its minimum solvency margin, or ECR, or if the declaration or payment of such dividend would cause such breach. Additionally, annual distributions that would result in a reduction of the insurer’s prior year-end balance of statutory capital and surplus by more than 25% also requires the prior approval of the BMA.

If F&G Life Re or F&G Re were to fail to meet its minimum solvency margin on the last day of any financial year, it would be prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA.

In addition, as Class C insurers, each of F&G Life Re and F&G Re must: (i) not make any payment from its long-term business fund for any purpose other than a purpose of the insurer’s long-term business, except in so far as such payment can be made out of any surplus certified by the insurer’s approved actuary to be available for distribution otherwise than to policyholders; and (ii) not declare or pay a dividend to any person other than a policyholder unless the value of the assets of its long-term business fund, as certified by the insurer’s approved actuary, exceeds the extent (as to certified) of the liabilities of the insurer’s long-term business. In the event a dividend complies with the above, each of F&G Life Re and F&G Re must ensure the amount of any such dividend does not exceed the aggregate of (i) that excess and (ii) any other funds properly available for the payment of dividend, being funds arising out of business of the insurer other than long-term business.

The Companies Act also limits F&G Life Re’s and F&G Re’s ability to pay dividends and make distributions to its shareholders. Each of F&G Life Re and F&G Re is not permitted to declare or pay a dividend, or make a distribution out of its contributed surplus, if it is, or would after the payment be, unable to pay its liabilities as they become due or if the realizable value of its assets would be less than its liabilities.

The laws and regulations of the Cayman Islands require that, among other things, FSRC maintain minimum levels of statutory capital, surplus and liquidity, meet solvency standards, submit to periodic examinations of its financial condition and restrict payments of dividends and reductions of capital. Statutes, regulations and policies that FSRC is subject to may also restrict the ability of FSRC to write insurance and reinsurance policies, make certain investments and distribute funds. Any failure to meet the applicable requirements or minimum statutory capital requirements could subject it to further examination or corrective action by Cayman Islands Monetary Authority ("CIMA"), including restrictions on dividend payments, limitations on our writing of additional business or engaging in finance activities, supervision or liquidation.

F-83

(17) Other Liabilities

Other liabilities consisted of the following:

	December 31, 2019		December 31, 2018
Amounts payable for investment purchases	$	11	$	39
Retained asset account	141		162
Option collateral liabilities	446		59
Remittances and items not allocated	119		101
Accrued expenses	116		72
Deferred reinsurance revenue	17		39
Unearned revenue liability	43		41
Preferred shares reimbursement feature embedded derivative	17		29
Negative cash liability	69		126
Commissions payable	13		9
Funds withheld embedded derivative	33		—
Rabbi trust investment	36		26
Other	47		(3		)
Total	$	1,108	$	700

(18) Quarterly Results (Unaudited)

Unaudited quarterly results of operations are summarized below.

	Quarter ended
	December 31, 2019		September 30, 2019		June 30, 2019		March 31, 2019
	(Dollars in millions, except per share data)
Premiums	$	7	$	9	$	8	$	16
Net investment income	324		301		315		289
Net investment gains (losses)	196		103		135		240
Insurance and investment product fees and other	36		42		37		55
Total revenues	563		455		495		600
Total benefits and expenses	282		391		428		412
Net income (loss)	225		65		46		171
Net income (loss) per common share - basic	1.02		0.26		0.17		0.74
Net income (loss) per common share - diluted	1.02		0.26		0.17		0.74

	Quarter ended
	December 31, 2018			September 30, 2018		June 30, 2018			March 31, 2018
	(Dollars in millions, except per share data)
Premiums	$	9		$	12	$	15		$	18
Net investment income	295			267		282			263
Net investment gains (losses)	(555		)	119		(2		)	(191		)
Insurance and investment product fees and other	40			46		45			48
Total revenues	(211		)	444		340			138
Total expenses	(20		)	365		280			28
Net income (loss)	(148		)	56		40			65
Net income (loss) per common share - basic	(0.70		)	0.23		0.15			0.27
Net income (loss) per common share - diluted	(0.70		)	0.23		0.15			0.27

F-84

Note 19. Subsequent Events

The equity market volatility subsequent to December 31, 2019 has the potential to materially impact the fair value of the Company’s invested assets, including derivatives, and policyholder liabilities.  In addition, a disruption in the financial and credit markets increases the risk of credit defaults.  As of the date of this filing, the Company has not quantified the impact of such equity market volatility on its consolidated financial statements.

F-85

Schedule I

FGL HOLDINGS

Summary of Investments - Other than Investments in Related Parties

December 31, 2019

(in millions)

	Amortized Cost		Fair Value		Amount at which shown on the balance sheet
Fixed Maturities:
Bonds:
United States Government and government agencies and authorities	$	166	$	168	$	168
States, municipalities and political subdivisions	1,284		1,343		1,343
Foreign governments	138		155		155
Public utilities	2,345		2,453		2,453
All other corporate bonds	18,981		19,607		19,607
Total fixed maturities	22,914		23,726		23,726
Equity securities:
Common stocks:
Banks, trust, and insurance companies	70		68		68
Industrial, miscellaneous and all other	2		2		2
Nonredeemable preferred stock	997		1,001		1,001
Total equity securities	1,069		1,071		1,071
Derivative investments	336		587		587
Mortgage loans	1,267		1,283		1,267
Other long-term investments	1,306		1,288		1,303
Total investments	$	26,892	$	27,955	$	27,954

See Report of Independent Registered Public Accounting Firm.

F-86

Schedule II

FGL HOLDINGS (Parent Only)

CONDENSED BALANCE SHEETS

(in millions)

	December 31, 2019			December 31, 2018
ASSETS
Investments in consolidated subsidiaries	$	2,750		$	900
Fixed maturity securities, available for sale	14			54
Cash and cash equivalents	5			7
Total assets	$	2,769		$	961
LIABILITIES AND SHAREHOLDERS' EQUITY
Other liabilities	26			71
Total liabilities	26			71
Shareholders' equity
Preferred stock	—			—
Common stock	—			—
Additional paid in capital	2,031			1,998
Retained earnings (accumulated deficit)	300			(167		)
Accumulated other comprehensive income (loss)	481			(937		)
Treasury stock	(69		)	(4		)
Total shareholder's equity	2,743			890
Total liabilities and shareholder's equity	$	2,769		$	961

See Report of Independent Registered Public Accounting Firm.

F-87

Schedule II

(continued)

FGL HOLDINGS (Parent Only)

CONDENSED STATEMENT OF OPERATIONS

(in millions)

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Revenues	$	34		$	2		$	12		$	—		$	—		$	(1	)
	34			2			12			—			—			(1		)
Operating expenses:										—
General and administrative expenses	(14		)	6			1			1			1			2
Total operating expenses	(14		)	6			1			1			1			2
Operating income (loss)	48			(4		)	11			(1		)	(1		)	(3		)
Other income:
Equity in net income of subsidiaries	459			17			(102		)	29			109			227
Income (loss) before income taxes	507			13			(91		)	28			108			224
Income tax expense	—			—			—			—			—			1
Net income (loss)	$	507		$	13		$	(91	)	$	28		$	108		$	223

See Report of Independent Registered Public Accounting Firm.

F-88

Schedule II

(continued)

FGL HOLDINGS (Parent Only)

CONDENSED STATEMENT OF CASH FLOWS

(in millions)

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
Cash flows from operating activities
Net income (loss)	$	507		$	13		$	(91	)	$	28		$	108		$	223
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Realized capital and other gains on investments	—			—			—			—			2			5
Equity in net income of subsidiaries	(459		)	(17		)	102			(29		)	(109		)	(227		)
Stock based compensation	5			4			—			1			1			2
Changes in assets and liabilities:
Other assets and other liabilities	(48		)	4			1			2			—			3
Net cash provided by (used in) operating activities	5			4			12			2			2			6
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:
Proceeds from available-for-sale investments, sold, matured or repaid:	41			—			—			—			5			12
Cost of available-for-sale investments:	—			(54		)	—			—			—			—
Net cash provided by (used in) investing activities	41			(54		)	—			—			5			12
Cash flows from financing activities:
Cash paid upon warrant tender and capitalized warrant tender costs	—			(66		)	—			—			—			—
Dividends payments	(9		)	—			—			(4		)	(4		)	(15		)
Treasury stock	(65		)	(4		)	—			—			(1		)	(1		)
Distribution to CF Bermuda and subsidiaries	26			57			(97		)	—			—			(2		)
Net cash provided by (used in) financing activities	(48		)	(13		)	(97		)	(4		)	(5		)	(18		)
Change in cash and cash equivalents	(2		)	(63		)	(85		)	(2		)	2			—
Cash and cash equivalents at beginning of period	7			70			155			2			2			2
Cash and cash equivalents at end of period	$	5		$	7		$	70		$	—		$	4		$	2

See Report of Independent Registered Public Accounting Firm.

F-89

Schedule III

FGL HOLDINGS

Supplementary Insurance Information

(in millions)

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Life Insurance (single segment):
Deferred acquisition costs	$	630		$	344		$	22		$	1,140		$	697		$	1,129
Future policy benefits, losses, claims and loss expenses	5,735			4,641			4,751			3,401			3,453			3,412
Other policy claims and benefits payable	71			64			78			69			53			67
Premium revenue	40			54			3			7			11			42
Net investment income	1,229			1,107			92			174			240			1,005
Benefits, claims, losses and settlement expenses	(1,057		)	(423		)	(124		)	(227		)	(20		)	(843		)
Amortization, interest, and unlocking of deferred acquisition costs	(19		)	—			(1		)	(33		)	(100		)	(171		)
Acquisition and operating expenses, net of deferrals	(330		)	(181		)	(16		)	(51		)	(28		)	(137		)

See Report of Independent Registered Public Accounting Firm.

F-90

Schedule IV

FGL HOLDINGS

Reinsurance

(In millions)

For the year ended December 31, 2019	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Life insurance in force	$	3,631	$	(2,060	)	$	—	$	1,571	—	%
Premiums and other considerations:
Traditional life insurance premiums	204		(164		)	—		40		—	%
Annuity product charges	209		(54		)	—		155		—	%
Total premiums and other considerations	$	413	$	(218	)	$	—	$	195	—	%

For the year ended December 31, 2018	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Life insurance in force	$	3,541	$	(2,111	)	$	1	$	1,431	—	%
Premiums and other considerations:
Traditional life insurance premiums	223		(169		)	—		54		—	%
Annuity product charges	237		(57		)	—		180		—	%
Total premiums and other considerations	$	460	$	(226	)	$	—	$	234	—	%

For the period from December 1 to December 31, 2017	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Life insurance in force	$	3,516	$	(2,163	)	$	1	$	1,354	—	%
Premiums and other considerations:
Traditional life insurance premiums	17		(14		)	—		3		—	%
Annuity product charges	21		(5		)	—		16		—	%
Total premiums and other considerations	$	38	$	(19	)	$	—	$	19	—	%

For the period from October 1 to November 30, 2017	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Predecessor
Life insurance in force	$	3,212	$	(2,031	)	$	—	$	1,181	—	%
Premiums and other considerations:
Traditional life insurance premiums	36		(29		)	—		7		—	%
Annuity product charges	44		(10		)	—		34		—	%
Total premiums and other considerations	$	80	$	(39	)	$	—	$	41	—	%

F-91

(Continued)

For the period from October 1 to December 31, 2016 (Unaudited)	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Predecessor
Life insurance in force	$	3,123	$	(2,033	)	$	—	$	1,090	—	%
Premiums and other considerations:
Traditional life insurance premiums	57		(46		)	—		11		—	%
Annuity product charges	54		(16		)	—		38		—	%
Total premiums and other considerations	$	111	$	(62	)	$	—	$	49	—	%

For the year ended September 30, 2017	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Predecessor
Life insurance in force	$	3,207	$	(2,036	)	$	—	$	1,171	—	%
Premiums and other considerations:
Traditional life insurance premiums	233		(191		)	—		42		—	%
Annuity product charges	229		(64		)	—		165		—	%
Total premiums and other considerations	$	462	$	(255	)	$	—	$	207	—	%

See Report of Independent Registered Public Accounting Firm.

F-92

EX-4.1

EXHIBIT 4.1

DESCRIPTION OF SECURITIES

The following summary of the material terms of our securities is not intended to be a complete summary of the rights and preferences of such securities. We urge you to read our Charter in its entirety for a complete description of the rights and preferences of our securities.

General

We are a Cayman Islands exempted company (company number 309054), our affairs are governed by the Companies Law, the common law of the Cayman Islands and our Charter. Pursuant to our Charter, our authorized share capital is $90,000 divided into 800,000,000 ordinary shares and 100,000,000 preferred shares, par value $0.0001 per share.

As of February 24, 2020, there were 221,807,598 ordinary shares issued and outstanding, held of record by 51 holders, 429,789 preferred shares issued and outstanding, held of record by 11 holders, and 5,509,769 warrants outstanding, held of record by 13 holders. The number of record holders does not include DTC participants or beneficial owners who hold securities through nominees.

Ordinary Shares

Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in our Charter, or as required by applicable provisions of the Companies Law or applicable stock exchange rules, the affirmative vote of a majority of ordinary shares that are voted is required to approve any matter voted on by our shareholders. Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least two-thirds of ordinary shares that are voted and, pursuant to our Charter, such actions include amending our Charter and approving a statutory merger or consolidation with another company.

Our board of directors is divided into three classes, each of which generally serves for a term of three years with only one class of directors being elected in each year. There is no cumulative voting with respect to the election of directors. Holders of more than 50% of the shares voted for the election of directors can elect all of the directors. Our shareholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor, subject to the limitations described below under “Preferred Shares” and to the terms contained in the agreements governing the Company and its subsidiaries’ indebtedness.

In December 2018, the Company's board of directors approved the implementation of a quarterly cash dividend of $0.01 per ordinary share, beginning in the first quarter of fiscal year 2019. The dividend equates to $0.04 per share on a full-year basis. The payment of any dividends on ordinary shares will be within the discretion of the Company’s board of directors at such time. In addition, the terms of the preferred shares and agreements governing the indebtedness of the Company and its subsidiaries contain restrictions on the Company’s ability to declare and pay dividends.

In the event of a liquidation, dissolution or winding up of the Company after the business combination, our shareholders are entitled to share ratably in all assets remaining available for distribution to them after payment of liabilities and after provision is made for each class of shares, if any, having preference over the ordinary shares. Our shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to the ordinary shares.

Register of Members

Under Cayman Islands law, we keep a register of members and there is entered therein:

the names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered as paid, on the shares of each member and the voting rights of the shares;

​ the date on which the name of any person was entered on the register as a member; and

​ the date on which any person ceased to be a member.

​Under Cayman Islands law, the register of members of the Company is prima facie evidence of the matters set out therein (i.e., the register of members will raise a presumption of fact on the matters referred to above unless rebutted) and a member registered in the register of members will be deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register of members. However, there are certain limited circumstances where an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct legal position. Further, the Cayman Islands court has the power to order that the register of members maintained by a company should be rectified where it considers that the register of members does not reflect the correct legal position. If an application for an order for rectification of the register of members were made in respect of our ordinary shares, then the validity of such shares may be subject to re-examination by a Cayman Islands court.

Preferred Shares

Our Charter provides that we have the authority to issue 100,000,000 preferred shares, including the 275,000 shares of Series A Preferred Shares and the 100,000 Series B Preferred Shares issued on November 30, 2017. Subject to certain consent rights of the holders of the Series A Preferred Shares and the Series B Preferred Shares, we may issue additional series of preferred shares that would rank on parity with the Series A Preferred Shares and the Series B Preferred Shares as to liquidation preference. Under our amended and restated articles of association, our board of directors has the authority, subject to the provisions, if any, in our amended and restated memorandum of association and any rights attached to any existing shares, to issue preferred shares and to fix the preferred, deferred or other rights or restrictions, whether in regard to dividends or other distributions, voting, return of capital or otherwise, including varying such rights at such times and on such other terms as the board of directors thinks proper.

Our board of directors will be able to, without shareholder approval, issue preferred shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have anti-takeover effects. The ability of our board of directors to issue preferred shares without shareholder approval could have the effect of delaying, deferring or preventing a change of control of the Company or the removal of existing management.

Series A Preferred Shares and Series B Preferred Shares

Ranking

The Series A Preferred Shares and Series B Preferred Shares will rank senior as to dividends as described below under “- Dividends” and will rank senior as to liquidation preference as described below under “- Liquidation Rights.”

Dividends

Holders of the Series A Preferred Shares and Series B Preferred Shares will be entitled to receive cumulative cash dividends only when, as and if declared by the board of directors, or a duly authorized committee thereof, out of assets lawfully available for that purpose. Dividends payable on the Series A Preferred Shares and Series B Preferred Shares may be paid in cash or, at our option, in lieu of paying such cash dividends, we may instead effect a share capitalization by issuing new duly authorized and fully paid and nonassessable preferred shares (“PIK Shares”).

Dividends will be payable quarterly in arrears in cash or PIK Shares, at a rate of 7.5% per annum for the first ten years. After year ten, the dividend rate will reset quarterly to the greater of 7.5% and a rate equal to the then-current three-month LIBOR plus 5.5% (provided, however, that in the event the three-month LIBOR is less than zero, the three-month LIBOR will be deemed to be zero).

If we elect to effect a share capitalization by issuing PIK Shares, the number of preferred shares to be issued will be calculated by dividing the portion of such dividend not paid in cash by the original liquidation preferences of such preferred shares. Such PIK Shares will be entitled to receive cumulative dividends at the same rates as the other preferred shares from their date of issuance.

The Certificates of Designations provide that so long as any Series A Preferred Shares or Series B Preferred Shares remain issued and outstanding, subject to the exceptions described below, we and our subsidiaries shall not declare, pay or set apart funds for any dividends or other distributions with respect to any junior shares or redeem, repurchase or otherwise acquire, or make a liquidation payment relating to, any junior shares, or make any guarantee payment with respect thereto (“junior payments”), unless: (i)(A) full dividends have been or contemporaneously are declared and paid in cash or in kind on the Series A Preferred Shares and Series B Preferred Shares for all prior dividend periods, and (B) no PIK Shares are then issued and outstanding, (ii) FGLIC, or any successor “primary” insurance subsidiary of the Company, maintains an A.M. Best Company financial strength rating of

A- or higher, (3) we are in compliance with the covenants in the respective Certificate of Designations and (4) any junior payments, when aggregated with other junior payments, in any given fiscal year do not exceed certain financial ratios set forth in the respective Certificate of Designations.

The foregoing restriction on junior payments will not apply to:

purchases, redemptions or other acquisitions of junior shares pursuant to the conversion or exchange provisions of such junior shares;

​ declaration of a non-cash divided on our capital stock in connection with the implementation of a shareholders rights plan on customary terms designed to protect us against unsolicited offers to acquire our capital stock, or the issuance of our capital stock under any such plan in the future, or the redemption or repurchase of any such rights pursuant thereto;

​ dividends or distributions payable solely in junior shares, or warrants, options or rights to acquire junior shares; or

​ conversions of any junior shares into, or exchanges of any junior shares for, a class or series of other junior shares.

​Notwithstanding anything described herein to the contrary, if any junior payment was permitted by the foregoing provisions at the time it was declared or when it first became a contractual obligation, it will be deemed permitted at the time it is actually paid; provided that such junior payment occurs within 60 days of such declaration or entry into such contractual obligation.

Liquidation Rights

Upon any voluntary or involuntary liquidation, dissolution or winding-up of the Company, holders of the Series A Preferred Shares and Series B Preferred Shares are entitled to receive out of our assets available for distribution to shareholders, before any distribution is made to holders of ordinary shares, a liquidating distribution in the amount of  $1,000 per preferred share plus all accumulated and unpaid dividends in respect of such share, whether or not declared (including arrearage and dividends accumulated in respect thereof), to, but excluding, the date fixed for liquidation or, if applicable, the date of remarketing or repurchase pursuant to redemption.

Optional Redemption

The Series A Preferred Shares and Series B Preferred Shares are perpetual and have no maturity date. The Series A Preferred Shares and Series B Preferred Shares may not be redeemed prior to the first dividend payment date falling on or after November 30, 2022. We, at the option of our board of directors or any duly authorized committee thereof, may redeem out of funds lawfully available therefor, in whole or in part, the Series A Preferred Shares and Series B Preferred Shares at the time issued and outstanding, at any time on or after November 30, 2022, upon notice, and at a redemption price in cash equal to the liquidation preference, including accumulated but unpaid dividends (calculated as if the date of redemption was the date fixed for winding up) on the preferred shares being redeemed.

In case of any redemption of only part of the Series A Preferred Shares and Series B Preferred Shares at the time issued and outstanding, the number of preferred shares to be redeemed from each holder will be pro rata in proportion to the number of issued and outstanding preferred shares held by such holders. Our board of directors or any duly authorized committee thereof will have full power and authority to prescribe the terms and conditions upon which the preferred shares will be redeemed from time to time.

Voting Rights

Except as provided below or otherwise from time to time required by law, the holders of the Series A Preferred Shares and Series B Preferred Shares will have no voting rights.

Whenever dividends on any preferred shares have not been declared and paid for at least six or more quarterly dividend periods, whether consecutive or not (a “nonpayment”), the holders of the Series A Preferred Shares and Series B Preferred Shares, together with the holders of any and all series of voting preferred shares then issued and outstanding having “like voting rights” (i.e., being similarly entitled to vote for two additional directors at such time) (collectively, the “voting holders”), will have the right, voting separately as a single class without regard to class or series, to appoint two additional directors from individuals the preferred shareholders nominate to the Company.

The appointment of the preferred share directors may take place at any general or special meeting of shareholders or a separate class of voting holders, or by means of a written resolution of the voting holders in lieu of a meeting thereof. The preferred share directors are to be appointed by a plurality of the votes cast by the voting holders at a relevant meeting (or, if the appointment is effected by written resolution, by the voting holders constituting a quorum which will also be the required voting threshold for purposes of a written resolution). Each preferred share director will be added to an already existing class of directors. The number of preferred share directors will never be more than two at any one time.

Any preferred shares director may be removed at any time without cause by the holders of record of a majority of the aggregate voting power, of preferred shares and any other shares of voting preferred shares then issued and outstanding (voting together as a single class) when they have the voting rights described above. So long as a nonpayment event shall continue, any vacancy in the office of a preferred shares director (other than prior to the initial election after a nonpayment event) may be filled by the written consent of the preferred shares director remaining in office, or if none remains in office, by a vote of the holders of record of a majority of the issued and outstanding preferred shares and any other shares of voting preferred shares then issued and outstanding (voting together as a single class) when they have the voting rights described above.

We may not consummate any action specified below without the consent of the holders of the Series A Preferred Shares and Series B Preferred Shares:

any amendment, alteration or repeal of any provision of the articles of association or the respective Certificates of Designations that would alter or change the voting powers, preferences or special rights of the preferred shares so as to affect them adversely;

​ any authorization or creation, or increase in the authorized amount of, or issuance of, any senior shares or parity shares, and any increase in the authorized number of preferred shares;

​ any change of control if an original holder is a holder of any preferred shares at the time of such change of control, unless, prior to such occurrence, such original holder has either (i) received a bona fide, binding offer to purchase all of such original holder’s preferred shares at a price equal to or greater than the then-current liquidation preference, including accumulated but unpaid dividends or (ii) provided its prior written consent to such change of control;

​ any incurrence of Indebtedness (as defined in the Credit Agreement) by the Company or any intermediate holding company between the Company and CF Bermuda Holdings Limited;

​ any issuance or reclassification of equity securities by the Company, unless all securities into which such equity securities are reclassified are held by one or more entities 100% of the equity of which is owned directly or indirectly by the Company;

​ to take any action or permit any omission that would be in breach of the affirmative and negative covenants set forth in the Credit Agreement; and

​ any consolidation, merger, amalgamation, binding share exchange or reclassification involving the Company, unless, (i) the preferred shares remain issued and outstanding or, in the case of any transaction where the Company is not the surviving or resulting entity, are converted into or exchanged for preferred securities of the surviving or resulting entity or its ultimate parent, (ii) the preferred shares remaining issued and outstanding have such rights, preferences, privileges and voting powers, taken as a whole, that are no less favorable to the holders than the rights, preferences, privileges and voting powers of the Series A Cumulative Convertible Preferred Shares and the Series B Convertible Preferred Shares, taken as a whole and (iii) upon completion of any such consolidation, merger, amalgamation, binding share exchange or reclassification, no condition exists with respect to the surviving or resulting entity that would require consent pursuant to the foregoing clauses (1), (2), (4) or (6) if such surviving or resulting issuer were the Company.

The foregoing voting provisions will not apply with respect to the Series A Preferred Shares and Series B Preferred Shares if, at or prior to the time when the act with respect to which such vote would otherwise be required shall be effected, all issued and outstanding preferred shares shall have been redeemed or called for redemption upon proper notice and sufficient funds shall have been set aside by us for the benefit of the holders of preferred shares to effect such redemption.

Remarketing

From and after November 30, 2022, upon request of an original holder, we will be required (subject to customary blackout provisions) to remarket the Series A Preferred Shares and Series B Preferred Shares on their existing terms. To the extent market conditions make such remarketing impracticable, we may temporarily delay such remarketing provided that such preferred shares are remarketed within six months of the date of the initial request. To the extent it is unlikely that remarketing the Series A Preferred

Shares and Series B Preferred Shares on the then existing terms will receive a valuation by a prospective purchaser of par or greater than par, we may, upon the request of an original holder, modify the terms of the Series A Preferred Shares and Series B Preferred Shares to improve the sale of such preferred shares with the intention of preserving rating agency equity credit. If the proceeds from any sales resulting from such remarketing are less than the outstanding balance of the applicable preferred shares (including dividends paid in kind and accumulated but unpaid dividends), we will reimburse such original holder, up to a maximum of 10% of par (including dividends paid in kind and accumulated but unpaid dividends) for actual losses incurred by such original holder, upon the sale of its preferred shares under the remarketing mechanism, with such amount payable either in cash, ordinary shares, or any combination thereof, at our option. If we choose to reimburse such original holder, by the delivery of ordinary shares (such dollar amount, the “Remarketing Loss Share Amount”), the number of shares to be delivered will be determined by dividing (i) the amount of actual losses to be paid to such holder by (ii) the higher of  (a) an 8% discount to the 30-day volume weighted average price (“VWAP”) of the ordinary shares following the remarketing period (the “Remarketing Loss Share Pricing Period”), and (b) $6.00. Such ordinary shares will be delivered to such original holder, on the first business day following the end of the Remarketing Loss Share Pricing Period plus an amount in cash equal to the interest on the Remarketing Loss Share Amount at a rate of 7.5% per annum accrued daily during the remarketing period.

Only the original holders may elect to participate in a remarketing. However, if the remarketing is successful, the modified terms will apply to all Series A Preferred Shares and Series B Preferred Shares, including those preferred shares that were not included in the remarketing.

Right of the Original Holders to Convert

From and after November 30, 2027, and provided that an original holder has first requested us to remarket the Series A Preferred Shares and Series B Preferred Shares as described above, any original holder, may, at their sole discretion, convert their holdings of such preferred shares, in whole or in part, into such number of ordinary shares as determined by dividing (i) the aggregate par value (including dividends paid in kind and accumulated but unpaid dividends) of the preferred shares that such original holder wishes to convert by (ii) the higher of  (a) a 5% discount to the 30-day VWAP of the ordinary shares following the conversion notice, and (b) the then-current Floor Price. The “Floor Price” will be $8.00 per share during the 11th year post-funding, $7.00 per share during the 12th year post-funding, and $6.00 during the 13th year post-funding and thereafter. The right to convert on the above terms are personal rights of the original holders and will not be a term of the preferred shares.

Warrants

Public and Forward Purchase Warrants

We issued 34,500,000 warrants as part of the units sold in the IPO. In connection with forward purchase agreements, at the closing of the business combination we issued 19,083,335 forward purchase warrants to the anchor investors. The forward purchase warrants have identical terms as the public warrants.

Each whole warrant entitled the holder thereof to purchase one ordinary share at a price of  $11.50 per share, subject to adjustment as described below, at any time commencing December 30, 2017, provided that we have an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or we permit holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the warrants (the “warrant agreement”)) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of ordinary shares. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued and only whole warrants trade. The Warrants will expire on November 30, 2022, at 5:00 p.m., New York City time, or upon earlier redemption or liquidation.

We will not be obligated to deliver any ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to the Company satisfying its obligations described below with respect to registration. No warrant will be exercisable and we will not be obligated to issue ordinary shares upon exercise of a warrant unless the ordinary shares issuable upon such warrant exercise have been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant.

We agreed that as soon as practicable, but in no event later than 15 business days after the closing of the business combination, we would use our best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the ordinary shares issuable upon exercise of the warrants. This registration statement was declared effective by the SEC on January 16, 2018 (File No. 333-222232), as discussed in more detail below. We agreed to use our best efforts to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement.

Once the warrants become exercisable, we may call the warrants for redemption:

in whole and not in part;

​ at a price of  $0.01 per warrant;

​ upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and

​ if, and only if, the last reported sales price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company sends to the notice of redemption to the warrant holders.

​If and when the warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws.

If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date. However, the price of the ordinary shares may fall below the $18.00 redemption trigger price (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) as well as the $11.50 warrant exercise price after the redemption notice is issued.

If we call the warrants for redemption as described above, our management will have the option to require any holder that wishes to exercise his, her or its warrant to do so on a “cashless basis.” In determining whether to require all holders to exercise their warrants on a “cashless basis,” management will consider, among other factors, our cash position, the number of warrants that are outstanding and the dilutive effect on our shareholders of issuing the maximum number of ordinary shares issuable upon the exercise of the warrants. If management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” will mean the average last sale price of the ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants. If management takes advantage of this option, the notice of redemption will contain the information necessary to calculate the number of ordinary shares to be received upon exercise of the warrants, including the “fair market value” in such case. Requiring a cashless exercise in this manner will reduce the number of shares to be issued and thereby lessen the dilutive effect of a warrant redemption. If we call the warrants for redemption and management does not take advantage of this option, the holders of the private placement warrants (as defined below) and their permitted transferees would still be entitled to exercise their private placement warrants for cash or on a cashless basis using the same formula described above that other warrant holders would have been required to use had all warrant holders been required to exercise their warrants on a cashless basis, as described in more detail below.

A holder of a warrant may notify the Company in writing in the event it elects to be subject to a requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would beneficially own in excess of 4.9% or 9.8% (as specified by the holder) of the ordinary shares issued and outstanding immediately after giving effect to such exercise.

If the number of issued and outstanding ordinary shares is increased by a share dividend payable in ordinary shares, or by a split-up of ordinary shares or other similar event, then, on the effective date of such share dividend, split-up or similar event, the number of ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the issued and outstanding ordinary shares. A rights offering to holders of ordinary shares entitling holders to purchase ordinary shares at a price less than the fair market value will be deemed a share dividend of a number of ordinary shares equal to the product of   (i) the number of ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for ordinary shares) and (ii) the quotient of  (x) the price per ordinary share paid in such rights offering and (y) the fair market value. For these purposes, (i) if the rights offering is for securities convertible into or exercisable for ordinary shares, in determining the price payable for ordinary shares, there will be taken into account any consideration received

for such rights, as well as any additional amount payable upon exercise or conversion and (ii) fair market value means the volume weighted average price of ordinary shares as reported during the 10 trading day period ending on the trading day prior to the first

date on which the ordinary shares trade on the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to the holders of ordinary shares on account of such ordinary shares (or other securities into which the warrants are convertible), other than (a) as described above or (b) certain ordinary cash dividends, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid on each ordinary share in respect of such event.

If the number of issued and outstanding ordinary shares is decreased by a consolidation, combination, reverse share split or reclassification of ordinary shares or other similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of ordinary shares issuable on exercise of each warrant will be decreased in proportion to such decrease in issued and outstanding ordinary shares.

Whenever the number of ordinary shares purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of ordinary shares purchasable upon the exercise of the warrants immediately prior to such adjustment and (y) the denominator of which will be the number of ordinary shares so purchasable immediately thereafter.

In case of any reclassification or reorganization of the issued and outstanding ordinary shares (other than those described above or that solely affects the par value of such ordinary shares), or in the case of any merger or consolidation of the Company with or into another corporation (other than a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification or reorganization of the Company’s issued and outstanding ordinary shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved, the holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the ordinary shares immediately theretofore purchasable and receivable upon the exercise of the rights represented thereby, the kind and amount of ordinary shares or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. If less than 70% of the consideration receivable by the holders of ordinary shares in such a transaction is payable in the form of ordinary shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the Black-Scholes value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants.

The warrants are subject to a warrant agreement between Continental Stock Transfer & Trust Company, as warrant agent, and the Company. The warrant agreement provides that the terms of the warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision, but requires the approval by the holders of at least 65% of the then outstanding public warrants and forward purchase to make any change that adversely affects the interests of the registered holders, subject to certain exceptions. Holders should review a copy of the warrant agreement for a complete description of the terms and conditions applicable to the warrants. The foregoing description of the warrants is qualified in its entirety by reference to the warrant agreement which is filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed with the SEC on May 19, 2016 and incorporated herein by reference.

The warrants may be exercised upon surrender of the warrant certificate on or prior to the expiration date at the offices of the warrant agent, with the exercise form on the reverse side of the warrant certificate completed and executed as indicated, accompanied by full payment of the exercise price (or on a cashless basis, if applicable), by certified or official bank check payable to the Company, for the number of warrants being exercised. The warrant holders do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive ordinary shares. After the issuance of ordinary shares upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders.

No fractional shares will be issued upon exercise of the warrants. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, the Company will, upon exercise, round down to the nearest whole number the number of ordinary shares to be issued to the warrant holder.

Private Placement Warrants

In connection with the IPO, we consummated a private placement of an aggregate of 15,800,000 private placement warrants to our Sponsor. Except as described herein, the private placement warrants have terms and provisions that are identical to those of the public warrants. Our Sponsor, or its permitted transferees, has the option to exercise the private placement warrants on a cashless basis. The private placement warrants (including the ordinary shares issuable upon exercise of the private placement warrants) were be transferable, assignable or salable until December 30, 2017, subject to certain exceptions, and they will not be redeemable by the Company so long as they are held by our Sponsor or its permitted transferees. If the private placement warrants are held by holders other than our Sponsor or its permitted transferees, the private placement warrants will be redeemable by the Company and exercisable by the holders on the same basis as the public warrants.

If holders of the private placement warrants elect to exercise them on a cashless basis, they would pay the exercise price by surrendering his, her or its warrants for that number of ordinary shares equal to the quotient obtained by dividing (x) the product of the number of ordinary shares underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” means the average last sale price of the ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent.

In order to finance transaction costs in connection with the business combination, our Sponsor loaned the Company $1,500,000 which amount was converted into warrants of the Company at a price of  $1.00 per warrant on November 29, 2017 pursuant to a convertible note issued to our Sponsor. These warrants have identical terms to the private placement warrants. The foregoing description of the private placement warrants is qualified in its entirety by reference the warrant agreement which is filed as Exhibit 4.4 to the Company’s Current Report on Form 8-K filed with the SEC on May 19, 2016 and incorporated herein by reference.

Offer to Exchange

We subsequently announced an offer to exchange (“Offer to Exchange”) any and all of the Company’s outstanding warrants (the “Warrants”) for 0.11 ordinary shares of the Company, par value $0.0001 (the “Exchange Shares”) and $0.98, in cash, without interest, per warrant (together, the “Exchange Consideration”), upon the terms and subject to the conditions set forth in the Company’s Tender Offer Statement on Schedule TO, originally filed by the Company with the Securities and Exchange Commission (the “SEC”) on September 6, 2018, as amended and supplemented by Amendment No. 1 filed by the Company with the SEC on September 21, 2018, the related Letter of Transmittal, as amended, and the other related Offer to Exchange materials. The Offer to Exchange expired on October 4, 2018. Based on information provided by Continental Stock Transfer & Trust Company, the depositary for the Offer to Exchange, a total of 65,373,565 Warrants were properly tendered and not properly withdrawn prior to the expiration of the Offer to Exchange. The Company accepted for exchange all such Warrants and issued an aggregate of 7,191,070 Exchange Shares, representing approximately 3.4% of the ordinary shares outstanding after such issuance, and paid an aggregate amount of approximately $64.1 million in cash, in exchange for the Warrants tendered.

After completion of the Offer to Exchange, 5,509,769 Warrants remained outstanding. The Warrants will expire on November 30, 2022, at 5:00 p.m., New York City time, or upon earlier redemption or liquidation.

Transfer Agent and Warrant Agent

The transfer agent for our ordinary shares and warrant agent for our warrants is Continental Stock Transfer & Trust Company. We have agreed to indemnify Continental Stock Transfer & Trust Company in its roles as transfer agent and warrant agent, its agents and each of its shareholders, directors, officers and employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any claims and losses due to any gross negligence or intentional misconduct of the indemnified person or entity.

Certain Differences in Corporate Law

Cayman Islands companies are governed by the Companies Law. The Companies Law is modeled on English Law but does not follow recent English Law statutory enactments, and differs from laws applicable to United States corporations and their shareholders. Set forth below is a summary of the material differences between the provisions of the Companies Law applicable to the Company and the laws applicable to companies incorporated in the United States and their shareholders.

Mergers and Similar Arrangements. In certain circumstances, the Companies Law allows for mergers or consolidations between two Cayman Islands companies, or between a Cayman Islands exempted company and a company incorporated in another jurisdiction (provided that is facilitated by the laws of that other jurisdiction).

Where the merger or consolidation is between two Cayman Islands companies, the directors of each company must approve a written plan of merger or consolidation containing certain prescribed information. That plan or merger or consolidation must then be authorized by either (a) a special resolution (usually a majority of 662∕3% in value of the voting shares voted at a general meeting) of the shareholders of each company; or (b) such other authorization, if any, as may be specified in such constituent company’s articles of association. No shareholder resolution is required for a merger between a parent company (i.e., a company that owns at least 90% of the issued shares of each class in a subsidiary company) and its subsidiary company. The consent of each holder of a fixed or floating security interest of a constituent company must be obtained, unless a court of competent jurisdiction waives such requirement. If the Cayman Islands Registrar of Companies is satisfied that the requirements of the Companies Law (which includes certain other formalities) have been complied with, the Registrar of Companies will register the plan of merger or consolidation.

Where the merger or consolidation involves a foreign company, the procedure is similar, save that with respect to the foreign company, the directors of the Cayman Islands exempted company are required to make a declaration to the effect that, having made due enquiry, they are of the opinion that the requirements set out below have been met: (i) that the merger or consolidation is permitted or not prohibited by the constitutional documents of the foreign company and by the laws of the jurisdiction in which the foreign company is incorporated, and that those laws and any requirements of those constitutional documents have been or will be complied with; (ii) that no petition or other similar proceeding has been filed and remains outstanding or order made or resolution adopted to wind up or liquidate the foreign company in any jurisdictions; (iii) that no receiver, trustee, administrator or other similar person has been appointed in any jurisdiction and is acting in respect of the foreign company, its affairs or its property or any part thereof; and (iv) that no scheme, order, compromise or other similar arrangement has been entered into or made in any jurisdiction whereby the rights of creditors of the foreign company are and continue to be suspended or restricted.

Where the surviving company is the Cayman Islands exempted company, the directors of the Cayman Islands exempted company are further required to make a declaration to the effect that, having made due enquiry, they are of the opinion that the following requirements have been met: (i) that the foreign company is able to pay its debts as they fall due and that the merger or consolidation is bona fide and not intended to defraud unsecured creditors of the foreign company; (ii) that in respect of the transfer of any security interest granted by the foreign company to the surviving or consolidated company (a) consent or approval to the transfer has been obtained, released or waived; (b) the transfer is permitted by and has been approved in accordance with the constitutional documents of the foreign company; and (c) the laws of the jurisdiction of the foreign company with respect to the transfer have been or will be complied with; (iii) that the foreign company will, upon the merger or consolidation becoming effective, cease to be incorporated, registered or exist under the laws of the relevant foreign jurisdiction; and (iv) that there is no other reason why it would be against the public interest to permit the merger or consolidation.

Where the above procedures are adopted, the Companies Law provides for a right of dissenting shareholders to be paid a payment of the fair value of his shares upon their dissenting to the merger or consolidation if they follow a prescribed procedure. In essence, that procedure is as follows: (a) the shareholder must give his written objection to the merger or consolidation to the constituent company before the vote on the merger or consolidation, including a statement that the shareholder proposes to demand payment for his shares if the merger or consolidation is authorized by the vote; (b) within 20 days following the date on which the merger or consolidation is approved by the shareholders, the constituent company must give written notice to each shareholder who made a written objection; (c) a shareholder must within 20 days following receipt of such notice from the constituent company, give the constituent company a written notice of his intention to dissent including, among other details, a demand for payment of the fair value of his shares; (d) within seven days following the date of the expiration of the period set out in paragraph (b) above or seven days following the date on which the plan of merger or consolidation is filed, whichever is later, the constituent company, the surviving company or the consolidated company must make a written offer to each dissenting shareholder to purchase his shares at a price that the company determines is the fair value and if the company and the shareholder agree the price within 30 days following the date on which the offer was made, the company must pay the shareholder such amount; and (e) if the company and the shareholder fail to agree a price within such 30 day period, within 20 days following the date on which such 30 day period expires, the company (and any dissenting shareholder) must file a petition with the Grand Court of the Cayman Islands to determine the fair value and such petition must be accompanied by a list of the names and addresses of the dissenting shareholders with whom agreements as to the fair value of their shares have not been reached by the company. At the hearing of that petition, the court has the power to determine the fair value of the shares together with a fair rate of interest, if any, to be paid by the company upon the amount determined to be the fair value. Any dissenting shareholder whose name appears on the list filed by the company may participate fully in all proceedings until the determination of fair value is reached. These rights of a dissenting shareholder are not available in certain circumstances, for example, to dissenters holding shares of any class in respect of which an open market exists on a recognized stock exchange or recognized interdealer quotation system at the relevant date or where the consideration for such shares to be contributed are shares of any company listed on a national securities exchange or shares of the surviving or consolidated company.

Moreover, Cayman Islands law has separate statutory provisions that facilitate the reconstruction or amalgamation of companies, and in certain circumstances, schemes of arrangement will generally be more suited for complex mergers or other transactions involving widely held companies, commonly referred to in the Cayman Islands as a “scheme of arrangement” which may be tantamount to a merger. In the event that a merger was sought pursuant to a scheme of arrangement (the procedures for which are more rigorous and take longer to complete than the procedures typically required to consummate a merger in the United States), the arrangement in question must be approved by a majority in number of each class of shareholders and creditors with whom the arrangement is to be made and who must in addition represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person or by proxy at a meeting, or meeting summoned for that purpose. The convening of the meetings and subsequently the terms of the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder would have the right to express to the court the view that the transaction should not be approved, the court can be expected to approve the arrangement if it satisfies itself that:

the Company is not proposing to act illegally or beyond the scope of its corporate authority and the statutory provisions as to majority vote have been complied with;

​ the shareholders have been fairly represented at the meeting in question;

​ the arrangement is such as a businessman would reasonably approve; and

​ the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Law or that would amount to a “fraud on the minority.”

​If a scheme of arrangement or takeover offer (as described below) is approved, any dissenting shareholder would have no rights comparable to appraisal rights (providing rights to receive payment in cash for the judicially determined value of the shares), which would otherwise ordinarily be available to dissenting shareholders of United States corporations.

Squeeze-out Provisions. When a takeover offer is made and accepted by holders of 90% of the shares to whom the offer relates is made within four months, the offeror may, within a two-month period, require the holders of the remaining shares to transfer such shares on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands, but this is unlikely to succeed unless there is evidence of fraud, bad faith, collusion or inequitable treatment of the shareholders.

Further, transactions similar to a merger, reconstruction and/or an amalgamation may in some circumstances be achieved through means other than these statutory provisions, such as a share capital exchange, asset acquisition or control, or through contractual arrangements of an operating business.

Shareholders’ Suits. The Company’s Cayman Islands counsel is not aware of any reported class action lawsuit having been brought in a Cayman Islands court. Derivative actions have been brought in the Cayman Islands courts, and the Cayman Islands courts have confirmed the availability for such actions. In most cases, the Company will be the proper plaintiff in any claim based on a breach of duty owed to the Company, and a claim against (for example) the Company’s officers or directors usually may not be brought by a shareholder. However, based both on Cayman Islands authorities and on English authorities, which would in all likelihood be of persuasive authority and be applied by a court in the Cayman Islands, exceptions to the foregoing principle apply in circumstances in which:

a company is acting, or proposing to act, illegally or beyond the scope of its authority;

the act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number of votes which have actually been obtained; or

​ those who control the company are perpetrating a “fraud on the minority.”

​A shareholder may have a direct right of action against the Company where the individual rights of that shareholder have been infringed or are about to be infringed.

Enforcement of Civil Liabilities. The Cayman Islands has a different body of securities laws compared to the United States and provides less protection to investors. Additionally, Cayman Islands companies may not have standing to sue before the federal courts of the United States.

We have been advised by its Cayman Islands legal counsel that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against the Company judgments of courts of the United States predicated upon the civil liability provisions of the federal

securities laws of the United States or any state; and (ii) in original actions brought in the Cayman Islands, to impose liabilities against the Company predicated upon the civil liability provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, and or be of a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement proceedings if concurrent proceedings are being brought elsewhere.

Special Considerations for Exempted Companies. The Company is an exempted company with limited liability (meaning the Company’s public shareholders have no liability, as members of the company, for liabilities of the company over and above the amount paid for their shares) under the Companies Law. The Companies Law distinguishes between ordinary resident companies and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The requirements for an exempted company are essentially the same as for an ordinary company except for the exemptions and privileges listed below:

annual reporting requirements are minimal and consist mainly of a statement that the company has conducted its operations mainly outside of the Cayman Islands and has complied with the provisions of the Companies Law;

​ an exempted company’s register of members is not open to inspection;

​ an exempted company does not have to hold an annual general meeting;

​ an exempted company may issue negotiable or bearer shares or shares with no par value;

​ an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance);

​ an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;

​ an exempted company may register as a limited duration company; and

​ an exempted company may register as a segregated portfolio company.

​Anti-Money Laundering - Cayman Islands

In order to comply with legislation or regulations aimed at the prevention of money laundering, we are required to adopt and maintain anti-money laundering procedures, and may require subscribers to provide evidence to verify their identity and source of funds. Where permitted, and subject to certain conditions, we may also delegate the maintenance of our anti-money laundering procedures (including the acquisition of due diligence information) to a suitable person.

We reserve the right to request such information as is necessary to verify the identity of a subscriber. In some cases the directors may be satisfied that no further information is required since an exemption applies under the Anti-Money Laundering Regulations (2020 Revision) of the Cayman Islands, as amended and revised from time to time (the “Regulations”). Depending on the circumstances of each application, a detailed verification of identity might not be required where:

the subscriber makes the payment for their investment from an account held in the subscriber’s name at a recognized financial institution;

​ the subscriber is regulated by a recognized regulatory authority and is based or incorporated in, or formed under the law of, a recognized jurisdiction; or

​ the application is made through an intermediary which is regulated by a recognized regulatory authority and is based in or incorporated in, or formed under the law of a recognized jurisdiction and an assurance is provided in relation to the procedures undertaken on the underlying investors.

​For the purposes of these exceptions, recognition of a financial institution, regulatory authority or jurisdiction will be determined in accordance with the Regulations by reference to those jurisdictions recognized by the Cayman Islands Monetary Authority as having equivalent anti-money laundering regulations.

In the event of delay or failure on the part of the subscriber in producing any information required for verification purposes, we may refuse to accept the application, in which case any funds received will be returned without interest to the account from which they were originally debited.

We also reserve the right to refuse to make any payment to a shareholder if our directors or officers suspect or are advised that the payment to such shareholder might result in a breach of applicable anti-money laundering or other laws or regulations by any person in any relevant jurisdiction, or if such refusal is considered necessary or appropriate to ensure the Company’s compliance with any such laws or regulations in any applicable jurisdiction.

If any person resident in the Cayman Islands knows or suspects, or has reasonable grounds for knowing or suspecting, that another person is engaged in criminal conduct or is involved with terrorism or terrorist property and the information for that knowledge or suspicion came to their attention in the course of business in the regulated sector or other trade, profession, business or employment, the person will be required to report such knowledge or suspicion to (i) the Financial Reporting Authority of the Cayman Islands, pursuant to the Proceeds of Crime Law (2020 Revision) of the Cayman Islands if the disclosure relates to criminal conduct or money laundering or (ii) a police officer of the rank of constable or higher, or the Financial Reporting Authority, pursuant to the Terrorism Law (2018 Revision) of the Cayman Islands, if the disclosure relates to involvement with terrorism or terrorist financing and property. Such a report will not be treated as a breach of confidence or of any restriction upon the disclosure of information imposed by any enactment or otherwise.

Data Protection - Cayman Islands

We have certain duties under the Data Protection Law, 2017 of the Cayman Islands (the "DPL") based on internationally accepted principles of data privacy.

Privacy Notice

Introduction

This privacy notice puts our shareholders on notice that through your investment in the Company you will provide us with certain personal information which constitutes personal data within the meaning of the DPL ("personal data").

In the following discussion, the "Company" refers to us and our affiliates and/or delegates, except where the context requires otherwise.

Investor Data

We will collect, use, disclose, retain and secure personal data to the extent reasonably required only and within the parameters that could be reasonably expected during the normal course of business. We will only process, disclose, transfer or retain personal data to the extent legitimately required to conduct our activities of on an ongoing basis or to comply with legal and regulatory obligations to which we are subject. We will only transfer personal data in accordance with the requirements of the DPL, and will apply appropriate technical and organizational information security measures designed to protect against unauthorised or unlawful processing of the personal data and against the accidental loss, destruction or damage to the personal data.

In our use of this personal data, we will be characterized as a "data controller" for the purposes of the DPL, while our affiliates and service providers who may receive this personal data from us in the conduct of our activities may either act as our "data processors" for the purposes of the DPL or may process personal information for their own lawful purposes in connection with services provided to us.

We may also obtain personal data from other public sources. Personal data includes, without limitation, the following information relating to a shareholder and/or any individuals connected with a shareholder as an investor: name, residential address, email address, contact details, corporate contact information, signature, nationality, place of birth, date of birth, tax identification, credit history, correspondence records, passport number, bank account details, source of funds details and details relating to the shareholder's investment activity.

Who this Affects

If you are a natural person, this will affect you directly. If you are a corporate investor (including, for these purposes, legal arrangements such as trusts or exempted limited partnerships) that provides us with personal data on individuals connected to you for any reason in relation your investment in the Company, this will be relevant for those individuals and you should transmit the content of this Privacy Notice to such individuals or otherwise advise them of its content.

How the Company May Use a Shareholder's Personal Data

The Company, as the data controller, may collect, store and use personal data for lawful purposes, including, in particular:

(i)    where this is necessary for the performance of our rights and obligations under any purchase agreements;

(ii)    where this is necessary for compliance with a legal and regulatory obligation to which we are subject (such as compliance with anti-money laundering and FATCA/CRS requirements); and/or

(iii)    where this is necessary for the purposes of our legitimate interests and such interests are not overridden by your interests, fundamental rights or freedoms.

Should we wish to use personal data for other specific purposes (including, if applicable, any purpose that requires your consent), we will contact you.

Why We May Transfer Your Personal Data

In certain circumstances we may be legally obliged to share personal data and other information with respect to your shareholding with the relevant regulatory authorities such as the Cayman Islands Monetary Authority or the Tax Information Authority. They, in turn, may exchange this information with foreign authorities, including tax authorities.

We anticipates disclosing personal data to persons who provide services to us and their respective affiliates (which may include certain entities located outside the United States, the Cayman Islands or the European Economic Area), who will process your personal data on our behalf.

The Data Protection Measures We Take

Any transfer of personal data by us or our duly authorised affiliates and/or delegates outside of the Cayman Islands shall be in accordance with the requirements of the DPL.

We and our duly authorised affiliates and/or delegates shall apply appropriate technical and organizational information security measures designed to protect against unauthorised or unlawful processing of personal data, and against accidental loss or destruction of, or damage to, personal data.

We shall notify you of any personal data breach that is reasonably likely to result in a risk to your interests, fundamental rights or freedoms or those data subjects to whom the relevant personal data relates.

Certain Anti-Takeover Provisions in our Charter

Our Charter contains a number of provisions that may be deemed to have the effect of discouraging or delaying attempts to gain control of the Company, including provisions (i) classifying our board of directors into three classes with each class to serve for three years with one class being elected annually, (ii) providing that directors may only be removed for cause, (iii) requiring shareholders to comply with advance notice procedures in order to bring business before an annual general meeting or to nominate candidates for election as directors, (iv) providing that only directors may call general meetings, (v) providing that resolutions may only be passed at a duly convened general meeting.

Our authorized but unissued ordinary shares and preferred shares are available for future issuances without shareholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved ordinary shares and preferred shares could render more difficult or discourage an attempt to obtain control of the Company by means of a proxy contest, tender offer, merger or otherwise.

In addition, our Charter limits the voting power attributable to our ordinary shares so that no “United States person” (as defined in Section 957 of the Code) holds, directly, indirectly or constructively (within the meaning of Section 958 of the Code), more than 9.5% of the total voting power of the Company’s ordinary shares. Subject to certain exceptions set forth in our Charter, the votes attributable to a U.S. holder of ordinary shares above 9.5% of the total voting power of the ordinary shares are redistributed to other holders of ordinary shares pro rata based on the then current voting power of each holder. This limitation would not apply to reduce the voting power of ordinary shares held by members of  (a) the Blackstone Group (as defined in our Charter) without the consent of a majority of the Blackstone Group shareholders (as determined based on their ownership of the ordinary shares) or (b) the FNF Group (as defined in our Charter) without the consent of the applicable member of the FNF Group. Such adjustments are likely to result in a shareholder having voting rights in excess of one vote per share. Therefore, a shareholder’s voting rights may increase above 5% of the aggregate voting power of the issued and outstanding ordinary shares, thereby possibly resulting in the shareholder becoming a reporting person subject to Schedule 13D or 13G filing requirements under the Exchange Act). Our Charter also provides that no shareholder or holder (or, to its actual knowledge, any direct or indirect beneficial owner thereof) of issued and outstanding ordinary shares, including any securities exchangeable for Derivative Securities, that is a “United States person” (as defined in Section 957 of the Code) shall knowingly permit itself to hold (directly, indirectly or constructively within the meaning of Section 958 of the Code) 50% or more of the total voting power or of the total value of the issued and outstanding ordinary shares, including Derivative Securities, in order to reduce the likelihood of us recognizing related person insurance income. This limitation would not apply to a shareholder or holder of Derivative Securities that is a member of the Blackstone Group or FNF Group.

Rule 144

Pursuant to Rule 144 of the Securities Act (“Rule 144”), a person who has beneficially owned restricted ordinary shares or warrants for at least six months would be entitled to sell their securities, provided that (i) such person is not deemed to have been one of the Company’s affiliates at the time of, or at any time during the three months preceding, a sale and (ii) the Company is subject to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required reports under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as the Company was required to file reports) preceding the sale.

Persons who have beneficially owned restricted ordinary shares or warrants for at least six months but who are the Company’s affiliates at the time of, or at any time during the three months preceding, a sale, would be subject to additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of:

one percent (1%) of the total number of shares of ordinary shares then issued and outstanding; or

​ the average weekly reported trading volume of the ordinary shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.

​Sales by the Company’s affiliates under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information about the Company.

Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies

Rule 144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell companies) or issuers that have been at any time previously a shell company. However, Rule 144 also includes an important exception to this prohibition if the following conditions are met:

the issuer of the securities that was formerly a shell company has ceased to be a shell company;

​ the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;

​ the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials), other than Form 8-K reports; and

​ at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.

​While the Company was formed as a shell company, upon the consummation of the business combination, the Company ceased to be a shell company, and so, once the conditions set forth in the exceptions listed above were satisfied, Rule 144 became available for the resale of the above-noted restricted securities.

Registration Rights

We are party to a registration rights agreement, dated as of May 19, 2016, with our Sponsor, pursuant to which our Sponsor and its permitted transferees have registration rights with respect to founder shares, private placement warrants (and any ordinary shares issuable upon the exercise of the private placement warrants). The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

In addition, pursuant to the warrant agreement, the Company agreed that as soon as practicable, but in no event later than 15 business days after the closing of the business combination, the Company would use its best efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the ordinary shares issuable upon exercise of the warrants. This registration statement was declared effective by the SEC on January 16, 2018 (File No. 333-222232), as discussed in more detail below. The Company has agreed to use its best efforts to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration of the warrants in accordance with the provisions of the warrant agreement.

Pursuant to (i) the equity purchase agreements with the BTO Purchaser and FNF Purchasers entered into in connection with the equity commitment letters with such parties relating to the business combination, (ii) the forward purchase agreements, (iii) the ROFO purchase agreements and (iv) the investment agreement, we agreed to use our commercially reasonable efforts (x) to file within 30 days after the closing of the business combination a registration statement with the SEC for a secondary offering of  (A) the ordinary shares issued under the equity purchase agreements with the BTO Purchaser and the FNF Purchasers, (B) the ordinary shares and warrants (and underlying ordinary shares) issued pursuant to the forward purchase agreements (C) the ordinary shares issued under the ROFO purchase agreements and (D) the ordinary shares issued to the GSO Purchasers and certain FNF Purchasers under the investment agreement, (y) to cause such registration statement to be declared effective promptly thereafter and (z) to maintain the effectiveness of such registration statement until the earliest of   (A) the date on which the counterparties to such agreements cease to hold the securities covered thereby and (B) the date all of the securities covered thereby can be sold publicly without restriction or limitation under Rule 144 under the Securities Act, subject to certain conditions and limitations set forth in the equity commitment letters, the forward purchase agreements, the ROFO purchase agreements and the investment agreement. In addition, under the investment agreement, once the offered preferred shares issued to the original holders become convertible, such original holders will have the right to cause the Company to undertake up to four underwritten secondary offerings of the ordinary shares issuable upon conversion of the offered preferred shares.

In partial fulfillment of the above-detailed rights, the Company filed a registration statement which was declared effective by the SEC on January 16, 2018 (File No. 333-222232). Pursuant to Supplement No. 1, dated January 30, 2018, to the prospectus, dated January 16, 2018, it relates to:

• the issuance from time to time by the Company of up to 70,883,335 of our ordinary shares, par value $0.0001 per share, or ordinary shares, including (i) 34,500,000 ordinary shares issuable, upon the exercise of redeemable warrants, which we refer to as the public warrants, that were issued as part of the units in our initial public offering, or our IPO, (ii) 19,083,335 ordinary shares issuable upon the exercise of redeemable warrants that we issued in private placements to certain accredited investors upon the closing of the business combination pursuant to forward purchase agreements, which we refer to as the forward purchase warrants and (iii) 17,300,000 ordinary shares issuable upon the exercise of warrants we issued to CF Capital Growth, LLC in a private placement simultaneously with the closing of our IPO and upon conversion of working capital loans, which we refer to as the private placement warrants and collectively with the public warrants and the forward purchase warrants, the warrants.

• the resale from time to time by the selling securityholders named in this prospectus or their permitted transferees, which we refer to as the Selling Securityholders, of up to (i) 181,753,335 ordinary shares, (ii) 600,000 Series A Cumulative Convertible Preferred Shares, par value $0.0001 per share, or the Series A Preferred Shares, (iii) 250,000 Series B Cumulative Convertible Preferred Shares, par value $0.0001 per share, or the Series B Preferred Shares and (iv) 36,383,335 warrants to purchase ordinary shares, consisting of 19,083,335 forward purchase warrants and 17,300,000 private placement warrants.

The ordinary shares covered by this prospectus that may be offered and sold by the Selling Securityholders include (i) 115,370,000 ordinary shares issued to certain accredited investors, including certain of our directors and/or entities controlled by them, in private placements at the closing of our initial business combination with Fidelity & Guaranty Life, which we refer to as the business combination, (ii) 30,000,000 ordinary shares issued upon conversion of our

outstanding Class B ordinary shares, par value $0.0001 per share, at the closing of the business combination, which ordinary shares are subject to varying transfer restrictions as described herein, (iii) 19,083,335 ordinary shares issuable upon the exercise of the forward purchase warrants and (iv) 17,300,000 ordinary shares issuable upon the exercise of the private placement warrants.

The preferred shares covered by this prospectus that may be offered and sold by the Selling Securityholders include (i) 275,000 Series A Preferred Shares and 100,000 Series B Preferred Shares issued to certain accredited investors in private placements at the closing of the business combination, (ii) 1,772 Series A Preferred Shares and 645 Series B Preferred Shares that were issued on January 1, 2018 as payment-in-kind dividends with respect to the Series A Preferred Shares and Series B Preferred Shares, respectively, and (iii) 323,228 Series A Preferred Shares and 149,355 Series B Preferred Shares that may be issued as payment-in-kind dividends with respect to the Series A Preferred Shares and Series B Preferred Shares, respectively, subsequent to the date of this prospectus. The Series A Preferred Shares and the Series B Preferred Shares are subject to transfer restrictions until November 30, 2018, as described herein.

Each warrant entitles the holder to purchase one ordinary share at an exercise price of  $11.50 per share commencing on December 30, 2017 and will expire on November 30, 2022, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. Once the warrants are exercisable, we may redeem the outstanding public warrants and forward purchase warrants at a price of  $0.01 per warrant if the last reported sales price of the ordinary shares equals or exceeds $18.00 per share (as adjusted for share splits, share capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before we send the notice of redemption to the warrant holders, as described herein.

Listing of Securities

The Company’s ordinary shares and warrants are listed on the NYSE under the symbols “FG” and “FG WS,” respectively.

EX-10.36

Exhibit 10.37

EMPLOYMENT AGREEMENT

THIS AGREEMENT (the “Agreement”) is made by and between Fidelity & Guaranty Life Business Services, Inc., a Delaware corporation with an address at Two Ruan Center, 601 Locust Street, Suite 1400, Des Moines, Iowa 50309 (“F&G”), and Rajesh Krishnan, an individual with a residence at 203 Ridgewood Road, Baltimore, Maryland 21210 (“Executive”), as of January 1, 2019.

WHEREAS, F&G and the Executive were previously parties to an employment agreement dated November 14, 2013, which agreement terminated when the Executive transferred employment to an affiliate of The Blackstone Group, L.P., on December 1, 2017;

WHEREAS, the Executive has terminated employment with the affiliate of The Blackstone Group, L.P., on December 31, 2018, and is being reemployed by F&G as of such date, under the terms and conditions set forth in this Agreement.

NOW, THEREFORE, in consideration of F&G’s reemployment of Executive, and the mutual obligations and rights set forth in this Agreement, the parties agree as follows:

1.    DEFINITIONS

(a) “Client” or “Client List” means all Past, Present and Potential Clients as defined below;

“Company” means F&G and its direct and indirect subsidiaries, its direct parent and its direct parent’s direct and indirect subsidiaries;

“Compensation” means Executive’s salary and any bonus that may be awarded in the Company’s sole discretion;

“Compensation Year” means a calendar year in which Executive earns compensation;

“Confidential Information” means all secret, confidential or otherwise non-public information, knowledge or data relating to the Group, and their respective businesses or financial affairs, whether or not in writing, including but not limited to information related to: their suppliers and their businesses; prices charged to and terms of business with their customers; their marketing plans and sales forecasts; their financial information, results and forecasts; their proposals or plans for the acquisition or disposal of a company or business or any part thereof; their proposals or plans for any expansion or reduction of activities; their employees, including the employees’ performance, compensation and benefits; their research activities, inventions, trade secrets, designs, formulas and product lines; any information provided to the Group in confidence by its affiliates, customers, suppliers or other parties; and the identity and other information concerning and related to Clients;

“Disability” means Executive’s inability to perform his/her duties on a full-time basis for 180 days during any 12-month period as a result of incapacity due to mental or physical illness, even with reasonable accommodations;

“Employment Period” means the period of time when Executive is employed by the Company, including any Notice Period set forth in Section 5.2(A) below;

“Group” means the Company and the Group Companies, collectively and singularly;

“Group Company” means any company that is an indirect parent or holding company (up to and including the ultimate parent or holding company) of the Company and any direct or indirect subsidiary of any such indirect parent or holding company other than the Company;

“Notice Period” means the period set forth in Section 5.2(A) ending three (3) months from the date of written notice to terminate Executive’s employment;

“Past Client” means any person or entity who had been an advisee, investment advisory or insurance customer, distributor or client of the Group;

“Potential Client” means any person or entity to whom the Company has offered (by means of a personal meeting, telephone call, or a letter or written proposal specifically directed to the particular person or entity) to serve as investment adviser or to provide or distribute insurance products but which is not at such time an advisee, investment advisory or insurance customer, distributor or client of the Group or any person or entity for which a plan exists to make such an offer; persons or entities solicited or to be solicited solely by non-personalized form letters and blanket mailings are excluded from this definition;

“Present Client” means any person or entity who is an advisee, investment advisory or insurance customer, distributor or client of the Group.

“Termination Date” means the date when Executive ceases to be an employee of the Group;

(a) References to Sections are, unless otherwise stated, to Sections of this Agreement; and

(b) Section headings are for convenience only and shall not affect the construction or interpretation of this Agreement.

2.    EMPLOYMENT

2.1    Executive’s employment with the Company is “at will,” meaning that Executive may resign at any time for any reason and the Company may discharge Executive at any time for any reason, subject only to any obligation to provide notice as set forth in Section 5.2(A) below. Therefore, beyond any obligation to give notice as set forth in Section 5.2(A) below, nothing in this Agreement obligates Executive to remain in the Company’s employ for any period of time, and the Company has no obligation to employ Executive for any definite or indefinite period of time.

2.2    Executive represents that the performance of this Agreement and his/her duties as an employee of the Company does not and will not breach (i) any pre-existing agreement to refrain from competing, directly or indirectly, with the business of any previous employer or any other party, (ii) any pre-existing agreement to keep in confidence proprietary information, knowledge or data acquired by Executive prior to his/her employment with the Company, or (iii) any other terms or obligations to which he/she is bound.

3.    SCOPE OF EMPLOYMENT

3.1    Executive will faithfully, diligently and efficiently perform such duties on behalf of the Company as the Company may assign to him/her. Executive agrees to abide by the rules, regulations, instructions, personnel practices and policies of the Company, including any changes which may be adopted from time to time. Executive’s actions shall at all times be consistent with, and pursued solely to further, the interests of the Company. Under no circumstances will Executive take any action contrary to the best interests of the Company at any time during the Employment Period.

3.2    Executive shall devote his/her full time and attention to the affairs of the Company and shall not undertake any outside employment, with or without compensation, without written permission of the President or CEO of F&G specifying the outside activity in which Executive may engage.

3.3    Executive shall not have an ownership interest in any company that is a competitor of the Group, except that Executive may have a passive investment in any such company to the extent that (1) the investment does not constitute more than 1% of the competitor’s ownership, and (2) the investment is an immaterial percentage of Executive’s net worth.

4.    COMPENSATION AND BENEFITS

4.1    Compensation: Executive’s Compensation will be determined in the Company’s sole discretion.

4.2    Benefits: Executive shall be eligible to receive the various benefits offered by the Company to its executive employees as may be determined from time to time by the Company. These benefits may be modified or eliminated from time to time at the sole discretion of the Company. Where a particular benefit is subject to a formal plan (for example, medical insurance), eligibility to participate in and receive the particular benefit shall be governed solely by the applicable plan document.

4.3    Expenses: Executive shall be entitled to reimbursement for reasonable out-of-pocket expenses incurred for the Group’s business (including travel and entertainment) in accordance with the policies, practices and procedures of the Company.

5.    TERMINATION OF EMPLOYMENT

5.1    Termination For Cause: The Company may terminate Executive’s employment for Cause immediately upon written notice. Upon termination of Executive’s employment with the Company in accordance with this Section 5.1, all Compensation and benefits will cease and Executive shall not be entitled to receive any other Compensation, payments or benefits, except (a) earned wages or accrued vacation time that remains due and payable, and (b) benefits to the extent that Executive is entitled to accrued benefits under the express terms of any plan governing such benefits and to the extent that such benefits cannot be cancelled under either the terms of the relevant plan documents or applicable law. Executive will have the right to elect to continue his/her health and dental insurance after the Termination Date to the extent permitted by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”). Such coverage shall be at Executive’s expense and is not the responsibility of the Company.

“Cause” means the Company’s determination, in its sole discretion, that: (i) Executive has breached Executive’s obligations under this Agreement; (ii) Executive has failed to perform duties assigned to Executive in a manner satisfactory to the Company, subject to the obligation of the Company to provide Executive with prior notice providing reasonable detail of the bases for the unsatisfactory performance and an opportunity to correct the performance deficiencies; (iii) Executive has engaged in acts of dishonesty or moral turpitude, or any unlawful conduct; or (iv) Executive has engaged in conduct that is likely to affect adversely the business and/or the reputation of the Company.

5.2    Termination For Reasons Other Than Cause:

(A)    Termination With Notice Period: Either party may terminate Executive’s employment for any reason other than for Cause, Disability or death by giving the other party three (3) months’ notice in writing; terminations for Cause are governed by Section 5.1 above, for Disability by Section 5.2(C) below and death by Section 5.2(D) below.

(i)    By The Company:

(a)    Continuation of Compensation and Benefits: In the event that the Company provides notice to Executive under this Section 5.2(A), then for the duration of the Notice Period Executive shall continue to receive the base salary that he/she received immediately prior to the notice of termination and shall continue to be eligible to receive all benefits to which he/she is entitled as an employee of the Company. Executive shall not be entitled to any bonus (either in full or pro rata) otherwise payable after the date on which notice is given, nor except as provided below shall Executive receive any Compensation or be eligible for any benefits after the Termination Date, including but not limited to salary and medical, dental, life and disability benefits. Executive will have the right to elect to continue his/her health and dental insurance after the Termination Date to the extent permitted by COBRA. Except as provided below, any COBRA coverage will be at Executive’s own expense and is not the responsibility of the Company.

(b)    Severance: Provided Executive signs and delivers, and does not revoke, a general release in a form acceptable to the Company in its sole discretion, (x) Executive shall be entitled to receive a severance payment equal to two (2) weeks of base salary for every full year that Executive was employed by the Group, subject to a minimum payment of twenty-six (26) weeks base salary and a maximum payment of fifty-two (52) weeks base salary, and (y) if Executive properly elects COBRA coverage, the Company will make payments to the insurance provider(s) equal to the amount due for Executive’s COBRA coverage payments for a period of time equal to the number of weeks of Executive’s severance payments or until Executive is eligible to receive health benefits under another medical plan, whichever is sooner (by way of example only, if Executive is entitled to a severance payment equal to thirty weeks base salary because he/she has been employed by the Company for fifteen (15) years, the Company will make monthly payments to the COBRA insurance provider for the first thirty weeks of COBRA coverage, assuming Executive has executed and not revoked the release and has not otherwise become eligible to receive benefits under another medical plan). Executive agrees to give the Company notice immediately if he/she becomes eligible to receive benefits under another medical plan. The release agreement shall be provided to the Executive during the first month of the Notice Period. The severance payment based on tenure with the Company shall be paid in a lump sum within ten (10) days following the expiration of the Notice Period, provided that Executive has executed the release agreement, returned it to the Company, and allowed the revocation period therefor to expire, by the end of the Notice Period. The release agreement will provide, among other things, for the general release of any and all claims that Executive may have against the Group and its officers, directors, employees and agents, whether known or unknown, and whether at common law or arising under any statute, including but not limited to statutes relating to discrimination and whistleblowing, and also

will require Executive to keep the terms of the release confidential, subject to appropriate carve outs as required by law. Executive shall not be entitled to any other payment of any kind, except (a) as expressly provided in this Agreement, (b) earned wages or accrued vacation time that remains due and payable, and (c) benefits to the extent that Executive is entitled to accrued benefits under the express terms of any plan governing such benefits and to the extent that such benefits cannot be cancelled under either the terms of the relevant plan documents or applicable law.

(ii)    By Executive: In the event that Executive provides notice to the Company under Section 5.2(A), Executive shall not be entitled to any bonus (either in full or pro rata) otherwise payable after the date on which notice is given or any other compensation, payment or benefits of any kind, except (a) for the duration of the Notice Period, Executive shall continue to receive the base salary that he/she received immediately prior to the notice of termination and shall continue to be eligible to receive all benefits to which he/she is entitled as an employee of the Company, (b) earned wages or accrued vacation time that remains due and payable after the Termination Date, and (c) benefits payable after the Termination Date to the extent that Executive is entitled to accrued benefits under the express terms of any plan governing such benefits and to the extent that such benefits cannot be cancelled under either the terms of the relevant plan documents or applicable law. Executive will have the right to elect to continue his/her health and dental insurance after the Termination Date to the extent permitted by COBRA. Such coverage shall be at Executive’s expense and is not the responsibility of the Company.

(B)    Conduct During the Notice Period: During the Notice Period, Executive remains employed by the Company and shall not commence employment with any other employer, and is subject to all of the obligations, rules, policies and practices of the Company, including the obligation to act solely in the best interest of the Company. During the Notice Period, Executive shall perform such duties and tasks as the Company may assign to Executive, provided, however, that the Company reserves the right to have Executive stay away from the Company’s premises and not contact any Group employee or Client.

(C)    Disability: The Company may terminate Executive’s employment on written notice to Executive that the Company has determined that a Disability of Executive has occurred. Should the Company terminate this Agreement by reason of Executive’s Disability, all Compensation and benefits will cease effective on the Termination Date, and Executive shall have no right to any further payments or benefits except (a) to the extent that Executive is entitled to wages, accrued but unused vacation time or accrued benefits under the express terms of any plan governing such benefits, and (b) a pro rata bonus for the period when Executive was performing his/her regular duties on a full-time basis to the extent such bonus would have otherwise been payable in the absence of such disability.

(D)    Death: Executive’s employment shall terminate automatically upon Executive’s death. All Compensation and benefits will cease effective on the date of Executive’s death, except that Executive’s estate shall be eligible to receive Executive’s bonus, to the extent such bonus would have otherwise been payable, for the period up through Executive’s death; in the event Executive’s death is prior to the end of a Compensation Year, the bonus shall be prorated based upon the number of days Executive worked during the Compensation Year.

(E)    Equity Compensation: Any unvested award granted under any Company equity compensation plan will be handled in accordance with the terms of the applicable plan and grant agreement.

(F)    IRC Section 409A Compliance: The parties intend that the payments and benefits to which Executive could become entitled in connection with a termination of employment shall comply with or meet an exemption from Section 409A of the Internal Revenue Code. In this regard, notwithstanding anything in this Agreement to the contrary, all cash amounts that become payable under this Agreement shall be paid no later than March 15 of the year following the year in which such amounts are earned or become payable, shall qualify for the exception for “separation pay” set forth in Section 1.409A-1(b)(9) of the Treasury Regulations, or shall comply with Section 409A of the Internal Revenue Code. Payments subject to Section 409A of the Internal Revenue Code that are due upon termination of employment shall be made only upon “separation from service” within the meaning of Section 409A(a)(2)(A)(i) of the Internal Revenue Code, and shall be subject to the 6-month payment delay described in Section 409A(a)(2)(B)(i) of the Internal Revenue Code if the Executive is a “specified employee” as described therein. In the event that it is determined that the terms of this Agreement do not comply with Section 409A of the Code, the parties will negotiate reasonably and in good faith to amend the terms of this Agreement so that it complies (in a manner that preserves the economic value of the payments and benefits to which Executive may become entitled) so that payments are made within the time period and in a manner permitted by the applicable Treasury Regulations.

5.3    Upon termination (or suspension) of Executive’s employment, regardless of the reason, Executive shall deliver to the Company all books, documents and materials described in Section 6 below, and all computers, blackberries, other personal data devices, phones, credit cards, keys and other property of the Group that are in Executive’s possession or control.

5.4    Termination of Executive’s employment with the Company for any reason shall constitute Executive’s resignation as an officer, director, trustee and/or any and all other positions held by him with any subsidiary or any pooled investment vehicle organized or advised by the Group, effective automatically. Executive shall execute any and all documents and take any and all action reasonably requested by the Group to acknowledge and effect such resignations.

6.    FURTHER COVENANTS.

6.1    All Business to Be the Property of the Group; Assignment of Intellectual Property.

(A)Executive agrees that any and all presently existing investment advisory and insurance business of the Group and all business developed by Executive or any other employee of the Group, including without limitation all investment advisory and insurance contracts, distribution agreements, fees, commissions, compensation records, performance records, Client Lists, agreements and any other incident of any business developed or sought by the Group or earned or carried on by Executive during his/her employment with the Group, are and shall be the exclusive property of the Group for its sole use and (where applicable) shall be payable directly to the Group. Executive grants to the Group Executive’s entire right, title and interest throughout the world, if any, in and to all research, information, Client Lists, product lists, distributor lists, identities, investment profiles and particular needs and characteristics of Clients, performance records, and all other investment advisory, insurance, technical and research data made, conceived, developed and/or acquired by Executive solely, jointly or in common with others during the period of Executive’s employment by the Group, that relate to the Group’s business as it was or is now rendered or as it may, from time to time, hereafter be rendered or proposed to be rendered during the Employment Period.

(B)Any inventions and any copyrightable material developed by Executive in the scope of his/her employment with the Group shall be promptly disclosed to the Group and will be “works for hire” owned by the Group. Executive will, at the Group’s expense, do whatever is necessary to transfer to the Group, and document its ownership of, any such property.

6.2    Confidentiality. Executive shall not, either during the period of Executive’s employment with the Group or thereafter, use for Executive’s own benefit or disclose to or use for the benefit of any person outside the Group, any information not already lawfully available to the public concerning Confidential Information, whether Executive has such information in Executive’s memory or embodied in writing or other tangible or electronic form. All Confidential Information, and all originals and copies of any Confidential Information, and any other written material relating to the business of the Group, including information stored electronically, shall be the sole property of the Group. Executive acknowledges and agrees that the Confidential Information has been and will be developed by the effort and expense of the Group; that such Confidential Information has economic value to the Group and would have significant economic value to the Group’s competitors if divulged; that the Confidential Information is not available to the Group’s competitors; and that keeping the Confidential Information from the Group’s competitors has economic value to the Group. Upon the termination of Executive’s employment in any manner or for any reason, Executive shall promptly surrender to the Group all originals and copies of any Confidential Information, and Executive shall not thereafter retain or use any Confidential Information for any purpose.

Notwithstanding any confidentiality obligations set forth in this Agreement, Executive acknowledges and understands that:

(A)    The restrictions on use and confidentiality contained herein shall not apply to any portion of the Confidential Information which: (i) was publicly known or generally known within the trade at the time of the disclosure; (ii) becomes public knowledge or generally known within the trade without breach of this Agreement by either party or anyone given access to the Confidential Information by either party; (iii) is required to be disclosed by law, but only to the extent required by law; or (iv) is obtained by the non-disclosing party from a third party who is under no obligation of confidentiality with respect to the Confidential Information, and who is not otherwise prohibited from transmitting the Confidential Information to the non-disclosing party; and

(B)    Pursuant to 18 U.S.C. § 1833(b), Executive has been and is hereby advised that he shall not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that (i) is made (a) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (b) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.

6.3    Client Information. Executive acknowledges that while employed by the Group, Executive will have contact with and become aware of the Group’s Clients and distributors and the representatives of those Clients and distributors, names and addresses, specific client and distributor needs and requirements, and leads and references to Potential Clients (together with the Client List, collectively, the “Client Information”). Executive agrees that the Client Information constitutes a trade secret and otherwise is a valuable asset of the Group. Executive further agrees that the Client Information has been and will be developed by the Group and would have significant economic value to the Group’s competitors if divulged; that the Client Information is not available to the Group’s competitors; that keeping the Client Information confidential from the Group’s competitors has economic value to the Group; and that the Group takes reasonable steps to protect the confidentiality of the Client Information.

6.4    Restrictive Covenants.

(A)For eighteen (18) months following the Termination Date, irrespective of the reason for the termination, Executive shall not, directly or indirectly, solicit or attempt to solicit, or assist others in soliciting or attempting to solicit, any Client of the Group for the purpose of providing investment advisory or insurance services or products or distribution services. Executive agrees that the restriction contained in this Section is necessary to protect the Group’s business and property in which the Group has made a considerable investment, and to prevent misuse of the Confidential and Client Information. For purposes of this Section 6.4(A), “Client” means:

“Past Client” means any person or entity who had been an advisee, investment advisory or insurance customer, distributor or client of the Group during the one (1) year period immediately preceding the termination of Executive’s employment with the Group and with which Executive dealt while at the Group or which became known to Executive during the course of his/her employment at the Company.

“Potential Client” means any person or entity to whom the Group has offered (by means of a personal meeting, telephone call, or a letter or written proposal specifically directed to the particular person or entity) within the one (1) year immediately preceding the termination of Executive’s employment to serve as investment adviser or to provide or distribute insurance products but which is not at such time an advisee, investment advisory or insurance customer, distributor or client of the Group and with which Executive dealt while at the Group or which became known to Executive during the course of his/her employment at the Group; this definition includes persons or entities for which a plan exists to make such an offer, but excludes persons or entities solicited or to be solicited solely by non-personalized form letters and blanket mailings.

“Present Client” means any person or entity who at the time of Executive’s termination of employment is an advisee, investment advisory or insurance customer, distributor or client of the Group and with which Executive dealt while at the Group or which became known to Executive during the course of his/her employment at the Group.

(B)For eighteen (18) months following the termination of Executive’s employment with the Group, irrespective of the reason for the termination, Executive shall not directly or indirectly solicit, recruit, induce away, or attempt to solicit, recruit, or induce away, or hire any employee, director, officer or agent, contractor or consultant of the Group with whom Executive had contact during Executive’s employment with the Group. For purposes of this paragraph, “contact” means any personal interaction whatsoever between the individual and Executive.

(C)For six (6) months following the termination of the Executive’s employment with the Group, irrespective of the reason for the termination, the Executive shall not, without the written consent of the Group, directly or indirectly carry on or participate in a Competing Business (as defined below). A “Competing Business” shall mean a life insurance or annuity business, or a business in the life insurance or annuity industry, in the United States of America. The phrase “carry on or participate in a Competing Business” shall include engaging in any of the following activities, directly or indirectly: (i) Carrying on or engaging in a Competing Business as a principal, or on the Executive’s own account, or solely or jointly with others as a director, officer, agent, employee, consultant or partner, or stockholder, limited partner or other interest holder owning more than five (5) percent of the stock or equity interests or securities convertible into more than five (5) percent of the stock or equity interests in any entity that is carrying on or engaging in a Competing Business; (ii) as agent or principal, carrying on or engaging in any activities or negotiations with respect to the acquisition or disposition of a Competing Business; (iii) extending credit for the purpose of establishing or operating a Competing Business; (iv) lending or allowing the Executive’s name or reputation to be used in a Competing Business; (v) otherwise allowing the Executive’s skill, knowledge or experience to be used in a Competing Business.

(D)Executive and the Group agree that the period of time and the geographic area applicable to the covenants of Section 6.4 are reasonable and necessary to protect the legitimate business interests and goodwill of the Group in view of (1) Executive’s senior executive position within the Group, (2) the geographic scope and nature of the business in which the Group is engaged, (3) Executive’s knowledge of the Group’s business and (4) Executive’s relationships with the Clients.

6.5    Executive shall comply with (a) every applicable rule of law and (b) the rules and regulations of regulatory authorities insofar as the same are applicable to his/her employment with the Group.

6.6    Executive shall not disparage, portray in a negative light or make any statement which would be harmful to, or lead to unfavorable publicity for, the Group, or any of their current or former directors, officers or employees, including, without limitation, in any and all interviews, oral statements, written materials, electronically displayed materials and materials or information displayed on internet or internet-related sites; provided, however, that this Agreement does not apply to the extent Executive is making truthful statements when required by law or by order of a court or other legal body having jurisdiction or when responding to an inquiry from any governmental or regulatory organization.

6.7    At no time after the Termination Date shall Executive represent him/herself as being interested in or employed by or in any way connected with the Group, other than as a former employee of the Group. After the Termination Date, Executive shall not in the course of carrying on any trade or business claim, represent or otherwise indicate any present association with the Group or for the purpose of carrying on or obtaining or retaining any business or customers claim, represent or otherwise indicate any past association with the Group.

6.8    Executive agrees to (i) provide truthful and reasonable cooperation, including but not limited to his/her appearance at interviews and depositions, in all legal matters, including but not limited to regulatory and litigation proceedings relating to his/her employment or area of responsibility at the Group, whether or not such matters have already been commenced and through the conclusion of such matters or proceedings, and (ii) provide to the Group’s counsel all documents in Executive’s possession or control relating to such regulatory or litigation matters. F&G will reimburse Executive for all reasonable travel expenses in connection with such cooperation.

6.9    The provisions of this Agreement, including but not limited to this Section 6, shall continue to apply with full force and effect should Executive transfer between or among the Group, wherever situated, or otherwise become employed by any other member of the Group, or be promoted or reassigned to any position. In the event that Executive becomes employed by a member of the Group other than the Company, this Agreement shall be read to substitute the other company’s name wherever the Company is referenced and the Company’s rights under this Agreement shall be assigned to Executive’s new employer and Executive consents to such assignment.

6.10    The Group shall have the right to communicate Executive’s ongoing obligations under this Agreement to any entity or individual by whom Executive becomes employed or with whom Executive becomes otherwise engaged following termination of employment with the Group and Executive consents to the Group making that communication.

6.11    To the extent any of the covenants of this Section 6 or any other provisions of this Agreement shall be deemed illegal or unenforceable by a court or other tribunal of competent jurisdiction with respect to (i) geographic area, (ii) time period, (iii) any activity or capacity covered by such covenant or contractual provision, or (iv) any other term or provision of such covenant or contractual provision, the covenant or contractual provision shall be construed to the maximum breadth determined to be legal and enforceable, and the illegality or unenforceability of any one covenant or contractual provision shall not affect the legality and enforceability of the other covenants or contractual provisions.

6.12     Executive acknowledges that his/her agreement to comply with these restrictions was an inducement for the Group to continue to employ Executive and to enter into this Agreement with Executive.

7.    GENERAL

7.1    This Agreement and any disputes relating to the parties’ relationship or the termination of that relationship, whether arising in law or equity and whether based on contract, tort or statutory rights, shall be deemed to have been made in the state of Iowa and shall take effect as an instrument under seal, and the validity, interpretation and performance of this Agreement shall be governed by, and construed in accordance with, the internal law of the state of Iowa, without giving effect to conflict-of-law principles. Both parties agree that any action, demand, claim or counterclaim (collectively, any “Legal Action”) relating to this Agreement or any other disputes relating to the parties’ relationship or the termination of that relationship, whether arising in law or equity and whether based on contract, tort or statutory rights, shall be commenced exclusively in Iowa in any state or federal court of competent jurisdiction. Both parties acknowledge material witnesses and documents would be located in Iowa, and neither party shall assert that Iowa is an inconvenient or otherwise inappropriate venue for the resolution of any dispute. Both parties further agree that any disputes relating to this Agreement or any other disputes relating to the parties’ relationship or the termination of that relationship, whether based on contract, tort or statutory rights, shall be resolved by a judge alone, and both parties waive and forever renounce the right to a trial before a civil jury.

7.2    This agreement may be executed in counterparts.

7.3    This Agreement contains the entire agreement of the parties and supersedes all oral or written employment, consulting or similar agreements, understandings or arrangements between Executive, on the one hand, and the Group, on the other hand, relating to Executive’s employment or the termination of his/her employment. In entering into this Agreement, neither party is relying on any oral or written representation, promise, agreement or understanding that is not set forth in this Agreement, and both parties expressly disclaim any reliance on any oral or written representation, promise, agreement or understanding not set forth in this Agreement.

7.4    This Agreement may not be amended or modified other than by a written agreement executed by both parties. The writing executed by the Company must be by the CEO of F&G. This Agreement is binding upon and inures to the benefit of both parties and their respective successors and assigns, including any corporation with which or into which the Company may be merged or which may succeed to its assets or business, although the obligations of Executive are personal, are not assignable, and may be performed only by him/her.

7.5    All notices and other communications required under this Agreement shall be in writing and shall be given by hand delivery to the other party, by overnight delivery service, signature required, or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows:

If to Executive:    Rajesh Krishnan

203 Ridgewood Road

Baltimore, MD 21210

If to the Company:     Fidelity & Guaranty Life Business Services, Inc.

Two Ruan Center

601 Locust Street, Suite 1400

Des Moines, IA 50309

Attn: General Counsel

or to such other address as either party shall have furnished to the other in writing in accordance with this provision. Notices and communications shall be effective when delivered to the addressee or, if addressee refuses delivery, on the date delivery was first attempted.

7.6    Executive’s or the Company’s failure to insist upon strict compliance with any provision of this Agreement or the failure to assert any right Executive or the Company may have hereunder shall not be deemed to be a waiver of such provision or right or any other provision or right under this Agreement.

7.7    All provisions in this Agreement that relate to compensation or benefits (including but not limited to salary, bonuses and employee benefits) are operative only to the extent that Executive continues to be employed by the Company as of the time that the payment or award of any of the above would be due except as otherwise provided for in Section 5 or under the express terms of any benefit plans. If Executive is no longer employed as of that time, none of the Compensation or benefits otherwise due shall be payable to Executive except (a) as expressly provided in Section 5 of this Agreement, (b) for earned but unpaid wages or accrued but not used vacation or (c) under the express terms of any benefit plans to the extent that such benefits cannot be cancelled under either the terms of the relevant plan documents or applicable law.

7.8    Executive acknowledges and agrees that the Company’s remedy at law for any breach of the provisions of this Agreement would be inadequate and that for breach of such provisions the Company shall, in addition to such other remedies as may be available to it at law or in equity or as provided in this Agreement, be entitled to temporary, preliminary and permanent injunctive relief as well as to enforce its rights by an action for specific performance to the extent permitted by law. Executive expressly consents to the granting of temporary, preliminary and permanent injunctive relief and/or specific performance for breach of this Agreement.

7.9    The Company shall have the right to set off any damages incurred by the Group against any amounts due to Executive by the Group, except for Executive’s salary and other sums that are non-forfeitable wages under the law or otherwise protected from offset or seizure by law. In addition to, and without limiting in any way, the Company’s rights and remedies as set forth in this Agreement or in law or equity, Executive agrees that if Executive engages in any activities prohibited by this Agreement, Executive will pay over to the Company all compensation or revenue received in connection with such activities.

7.10     All compensation and benefits payable under this Agreement shall be subject to withholding by the Company of all applicable taxes. The parties further understand and agree that should any relevant law (including without limitation any regulatory interpretations thereof) change between the time of execution of this Agreement and the payment of the various payments to Executive called for by the Agreement, the parties will revise the Agreement accordingly in a good-faith attempt to ensure ongoing compliance with such law upon mutual agreement of the parties, staying as consistent as possible with the financial and other business terms of this Agreement, but in any case Executive hereby agrees that all personal income taxes on his/her compensation and benefits under this Agreement and all penalties and interest with respect to such personal income taxes, including but not limited to under Section 409A of the Internal Revenue Code, if any, are his own responsibility.

7.11     Executive and the Company represent and acknowledge that the consideration that each has received under this Agreement is sufficient and adequate for the obligations that each has agreed to undertake, and expressly waives any right to assert that they have not received adequate consideration for agreeing to the obligations undertaken in this Agreement.

7.12     Executive acknowledges and represents that he/she understands his/her obligations and rights under this Agreement, has had adequate time to consider it, and has had adequate time and opportunity to ask any questions and obtain any advice he/she felt necessary or appropriate. No one has placed any pressure on Executive to execute this Agreement prior to the expiration of a reasonable time for him/her to read it, ask any questions and obtain any advice he/she felt necessary or appropriate. Executive enters into this Agreement freely and voluntarily.

7.13     The officer executing this Agreement on behalf of F&G has the authority to enter into this Agreement, and Executive is relying on his/her authority to do so.

IN WITNESS whereof this Agreement has been executed the day and year first above written.

EXECUTIVE

By:    Rajesh Krishnan

FIDELITY & GUARANTY LIFE BUSINESS

SERVICES, INC.

By:    

Its:    ________________________

EX-10.37

AMENDED & RESTATED EMPLOYMENT AGREEMENT

THIS AGREEMENT (the “Agreement”), made as of March 29, 2019 (the “Restatement Date”), by and between Fidelity & Guaranty Life Business Services, Inc., a Delaware corporation (“F&G”) and Dennis Vigneau (“Executive”), amends and restates in its entirety the employment agreement between F&G and Executive, dated as of January 27, 2014 (the “Original Agreement”).

WHEREAS, Executive has informed the Company that he intends to retire from employment with the Company effective as of December 31, 2019;

WHEREAS, the Company and Executive desire to enter into this Agreement to set forth the terms and conditions of Executive’s continuing employment with the Company through the end of the Transition Period (as defined below); and

WHEREAS, this Agreement will amend and restate the Original Agreement in its entirety, effective as of the Restatement Date.

NOW, THEREFORE, in consideration of F&G’s continued employment of Executive through the end of the Transition Period, and the mutual obligations and rights set forth in this Agreement, the parties agree as follows:

1. DEFINITIONS

(a)     “Client” or “Client List” means all Past, Present and Potential Clients as defined below;

“Company” means F&G and its direct and indirect subsidiaries, its direct parent    and its direct parent’s direct and indirect subsidiaries;

“Compensation” means Executive’s salary and any bonus that may be awarded in the Company’s sole discretion;

“Compensation Year” means a calendar year in which Executive earns compensation;

“Confidential Information” means all secret, confidential or otherwise non-public information, knowledge or data relating to the Group, and their respective businesses or financial affairs, whether or not in writing, including but not limited to information related to: their suppliers and their businesses; prices charged to and terms of business with their customers; their marketing plans and sales forecasts; their financial information, results and forecasts; their proposals or plans for the acquisition or disposal of a company or business or any part thereof; their proposals or plans for any expansion or reduction of activities; their employees, including the employees’ performance, compensation and benefits; their research activities, inventions, trade secrets, designs, formulas and product lines; any information provided to the Group in confidence by its affiliates, customers, suppliers or other parties; and the identity and other information concerning and related to Clients;

“Disability” means Executive’s inability to perform his duties on a full-time basis for 180 days during any 12-month period as a result of incapacity due to mental or physical illness, even with reasonable accommodations;

“Employment Period” means the period of time when Executive is employed by the Company; provided, that the Employment Period will automatically terminate upon Executive’s retirement on December 31, 2019;

“Group” means the Company and the Group Companies, collectively and singularly;

“Group Company” means any company that is an indirect parent or holding company (up to and including the ultimate parent or holding company) of the Company and any direct or indirect subsidiary of any such indirect parent or holding company other than the Company;

“Past Client” means any person or entity who had been an advisee, investment advisory or insurance customer, distributor or client of the Group;

“Potential Client” means any person or entity to whom the Company has offered (by means of a personal meeting, telephone call, or a letter or written proposal specifically directed to the particular person or entity) to serve as investment adviser or to provide or distribute insurance products but which is not at such time an advisee, investment advisory or insurance customer, distributor or client of the Group or any person or entity for which

a plan exists to make such an offer; persons or entities solicited or to be solicited solely by non-personalized form letters and blanket mailings are excluded from this definition;

“Present Client” means any person or entity who is an advisee, investment advisory or insurance customer, distributor or client of the Group;

“Strategic Initiative” has the meaning set forth in Section 3.1;

“Transition Period” means the period beginning on the Restatement Date and ending on December 31, 2019;

“Termination Date” means the date when Executive ceases to be an employee of the Group;

(b) References to Sections are, unless otherwise stated, to Sections of this Agreement; and

(c) Section headings are for convenience only and shall not affect the construction or interpretation of this Agreement.

2. EMPLOYMENT

2.1 Executive’s employment with the Company is “at will,” meaning that Executive may resign at any time for any reason and the Company may discharge Executive at any time for any reason, subject only to any obligation to provide notice as set forth in Section 5.2(A) below. Therefore, beyond any obligation to give notice as set forth in Section 5.2(A) below, nothing in this Agreement obligates Executive to remain in the Company’s employ for any period of time, and the Company has no obligation to employ Executive for any definite or indefinite period of time.

2.2 Executive represents that the performance of this Agreement and his/her duties as an employee of the Company does not and will not breach (i) any pre-existing agreement to refrain from competing, directly or indirectly, with the business of any previous employer or any other party, (ii) any pre-existing agreement to keep in confidence proprietary information, knowledge or data acquired by Executive prior to his/her employment with the Company, or (iii) any other terms or obligations to which he/she is bound.

3. SCOPE OF EMPLOYMENT

3.1 Executive will faithfully, diligently and efficiently perform such duties on behalf of the Company as the Company may assign to him in accordance with this Section 3.1. Executive agrees to abide by the rules, regulations, instructions, personnel practices and policies of the Company, including any changes which may be adopted from time to time. Executive’s actions shall at all times be consistent with, and pursued solely to further, the interests of the Company. Under no circumstances will Executive take any action contrary to the best interests of the Company at any time during the Employment Period. During the Transition Period, Executive will initially continue to serve as Chief Financial Officer of the Company until such time as an interim or permanent successor Chief Financial Officer is named, at which point Executive will continue to serve as a non-executive officer employee of the Company through the applicable Termination Date. In addition to his role as Chief Financial Officer for the applicable period referenced in the prior sentence, Executive’s duties during the Transition Period will consist of the following: (A) oversight of strategic initiatives currently being contemplated with the Group, as listed on Exhibit A hereto (the “Strategic Initiatives”); provided, that, for all purposes of this Agreement, a “Strategic Initiative” shall include the applicable initiative in its currently contemplated form or as may be modified after the Restatement Date; (B) assistance in the Company’s search for and transition to a permanent Chief Financial Officer (the “CFO Transitional Duties”); and (C) any other duties that are reasonably assigned to Executive by the Company’s CEO, to whom Executive will report directly. During the Transition Period, Executive shall continue to provide services from the same principal locations of employment as such services were provided immediately prior to the Restatement Date.

3.2 Executive shall devote his full time and attention to the affairs of the Company and shall not undertake any outside employment, with or without compensation, without written permission of the CEO of the Company specifying the outside activity in which Executive may engage.

3.3 Executive shall not have an ownership interest in any company that is a competitor of the Group, except that Executive may have a passive investment in any such company to the extent that (1) the investment does not constitute more than 1% of the

competitor’s ownership, and (2) the investment is an immaterial percentage of Executive’s net worth.

4. COMPENSATION AND BENEFITS

4.1 Compensation: Executive’s Compensation during the Employment Period for the calendar year of 2019 will be comprised of:

(a) a base salary of $440,000 per year;

(b) a fixed performance bonus of $500,000 (the “Fixed Performance Bonus”), subject to either (i) Executive’s continued employment hereunder for the duration of the Transition Period or (ii) a termination of Executive’s

employment by the Company without Cause prior to the expiration of the Transition Period under Section 5.2 below;

(c) a bonus equal to $500,000 (the “CFO Transition Bonus”) in respect of Executive’s provision of the CFO Transitional Duties, subject to either (i) Executive’s continued employment hereunder for the duration of the Transition Period or (ii) a termination of Executive’s employment by the Company without Cause prior to the expiration of the Transition Period under Section 5.2 below, and in each case payable regardless of whether the Company names a permanent Chief Financial Officer prior to the expiration of the Transition Period; and

(d) a total of two (2) bonus payments each equal to $200,000 upon the consummation of each of the Strategic Initiatives (the “Strategic Initiative Bonuses”), subject to either (i) a definitive agreement in respect of the applicable Strategic Initiative being signed by no later than June 30, 2020, the applicable Strategic Initiative ultimately closing by no later than December 31, 2020 and Executive’s continued employment hereunder for the duration of the Transition Period, or (ii) a termination of Executive’s employment by the Company without Cause prior to the expiration of the Transition Period under Section 5.2 below.

4.2 Payment Timing:

(a) The Fixed Performance Bonus will not be paid currently to Executive but will instead be credited to Executive’s account under the Company’s deferred compensation plan effective as of December 31, 2019 (or such earlier date of termination pursuant to Section 4.1(b)(ii)) in accordance with Executive’s prior election thereunder without regard to any requirement under such plan that Executive be employed on the date on which it is so credited; and

(b) The CFO Transition Bonus shall be paid to Executive in 2020, but no later than ten (10) days following the expiration of the Transition Period (the “Regular Payment Date”), and the Strategic Initiative Bonuses shall be paid upon the consummation of the applicable Strategic Initiative; provided, that, if Executive’s employment is terminated by the Company without Cause prior to the expiration of the Transition Period and Executive complies with the Release (as defined below) requirements set forth in Section 5.2(A)(1)(b), then the CFO Transition Bonus and the Strategic Initiative Bonuses shall be paid to Executive in 2020, but no later than the later of (i) the Regular Payment Date and (ii) the date that is ten (10) days following Executive’s execution and non-revocation of the Release (the “Termination Payment Date”).

4.3 Benefits: Executive shall be eligible to receive the various benefits offered by the Company to its executive employees as may be determined from time to time by the Company. These benefits may be modified or eliminated from time to time at the sole discretion of the Company. Where a particular benefit is subject to a formal plan (for example, medical insurance), eligibility to participate in and receive the particular benefit shall be governed solely by the applicable plan document.

4.4 Expenses: Executive shall be entitled to reimbursement for reasonable out-of-pocket expenses incurred for the Group’s business (including travel and entertainment) in accordance with the policies, practices and procedures of the Company; provided, that, for the avoidance of doubt, such reimbursement shall cover Executive’s reasonable travel expenses to and from any Company office (including the Company’s offices in the Baltimore, Maryland area) and any related lodging and similar expenses incurred while Executive is providing services in such Company office (in all cases in accordance with the policies, practices and procedures of the Company).

4.5 Attorneys’ Fees: Executive shall be entitled to reimbursement for attorneys’ fees of up to $40,000 for the negotiation and review of this Agreement and all other arrangements relating to his retirement from the Company. Additionally, the Company hereby waives any conflicts that may apply in respect of Executive engaging Skadden, Arps, Slate, Meagher & Flom LLP as his counsel.

5. TERMINATION OF EMPLOYMENT

5.1 Termination For Cause: The Company may terminate Executive’s employment for Cause upon written notice. Upon termination of Executive’s employment with the Company in accordance with this Section 5.1, all Compensation and benefits will cease and Executive shall not be entitled to receive any other Compensation, payments or benefits, except (a) earned wages

or accrued vacation time that remains due and payable, and (b) benefits to the extent that Executive is entitled to accrued benefits under the express terms of any plan governing such benefits and to the extent that such benefits cannot be cancelled under either the terms of the relevant plan documents or applicable law. Executive will have the right to elect to continue his/her health and dental insurance after the Termination Date to the extent permitted by the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”). Such coverage shall be at Executive’s expense and is not the responsibility of the Company.

“Cause” means the occurrence of any of the following conditions, provided that such occurrence is likely to have a material adverse effect on the business or reputation of the Company: (i) Executive willfully and materially breaches his obligations under this Agreement or (ii) Executive is convicted, indicted for, or enters a plea of nolo contendere to, any felony or any other act involving fraud, theft, misappropriation, dishonesty or embezzlement; provided, that, (x) no such condition shall constitute “Cause” unless the Company (A) provides written notice of such condition to Executive and (B) provides Executive a reasonable opportunity to cure such condition and Executive is not able to materially cure such condition and (y) no act or failure to act by Executive shall be considered “willful” unless it is done or omitted to be done by Executive in bad faith and without reasonable belief that his action or omission was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or based upon the written advice of counsel for the Company, shall be presumed to be done by Executive in good faith and in the best interests of the Company.

5.2 Termination For Reasons Other Than Cause:

(A) Termination With Notice: Either party may terminate Executive’s employment for any reason other than for Cause, Disability or death at any time by giving the other party notice in writing; terminations for Cause are governed by Section 5.1 above, for Disability by Section 5.2(A)(ii)(B) below and death by Section 5.2(A)(ii)(C) below.

(i) By The Company:

(a) Continuation of Compensation and Benefits: In the event that the Company provides notice to Executive under this Section 5.2(A), then for the duration of the Transition Period Executive shall continue to receive the base salary at a rate of $440,000 per year and shall continue to be eligible to receive all benefits to which he is entitled as an employee of the Company.

(b) Severance: Provided Executive signs and delivers, and does not revoke, a general release of claims in the form set forth on Exhibit B hereto (the “Release”) within fifty-two (52) days after the Termination Date: (i) Executive shall be entitled to receive a payment equal to $330,000, payable in a lump sum on the Termination Payment Date (the “Cash Severance”); (ii) if Executive properly elects COBRA coverage, the Company will make payments to the insurance provider(s) equal to the amount due for Executive’s COBRA coverage payments for a period of time equal to eighteen (18) months or until Executive is eligible to receive health benefits under another medical plan that are reasonably similar in the aggregate to those provided to Executive by the Company, whichever is sooner (the “COBRA Coverage”); and (iii) Executive shall be entitled to full payment of the Fixed Performance Bonus, the CFO Transition Bonus and the Strategic Initiative Bonuses, each in accordance with Section 4.1 and payable in a lump sum on the applicable Termination Payment Date (the payments under clause (iii) constituting the “Severance Payment”). Executive agrees to give the Company notice immediately if he becomes eligible to receive benefits under another medical plan during the period that COBRA coverage is being provided. The Release shall be provided upon the Termination Date. Executive shall not be entitled to any other payment of any kind, except (a) as expressly provided in this Agreement, (b) earned wages or accrued vacation time that remains due and payable, and (c) benefits to the extent that Executive is entitled to accrued benefits under the express terms of any plan governing such benefits and to the extent that such benefits cannot be cancelled under either the terms of the relevant plan documents or applicable law.

(ii) By Executive: In the event that Executive provides notice to the Company under Section 5.2(A) prior to the expiration of the Transition Period, Executive shall not be entitled to any Compensation or Severance Payments or any other compensation, payment or benefits of any kind not already paid, except (a) earned wages or accrued vacation time that remain due and payable after the Termination Date, and (b) benefits payable after the Termination Date to the extent that Executive is entitled to accrued benefits under the express terms of any plan governing such benefits and to the extent that such benefits cannot be cancelled under either the terms of the relevant plan documents or applicable law. Executive will have the right to elect to continue his/her health and dental insurance after the Termination Date to the extent permitted by COBRA. Such coverage shall be at Executive’s expense and is not the responsibility of the Company.

(B) Disability: The Company may terminate Executive’s employment on written notice to Executive that the Company has determined that a Disability of Executive has occurred. Should the Company terminate this Agreement by reason of Executive’s Disability, all Compensation and benefits will cease effective on the Termination Date, and Executive shall have no right to any further payments or benefits except (i) to the extent that Executive is entitled to wages, accrued but unused vacation time or accrued benefits under the express terms of any plan governing such benefits, and (ii) a pro rata bonus for the period when Executive was performing his regular duties on a full-time basis to the extent such bonus would have otherwise been payable in the absence of such Disability.

(C) Death: Executive’s employment shall terminate automatically upon Executive’s death. All Compensation and benefits will cease effective on the date of Executive’s death, except that Executive’s estate shall be eligible to receive Executive’s bonus, to the extent such bonus would have otherwise been payable, for the period up through Executive’s death; in the event Executive’s death is prior to the end of a Compensation Year, the bonus shall be prorated based upon the number of days Executive worked during the Compensation Year.

(D) Equity Compensation: Any unvested award granted under any Company equity compensation plan will be handled in accordance with the terms of the applicable plan and grant agreement.

(E) IRC Section 409A Compliance: The parties intend that the payments and benefits to which Executive could become entitled in connection with a termination of employment shall comply with or meet an exemption from Section 409A of the Internal Revenue Code. In this regard, notwithstanding anything in this Agreement to the contrary, all cash amounts that become payable under this Agreement shall be paid no later than March 15 of the year following the year in which such amounts are earned or become payable, shall qualify for the exception for “separation pay” set forth in Section 1.409A-1(b)(9) of the Treasury Regulations, or shall comply with Section 409A of the Internal Revenue Code. Payments subject to Section 409A of the Internal Revenue Code that are due upon termination of employment shall be made only upon “separation from service” within the meaning of Section 409A(a)(2)(A)(i) of the Internal Revenue Code, and shall be subject to the 6-month payment delay described in Section 409A(a)(2)(B)(i) of the Internal Revenue Code if the Executive is a “specified employee” as described therein. In the event that it is determined that the terms of this Agreement do not comply with Section 409A of the Code, the parties will negotiate reasonably and in good faith to amend the terms of this Agreement so that it complies (in a manner that preserves the economic value of the payments and benefits to which Executive may become entitled) so that payments are made within the time period and in a manner permitted by the applicable Treasury Regulations.

5.3 Upon termination (or suspension) of Executive’s employment, regardless of the reason, Executive shall deliver to the Company all books, documents and materials described in Section 6 below, and all computers, blackberries, other personal data devices, phones, credit cards, keys and other property of the Group that are in Executive’s possession or control.

5.4 Termination of Executive’s employment with the Company for any reason shall constitute Executive’s resignation as an officer, director, trustee and/or any and all other positions held by him with any subsidiary or any pooled investment vehicle organized or advised by the Group, effective automatically. Executive shall execute any and all documents and take

any and all action reasonably requested by the Group to acknowledge and effect such resignations.

5.5 Expiration of Transition Period. In the event Executive is employed with the Company for the duration of the Transition Period, Executive shall be entitled to receive the Cash Severance and the COBRA Coverage set forth in Section 5.2(A)(i)(b), subject to the terms thereof, together with any other payments that become payable to Executive in accordance with the terms of this Agreement or any other arrangement between the Company and Executive, provided that no payment under this Section 5.5 shall result in any duplication of benefits.

6. FURTHER COVENANTS.

6.1 All Business to Be the Property of the Group; Assignment of Intellectual Property.

(A) Executive agrees that any and all presently existing investment advisory and insurance business of the Group and all business developed by Executive or any other employee of the Group, including without limitation all investment advisory and insurance contracts, distribution agreements, fees, commissions, compensation records, performance records, Client Lists, agreements and any other incident of any business developed or sought by the Group or earned or carried on by Executive during his/her employment with the Group, are and shall be the exclusive property of the Group for its sole use and (where applicable) shall be payable directly to the Group. Executive grants to the Group Executive’s entire right, title and interest throughout the world, if any, in and to all research, information, Client Lists, product lists, distributor lists, identities, investment profiles and particular needs and characteristics of Clients, performance records, and all other investment advisory, insurance, technical and research data made, conceived, developed and/or acquired by Executive solely, jointly or in common with others during the period of Executive’s employment by the Group, that relate to the Group’s business as it was or is now rendered or as it may, from time to time, hereafter be rendered or proposed to be rendered during the Employment Period.

(B) Any inventions and any copyrightable material developed by Executive in the scope of his/her employment with the Group shall be promptly disclosed to the Group and will be “works for hire” owned by the Group. Executive will, at the Group’s expense, do whatever is necessary to transfer to the Group, and document its ownership of, any such property.

6.2 Confidentiality. Executive shall not, either during the period of Executive’s employment with the Group or thereafter, use for Executive’s own benefit or disclose to or use for the benefit of any person outside the Group, any information not already lawfully available to the public concerning Confidential Information, whether Executive has such information in Executive’s memory or embodied in writing or other tangible or electronic form. All Confidential Information, and all originals and copies of any Confidential Information, and any other written material relating to the business of the Group, including information stored

electronically, shall be the sole property of the Group. Executive acknowledges and agrees that the Confidential Information has been and will be developed by the effort and expense of the Group; that such Confidential Information has economic value to the Group and would have significant economic value to the Group’s competitors if divulged; that the Confidential Information is not available to the Group’s competitors; and that keeping the Confidential Information from the Group’s competitors has economic value to the Group. Upon the termination of Executive’s employment in any manner or for any reason, Executive shall promptly surrender to the Group all originals and copies of any Confidential Information, and Executive shall not thereafter retain or use any Confidential Information for any purpose.

6.3 Client Information. Executive acknowledges that while employed by the Group, Executive will have contact with and become aware of the Group’s Clients and distributors and the representatives of those Clients and distributors, names and addresses, specific client and distributor needs and requirements, and leads and references to Potential Clients (together with

the Client List, collectively, the “Client Information”). Executive agrees that the Client Information constitutes a trade secret and otherwise is a valuable asset of the Group. Executive further agrees that the Client Information has been and will be developed by the Group and would have significant economic value to the Group’s competitors if divulged; that the Client Information is not available to the Group’s competitors; that keeping the Client Information confidential from the Group’s competitors has economic value to the Group; and that the Group takes reasonable steps to protect the confidentiality of the Client Information.

6.4 Restrictive Covenants.

(A) For eighteen (18) months following the Termination Date, irrespective of the reason for the termination, Executive shall not, directly or indirectly, solicit or attempt to solicit, or assist others in soliciting or attempting to solicit, any Client of the Group for the purpose of providing investment advisory or insurance services or products or distribution services. Executive agrees that the restriction contained in this Section 6.4(A) is necessary to protect the Group’s business and property in which the Group has made a considerable investment, and to prevent misuse of the Confidential and Client Information. For purposes of this Section 6.4(A), “Client” means:

“Past Client” means any person or entity who had been an advisee, investment advisory or insurance customer, distributor or client of the Group during the one (1) year period immediately preceding the termination of Executive’s employment with the Group and with which Executive dealt while at the Group or which became known to Executive during the course of his/her employment at the Company.

“Potential Client” means any person or entity to whom the Group has offered (by means of a personal meeting, telephone call, or a letter or written proposal specifically directed to the particular person or entity) within the one (1) year immediately preceding the termination of Executive’s employment to serve as investment adviser or to provide or distribute insurance products but which is not at such time an advisee, investment advisory or insurance customer, distributor or client of the Group and with which Executive dealt while at the Group or which became known to Executive during the course of his/her employment at the Group; this definition includes persons or entities for which a plan exists to make such an offer, but excludes persons or entities solicited or to be solicited solely by non-personalized form letters and blanket mailings.

“Present Client” means any person or entity who at the time of Executive’s termination of employment is an advisee, investment advisory or insurance customer, distributor or client of the Group and with which Executive dealt while at the Group or which became known to Executive during the course of his/her employment at the Group.

(B) For eighteen (18) months following the termination of Executive’s employment with the Group, irrespective of the reason for the termination, Executive shall not directly or indirectly solicit, recruit, induce away, or attempt to solicit, recruit, or induce away, or hire any employee, director, officer or agent, contractor or consultant of the Group with whom Executive had contact during Executive’s employment with the Group. For purposes of this paragraph, “contact” means any personal interaction whatsoever between the individual and Executive.

(C) For six (6) months following the termination of the Executive’s employment with the Group, irrespective of the reason for the termination, the Executive shall not, without the written consent of the Group, directly or indirectly carry on or participate in a Competing Business (as defined below) (the “Non-Compete”); provided that, the Non-Compete shall not apply if either (i) Executive remains employed with the Group through the Transition Period or (ii) the Company terminates Executive’s employment in accordance with Section 5.2(A). A “Competing Business” shall mean a life insurance or annuity business, or a business in the life insurance or annuity industry, in the United States of America. The phrase “carry on or participate in a Competing Business” shall include engaging in any of the following activities, directly or indirectly: (i) Carrying on or engaging in a Competing Business as a principal, or on the Executive’s own account, or solely or jointly with others as a director, officer, agent, employee, consultant or partner, or stockholder, limited partner or other interest holder owning more than five (5) percent of the stock or equity interests or securities convertible into more than five (5) percent of the stock or equity interests in any entity that is carrying on or engaging in a Competing Business; (ii) as agent or principal, carrying on or engaging in any activities or negotiations with respect to the acquisition or disposition of a Competing Business; (iii) extending credit for the purpose of establishing or operating a Competing Business; (iv) lending or allowing the Executive’s name or reputation to be used in a Competing Business; (v) otherwise allowing the Executive’s skill, knowledge or experience to be used in a Competing Business

(D) Executive and the Group agree that the period of time and the geographic area applicable to the covenants of Section 6.4 are reasonable and necessary to protect the legitimate business interests and goodwill of the Group in view of (1) Executive’s senior executive position within the Group, (2) the geographic scope and nature of the business in which the Group is engaged, (3) Executive’s knowledge of the Group’s business and (4) Executive’s relationships with the Clients.

6.5 Executive shall comply with (a) every applicable rule of law and (b) the rules and regulations of regulatory authorities insofar as the same are applicable to his/her employment with the Group.

6.6 Executive shall not disparage, portray in a negative light or make any statement which would be harmful to, or lead to unfavorable publicity for, the Group, or any of their current or former directors, officers or employees, including, without limitation, in any and all interviews, oral statements, written materials, electronically displayed materials and materials or information displayed on internet or internet-related sites; provided, however, that this Agreement does not apply to the extent Executive is making truthful statements when required by law or by order of a court or other legal body having jurisdiction or when responding to an inquiry from any governmental or regulatory organization.

6.7 At no time after the Termination Date shall Executive represent himself as being interested in or employed by or in any way connected with the Group, other than as a former employee of the Group. After the Termination Date, Executive shall not in the course of carrying on any trade or business claim, represent or otherwise indicate any present association

with the Group or for the purpose of carrying on or obtaining or retaining any business or customers claim, represent or otherwise indicate any past association with the Group.

6.8 Executive agrees to (i) provide truthful and reasonable cooperation, including but not limited to his/her appearance at interviews and depositions, in all legal matters, including but not limited to regulatory and litigation proceedings relating to his/her employment or area of responsibility at the Group, whether or not such matters have already been commenced and through the conclusion of such matters or proceedings, and (ii) provide to the Group’s counsel all documents in Executive’s possession or control relating to such regulatory or litigation matters. F&G will reimburse Executive for all reasonable travel expenses in connection with such cooperation.

6.9 The provisions of this Agreement, including but not limited to this Section 6, shall continue to apply with full force and effect should Executive transfer between or among the Group, wherever situated, or otherwise become employed by any other member of the Group, or be promoted or reassigned to any position. In the event that Executive becomes employed by a member of the Group other than the Company, this Agreement shall be read to substitute the other company’s name wherever the Company is referenced and the Company’s rights under this Agreement shall be assigned to Executive’s new employer and Executive consents to such assignment.

6.10 The Group shall have the right to communicate Executive’s ongoing obligations under this Agreement to any entity or individual by whom Executive becomes employed or with whom Executive becomes otherwise engaged following termination of employment with the Group, and Executive consents to the Group making that communication.

6.11 To the extent any of the covenants of this Section 6 or any other provisions of this Agreement shall be deemed illegal or unenforceable by a court or other tribunal of competent jurisdiction with respect to (i) geographic area, (ii) time period, (iii) any activity or capacity covered by such covenant or contractual provision, or (iv) any other term or provision of such covenant or contractual provision, the covenant or contractual provision shall be construed to the maximum breadth determined to be legal and enforceable and the illegality or unenforceability of any one covenant or contractual provision shall not affect the legality and enforceability of the other covenants or contractual provisions.

6.12 Executive acknowledges that his/her agreement to comply with these restrictions was an inducement for the Group to continue to employ Executive and to enter into this Agreement with Executive.

6.13 The Company and Executive acknowledge and agree that the provisions of this Section 6 represent all of the restrictive covenants to which Executive shall be subject in respect of the Company and its subsidiaries and affiliates on or after the Restatement Date, and any other such restrictive covenants (including any non-competition, non-solicitation, non-disclosure and/or other similar provisions) contained in any other agreement with Executive or to which Executive is otherwise subject shall be null and void and of no further force or effect as of the Restatement Date.

7. GENERAL

7.1 This Agreement and any disputes relating to the parties’ relationship or the termination of that relationship, whether arising in law or equity and whether based on contract, tort or statutory rights, shall be deemed to have been made in the state of Maryland and shall take effect as an instrument under seal, and the validity, interpretation and performance of this Agreement shall be governed by, and construed in accordance with, the internal law of the state of Maryland, without giving effect to conflict-of-law principles. Both parties agree that any action, demand, claim or counterclaim (collectively, any “Legal Action”) relating to this Agreement or any other disputes relating to the parties’ relationship or the termination of that relationship, whether arising in law or equity and whether based on contract, tort or statutory rights, shall be commenced exclusively in Maryland in any state or federal court of competent jurisdiction. Both parties acknowledge material witnesses and documents would be located in Maryland, and neither party shall assert that Maryland is an inconvenient or otherwise inappropriate venue for the resolution of any dispute. Both parties further agree that any disputes relating to this Agreement or any other disputes relating to the parties’ relationship or the termination of that relationship, whether based on contract, tort or statutory rights, shall be resolved by a judge alone, and both parties waive and forever renounce the right to a trial before a civil jury.

7.2 This agreement may be executed in counterparts.

7.3 This Agreement contains the entire agreement of the parties and supersedes all oral or written employment, consulting or similar agreements, understandings or arrangements between Executive, on the one hand, and the Group, on the other hand, relating to Executive’s employment or the termination of his/her employment, including the Original Agreement. In entering into this Agreement, neither party is relying on any oral or written representation, promise, agreement or understanding that is not set forth in this Agreement, and both parties expressly disclaim any reliance on any oral or written representation, promise, agreement or understanding not set forth in this Agreement.

7.4 This Agreement may not be amended or modified other than by a written agreement executed by both parties. The writing executed by the Company must be by the CEO of the Company. This Agreement is binding upon and inures to the benefit of both parties and their respective successors and assigns, including any corporation with which or into which the Company may be merged or which may succeed to its assets or business, although the obligations of Executive are personal, are not assignable, and may be performed only by him/her.

7.5 All notices and other communications required under this Agreement shall be in writing and shall be given by hand delivery to the other party, by overnight delivery service, signature required, or by registered or certified mail, return receipt requested, postage prepaid, addressed as follows:

If to Executive:         Dennis Vigneau

At the most recent address in the Company’s records

If to the Company:     Fidelity & Guaranty Life Business Services, Inc.

1001 Fleet Street

Baltimore, MD 21202

Attn: Chris Blunt

or to such other address as either party shall have furnished to the other in writing in accordance with this provision. Notices and communications shall be effective when delivered to the addressee or, if addressee refuses delivery, on the date delivery was first attempted.

7.6 Executive’s or the Company’s failure to insist upon strict compliance with any provision of this Agreement or the failure to assert any right Executive or the Company may have hereunder shall not be deemed to be a waiver of such provision or right or any other provision or right under this Agreement.

7.7 All provisions in this Agreement that relate to Compensation or benefits (including but not limited to salary, bonuses and employee benefits) are operative only to the extent that Executive continues to be employed by the Company as of the time that the payment or award of any of the above would be due except as otherwise provided for in this Agreement or under the express terms of any benefit plans. If Executive is no longer employed as of that time, none of the Compensation or benefits otherwise due shall be payable to Executive except (a) as expressly provided in this Agreement, (b) for earned but unpaid wages or accrued but not used vacation or (c) under the express terms of any benefit plans to the extent that such benefits cannot be cancelled under either the terms of the relevant plan documents or applicable law.

7.8 Executive acknowledges and agrees that the Company’s remedy at law for any breach of the provisions of this Agreement would be inadequate and that for breach of such provisions the Company shall, in addition to such other remedies as may be available to it at law or in equity or as provided in this Agreement, be entitled to temporary, preliminary and permanent injunctive relief as well as to enforce its rights by an action for specific performance to the extent permitted by law. Executive expressly consents to the granting of temporary, preliminary, and permanent injunctive relief and/or specific performance for breach of this Agreement.

7.9 The Company shall have the right to set off any damages incurred by the Group against any amounts due to Executive by the Group, except for Executive’s salary and other sums that are non-forfeitable wages under the law or otherwise protected from offset or seizure by law. In addition to, and without limiting in any way, the Company’s rights and remedies as set forth in this Agreement or in law or equity, Executive agrees that if Executive engages in any activities prohibited by this Agreement, Executive will pay over to the Company all compensation or revenue received in connection with such activities.

7.10 All compensation and benefits payable under this Agreement shall be subject to withholding by the Company of all applicable taxes. The parties further understand and agree that should any relevant law (including without limitation any regulatory interpretations thereof) change between the time of execution of this Agreement and the payment of the various payments to Executive called for by the Agreement, the parties will revise the Agreement accordingly in a good-faith attempt to ensure ongoing compliance with such law upon mutual agreement of the parties, staying as consistent as possible with the financial and other business terms of this Agreement, but in any case Executive hereby agrees that all personal income taxes on his/her compensation and benefits under this Agreement and all penalties and interest with respect to such personal income taxes, including but not limited to under Section 409A of the Internal Revenue Code, if any, are his own responsibility.

7.11 Executive and the Company represent and acknowledge that the consideration that each has received under this Agreement is sufficient and adequate for the obligations that each has agreed to undertake, and expressly waives any right to assert that they have not received adequate consideration for agreeing to the obligations undertaken in this Agreement.

7.12 Executive acknowledges and represents that he understands his obligations and rights under this Agreement, has had adequate time to consider it, and has had adequate time and opportunity to ask any questions and obtain any advice he/she felt necessary or appropriate. No one has placed any pressure on Executive to execute this Agreement prior to the expiration of a

reasonable time for him/her to read it, ask any questions and obtain any advice he/she felt necessary or appropriate. Executive enters into this Agreement freely and voluntarily.

7.13 The officer executing this Agreement on behalf of F&G has the authority to enter into this Agreement, and Executive is relying on his/her authority to do so.

IN WITNESS WHEREOF, this Agreement has been executed the Restatement Date.

EXECUTIVE

By: Dennis Vigneau

FIDELITY & GUARANTY LIFE

BUSINESS SERVICES, INC.

Its : ___________ _

IN WITNESS WHEREOF, this Agreement has been executed the Restatement Date.

EXECUTIVE

Br&i , ;i gn;! Li,

FIDELITY & GUARANTY LIFE

BUSINESS SERVICES, INC.

By:

Its: ____________ _

Exhibit A-1

Exhibit A

List of Strategic Initiatives

·h Project Falcon

·h Project Enterprise

Exhibit B-1

Exhibit B

Release

[Attached]

EX-10.38

Exhibit 10.38

EMPLOYMENT AGREEMENT

This Employment Agreement (the “Agreement”), dated as of November 11, 2019 (the “Effective Date”), is made by and between FGL HOLDINGS (together with its subsidiaries, the “Company”) and John Fleurant (the “Executive”). The Company and the Executive are hereinafter also referred to individually as “Party” and together as “Parties.”

W I T N E S S E T H:

WHEREAS, the Company desires to employ the Executive as the Executive Vice President and Chief Financial Officer of the Company; and

WHEREAS, the Company and the Executive desire to enter into this Agreement as to the terms of the Executive’s employment with the Company.

NOW, THEREFORE, in consideration of the promises, and of the mutual covenants and agreements hereinafter contained, the Company and the Executive agree as follows:

1.Term.The Executive’s employment under this Agreement commenced on November 11, 2019 and shall continue until terminated pursuant to Section 7 below. The period during which Executive is employed pursuant to this Agreement shall be referred to as the“Term”.

2.Title.During the Term, the Executive shall serve as the Executive Vice President and Chief Financial Officer of the Company.

3.Reporting.During the Term, the Executive shall report to the Chief Executive Officer (the “CEO) of the Company.

4.Duties.

(a)During the Term, the Executive shall have the duties and responsibilities customarily associated with the position of Chief Financial Officer of a company the general size and nature as the Company, and such other duties and responsibilities as are consistent with his positions that may be assigned to him from time to time by the CEO and the Board of Directors of FGL Holdings (the “Board”). The Executive agrees to devote his full time, attention, skill, and energy to the duties set forth herein and to the business of the Company, and to use his reasonable best efforts to promote the success of the Company’s business. During the Term, at the request of the Board, the Executive may also serve as an officer or director of and shall perform certain services for subsidiaries and affiliates of the Company, in each case without any additional compensation.

(b)During the Term, the Executive shall devote substantially all of his business time and attention and his best efforts to the performance of his duties and responsibilities under this Agreement and shall not engage in any other business activity, except as may be approved by the CEO or the Board; provided that nothing in this Agreement shall prohibit the Executive from (i) engaging in religious, charitable or other community or non-profit activities that do not impair the Executive’s ability to fulfill the Executive’s duties and responsibilities under this Agreement; or (ii) holding directorships in other companies after obtaining the prior written consent of the CEO or the Board; provided further that none of the activities permitted in clauses (i) and (ii) individually or in the aggregate materially interfere with the performance of the Executive’s duties under this Agreement. The Executive shall not acquire or hold more than two (2) percent of any class of publicly-traded securities of any business, except that the Executive may have a passive investment in any such company to the extent that (i) the investment does not constitute more than two (2) percent of the ownership, and (ii) the Executive shall provide all required disclosure according to applicable Company policies including but not limited to the Company’s Personal Trading Policy and Conflicts of Interest Policy applicable to all employees.

5.Location.During the Term, the Executive shall be based in the Company’s offices in Des Moines, Iowa. However, the Executive acknowledges that in order to effectively perform his duties, he may be required to travel to such other places by such means and on such occasions as the Company may require.

6.Compensation and Benefits.

(a)Base Salary. Effective as of the Effective Date the Executive shall receive an annual base salary of US $500,000. The Executive’s base salary shall be payable in accordance with the Company’s normal payroll practices. Such base salary shall be subject to periodic review, and may be increased at the sole discretion of the Compensation Committee of the Board or by the Board. The annual base salary payable to Executive under this Section 6, as the same may be increased from time to time, shall hereinafter be referred to as the “Base Salary.”

(b)Bonus.The Executive shall be eligible to receive an annual cash bonus in accordance with the terms of the Company’s annual bonus program, as such program may be amended, suspended or terminated from time to time, subject to and based on the attainment by Executive and/or the Company of applicable performance targets to be set by the Compensation Committee of the Board or by the Board (and any subcommittee that it may delegate to). The Executive shall be eligible for an annual target bonus opportunity that is expected to be equal to 100% of his Base Salary. Actual bonus payout may be more or less than target, based on Company and individual performance during the performance-measurement period. In order to receive any such bonus, the Executive must be actively employed by the Company on the date on which such bonus is scheduled to be paid to the Executive.

(c)Vacation.During the Term, the Executive shall be entitled to twenty (20) days of paid vacation annually, exclusive of United States legal holidays, during a calendar year (prorated for a partial year of employment during a calendar year), provided that the scheduling of the Executive’s vacation does not interfere with the Company’s normal business operations. Up to five (5) unused vacation days may be carried over from one calendar year to the next.

(d)Benefits.During the Term, and provided that the Executive satisfies, and continues to satisfy, any individual plan eligibility requirements, the Executive shall be eligible to participate in, and receive benefits under, benefit programs maintained by the Company for its senior executives on terms and conditions set forth in such plans (as may be amended, modified or terminated). In addition, the Executive shall be eligible to receive relocation benefits pursuant to Company policy.

(e)Reimbursement of Business Expenses.The Company shall reimburse the Executive for all reasonable and properly documented expenses incurred or paid by him in connection with the performance of his duties hereunder; provided that the Executive submits a request for such expense reimbursement together with such supporting documentation as the Company may require within thirty (30) days after such expenses are incurred and the Company shall reimburse all properly documented expenses no later than thirty (30) days after submission of such request for reimbursement and in any event no later than March 15th of the calendar year following the year in which such expenses were incurred.

(f)Withholdings.All payments made under this Agreement shall be subject to any and all federal, state and local taxes and other withholdings to the extent required by applicable law. The Company shall have the power to withhold, or require the Executive to remit to the Company promptly upon notification of the amount due, an amount sufficient to satisfy the statutory minimum amount of all federal, state, local and foreign withholding tax requirements with respect to any payment of cash, or issuance or delivery of any other property hereunder to the Executive or any third party.

7.Separation from Service.

(a)Due to Death.The Executive’s employment with the Company shall automatically terminate immediately upon his death.

(b)Due to Disability. If the Executive incurs a “Disability” (as defined below) during the Term, then the Board, in its sole discretion, shall be entitled to terminate the Executive’s employment upon written notice to the Executive. For purposes of this Agreement, “Disability” means that the Executive, as a result of illness or incapacity, is unable to perform substantially his required duties for a period of four (4) consecutive months or for any aggregate period of six (6) months in any twelve (12) month period. A termination of the Executive’s employment by the Company for Disability shall be communicated to the Executive by written notice and shall be effective on the tenth (10th) business day after receipt of such notice by the Executive, unless the Executive returns to full-time performance of his duties before such tenth (10th) business day. Any termination pursuant to this Section 7(b) shall be in accordance with applicable law.

(c)By the Company.During the Term, the Company shall be entitled to terminate the Executive’s employment with or without “Cause” by providing written notice to the Executive. If the Company terminates the Executive’s employment without Cause, the Company shall provide the written notice at least three months in advance of the effective date of employment termination, or alternatively, shall increase the period for which Base Salary will be continued as severance described in Section 8(c)(ii) by the period for which advance notice of employment termination falls short of three months. For purposes of this Agreement, the Executive shall be deemed terminated for “Cause” if the Company terminates the Executive’s employment in writing after the Executive’s: (i) willful misconduct or gross negligence in the performance of the Executive’s duties to the Company (other than as a result of the Executive’s death or disability); (ii) willful and repeated failure to follow the lawful directives of the Board or Chief Executive Officer which are consistent with his role as Executive Vice President and Chief Financial Officer; (iii) indictment for, conviction of, or pleading of guilty or nolo contendere to, a felony or any crime resulting in reputational or financial harm to the Company; (iv) performance of any act of theft, embezzlement, fraud, or unlawful misappropriation of Company property; (v) use of illegal drugs, or abuse of alcohol that materially impairs the Executive’s ability to perform the Executive’s duties to the Company; (vi) material breach of any fiduciary duty owed to the Company (including, without limitation, the duty of care and the duty of loyalty); (vii) material breach of the Agreement or any other agreement between

the Executive and the Company; (viii) material violation of the Company’s code of conduct or other written policy; or (ix) prohibition from serving in the insurance industry or serving as an officer of the Company. Prior to the Company’s termination of the Agreement for Cause pursuant to clauses (i), (ii), (v), or (vii), the Board will provide the Executive with written notice detailing the specific actions or inactions giving rise to Cause and a period of fifteen (15) days following the Executive’s receipt of such notice to cure such actions or inactions in all material respects; provided that the foregoing cure right will not apply if there are habitual actions or inactions giving rise to the Executive’s termination for Cause. For purposes of determining Cause, no act or failure to act by the Executive shall be considered “willful” unless it is done or omitted to be done by the Executive in bad faith and without reasonable belief that his action or omission was in the best interests of the Company. Any act, or failure to act, based upon authority given pursuant to a resolution duly adopted by the Board or based upon the written advice of counsel for the Company, shall be presumed to be done by the Executive in good faith and in the best interests of the Company. Any voluntary termination by the Executive in anticipation of a termination for Cause under this Section 7(c) shall be deemed a termination for Cause.

(d)By the Executive.

(i)During the Term, the Executive shall be entitled to terminate his employment with the Company with or without Good Reason by providing the Company with at least three (3) months of advance written notice of such decision. Upon the receipt of such written notice by the Company, the Company may accelerate the three (3) month notice period in order to make such termination effective prior to the expiration of the notice period. The Company shall only be required to compensate the Executive through the effective date of his separation from service, except as otherwise provided in Section 8. The Company reserves the right to withdraw any and all duties and responsibilities from the Executive, and to exclude the Executive from the Company’s premises, during such three (3) month notice period, which shall not constitute “Good Reason” or otherwise violate this Agreement.

(ii)The Executive shall have “Good Reason” to terminate his employment with the Company upon the occurrence of one or more of the following events without the Executive’s written consent: (i) a material diminution of the Executive’s Base Salary or target bonus opportunity; (ii) a material diminution in the Executive’s authority, duties, or responsibilities (including reporting responsibilities) as Chief Financial Officer of the Company; or (iv) a material breach by the Company of any written agreement between the Executive and the Company (including, but not limited to, the agreement and the documentation related to the Company’s equity incentive plan). Prior to any termination for Good Reason, the Executive must provide written notice to the Company within sixty (60) days following the date of the first occurrence of an alleged Good Reason event, setting forth in reasonable detail the conduct alleged to be a basis for a termination for Good Reason. The Executive will not have the right to terminate his employment for Good Reason if, within the thirty (30) day period following delivery of the Executive’s written notice, the Company cures, in all material respects, the conduct alleged to be a basis for a termination for Good Reason. If the Company does not cure alleged conduct within the prescribed thirty (30) day period, the Executive must actually terminate his employment within thirty (30) day period immediately following the expiration of the Company’s cure period; otherwise, any claim of such circumstances as constituting “Good Reason” will be deemed irrevocably waived by the Executive.

8.Compensation Upon Separation from Service.

(a)By Reason of Death or Disability.If the Executive incurs a separation from service with the Company by reason of his death or Disability pursuant to Section 7(a) or 7(b) above, then the Company shall pay to the Executive (or his estate, as appropriate) (i) his then current Base Salary through the termination date, (ii) employee benefits in accordance with terms of the applicable plan documents, and (iii) any earned and unpaid cash bonuses for any previously completed bonus years (clauses (i) through (iii) collectively, the “Accrued Obligations”), within thirty (30) days after the date of separation from service. In addition, if the Executive incurs a separation from service with the Company by reason of his death or Disability pursuant to Section 7(a) or 7(b) above, then the Company shall pay to the Executive (or his estate, as appropriate) within 2-1/2 months following the fiscal year in which such separation of service occurs an amount equal to a pro rata share of the Executive’s cash bonus for the fiscal year in which such separation from service occurs based on actual performance for such fiscal year (without regard to the requirement to be employed on the payment date) in an amount equal to the Executive’s bonus multiplied by the number of days the Executive was employed by the Company in such fiscal year divided by three hundred and sixty-five (365) (the “Pro Rata Bonus”). Thereafter, the Company shall have no further obligations to the Executive.

(b)By the Company for Cause.If the Executive incurs a separation from service as a result of termination of employment by the Company for Cause pursuant to Section 7(c) above, then the Company shall pay to the Executive the Accrued Obligations within thirty (30) days after the date of the Executive’s separation from service due to Cause. Thereafter, the Company shall have no further obligations to the Executive.

(c)By the Company without Cause or by the Executive for Good Reason.If the Executive incurs a separation from service as a result of termination of employment by the Company without Cause (and not as a result of death or

a Disability) pursuant to Section 7(c) above or by the Executive for Good Reason pursuant to Section 7(d)(i) above, then the Company shall pay or provide to the Executive:

(i)the Accrued Obligations, within thirty (30) days after the date of such separation from service;

(ii)an amount equal to six months of the Executive’s Base Salary, payable in equal installments for six (6) months following such separation from service. All amounts owing under this clause (c)(ii) shall be payable in accordance with the Company’s normal payroll practices;

(iii)an amount equal to a pro-rata portion of the Executive’s annual bonus (pursuant to Section 6(b) hereof) for the calendar year in which the Executive’s termination occurs, based on actual performance, payable at the same time that annual bonuses are paid to Senior Executives of the Company; and

(iv)subject to Executive’s timely election to continue coverage for the Executive and his spouse and eligible dependents, if any, under the Company’s group health plans under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), the Company shall promptly pay the premiums to effect and continue such coverage commencing on the date of the separation from service and ending six (6) months thereafter, after which time the Executive may continue COBRA (to the extent provided by applicable law) at the Executive’s own expense. Notwithstanding the foregoing, if the benefits cannot be provided without penalty, tax or other adverse impact on the Company, then the Company and the Executive shall negotiate in good faith to determine an alternative manner in which the Company may provide substantially equivalent benefits without such adverse impact.

(d)By the Executive without Good Reason. If the Executive incurs a separation from service with the Company as a result of termination of employment by the Executive without Good Reason pursuant to Section 7(d)(i) above, then the Company shall pay to the Executive the Accrued Obligations within thirty (30) days of his separation from service. Thereafter, the Company shall have no further obligations to the Executive.

(e)General Release and Other Requirements.

(i)Notwithstanding any other provision of this Agreement to the contrary, as a condition to receiving any payments other than the Accrued Obligations that may be made pursuant to this Section 8, the Executive (or the executor or administrator of his estate in the event of Executive’s death) must execute and not revoke a general release agreement substantially in the form set forth in Exhibit A within sixty (60) days of the Executive’s separation from service with the Company and must comply with the Executive’s obligations under this Agreement. Notwithstanding anything else in this Section 8, except as otherwise required by Section 11(b) of this Agreement and subject to the Executive’s execution of the release agreement in accordance with this Section 8(e)(i), payment of any amounts pursuant to this Section 8 (other than the Accrued Obligations) that would otherwise be paid in the first sixty (60) days following the Executive’s separation from service shall be paid on the 61st day following such separation from service.

(ii)Notwithstanding any other provision of this Agreement to the contrary, upon termination of the Executive’s employment for any reason, and regardless of whether the Executive continues as a consultant to the Company, unless otherwise requested by the Company in writing, the Executive shall automatically resign, as of the date of such termination of employment or such other date requested, from the Board and any committees thereof (and, if applicable, from the board of directors (and any committees thereof) of the Group and any affiliate of the Group) to the extent the Executive is then serving thereon. The form of such resignation shall be as set forth on Exhibit B, and the failure of the Executive to comply with this Section 8(e)(ii) (by not resigning from the Board and any and all committees as contemplated hereby), shall constitute a material breach of this Agreement and may result in a termination for Cause (whether prospectively or retroactively) and the Executive shall not be entitled to receive or retain any severance or other payments under this Agreement (other than the Accrued Obligations).

(f)No Mitigation.The Executive shall not have a duty to mitigate damages by seeking other employment and there shall be no offset against any amounts or entitlements due to him hereunder or otherwise on account of any remuneration or benefits provided by any subsequent employment he may obtain.

(g)Section 280G of the Code.Notwithstanding any provision of this Agreement to the contrary, if any payment or benefit the Executive would receive from the Company pursuant to this Agreement or otherwise (a “Payment”) would (a) constitute a “parachute payment” within the meaning of Section 280G of the Code and (b) but for this Section 8(g), be subject to the excise tax imposed by Section 4999 of the Code (the “Excise Tax”), then such Payment will be equal to the Reduced Amount (as defined below). The “Reduced Amount” will be either (1) the largest portion of the Payment that would result in no portion of the Payment (after reduction) being subject to the Excise Tax or (2) the entire Payment, whichever amount after taking into

account all applicable federal, state and local employment taxes, income taxes, and the Excise Tax (all computed at the highest applicable marginal rate, net of the maximum reduction in federal income taxes which could be obtained from a deduction of such state and local taxes), results in the Executive’s receipt, on an after-tax basis, of the greatest amount of the Payment. If a reduction in the Payment is to be made, the reduction in payments and/or benefits will occur in the following order: (1) reduction of cash payments; and (2) reduction of other benefits paid to the Executive. In the event that acceleration of vesting of equity award compensation is to be reduced, such acceleration of vesting will be cancelled in the reverse order of the date of grant of the Executive’s equity awards. If any portion of the Payments that would be reduced pursuant to the foregoing would not be so reduced if the stockholder approval requirements of Section 280G(b)(5) of the Code are satisfied, then the Company shall use commercially reasonable efforts to cause such portion of the Payments to be submitted for such approval prior to the event giving rise to such Payments.

9.Further Covenants.

(a)Definitions.

(i)“Client” or “Client List” means all Past, Present and Potential Clients as defined below.

(ii)“Confidential Information” means all secret, confidential or otherwise non-public information, knowledge or data relating to the Group, and their respective businesses or financial affairs, whether or not in writing, including but not limited to information related to: their suppliers and their businesses; prices charged to and terms of business with their customers; their marketing plans and sales forecasts; their financial information, results and forecasts; their proposals or plans for the acquisition or disposal of a company or business or any part thereof; their proposals or plans for any expansion or reduction of activities; their employees, including the employees’ performance, compensation and benefits; their research activities, inventions, trade secrets, designs, formulas and product lines; any information provided to the Group in confidence by its affiliates, customers, suppliers or other parties; and other information concerning and related to Clients; provided, however, that Confidential Information shall not include information that is already lawfully available to the public.

(iii)“Group” means the Company and its affiliates.

(iv)“Past Client” means any person or entity who had been an investment advisory or insurance customer, distributor or client of the Group during the one (1) year period immediately preceding the termination of the Executive’s employment with the Company and with which the Executive dealt while at the Company or which became known to the Executive during the course of his employment at the Company.

(v)“Potential Client” means any person or entity to whom the Group has offered (by means of a personal meeting, telephone call, or a letter or written proposal specifically directed to the particular person or entity) within the one (1) year immediately preceding the termination of the Executive’s employment to serve as investment adviser or to provide or distribute insurance products but which is not at such time an investment advisory or insurance customer, distributor or client of the Group and with which the Executive dealt while at the Company or which became known to the Executive during the course of his employment at the Company; this definition includes persons or entities for which a plan exists to make such an offer, but excludes persons or entities solicited or to be solicited solely by form letters and blanket mailings.

(vi)“Present Client” means any person or entity who at the time of the Executive’s termination of employment is an investment advisory or insurance customer, distributor or client of the Group and with which the Executive dealt while at the Company or which became known to the Executive during the course of his employment at the Company.

(vii)“Primary Competitor” means each of Allianz SE, American Equity Investment Life Insurance Company, Athene Annuity & Life Assurance Company, EquiTrust Life Insurance Co, Nationwide Mutual Insurance Company, North American Company, Great American Insurance Group, Security Benefit Life Insurance Company, Annexus and C&O Insurance.

(b)All Business to Be the Property of the Group: Assignment of Intellectual Property.

(i)The Executive agrees that any and all presently existing investment advisory and insurance business of the Group and all business developed by the Executive or any other employee of the Group, including without limitation all investment advisory and insurance contracts, distribution agreements, fees, commissions, compensation records, performance records, Client Lists, agreements and any other incident of any business developed or sought by the Group or earned or carried on by the Executive during his employment with the Group, are and shall be the exclusive property of the Group for its sole use and (where applicable) shall be payable directly to the Group. The Executive grants to the Group the Executive’s entire right, title and interest throughout the world, if any, in and to all research, information. Client Lists, product lists, distributor lists, identities, investment profiles and particular needs and characteristics of Clients, performance records, and all other investment advisory, insurance, technical and research data made, conceived, developed and/or acquired by the Executive solely, jointly or in common

with others during the period of the Executive’s employment by the Group, that relate to the Group’s business as it was or is now rendered or as it may, from time to time, hereafter be rendered or proposed to be rendered during the Term.

(ii)Any inventions and any copyrightable material developed by the Executive in the scope of his employment with the Group shall be promptly disclosed to the Group and will be “works for hire” owned by the Group, and the Executive will, at the Group’s expense, do whatever is necessary to transfer to the Group, and document its ownership of, any such property.

(c)Confidentiality

(i)The Executive shall not, either during the period of the Executive’s employment with the Group or thereafter, use for the Executive’s own benefit or disclose to or use for the benefit of any person outside the Group, any information concerning Confidential Information, whether the Executive has such information in the Executive’s memory or embodied in writing or other tangible or electronic form. All Confidential Information, and all originals and copies of any Confidential Information, and any other written material relating to the business of the Group, including information stored electronically, shall be the sole property of the Group. The Executive acknowledges and agrees that the Confidential Information has been and will be developed by the effort and expense of the Group; that such Confidential Information has economic value to the Group and would have significant economic value to the Group’s competitors if divulged; that the Confidential Information is not available to the Group’s competitors; and that keeping the Confidential Information from the Group’s competitors has economic value to the Group. Upon the termination of the Executive’s employment in any manner or for any reason, the Executive shall promptly surrender to the Group or destroy all originals and copies of any Confidential Information, and the Executive shall not thereafter retain or use any Confidential Information for any purpose.

(ii)18 U.S.C. § 1833(b) provides: “An individual shall not be held criminally or civilly liable under any Federal or State trade secret law for the disclosure of a trade secret that-(A) is made-(i) in confidence to a Federal, State, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (B) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal.” Nothing in this Agreement is intended to conflict with 18 U.S.C. § 1833(b) or create liability for disclosures of trade secrets that are expressly allowed by 18 U.S.C. § 1833(b). Accordingly, the parties to this Agreement have the right to disclose in confidence trade secrets to federal, state, and local government officials, or to an attorney, for the sole purpose of reporting or investigating a suspected violation of law. The parties also have the right to disclose trade secrets in a document filed in a lawsuit or other proceeding, but only if the filing is made under seal and protected from public disclosure.

(iii)Notwithstanding anything to the contrary contained herein, no provision of this Agreement shall be interpreted so as to impede the Executive (or any other individual) from reporting possible violations of federal law or regulation to any governmental agency or entity, including the Department of Justice, the Securities and Exchange Commission, Congress and any agency Inspector General, or making other disclosures under the whistleblower provisions of federal law or regulation. The Executive does not need the prior authorization of the Company to make any such reports or disclosures and the Executive shall not be not required to notify the Company that such reports or disclosures have been made.

(d)Trade Secrets.The Executive acknowledges that while employed by the Group, the Executive will have contact with and become aware of the Group’s proprietary insurance product information, and proprietary business processes and strategy (the “Trade Secrets”). The Executive agrees that the Trade Secrets are a valuable asset of the Group. The Executive further agrees that the Trade Secrets have been and will be developed by the Group and would have significant economic value to the Group’s competitors if divulged; that the Trade Secrets are not available to the Group’s competitors; that keeping the Trade Secrets confidential from the Group’s competitors has economic value to the Group; and that the Group takes reasonable steps to protect the confidentiality of the Trade Secrets.

(e)Restrictive Covenants.The Executive agrees that the restrictions contained in this Section 9(e) are necessary to protect the Company’s business and property in which the Company has made a considerable investment, and to prevent misuse of the Confidential Information and Trade Secrets.

(i)During the Term and for twelve (12) months following the date when the Executive ceases to be an employee of the Company (“Termination Date”), irrespective of the reason for the termination, the Executive shall not, directly or indirectly, solicit or attempt to solicit, or assist others in soliciting or attempting to solicit, any Client of the Group for the purpose of providing investment advisory or insurance services, insurance products or insurance distribution services. During the Term and for twelve (12) months following the Termination Date, irrespective of the reason for the termination, the Executive shall not, directly or indirectly, solicit or attempt to solicit, or assist others in soliciting or attempting to solicit, any independent

marketing organizations of the Group for the purpose of providing investment advisory or insurance services or products or distribution services.

(ii)During the Term and for twelve (12) months following the Termination Date, irrespective of the reason for the termination, the Executive shall not directly or indirectly solicit, recruit, induce away, or attempt to solicit, recruit, or induce away, or hire any employee, director or officer of the Group with whom the Executive had contact during the Executive’s employment with the Company. For purposes of this Paragraph, “contact” means any personal interaction whatsoever between the individual and the Executive.

(iii)During the Term and for twelve (12) months following the Termination Date, irrespective of the reason for the termination, the Executive shall not, without the written consent of the Group, directly or indirectly carry on or participate in a Competing Business (as defined below) for or with a Primary Competitor, and during the term and for three (3) months following the Termination Date, irrespective of the reason for the termination, the Executive shall not, without the written consent of the Group, directly or indirectly carry on or participate in a Competing Business with any person, entity or otherwise that is not a Primary Competitor. A “Competing Business” shall mean a life insurance or annuity business, or a business in the life insurance or annuity industry, in the United States of America. The phrase “carry on or participate in a Competing Business” shall include engaging in any of the following activities, directly or indirectly: (A) Carrying on or engaging in a Competing Business as a principal, or on the Executive’s own account, or solely or jointly with others as a director, officer, agent, employee, consultant or partner, or stockholder, limited partner or other interest holder owning more than five (5) percent of the stock or equity interests or securities convertible into more than five (5) percent of the stock or equity interests in any entity that is carrying on or engaging in a Competing Business; (B) as agent or principal, carrying on or engaging in any activities or negotiations with respect to the acquisition or disposition of a Competing Business; (C) extending credit for the purpose of establishing or operating a Competing Business; (D) lending or allowing the Executive’s name or reputation to be used in a Competing Business; or (E) otherwise allowing the Executive’s skill, knowledge or experience to be used in a Competing Business.

(iv)The Executive and the Group agree that the period of time and the geographic area applicable to the covenants of Section 9(e) are reasonable and necessary to protect the legitimate business interests and goodwill of the Group in view of (A) the Executive’s senior executive position within the Company, (B) the geographic scope and nature of the business in which the Group is engaged, (C) the Executive’s knowledge of the Groups’ business, and (D) the Executive’s relationships with the Clients.

(a)The Executive shall comply with every applicable rule of law and the rules and regulations of regulatory authorities insofar as the same are applicable to his employment with the Group.

(f)The Executive shall not disparage, portray in a negative light or make any statement which would be harmful to, or lead to unfavorable publicity for, the Group, or any of their current or former directors, officers, employees or investors (in their capacity as investors), including, without limitation, in any and all interviews, oral statements, written materials, electronically displayed materials and materials or information displayed on internet or internet-related sites; provided, however, that this agreement does not apply to (i) the extent the Executive is making truthful statements when required by law or by order of a court or other legal body having jurisdiction or when responding to a written inquiry from any governmental or regulatory organization or (ii) private statements made by Executive in the course of Executive’s employment with the Company.

(g)The Company shall direct its senior officers and directors not to disparage, portray in a negative light or make any statement which would be harmful to or lead to unfavorable publicity for, Executive, including, without limitation, in any and all interviews, oral statements, written materials, electronically displayed materials and materials or information displayed on internet or internet-related sites; provided, however, that this paragraph does not apply to (i) the extent the Company or any other person or entity listed in this paragraph is making truthful statements when required by law or by order of a court or other legal body having jurisdiction or when responding to a written inquiry from any governmental or regulatory organization or (ii) private statements made by a person in the course of employment with the Company.

(i)At no time after the Termination Date shall the Executive represent himself as being interested in or employed by or in any way connected with the Group, other than as a former employee of the Group.

(j)    During the Term and thereafter, the Executive agrees to (i) provide truthful and reasonable cooperation, including but not limited to his appearance at interviews and depositions, in all legal matters, including but not limited to regulatory and litigation proceedings relating to his employment or area of responsibility at the Group, whether or not such matters have already been commenced and through the conclusion of such matters or proceedings, and (ii) to provide to the Group’s counsel all documents in the Executive’s possession or control relating to such regulatory or litigation matters. The Group will reimburse the Executive for all reasonable travel expenses in connection with such cooperation.

(h)The provisions of this Agreement, including but not limited to this Section 9, shall continue to apply with full force and effect should the Executive transfer between or among the Group, wherever situated, or otherwise become employed by any other member of the Group, or be promoted or reassigned to any position.

(i)The Group shall have the right to communicate the Executive’s ongoing obligations under this Agreement to any entity or individual by whom the Executive becomes employed or with whom the Executive becomes otherwise engaged following termination of employment with the Group, and the Executive consents to the Group making that communication.

(j)To the extent any of the covenants of this Section 9 or any other provisions of this Agreement shall be deemed illegal or unenforceable by a court or other tribunal of competent jurisdiction with respect to (i) geographic area, (ii) time period, (iii) any activity or capacity covered by such covenant or contractual provision, or (iv) any other term or provision of such covenant or contractual provision, the covenant or contractual provision shall be construed to the maximum breadth determined to be legal and enforceable and the illegality or unenforceability of any one covenant or contractual provision shall not affect the legality and enforceability of the other covenants or contractual provisions.

(k)The Executive acknowledges and agrees that the Company’s remedy at law for any breach of the provisions of Section 9 of this Agreement would be inadequate and that for breach of such provisions the Company shall, in addition to such other remedies as may be available to it at law or in equity or as provided in this Agreement, be entitled to temporary, preliminary and permanent injunctive relief as well as to enforce its rights by an action for specific performance to the extent permitted by law. The Executive expressly consents to the granting of temporary, preliminary, and permanent injunctive relief and/or specific performance for breach of this Agreement.

(l)The Executive acknowledges that his agreement to comply with these restrictions was an inducement for the Group to continue to employ the Executive and to enter into this Agreement with Executive.

10.Arbitration.

(a)Except as provided in Section 10(b), any dispute or controversy between the parties hereto, including without limitation, any and all matters relating to this Agreement, the Executive’s employment with the Company and the cessation thereof, and all matters arising under any federal, state or local statute, rule or regulation, or principle of contract law or common law, including but not limited to any and all medical leave statutes, wage-payment statutes, employment discrimination statutes and any other equivalent federal, state or local statute, shall be settled by arbitration administered by the American Arbitration Association (“AAA”) in the Greater Des Moines, Iowa metropolitan area pursuant to the AAA’s National Rules for the Resolution of Employment Disputes (or their equivalent), which arbitration shall be confidential, final and binding to the fullest extent permitted by law. Except as provided in Section 10(c), the Company shall pay seventy-five percent (75%) of the fees and costs imposed by the arbitrator and the Executive shall pay twenty-five percent (25%) of such fees and costs, and each Party shall be responsible for its own attorneys’ fees. Each Party hereby agrees to and does take the following action:

(i)irrevocably submits to the jurisdiction of state or federal courts in the State of Iowa for the purpose of enforcing the award or decision in any such proceeding;

(ii)waives, and agrees not to assert, by way of motion, as a defense or otherwise, in any such suit, action or proceeding, any claim that (A) the Party is not subject personally to the jurisdiction of the above-named courts, (B) the Party’s property is exempt or immune from attachment or execution, e.g. the suit, action or proceeding is brought in an inconvenient forum, (C) the venue of the suit, action or proceeding is improper, or (D) this Agreement or the subject matter hereof may not be enforced in or by such court;

(iii)waives, and agrees not to seek any review by a court in another jurisdiction that may be called upon to enforce the judgment of any of the above-referenced courts; and

(iv)consents to service of process by registered or certified United States mail, postage-prepaid, return receipt requested, or an equivalent governmental mail service, at the address set forth in Section 12.

(b)    Each Party agrees that such Party’s submission to jurisdiction and consent to service of process by United States registered or certified mail, or an equivalent governmental mail service, is for the express benefit of the other Party. Final judgment against either Party in any action, suit or proceeding may be enforced in other jurisdictions by suit, action or proceeding on the judgment, or in any other manner provided by or pursuant to the laws of such other jurisdiction.

(c)    Notwithstanding Section 10(a), if the legal action involves an alleged breach of an obligation under Section 9 of this Agreement (Further Covenants) by the Executive, which breach may give rise to immediate and irreparable harm, the Company may seek injunctive relief in any state or federal court of competent jurisdiction in the State of Iowa. (Such action for injunctive relief shall be resolved by a judge alone, and both Parties waive the right to a jury.)

(d)     If either Party brings an arbitration proceeding under Section 10(a) resulting from an alleged breach of an obligation under Section 9 of this Agreement (Further Covenants) by the other Party, or files suit for injunctive relief to enforce its rights under Section 10(c), and prevails in its action, the prevailing Party shall also be entitled to recover from the other Party all reasonable expenses incurred by the prevailing party in preparing for and taking such action, including, but not limited to, investigative costs, arbitration or court costs (as the ease may be), and attorneys’ fees.

11.Section 409A.

(a)Section 409A.This Agreement shall be construed to be in compliance with or exempt from Section 409A. For purposes of this Agreement, the term “separation from service” has the meaning set forth in Section 409A. For purposes of this Agreement, with respect to payments of any amounts that are considered to be “deferred compensation” subject to Section 409A, references to “termination of employment” (and substantially similar phrases) shall be interpreted and applied in a manner that is consistent with the requirements of Section 409A relating to “separation from service.” To the extent that any reimbursements under this Agreement are taxable to the Executive, any such reimbursement payment due to the Executive shall be paid to the Executive as promptly as practicable, and in all events on or before the last day of Executive’s taxable year following the taxable year in which the related expense was incurred. The reimbursements pursuant to this Agreement are not subject to liquidation or exchange for another benefit and the amount of such benefits and reimbursements that the Executive receives in one taxable year shall not affect the amount of such benefits or reimbursements that the Executive receives in any other taxable year.

(b)Six Month Wait.Notwithstanding anything else to the contrary in this Agreement, if (i) the Executive is entitled to receive payments or benefits under this Agreement by reason of his separation from service other than as a result of his death, (ii) the Executive is a “specified employee” (within the meaning of Section 409A) of a company, the stock of which is publicly traded, for the period in which the payment or benefits would otherwise commence, and (iii) such payment or benefit would otherwise subject the Executive to any tax, interest or penalty imposed under Section 409A (or any regulation promulgated thereunder) if the payment or benefit would commence within six months of a termination of the Executive’s employment with the Company, then such payment or benefit required under this Agreement shall not commence until the day immediately following the six-month anniversary of the termination of the Executive’s employment. For purposes of Section 409A, each of the payments that may be made under this Agreement are designated as separate payments.

12.Notices.All notices, requests, demands and other communications provided for in this Agreement shall be sufficient if in writing and delivered in person or sent by a nationally recognized overnight courier service or by registered or certified United States mail, as appropriate, postage-prepaid, return receipt requested, or an equivalent governmental mail service, to the following addresses, or such other addresses as the Parties may furnish in accordance with this Section 12:

If to the Company:

FGL Holdings

4th Floor

Boundary Hall, Cricket Square

Grand Cayman, KY 1-1102

Cayman Islands

Attn: General Counsel

If to the Executive:

to the address of the Executive’s primary residence (as reflected on the records of the Company)

or to such other address as either party shall have furnished to the other in writing in accordance herewith. Notice pursuant to this Section 12 shall be effective on the date of delivery in person or by courier, or three (3) days after the date mailed.

13.Severability.In the event that any of the provisions of this Agreement, or the application of any such provisions to the Executive or the Company with respect to obligations hereunder, is held to be unlawful or unenforceable by any court or arbitrator, the remaining portions of this Agreement will remain in full force and effect and will not be invalidated or impaired in any manner.

14.Waiver.No waiver by any party hereto of the breach of any term or covenant contained in this Agreement, whether by conduct or otherwise, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such breach, or a waiver of any other term or covenant contained in this Agreement.

15.Entire Agreement.This Agreement contains the entire agreement between the Executive and the Company with respect to the subject matter of this Agreement, and supersedes any and all prior agreements and understandings, oral or written, between the Executive and the Company with respect to the subject matter of this Agreement. For the avoidance of doubt, any equity awards granted to the Executive by the Company shall be governed by the terms of those equity awards and severance, if any, payable to the Executive shall be in accordance with the terms of this Agreement and the Executive shall not be entitled to receive severance under any other plan, policy or arrangement.

16.Amendments.This Agreement may be amended only by an agreement in writing signed by the Executive and an authorized representative of the Company (other than the Executive).

17.Successors and Assigns.Because the Executive’s obligations under this Agreement are personal in nature, the Executive’s obligations may only be performed by the Executive and may not be assigned by him. This Agreement is binding upon the Executive’s successors, heirs, executors, administrators and other legal representatives, and shall inure to the benefit of the Company and its subsidiaries, successors and assigns. The Company may assign its rights and obligations under this Agreement without prior written approval of the Executive upon the transfer of all or substantially all of the business and/or assets of the Company (by whatever means).

18.Consultation with Counsel.The Executive acknowledges that he has had a full and complete opportunity to consult with counsel of his own choosing concerning the terms, enforceability and implications of this Agreement.

19.Attorneys’ Fees.Subject to appropriate documentation of fees and services, the Company agrees to reimburse the Executive for reasonable attorneys’ fees incurred for the review and negotiation of this Agreement, up to a maximum amount of $10,000, but reduced to reflect any applicable tax withholdings required at law.

20.No Other Representations. The Executive acknowledges that the Company has made no representations or warranties to the Executive concerning the terms, enforceability or implications of this Agreement other than as reflected in this Agreement.

21.Headings.The titles and headings of sections and subsections contained in this Agreement are included solely for convenience of reference and shall not control the meaning or interpretation of any of the provisions of this Agreement.

22.Counterparts.This Agreement may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, and such counterparts shall together constitute but one agreement.

23.Governing Law.This Agreement shall be governed by, and construed in accordance with, the laws of the State of Iowa, without giving effect to its conflict of laws principles.

24.No Construction against Drafter.No provision of this Agreement or any related document will be construed against or interpreted to the disadvantage of any party hereto by any court or other governmental or judicial authority by reason of such party having or being deemed to have structured or drafted such provision.

25.Further Assurances.The Parties hereby agree, at the request of any other party, to execute and deliver all such other and additional instruments and documents and to do such other acts and things as may be reasonably necessary or appropriate to carry out the intent and purposes of this Agreement.

26.Survival.The rights and obligations of the parties under the provisions of this Agreement (including without limitation, Sections 7 through 11) shall survive, and remain binding and enforceable, notwithstanding the expiration of the Term, the termination of this Agreement, the termination of Executive’s employment hereunder or any settlement of the financial rights and obligations arising from Executive’s employment hereunder, to the extent necessary to preserve the intended benefits of such provisions.

IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the date first written above.

FGL HOLDINGS

By:     

Name:

Title:

EXECUTIVE

________

John Fleurant

EXHIBIT A

SEVERANCE AGREEMENT, RELEASE, AND COVENANT NOT TO SUE

THIS SEVERANCE AGREEMENT, RELEASE, AND COVENANT NOT TO SUE (the “Agreement”) is entered into by and between FGL Holdings, including all of its past and present parents, subsidiaries, affiliates and related entities (collectively, the “Employer”), and John Fleurant (or if applicable, the administrator or personal representative of his estate) (the “Executive”).

WHEREAS, the Executive’s employment with the Employer in accordance with the terms of the Employment Agreement, dated [November X, 2019, between Employer and Executive (the “Employment Agreement”) will terminate or has terminated, and Executive and Employer wish to resolve all outstanding matters pertaining to Executive’s employment and intend that this termination be accomplished in a positive spirit and in the interest of goodwill between them.

NOW THEREFORE, in consideration of the promises and covenants contained herein, Executive and Employer agree as follows:

1.     Conclusion of Executive’s Employment.Effective [insert date] (the “Separation Date”), Executive’s employment with Employer will end (or has ended) and, except for the obligations undertaken by Employer in this Agreement, Employer shall have no further obligations to Executive. Notwithstanding anything in this Agreement to the contrary, upon termination of Executive’s employment for any reason, and regardless of whether Executive continues as a consultant to the Company, unless otherwise requested by the Company in writing, the Executive shall automatically resign, as of the date of such termination of employment or such other date requested, from the Board and any committees thereof (and, if applicable, from the board of directors (and any committees thereof) of the Group and any affiliate of the Group) to the extent Executive is then serving thereon. The form of such resignation shall be as set forth on Exhibit B and the Executive agrees to execute any documents reasonably required to effectuate the foregoing and failure to comply with this provision shall constitute a material breach of this Agreement and may result in a termination for Cause (whether prospectively or retroactively) and the Executive shall not be entitled to receive or retain any severance or other payments under this Agreement or the Employment Agreement (other than the Accrued Obligations). Capitalized terms used but not defined herein shall have the meaning set forth in the Employment Agreement.

2.    Separation Benefits and IRC Section 409A Compliance.

(a)In exchange for execution of this Agreement, Executive (or his estate) shall be entitled to the payments and benefits:

(i)[Payments and benefits to be included.]

The parties intend that the payments and benefits to which Executive could become entitled in connection with a termination of employment shall comply with or meet an exemption from Section 409A of the Internal Revenue Code. In this regard, notwithstanding anything in this Agreement to the contrary, all cash amounts that become payable under this Agreement shall be paid within the “short-term deferral” period described in Section 1.409A-l(b)(4) of the Treasury Regulations, shall qualify for the exception for “separation pay” set forth in Section 1.409A-l(b)(9) of the Treasury Regulations or another exception, or shall comply with Section 409A of the Internal Revenue Code. Payments subject to Section 409A of the Internal Revenue Code that are due upon termination of employment shall be made only upon “separation from service” within the meaning of Section 409A(a)(2)(A)(i) of the Internal Revenue Code, and shall be subject to the 6-month payment delay described in Section 409A(a)(2)(B)(i) of the Internal Revenue Code if the Executive is a “specified employee” as described therein. In the event that it is determined that the terms of this Agreement do not comply with Section 409A of the Code, the parties will negotiate reasonably and in good faith to amend the terms of this Agreement so that it complies (in a manner that preserves the economic value of the payments and benefits to which Executive may become entitled without material increased cost to the Company) so that payments are made within the time period and in a manner permitted by the applicable Treasury Regulations. The Executive shall be solely responsible and liable for the satisfaction of all taxes and penalties that may be imposed on or for the account of the Executive in connection with this Agreement (including any taxes and penalties under Section 409A of the Code), and neither the Company nor any of the Group or any of their affiliates shall have any obligation to indemnify or otherwise hold the Executive (or any beneficiary) harmless from any or all of such taxes or penalties.

3.    Return of Property.Executive shall return all Employer property, including all computers, blackberries, other personal data devices, phones, credit cards, keys, and other property of the Employer that are in the Executive’s possession or control, to Employer on or before the Separation Date and hereby represents compliance with this Paragraph 3. Specifically, Executive covenants that, as of the Separation Date, Executive returned to Employer, in good order and condition, any and all books, records, lists, and other written, typed, printed, or electronically stored material (including, but not limited to, computer

disks and customized computer programs), or any other information of any kind deemed by Employer to be confidential and/or proprietary, whether furnished by Employer, or prepared by Executive, that contains any information relating to the business of Employer, and Executive covenants that Executive has not and will not retain copies of those materials, nor will Executive retain electronically stored data containing such information.

4.    General Release and Covenant Not To Sue.Executive hereby irrevocably discharges and releases Employer, its officers, directors, employees, agents, predecessors, successors and assigns, and all other persons, corporations, partnerships, affiliates, or other entities acting on its behalf (collectively, “Released Parties”), from any and all past, present, or future grievances, claims, demands, debts, defenses, actions, or causes of action (including, but not limited to, breach of contract, defamation, intentional infliction of emotional distress, harassment, battery, or any other cause of action arising under common law, tort, or contract), covenants, contracts, agreements, promises, obligations, damages, or liabilities of whatever kind or nature, known or unknown, including, but not limited to, any claim of employment discrimination arising under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of 1991, the Americans With Disabilities Act, the Family and Medical Leave Act of 1993 (“FMLA”), 42 U.S.C. §§ 1981. 1985(3), and 1986, the Employee Retirement Income Security Act of 1974, the Age Discrimination In Employment Act (“ADEA”), and/or any other federal or state statute or common law prohibiting employment discrimination that Executive now has, has had, or may have, whether the same be at law, in equity, or mixed, in any way arising from or relating to any act, omission, failure to act, occurrence, or transaction occurring before termination of employment, it being expressly understood by Executive that, by the execution of this Agreement, Executive has given Employer a general release of any and all such claims Executive may have against Employer. This is a general release. Executive expressly acknowledges that this general release includes, but is not limited to, any claims arising out of or related to Executive’s employment with the Company and Executive’s separation therefrom.

By signing this Agreement, Executive expressly acknowledges and represents that: (i) Executive suffered no injuries or occupational diseases arising out of or in connection with Executive’s employment with Employer; (ii) Executive received all wages to which Executive was entitled, including all commission payments; (iii) Executive received all leave to which Executive was entitled under the FMLA; and (iv) Executive is not aware of any facts or circumstances constituting a violation of the FMLA, the FLSA, or any applicable state wage payment act.

Executive expressly states, understands, intends, and agrees that, to the fullest extent permitted by law, this Agreement forever precludes Executive from bringing, instituting, maintaining, further pursuing, or participating in any lawsuit against the Released Parties for any causes or claims released in this Paragraph 4, other than a lawsuit to challenge this Agreement’s compliance with the Older Workers Benefit Protection Act (“OWBPA”). Executive represents and agrees that he has not, by himself or on his behalf, instituted, prosecuted, filed, or processed any litigation, claims or proceedings against the Released Parties, nor has he encouraged or assisted anyone to institute, prosecute, file, or process any litigation, claims or proceedings against the Released Parties. Nothing in this Paragraph 4 shall release or impair (i) any claim or right that may arise after the date of this Agreement; (ii) any vested benefits under a 401(k) plan or any other benefit plan on or prior to the Separation Date; or (iii) any claim or right Executive may have pursuant to indemnification, advancement, defense, or reimbursement pursuant to any applicable D&O policies, any similar insurance policies, applicable law or otherwise; or (iv) any claim which by law cannot be waived. Nothing in this Agreement is intended to prohibit or restrict Executive’s right to file a charge with or participate in a charge by the Equal Employment Opportunity Commission, or any other local, state, or federal administrative body or government agency that is authorized to enforce or administer laws related to employment; provided that Executive hereby waives the right to recover any monetary damages or other relief against any Released Parties; provided, however, that nothing in this Agreement shall prohibit Executive from receiving any monetary award to which Executive becomes entitled pursuant to Section 922 of the Dodd-Frank Wall Street Reform and Consumer Protection Act.

5.    OWBPA. Pursuant to the OWBPA, Executive acknowledges and understands that:

(a)    Executive is waiving claims for age discrimination under the ADEA in exchange for the payment and benefits described above, to which Executive is not otherwise entitled;

(b)Executive has been advised in writing to consult an attorney prior to signing this Agreement;

(c)Executive has been given a period of [XX] days (from the date of notification) within which to review and consider this Agreement before signing it, although Executive need not wait for the [XX]-day period to expire before executing the Agreement. Absent such execution, this Agreement shall be deemed withdrawn and rendered null and void;

(d)Executive may revoke this Agreement by providing written notice to the Employer within seven days following its execution, and that the Agreement shall not become effective and enforceable until such seven-day period has expired;

(e)Executive has carefully read and fully understands all of the provisions of the Agreement, including the rights provided in this Paragraph, and Executive is knowingly and voluntarily agreeing to its terms by executing the Agreement; and

(f)Any notice of revocation of this Agreement shall not be effective unless given in writing and received by the Employer within the seven-day revocation period via personal delivery or overnight mail addressed as follows:

FGL Holdings

4th Floor

Boundary Hall, Cricket Square

Grand Cayman, KY 1-1102

Cayman Islands

Attn: General Counsel

6.    Conditions Precedent.The performance by Employer of the obligations imposed upon it by this Agreement is expressly conditioned upon Executive delivering a signed copy of this Agreement to Employer and not revoking it in accordance with Paragraph 5.

7.    Discovery of New Facts. Executive acknowledges that Executive may, following the Separation Date, discover facts different from or in addition to what Executive now knows or believes to be true with respect to the matters released herein or set forth herein, and Executive agrees that the release contained herein shall be and will remain effective in all respects notwithstanding such different or additional facts. It is intended hereby that Executive fully and forever settles and releases all such matters and all claims relative thereto that now exist, may now exist, or heretofore have existed relating to Executive’s employment with Employer.

8.    Adequate Investigation.Executive represents that Executive has made such investigation of the facts pertaining to this Agreement as Executive deems necessary, and in executing this Agreement, Executive assumes the risk of mistake with respect to such facts. This Agreement is intended to be final and binding upon Executive, regardless of any claims of mistake.

9.    Protection of Business.

(a)    Covenants.The provisions of Section 9 (Further Covenants) of the Employment Agreement are hereby incorporated into this Agreement and shall continue to apply in accordance with their terms.

(b)    Remedies. Executive acknowledges that Employer will suffer irreparable injury should Executive breach any of the provisions incorporated by reference into this Paragraph 9. Employer shall be entitled to injunctive or other equitable relief because of irreparable injury and damage caused by a breach of any provision incorporated by reference into this Paragraph 9. The existence of this right shall not preclude any other rights or remedies at law or in equity that Employer may have, including monetary relief. This right to injunctive relief shall include the right to both preliminary and permanent injunctions, without the necessity of Employer posting any bond. Executive waives the right to assert a breach of contract or other alleged wrong by Employer, other than an alleged breach by the Employer of its obligations under Section 8(a) (Death or Disability) or 8(c) (Involuntary Termination without Cause, or Termination with Good Reason).

10.    Fully-Inclusive Agreement.Executive represents that Executive has not relied on any other oral or written representations of any kind made by any person in connection with Executive’s decision to sign the Agreement. This Agreement contains the entire agreement between the Executive and Employer with regard to the matters set forth herein, and the Agreement supersedes any and all prior agreements, contracts, understandings, discussions, or negotiations, whether oral or written, express or implied, between the parties with respect to the subject matter hereof, except for the provisions of the Employment Agreement which survive in accordance with its terms.

11.    Binding Agreement. This Agreement is binding upon and for the benefit of Executive and his heirs, executors, administrators, and successors, wherever the context requires or admits.

12.    No Transfer of Rights.Executive represents that Executive has not assigned or transferred, or purported to assign or transfer, to any person, firm, corporation, or other entity whatsoever any of the claims, demands, or causes of action released in Paragraph 4. Executive agrees to indemnify and hold harmless Employer against any claim, demand, debt, obligation, liability, cost, expense, right of action, or cause of action based on, arising out of, or connected with any such transfer or assignment, or purported transfer or assignment, including attorneys’ fees.

13.    No Admission of Liability.This Agreement is not intended to be, nor will it be alleged to constitute, evidence or an admission by Employer of any liability, omission, or wrongdoing of any kind whatsoever, nor shall this Agreement be offered or received into evidence or otherwise filed or lodged in any proceeding against Employer, except as may be necessary to prove the terms of this Agreement or to enforce the same.

14.    Severability and Reformation.If any provision or any portion of any provision of this Agreement is held to be invalid or unenforceable, the Parties hereto expressly agree and authorize the court to modify or sever such provision or portion thereof so as to render such provision valid and enforceable to the maximum extent lawfully permissible.

15.    Miscellaneous.This Agreement embodies the entire agreement and understanding between the parties hereto with respect to the subject matters hereof and may not be changed, waived, discharged, or terminated unless agreed to by both parties and only by an instrument in writing, signed by both parties. The use of any tense or conjugation includes all tenses and conjugations. This Agreement shall be construed in accordance with and governed by the laws of the State of Iowa, without reference to the principles of conflicts of laws.

16.    Cooperation With Employer.Executive agrees that he will cooperate with Employer, its agents, and its attorneys with respect to any matters in which Executive was involved during Executive’s employment with Employer or about which Executive has information, and will provide upon request from Employer all such information or information about any such matter.

17.    Enforcement. The provisions set forth in Sections 9(m) and 10 of the Employment Agreement regarding injunctive relief and arbitration are hereby incorporated by reference and shall apply for purposes of this Agreement.

IN WITNESS WHEREOF, the parties have executed this Agreement with the intention of making this a document under seal.

THIS IS A KNOWING AND VOLUNTARY WAIVER AND RELEASE OF ALL LEGAL CLAIMS THAT EXECUTIVE MAY POSSESS. EXECUTIVE IS INSTRUCTED TO READ THE AGREEMENT CAREFULLY BEFORE SIGNING.

___________________________________	_____________________________________
John Fleurant	Date
FGL HOLDINGS
By: _______________________________	_____________________________________
	Date

EXHIBIT B

Resignation Letter

[insert date of termination]

The undersigned hereby irrevocably resigns from any and all positions he may hold as an officer, director or manager of FGL Holdings (together with its subsidiaries and affiliates, the “Company Group”), effective as of [insert date of termination]. Such resignation is irrevocable once executed and shall be effective without the need for acceptance or any further action by any member of the Company Group.

John Fleurant

EX-10.50

Exhibit 10.50

[F & G Life Letterhead]

(Form of)

TRANSACTION BONUS AGREEMENT

February 25, 2020

[Name]

Dear [Name]:

As you may know, FGL Holdings (the “FGL”) has entered into an Agreement and Plan of Merger with Fidelity National Financial, Inc. (“FNF”) F I Corp. and F II Corp., dated as of February 7, 2020 (the “Merger Agreement”), pursuant to which FGL, along with Fidelity & Guaranty Life Business Services, Inc. (the “Company”), will be acquired by FNF (the “Merger”).

In order to reward you for the critical role you have undertaken as an integral member of the organization working towards the closing of the Merger (the “Closing”), subject the occurrence of the Closing, you will be eligible to receive a cash transaction bonus in the amount of $[_______] (the “Transaction Bonus”) for your continued services through the date of the Closing set forth in Section 1 below and on the following terms and conditions. If the Merger Agreement is terminated prior to the Closing, you will no longer be eligible to receive the Transaction Bonus and this letter agreement will terminate and have no further force and effect.

The Company and you each agree as follows:

1. Transaction Bonus. Except as provided under Section 2 below, you will be entitled to the Transaction Bonus on the date of the Closing, subject to your continued employment with FGL or its subsidiaries, including the Company, through the date of Closing. The Transaction Bonus will be paid as a lump sum payment as soon as reasonably practicable following the date of Closing, but no later than thirty (30) days following the date of Closing, subject to any and all applicable federal, state, local, foreign and/or other withholding taxes and all other authorized payroll deductions.

2. Termination of Employment. You will no longer be eligible to receive the Transaction Bonus if your employment is terminated for any reason by you or FGL or its subsidiaries, including the Company, prior to the date of Closing.

3. No Effect on Severance and Other Benefits. This letter agreement will not affect your eligibility or entitlement to receive any benefits payable to you under any severance, change of control or similar plan, policy or agreement with the Company.

4. Other Rights and Agreements. This letter agreement does not create any employment rights not specifically set forth herein with respect to you. Your employment remains at-will and can be terminated by the Company at any time and for any reason, with or without Cause. This letter agreement contains the entire understanding of the Company and you with respect to the subject matter hereof.

5. Confidentiality. You agree that the matters described in this letter agreement are highly confidential. Accordingly, you agree and covenant that, except as required by applicable law, you will not disclose, reveal, publish, disseminate, or discuss, directly or indirectly, to or with any other person or entity the terms of this letter agreement other than your immediate family, lawyer and tax advisor and that any such disclosure, revelation, publication, dissemination or discussion shall result in the immediate forfeiture of the entire Transaction Bonus.

6. Amendment. This letter agreement may be amended or revised only by written agreement signed by an authorized officer of the Company and you.

7. Binding Effect. This letter agreement shall be binding on you and your executor, administrator and heirs, but may not be assigned by you. This letter agreement may be transferred or assigned by the Company and shall be binding on the transferee or assignee. This letter agreement shall automatically be transferred or assigned to and be binding upon any successor in interest to the Company, whether by merger, consolidation, sale of stock, sale of assets or otherwise.

8. Section 409A. The parties intend for the payments and benefits under this letter agreement to be exempt from Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) or, if not so exempt, to be paid or provided in a manner which complies with the requirements of such section, and intend that this letter agreement shall be construed and administered in accordance with such intention. Notwithstanding anything contained herein to the contrary, to the extent required in order to avoid accelerated taxation and/or tax penalties under Section 409A of the Code, (i) no amounts

that are payable on account of your termination of employment shall be paid to you until you have incurred a “separation from service” from your employer within the meaning of Section 409A of the Code, (ii) amounts that would otherwise be payable that would otherwise be provided pursuant to this agreement during the six-month period immediately following your separation from service shall instead be paid on the first business day after the date that is six (6) months following your separation from service (or death, if earlier) and (iii) any payments that are due within the “short-term deferral period” as defined in Section 409A of the Code shall not be treated as deferred compensation unless applicable law requires otherwise.

9. Counterparts. This letter agreement may be (a) executed in separate counterparts, each of which is deemed to be an original and all of which taken together constitute one and the same agreement, and (b) executed and delivered by facsimile or other electronic transmission with the same effect as if a manually signed original were personally delivered.

10. Applicable Law. This letter agreement shall be construed and enforced in accordance with the laws of the State of Delaware, without giving effect to the principles of conflict of laws thereof.

[signature page follows]

[Signature Page to Transaction Bonus Agreement]

Accordingly, the parties have executed this letter agreement as of the date first above written.

FIDELITY & GUARANTY LIFE BUSINESS SERVICES, INC.

By: __________________________

Name:

Title:

Agreed and Accepted:

______________________________

[Name]

EX-21

Exhibit 21

Subsidiaries of FGL Holdings, a Cayman Islands exempted company

Entity	Jurisdiction
CF Bermuda Holdings Limited	Bermuda
FGL US Holdings, Inc.	Delaware
F&G Re Ltd	Bermuda
Front Street Re Ltd.	Bermuda
Front Street Re (Cayman) Ltd.	Cayman
Fidelity & Guaranty Life Business Services, Inc.	Delaware
Fidelity & Guaranty Life Holdings, Inc.	Delaware
Fidelity & Guaranty Life Assignment, LLC	Maryland
Fidelity & Guaranty Life Brokerage, Inc.	Maryland
Fidelity & Guaranty Life Insurance Agency, Inc.	Maryland
Fidelity & Guaranty Life Insurance Company	Iowa
Fidelity & Guaranty Life Insurance Company of New York	New York
Raven Reinsurance Company	Vermont

EX-23

Exhibit 23

Consent of Independent Registered Public Accounting Firm

The Board of Directors

FGL Holdings and subsidiaries:

We consent to the incorporation by reference in the registration statement (No. 333-222232) on Form S-3 and in the registration statement (No. 333-223085) on Form S-8 of FGL Holdings and subsidiaries of our reports dated March 2, 2020, with respect to the consolidated balance sheets of FGL Holdings and subsidiaries as of December 31, 2019 and 2018, the related consolidated statements of operations, comprehensive income (loss), changes in shareholders’ equity, and cash flows for each of the years in the two year period ended December 31, 2019 and the period from December 1, 2017 to December 31, 2017, the consolidated statements of operations, comprehensive income (loss), changes in shareholders’ equity, and cash flows of Fidelity & Guaranty Life and subsidiaries for the period from October 1, 2017 to November 30, 2017, and for the year ended September 30, 2017 (Predecessor Company operations), and the related notes and financial statement schedules I to IV (collectively, the consolidated financial statements), and the effectiveness of internal control over financial reporting as of December 31, 2019, which reports appear in the December 31, 2019 annual report on Form 10-K of FGL Holdings and subsidiaries.

/s/ KPMG LLP

Des Moines, Iowa

March 2, 2020

EX-31.1

Exhibit 31.1

CERTIFICATION OF CEO PURSUANT TO RULE 13a-14(a) or 15d-14(a) OF THE SECURITIES

EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, Christopher O. Blunt, certify that:

1. I have reviewed this annual report on Form 10-K for the year ended December 31, 2019 of FGL Holdings;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 2, 2020

/s/ CHRISTOPHER O. BLUNT

Christopher O. Blunt

President & Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATION OF CFO PURSUANT TO RULE 13a-14(a) or 15d-14(a) OF THE SECURITIES

EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

I, John Fleurant, certify that:

1. I have reviewed this annual report on Form 10-K for the year ended December 31, 2019 of FGL Holdings;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: March 2, 2020

/s/ JOHN FLEURANT

John Fleurant

Chief Financial Officer

EX-32.1

Exhibit 32.1

CERTIFICATION OF CEO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of FGL Holdings (the “Company”) on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Christopher O. Blunt, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ CHRISTOPHER O. BLUNT

Christopher O. Blunt

President & Chief Executive Officer

March 2, 2020

This Certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

EX-32.2

Exhibit 32.2

CERTIFICATION OF CFO PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of FGL Holdings (the “Company”) on Form 10-K for the year ended December 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, John Fleurant, hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 to the best of my knowledge, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ JOHN FLEURANT

John Fleurant

Chief Financial Officer

March 2, 2020

This Certification accompanies this Report pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

XML

Intangibles - Estimated Amortization Expense for VOBA in Future Fiscal Periods (Detail) $ in Millions	Dec. 31, 2019 USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2020	$ 62
2021	85
2022	80
2023	72
2024	65
Thereafter	$ 337

XML

Stock Compensation - Nonvested Phantom Units Outstanding (Details) - Phantom Share Units (PSUs) - Management Incentive Plan shares in Thousands	12 Months Ended
	Dec. 31, 2019 $ / shares shares
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]
beginning of period (in shares) | shares	356
Granted (in shares) | shares	541
Vested (in shares) | shares	59
Forfeited or expired (in shares) | shares	93
end of period (in shares) | shares	745
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Weighted Average Grant [Roll Forward]
beginning of period (in dollars per share) | $ / shares	$ 8.95
Granted (in dollars per share) | $ / shares	8.54
Vested (in dollars per share) | $ / shares	10.00
Forfeited or expired (in dollars per share) | $ / shares	9.33
end of period (in dollars per share) | $ / shares	$ 9.02

XML

Equity - Schedule of Dividends Declared (Details) - Preferred Stock shares in Thousands, $ in Thousands																1 Months Ended
	Dec. 15, 2019 shares	Oct. 01, 2019 USD ($) shares	Sep. 15, 2019 shares	Jul. 01, 2019 USD ($) shares	Jun. 15, 2019 shares	Apr. 01, 2019 USD ($) shares	Mar. 15, 2019 shares	Jan. 01, 2019 USD ($) shares	Dec. 15, 2018 shares	Oct. 01, 2018 USD ($) shares	Sep. 15, 2018 shares	Jul. 01, 2018 USD ($) shares	Jun. 15, 2018 shares	Apr. 01, 2018 USD ($) shares	Mar. 15, 2018 shares	Feb. 01, 2020 USD ($) shares
Series A Cumulative Preferred Stock
Class of Stock [Line Items]
Shareholders of record (in thousands)	316		310		304		298		293		287		282		277
Total cash paid | $		$ 0		$ 0		$ 0		$ 0		$ 0		$ 0		$ 0		$ 0
Total shares paid in kind (in thousands)		6		6		6		6		5		5		5		5
Series B Cumulative Preferred Stock
Class of Stock [Line Items]
Shareholders of record (in thousands)	114		112		110		108		106		104		102		101
Total cash paid | $		$ 0		$ 0		$ 0		$ 0		$ 0		$ 0		$ 0		$ 0
Total shares paid in kind (in thousands)		2		2		2		2		2		2		1		3

XML

Fair Value of Financial Instruments - Narrative (Detail) $ in Millions		1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Nov. 30, 2017	Dec. 31, 2017 USD ($)	Nov. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2019 USD ($)	Dec. 31, 2018 USD ($)	Sep. 30, 2017 USD ($) $ / Contract
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years
Change in fair value of other derivatives and embedded derivatives		$ 0	$ 1	$ 12	$ 57	$ (42)	$ (16)
Assets, net transfer in (out) of Level 3		10	(21)	(28)	(259)	(505)	(150)
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Assets, net transfer in (out) of Level 3		45	(29)	(29)	(182)	(412)	$ (125)
Income Approach Valuation Technique | Other invested assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative, strike price | $ / Contract							0
Preferred Stock
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years
Preferred Stock, Dividend Rate, Percentage, Less Than Par	90.00%
FSRC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Undiscounted Cash flows used in fair value measurement					2,569	1,199
Preferred shares reimbursement feature embedded derivative
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value of other derivatives and embedded derivatives		$ 0	$ 0	$ 0	$ (13)	$ 6	$ 0

XML

Significant Accounting Policies and Practices (Details) - USD ($)				1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended			39 Months Ended
	Jan. 01, 2018	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2019	Dec. 31, 2018
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
New Accounting Pronouncement or Change in Accounting Principle, Effect of Adoption, Quantification	$ 4,000,000
Available-for-sale Securities							$ 23,726,000,000	$ 21,109,000,000		$ 23,726,000,000	$ 21,109,000,000
Future policy benefits, including $1,953 and $725 at fair value at December 31, 2019 and December 31, 2018, respectively							5,735,000,000	4,641,000,000		5,735,000,000	4,641,000,000
Cash and cash equivalents							38,000,000	84,000,000		38,000,000	84,000,000
Unrecognized tax benefits							0	0	$ 0	0	0
Reserves for funding agreements							1,096,000,000	878,000,000		1,096,000,000	878,000,000
FHLB collateral pledged							1,472,000,000	1,401,000,000		1,472,000,000	1,401,000,000
Preferred Stock, Call Features, Minimum Term			5 years
Preferred stock dividend rate			10.00%
Change in fair value of other derivatives and embedded derivatives				$ 0	$ 1,000,000	$ 12,000,000	57,000,000	(42,000,000)	(16,000,000)
Federal home Loan Bank, Advances, General Debt Obligations, Disclosures, Cash and Collateral Pledged							1,521,000,000	1,414,000,000		1,521,000,000	$ 1,414,000,000
Other Assets, Miscellaneous							1,000,000			1,000,000
Minimum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Available-for-sale Securities							29,000,000			29,000,000
Reinsurance Recoverables, Gross							20,000,000			20,000,000
Proceeds from Mortgage Deposits							7,000,000
Maximum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Available-for-sale Securities							39,000,000			39,000,000
Reinsurance Recoverables, Gross							24,000,000			$ 24,000,000
Proceeds from Mortgage Deposits							$ 14,000,000
Fixed indexed annuities | Minimum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Interest crediting rates associated with subsidiaries										0.50%
Fixed indexed annuities | Maximum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Interest crediting rates associated with subsidiaries										6.00%
Indexed Universal Life | Minimum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Interest crediting rates associated with subsidiaries										3.00%
Indexed Universal Life | Maximum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Interest crediting rates associated with subsidiaries											4.80%
Traditional life insurance premiums | Minimum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Estimated investment yield							5.70%			5.70%
Life Contingent Payout Annuity | Minimum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Estimated investment yield							0.10%			0.10%
Life Contingent Payout Annuity | Maximum
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Estimated investment yield							5.50%			5.50%
Royal Bank Of Canada | Revolving Credit Facility
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
senior unsecured revolving credit facility			$ 250,000,000		250,000,000
Debt term			3 years
Preferred Stock
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Preferred Stock, Call Features, Minimum Term			5 years
Preferred stock dividend rate			10.00%
Series A Cumulative Preferred Stock | Preferred Stock
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Stock Issued During Period, Shares, New Issues			275,000
Series B Cumulative Preferred Stock | Preferred Stock
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Stock Issued During Period, Shares, New Issues			100,000
Contractholder funds
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Quantifying Misstatement in Current Year Financial Statements, Amount		$ 17,000,000
Indefinite-lived Intangible Assets [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Quantifying Misstatement in Current Year Financial Statements, Amount		3,000,000
Deferred Tax Asset [Domain]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Quantifying Misstatement in Current Year Financial Statements, Amount		$ 3,000,000
Net investment (losses) gains
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Change in fair value of other derivatives and embedded derivatives				37,000,000	140,000,000	51,000,000	$ 498,000,000	(295,000,000)	335,000,000
Benefits and Other Changes in Policy Reserves [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Quantifying Misstatement in Current Year Financial Statements, Amount				17,000,000
Amortization of Intangible Assets [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Quantifying Misstatement in Current Year Financial Statements, Amount				3,000,000
income tax expense [Member]
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Quantifying Misstatement in Current Year Financial Statements, Amount				3,000,000
Preferred shares reimbursement feature embedded derivative
Federal Home Loan Bank, Advances, Branch of FHLB Bank [Line Items]
Change in fair value of other derivatives and embedded derivatives				$ 0	$ 0	$ 0	$ (13,000,000)	$ 6,000,000	$ 0

XML

Investments - Fair Value and Gross Unrealized Losses of Available-for-Sale Securities (Details) $ in Millions	Dec. 31, 2019 USD ($) Security	Dec. 31, 2018 USD ($) Security
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	$ 2,174	$ 14,369
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(44)	(1,045)
Available-for-sale securities, Fair Value, 12 months or longer	3,500	2,857
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(123)	(120)
Available-for-sale securities, Fair Value, Total	5,674	17,226
Available-for-sale Securities, Gross Unrealized Losses, Total	$ (167)	$ (1,165)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	290	1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	446	556
Total number of available-for-sale securities in an unrealized loss position | Security	736	2,107
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	$ 719	$ 2,924
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(12)	(116)
Available-for-sale securities, Fair Value, 12 months or longer	2,453	643
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(65)	(21)
Available-for-sale securities, Fair Value, Total	3,172	3,567
Available-for-sale Securities, Gross Unrealized Losses, Total	(77)	(137)
Commercial mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	232	1,466
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(4)	(34)
Available-for-sale securities, Fair Value, 12 months or longer	16	262
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(2)	(6)
Available-for-sale securities, Fair Value, Total	248	1,728
Available-for-sale Securities, Gross Unrealized Losses, Total	(6)	(40)
Corporates
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	1,030	8,016
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(25)	(772)
Available-for-sale securities, Fair Value, 12 months or longer	804	1,465
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(47)	(76)
Available-for-sale securities, Fair Value, Total	1,834	9,481
Available-for-sale Securities, Gross Unrealized Losses, Total	(72)	(848)
Hybrids
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	23	858
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1)	(90)
Available-for-sale securities, Fair Value, 12 months or longer	60	7
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(3)	(1)
Available-for-sale securities, Fair Value, Total	83	865
Available-for-sale Securities, Gross Unrealized Losses, Total	(4)	(91)
Municipals
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	123	850
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(2)	(27)
Available-for-sale securities, Fair Value, 12 months or longer	60	172
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(3)	(5)
Available-for-sale securities, Fair Value, Total	183	1,022
Available-for-sale Securities, Gross Unrealized Losses, Total	(5)	(32)
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	41	139
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		(3)
Available-for-sale securities, Fair Value, 12 months or longer	107	190
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	(3)	(5)
Available-for-sale securities, Fair Value, Total	148	329
Available-for-sale Securities, Gross Unrealized Losses, Total	(3)	(8)
U.S. Government
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months	6	69
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		0
Available-for-sale securities, Fair Value, 12 months or longer	0	50
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer	0	(1)
Available-for-sale securities, Fair Value, Total	6	119
Available-for-sale Securities, Gross Unrealized Losses, Total	$ 0	(1)
Debt Security, Government, Non-US
Debt Securities, Available-for-sale [Line Items]
Available-for-sale securities, Fair Value, Less than 12 months		47
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		(3)
Available-for-sale securities, Fair Value, 12 months or longer		68
Available-for-sale Securities, Gross Unrealized Losses, 12 months or longer		(5)
Available-for-sale securities, Fair Value, Total		115
Available-for-sale Securities, Gross Unrealized Losses, Total		$ (8)

XML

Investments - Schedule of Commercial Mortgage Loan Investment (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage		$ 482
Loans and Leases Receivable, Gross	$ 422	$ 482
Commercial Mortgage Receivable, Percentage of Total	100.00%	100.00%
Commercial mortgage loans, % of total	2.00%	2.00%
Carrying Value	$ 1,267	$ 667
LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	$ 352	$ 302
Commercial Mortgage Receivable, Percentage of Total	83.00%	63.00%
LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	$ 70	$ 169
Commercial Mortgage Receivable, Percentage of Total	17.00%	35.00%
LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage		$ 11
Commercial Mortgage Receivable, Percentage of Total		2.00%
East North Central
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 64	$ 98
Commercial Mortgage Receivable, Percentage of Total	15.00%	20.00%
East South Central
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 19	$ 19
Commercial Mortgage Receivable, Percentage of Total	5.00%	4.00%
Middle Atlantic
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 77	$ 79
Commercial Mortgage Receivable, Percentage of Total	18.00%	17.00%
Mountain
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 51	$ 65
Commercial Mortgage Receivable, Percentage of Total	12.00%	13.00%
New England
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 4	$ 10
Commercial Mortgage Receivable, Percentage of Total	1.00%	2.00%
Pacific
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 113	$ 116
Commercial Mortgage Receivable, Percentage of Total	27.00%	24.00%
South Atlantic
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 56	$ 57
Commercial Mortgage Receivable, Percentage of Total	13.00%	12.00%
West North Central
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 13	$ 13
Commercial Mortgage Receivable, Percentage of Total	3.00%	3.00%
West South Central
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 25	$ 25
Commercial Mortgage Receivable, Percentage of Total	6.00%	5.00%
Hotel
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 21	$ 21
Commercial Mortgage Receivable, Percentage of Total	5.00%	4.00%
Industrial - General
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 37	$ 37
Commercial Mortgage Receivable, Percentage of Total	9.00%	8.00%
Industrial - Warehouse
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 20	$ 20
Commercial Mortgage Receivable, Percentage of Total	4.00%	4.00%
Multifamily
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 54	$ 56
Commercial Mortgage Receivable, Percentage of Total	13.00%	12.00%
Office
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 143	$ 147
Commercial Mortgage Receivable, Percentage of Total	34.00%	30.00%
Retail
Schedule of Investments [Line Items]
Loans and Leases Receivable, Gross	$ 147	$ 201
Commercial Mortgage Receivable, Percentage of Total	35.00%	42.00%
Greater than 1.25
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	$ 416	$ 476
Greater than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	346	296
Greater than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	70	169
Greater than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage		11
Greater than 1.00 but less than 1.25
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	6	6
Greater than 1.00 but less than 1.25 | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	6	6
Greater than 1.00 but less than 1.25 | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	0	0
Greater than 1.00 but less than 1.25 | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage		0
Fair Value
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	$ 435	$ 483
Commercial Mortgage Receivable, Percentage of Total	100.00%	100.00%
Fair Value | LTV Less Than 50 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	$ 363	$ 302
Commercial Mortgage Receivable, Percentage of Total	83.00%	63.00%
Fair Value | LTV 50 to 60 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	$ 72	$ 170
Commercial Mortgage Receivable, Percentage of Total	17.00%	35.00%
Fair Value | LTV 60 to 75 Percent
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage		$ 11
Commercial Mortgage Receivable, Percentage of Total		2.00%
Commercial Portfolio Segment
Schedule of Investments [Line Items]
Loans Receivable, Gross, Residential, Mortgage	$ 422
Loans and Leases Receivable, Gross	$ 422	$ 482
Commercial Mortgage Receivable, Percentage of Total	100.00%	100.00%
Loans and Leases Receivable, Allowance	$ 0	$ 0
Carrying Value	$ 422	$ 482

XML

Debt (Tables)

12 Months Ended

Dec. 31, 2019

Debt Disclosure [Abstract]

Schedule of Debt

The carrying amount of the Company's outstanding debt as of December 31, 2019 and December 31, 2018 is as follows:

	December 31, 2019		December 31, 2018
Debt	$	542	$	541
Revolving credit facility	—		—

Interest rates on the revolving credit facility were equal to 4.55% and 5.27% as of December 31, 2019 and December 31, 2018, respectively. As of December 31, 2019 and December 31, 2018, the amount available to be drawn on the revolver was $250.

The interest expense and amortization of debt issuance costs for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, were as follows:

	Year ended									Period from December 1 to December 31, 2017
	December 31, 2019				December 31, 2018
	Interest Expense		Amortization		Interest Expense			Amortization		Interest Expense		Amortization
Debt	$	30	$	2	$	28		$	1	$	2	$	—
Revolving credit facility	—		—		2			—		—		—
Gain on extinguishment of debt	—		—		(2		)	—		—		—

The interest expense and amortization of debt issuance costs for the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, were not material.

XML

Investments (Tables)

12 Months Ended

Dec. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Consolidated Investments

The Company’s consolidated investments at December 31, 2019 and December 31, 2018 are summarized as follows:

         

	December 31, 2019
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	5,720	$	51	$	(77	)	$	5,694	$	5,694
Commercial mortgage-backed securities	2,788		140		(6		)	2,922		2,922
Corporates	11,051		618		(72		)	11,597		11,597
Hybrids	983		48		(4		)	1,027		1,027
Municipals	1,284		64		(5		)	1,343		1,343
Residential mortgage-backed securities	917		40		(3		)	954		954
U.S. Government	33		1		—			34		34
Foreign Governments	138		17		—			155		155
Total available-for-sale securities	22,914		979		(167		)	23,726		23,726
Equity securities	1,069		19		(17		)	1,071		1,071
Derivative investments	336		261		(10		)	587		587
Commercial mortgage loans	422		—		—			435		422
Residential mortgage loans	845		—		—			848		845
Other invested assets	1,306		—		(3		)	1,288		1,303
Total investments	$	26,892	$	1,259	$	(197	)	$	27,955	$	27,954

	December 31, 2018
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	4,954	$	15	$	(137	)	$	4,832	$	4,832
Commercial mortgage-backed securities	2,568		9		(40		)	2,537		2,537
Corporates	11,213		16		(848		)	10,381		10,381
Hybrids	992		—		(91		)	901		901
Municipals	1,216		3		(32		)	1,187		1,187
Residential mortgage-backed securities	1,027		12		(8		)	1,031		1,031
U.S. Government	120		—		(1		)	119		119
Foreign Governments	129		—		(8		)	121		121
Total available-for-sale securities	22,219		55		(1,165		)	21,109		21,109
Equity securities	1,526		1		(145		)	1,382		1,382
Derivative investments	330		2		(235		)	97		97
Commercial mortgage loans	482		—		—			483		482
Residential mortgage loans	185		—		—			187		185
Other invested assets	662		—		—			651		662
Total investments	$	25,404	$	58	$	(1,545	)	$	23,909	$	23,917

Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities

The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.

	December 31, 2019
	Amortized Cost		Fair Value
Corporates, Non-structured Hybrids, Municipal and Government securities:
Due in one year or less	$	85	$	85
Due after one year through five years	888		914
Due after five years through ten years	2,020		2,082
Due after ten years	10,496		11,075
Subtotal	13,489		14,156
Other securities which provide for periodic payments:
Asset-backed securities	5,720		5,694
Commercial mortgage-backed securities	2,788		2,922
Residential mortgage-backed securities	917		954
Subtotal	9,425		9,570
Total fixed maturity available-for-sale securities	$	22,914	$	23,726

Fair Value and Gross Unrealized Losses of Available-for-Sale-Securities

The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows:

	December 31, 2019
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	719	$	(12	)	$	2,453	$	(65	)	$	3,172	$	(77	)
Commercial mortgage-backed securities	232		(4		)	16		(2		)	248		(6		)
Corporates	1,030		(25		)	804		(47		)	1,834		(72		)
Hybrids	23		(1		)	60		(3		)	83		(4		)
Municipals	123		(2		)	60		(3		)	183		(5		)
Residential mortgage-backed securities	41		—			107		(3		)	148		(3		)
U.S. Government	6		—			—		—			6		—
Total available-for-sale securities	$	2,174	$	(44	)	$	3,500	$	(123	)	$	5,674	$	(167	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													290
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													446
Total number of available-for-sale securities in an unrealized loss position													736

	December 31, 2018
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	2,924	$	(116	)	$	643	$	(21	)	$	3,567	$	(137	)
Commercial mortgage-backed securities	1,466		(34		)	262		(6		)	1,728		(40		)
Corporates	8,016		(772		)	1,465		(76		)	9,481		(848		)
Hybrids	858		(90		)	7		(1		)	865		(91		)
Municipals	850		(27		)	172		(5		)	1,022		(32		)
Residential mortgage-backed securities	139		(3		)	190		(5		)	329		(8		)
U.S. Government	69		—			50		(1		)	119		(1		)
Foreign Government	47		(3		)	68		(5		)	115		(8		)
Total available-for-sale securities	$	14,369	$	(1,045	)	$	2,857	$	(120	)	$	17,226	$	(1,165	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													556
Total number of available-for-sale securities in an unrealized loss position													2,107

Reconciliation of Other-than-Temporary Impairment on Fixed Maturity

The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the periods presented, for which a portion of the OTTI was recognized in AOCI:

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
							Predecessor		Predecessor		Predecessor
Beginning balance	$	—	$	—	$	—	$	3	$	3	$	3
Increases attributable to credit losses on securities:
OTTI was previously recognized	—		—		—		—		—		—
OTTI was not previously recognized	—		—		—		—		—		—
Ending balance	$	—	$	—	$	—	$	3	$	3	$	3

The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the periods presented:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Credit impairment losses in operations	$	(21	)	$	(24	)	$	—	$	—	$	(1	)	$	(22	)
Change-of-intent losses in operations	(2		)	—			—		—		—			—
Amortized cost	37			64			—		—		19			—
Fair value	37			64			—		—		19			—
Non-credit losses in other comprehensive income for investments which experienced OTTI	—			—			—		—		(1		)	—

Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Asset-backed securities	$	—		$	—		$	—	$	—	$	(1	)	$	(2	)
Corporates	(21		)	(24		)	—		—		—			(20		)
Equity security	(2		)	—			—		—		—			—
Total	$	(23	)	$	(24	)	$	—	$	—	$	(1	)	$	(22	)

Schedule of Accounts, Notes, Loans and Financing Receivable

The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables:

	December 31, 2019				December 31, 2018
	Gross Carrying Value		% of Total		Gross Carrying Value		% of Total
Property Type:
Hotel	21		5	%	21		4	%
Industrial - General	37		9	%	37		8	%
Industrial - Warehouse	20		4	%	20		4	%
Multifamily	54		13	%	56		12	%
Office	143		34	%	147		30	%
Retail	147		35	%	201		42	%
Total commercial mortgage loans, gross of valuation allowance	$	422	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	422			$	482
U.S. Region:
East North Central	$	64	15	%	$	98	20	%
East South Central	19		5	%	19		4	%
Middle Atlantic	77		18	%	79		17	%
Mountain	51		12	%	65		13	%
New England	4		1	%	10		2	%
Pacific	113		27	%	116		24	%
South Atlantic	56		13	%	57		12	%
West North Central	13		3	%	13		3	%
West South Central	25		6	%	25		5	%
Total commercial mortgage loans, gross of valuation allowance	$	422	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	422			$	482

Schedule of Investment in Mortgage Loans by Loan to Value and Debt Service Coverage Ratios

	Debt-Service Coverage Ratios				Total Amount		% of Total		Estimated Fair Value		% of Total
	>1.25		1.00 - 1.25
December 31, 2019
LTV Ratios:
Less than 50%	$	346	$	6	$	352	83	%	$	363	83	%
50% to 60%	70		—		70		17	%	72		17	%
Commercial mortgage loans	$	416	$	6	$	422	100	%	$	435	100	%
December 31, 2018
LTV Ratios:
Less than 50%	$	296	$	6	$	302	63	%	$	302	63	%
50% to 60%	169		—		169		35	%	170		35	%
60% to 75%	11		—		11		2	%	11		2	%
Commercial mortgage loans	$	476	$	6	$	482	100	%	$	483	100	%

Past Due Financing Receivables

Net Investment Income

The major sources of “Net investment income” on the accompanying Consolidated Statements of Operations were as follows:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Fixed maturity securities, available-for-sale	$	1,054		$	1,009		$	80		$	164		$	228		$	953
Equity securities	73			73			6			5			10			41
Mortgage loans	42			24			2			4			6			23
Invested cash and short-term investments	18			16			1			1			—			3
Funds withheld	65			28			2			—			—			—
Limited partnerships	81			17			1			3			1			5
Other investments	12			10			1			1			—			2
Gross investment income	1,345			1,177			93			178			245			1,027
Investment expense	(116		)	(70		)	(1		)	(4		)	(5		)	(22		)
Net investment income	$	1,229		$	1,107		$	92		$	174		$	240		$	1,005

Net Investment Gains

Details underlying “Net investment gains (losses)” reported on the accompanying Consolidated Statements of Operations were as follows:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Net realized gains (losses) on fixed maturity available-for-sale securities	$	46		$	(187	)	$	5	$	5	$	2		$	(20	)
Net realized/unrealized gains (losses) on equity securities	127			(142		)	—		1		—			3
Realized gains (losses) on other invested assets	3			(5		)	—		—		(2		)	(2		)
Derivatives and embedded derivatives:
Realized gains (losses) on certain derivative instruments	(15		)	(2		)	3		80		1			219
Unrealized gains (losses) on certain derivative instruments	449			(248		)	34		58		38			129
Change in fair value of funds withheld for reinsurance receivables and reinsurance related embedded derivatives (a)	57			(42		)	—		1		12			(16		)
Change in fair value of other derivatives and embedded derivatives	7			(3		)	—		1		—			3
Realized gains (losses) on derivatives and embedded derivatives	498			(295		)	37		140		51			335
Net investment gains (losses)	$	674		$	(629	)	$	42	$	146	$	51		$	316

Schedule of Realized Gain (Loss)

The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Proceeds	$	2,848		$	6,260		$	125	$	151	$	97		$	703
Gross gains	91			12			—		6		2			25
Gross losses	(27		)	(171		)	—		—		(2		)	(20		)

XML

Schedule III - Supplementary Insurance Information

12 Months Ended

Dec. 31, 2019

SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]

Schedule III - Supplementary Insurance Information

Supplementary Insurance Information

(in millions)

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Life Insurance (single segment):
Deferred acquisition costs	$	630		$	344		$	22		$	1,140		$	697		$	1,129
Future policy benefits, losses, claims and loss expenses	5,735			4,641			4,751			3,401			3,453			3,412
Other policy claims and benefits payable	71			64			78			69			53			67
Premium revenue	40			54			3			7			11			42
Net investment income	1,229			1,107			92			174			240			1,005
Benefits, claims, losses and settlement expenses	(1,057		)	(423		)	(124		)	(227		)	(20		)	(843		)
Amortization, interest, and unlocking of deferred acquisition costs	(19		)	—			(1		)	(33		)	(100		)	(171		)
Acquisition and operating expenses, net of deferrals	(330		)	(181		)	(16		)	(51		)	(28		)	(137		)

See Report of Independent Registered Public Accounting Firm.

XML

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Preferred Stock	Common Stock	Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Preferred Stock	Preferred Stock Additional Paid-in Capital	Preferred Stock Retained Earnings (Accumulated Deficit)	Common Stock	Common Stock Retained Earnings (Accumulated Deficit)
Beginning Balance at Sep. 30, 2016	$ 1,934	$ 0	$ 1	$ 714	$ 792	$ 439	$ (12)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares purchased	(1)						(1)
Dividends	(4)				(4)
Net income (loss)	108				108
Unrealized investment gains (losses), net	(286)					(286)
Dividend, Share-based Payment Arrangement, Shares	$ 1			1
Warrants Tendered	0
Ending Balance at Dec. 31, 2016	$ 1,752	0	1	715	896	153	(13)
Beginning Balance at Sep. 30, 2016	1,934	0	1	714	792	439	(12)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares purchased	(1)						(1)
Dividends	(15)											$ (15)
Net income (loss)	223				223
Unrealized investment gains (losses), net	104					104
Dividend, Share-based Payment Arrangement, Shares	$ 2			2
Warrants Tendered	0
Ending Balance at Sep. 30, 2017	$ 2,247	0	1	716	1,000	543	(13)
Beginning Balance at Dec. 31, 2016	1,752	0	1	715	896	153	(13)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	0
Ending Balance at Dec. 31, 2017	1,963	0	0	2,037	(149)	75	0
Beginning Balance at Sep. 30, 2017	2,247	0	1	716	1,000	543	(13)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends	(4)											(4)
Net income (loss)	28				28
Unrealized investment gains (losses), net	12					12
Dividend, Share-based Payment Arrangement, Shares	$ 1			1
Warrants Tendered	0
Ending Balance at Nov. 30, 2017	$ 2,284	0	1	717	1,024	555	(13)
Beginning Balance at Sep. 30, 2017	2,247	0	1	716	1,000	543	(13)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	13
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	$ 4
Warrants Tendered	66
Ending Balance at Dec. 31, 2018	$ 890	0	0	1,998	(167)	(937)	(4)
Beginning Balance at Nov. 30, 2017	2,284	0	1	717	1,024	555	(13)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Dividends	(2)									$ (2)
Net income (loss)	(91)				(91)
Unrealized investment gains (losses), net	$ 75					75
Warrants Tendered	0
Ending Balance at Dec. 31, 2017	$ 1,963	0	0	2,037	(149)	75	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares purchased	(4)						(4)
Dividends	(6)								$ 23	(29)
Net income (loss)	13				13
Unrealized investment gains (losses), net	(1,020)					(1,020)
Dividend, Share-based Payment Arrangement, Shares	4			$ 4
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	$ 4					4
Warrants Tendered	(66)			(66)
Ending Balance at Dec. 31, 2018	$ 890	0	0	$ 1,998	(167)	(937)	(4)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury shares purchased	(65)						(65)
Dividends								$ (2)	$ 29	$ (31)	$ (9)	$ (9)
Net income (loss)	507				507
Unrealized investment gains (losses), net	1,433					1,433
Dividend, Share-based Payment Arrangement, Shares	4			4
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk	$ (15)					(15)
Warrants Tendered	0
Ending Balance at Dec. 31, 2019	$ 2,743	$ 0	$ 0	$ 2,031	$ 300	$ 481	$ (69)

XML

Derivative Financial Instruments

12 Months Ended

Dec. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Financial Instruments

Derivative Financial Instruments

The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows:

	December 31, 2019		December 31, 2018
Assets:
Derivative investments:
Call options	$	587	$	97
Futures contracts	—		—
Other invested assets:
Other derivatives and embedded derivatives	21		14
Funds withheld:
Call options	3		—
	$	611	$	111

Liabilities:
Contractholder funds:
FIA embedded derivative	$	3,235	$	2,476
Other liabilities:
Reinsurance related embedded derivative	33		—
Preferred shares reimbursement feature embedded derivative	16		29
	$	3,284	$	2,505

 

The change in fair value of derivative instruments included in the accompanying Consolidated Statements of Operations is as follows:

	Year ended														Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor		Predecessor			Predecessor
Net investment gains (losses):
Call options	$	404		$	(244	)	$	34		$	129	$	39		$	338
Futures contracts	27			(8		)	3			9		—			10
Foreign currency forward	3			2			—			—		—			—
Other derivatives and embedded derivatives	7			(3		)	—			1		—			3
Reinsurance related embedded derivatives (a)	57			(42		)	—			1		12			(16		)
Total net investment gains (losses)	$	498		$	(295	)	$	37		$	140	$	51		$	335
Benefits and other changes in policy reserves:
FIA embedded derivatives	$	759		$	199		$	(54	)	$	123	$	(133	)	$	244
Acquisition and operating expenses, net of deferrals:
Preferred shares reimbursement feature embedded derivative (b)	$	(13	)	$	6		$	—		$	—	$	—		$	—

(a) Change in fair value of reinsurance related embedded derivatives starting December 1, 2017 and after is due to F&G Re and FSRC unaffiliated third party business under the fair value option election. Starting January 1, 2019, the balance also includes activity related to the FGL Insurance and Kubera reinsurance treaty. The predecessor periods activity is due to the FGL Insurance and FSRC reinsurance treaty. See "Note 13. Reinsurance".

(b) Only applicable to periods after December 1, 2017.

Additional Disclosures

Other Derivatives and Embedded Derivatives

The Company holds a fund-linked note issued by Nomura International Funding Pte. Ltd with a face value of $35. The note provides for an additional payment at maturity based on the value of an embedded derivative in AnchorPath Dedicated Return Fund (the "AnchorPath Fund") which was based on the actual return of the fund. At December 31, 2019, the fair value of the fund-linked note and embedded derivative were $29 and $21, respectively. At December 31, 2018, the fair value of the fund-linked note and embedded derivative were $26 and $14, respectively. At maturity of the fund-linked note, FGL Insurance will receive the $35 face value of the note plus the value of the embedded derivative in the AnchorPath Fund. The additional payment at maturity is an embedded derivative reported in "Other invested assets", while the host is an available-for-sale security reported in "Fixed maturities, available-for-sale".

Fixed Index Annuity ("FIA") Embedded Derivative, and Call Options and Futures

The Company has FIA Contracts that permit the holder to elect an interest rate return or an equity index linked component, where interest credited to the contracts is linked to the performance of various equity indices, primarily the S&P 500 Index. This feature represents an embedded derivative under GAAP. The FIA embedded derivative is valued at fair value and included in the liability for contractholder funds in the accompanying Consolidated Balance Sheets with changes in fair value included as a component of “Benefits and other changes in policy reserves” in the Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments".

The Company purchases derivatives consisting of a combination of call options and futures contracts on the applicable market indices to fund the index credits due to FIA contractholders. The call options are one, two, three, and five year options purchased to match the funding requirements of the underlying policies. On the respective anniversary dates of the index policies, the index used to compute the interest credit is reset and the Company purchases new one, two, three, or five year call options to fund the next index credit. The Company manages the cost of these purchases through the terms of its FIA contracts, which permit the Company to change caps, spreads or participation rates, subject to guaranteed minimums, on each contract’s anniversary date. The change in the fair value of the call options and futures contracts is generally designed to offset the portion of the change in the fair value of the FIA embedded derivative related to index performance through the current credit period. The call options and futures contracts are marked to fair value with the change in fair value included as a component of “Net investment gains (losses).” The change in fair value of the call options and futures contracts includes the gains and losses recognized at the expiration of the instrument's term or upon early termination and the changes in fair value of open positions.

Other market exposures are hedged periodically depending on market conditions and the Company’s risk tolerance. The Company’s FIA hedging strategy economically hedges the equity returns and exposes the Company to the risk that unhedged market exposures result in divergence between changes in the fair value of the liabilities and the hedging assets. The Company uses a variety of techniques, including direct estimation of market sensitivities, to monitor this risk daily. The Company intends to continue to adjust the hedging strategy as market conditions and the Company’s risk tolerance change.

Credit Risk

The Company is exposed to credit loss in the event of non-performance by its counterparties on the call options and assumptions regarding this non-performance risk are reflected in the fair value of the call options. The non-performance risk is the net counterparty exposure based on the fair value of the open contracts less collateral held. The Company maintains a policy of requiring all derivative contracts to be governed by an International Swaps and Derivatives Association (“ISDA”) Master Agreement.

Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table:

		December 31, 2019
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	2,718	$	88	$	43	$	45
Deutsche Bank	BBB/A3/BBB+	157		7		7		—
Morgan Stanley	*/A1/A+	2,053		66		65		1
Barclay's Bank	A+/A2/A	4,290		211		193		18
Canadian Imperial Bank of Commerce	*/Aa2/A+	2,691		106		74		32
Wells Fargo	A+/A2/A-	2,165		81		80		1
Goldman Sachs	A/A3/BBB+	1,065		31		27		4
Total		$	15,139	$	590	$	489	$	101

		December 31, 2018
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	3,952	$	25	$	—	$	25
Deutsche Bank	A-/A3/BBB+	1,327		5		6		(1		)
Morgan Stanley	*/A1/A+	1,648		9		6		3
Barclay's Bank	A+/A2/A	2,205		27		20		7
Canadian Imperial Bank of Commerce	*/Aa2/A+	1,716		11		8		3
Wells Fargo	A+/A2/A-	1,635		17		16		1
Goldman Sachs	A/A3/BBB+	647		3		3		—
Total		$	13,130	$	97	$	59	$	38

(a) An * represents credit ratings that were not available.

Collateral Agreements

The Company is required to maintain minimum ratings as a matter of routine practice as part of its over-the-counter derivative agreements on ISDA forms. Under some ISDA agreements, the Company has agreed to maintain certain financial strength ratings. A downgrade below these levels provides the counterparty under the agreement the right to terminate the open option contracts between the parties, at which time any amounts payable by the Company or the counterparty would be dependent on the market value of the underlying option contracts. The Company’s current rating doesn't allow any counterparty the right to terminate ISDA agreements. In certain transactions, the Company and the counterparty have entered into a collateral support agreement requiring either party to post collateral when the net exposures exceed pre-determined thresholds. For all counterparties, except one, this threshold is set to zero. As of December 31, 2019 and December 31, 2018, counterparties posted $489 and $59 of collateral, respectively, of which $446 and $59, respectively, is included in "Cash and cash equivalents" with an associated payable for this collateral included in "Other liabilities" on the Consolidated Balance Sheets. The remaining $43 and $0, respectively, of non-cash collateral was held by a third-party custodian and may not be sold or re-pledged, except in the event of default, and, therefore, is not included in the Company's Consolidated Balance Sheets at December 31, 2019 and December 31, 2018, respectively. This collateral generally consists of U.S. treasury bonds and agency mortgage-backed securities ("Agency MBS"). Accordingly, the maximum amount of loss due to credit risk that the Company would incur if parties to the call options failed completely to perform according to the terms of the contracts was $101 and $38 at December 31, 2019 and December 31, 2018, respectively.

The Company is required to pay counterparties the effective federal funds rate each day for cash collateral posted to FGL for daily mark to market margin changes.  The Company reinvests derivative cash collateral to reduce the interest cost. Cash collateral is invested in overnight investment sweep products which are included in "Cash and cash equivalents" in the Consolidated Balance Sheets.

The Company held 879 and 664 futures contracts at December 31, 2019 and December 31, 2018, respectively. The fair value of the futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements). The Company provides cash collateral to the counterparties for the initial and variation margin on the futures contracts which is included in "Cash and cash equivalents" in the Consolidated Balance Sheets. The amount of cash collateral held by the counterparties for such contracts was $5 and $3 at December 31, 2019 and December 31, 2018, respectively.

Preferred Equity Remarketing Reimbursement Embedded Derivative Liability

On November 30, 2017 the Company issued 275,000 Series A cumulative preferred shares and 100,000 Series B cumulative preferred shares (together the “Preferred Shares”). The Preferred Shares do not have a maturity date and are non-callable for the first five years. From and after November 30, 2022, the original holders of the Preferred Shares may request and thus require, the Company (subject to customary blackout provisions) to remarket the Preferred Shares on their existing terms. If the remarketing is successful and the original holders elect to sell their preferred shares at the remarketed price and proceeds from such sale are less than the outstanding balance of the applicable shares (including dividends paid in kind and accumulated but unpaid dividends), the Company will be required to reimburse the sellers, up to a maximum of 10% of the par value of the originally issued preferred shares (including dividends paid in kind and accumulated but unpaid dividends) with such amount payable either in cash, ordinary shares, or any combination thereof, at the Company's option (the “Reimbursement Feature”). The Reimbursement Feature represents an embedded derivative that is not clearly and closely related to the preferred stock host and must be bifurcated. The Reimbursement Feature liability is held at fair value within “Other liabilities” in the accompanying Consolidated Balance Sheets and it is determined using a Black Derman Toy model incorporating among other things the paid in kind dividend coupon rate and the Company’s call option. Changes in fair value of this derivative are recognized within “Acquisition and operating expenses, net of deferrals” in the accompanying Consolidated Statements of Operations.

Reinsurance Related Embedded Derivatives

FGL Insurance entered into a reinsurance agreement with Kubera effective December 31, 2018, to cede certain MYGA and deferred annuity statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. This arrangement creates an obligation for FGL Insurance to pay Kubera at a later date, which results in an embedded derivative. This embedded derivative is considered a total return swap with contractual returns that are attributable to the assets and liabilities associated with this reinsurance arrangement. The fair value

of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, were passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. The reinsurance related embedded derivative is reported in “Other assets” if in a net gain position, or “Other liabilities”, if in a net loss position, on the Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains (losses)” on the Consolidated Statements of Operations.

In the predecessor periods, FGL Insurance had a funds withheld coinsurance arrangement with FSRC, meaning that funds were withheld by FGL Insurance. This arrangement resulted in an embedded derivative in predecessor periods, similar to the embedded derivative described above related to the Kubera agreement. Due to the acquisition of FSRC, the reinsurance related embedded derivative is eliminated in consolidation in the periods after December 1, 2017.

XML

Equity

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Equity

Equity

General

The Company is a Cayman Islands exempted company and our affairs are governed by the Companies Law, the common law of the Cayman Islands and our Charter. Pursuant to our Charter, our authorized share capital is $90 thousand divided into 800,000 thousand ordinary shares and 100,000 thousand preferred shares, par value $0.0001 per share.

Common Stock

Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Unless specified in our Charter, or as required by applicable provisions of the Companies Law or applicable stock exchange rules, the affirmative vote of a majority of ordinary shares that are voted is required to approve any matter voted on by our shareholders. Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least two-thirds of ordinary shares that are voted and, pursuant to our Charter, such actions include amending our Charter and approving a statutory merger or consolidation with another company.

The Company consummated the initial public offering ("IPO") of 60,000 thousand ordinary shares for $10.00 per share on May 25, 2016. On June 29, 2016, the Company consummated the closing of the sale of 9,000 thousand ordinary shares pursuant to the exercise in full of the underwriter’s over-allotment option. An additional 145,370 thousand ordinary shares were issued for $10.00 per share on November 30, 2017 in advance of the Business Combination.

In accordance with the Merger Agreement, FGL’s common stock outstanding as of the date of the business combination were retired and ceased to exist upon conversion.

Preferred Stock

On November 30, 2017, the Company issued 275 thousand shares of Series A Cumulative Preferred Shares ("Series A Preferred Shares"), $1,000 liquidation preference per share for $275, and 100 thousand Series B Cumulative Convertible Preferred Shares ("Series B Preferred Shares"), $1,000 liquidation per share for $100. In connection with offering of the Series A Preferred Shares and Series B Preferred Shares, the Company incurred $12 of issuance costs which have been recorded as a reduction of additional paid-in-capital.

The Series A Preferred Shares and the Series B Preferred Shares (together, the "preferred shares") do not have a maturity date and are non-callable for the first five years. The dividend rate of the preferred shares is 7.5% per annum, payable quarterly in cash or additional preferred shares, at the Company's option, subject to increase beginning 10 years after issuance based on the then-current three-month LIBOR rate plus 5.5%. In addition, commencing 10 years after issuance of the preferred shares, and following a failed remarketing event, the holders of the preferred shares will have the right to convert their preferred shares into ordinary shares of the Company as determined by dividing (i) the aggregate par value (including dividends paid in kind and unpaid accrued dividends) of the preferred shares that the holders of the preferred shares wish to convert by (ii) the higher of (a) 5% discount to the 30-day volume weighted average of the ordinary shares following the conversion notice, and (b) the then-current floor price. The floor price will be $8.00 per share during the 11th year post-funding, $7.00 per share during the 12th year post funding, and $6.00 during the 13th year post-funding and thereafter.

Warrants

The Company issued 34,500 thousand warrants as part of the units sold in the IPO. The Company issued 15,800 thousand and 1,500 thousand warrants to CF Capital Growth, LLC, at $1.00 per private placement warrant in a private placement consummated simultaneously with the closing of the IPO and upon conversion of working capital loans at the time of the business combination, respectively. In connection with forward purchase agreements, at the closing of the business combination the Company issued 19,083 thousand forward purchase warrants to the anchor investors. The forward purchase warrants have identical terms as the public warrants.

Each whole warrant entitles the holder thereof to purchase one ordinary share at a price of $11.50 per share, subject to adjustment as described below, at any time commencing December 30, 2017, provided that the Company has an effective registration statement under the Securities Act covering the ordinary shares issuable upon exercise of the warrants and a current prospectus relating to them is available (or we permit holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement governing the warrants (the “warrant agreement”)) and such shares are registered, qualified or exempt from registration under the securities, or blue sky, laws of the state of residence of the holder. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of ordinary shares. This means only a whole warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued and only whole warrants trade. The warrants will expire on November 30, 2022, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation.

We have the ability to redeem outstanding warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of our ordinary shares equals or exceeds $18.00 per share for any 20 trading days within a 30 trading-day period ending on the third trading day prior to the date the Company sends the notice of redemption to the warrant holders. If and when the warrants become redeemable by us, the Company may exercise our redemption right even if the Company is unable to register or qualify the underlying securities for sale under all applicable state securities laws.

The Company conducted an offer to exchange its outstanding warrants for 0.11 ordinary shares of the Company, par value $0.0001 (the "Exchange Shares") and $0.98, in cash without interest, per warrant, which expired on October 4, 2018. A total of 65,374 thousand warrants were properly tendered prior to the expiration of the offer to exchange. On October 9, 2018 the Company issued 7,191 thousand shares and paid $64 in cash in exchange for the warrants tendered. After completion of the Offer to Exchange, 5,510 thousand warrants still remain outstanding, which will expire on November 30, 2022, or upon earlier redemption or liquidation.

Share Repurchases

On December 19, 2018, the Company's Board of Directors authorized a share repurchase program of up to $150 of the Company's outstanding common stock. This program will expire on December 15, 2020, and may be modified at any time. Under the share repurchase program, the Company may repurchase shares from time to time in open market transactions or through privately negotiated transactions in accordance with applicable federal securities laws. Repurchases may also be made pursuant to a trading plan under Rule 10b5-1 of the Securities Exchange Act of 1934. The extent to which the Company repurchases its shares, and the timing of such purchases, will depend upon a variety of factors, including market conditions, regulatory requirements and other considerations, as determined by the Company.

During the years ended December 31, 2019 and December 31, 2018, the Company purchased 8,052 and 600 thousand shares, respectively, for a total cost of $65 and $4, respectively. As of December 31, 2019, the Company had repurchased 8,652 thousand shares for a total cost of $69.

Dividends

The Company declared the following cash dividends to its common shareholders during the year ended December 31, 2019:

Date Declared	Date Paid	Date Shareholders of record	Shareholders of record (in thousands)	Cash Dividend declared (per share)	Total cash paid
February 27, 2019	April 1, 2019	March 18, 2019	221,661	$0.01	$2
May 7, 2019	June 10, 2019	May 28, 2019	221,661	$0.01	$2
August 7, 2019	September 9, 2019	August 26, 2019	221,661	$0.01	$2
November 6, 2019	December 9, 2019	November 25, 2019	221,661	$0.01	$2

On February 26, 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on March 30, 2020 to shareholders of record as of the close of business on March 16, 2020.

The Company declared the following dividends to its preferred shareholders during the years ended December 31, 2019 and December 31, 2018:

Type of Preferred Share	Date Declared	Date Paid	Date Shareholders of record	Shareholders of record (in thousands)	Method of Payment	Total cash paid	Total shares paid in kind (in thousands)
Series A Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	277	Paid in kind	$—	5
Series B Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	101	Paid in kind	$—	1
Series A Preferred Shares	June 29, 2018	July 1, 2018	June 15, 2018	282	Paid in kind	$—	5
Series B Preferred Shares	June 29, 2018	July 1, 2018	June 15, 2018	102	Paid in kind	$—	2
Series A Preferred Shares	September 28, 2018	October 1, 2018	September 15, 2018	287	Paid in kind	$—	5
Series B Preferred Shares	September 28, 2018	October 1, 2018	September 15, 2018	104	Paid in kind	$—	2
Series A Preferred Shares	December 31, 2018	January 1, 2019	December 15, 2018	293	Paid in kind	$—	6
Series B Preferred Shares	December 31, 2018	January 1, 2019	December 15, 2018	106	Paid in kind	$—	2
Series A Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	298	Paid in kind	$—	6
Series B Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	108	Paid in kind	$—	2
Series A Preferred Shares	June 28, 2019	July 1, 2019	June 15, 2019	304	Paid in kind	$—	6
Series B Preferred Shares	June 28, 2019	July 1, 2019	June 15, 2019	110	Paid in kind	$—	2
Series A Preferred Shares	September 30, 2019	October 1, 2019	September 15, 2019	310	Paid in kind	$—	6
Series B Preferred Shares	September 30, 2019	October 1, 2019	September 15, 2019	112	Paid in kind	$—	2
Series A Preferred Shares	December 31, 2019	January 1, 2020	December 15, 2019	316	Paid in kind	$—	5
Series B Preferred Shares	December 31, 2019	January 1, 2020	December 15, 2019	114	Paid in kind	$—	3

Restricted Net Assets of Subsidiaries

CF Bermuda’s equity in restricted net assets of consolidated subsidiaries was approximately $2,501 as of December 31, 2019 representing 91% of CF Bermuda’s consolidated stockholder’s equity as of December 31, 2019 and consisted of net assets of CF Bermuda which were restricted as to transfer to the Company in the form of cash dividends, loans or advances under regulatory restrictions.

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Investments:
Fixed maturity securities, available-for-sale, at fair value (amortized cost: December 31, 2019 - $22,914; December 31, 2018 - $22,219)	$ 23,726	$ 21,109
Equity securities, at fair value (cost: December 31, 2019 - $1,069; December 31, 2018 - $1,526)	1,071	1,382
Derivative investments	587	97
Mortgage loans	1,267	667
Other invested assets	1,303	662
Total investments	27,954	23,917
Cash and cash equivalents	969	571
Accrued investment income	228	216
Funds withheld for reinsurance receivables, at fair value	2,172	757
Reinsurance recoverable	3,213	3,190
Intangibles, net	1,455	1,359
Deferred tax assets, net	61	343
Goodwill	467	467
Other assets	195	125
Total assets	36,714	30,945
LIABILITIES AND SHAREHOLDERS' EQUITY
Contractholder funds	25,684	23,387
Future policy benefits, including $1,953 and $725 at fair value at December 31, 2019 and December 31, 2018, respectively	5,735	4,641
Funds withheld for reinsurance liabilities	831	722
Liability for policy and contract claims	71	64
Debt Instrument, Face Amount	542	541
Other liabilities	1,108	700
Total liabilities	33,971	30,055
Shareholders' equity:
Preferred stock ($.0001 par value, 100,000,000 shares authorized, 429,789 and 399,033 shares issued and outstanding at December 31, 2019 and December 31, 2018, respectively)	0	0
Common stock ($.0001 par value, 800,000,000 shares authorized, 221,807,598 and 221,660,974 issued and outstanding at December 31, 2019 and December 31, 2018, respectively	0	0
Additional paid-in capital	2,031	1,998
Retained earnings (Accumulated deficit)	300	(167)
Accumulated other comprehensive income (loss)	481	(937)
Treasury stock, at cost (8,652,400 shares at December 31, 2019; 600,000 shares at December 31, 2018)	(69)	(4)
Total shareholders' equity	2,743	890
Total liabilities and shareholders' equity	$ 36,714	$ 30,945

XML

Reinsurance

12 Months Ended

Dec. 31, 2019

Reinsurance Disclosures [Abstract]

Reinsurance

Reinsurance

The Company reinsures portions of its policy risks with other insurance companies. The use of indemnity reinsurance does not discharge an insurer from liability on the insurance ceded. The insurer is required to pay in full the amount of its insurance liability regardless of whether it is entitled to or able to receive payment from the reinsurer. The portion of risks exceeding the Company's retention limit is reinsured. The Company primarily seeks reinsurance coverage in order to limit its exposure to mortality losses and enhance capital management. The Company follows reinsurance accounting when there is adequate risk transfer. Otherwise, the deposit method of accounting is followed. The Company also assumes policy risks from other insurance companies.

The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017 were as follows:

	Year ended												Period from December 1 to December 31, 2017
	December 31, 2019						December 31, 2018
	Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred
Direct	$	204		$	1,277		$	223		$	646		$	17		$	142
Assumed	—			(19		)	—			(13		)	—			7
Ceded	(164		)	(201		)	(169		)	(210		)	(14		)	(25		)
Net	$	40		$	1,057		$	54		$	423		$	3		$	124

	Period from October 1 to November 30, 2017						Period from October 1 to December 31, 2016 (Unaudited)						Year ended
													September 30, 2017
	Predecessor						Predecessor						Predecessor
	Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred
Direct	$	36		$	267		$	57		$	69		$	233		$	1,097
Assumed	—			—			—			—			—			—
Ceded	(29		)	(40		)	(46		)	(49		)	(191		)	(254		)
Net	$	7		$	227		$	11		$	20		$	42		$	843

Amounts payable or recoverable for reinsurance on paid and unpaid claims are not subject to periodic or maximum limits. The Company did not write off any significant reinsurance balances during the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, or the Predecessor year ended September 30, 2017. The Company did not commute any ceded reinsurance during the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, or the Predecessor year ended September 30, 2017.

No policies issued by the Company have been reinsured with any foreign company, which is controlled, either directly or indirectly, by a party not primarily engaged in the business of insurance.

The Company has not entered into any reinsurance agreements in which the reinsurer may unilaterally cancel any reinsurance for reasons other than non-payment of premiums or other similar credit issues.

Effective January 1, 2017, FGL Insurance entered into an indemnity reinsurance agreement with Hannover Re, a third party reinsurer, to reinsure an inforce block of its FIA and fixed deferred annuity contracts with GMWB and Guaranteed Minimum Death Benefit (“GMDB”) guarantees.  In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of the net retention of guarantee payments in excess of account value for GMWB and GMDB guarantees. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective July 1, 2017, FGL Insurance extended this agreement to include new business issued during 2017. Effective January 1, 2018, FGL Insurance extended this agreement to include new business issued during 2018 and extended the recapture period from 8 to 12 years. Effective January 1, 2019, FGL Insurance extended this agreement to include new business issued during 2019. FGL Insurance incurred risk charge fees of $17, $11, $2, $2 and $4 during the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, and the Predecessor year ended September 30, 2017, respectively, in relation to this reinsurance agreement.

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $758 of certain MYGA and deferred annuity GAAP reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of MYGA and deferred annuity policies for certain issue years to Kubera. Effective June

30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $185 of MYGA GAAP reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019.

Effective December 31, 2018, FGL Insurance entered into a reinsurance agreement with Kubera to cede approximately $4 billion of certain FIA statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. In accordance with the terms of this agreement, FGL Insurance cedes a quota share percentage of FIA policies for certain issue years to Kubera. The effects of this agreement are not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP, since it is not “reasonably possible” that the reinsurer may realize significant loss from assuming the insurance risk. Effective June 30, 2019, FGL Insurance and Kubera executed a letter of intent to amend this agreement and cede an additional $1 billion of FIA statutory reserves on a coinsurance funds withheld basis via a quota share percentage of certain issue years. The amended reinsurance agreement was executed on July 31, 2019. The effects of the amendment are also not accounted for as reinsurance as it does not satisfy the risk transfer requirements for GAAP.

Intercompany Reinsurance Agreements

A description of significant intercompany reinsurance agreements appears below. All intercompany balances have been eliminated in the preparation of the Company’s consolidated financial statements. However, these agreements have a material impact on the regulatory capital position of FGL Insurance and the effective tax rate of the Company.

Effective December 31, 2012, FGL Insurance entered into a reinsurance treaty with FSRC, an affiliated reinsurer, whereby FGL Insurance ceded 10% of its June 30, 2012 in-force annuity block of business not already reinsured on a funds withheld basis. Effective September 17, 2014, FGL Insurance entered into a second reinsurance treaty with FSRC whereby FGL Insurance ceded 30% of any new business of its MYGA issued effective September 17, 2014 and later on a funds withheld basis. The September 17, 2014 treaty was subsequently terminated as to new business effective April 30, 2015, but will remain in effect for policies ceded to FSRC with an effective date between September 17, 2014 and April 30, 2015. Accordingly, MYGA policies issued with an effective date of May 1, 2015 and later will not be ceded to FSRC.

In anticipation of the merger of CF Corp. and FGL, a new Bermuda based reinsurance entity, F&G Life Re Ltd. (“F&G Life Re”) was formed as an indirect wholly owned subsidiary of the Company. Effective December 1, 2017, FGL Insurance entered into an indemnity modified coinsurance agreement with F&G Life Re to reinsure up to 80% of its in-force FIA business and 40% of its in-force deferred annuity business on a net retained basis. Effective October 1, 2018, FGL Insurance and F&G Life Re mutually agreed to terminate this reinsurance agreement. Upon termination of the reinsurance agreement, F&G Life Re made a $1,094 extraordinary dividend to its sole shareholder, CF Bermuda of which $830 was contributed to FGL Insurance to support the recapture of the insurance liabilities and to allow FGL Insurance to maintain appropriate solvency ratios.  The $1,094 extraordinary dividend included $750 return of capital which was approved by the Bermuda Monetary Authority (“BMA”).

Effective October 1, 2012, FGL Insurance entered into a reinsurance treaty with Raven Reinsurance Company ("Raven Re"), its wholly-owned captive reinsurance company, to cede the Commissioners Annuity Reserve Valuation Method (CARVM) liability for annuity benefits where surrender charges are waived. In connection with the CARVM reinsurance agreement, FGL Insurance and Raven Re entered into an agreement with Nomura Bank International plc (“NBI”) to establish a $295 reserve financing facility in the form of a letter of credit issued by NBI.

Effective January 1, 2019, the letter of credit facility was amended to reduce the available amount to $100 and extend the termination date to October 1, 2022, although the facility may terminate earlier, in accordance with the terms of the Reimbursement Agreement. Under the terms of the reimbursement agreement, in the event the letter of credit is drawn upon, Raven Re is required to repay the amounts utilized, and FGLH is obligated to repay the amounts utilized if Raven Re fails to make the required reimbursement. FGLH also is required to make capital contributions to Raven Re in the event that Raven Re’s statutory capital and surplus falls below certain defined levels. As of December 31, 2019 and 2018, Raven Re’s statutory capital and surplus was $33 and $20, respectively, in excess of the minimum level required under the Reimbursement Agreement.

As this letter of credit is provided by an unaffiliated financial institution, Raven Re is permitted to carry the letter of credit as an admitted asset on the Raven Re statutory balance sheet.

F&G Reinsurance Companies

FSRC has entered into various reinsurance agreements on a funds withheld basis, meaning that funds are withheld by the ceding company from the coinsurance premium owed to FSRC as collateral for FSRC's payment obligations. Accordingly, the collateral assets remain under the ultimate ownership of the ceding company. FSRC manages the assets supporting the reserves assumed in accordance with the internal investment policy of the ceding companies and applicable law.

At December 31, 2019 and 2018, FSRC had $307 and $275 of funds withheld receivables and $285 and $254 of insurance reserves related to these reinsurance treaties, respectively.

F&G Re has entered into multiple reinsurance agreements on a funds withheld basis with unaffiliated parties. At December 31, 2019 and December 31, 2018, F&G Re had $1,865 and $482 of funds withheld receivables, respectively, and $1,668 and $471, respectively, of insurance reserves related to these reinsurance treaties. Effective April 1, 2019, F&G Re entered into a reinsurance agreement with an unaffiliated company to reinsure an inforce block of fixed deferred annuity contracts on a 100% coinsurance funds withheld basis. In accordance with the terms of this agreement, F&G Re established a fair value of funds withheld asset and future policy benefits liability of $983 and $896, respectively.

See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts as described under the section titled "Reinsurance" in Note 2. Significant Accounting Policies and Practices.

XML

Other Liabilities

12 Months Ended

Dec. 31, 2019

Other Liabilities Disclosure [Abstract]

Other Liabilities

Other Liabilities

Other liabilities consisted of the following:

	December 31, 2019		December 31, 2018
Amounts payable for investment purchases	$	11	$	39
Retained asset account	141		162
Option collateral liabilities	446		59
Remittances and items not allocated	119		101
Accrued expenses	116		72
Deferred reinsurance revenue	17		39
Unearned revenue liability	43		41
Preferred shares reimbursement feature embedded derivative	17		29
Negative cash liability	69		126
Commissions payable	13		9
Funds withheld embedded derivative	33		—
Rabbi trust investment	36		26
Other	47		(3		)
Total	$	1,108	$	700

XML

Schedule II - Condensed Financial Information

1 Months Ended

12 Months Ended

Dec. 31, 2017

Dec. 31, 2019

Condensed Financial Information Disclosure [Abstract]

Schedule II - Condensed Financial Information

CONDENSED STATEMENT OF OPERATIONS

(in millions)

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Revenues	$	34		$	2		$	12		$	—		$	—		$	(1	)
	34			2			12			—			—			(1		)
Operating expenses:										—
General and administrative expenses	(14		)	6			1			1			1			2
Total operating expenses	(14		)	6			1			1			1			2
Operating income (loss)	48			(4		)	11			(1		)	(1		)	(3		)
Other income:
Equity in net income of subsidiaries	459			17			(102		)	29			109			227
Income (loss) before income taxes	507			13			(91		)	28			108			224
Income tax expense	—			—			—			—			—			1
Net income (loss)	$	507		$	13		$	(91	)	$	28		$	108		$	223

See Report of Independent Registered Public Accounting Firm.

CONDENSED STATEMENT OF CASH FLOWS

(in millions)

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
Cash flows from operating activities
Net income (loss)	$	507		$	13		$	(91	)	$	28		$	108		$	223
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Realized capital and other gains on investments	—			—			—			—			2			5
Equity in net income of subsidiaries	(459		)	(17		)	102			(29		)	(109		)	(227		)
Stock based compensation	5			4			—			1			1			2
Changes in assets and liabilities:
Other assets and other liabilities	(48		)	4			1			2			—			3
Net cash provided by (used in) operating activities	5			4			12			2			2			6
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:
Proceeds from available-for-sale investments, sold, matured or repaid:	41			—			—			—			5			12
Cost of available-for-sale investments:	—			(54		)	—			—			—			—
Net cash provided by (used in) investing activities	41			(54		)	—			—			5			12
Cash flows from financing activities:
Cash paid upon warrant tender and capitalized warrant tender costs	—			(66		)	—			—			—			—
Dividends payments	(9		)	—			—			(4		)	(4		)	(15		)
Treasury stock	(65		)	(4		)	—			—			(1		)	(1		)
Distribution to CF Bermuda and subsidiaries	26			57			(97		)	—			—			(2		)
Net cash provided by (used in) financing activities	(48		)	(13		)	(97		)	(4		)	(5		)	(18		)
Change in cash and cash equivalents	(2		)	(63		)	(85		)	(2		)	2			—
Cash and cash equivalents at beginning of period	7			70			155			2			2			2
Cash and cash equivalents at end of period	$	5		$	7		$	70		$	—		$	4		$	2

See Report of Independent Registered Public Accounting Firm.

CONDENSED BALANCE SHEETS

(in millions)

	December 31, 2019			December 31, 2018
ASSETS
Investments in consolidated subsidiaries	$	2,750		$	900
Fixed maturity securities, available for sale	14			54
Cash and cash equivalents	5			7
Total assets	$	2,769		$	961
LIABILITIES AND SHAREHOLDERS' EQUITY
Other liabilities	26			71
Total liabilities	26			71
Shareholders' equity
Preferred stock	—			—
Common stock	—			—
Additional paid in capital	2,031			1,998
Retained earnings (accumulated deficit)	300			(167		)
Accumulated other comprehensive income (loss)	481			(937		)
Treasury stock	(69		)	(4		)
Total shareholder's equity	2,743			890
Total liabilities and shareholder's equity	$	2,769		$	961

See Report of Independent Registered Public Accounting Firm.

XML

Investments - Narrative (Details) $ in Millions			12 Months Ended
	Sep. 30, 2019 loan	Dec. 31, 2017 loan	Dec. 31, 2019 USD ($) loan	Dec. 31, 2018 USD ($) loan
Debt Securities, Available-for-sale [Line Items]
FHLB collateral pledged			$ 1,472	$ 1,401
Available for sale depressed securities fair value disclosure			$ 35	$ 132
Percentage of available for sale depressed securities above amortized cost		20.00%	20.00%
Number of delinquent CMLs | loan			0	0
Impaired loans, number | loan	0	0
Unfunded investment commitment			$ 83
Available-for-sale Securities
Debt Securities, Available-for-sale [Line Items]
Assets held by insurance regulators			$ 17,591	$ 19,930
Mortgage loans
Debt Securities, Available-for-sale [Line Items]
Ratio of performing loans to all loans				100.00%
Loan to value, threshold			75.00%	75.00%
Commitment to Invest
Debt Securities, Available-for-sale [Line Items]
Unfunded investment commitment			$ 1,358
Crescent Capital BDC Inc. | Commitment to Invest
Debt Securities, Available-for-sale [Line Items]
Other Investments			69
Golub Capital Partners 10, L.P. | Commitment to Invest
Debt Securities, Available-for-sale [Line Items]
Unfunded investment commitment			1,010	$ 510
Other Investments			1,202	$ 1,132
Mortgage-backed Securities, Issued by Private Enterprises
Debt Securities, Available-for-sale [Line Items]
Unrealized Gain Related To Non Credit Portion Of Other Than Temporary Impairments Included In Accumulated Other Comprehensive Income			0
Unrealized losses related to non-credit portion of OTTI included in AOCI			0
Variable Interest Entity, Primary Beneficiary [Member] | BISA Co-Invest Fund II L.P. [Member]
Debt Securities, Available-for-sale [Line Items]
Other Investments			$ 22

XML

Label	Element	Value
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	$ 1,981,000,000
Deferred Policy Acquisition Cost	us-gaap_DeferredPolicyAcquisitionCosts	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1,450,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1,785,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1,648,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1,449,000,000
Deferred Sale Inducement Cost	us-gaap_DeferredSalesInducementsNet	0
Present Value of Future Insurance Profits, Net	us-gaap_ValueOfBusinessAcquiredVOBA	844,000,000
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held	us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	3,000,000
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held	us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	0
Other than Temporary Impairment, Credit Losses Recognized in Earnings, Credit Losses on Debt Securities Held	us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCreditLossesOnDebtSecuritiesHeld	3,000,000
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	2,000,000
Deferred Policy Acquisition Costs and Present Value of Future Insurance Profits, Net	us-gaap_DeferredPolicyAcquisitionCostsAndValueOfBusinessAcquired	844,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3,077,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	3,028,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2,383,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2,627,000,000
Future Policy Benefits [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	723,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	728,000,000
Preferred Shares Reimbursement Feature Embedded Derivative [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	23,000,000
Embedded Derivatives Included In Contractholder Funds [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2,331,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2,627,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2,277,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	2,383,000,000
Asset-backed Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	159,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	412,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	172,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	225,000,000
Debt Security, Government, Non-US [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	17,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	17,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	17,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	17,000,000
Equity Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	2,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	3,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	38,000,000
US States and Political Subdivisions Debt Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	38,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	38,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	41,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	38,000,000
Corporate Debt Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1,097,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1,104,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1,163,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	1,169,000,000
Commercial Mortgage Backed Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	49,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	95,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	49,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	79,000,000
Bank Loan Obligations [Member] | Affiliated Entity [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0
Residential Mortgage Backed Securities [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	66,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	67,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	15,000,000
Reinsurance Receivables, Funds Withheld [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4,000,000
Fixed Maturity Security Embedded Derivative [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	16,000,000
HIG Energy Notes [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	20,000,000
Salus 2013 Participations [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	21,000,000
Available For Sale Embedded Derivatives [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	17,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	13,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	17,000,000
Hybrids [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	10,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	0
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	10,000,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	10,000,000
HGI Energy Note [Member]
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value	us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue	4,000,000
Additional Paid-in Capital [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	2,037,000,000
AOCI Attributable to Parent [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	0
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	4,000,000
Retained Earnings [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	(56,000,000)
Cumulative Effect of New Accounting Principle in Period of Adoption	us-gaap_CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption	(2,000,000)
Treasury Stock [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	0
Preferred Stock [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	0
Common Stock [Member]
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest	us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	$ 0

XML

Income Taxes - Deferred Tax Expense to OCI (Details) - USD ($) $ in Millions	2 Months Ended	3 Months Ended	12 Months Ended
	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Sep. 30, 2017
Income Taxes [Line Items]
Deferred Tax Assets, Funds Held under Reinsurance Agreements			$ 11	$ 0
Deferred Tax Expense in OCI	$ (7)	$ 154	$ (242)	$ 132	$ (19)	$ (56)

XML

Reinsurance - Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes (Detail) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Premiums and other considerations:
Direct	$ 38	$ 80	$ 111	$ 413	$ 460	$ 462
Assumed	0	0	0	0	0	0
Ceded	(19)	(39)	(62)	(218)	(226)	(255)
Net	19	41	49	195	234	207
Benefits and Other Changes in Insurance Policy Reserves:
Net	124	227	20	1,057		843	$ 423
Traditional life insurance premiums
Premiums and other considerations:
Direct	17	36	57	204	223	233
Assumed	0	0	0	0	0	0
Ceded	(14)	(29)	(46)	(164)	(169)	(191)
Net	3	7	11	40	54	42
Benefits and Other Changes in Insurance Policy Reserves:
Direct	142	267	69	1,277	646	1,097
Assumed	7	0	0	(19)	(13)	0
Ceded	(25)	(40)	(49)	(201)	(210)	(254)
Net	$ 124	$ 227	$ 20	$ 1,057	$ 423	$ 843

XML

Derivative Financial Instruments - Narrative (Details) $ in Millions		12 Months Ended
	Nov. 30, 2017 shares	Dec. 31, 2019 USD ($) contract	Dec. 31, 2018 USD ($) contract	Jun. 16, 2014 USD ($)
Derivative [Line Items]
Fair Value		$ 611	$ 111
Preferred Stock, Call Features, Minimum Term	5 years
Preferred stock dividend rate	10.00%
Other derivatives and embedded derivatives
Derivative [Line Items]
Term of contract, term one		1 year
Term of contract, term two		2 years
Term of contract, term three		3 years
Term of contract, term four		5 years
Futures contracts
Derivative [Line Items]
Number of instruments held | contract		879,000,000	664,000,000
Collateral held		$ 5	$ 3
Other invested assets | Other derivatives and embedded derivatives
Derivative [Line Items]
Fair Value		21	14
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		590	97
Collateral posted		489	59
Maximum amount of loss due to credit risk		101	38
Cash and Cash Equivalents | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Collateral posted		446	59
Other Investments Asset | Other invested assets
Derivative [Line Items]
Fixed maturities securities, available-for-sale, at fair value		29	26	$ 35
Merrill Lynch | Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivative [Line Items]
Fair Value		88	25
Collateral posted		43	0
Maximum amount of loss due to credit risk		$ 45	$ 25
Preferred Stock
Derivative [Line Items]
Preferred Stock, Call Features, Minimum Term	5 years
Preferred stock dividend rate	10.00%
Series A Cumulative Preferred Stock | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	275,000
Series B Cumulative Preferred Stock | Preferred Stock
Derivative [Line Items]
Stock Issued During Period, Shares, New Issues | shares	100,000

XML

Schedule II - Condensed Financial Information - Condensed Balance Sheets (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 01, 2017	Nov. 30, 2017	Sep. 30, 2017	Dec. 31, 2016	Sep. 30, 2016
Condensed Balance Sheet Statements, Captions [Line Items]
Cash and cash equivalents	$ 969	$ 571	$ 1,215	$ 1,107	$ 924	$ 885	$ 632	$ 864
Total assets	36,714	30,945
Other liabilities	1,108	700
Total liabilities	(33,971)	(30,055)
Preferred stock	0	0
Common stock	0	0
Additional paid-in capital	2,031	1,998
Retained earnings (Accumulated deficit)	300	(167)
Accumulated other comprehensive income (loss)	481	(937)
Treasury stock	(69)	(4)
Total shareholders' equity	2,743	890
Total liabilities and shareholders' equity	36,714	30,945
Parent Company
Condensed Balance Sheet Statements, Captions [Line Items]
Investments in consolidated subsidiaries	2,750	900
Fixed maturity securities, available for sale	14	54
Cash and cash equivalents	5	7	$ 70	$ 155	$ 0	$ 2	$ 4	$ 2
Total assets	2,769	961
Other liabilities	26	71
Total liabilities	(26)	(71)
Preferred stock	0	0
Common stock	0	0
Additional paid-in capital	2,031	1,998
Retained earnings (Accumulated deficit)	300	(167)
Accumulated other comprehensive income (loss)	481	(937)
Treasury stock	(69)	(4)
Total shareholders' equity	2,743	890
Total liabilities and shareholders' equity	$ 2,769	$ 961

XML

Quarterly Results (Unaudited) (Tables)

12 Months Ended

Dec. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Schedule of Quarterly Financial Information

uarterly results of operations are summarized below.

	Quarter ended
	December 31, 2019		September 30, 2019		June 30, 2019		March 31, 2019
	(Dollars in millions, except per share data)
Premiums	$	7	$	9	$	8	$	16
Net investment income	324		301		315		289
Net investment gains (losses)	196		103		135		240
Insurance and investment product fees and other	36		42		37		55
Total revenues	563		455		495		600
Total benefits and expenses	282		391		428		412
Net income (loss)	225		65		46		171
Net income (loss) per common share - basic	1.02		0.26		0.17		0.74
Net income (loss) per common share - diluted	1.02		0.26		0.17		0.74

	Quarter ended
	December 31, 2018			September 30, 2018		June 30, 2018			March 31, 2018
	(Dollars in millions, except per share data)
Premiums	$	9		$	12	$	15		$	18
Net investment income	295			267		282			263
Net investment gains (losses)	(555		)	119		(2		)	(191		)
Insurance and investment product fees and other	40			46		45			48
Total revenues	(211		)	444		340			138
Total expenses	(20		)	365		280			28
Net income (loss)	(148		)	56		40			65
Net income (loss) per common share - basic	(0.70		)	0.23		0.15			0.27
Net income (loss) per common share - diluted	(0.70		)	0.23		0.15			0.27

XML

Insurance Subsidiary Financial Information and Regulatory Matters - Narrative (Details) - USD ($)						1 Months Ended		2 Months Ended	3 Months Ended		12 Months Ended
	Apr. 03, 2019	Apr. 01, 2019	Jul. 03, 2018	Jun. 28, 2018	May 14, 2018	Sep. 30, 2019	Dec. 31, 2017	Nov. 30, 2017	Jun. 30, 2019	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Statutory Accounting Practices [Line Items]
Dividends							$ 2,000,000	$ 4,000,000		$ 4,000,000		$ 6,000,000	$ 15,000,000
Change in statutory capital surplus											$ 100,000,000	110,000,000
Non-permitted statutory accounting practices											(19,000,000)	(16,000,000)
Statutory capital and surplus											87,000,000	94,000,000
Increase (decrease) in statutory capital surplus											110,000,000	30,000,000
Intercompany Loans			$ 50,000,000
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries					$ 27,000,000				$ 20
IOWA
Statutory Accounting Practices [Line Items]
Change in statutory capital surplus											6,000,000	0
Statutory capital and surplus											1,513,000,000	1,545,000,000
FGLH
Statutory Accounting Practices [Line Items]
Dividends						$ 100,000,000
Raven Re
Statutory Accounting Practices [Line Items]
Statutory capital and surplus											33,000,000	$ 20,000,000
FGL Insurance [Member]
Statutory Accounting Practices [Line Items]
Proceeds from Contributions from Parent				$ 125,000,000
F&G Life Re Ltd [Member]
Statutory Accounting Practices [Line Items]
Notes Issued				65,000,000
FGLH
Statutory Accounting Practices [Line Items]
Proceeds from Contributions from Parent				$ 65,000,000
F&G Re [Member]
Statutory Accounting Practices [Line Items]
Proceeds from Contributions from Parent			$ 50,000,000								$ 198,000,000
Freestone Re [Member]
Statutory Accounting Practices [Line Items]
Proceeds from Contributions from Parent	$ 2,000,000
Maximum
Statutory Accounting Practices [Line Items]
SEC Schedule, 12-04, Cash Dividends Paid to Registrant, Consolidated Subsidiaries		$ 30

XML

Related Party Transactions (Tables)

12 Months Ended

Dec. 31, 2019

Related Party Transactions [Abstract]

Schedule of Related Party Transactions

The Company earned $112, $33 and $1 net investment income for the years ended December 31, 2019 and December 31, 2018, and the period from December 1, 2017 to December 31, 2017, respectively, on affiliated investments. The Company had no gross realized gains (losses) and realized impairment losses on related party investments during the years ended December 31, 2019 and December 31, 2018 and the period from December 1, 2017 to December 31, 2017.

XML

Stock Compensation (Tables)

12 Months Ended

Dec. 31, 2019

Share-based Payment Arrangement [Abstract]

Schedule of Outstanding Stock Option Activity

A summary of the Company’s outstanding stock options as of December 31, 2019, and related activity during the twelve months ended December 31, 2019, is as follows (share amount in thousands):

Stock Option Awards	Options		Weighted Average Exercise Price
Stock options outstanding at December 31, 2018	13,007		$	9.68
Granted	7,749		9.18
Exercised	—		—
Forfeited or expired	(5,542	)	10.00
Stock options outstanding at December 31, 2019	15,214		9.30
Exercisable at December 31, 2019	1,009		9.16
Vested or projected to vest at December 31, 2019	15,214		$	9.30

Schedule of Nonvested Restricted Shares Outstanding

A summary of the Company’s nonvested restricted shares outstanding as of December 31, 2019, and related activity during the twelve months ended, is as follows (share amount in thousands):

Restricted Stock Awards	Shares		Weighted Average Grant Date Fair Value
Restricted shares outstanding at December 31, 2018	—		$	—
Granted	147		6.82
Vested	(147	)	6.82
Vested or expected to vest at December 31, 2019	—		—

Schedule of Nonvested Performance

A summary of the Management Incentive Plan nonvested phantom units outstanding as of December 31, 2019, and related activity during the twelve months ended is as follows (share amount in thousands):

Phantom units	Shares		Weighted Average Grant Date Fair Value
Phantom units outstanding at December 31, 2018	356		$	8.95
Granted	541		8.54
Vested	(59	)	10.00
Forfeited or expired	(93	)	9.33
Phantom units outstanding at December 31, 2019	745		$	9.02

Schedule of Stock Based Compensation

The Company recognized total stock compensation expense related to the FGL Incentive Plan and Management Incentive Plan is as follows:

	Year ended
	December 31, 2019		December 31, 2018
Total stock compensation expense	5		4
Related tax benefit	1		1
Net stock compensation expense	$	4	$	3

Schedule of Incentive Plans

Total compensation expense related to the FGL Incentive Plan and Management Incentive Plan not yet recognized as of December 31, 2019 and the weighted-average period over which this expense will be recognized are as follows:

	Unrecognized Compensation Expense		Weighted Average Recognition Period in Years
FGL Incentive Plan	$	18	3
Management Incentive Plan	4		2
Total unrecognized stock compensation expense	$	22	3

XML

Schedule I - Summary of Investments

12 Months Ended

Dec. 31, 2019

SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Abstract]

Schedule I - Summary of Investments

Summary of Investments - Other than Investments in Related Parties

December 31, 2019

(in millions)

	Amortized Cost		Fair Value		Amount at which shown on the balance sheet
Fixed Maturities:
Bonds:
United States Government and government agencies and authorities	$	166	$	168	$	168
States, municipalities and political subdivisions	1,284		1,343		1,343
Foreign governments	138		155		155
Public utilities	2,345		2,453		2,453
All other corporate bonds	18,981		19,607		19,607
Total fixed maturities	22,914		23,726		23,726
Equity securities:
Common stocks:
Banks, trust, and insurance companies	70		68		68
Industrial, miscellaneous and all other	2		2		2
Nonredeemable preferred stock	997		1,001		1,001
Total equity securities	1,069		1,071		1,071
Derivative investments	336		587		587
Mortgage loans	1,267		1,283		1,267
Other long-term investments	1,306		1,288		1,303
Total investments	$	26,892	$	27,955	$	27,954

See Report of Independent Registered Public Accounting Firm.

XML

Commitments and Contingencies

12 Months Ended

Dec. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Commitments and Contingencies

Commitments

The Company has unfunded investment commitments as of December 31, 2019 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. A summary of unfunded commitments by invested asset class are included below:

	December 31, 2019
Asset Type
Other invested assets	$	1,202
Equity securities	14
Fixed maturity securities, available-for-sale	48
Other assets	78
Residential mortgage loans	16
Total	$	1,358

As of December 31, 2019, the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information.

Lease Commitments

The Company leases office space under non-cancelable operating leases that expire in May 2021 and January 2031. Rent expense and minimum rental commitments under non-cancelable leases are immaterial.

Contingencies

Regulatory and Litigation Matters

The Company is involved in various pending or threatened legal proceedings, including purported class actions, arising in the ordinary course of business. In some instances, these proceedings include claims for unspecified or substantial punitive damages and similar types of relief in addition to amounts for alleged contractual liability or requests for equitable relief. In the opinion of the Company's management and in light of existing insurance and other potential indemnification, reinsurance and established accruals, such litigation is not expected to have a material adverse effect on the Company's financial position, although it is possible that the results of operations and cash flows could be materially affected by an unfavorable outcome in any one period.

The Company is assessed amounts by state guaranty funds to cover losses to policyholders of insolvent or rehabilitated insurance companies. Those mandatory assessments may be partially recovered through a reduction in future premium taxes in certain states. At December 31, 2019, the Company has accrued $2 for guaranty fund assessments that is expected to be offset by estimated future premium tax deductions of $2.

The Company has received inquiries from a number of state regulatory authorities regarding our use of the U.S. Social Security Administration’s Death Master File (“Death Master File”) and compliance with state claims practices regulations and unclaimed property or escheatment laws. We have established procedures to periodically compare our in-force life insurance and annuity policies against the Death Master File or similar databases; investigate any identified potential matches to confirm the death of the insured; determine whether benefits are due, and attempt to locate the beneficiaries of any benefits due or, if no beneficiary can be located, escheat the benefit to the state as unclaimed property. We believe we have established sufficient reserves with respect to these matters; however, it is possible that third parties could dispute these amounts and additional payments or additional unreported claims or liabilities could be identified which could be significant and could have a material adverse effect on our results of operations.

On June 30, 2017, a putative class action complaint was filed against FGL Insurance, FGL, and FS Holdco II Ltd in the United States District Court for the District of Maryland, captioned Brokerage Insurance Partners v. Fidelity & Guaranty Life Insurance Company, Fidelity & Guaranty Life, FS Holdco II Ltd, and John Doe, No. 17-cv-1815. The complaint alleges that FGL Insurance breached the terms of its agency agreement with Brokerage Insurance Partners (“BIP”) and other agents by changing certain compensation terms. The complaint asserts, among other causes of action, breach of contract, defamation, tortious interference with contract, negligent misrepresentation, and violation of the Racketeer Influenced and Corrupt Organizations Act (“RICO”).  The complaint seeks to certify a class composed of all persons who entered into an agreement with FGL Insurance to sell life insurance and who sold at least one life insurance policy between January 1, 2015 and January 1, 2017.  The complaint seeks unspecified compensatory, consequential, and punitive damages in an amount not presently determinable, among other forms of relief.

On September 1, 2017, FGL Insurance filed a counterclaim against BIP and John and Jane Does 1-10, asserting, among other causes of action, breach of contract, fraud, civil conspiracy and violations of RICO. On September 22, 2017, Plaintiff filed an Amended Complaint, and on October 16, 2017, FGL Insurance filed an Amended Counterclaim against BIP, Agent Does 1-10, and Other Person Does 1-10. The parties also filed cross-Motions to Dismiss in Part.

On August 17, 2018, the Court in the BIP Litigation denied all pending Motions to Dismiss filed by all parties without prejudice, pending a decision as to whether the BIP Litigation will be consolidated into related litigation, captioned Fidelity & Guaranty Life Insurance Company v. Network Partners, et al., Case No. 17-cv-1508. On August 31, 2018, FGL Insurance filed its Answer to BIP’s Amended Complaint. Also on that date, FGL Insurance filed its Answer to Amended Complaint, Affirmative Defenses, and Counterclaim, Filed Pursuant to Fed. R. Civ. P. 12(a)(4)(A).

On October 15, 2019, BIP filed with the Court an Unopposed Motion for Preliminary Approval of Settlement and Class Certification, along with a copy of the Class Action Settlement Agreement signed by all parties. A Fairness Hearing on Plaintiff’s Motion for Preliminary Approval of Class Settlement was held on Monday, January 13, 2020.

On January 15, 2020, the Court issued the Modified Findings and Order Preliminarily Approving Class Settlement Between Plaintiff and Defendants, Granting Conditional Certification of Settlement Class, Directing Issuance of Notice to the Class, and Setting of Final Approval Hearing. In preliminarily approving the Class Settlement, the Court also approved the Settlement Schedule that had been filed by Class Counsel on January 10, 2020.

Final settlement is subject to, among other requirements, satisfactory completion of confirmatory discovery by the Defendants and the Class Representative and final approval by the Court after Court-approved Notice has been provided to the absent members of the putative class.

As of the date of this report, the Company does not have sufficient information to determine whether it has exposure to any losses that would be either probable or reasonably estimable.

XML

Insurance Subsidiary Financial Information and Regulatory Matters

12 Months Ended

Dec. 31, 2019

Insurance [Abstract]

Insurance Subsidiary Financial Information and Regulatory Matters

Insurance Subsidiary Financial Information and Regulatory Matters

The Company’s U.S. insurance subsidiaries file financial statements with state insurance regulatory authorities and the National Association of Insurance Commissioners (“NAIC”) that are prepared in accordance with Statutory Accounting Principles (“SAP”) prescribed or permitted by such authorities, which may vary materially from GAAP. Prescribed SAP includes the Accounting Practices and Procedures Manual of the NAIC as well as state laws, regulations and administrative rules. Permitted SAP encompasses all accounting practices not so prescribed. The principal differences between SAP financial statements and financial statements prepared in accordance with GAAP are that SAP financial statements do not reflect DAC, DSI and VOBA, some bond portfolios may be carried at amortized cost, assets and liabilities are presented net of reinsurance, contractholder liabilities are generally valued using more conservative assumptions and certain assets are non-admitted. Accordingly, SAP operating results and SAP capital and surplus may differ substantially from amounts reported in the GAAP basis financial statements for comparable items.

FSRC (Cayman), F&G Re (Bermuda) and F&G Life Re (Bermuda) file financial statements based on U.S. GAAP with their respective regulators.

The Company’s principal insurance subsidiaries’ statutory (SAP and GAAP) financial statements are based on a December 31 year end. Statutory net income and statutory capital and surplus of the Company’s wholly-owned insurance subsidiaries were as follows:

	Subsidiary (state/country of domicile) (a)
	FGL Insurance (IA)			FGL NY Insurance (NY)			F&G Life Re (Bermuda)
Statutory Net Income (loss):
Year ended December 31, 2019	$	152		$	(1	)	$	3
Year ended December 31, 2018	(151		)	(3		)	319
Statutory Capital and Surplus:
December 31, 2019	$	1,513		$	95		$	2
December 31, 2018	1,545			85			2

(a) FGL NY Insurance is a subsidiary of FGL Insurance, and the columns should not be added together.

	Subsidiary (state/country of domicile)
	FSR (Cayman)			F&G Re (Bermuda)
Statutory Net Income (loss):
Year ended December 31, 2019	$	(29	)	$	69
Year ended December 31, 2018	(29		)	(14		)
Statutory Capital and Surplus:
December 31, 2019	$	73		$	295
December 31, 2018	73			38

Capital Requirements and Restrictions on Dividends and Distribution

U.S. Companies

The amount of statutory capital and surplus necessary to satisfy the applicable regulatory requirements is less than FGL Insurance’s and FGL NY Insurance’s respective statutory capital and surplus.

Life insurance companies domiciled in the U.S. are subject to certain Risk-Based Capital (“RBC”) requirements as specified by the NAIC. The RBC is used to evaluate the adequacy of capital and surplus maintained by an insurance company in relation to risks associated with: (i) asset risk, (ii) insurance risk, (iii) interest rate risk and (iv) business risk. The Company monitors the RBC of FGLH’s insurance subsidiaries. As of December 31, 2019 and December 31, 2018, each of FGLH's insurance subsidiaries had exceeded the minimum RBC requirements.

The Company’s insurance subsidiaries domiciled in the U.S. are restricted by state laws and regulations as to the amount of dividends they may pay to their parent without regulatory approval in any year, the purpose of which is to protect affected insurance policyholders, depositors or investors. Any dividends in excess of limits are deemed “extraordinary” and require regulatory approval. In addition, and pursuant to an order issued in connection with the approval of the Merger Agreement by the Iowa Commissioner on November 28, 2017, FGL Insurance shall not pay any dividend or other distribution to shareholders prior to November 28, 2021 without the prior

approval of the Iowa Commissioner. In September 2019 and December 2019, upon approval by the Iowa Commissioner, FGL Insurance declared and paid, respectively, extraordinary dividends of $100 to its Parent, FGLH.

FGL Insurance applies Iowa-prescribed accounting practices that permit Iowa-domiciled insurers to report equity call options used to economically hedge FIA index credits at amortized cost for statutory accounting purposes and to calculate FIA statutory reserves such that index credit returns will be included in the reserve only after crediting to the annuity contract. This resulted in a $110 decrease and $30 increase to statutory capital and surplus at December 31, 2019 and December 31, 2018, respectively.

Raven Re is also permitted to follow Iowa prescribed statutory accounting practice for its reserves on reinsurance assumed from FGL Insurance which increased Raven Re’s statutory capital and surplus by $6 and $0 at December 31, 2019 and December 31, 2018, respectively. Without such permitted statutory accounting practices Raven Re’s statutory capital and (deficit) surplus would be $(19) and $(16) at December 31, 2019 and December 31, 2018, respectively, and its risk-based capital would fall below the minimum regulatory requirements. The letter of credit facility is collateralized by NAIC 1 rated debt securities. If the permitted practice was revoked, the letter of credit could be replaced by the collateral assets with Nomura’s consent. FGL Insurance’s statutory carrying value of Raven Re at December 31, 2019 and December 31, 2018 was $87 and $94, respectively.

Effective April 1, 2019, Raven Re and FGL Insurance executed the third amended and restated Reinsurance Agreement (the "CARVM treaty"). The amendment allowed Raven Re to declare and pay a one-time dividend of up to $30 to FGL Insurance provided that the dividend was paid on or before June 30, 2020 and subject to other provisions outlined in the amendment. The Vermont Department of Financial Regulation approved the amendment on April 15, 2019. Pursuant to the provisions of the amended CARVM treaty, Raven Re paid a $20 dividend to FGL Insurance in June 2019.

FGL Insurance’s statutory carrying value of Raven Re reflects the effect of permitted practices Raven Re received to treat the available amount of a letter of credit as an admitted asset which increased Raven Re’s statutory capital and surplus by $100 and $110 at December 31, 2019 and December 31, 2018, respectively.

Pursuant to an order issued in connection with the Merger agreements, F&G Life Re will not, for a period of three (3) years from November 28, 2017, declare, set aside or distribute any dividends or distributions other than solely (a) dividends or distributions that would be permitted in accordance with Section 521A.5(3) of the Iowa Code if F&G Life Re were a life insurance company domesticated in Iowa, upon prior written notice to the Iowa Commissioner, but limited only to the amount necessary to service interest payments on outstanding indebtedness and other obligations of CF Bermuda and FGLH, and (b) dividends or distributions upon written notice to, and with the prior written approval of, the Iowa Commissioner.

The prescribed and permitted statutory accounting practices have no impact on the Company’s unaudited condensed consolidated financial statements which are prepared in accordance with GAAP.

As of December 31, 2019, FGL NY Insurance did not follow any prescribed or permitted statutory accounting practices that differ from the NAIC's statutory accounting practices.

On May 14, 2018, FGLH made a dividend payment of $27 to FGL US Holdings, Inc. ("FGL US Holdings"). On June 28, 2018, FGL US Holdings issued a $65 intercompany note to F&G Life Re and subsequently approved a $65 capital contribution to its wholly owned subsidiary, FGLH. On June 28, 2018, FGLH made a capital contribution for $125 to FGL Insurance. On July 3, 2018, CF Bermuda issued a $50 intercompany note to F&G Life Re and subsequently approved a $50 capital contribution to its wholly owned subsidiary, F&G Re. On April 3, 2019, CF Bermuda made a capital contribution of $2 to Freestone. In 2019, CF Bermuda made capital contributions of $198 to F&G Re.

Non-U.S. companies

As licensed class C insurers in Bermuda, F&G Life Re and F&G Re are required to maintain available capital and surplus at a level equal to or in excess of the applicable enhanced capital requirement ("ECR"), which is established by reference to either the applicable Bermuda Solvency Capital Requirements ("BSCR") model or an approved internal capital model. Furthermore, to enable the Bermuda Monetary Authority ("BMA") to better assess the quality of the insurer’s capital resources, a Class C insurer is required to disclose the makeup of its capital in accordance with its 3-tiered capital system. An insurer may file an application under the Insurance Act to have the aforementioned ECR requirements waived.

In addition to the requirements under the Companies Act (as discussed below), the Insurance Act limits the maximum amount of annual dividends and distributions that may be paid or distributed by F&G Life Re and F&G Re without prior regulatory approval.

F&G Life Re and F&G Re are prohibited from declaring or paying a dividend if it fails to meet its minimum solvency margin, or ECR, or if the declaration or payment of such dividend would cause such breach. Additionally, annual distributions that would result in a reduction of the insurer’s prior year-end balance of statutory capital and surplus by more than 25% also requires the prior approval of the BMA.

If F&G Life Re or F&G Re were to fail to meet its minimum solvency margin on the last day of any financial year, it would be prohibited from declaring or paying any dividends during the next financial year without the approval of the BMA.

In addition, as Class C insurers, each of F&G Life Re and F&G Re must: (i) not make any payment from its long-term business fund for any purpose other than a purpose of the insurer’s long-term business, except in so far as such payment can be made out of any surplus certified by the insurer’s approved actuary to be available for distribution otherwise than to policyholders; and (ii) not declare or pay a dividend to any person other than a policyholder unless the value of the assets of its long-term business fund, as certified by the insurer’s approved actuary, exceeds the extent (as to certified) of the liabilities of the insurer’s long-term business. In the event a dividend complies with the above, each of F&G Life Re and F&G Re must ensure the amount of any such dividend does not exceed the aggregate of (i) that excess and (ii) any other funds properly available for the payment of dividend, being funds arising out of business of the insurer other than long-term business.

The Companies Act also limits F&G Life Re’s and F&G Re’s ability to pay dividends and make distributions to its shareholders. Each of F&G Life Re and F&G Re is not permitted to declare or pay a dividend, or make a distribution out of its contributed surplus, if it is, or would after the payment be, unable to pay its liabilities as they become due or if the realizable value of its assets would be less than its liabilities.

The laws and regulations of the Cayman Islands require that, among other things, FSRC maintain minimum levels of statutory capital, surplus and liquidity, meet solvency standards, submit to periodic examinations of its financial condition and restrict payments of dividends and reductions of capital. Statutes, regulations and policies that FSRC is subject to may also restrict the ability of FSRC to write insurance and reinsurance policies, make certain investments and distribute funds. Any failure to meet the applicable requirements or minimum statutory capital requirements could subject it to further examination or corrective action by Cayman Islands Monetary Authority ("CIMA"), including restrictions on dividend payments, limitations on our writing of additional business or engaging in finance activities, supervision or liquidation.

XML

Investments - Net Investment Gains (Losses) (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended									12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Gain (Loss) on Securities [Line Items]
Net realized gains (losses) on fixed maturity available-for-sale securities	$ 5	$ 5									$ 2	$ 46	$ (187)	$ (20)
Net realized/unrealized gains (losses) on equity securities	0	1									0	127	(142)	3
Realized gains (losses) on other invested assets	0	0									(2)	3	(5)	(2)
Net realized gains on securities	3	80									1	(15)	(2)	219
Unrealized gains (losses) on certain derivative instruments	34	58									38	449	(248)	129
Change in fair value of funds withheld for reinsurance receivables and reinsurance related embedded derivatives (a)	0	1									12	57	(42)	(16)
Change in fair value of other derivatives and embedded derivatives	0	1									0	7	(3)	3
Realized gains (losses) on derivatives and embedded derivatives	37	140									51	498	(295)	335
Net investment gains (losses)	$ 42	$ 146	$ 196	$ 103	$ 135	$ 240	$ (555)	$ 119	$ (2)	$ (191)	$ 51	$ 674	$ (629)	$ 316	$ (629)

XML

Income Taxes - Reconciliation of Effective Income Tax (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Income Tax Contingency [Line Items]
Expected income tax (expense)/benefit at Federal statutory rate	$ (7)	$ (15)	$ (57)	$ (119)	$ (6)	$ (117)
Valuation allowance for deferred tax assets	13	(2)	0	39	(38)	1
Amortization of low income housing tax credits	(1)	(1)	0	(8)	(4)	(4)
Benefit on LIHTC under proportional amortization method	0	1	0	9	5	5
Write off of expired capital loss carryforward	0	0	0	0	0	0
Remeasurement of deferred taxes under U.S. tax reform	(131)	0	0	0	0	0
Dividends received deduction	0	1	0	4	5	4
Benefit on Outside of United States Income taxed at 0%	26	0	0	21	63	0
Withholding Tax on 0% Taxed Jurisdictions	0	0	0	(5)	0	0
Write off of 382 Limited NOL	(12)	0	0	0	0	0
Base Erosion & Antiabuse Tax BEAT	0	0	0	0	(44)	0
Other	2	0	2	(2)	3	1
Income tax (expense)/benefit	$ (110)	$ (16)	$ (55)	$ (61)	$ (16)	$ (110)	$ (16)
Effective tax rate	579.00%	37.00%	34.00%	11.00%	55.00%	33.00%

XML

Commitments and Contingencies - Narrative (Details)	12 Months Ended
	Dec. 31, 2019 USD ($)
Loss Contingencies [Line Items]
Accrued amount of guaranty fund assessments	$ 2
Loss Contingency Accrual, Insurance-related Assessment, Premium Tax Offset	$ 2

XML

Derivative Financial Instruments - FGL's Exposure to Credit Loss on Call Options Held (Detail) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Derivatives, Fair Value [Line Items]
Fair Value	$ 611	$ 111
Merrill Lynch
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P)	A+/*/A+	A+/*/A+
Deutsche Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P)	BBB/A3/BBB+	A-/A3/BBB+
Notional Amount	$ 157	$ 1,327
Fair Value	7	5
Collateral	7	6
Net Credit Risk	$ 0	$ (1)
Morgan Stanley
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P)	*/A1/A+	*/A1/A+
Notional Amount	$ 2,053	$ 1,648
Fair Value	66	9
Collateral	65	6
Net Credit Risk	$ 1	$ 3
Barclay's Bank
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P)	A+/A2/A	A+/A2/A
Notional Amount	$ 4,290	$ 2,205
Fair Value	211	27
Collateral	193	20
Net Credit Risk	$ 18	$ 7
Canadian Imperial Bank of Commerce
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P)	*/Aa2/A+	*/Aa2/A+
Notional Amount	$ 2,691	$ 1,716
Fair Value	106	11
Collateral	74	8
Net Credit Risk	$ 32	$ 3
Wells Fargo
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P)	A+/A2/A-	A+/A2/A-
Notional Amount	$ 2,165	$ 1,635
Fair Value	81	17
Collateral	80	16
Net Credit Risk	$ 1	$ 1
Goldman Sachs
Derivatives, Fair Value [Line Items]
Credit Rating (Fitch/Moody's/S&P)	A/A3/BBB+	A/A3/BBB+
Notional Amount	$ 1,065	$ 647
Fair Value	31	3
Collateral	27	3
Net Credit Risk	4	0
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options
Derivatives, Fair Value [Line Items]
Notional Amount	15,139	13,130
Fair Value	590	97
Collateral	489	59
Net Credit Risk	101	38
Derivatives For Trading And Investment | Not Designated as Hedging Instrument | Call options | Merrill Lynch
Derivatives, Fair Value [Line Items]
Notional Amount	2,718	3,952
Fair Value	88	25
Collateral	43	0
Net Credit Risk	$ 45	$ 25

XML

Earnings Per Share (Tables)

12 Months Ended

Dec. 31, 2019

Earnings Per Share [Abstract]

Summary of Basic and Diluted EPS

The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands):

	Year Ended												Year ended
	December 31, 2019		December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
									Predecessor		Predecessor		Predecessor
Net income (loss)	$	507	$	13		$	(91	)	$	28	$	108	$	223
Less Preferred stock dividend	31		29			2			—		—		—
Net income (loss) available to common shares	476		(16		)	(93		)	28		108		223
Weighted-average common shares outstanding - basic	216,592		216,019			214,370			58,341		58,281		58,320
Dilutive effect of unvested restricted stock & PRSU	86		—			—			61		57		43
Dilutive effect of stock options	59		—			—			92		28		52
Weighted-average shares outstanding - diluted	216,738		216,019			214,370			58,494		58,366		58,415
Net income (loss) per common share:
Basic	$	2.19	$	(0.07	)	$	(0.44	)	$	0.48	$	1.85	$	3.83
Diluted	$	2.19	$	(0.07	)	$	(0.44	)	$	0.47	$	1.85	$	3.83

XML

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Schedule of Income before Income Tax, Domestic and Foreign

Income tax (expense) benefit is calculated based upon the following components of income before income taxes:

	Year ended												Year ended
	December 31, 2019		December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
									Predecessor		Predecessor		Predecessor
Pretax income (loss):
United States	$	467	$	(271	)	$	(55	)	$	44	$	163	$	333
Outside the United States	101		300			74			—		—		—
Total pretax income	$	568	$	29		$	19		$	44	$	163	$	333

Schedule of Components of Income Tax Expense (Benefit)

The components of income tax (expense) benefit are as follows:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Current:
Federal	$	(22	)	$	(42	)	$	(5	)	$	(23	)	$	21		$	(114	)
State	—			—			—			—			—			—
Total current	$	(22	)	$	(42	)	$	(5	)	$	(23	)	$	21		$	(114	)
Deferred:
Federal	$	(39	)	$	26		$	(105	)	$	7		$	(76	)	$	4
State	—			—			—			—			—			—
Total deferred	$	(39	)	$	26		$	(105	)	$	7		$	(76	)	$	4
Income tax (expense)/benefit	$	(61	)	$	(16	)	$	(110	)	$	(16	)	$	(55	)	$	(110	)

Schedule of Effective Income Tax Rate Reconciliation

The difference between income taxes expected at the U.S. Federal statutory income tax rate of 21% and reported income tax (expense) benefit is summarized as follows:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Expected income tax (expense)/benefit at Federal statutory rate	$	(119	)	$	(6	)	$	(7	)	$	(15	)	$	(57	)	$	(117	)
Valuation allowance for deferred tax assets	39			(38		)	13			(2		)	—			1
Amortization of low income housing tax credits	(8		)	(4		)	(1		)	(1		)	—			(4		)
Benefit on LIHTC under proportional amortization method	9			5			—			1			—			5
Write off of expired capital loss carryforward	—			—			—			—			—			—
Remeasurement of deferred taxes under U.S. tax reform	—			—			(131		)	—			—			—
Dividends received deduction	4			5			—			1			—			4
Benefit on Outside of United States Income taxed at 0%	21			63			26			—			—			—
Withholding Tax on 0% Taxed Jurisdictions	(5		)	—			—			—			—			—
Write off of 382 Limited NOL	—			—			(12		)	—			—			—
Base Erosion & Antiabuse Tax "BEAT"	—			(44		)	—			—			—			—
Other	(2		)	3			2			—			2			1
Reported income tax (expense)/benefit	$	(61	)	$	(16	)	$	(110	)	$	(16	)	$	(55	)	$	(110	)
Effective tax rate	11		%	55		%	579		%	37		%	34		%	33		%

Schedule Of Deferred Tax Expense To Other Comprehensive Income [Table Text Block]

The Company recorded the following deferred tax expense to OCI:

	Year ended													Year ended
	December 31, 2019			December 31, 2018		Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
									Predecessor			Predecessor		Predecessor
Deferred Tax Expense in OCI	$	(242	)	$	132	$	(19	)	$	(7	)	$	154	$	(56	)

Schedule of Deferred Tax Assets and Liabilities

The following table is a summary of the components of deferred income tax assets and liabilities:

	December 31, 2019			December 31, 2018
Deferred tax assets:
Net operating loss, credit and capital loss carryforwards	$	35		$	94
Insurance reserves and claim related adjustments	716			620
Unrealized Investment Losses	—			201
Derivatives	—			36
Deferred acquisition costs	—			—
Funds held under Reinsurance Agreements	11			—
Other	37			30
Valuation allowance	(14		)	(154		)
Total deferred tax assets	$	785		$	827
Deferred tax liabilities:
Value of business acquired	$	(124	)	$	(181	)
Unrealized Investment Gains	(221		)	—
Investments	(121		)	(133		)
Derivatives	(45		)	—
Deferred acquisition costs	(139		)	(76		)
Transition reserve on new reserve method	(63		)	(75		)
Funds held under Reinsurance Agreements	—			(11		)
Other	(11		)	(8		)
Total deferred tax liabilities	$	(724	)	$	(484	)
Net deferred tax assets and (liabilities)	$	61		$	343

XML

Schedule II - Condensed Financial Information - Condensed Statement of Operations (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended									12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Condensed Income Statements, Captions [Line Items]
Revenues	$ 165	$ 362	$ 563	$ 455	$ 495	$ 600	$ (211)	$ 444	$ 340	$ 138	$ 340	$ 2,113		$ 1,530	$ 711
General and administrative expenses	16	51									28	330		137	181
Total operating expenses	144	314	282	391	428	412	(20)	365	280	28	171	1,513		1,173	653
Operating income	21	48									169	600		357	58
Income (loss) before income taxes	19	44									163	568	$ 29	333	29
Income tax expense	110	16									55	61	16	110	16
Net income (loss)	(91)	28	$ 225	$ 65	$ 46	$ 171	$ (148)	$ 56	$ 40	$ 65	108	507	13	223	$ 13
Parent Company
Condensed Income Statements, Captions [Line Items]
Revenues	12	0									0	34	2	(1)
Gross Profit	12	0									0	34	2	(1)
General and administrative expenses	1	1									1	(14)	6	2
Total operating expenses	1	1									1	(14)	6	2
Operating income	11	(1)									(1)	48	(4)	(3)
Equity in net income of subsidiaries	(102)	29									109	459	17	227
Income (loss) before income taxes	(91)	28									108	507	13	224
Income tax expense	0	0									0	0	0	1
Net income (loss)	$ (91)	$ 28									$ 108	$ 507	$ 13	$ 223

XML

Basis of Presentation and Nature of Business - Narrative (Details) $ / shares in Units, $ in Millions		12 Months Ended
	Feb. 07, 2020 USD ($) $ / shares	Dec. 31, 2019 USD ($) segment
Effects of Reinsurance [Line Items]
Reporting segments | segment		1
FGL
Effects of Reinsurance [Line Items]
Preferred shares Acquired Through Acquisition, Value		$ 321
Subsequent Event [Member] | FGL
Effects of Reinsurance [Line Items]
Acquisition share price (in USD per share) | $ / shares	$ 12.50
Business Combination, Consideration Transferred	$ 2,700
Business Acquisition, Percentage of Voting Interests Acquired	7.90%
Subsequent Event [Member] | Fidelity national Financial, Inc [Member]
Effects of Reinsurance [Line Items]
Shareholders equity Convertible Basis ,in cash | $ / shares	$ 12.50
Stockholders' Equity Note, Stock Split, Conversion Ratio	0.2558
Consideration Paid In Cash, Percent	60.00%
Consideration Paid In Common Stock, Percent	40.00%
Senior Notes | FGL
Effects of Reinsurance [Line Items]
Debt Assumed Through Acquisition		$ 550

XML

Other Liabilities - Schedule of Other Liabilities (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Other Liabilities Disclosure [Abstract]
Amounts payable for investment purchases	$ 11	$ 39
Retained asset account	141	162
Option collateral liabilities	446	59
Remittances and items not allocated	119	101
Accrued expenses	116	72
Deferred reinsurance revenue	17	39
Unearned revenue liability	43	41
Preferred shares reimbursement feature embedded derivative	17	29
Negative cash liability	69	126
Commissions payable	13	9
Funds withheld embedded derivative	33	0
Rabbi trust investment	36	26
Other	47	(3)
Total	$ 1,108	$ 700

XML

Intangibles - Definite Lived Intangible Assets (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Finite-Lived Intangible Assets [Line Items]
Intangibles, net	$ 1,455	$ 1,359
FGL
Finite-Lived Intangible Assets [Line Items]
Intangibles, net	18
FGL | Trade names
Finite-Lived Intangible Assets [Line Items]
Cost	16
Accumulated amortization	4
Net	$ 12
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life	10 years
Licensing Agreements | FGL
Finite-Lived Intangible Assets [Line Items]
Intangibles, net	$ 6

XML

Stock Compensation - Schedule of Stock Based Compensation Costs (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Related tax benefit	$ 1	$ 1
Phantom Share Units (PSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
stock compensation expense	5	4
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
stock compensation expense	$ 4	$ 3

XML

Stock Compensation - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Aug. 08, 2017
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant	5,712,000
FGL Holdings [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share Price	$ 10.65
2017 Stock Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized			15,006,000
FGL Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	7,749,000
FGL Incentive Plan | Restricted shares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	147,000	112,000
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date	$ 1	$ 1
Management Incentive Plan | Phantom Share Units (PSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period	541,000
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date	$ 5	$ 3
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Share-based Liabilities	$ 1
Management Incentive Plan | Phantom Share Units (PSUs) | Management [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	541,000	374,000
Stock Option Awards | FGL Incentive Plan | Officer
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross	7,749,000	17,255,000
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Options Fair Value At Grant Date	$ 12	$ 32

XML

Fair Value of Financial Instruments - Gross Transfers Into and Out of Certain Fair Value Levels by Asset Class (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	$ 41	$ 0	$ 0	$ 29	$ 30	$ 0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	78	75	72	351	596	278
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	126	672	44	70	106	128
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	46	54	44	79	61	128
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	37	75	72	338	566	278
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	80	618	0	7	45	0
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0	0	0	0	0	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	1	29	68	233	425	222
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	46	0	39	51	13	112
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	46	0	39	51	13	112
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	1	29	68	233	425	222
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	0	0	0	0	0	0
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	0	0		0	0	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	1	46		37	28	7
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	0	1		1	9	6
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0	1		1	9	6
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	1	46		37	28	7
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	0	0		0	0	0
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount		0	0	0	0	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount		0	4	1	75	49
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount		18	5	11	4	10
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount		18	5	11	4	10
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount		0	4	1	75	49
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount		0	$ 0	0	0	$ 0
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	15	0			0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	15	0			0
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	27	244			20
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0	0			0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	0	0			0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	27	244			20
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount				0	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount				29	36
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount				0	35
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount				0	35
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount				29	36
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount				0	0
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount	26	0		29	30
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount	61	0		29	30
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount	53	409		7	25
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount	0	35		16	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount	35	0		16	0
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount	$ 53	$ 374		7	25
Reinsurance Receivables, Funds Withheld
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets, Level 1 to Level 2 Transfers, Amount				0	0
Fair Value, Assets, Level 1 Or Level 3 To Level 2 Transfers, Amount				22	2
Fair Value, Assets, Level 2 To Level 1 Or Level 3 Transfers, Amount				0	0
Fair Value, Assets, Level 1 Or Level 2 To Level 3 Transfers, Amount				0	0
Fair Value, Assets, Level 3 To Level 1 Or Level 2 Transfers, Amount				22	2
Fair Value, Assets, Level 2 Or Level 3 From Level 1 Transfers, Amount				$ 0	$ 0

XML

Investments - Other-than-Temporary Impairments (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Schedule of Investments [Line Items]
Total other-than-temporary impairments	$ 0	$ 0	$ (1)	$ (23)	$ (24)	$ (22)
Asset-backed securities
Schedule of Investments [Line Items]
Total other-than-temporary impairments	0	0	(1)	0	0	(2)
Corporates
Schedule of Investments [Line Items]
Total other-than-temporary impairments	0	0	0	(21)	(24)	(20)
Equity security
Schedule of Investments [Line Items]
Total other-than-temporary impairments	$ 0	$ 0	$ 0	$ (2)	$ 0	$ 0

XML

Basis of Presentation and Nature of Business - Schedule of Premiums and Annuity Deposits, net of Coinsurance, Not Included in Revenue (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	$ 239	$ 434	$ 707	$ 3,556	$ 2,520	$ 2,639
Fixed indexed annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	178	288	556	2,800	2,253	1,892
Fixed rate annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	45	116	99	539	61	556
Single premium immediate annuities
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	0	1	2	14	24	15
Traditional life insurance premiums
Liabilities for Guarantees on Long-Duration Contracts [Line Items]
Premiums and annuity deposits, net of coinsurance, not included as revenue, excluding traditional premiums	$ 16	$ 29	$ 50	$ 203	$ 182	$ 176

XML

Investments - Amortized Cost and Fair Value of Fixed Maturity Available-for-Sale Securities (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]
Due in one year or less, Amortized Cost	$ 85
Due after one year through five years, Amortized Cost	888
Due after five years through ten years, Amortized Cost	2,020
Due after ten years, Amortized Cost	10,496
Subtotal, Amortized Cost	13,489
Other securities which provide for periodic payments, Amortized Cost	9,425
Total fixed maturity available-for-sale securities, Amortized Cost	22,914	$ 22,219
Due in one year or less, Fair Value	85
Due after one year through five years, Fair Value	914
Due after five years through ten years, Fair Value	2,082
Due after ten years, Fair Value	11,075
Subtotal, Fair Value	14,156
Other securities which provide for periodic payments, Fair Value	9,570
Total fixed maturity available-for-sale securities, Fair Value	23,726
Asset-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	5,720
Other securities which provide for periodic payments, Fair Value	5,694
Commercial mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	2,788
Other securities which provide for periodic payments, Fair Value	2,922
Residential mortgage-backed securities
Debt Securities, Available-for-sale [Line Items]
Other securities which provide for periodic payments, Amortized Cost	917
Other securities which provide for periodic payments, Fair Value	$ 954

XML

Derivative Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2019

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Fair Value of Outstanding Derivative Contracts in Condensed Consolidated Balance Sheets

The carrying amounts of derivative instruments, including derivative instruments embedded in FIA contracts, is as follows:

	December 31, 2019		December 31, 2018
Assets:
Derivative investments:
Call options	$	587	$	97
Futures contracts	—		—
Other invested assets:
Other derivatives and embedded derivatives	21		14
Funds withheld:
Call options	3		—
	$	611	$	111

Liabilities:
Contractholder funds:
FIA embedded derivative	$	3,235	$	2,476
Other liabilities:
Reinsurance related embedded derivative	33		—
Preferred shares reimbursement feature embedded derivative	16		29
	$	3,284	$	2,505

Schedule of Change in Fair Value of Derivative Instruments

The change in fair value of derivative instruments included in the accompanying Consolidated Statements of Operations is as follows:

	Year ended														Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor		Predecessor			Predecessor
Net investment gains (losses):
Call options	$	404		$	(244	)	$	34		$	129	$	39		$	338
Futures contracts	27			(8		)	3			9		—			10
Foreign currency forward	3			2			—			—		—			—
Other derivatives and embedded derivatives	7			(3		)	—			1		—			3
Reinsurance related embedded derivatives (a)	57			(42		)	—			1		12			(16		)
Total net investment gains (losses)	$	498		$	(295	)	$	37		$	140	$	51		$	335
Benefits and other changes in policy reserves:
FIA embedded derivatives	$	759		$	199		$	(54	)	$	123	$	(133	)	$	244
Acquisition and operating expenses, net of deferrals:
Preferred shares reimbursement feature embedded derivative (b)	$	(13	)	$	6		$	—		$	—	$	—		$	—

(a) Change in fair value of reinsurance related embedded derivatives starting December 1, 2017 and after is due to F&G Re and FSRC unaffiliated third party business under the fair value option election. Starting January 1, 2019, the balance also includes activity related to the FGL Insurance and Kubera reinsurance treaty. The predecessor periods activity is due to the FGL Insurance and FSRC reinsurance treaty. See "Note 13. Reinsurance".

(b) Only applicable to periods after December 1, 2017.

FGL's Exposure to Credit Loss on Call Options Held

Information regarding the Company’s exposure to credit loss on the call options it holds is presented in the following table:

		December 31, 2019
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	2,718	$	88	$	43	$	45
Deutsche Bank	BBB/A3/BBB+	157		7		7		—
Morgan Stanley	*/A1/A+	2,053		66		65		1
Barclay's Bank	A+/A2/A	4,290		211		193		18
Canadian Imperial Bank of Commerce	*/Aa2/A+	2,691		106		74		32
Wells Fargo	A+/A2/A-	2,165		81		80		1
Goldman Sachs	A/A3/BBB+	1,065		31		27		4
Total		$	15,139	$	590	$	489	$	101

		December 31, 2018
Counterparty	Credit Rating (Fitch/Moody's/S&P) (a)	Notional Amount		Fair Value		Collateral		Net Credit Risk
Merrill Lynch	A+/*/A+	$	3,952	$	25	$	—	$	25
Deutsche Bank	A-/A3/BBB+	1,327		5		6		(1		)
Morgan Stanley	*/A1/A+	1,648		9		6		3
Barclay's Bank	A+/A2/A	2,205		27		20		7
Canadian Imperial Bank of Commerce	*/Aa2/A+	1,716		11		8		3
Wells Fargo	A+/A2/A-	1,635		17		16		1
Goldman Sachs	A/A3/BBB+	647		3		3		—
Total		$	13,130	$	97	$	59	$	38

(a) An * represents credit ratings that were not available.

XML

Schedule IV - Reinsurance

12 Months Ended

Dec. 31, 2019

SEC Schedule, 12-17, Insurance Companies, Reinsurance [Abstract]

Schedule IV - Reinsurance

Reinsurance

(In millions)

For the year ended December 31, 2019	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Life insurance in force	$	3,631	$	(2,060	)	$	—	$	1,571	—	%
Premiums and other considerations:
Traditional life insurance premiums	204		(164		)	—		40		—	%
Annuity product charges	209		(54		)	—		155		—	%
Total premiums and other considerations	$	413	$	(218	)	$	—	$	195	—	%

For the year ended December 31, 2018	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Life insurance in force	$	3,541	$	(2,111	)	$	1	$	1,431	—	%
Premiums and other considerations:
Traditional life insurance premiums	223		(169		)	—		54		—	%
Annuity product charges	237		(57		)	—		180		—	%
Total premiums and other considerations	$	460	$	(226	)	$	—	$	234	—	%

For the period from December 1 to December 31, 2017	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Life insurance in force	$	3,516	$	(2,163	)	$	1	$	1,354	—	%
Premiums and other considerations:
Traditional life insurance premiums	17		(14		)	—		3		—	%
Annuity product charges	21		(5		)	—		16		—	%
Total premiums and other considerations	$	38	$	(19	)	$	—	$	19	—	%

For the period from October 1 to November 30, 2017	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Predecessor
Life insurance in force	$	3,212	$	(2,031	)	$	—	$	1,181	—	%
Premiums and other considerations:
Traditional life insurance premiums	36		(29		)	—		7		—	%
Annuity product charges	44		(10		)	—		34		—	%
Total premiums and other considerations	$	80	$	(39	)	$	—	$	41	—	%

(Continued)

For the period from October 1 to December 31, 2016 (Unaudited)	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Predecessor
Life insurance in force	$	3,123	$	(2,033	)	$	—	$	1,090	—	%
Premiums and other considerations:
Traditional life insurance premiums	57		(46		)	—		11		—	%
Annuity product charges	54		(16		)	—		38		—	%
Total premiums and other considerations	$	111	$	(62	)	$	—	$	49	—	%

For the year ended September 30, 2017	Gross Amount		Ceded to other companies			Assumed from other companies		Net Amount		Percentage of amount assumed of net
Predecessor
Life insurance in force	$	3,207	$	(2,036	)	$	—	$	1,171	—	%
Premiums and other considerations:
Traditional life insurance premiums	233		(191		)	—		42		—	%
Annuity product charges	229		(64		)	—		165		—	%
Total premiums and other considerations	$	462	$	(255	)	$	—	$	207	—	%

See Report of Independent Registered Public Accounting Firm.

XML

Equity (Tables)

12 Months Ended

Dec. 31, 2019

Equity [Abstract]

Dividends Declared

The Company declared the following cash dividends to its common shareholders during the year ended December 31, 2019:

Date Declared	Date Paid	Date Shareholders of record	Shareholders of record (in thousands)	Cash Dividend declared (per share)	Total cash paid
February 27, 2019	April 1, 2019	March 18, 2019	221,661	$0.01	$2
May 7, 2019	June 10, 2019	May 28, 2019	221,661	$0.01	$2
August 7, 2019	September 9, 2019	August 26, 2019	221,661	$0.01	$2
November 6, 2019	December 9, 2019	November 25, 2019	221,661	$0.01	$2

On February 26, 2020, the Company's Board of Directors declared a quarterly cash dividend of $0.01 per share. The dividend will be paid on March 30, 2020 to shareholders of record as of the close of business on March 16, 2020.

The Company declared the following dividends to its preferred shareholders during the years ended December 31, 2019 and December 31, 2018:

Type of Preferred Share	Date Declared	Date Paid	Date Shareholders of record	Shareholders of record (in thousands)	Method of Payment	Total cash paid	Total shares paid in kind (in thousands)
Series A Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	277	Paid in kind	$—	5
Series B Preferred Shares	March 29, 2018	April 1, 2018	March 15, 2018	101	Paid in kind	$—	1
Series A Preferred Shares	June 29, 2018	July 1, 2018	June 15, 2018	282	Paid in kind	$—	5
Series B Preferred Shares	June 29, 2018	July 1, 2018	June 15, 2018	102	Paid in kind	$—	2
Series A Preferred Shares	September 28, 2018	October 1, 2018	September 15, 2018	287	Paid in kind	$—	5
Series B Preferred Shares	September 28, 2018	October 1, 2018	September 15, 2018	104	Paid in kind	$—	2
Series A Preferred Shares	December 31, 2018	January 1, 2019	December 15, 2018	293	Paid in kind	$—	6
Series B Preferred Shares	December 31, 2018	January 1, 2019	December 15, 2018	106	Paid in kind	$—	2
Series A Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	298	Paid in kind	$—	6
Series B Preferred Shares	March 29, 2019	April 1, 2019	March 15, 2019	108	Paid in kind	$—	2
Series A Preferred Shares	June 28, 2019	July 1, 2019	June 15, 2019	304	Paid in kind	$—	6
Series B Preferred Shares	June 28, 2019	July 1, 2019	June 15, 2019	110	Paid in kind	$—	2
Series A Preferred Shares	September 30, 2019	October 1, 2019	September 15, 2019	310	Paid in kind	$—	6
Series B Preferred Shares	September 30, 2019	October 1, 2019	September 15, 2019	112	Paid in kind	$—	2
Series A Preferred Shares	December 31, 2019	January 1, 2020	December 15, 2019	316	Paid in kind	$—	5
Series B Preferred Shares	December 31, 2019	January 1, 2020	December 15, 2019	114	Paid in kind	$—	3

XML

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended		15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Sep. 30, 2017	Dec. 31, 2018
Statement of Comprehensive Income [Abstract]
Net income (loss)	$ (91)	$ 28	$ 108	$ 507	$ 223	$ 13
Debt and Equity Securities, Unrealized Gain (Loss) [Abstract]
Net change in unrealized gains/losses on investments (net of intangibles and deferred tax asset)	75	12	(286)	1,433	104	(1,020)
Change in reinsurance liabilities held at fair value resulting from a change in the instrument-specific credit risk				(15)		4
Net changes to derive comprehensive income (loss) for the period	75	12	(286)	1,418	104	(1,016)
Comprehensive income (loss), net of tax	$ (16)	$ 40	$ (178)	$ 1,925	$ 327	$ (1,003)

XML

Investments

12 Months Ended

Dec. 31, 2019

Investments, Debt and Equity Securities [Abstract]

Investments

Investments

The Company’s fixed maturity securities investments have been designated as available-for-sale and are carried at fair value with unrealized gains and losses included in AOCI, net of associated adjustments for DAC, VOBA, DSI, UREV, and deferred income taxes. The Company's equity securities investments are carried at fair value with unrealized gains and losses included in net income. The Company’s consolidated investments at December 31, 2019 and December 31, 2018 are summarized as follows:

         

	December 31, 2019
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	5,720	$	51	$	(77	)	$	5,694	$	5,694
Commercial mortgage-backed securities	2,788		140		(6		)	2,922		2,922
Corporates	11,051		618		(72		)	11,597		11,597
Hybrids	983		48		(4		)	1,027		1,027
Municipals	1,284		64		(5		)	1,343		1,343
Residential mortgage-backed securities	917		40		(3		)	954		954
U.S. Government	33		1		—			34		34
Foreign Governments	138		17		—			155		155
Total available-for-sale securities	22,914		979		(167		)	23,726		23,726
Equity securities	1,069		19		(17		)	1,071		1,071
Derivative investments	336		261		(10		)	587		587
Commercial mortgage loans	422		—		—			435		422
Residential mortgage loans	845		—		—			848		845
Other invested assets	1,306		—		(3		)	1,288		1,303
Total investments	$	26,892	$	1,259	$	(197	)	$	27,955	$	27,954

	December 31, 2018
	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value		Carrying Value
Available-for sale securities
Asset-backed securities	$	4,954	$	15	$	(137	)	$	4,832	$	4,832
Commercial mortgage-backed securities	2,568		9		(40		)	2,537		2,537
Corporates	11,213		16		(848		)	10,381		10,381
Hybrids	992		—		(91		)	901		901
Municipals	1,216		3		(32		)	1,187		1,187
Residential mortgage-backed securities	1,027		12		(8		)	1,031		1,031
U.S. Government	120		—		(1		)	119		119
Foreign Governments	129		—		(8		)	121		121
Total available-for-sale securities	22,219		55		(1,165		)	21,109		21,109
Equity securities	1,526		1		(145		)	1,382		1,382
Derivative investments	330		2		(235		)	97		97
Commercial mortgage loans	482		—		—			483		482
Residential mortgage loans	185		—		—			187		185
Other invested assets	662		—		—			651		662
Total investments	$	25,404	$	58	$	(1,545	)	$	23,909	$	23,917

Included in AOCI were cumulative gross unrealized gains of $0 and gross unrealized losses of $0 related to the non-credit portion of other-than-temporary-impairments ("OTTI") on non-agency residential mortgage backed securities ("RMBS") for both December 31, 2019 and December 31, 2018.

Securities held on deposit with various state regulatory authorities had a fair value of $17,591 and $19,930 at December 31, 2019 and December 31, 2018, respectively. Under Iowa regulations, insurance companies are required to hold securities on deposit in an amount no less than the legal reserve.

At December 31, 2019 and December 31, 2018, the Company held no material investments that were non-income producing for a period greater than twelve months.

In accordance with the Company's FHLB agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to the Company for general purposes. The collateral investments had a fair value of $1,472 and $1,401 at December 31, 2019 and December 31, 2018, respectively.

The amortized cost and fair value of fixed maturity available-for-sale securities by contractual maturities, as applicable, are shown below. Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.

	December 31, 2019
	Amortized Cost		Fair Value
Corporates, Non-structured Hybrids, Municipal and Government securities:
Due in one year or less	$	85	$	85
Due after one year through five years	888		914
Due after five years through ten years	2,020		2,082
Due after ten years	10,496		11,075
Subtotal	13,489		14,156
Other securities which provide for periodic payments:
Asset-backed securities	5,720		5,694
Commercial mortgage-backed securities	2,788		2,922
Residential mortgage-backed securities	917		954
Subtotal	9,425		9,570
Total fixed maturity available-for-sale securities	$	22,914	$	23,726

The Company's available-for-sale securities with unrealized losses are reviewed for potential OTTI. For factors considered in evaluating whether a decline in value is other-than-temporary, please refer to “Note 2. Significant Accounting Policies and Practices". Based on the results of our process for evaluating available-for-sale securities in unrealized loss positions for OTTI as discussed above, the Company determined the unrealized losses as of December 31, 2019 decreased due to lower interest rates during the year in conjunction with tighter credit spreads over Treasuries.

The fair value and gross unrealized losses of available-for-sale securities, aggregated by investment category and duration of fair value below amortized cost, were as follows:

	December 31, 2019
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	719	$	(12	)	$	2,453	$	(65	)	$	3,172	$	(77	)
Commercial mortgage-backed securities	232		(4		)	16		(2		)	248		(6		)
Corporates	1,030		(25		)	804		(47		)	1,834		(72		)
Hybrids	23		(1		)	60		(3		)	83		(4		)
Municipals	123		(2		)	60		(3		)	183		(5		)
Residential mortgage-backed securities	41		—			107		(3		)	148		(3		)
U.S. Government	6		—			—		—			6		—
Total available-for-sale securities	$	2,174	$	(44	)	$	3,500	$	(123	)	$	5,674	$	(167	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													290
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													446
Total number of available-for-sale securities in an unrealized loss position													736

	December 31, 2018
	Less than 12 months					12 months or longer					Total
	Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses			Fair Value		Gross Unrealized Losses
Available-for-sale securities
Asset-backed securities	$	2,924	$	(116	)	$	643	$	(21	)	$	3,567	$	(137	)
Commercial mortgage-backed securities	1,466		(34		)	262		(6		)	1,728		(40		)
Corporates	8,016		(772		)	1,465		(76		)	9,481		(848		)
Hybrids	858		(90		)	7		(1		)	865		(91		)
Municipals	850		(27		)	172		(5		)	1,022		(32		)
Residential mortgage-backed securities	139		(3		)	190		(5		)	329		(8		)
U.S. Government	69		—			50		(1		)	119		(1		)
Foreign Government	47		(3		)	68		(5		)	115		(8		)
Total available-for-sale securities	$	14,369	$	(1,045	)	$	2,857	$	(120	)	$	17,226	$	(1,165	)
Total number of available-for-sale securities in an unrealized loss position less than twelve months													1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer													556
Total number of available-for-sale securities in an unrealized loss position													2,107

At December 31, 2019 and December 31, 2018, securities with a fair value of $35 and $132, respectively, had an unrealized loss greater than 20% of amortized cost (excluding U.S. Government and U.S. Government sponsored agency securities), which were insignificant to the carrying value of all investments, respectively.

The following table provides a reconciliation of the beginning and ending balances of the credit loss portion of OTTI on fixed maturity available-for-sale securities held by the Company for the periods presented, for which a portion of the OTTI was recognized in AOCI:

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
							Predecessor		Predecessor		Predecessor
Beginning balance	$	—	$	—	$	—	$	3	$	3	$	3
Increases attributable to credit losses on securities:
OTTI was previously recognized	—		—		—		—		—		—
OTTI was not previously recognized	—		—		—		—		—		—
Ending balance	$	—	$	—	$	—	$	3	$	3	$	3

The following table breaks out the credit impairment loss type, the associated amortized cost and fair value of the investments at the balance sheet date and non-credit losses in relation to fixed maturity securities and other invested assets held by the Company for the periods presented:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Credit impairment losses in operations	$	(21	)	$	(24	)	$	—	$	—	$	(1	)	$	(22	)
Change-of-intent losses in operations	(2		)	—			—		—		—			—
Amortized cost	37			64			—		—		19			—
Fair value	37			64			—		—		19			—
Non-credit losses in other comprehensive income for investments which experienced OTTI	—			—			—		—		(1		)	—

Details of OTTI that were recognized in "Net income (loss)" and included in net realized gains on securities were as follows:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Asset-backed securities	$	—		$	—		$	—	$	—	$	(1	)	$	(2	)
Corporates	(21		)	(24		)	—		—		—			(20		)
Equity security	(2		)	—			—		—		—			—
Total	$	(23	)	$	(24	)	$	—	$	—	$	(1	)	$	(22	)

Mortgage Loans

The Company's mortgage loans are collateralized by commercial and residential properties.

Commercial Mortgage Loans

Commercial mortgage loans ("CMLs") represented approximately 2% of the Company’s total investments as of December 31, 2019 and December 31, 2018, respectively. The Company primarily invests in mortgage loans on income producing properties including hotels, industrial properties, retail buildings, multifamily properties and office buildings. The Company diversifies its CML portfolio by geographic region and property type to reduce concentration risk. The Company continuously evaluates CMLs based on relevant current information to ensure properties are performing at a consistent and acceptable level to secure the related debt. The distribution of CMLs, gross of valuation allowances, by property type and geographic region is reflected in the following tables:

	December 31, 2019				December 31, 2018
	Gross Carrying Value		% of Total		Gross Carrying Value		% of Total
Property Type:
Hotel	21		5	%	21		4	%
Industrial - General	37		9	%	37		8	%
Industrial - Warehouse	20		4	%	20		4	%
Multifamily	54		13	%	56		12	%
Office	143		34	%	147		30	%
Retail	147		35	%	201		42	%
Total commercial mortgage loans, gross of valuation allowance	$	422	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	422			$	482
U.S. Region:
East North Central	$	64	15	%	$	98	20	%
East South Central	19		5	%	19		4	%
Middle Atlantic	77		18	%	79		17	%
Mountain	51		12	%	65		13	%
New England	4		1	%	10		2	%
Pacific	113		27	%	116		24	%
South Atlantic	56		13	%	57		12	%
West North Central	13		3	%	13		3	%
West South Central	25		6	%	25		5	%
Total commercial mortgage loans, gross of valuation allowance	$	422	100	%	$	482	100	%
Allowance for loan loss	—				—
Total commercial mortgage loans	$	422			$	482

All of the Company's investments in CMLs had a loan-to-value ("LTV") ratio of less than 75% at December 31, 2019 and December 31, 2018, as measured at inception of the loans unless otherwise updated. As of December 31, 2019, all CMLs are current and have not experienced credit or other events which would require the recording of an impairment loss.

LTV and DSC ratios are measures commonly used to assess the risk and quality of mortgage loans. The LTV ratio is expressed as a percentage of the amount of the loan relative to the value of the underlying property. A LTV ratio in excess of 100% indicates the unpaid loan amount exceeds the underlying collateral. The DSC ratio, based upon the most recently received financial statements, is expressed as a percentage of the amount of a property’s net income to its debt service payments. A DSC ratio of less than 1.00 indicates that a property’s operations do not generate sufficient income to cover debt payments. We normalize our DSC ratios to a 25-year amortization period for purposes of our general loan allowance evaluation.

The following table presents the recorded investment in CMLs by LTV and DSC ratio categories and estimated fair value by the indicated loan-to-value ratios at December 31, 2019 and December 31, 2018:

	Debt-Service Coverage Ratios				Total Amount		% of Total		Estimated Fair Value		% of Total
	>1.25		1.00 - 1.25
December 31, 2019
LTV Ratios:
Less than 50%	$	346	$	6	$	352	83	%	$	363	83	%
50% to 60%	70		—		70		17	%	72		17	%
Commercial mortgage loans	$	416	$	6	$	422	100	%	$	435	100	%
December 31, 2018
LTV Ratios:
Less than 50%	$	296	$	6	$	302	63	%	$	302	63	%
50% to 60%	169		—		169		35	%	170		35	%
60% to 75%	11		—		11		2	%	11		2	%
Commercial mortgage loans	$	476	$	6	$	482	100	%	$	483	100	%

The Company establishes a general mortgage loan allowance based upon the underlying risk and quality of the mortgage loan portfolio using the DSC ratio and LTV ratio. The Company believes that the LTV ratio is an indicator of the principal recovery risk for loans that default. A higher LTV ratio will result in a higher allowance. The Company believes that the DSC ratio is an indicator of default risk on loans. A higher DSC ratio will result in a lower allowance.

The Company recognizes a mortgage loan as delinquent when payments on the loan are greater than 30 days past due. At December 31, 2019 and December 31, 2018, the Company had no CMLs that were delinquent in principal or interest payments.

Mortgage loan workouts, refinances or restructures that are classified as debt restructurings ("TDRs") are individually evaluated and measured for impairment. As of December 31, 2019 and December 31, 2018, our CML portfolio had no impairments, modifications or TDRs.

Residential Mortgage Loans

Residential mortgage loans ("RMLs") represented approximately 3% and 1% of the Company’s total investments as of December 31, 2019 and December 31, 2018, respectively. The Company's residential mortgage loans are closed end, amortizing loans and 100% of the properties are located in the United States. The Company diversifies its RML portfolio by state to reduce concentration risk. The distribution of RMLs by state with highest-to-lowest concentration is reflected in the following tables at December 31, 2019 and December 31, 2018:

	December 31, 2019
US State:	Unpaid Principal Balance		% of Total
California	$	167	20	%
Florida	141		17	%
New Jersey	76		9	%
All Other States (a)	447		54	%
Total mortgage loans	$	831	100	%

(a) The individual concentration of each state is less than 9%.

	December 31, 2018
US State:		Unpaid Principal Balance		% of Total
Florida		$	25	14	%
Illinois		24		13	%
New Jersey		17		9	%
All Other States (a)		114		64	%
Total mortgage loans		$	180	100	%

(a) The individual concentration of each state is less than 9%.

Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines non-performing residential mortgage loans as those that are 90 or more days past due or in nonaccrual status which is assessed monthly. The credit quality of RMLs as at December 31, 2019 and December 31, 2018 were as follows:

	December 31, 2019				December 31, 2018
Performance indicator:	Carrying Value		% of Total		Carrying Value		% of Total
Performing	$	843	100	%	$	185	100	%
Non-performing	2		—	%	—		—	%
Total residential mortgage loans, gross of valuation allowance	$	845	100	%	$	185	100	%
Allowance for loan loss	—		—	%	—		—	%
Total residential mortgage loans	$	845	100	%	$	185	100	%

Net Investment Income

The major sources of “Net investment income” on the accompanying Consolidated Statements of Operations were as follows:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Fixed maturity securities, available-for-sale	$	1,054		$	1,009		$	80		$	164		$	228		$	953
Equity securities	73			73			6			5			10			41
Mortgage loans	42			24			2			4			6			23
Invested cash and short-term investments	18			16			1			1			—			3
Funds withheld	65			28			2			—			—			—
Limited partnerships	81			17			1			3			1			5
Other investments	12			10			1			1			—			2
Gross investment income	1,345			1,177			93			178			245			1,027
Investment expense	(116		)	(70		)	(1		)	(4		)	(5		)	(22		)
Net investment income	$	1,229		$	1,107		$	92		$	174		$	240		$	1,005

Net Investment Gains (Losses)

Details underlying “Net investment gains (losses)” reported on the accompanying Consolidated Statements of Operations were as follows:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Net realized gains (losses) on fixed maturity available-for-sale securities	$	46		$	(187	)	$	5	$	5	$	2		$	(20	)
Net realized/unrealized gains (losses) on equity securities	127			(142		)	—		1		—			3
Realized gains (losses) on other invested assets	3			(5		)	—		—		(2		)	(2		)
Derivatives and embedded derivatives:
Realized gains (losses) on certain derivative instruments	(15		)	(2		)	3		80		1			219
Unrealized gains (losses) on certain derivative instruments	449			(248		)	34		58		38			129
Change in fair value of funds withheld for reinsurance receivables and reinsurance related embedded derivatives (a)	57			(42		)	—		1		12			(16		)
Change in fair value of other derivatives and embedded derivatives	7			(3		)	—		1		—			3
Realized gains (losses) on derivatives and embedded derivatives	498			(295		)	37		140		51			335
Net investment gains (losses)	$	674		$	(629	)	$	42	$	146	$	51		$	316

(a) Change in fair value of reinsurance related embedded derivatives starting December 1, 2017 and after is due to F&G Re and FSRC unaffiliated third party business under the fair value option election. Starting January 1, 2019, the balance also includes activity related to the FGL Insurance and Kubera reinsurance treaty. The predecessor periods activity is due to the FGL Insurance and FSRC reinsurance treaty. See "Note 13. Reinsurance".

The proceeds from the sale of fixed-maturity available for-sale-securities and the gross gains and losses associated with those transactions were as follows:

	Year ended													Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
									Predecessor		Predecessor			Predecessor
Proceeds	$	2,848		$	6,260		$	125	$	151	$	97		$	703
Gross gains	91			12			—		6		2			25
Gross losses	(27		)	(171		)	—		—		(2		)	(20		)

Variable Interest Entities

FGL Insurance owns investments in VIEs that are not consolidated within the Company’s financial statements, and one investment in a VIE that is consolidated within the Company’s financial statements.  VIEs do not have sufficient equity to finance their own activities without additional financial support and certain of its investors lack certain characteristics of a controlling financial interest. VIE’s are consolidated by their ‘primary beneficiary’, a designation given to an entity that receives both the benefits from the VIE as well as the substantive power to make its key economic decisions. While FGL Insurance participates in the benefits from VIEs in which it invests, but does not consolidate, the substantive power to make the key economic decisions for each respective VIE resides with entities not under common control with FGL Insurance. It is for this reason that FGL Insurance is not considered the primary beneficiary for the VIE investments that are not consolidated.

The Company has concluded it is the primary beneficiary of BISA Co-Invest Fund II L.P (“Co-Invest II”). The primary beneficiary conclusion was drawn given the fact that substantially all of Co-Invest II’s activities are

conducted on behalf of the Company, its sole investor and limited partner. As the Company is considered the primary beneficiary, Co-Invest II is consolidated within the Company’s financial statements. As of December 31, 2019, the Company has $22 of net assets recorded related to Co-Invest II.

The Company previously executed a commitment of $83 to purchase common shares in an unaffiliated private business development company ("BDC"). The BDC invests in secured and unsecured fixed maturity and equity securities of middle market companies in the United States. Due to the voting structure of the transaction, the Company does not have voting power.  The initial capital call occurred June 30, 2015, with the remaining commitment expected to fund June 2020. The Company has funded $69 as of December 31, 2019.

The Company invests in various limited partnerships as a passive investor. These investments are in credit funds with a bias towards current income, real assets, or private equity. Limited partnership interests are accounted for under the equity method and are included in “Other invested assets” on the Company’s consolidated balance sheet. The Company's maximum exposure to loss with respect to these investments is limited to the investment carrying amounts reported in the Company's consolidated balance sheet in addition to any required unfunded commitments. As of December 31, 2019 and December 31, 2018, the Company's maximum exposure to loss was $1,010 and $510 in recorded carrying value, respectively, and $1,202 and $1,132 in unfunded commitments, respectively.

XML

Debt

12 Months Ended

Dec. 31, 2019

Debt Disclosure [Abstract]

Debt

Debt

On November 30, 2017, FGLH and CF Bermuda, together as borrowers and each as a borrower, entered into a credit agreement with certain financial institutions party thereto, as lenders, and Royal Bank of Canada, as administrative agent and letter of credit issuer, which provides for a $250 senior unsecured revolving credit facility with a maturity of three years (the “Credit Agreement”). Various financing options are available within the Credit Agreement, including overnight and term based borrowing.  In each case, a margin is ascribed based on the Debt to Capitalization ratio of CF Bermuda. The loan proceeds from the Credit Agreement may be used for working capital and general corporate purposes.

On April 20, 2018, FGLH completed a debt offering of $550 aggregate principal amount of 5.50% senior notes due 2025, issued at 99.5% for proceeds of $547. The Company used the net proceeds of the offering (i) to repay $135 of borrowings under its revolving credit facility and related expenses and (ii) to redeem in full and satisfy and discharge all of the outstanding $300 aggregate principal amount of FGLH's outstanding 6.375% Senior Notes due 2021. The remaining proceeds of the offering were used for general corporate purposes, including additional capital contributions to the Company's insurance subsidiaries. This exchange of debt instruments constituted an extinguishment. As a result, the Company recognized a $2 gain on the extinguishment of the 6.375% Senior Notes.

The Company capitalized $7 of debt issuance costs in connection with the 5.50% Senior Notes offering, which are classified as an offset within the "Debt" line on the Company's Consolidated Balance Sheets, and are being amortized from the date of issue to the redemption date using the straight-line method.

The carrying amount of the Company's outstanding debt as of December 31, 2019 and December 31, 2018 is as follows:

	December 31, 2019		December 31, 2018
Debt	$	542	$	541
Revolving credit facility	—		—

Interest rates on the revolving credit facility were equal to 4.55% and 5.27% as of December 31, 2019 and December 31, 2018, respectively. As of December 31, 2019 and December 31, 2018, the amount available to be drawn on the revolver was $250.

The interest expense and amortization of debt issuance costs for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, were as follows:

	Year ended									Period from December 1 to December 31, 2017
	December 31, 2019				December 31, 2018
	Interest Expense		Amortization		Interest Expense			Amortization		Interest Expense		Amortization
Debt	$	30	$	2	$	28		$	1	$	2	$	—
Revolving credit facility	—		—		2			—		—		—
Gain on extinguishment of debt	—		—		(2		)	—		—		—

The interest expense and amortization of debt issuance costs for the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, were not material.

XML

Investments - Proceeds From The Sale of Fixed-maturity available for-sale-securities - Available-for-sale Securities - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Debt Securities, Available-for-sale [Line Items]
Proceeds	$ 313	$ 626	$ 733	$ 4,506		$ 2,755	$ 8,265
Total fixed maturities
Debt Securities, Available-for-sale [Line Items]
Proceeds	125	151	97	2,848	$ 6,260	703
Gross gains	0	6	2	91	12	25
Gross losses	$ 0	$ 0	$ (2)	$ (27)	$ (171)	$ (20)

XML

Related Party Transactions

12 Months Ended

Dec. 31, 2019

Related Party Transactions [Abstract]

Related Party Transactions

Related Party Transactions

Affiliated Investments

The Company has determined that related parties would fall into the following categories; (i) affiliates of the entity, (ii) entities for which investments in their equity securities would be required to be accounted for by the equity method by the investing entity, (iii) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management, (iv) principal owners (>10% equity stake) of the entity and members of their immediate families, (v) management (including BOD, CEO, and other persons responsible for achieving the objectives of the entity and who have the authority to establish policies and make decisions) of the entity and other members of their immediate families, (vi) other parties with which the entity may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests (vii) other parties that can significantly influence management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate business, (viii) attorney in fact of a reciprocal reporting entity or any affiliate of the attorney in fact, and (ix) a U.S. manager of a U.S. branch or any affiliate of the U.S. manager of a U.S. branch. The Company has determined that for the years ended December 31, 2019 and December 31, 2018, the Blackstone Group LP ("Blackstone") and its affiliates as well as the FGL Holdings’ directors and officers (along with their immediate family members) are FGL Holdings' related parties.

FGL Insurance, and certain subsidiaries of the Company, entered into investment management agreements (“IMAs”) with Blackstone ISG-I Advisors LLC (“BISGA”), a wholly-owned subsidiary of Blackstone on December 1, 2017. On December 31, 2019, to be effective as of October 31, 2019, FGL Insurance and certain subsidiaries of the Company entered into amended and restated IMAs (the “Restated IMAs”) with BISGA, pursuant to which BISGA was appointed as investment manager of the Company’s general accounts (the “F&G Accounts”). Pursuant to the terms of the IMAs, BISGA may delegate any or all of its discretionary investment, advisory and other rights, powers, functions and obligations under the IMAs to one or more sub-managers, including its affiliates. BISGA delegated certain investment services to its affiliates, Blackstone Real Estate Special Situations Advisors L.L.C. (“BRESSA”) and GSO Capital Advisors II LLC (“GSO Capital Advisors”), pursuant to sub-management agreements executed between BISGA and each of BRESSA and GSO Capital Advisors. For the year ended December 31, 2019, the fees paid to BISGA under the Restated IMAs and the IMAs were approximately $95. As of December 31, 2019 and 2018, the Company has a net liability of $47 and $20, respectively, for the services consumed under the Restated IMAs, the IMAs and related sub-management agreements, partially offset by fees received and expense reimbursements from BISGA.

During the years ended December 31, 2019 and December 31, 2018, the Company received expense reimbursements from BISGA for the services consumed under these agreements. Fees received for these types of services are $10 and $9 for years ended December 31, 2019 and December 31, 2018.

The Company holds certain fixed income security interests, limited partnerships and bank loans issued by portfolio companies that are affiliates of Blackstone Tactical Opportunities, an affiliate of Blackstone Tactical Opportunities LR Associates-B (Cayman) Ltd (the “Blackstone Fixed Income Securities”) both on a direct and indirect basis.  Indirect investments include an investment made in an affiliates’ asset backed fund while direct investments are an investment in affiliates' equity or debt securities.  As of December 31, 2019 and December 31, 2018, the Company held $2,001 and $1,461 in affiliated investments, respectively, which includes foreign exchange unrealized loss of $(3) and $(2), respectively. As of December 31, 2019 and December 31, 2018, the Company had unfunded commitments relating to affiliated investments of $993 and $990, respectively.

The Company purchased $89 and $185 of residential loans from Finance of America Holdings LLC, a Blackstone affiliate, during the year ended December 31, 2019 and on December 17, 2018, respectively. 

The Company earned $112, $33 and $1 net investment income for the years ended December 31, 2019 and December 31, 2018, and the period from December 1, 2017 to December 31, 2017, respectively, on affiliated investments. The Company had no gross realized gains (losses) and realized impairment losses on related party investments during the years ended December 31, 2019 and December 31, 2018 and the period from December 1, 2017 to December 31, 2017.

XML

Quarterly Results (Unaudited)

12 Months Ended

Dec. 31, 2019

Quarterly Financial Information Disclosure [Abstract]

Quarterly Results (Unaudited)

Quarterly Results (Unaudited)

Unaudited quarterly results of operations are summarized below.

	Quarter ended
	December 31, 2019		September 30, 2019		June 30, 2019		March 31, 2019
	(Dollars in millions, except per share data)
Premiums	$	7	$	9	$	8	$	16
Net investment income	324		301		315		289
Net investment gains (losses)	196		103		135		240
Insurance and investment product fees and other	36		42		37		55
Total revenues	563		455		495		600
Total benefits and expenses	282		391		428		412
Net income (loss)	225		65		46		171
Net income (loss) per common share - basic	1.02		0.26		0.17		0.74
Net income (loss) per common share - diluted	1.02		0.26		0.17		0.74

	Quarter ended
	December 31, 2018			September 30, 2018		June 30, 2018			March 31, 2018
	(Dollars in millions, except per share data)
Premiums	$	9		$	12	$	15		$	18
Net investment income	295			267		282			263
Net investment gains (losses)	(555		)	119		(2		)	(191		)
Insurance and investment product fees and other	40			46		45			48
Total revenues	(211		)	444		340			138
Total expenses	(20		)	365		280			28
Net income (loss)	(148		)	56		40			65
Net income (loss) per common share - basic	(0.70		)	0.23		0.15			0.27
Net income (loss) per common share - diluted	(0.70		)	0.23		0.15			0.27

XML

Other Liabilities (Tables)

12 Months Ended

Dec. 31, 2019

Other Liabilities Disclosure [Abstract]

Schedule Other Liabilities

Other liabilities consisted of the following:

	December 31, 2019		December 31, 2018
Amounts payable for investment purchases	$	11	$	39
Retained asset account	141		162
Option collateral liabilities	446		59
Remittances and items not allocated	119		101
Accrued expenses	116		72
Deferred reinsurance revenue	17		39
Unearned revenue liability	43		41
Preferred shares reimbursement feature embedded derivative	17		29
Negative cash liability	69		126
Commissions payable	13		9
Funds withheld embedded derivative	33		—
Rabbi trust investment	36		26
Other	47		(3		)
Total	$	1,108	$	700

XML

Schedule III - Supplementary Insurance Information (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
SEC Schedule, 12-16, Insurance Companies, Supplementary Insurance Information [Abstract]
Deferred acquisition costs	$ 22	$ 1,140	$ 697	$ 630	$ 344	$ 1,129
Future policy benefits, losses, claims and loss expenses	4,751	3,401	3,453	5,735	4,641	3,412
Other policy claims and benefits payable	78	69	53	71	64	67
Premium revenue	3	7	11	40	54	42
Net investment income	92	174	240	1,229	1,107	1,005
Benefits, claims, losses and settlement expenses	(124)	(227)	(20)	(1,057)	(423)	(843)
Amortization, interest, and unlocking of deferred acquisition costs	(1)	(33)	(100)	(19)	0	(171)
Acquisition and operating expenses, net of deferrals	$ (16)	$ (51)	$ (28)	$ (330)	$ (181)	$ (137)

XML

Reinsurance (Tables)

12 Months Ended

Dec. 31, 2019

Reinsurance Disclosures [Abstract]

Effect of Reinsurance on Premiums Earned, Benefits Incurred and Reserve Changes

The effect of reinsurance on net premiums earned and net benefits incurred (benefits incurred and reserve changes) for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017 were as follows:

	Year ended												Period from December 1 to December 31, 2017
	December 31, 2019						December 31, 2018
	Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred
Direct	$	204		$	1,277		$	223		$	646		$	17		$	142
Assumed	—			(19		)	—			(13		)	—			7
Ceded	(164		)	(201		)	(169		)	(210		)	(14		)	(25		)
Net	$	40		$	1,057		$	54		$	423		$	3		$	124

	Period from October 1 to November 30, 2017						Period from October 1 to December 31, 2016 (Unaudited)						Year ended
													September 30, 2017
	Predecessor						Predecessor						Predecessor
	Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred			Net Premiums Earned			Net Benefits Incurred
Direct	$	36		$	267		$	57		$	69		$	233		$	1,097
Assumed	—			—			—			—			—			—
Ceded	(29		)	(40		)	(46		)	(49		)	(191		)	(254		)
Net	$	7		$	227		$	11		$	20		$	42		$	843

XML

Schedule I - Summary of Investments (Details) $ in Millions	Dec. 31, 2019 USD ($)
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	$ 26,892
Fair Value	27,955
Amount at which shown on the balance sheet	27,954
United States Government and government agencies and authorities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	166
Fair Value	168
Amount at which shown on the balance sheet	168
States, municipalities and political subdivisions
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	1,284
Fair Value	1,343
Amount at which shown on the balance sheet	1,343
Foreign governments
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	138
Fair Value	155
Amount at which shown on the balance sheet	155
Public utilities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	2,345
Fair Value	2,453
Amount at which shown on the balance sheet	2,453
All other corporate bonds
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	18,981
Fair Value	19,607
Amount at which shown on the balance sheet	19,607
Total fixed maturities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	22,914
Fair Value	23,726
Amount at which shown on the balance sheet	23,726
Banks, trust, and insurance companies
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	70
Fair Value	68
Amount at which shown on the balance sheet	68
Industrial, miscellaneous and all other
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	2
Fair Value	2
Amount at which shown on the balance sheet	2
Nonredeemable preferred stock
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	997
Fair Value	1,001
Amount at which shown on the balance sheet	1,001
Total equity securities
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	1,069
Fair Value	1,071
Amount at which shown on the balance sheet	1,071
Derivative investments
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	336
Fair Value	587
Amount at which shown on the balance sheet	587
Mortgage loans
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	1,267
Fair Value	1,283
Amount at which shown on the balance sheet	1,267
Other long-term investments
SEC Schedule, 12-15, Insurance Companies, Summary of Investments, Other than Investments in Related Parties [Line Items]
Amortized Cost	1,306
Fair Value	1,288
Amount at which shown on the balance sheet	$ 1,303

XML

Insurance Subsidiary Financial Information and Regulatory Matters - Statutory Income and Net Capital (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Statutory Accounting Practices [Line Items]
Statutory capital and surplus	$ 87	$ 94
IOWA
Statutory Accounting Practices [Line Items]
Statutory net income	152	(151)
Statutory capital and surplus	1,513	1,545
NEW YORK
Statutory Accounting Practices [Line Items]
Statutory net income	(1)	(3)
Statutory capital and surplus	95	85
BERMUDA
Statutory Accounting Practices [Line Items]
Statutory net income	3	319
Statutory capital and surplus	2	2
FSRC
Statutory Accounting Practices [Line Items]
Statutory net income	(29)	(29)
Statutory capital and surplus	73	73
F&G Re [Member]
Statutory Accounting Practices [Line Items]
Statutory net income	69	(14)
Statutory capital and surplus	$ 295	$ 38

XML

Investments - Schedule of Residential Mortgage Loan Investment (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Loans Receivable, Gross, Residential, Mortgage		$ 482
Residential Mortgage
Residential Mortgage Receivable, Percentage of Total	3.00%	1.00%
California
Loans Receivable, Gross, Residential, Mortgage	$ 167	$ 25
Residential Mortgage Receivable, Percentage of Total	20.00%	14.00%
Florida
Loans Receivable, Gross, Residential, Mortgage	$ 141	$ 24
Residential Mortgage Receivable, Percentage of Total	17.00%	13.00%
New Jersey
Loans Receivable, Gross, Residential, Mortgage	$ 76	$ 17
Residential Mortgage Receivable, Percentage of Total	9.00%	9.00%
All Other States
Loans Receivable, Gross, Residential, Mortgage	$ 447	$ 114
Residential Mortgage Receivable, Percentage of Total	54.00%	64.00%
Total Mortgage Loans
Loans Receivable, Gross, Residential, Mortgage	$ 831	$ 180
Residential Portfolio Segment
Loans Receivable, Gross, Residential, Mortgage	845	185
Loans and Leases Receivable, Allowance	$ 0	$ 0
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Performing
Loans Receivable, Gross, Residential, Mortgage	$ 843	$ 185
Residential Mortgage Receivable, Percentage of Total	100.00%	100.00%
Non-performing
Loans Receivable, Gross, Residential, Mortgage	$ 2	$ 0
Residential Mortgage Receivable, Percentage of Total	0.00%	0.00%

XML

Income Taxes - Schedule of Income Before Income Tax (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Tax Credit Carryforward [Line Items]
United States	$ (55)	$ 44	$ 163	$ 467	$ (271)	$ 333
Outside the United States	74	0	0	101	300	0
Income (loss) before income taxes	$ 19	$ 44	$ 163	$ 568	$ 29	$ 333	$ 29

XML

Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Deferred tax assets:
Net operating loss, credit and capital loss carryforwards	$ 35,000,000	$ 94,000,000
Insurance reserves and claim related adjustments	716,000,000	620,000,000
Unrealized Investment Losses	0	201,000,000
Derivatives	0	36,000,000
Deferred acquisition costs	0	0
Deferred Tax Assets, Funds Held under Reinsurance Agreements	11,000,000	0
Funds withheld for reinsurance liabilities	831,000,000	722,000,000
Other	37,000,000	30,000,000
Valuation allowance	(14,000,000)	(154,000,000)	$ (15,000,000)
Total deferred tax assets	785,000,000	827,000,000
Deferred tax liabilities:
Value of business acquired	(124,000,000)	(181,000,000)
Unrealized Investment Gains	(221,000,000)	0
Investments	(121,000,000)	(133,000,000)
Derivatives	(45,000,000)	0
Deferred acquisition costs	(139,000,000)	(76,000,000)
Transition reserve on new reserve method	(63,000,000)	(75,000,000)
Funds held under Reinsurance Agreements	0	(11,000,000)
Other	(11,000,000)	(8,000,000)
Total deferred tax liabilities	(724,000,000)	(484,000,000)
Net deferred tax assets and (liabilities)	$ 61,000,000
Net deferred tax assets and (liabilities)		$ (343,000,000)

XML

Derivative Financial Instruments - Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Derivative [Line Items]
Total asset derivatives	$ 611	$ 111
Total liability derivatives	3,284	2,505
Other Liabilities
Derivative [Line Items]
Total liability derivatives	33	0
Funds withheld
Derivative [Line Items]
Total asset derivatives	3	0
Call options | Derivative investments
Derivative [Line Items]
Total asset derivatives	587	97
Futures contracts | Derivative investments
Derivative [Line Items]
Total asset derivatives	0	0
Other derivatives and embedded derivatives | Other invested assets
Derivative [Line Items]
Total asset derivatives	21	14
FIA embedded derivative | Contractholder funds
Derivative [Line Items]
Total liability derivatives	3,235	2,476
Preferred shares reimbursement feature embedded derivative | Other Liabilities
Derivative [Line Items]
Total liability derivatives	$ 16	$ 29

XML

Fair Value of Financial Instruments - Assets and Liabilities Carrying at Fair Value Measured on a Recurring Basis (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 01, 2017
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 23,726	$ 21,109
Derivative investments	587	97
Total financial assets at fair value	2,811	2,466
Funds withheld for reinsurance receivables, at fair value	2,172	757
Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	969	571
FHLB Common Stock, Fair Value	0	0
Equity securities	387	454
Derivative investments	0	0
Other invested assets		0
Total financial assets at fair value	1,997	1,581
Commercial mortgage loans	0	0
Investments, Residential Mortgage Loans, Fair Value Disclosure	0
Residential mortgage loans	0	0
Bank Owned Life Insurance	0
Investments, Affiliated Bank Loan, Fair Value Disclosure	0
Funds withheld for reinsurance receivables, at fair value	0
Total assets carried on balance sheet at amounts other than fair value	0	0
Total liabilities carried on balance sheet at amounts other than fair value	0	0
Liabilities Related to Investment Contracts, Fair Value Disclosure	0	0
Debt Instrument, Fair Value Disclosure	0	0
Financial Liabilities Fair Value Disclosure	0	0
Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
FHLB Common Stock, Fair Value	62	52
Equity securities	614	874
Derivative investments	587	97
Other invested assets		0
Total financial assets at fair value	23,693	19,858
Commercial mortgage loans	0	0
Investments, Residential Mortgage Loans, Fair Value Disclosure	0
Residential mortgage loans	0	0
Bank Owned Life Insurance	0
Investments, Affiliated Bank Loan, Fair Value Disclosure	0
Funds withheld for reinsurance receivables, at fair value	0
Total assets carried on balance sheet at amounts other than fair value	62	52
Total liabilities carried on balance sheet at amounts other than fair value	578	520
Liabilities Related to Investment Contracts, Fair Value Disclosure	0	0
Debt Instrument, Fair Value Disclosure	578	520
Financial Liabilities Fair Value Disclosure	33	0
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	0	0
FHLB Common Stock, Fair Value	0	0
Equity securities	1	4
Derivative investments	0	0
Other invested assets		39
Total financial assets at fair value	2,811	2,466
Commercial mortgage loans	435	483
Investments, Residential Mortgage Loans, Fair Value Disclosure	848
Residential mortgage loans	14	187
Bank Owned Life Insurance	129
Investments, Affiliated Bank Loan, Fair Value Disclosure	28
Funds withheld for reinsurance receivables, at fair value	1
Total assets carried on balance sheet at amounts other than fair value	1,455	720
Total liabilities carried on balance sheet at amounts other than fair value	19,285	18,358
Liabilities Related to Investment Contracts, Fair Value Disclosure	19,285	18,358
Debt Instrument, Fair Value Disclosure	0	0
Financial Liabilities Fair Value Disclosure	5,204	3,230
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	969	571
FHLB Common Stock, Fair Value	62	52
Equity securities	1,002	1,332
Derivative investments	587	97
Other invested assets		39
Total financial assets at fair value	28,501	23,905
Commercial mortgage loans	435	483
Investments, Residential Mortgage Loans, Fair Value Disclosure	848
Residential mortgage loans	14	187
Bank Owned Life Insurance	129
Investments, Affiliated Bank Loan, Fair Value Disclosure	28
Funds withheld for reinsurance receivables, at fair value	1
Total assets carried on balance sheet at amounts other than fair value	1,517	772
Total liabilities carried on balance sheet at amounts other than fair value	19,863	18,878
Liabilities Related to Investment Contracts, Fair Value Disclosure	19,285	18,358
Debt Instrument, Fair Value Disclosure	578	520
Financial Liabilities Fair Value Disclosure	5,237	3,230
Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	969	571
FHLB Common Stock, Fair Value	62	52
Equity securities	1,002	1,332
Derivative investments	587	97
Other invested assets		39
Total financial assets at fair value	28,501	23,905
Commercial mortgage loans	422	482
Investments, Residential Mortgage Loans, Fair Value Disclosure	845
Residential mortgage loans	28	185
Bank Owned Life Insurance	129
Investments, Affiliated Bank Loan, Fair Value Disclosure	28
Funds withheld for reinsurance receivables, at fair value	1
Total assets carried on balance sheet at amounts other than fair value	1,515	780
Total liabilities carried on balance sheet at amounts other than fair value	22,991	21,452
Liabilities Related to Investment Contracts, Fair Value Disclosure	22,449	20,911
Debt Instrument, Fair Value Disclosure	542	541
Financial Liabilities Fair Value Disclosure	5,237	3,230
Reinsurance related embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Reinsurance related embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	33
Reinsurance related embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Reinsurance related embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	33
Reinsurance related embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	33
Fixed indexed annuities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Fixed indexed annuities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Fixed indexed annuities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,235	2,476
Fixed indexed annuities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,235	2,476
Fixed indexed annuities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	3,235	2,476
Future Policy Benefits | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Future Policy Benefits | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Future Policy Benefits | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,953	725
Future Policy Benefits | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,953	725
Future Policy Benefits | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,953	725
Preferred shares reimbursement feature embedded derivative | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Preferred shares reimbursement feature embedded derivative | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Preferred shares reimbursement feature embedded derivative | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	16	29
Preferred shares reimbursement feature embedded derivative | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	16	29	$ 23	$ 23
Preferred shares reimbursement feature embedded derivative | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	16	29
Asset-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	5,694	4,832
Asset-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Asset-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	4,866	4,388
Asset-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	828	444
Asset-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	5,694	4,832
Asset-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	5,694	4,832
Commercial mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,922	2,537
Commercial mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Commercial mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,895	2,470
Commercial mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	27	67
Commercial mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,922	2,537
Commercial mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,922	2,537
Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	11,597	10,381
Corporates | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Corporates | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10,305	9,150
Corporates | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,292	1,231
Corporates | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	11,597	10,381
Corporates | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	11,597	10,381
Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,027	901
Hybrids | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	299	265
Hybrids | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	718	626
Hybrids | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	10	10
Hybrids | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,027	901
Hybrids | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,027	901
States, municipalities and political subdivisions | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
States, municipalities and political subdivisions | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,301	1,150
States, municipalities and political subdivisions | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	42	37
States, municipalities and political subdivisions | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,343	1,187
States, municipalities and political subdivisions | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,343	1,187
Residential mortgage-backed securities
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	954	1,031
Residential mortgage-backed securities | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Residential mortgage-backed securities | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	408	417
Residential mortgage-backed securities | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	546	614
Residential mortgage-backed securities | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	954	1,031
Residential mortgage-backed securities | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	954	1,031
U.S. Government
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	34	119
U.S. Government | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	28	114
U.S. Government | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	6	5
U.S. Government | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
U.S. Government | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	34	119
U.S. Government | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	34	119
Debt Security, Government, Non-US
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	155	121
Debt Security, Government, Non-US | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0	0
Debt Security, Government, Non-US | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	137	105
Debt Security, Government, Non-US | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	18	16
Debt Security, Government, Non-US | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	155	121
Debt Security, Government, Non-US | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	155	121
Other invested assets | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	0
Other invested assets | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	46
Other invested assets | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	46
Other invested assets | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	46
Reinsurance Receivables, Funds Withheld | Level 1
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	314	177
Reinsurance Receivables, Funds Withheld | Level 2
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1,856	576
Reinsurance Receivables, Funds Withheld | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	1	4
Reinsurance Receivables, Funds Withheld | Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	2,171	757
Reinsurance Receivables, Funds Withheld | Carrying Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	$ 2,171	757
Income Approach Valuation Technique | Corporates
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets at fair value		654
Income Approach Valuation Technique | Hybrids
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total financial assets at fair value		$ 10

XML

Reinsurance - Narrative (Details)							1 Months Ended	2 Months Ended	3 Months Ended	6 Months Ended	12 Months Ended
	Jun. 30, 2019 USD ($)	Dec. 31, 2018 USD ($)	Oct. 01, 2018 USD ($)	Dec. 01, 2017	Sep. 17, 2014	Dec. 31, 2012	Dec. 31, 2017 USD ($)	Nov. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)	Jun. 30, 2019 USD ($)	Dec. 31, 2019 USD ($) policy	Dec. 31, 2018 USD ($)	Sep. 30, 2017 USD ($)	Apr. 01, 2019 USD ($)	Jan. 01, 2019 USD ($)	Oct. 01, 2012 USD ($)
Ceded Credit Risk [Line Items]
Ceded							$ 19,000,000	$ 39,000,000	$ 62,000,000		$ 218,000,000	$ 226,000,000	$ 255,000,000
Proceeds from Equity Method Investment, Distribution, Return of Capital			$ 750,000,000
Reinsurance Risk Charge Fee							$ 2,000,000	$ 2,000,000			$ 17,000,000	11,000,000	$ 4,000,000
Number of policies reinsured by foreign company not engaged in insurance | policy											0
Statutory capital and surplus		$ 94,000,000									$ 87,000,000	94,000,000
Funds withheld for reinsurance receivables, at fair value		757,000,000									2,172,000,000	757,000,000
Funds withheld for reinsurance liabilities		722,000,000									831,000,000	722,000,000
CF Bermuda Holdings Limited [Member]
Ceded Credit Risk [Line Items]
Extraordinary Dividend			1,094,000,000
FGL Insurance [Member]
Ceded Credit Risk [Line Items]
Extraordinary Dividend			$ 830,000,000
Nomura | Letter of Credit
Ceded Credit Risk [Line Items]
Maximum borrowing capacity															$ 100,000,000	$ 295,000,000
Raven Re
Ceded Credit Risk [Line Items]
Statutory capital and surplus		20,000,000									33,000,000	20,000,000
Life and Annuity Insurance Product Line
Ceded Credit Risk [Line Items]
Reinsurance Retention Policy, Excess Retention, Amount Reinsured	$ 185,000,000	758,000,000
Fixed indexed annuities
Ceded Credit Risk [Line Items]
Reinsurance Retention Policy, Excess Retention, Amount Reinsured		4,000,000,000								$ 1,000,000,000
In-Force Annuity Block [Member]
Ceded Credit Risk [Line Items]
Reinsured risk						10.00%
New Business [Member]
Ceded Credit Risk [Line Items]
Reinsured risk					30.00%
In-Force FIA [Member]
Ceded Credit Risk [Line Items]
Reinsurance arrangement in percentage				80.00%
In-Force Deferred Annuity [Member]
Ceded Credit Risk [Line Items]
Reinsurance arrangement in percentage				40.00%
FSRC
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value		275,000,000									307,000,000	275,000,000
Funds withheld for reinsurance liabilities		254,000,000									285,000,000	254,000,000
F&G Re [Member]
Ceded Credit Risk [Line Items]
Funds withheld for reinsurance receivables, at fair value		482,000,000									1,865,000,000	482,000,000		$ 983
Funds withheld for reinsurance liabilities		$ 471,000,000									$ 1,668,000,000	$ 471,000,000		$ 896

XML

Schedule IV - Reinsurance (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Life insurance in force
Gross Amount	$ 3,516	$ 3,212	$ 3,123	$ 3,631	$ 3,541	$ 3,207
Ceded to other companies	(2,163)	(2,031)	(2,033)	(2,060)	(2,111)	(2,036)
Assumed from other companies	1	0	0	0	1	0
Net Amount	$ 1,354	$ 1,181	$ 1,090	$ 1,571	$ 1,431	$ 1,171
Percentage of amount assumed of net	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Premiums and other considerations:
Direct	$ 38	$ 80	$ 111	$ 413	$ 460	$ 462
Ceded to other companies	(19)	(39)	(62)	(218)	(226)	(255)
Assumed from other companies	0	0	0	0	0	0
Net	$ 19	$ 41	$ 49	$ 195	$ 234	$ 207
Percentage of amount assumed of net	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Traditional life insurance premiums
Premiums and other considerations:
Direct	$ 17	$ 36	$ 57	$ 204	$ 223	$ 233
Ceded to other companies	(14)	(29)	(46)	(164)	(169)	(191)
Assumed from other companies	0	0	0	0	0	0
Net	$ 3	$ 7	$ 11	$ 40	$ 54	$ 42
Percentage of amount assumed of net	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Annuity product charges
Premiums and other considerations:
Direct	$ 21	$ 44	$ 54	$ 209	$ 237	$ 229
Ceded to other companies	(5)	(10)	(16)	(54)	(57)	(64)
Assumed from other companies	0	0	0	0	0	0
Net	$ 16	$ 34	$ 38	$ 155	$ 180	$ 165
Percentage of amount assumed of net	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

XML

Significant Risks and Uncertainties - Narrative (Details)		1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended		15 Months Ended
	Dec. 31, 2019 USD ($) issuer	Dec. 31, 2017 USD ($)	Nov. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2019 USD ($) issuer	Sep. 30, 2017 USD ($)	Dec. 31, 2018 USD ($) issuer
Concentration Risk [Line Items]
Change in DAC and VOBA amortization					$ 3,000,000		$ 2,000,000
Increase/(decrease) in liability for annuity contracts					(13,000,000)		5,000,000
Liability for Future Policy Benefits, Life	$ 14,000,000				14,000,000
Increase (decrease) in derivative liabilities					1,000,000
Increase (decrease) in future policy benefit reserves		$ 4,000,000	$ (11,000,000)	$ (14,000,000)	1,079,000,000	$ (55,000,000)	$ (110,000,000)
Exposure of FGL's invested assets							7.00%
Fair Value In Investments							$ 1,634,000,000
Number of issuers in investment | issuer							16
Wilton Reassurance Company
Concentration Risk [Line Items]
Net amount recoverable	1,496,000,000
Kubera Reassurance Company
Concentration Risk [Line Items]
Net amount recoverable	842,000,000
Scottish Re
Concentration Risk [Line Items]
Net amount recoverable					47,000,000
Pavonia Life Insurance Company
Concentration Risk [Line Items]
Net amount recoverable					85
All Financial Instruments
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 2,414,000,000				$ 2,414,000,000		$ 2,491,000,000
Exposure of FGL's invested assets	9.00%				9.00%		10.00%
Single Issuer
Concentration Risk [Line Items]
FGL's investment securities in the banking industry	$ 132,000,000				$ 132,000,000		$ 115,000,000
Exposure of FGL's invested assets	1.00%				1.00%		1.00%
Banking Industry | All Financial Instruments
Concentration Risk [Line Items]
Investment securities held by subsidiaries subject to specialized industry accounting principles, amortized cost	$ 2,325,000,000				$ 2,325,000,000		$ 2,691,000,000
Top Ten Holdings
Concentration Risk [Line Items]
Exposure of FGL's invested assets	39.00%				39.00%
Number of issuers in investment | issuer	98				98
JP MORGAN - JPMI MARKET
Concentration Risk [Line Items]
Exposure of FGL's invested assets	10.00%				10.00%
Minimum
Concentration Risk [Line Items]
Exposure of FGL's invested assets							10.00%
FGL
Concentration Risk [Line Items]
Liability for Future Policy Benefits, Life	$ 10,000,000				$ 10,000,000

XML

Investments - Reconciliation of Other than Temporary Impairment on Fixed Maturity (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Other than Temporary Impairment, Credit Losses Recognized in Earnings [Roll Forward]
Balance at the beginning of the period	$ 3	$ 3		$ 0	$ 0
Increases attributable to credit losses on securities:
OTTI was previously recognized	0	0	$ 0	0	0	$ 0
OTTI was not previously recognized	0	0	0	0	0	0
Balance at the end of the period	$ 0	$ 3	$ 3	$ 0	$ 0	$ 3

XML

Income Taxes - Narrative (Detail) - USD ($)			1 Months Ended	2 Months Ended	3 Months Ended		12 Months Ended			15 Months Ended
	Dec. 22, 2017	Sep. 30, 2017	Dec. 31, 2017	Nov. 30, 2017	May 31, 2018	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Tax Credit Carryforward [Line Items]
Payment for Contingent Consideration Liability, Investing Activities			$ 0	$ 0	$ 57,000,000	$ 0	$ 0		$ 0	$ 57,000,000
Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Asset, Income Tax Expense			131,000,000				$ 18,000,000
Tax Cuts and Jobs Act, Change in Tax Rate, Deferred Tax Liability, Income Tax Benefit			$ 0
Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent			0.00%
Effective tax rate			579.00%	37.00%		34.00%	11.00%	55.00%	33.00%
Write off of expired capital loss carryforward			$ 0	$ 0		$ 0	$ 0	$ 0	$ 0
Valuation allowance increase (decrease)			13,000,000	$ (2,000,000)		$ 0	(39,000,000)	(38,000,000)
Valuation allowance			$ 15,000,000				14,000,000	154,000,000		154,000,000
Unrecognized tax benefits		$ 0					0	0	$ 0	0
Deferred Tax Asset, Net Operating Loss, Credits, and Capital Loss Carryforwards							$ 35,000,000	94,000,000		94,000,000
Federal tax rates			34.00%				21.00%
Life Company Capital Loss Carryforwards
Tax Credit Carryforward [Line Items]
Valuation allowance increase (decrease)							$ (14,000,000)	(14,000,000)
Valuation allowance			$ 0					115,000,000		$ 115,000,000
Deferred Tax Asset, Net Operating Loss, Credits, and Capital Loss Carryforwards							113,000,000
Non-Life Company Capital Loss Carryforwards
Tax Credit Carryforward [Line Items]
Valuation allowance increase (decrease)		$ (1,000,000)					(6,000,000)	(3,000,000)
Deferred Tax Asset, Net Operating Loss, Credits, and Capital Loss Carryforwards							165,000,000
FSRC
Tax Credit Carryforward [Line Items]
Valuation allowance increase (decrease)							(31,000,000)	$ (21,000,000)
Deferred Tax Asset, Net Operating Loss, Credits, and Capital Loss Carryforwards							$ 52,000,000
Maximum
Tax Credit Carryforward [Line Items]
Federal tax rates	35.00%
Minimum
Tax Credit Carryforward [Line Items]
Federal tax rates	21.00%

XML

Debt - Schedule of Debt (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2019	Dec. 31, 2018	Apr. 20, 2018
Debt Instrument [Line Items]
Debt Instrument, Face Amount		$ 542	$ 541
Revolving credit facility		0	0
Interest expense excluding amortization	$ 2	30	28
Amortization of debt issuance costs	0	2	1
Gain on Extinguishment of Debt	0	0
Gain (Loss) on Extinguishment of Debt			(2)
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility				$ 135
Interest expense excluding amortization	0	0	2
Amortization of debt issuance costs	$ 0	$ 0	$ 0

XML

Intangibles - Narrative (Detail) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Finite-Lived Intangible Assets [Line Items]
Adjustment for net unrealized investment (gains) losses	$ 0	$ 0	$ 0	$ (30)	$ 2	$ 0
Unearned revenue liability				(43)	(41)
Unearned Revenue, Additions				(41)	(37)
Unearned Revenue, Amortization Expense				(4)	18
Unearned Revenue Interest Expense				(2)
Unearned Revenue, Unlocking Adjustment				1	4
Unearned Revenue, Unrealized Gain (Loss) on Investment				44	(26)
Goodwill		$ 467		$ 467	467
Minimum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset				0.05%
Maximum
Finite-Lived Intangible Assets [Line Items]
Value of Business Acquired, Assumption, Interest Rate to Calculate Accretion on Intangible Asset				4.01%
VOBA
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains				$ 108	(75)
DAC
Finite-Lived Intangible Assets [Line Items]
Cumulative Adjustments For Net Unrealized Investment Gains				70	(5)
Adjustment for net unrealized investment (gains) losses				$ (28)	$ 2

XML

Stock Compensation - Summary of Company’s Nonvested Restricted Shares Outstanding (Details) - FGL Incentive Plan - Restricted shares - $ / shares shares in Thousands	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018
Shares:
beginning of period (in shares)	0
Granted (in shares)	147	112
Vested (in shares)	(147)
end of period (in shares)	0	0
Weighted Average Grant Date Fair Value (in dollars per share):
beginning of period (in dollars per share)	$ 0
Average grant date fair value, Granted (in dollars per share)	6.82
Average grant date fair value, Exercised (in dollars per share)	6.82
end of period (in dollars per share)	$ 0	$ 0

XML

Equity - Schedule of Dividends (Details) - USD ($) $ / shares in Units, $ in Millions	Dec. 09, 2019	Nov. 06, 2019	Sep. 09, 2019	Aug. 07, 2019	Jun. 10, 2019	May 07, 2019	Apr. 01, 2019	Feb. 27, 2019	Dec. 31, 2019	Nov. 25, 2019	Aug. 26, 2019	May 28, 2019	Mar. 18, 2019	Dec. 31, 2018
Equity [Abstract]
Common stock, shares outstanding (in shares)									221,807,598	221,661,000	221,661,000	221,661,000	221,661,000	221,660,974
Cash dividend per common share (in dollars per share)		$ 0.01		$ 0.01		$ 0.01		$ 0.01
Total cash paid	$ 2		$ 2		$ 2		$ 2

XML

Fair Value of Financial Instruments - NAV (Details) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure	$ 2,811	$ 2,466
Future Policy Benefit		725
Financial and Nonfinancial Liabilities, Fair Value Disclosure	5,204	3,230
Private Equity Funds
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Alternative Investment	1,010	510
Equity securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Alternative Investment	69	50
Income Approach Valuation Technique | Corporates
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure		654
Income Approach Valuation Technique | Hybrids
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure		10
Market Approach | Asset-backed securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure	801	405
Market Approach | Commercial mortgage-backed securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure	27	43
Market Approach | Corporates
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure	346	577
Market Approach | States, municipalities and political subdivisions
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure	42	37
Market Approach | Residential mortgage-backed securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure	546
Residential Mortage Backed securities		614
Market Approach | Debt Security, Government, Non-US
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure	18	16
Affiliated Entity | Income Approach Valuation Technique | Equity securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure	1
Affiliated Entity | Income Approach Valuation Technique | Other invested assets
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure		14
Affiliated Entity | Market Approach | Equity securities
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Assets, Fair Value Disclosure		4
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Financial and Nonfinancial Liabilities, Fair Value Disclosure	$ 3,235	$ 2,476

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	800,000,000	800,000,000
Common stock, shares issued (in shares)	221,807,598	221,660,974
Common stock, shares outstanding (in shares)	221,807,598	221,660,974
Preferred Stock, par value (in dollars per share)	$ 0.0001	$ 0.0001
Preferred Stock, shares authorized (in shares)	100,000,000	100,000,000
Preferred Stock, shares issued (in shares)	429,789	399,033
Preferred Stock, shares outstanding (in shares)	429,789	399,033
Treasury Stock, shares (in shares)	8,652,400	600,000
Fixed maturity securities, available-for-sale, at fair value (amortized cost)	$ 22,914	$ 22,219
Equity securities, available-for-sale, at fair value (amortized cost)	1,069	1,526
Future policy benefits. at fair value	$ 1,953	$ 725

XML

Significant Accounting Policies and Practices

12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Significant Accounting Policies and Practices

Significant Accounting Policies and Practices

Principles of Consolidation

The accompanying audited consolidated financial statements include the accounts of the Company and all other entities in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.

We are involved in certain entities that are considered variable interest entities ("VIEs") as defined under U.S. GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control, to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our audited consolidated financial statements. See "Note 4. Investments" for additional information on the Company’s investments in VIEs.

Revenue Recognition

Insurance Premiums

The Company’s insurance premiums for traditional life insurance products are recognized as revenue when due from the contractholder. The Company’s traditional life insurance products include those products with fixed and guaranteed premiums and benefits and consist primarily of term life insurance and certain annuities with life contingencies, net of premiums ceded under reinsurance.

Premium collections for fixed indexed and fixed rate annuities, indexed universal life (“IUL”) policies and immediate annuities without life contingency are reported as an increase to deposit liabilities (i.e., contractholder funds) instead of as revenues. Similarly, cash payments to policyholders are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Surrender charges are earned when a policyholder withdraws funds from the contract early or cancels the contract. Other income related to riders is earned when elected by the policyholder.

See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts as described under "Reinsurance".

Net Investment Income

Dividends and interest income are recorded in “Net investment income” and recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities are recognized in "Net investment income". Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in “Net investment income” based on the earliest call date of the investments in a manner that produces a constant effective yield.

FSRC and F&G Re's dividends and interest income are recorded in "Net investment income" in the consolidated financial statements and are recognized on an accrual basis. Amortization of premiums and accretion of discounts on investment in debt securities are reflected in "Net investment income" over the contractual terms of the investments in a manner that produces a constant effective yield.

For mortgage-backed and asset-backed securities, included in the fixed maturity available-for-sale (“AFS”) securities portfolios, the Company recognizes income using a constant effective yield based on anticipated cash flows and the estimated economic life of the securities. When actual prepayments differ significantly from originally anticipated prepayments, the effective yield is generally recalculated prospectively to reflect actual payments to date plus anticipated future payments. Any adjustments resulting from changes in effective yield are reflected in “Net investment income’’.

"Net investment income" is presented net of earned investment management fees.

Net Investment Gains (Losses)

Net investment gains (losses) include realized gains and losses from the sale of investments, unrealized gains and losses on equity securities at fair value, write-downs for other-than-temporary impairments (“OTTI”) of AFS investments, and realized and unrealized gains and losses on derivatives and embedded derivatives. FSRC and F&G Re's net investment gains (losses) include realized losses and gains from the sale of investments, changes in

the fair value of funds withheld receivables and realized and unrealized gains and losses on derivative investments. Realized gains and losses on the sale of investments are determined using the specific identification method on the trade date.

Insurance and Investment Product Fees and Other

Product fee revenue from IUL products and annuities is comprised of policy and contract fees charged for the cost of insurance, policy administration and rider fees. Fees are assessed on a monthly basis and recognized as revenue when earned. Product fee revenue also includes surrender charges which are collected and recognized as revenue when the policy is surrendered. Some of the product fee revenue is not level by policy year.  The unearned portion of the revenues are deferred and brought into income relative to the gross profits of the business.

Benefits and Other Changes in Policy Reserves

Benefit expenses for deferred annuity, FIA and IUL policies include index credits and interest credited to contractholder account balances and benefit claims in excess of contract account balances, net of reinsurance recoveries, are charged to expense in the period that they are earned by the policyholder based on their selected strategy. Interest crediting rates associated with funds invested in the general account of our insurance subsidiaries during 2017 through 2019 ranged from 0.5% to 6.0% for deferred annuities and FIA's, combined, and 3.0% to 4.8% for IUL's. Other changes in policy reserves include the change in the fair value of the FIA embedded derivative and the change in the reserve for secondary guarantee benefit payments.

Other changes in policy reserves also include the change in reserves for life insurance products. For traditional life and immediate annuities, policy benefit claims are charged to expense in the period that the claims are incurred, net of reinsurance recoveries.

See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts as described under "Future Policy Benefits" in Note 2.

Stock-Based Compensation

We expense the fair value of stock awards included in our incentive compensation plans. The Company issues stock options with three different types of vesting conditions. As of the date that there is a mutual understanding between the Company and the grantee of key terms of the awards, the fair value of stock options that vest based on service or non-market based performance conditions are determined using a Black-Scholes options valuation methodology. The Company uses a Monte Carlo simulation to determine the fair value of stock awards that vest based upon market conditions. The fair value of the awards is expensed over the performance or service period, which generally corresponds to the vesting period, and is recognized as an increase to “Additional paid-in capital” in “Shareholders’ equity”. We classify certain stock awards settled in cash as liabilities. For these awards, the fair value is classified as a liability on our Consolidated Balance Sheets, and the liability is marked-to-market through net income (loss) at the end of each reporting period. Stock-based compensation expense is reflected in “Acquisition and operating expenses, net of deferrals” on our Consolidated Statements of Operations.

Interest Expense

Interest expense on our debt is recognized as due and any associated premiums, discounts, and issuance costs are amortized (accreted) over the term of the related borrowing utilizing the straight line method. Interest expense also includes non-use fees on the revolving line of credit facility.

Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the average common shares outstanding. Diluted EPS is computed assuming the conversion or exercise of nonvested stock, stock options, warrants and performance share units outstanding during the year. The effect of a potential conversion of outstanding preferred shares to common shares is not considered in the diluted EPS calculation as the preferred shareholders do not yet have the right to convert. Stock options and warrants are excluded from the computation of diluted EPS, based on the application of the treasury stock method, if they are anti-dilutive.

Cash Equivalents

The Company considers money market funds and highly liquid debt instruments purchased with original maturities of three months or less to be cash equivalents. As of December 31, 2019 and December 31, 2018, the Company held cash equivalents of $38 and $84 respectively.

Investments

Investment Securities

The Company’s investments in fixed maturity securities have been designated as AFS and are carried at fair value with unrealized gains and losses included in “Accumulated other comprehensive income” (“AOCI”), net of associated intangible asset and unearned revenue ("UREV") “shadow adjustments” (discussed in "Note 7. Intangibles") and deferred income taxes. The Company's investments in equity securities are carried at fair value with unrealized gains and losses included in “Realized gains (losses)”. Prior to the adoption of ASU 2016-01, effective January 1, 2018, unrealized gains and losses on equity securities were included in AOCI.

Available-for-Sale Securities' Other-Than-Temporary Impairments

The Company regularly reviews AFS securities for declines in fair value that it determines to be other-than-temporary. Prior to the adoption of ASU 2016-01, for an equity security, if the Company did not have the ability and intent to hold the security for a sufficient and reasonable period of time to allow for a recovery in value, it concluded that an OTTI had occurred and the amortized cost of the security was written down to the current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. Following the adoption of ASU 2016-01, equity securities are no longer reviewed for OTTI. When assessing its ability and intent to hold a security to recovery, the Company considers, among other things, the severity and duration of the decline in fair value of the security as well as the cause of the decline, business prospects and the overall financial condition of the issuer. When evaluating redeemable preferred stocks for OTTI the Company applies the accounting policy described above for fixed maturity securities (including an anticipated recovery period), provided there has been no evidence of a deterioration in credit of the issuer.

For its fixed maturity AFS securities, the Company generally considers the following in determining whether its unrealized losses are other-than-temporary:

• The estimated period until recovery;

• The extent and the duration of the decline;

• The reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening);

• The financial condition of and near-term prospects of the issuer (including issuer’s current credit rating and the probability of full recovery of principal based upon the issuer’s financial strength);

• Current delinquencies and nonperforming assets of underlying collateral;

• Expected future default rates;

• Collateral value by vintage, geographic region, industry concentration or property type;

• Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and

• Contractual and regulatory cash obligations and the issuer's plans to meet such obligations.

The Company recognizes OTTI on fixed maturity securities in an unrealized loss position when one of the following circumstances exists:

• The Company does not expect full recovery of its amortized cost based on the present value of cash flows expected to be collected;

• The Company intends to sell a security; or

• It is more likely than not that the Company will be required to sell a security prior to recovery.

If the Company intends to sell a fixed maturity AFS security or it is more likely than not the Company will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, the Company will conclude that an OTTI has occurred and the amortized cost is written down to current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. If the Company does not intend to sell a fixed maturity security or it is more likely than not the Company will not be required to sell a fixed maturity security before recovery of its amortized cost basis and the present value of the cash flows expected to be collected is less than the amortized cost of the security (referred to as the credit loss), an OTTI has occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations, as this amount is deemed the credit loss portion of the OTTI. The remainder of the

decline to fair value is recorded in AOCI as an unrealized loss on AFS securities, as this amount is considered a non-credit impairment.

When assessing the Company’s intent to sell a fixed maturity security or if it is more likely than not the Company will be required to sell a fixed maturity security before recovery of its cost basis, the Company evaluates facts and circumstances at the individual security level based on facts and circumstances relevant to that security. Management also consider decisions to reposition the Company’s security portfolio, sale of securities to meet cash flow needs and sales of securities to capitalize on favorable pricing and tax planning strategies.

When evaluating mortgage-backed securities and asset-backed securities, the Company considers a number of pool-specific factors as well as market level factors when determining whether or not the impairment on the security is temporary or other-than-temporary. The most important factor is the performance of the underlying collateral in the security and the trends of that performance. The Company uses this information about the collateral to forecast the timing and rate of mortgage loan defaults, including making projections for loans that are already delinquent and for those loans that are currently performing but may become delinquent in the future. Other factors used in this analysis include type of underlying collateral (e.g., prime, Alternative A-paper (“Alt-A”), or subprime), geographic distribution of underlying loans and timing of liquidations by state. Once default rates and timing assumptions are determined, the Company then makes assumptions regarding the severity of a default if it were to occur. Factors that impact the severity assumption include expectations for future home price appreciation or depreciation, loan size, first lien versus second lien, existence of loan level private mortgage insurance, type of occupancy and geographic distribution of loans. Once default and severity assumptions are determined for the security in question, cash flows for the underlying collateral are projected, including expected defaults and prepayments. These cash flows on the collateral are then translated to cash flows on the Company’s tranche based on the cash flow waterfall of the entire capital security structure. If this analysis indicates the entire principal on a particular security will not be returned, the security is reviewed for OTTI by comparing the present value of expected future cash flows to amortized cost. To the extent that the security has already been impaired or was purchased at a discount, such that the amortized cost of the security is less than or equal to the present value of cash flows expected to be collected, no impairment is required. The Company also considers the ability of monoline insurers to meet their contractual guarantees on wrapped mortgage-backed securities. Otherwise, if the amortized cost of the security is greater than the present value of the cash flows expected to be collected, then an OTTI is recognized.

The Company includes the total OTTI recognized in "Net investment gains (losses)" in the Consolidated Statements of Operations, with an offset for the amount of non-credit impairments recognized in AOCI. See "Note 4. Investments" for additional disclosures related to OTTI, including the amount of OTTI recognized in AOCI.

Mortgage Loans on Real Estate

The Company’s investment in mortgage loans consists of commercial and residential mortgage loans on real estate, which are reported at amortized cost, less impairment write-downs and allowance for losses. If a mortgage loan is determined to be impaired (i.e., when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement or the loan is modified in a troubled debt restructuring), the carrying value of the mortgage loan is reduced to the lower of either the present value of expected cash flows from the loan, discounted at the loan’s original purchase yield, or fair value of the collateral. For those mortgages that are determined to require foreclosure, the carrying value is reduced to the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. The carrying value of the impaired loans is reduced by establishing an allowance with the offset recorded in "Net investment gains (losses)" in the Consolidated Statements of Operations.

Commercial mortgage loans are continuously monitored by reviewing appraisals, operating statements, rent revenues, annual inspection reports, loan specific credit quality, property characteristics, market trends and other factors.

Commercial mortgage loans are rated for the purpose of quantifying the level of risk. Loans are placed on a watch list when the debt service coverage ("DSC") ratio falls below and the loan-to-value ("LTV") ratios exceeds certain thresholds. Loans on the watchlist are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. The Company defines delinquent mortgage loans as 30 days past due, consistent with industry practice.

Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines nonperforming residential mortgage loans as those that are 90 or more days past due

and/or in nonaccrual status which is assessed monthly. Generally, nonperforming residential mortgage loans have a higher risk of experiencing a credit loss.

Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan.

We establish mortgage loan valuation allowances both on a loan specific basis for those loans considered impaired where a property specific or market specific risk has been identified that could likely result in a future loss, as well as for pools of loans with similar risk characteristics where a property specific or market specific risk has not been identified, but for which we expect to incur a loss. Accordingly, a valuation allowance is provided to absorb these estimated probable credit losses. As of December 31, 2019 and 2018, the Company did not identify any specific loans that were impaired.

The determination of the amount of valuation allowances is based upon our periodic evaluation and assessment of inherent risks associated with our loan portfolios. Such evaluations and assessments are based upon several factors, including our experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. We evaluate and monitor LTV ratios and DSC ratios of our loans as indicators of potential risk of default in establishing our valuation allowance.

Derivative Financial Instruments

The Company hedges certain portions of its exposure to product related equity market risk by entering into derivative transactions (primarily call options). All such derivative instruments are recognized as either assets or liabilities in the accompanying Consolidated Balance Sheets at fair value. The changes in fair value are reported within “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations.

The Company purchases financial instruments and issues products that may contain embedded derivative instruments. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract for measurement purposes. The embedded derivative is carried at fair value, which is determined through a combination of market observable inputs such as market value of option and interest swap rates and unobservable inputs such as the mortality multiplier, surrender and withdrawal rates and non-performance spread. The changes in fair value are reported within “Benefits and other changes in policy reserves” in the accompanying Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments".

Reinsurance Related Embedded Derivatives

As discussed in “Note 13. Reinsurance”, FGL Insurance entered into a reinsurance agreement with Kubera effective December 31, 2018, to cede certain MYGA and deferred annuity statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. Funds withheld arrangements allow the Company to retain legal ownership of assets backing reinsurance arrangements until they are earned by the reinsurer while passing credit risk associated with the assets in the funds withheld account to the reinsurer. These arrangements create embedded derivatives considered total return swaps with contractual returns that are attributable to the assets and liabilities associated with the reinsurance arrangement. The fair value of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, are passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. These total return swaps are not clearly and closely related to the underlying reinsurance contract and thus require bifurcation. The reinsurance related embedded derivative is reported in “Other assets” if in a net gain position, or “Other liabilities”, if in a net loss position on the Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains (losses)” on the Consolidated Statements of Operations.

FGL Insurance has a funds withheld coinsurance arrangement with FSRC, which creates an embedded derivative similar to the embedded derivative described above related to the Kubera reinsurance agreement. Due to the acquisition of FSRC, the reinsurance related embedded derivative is eliminated in consolidation in the periods after December 1, 2017.

Preferred Equity Remarketing Reimbursement Embedded Derivative Liability

On November 30, 2017 the Company issued 275,000 Series A cumulative preferred shares and 100,000 Series B cumulative preferred shares (together the “Preferred Shares”). The Preferred Shares do not have a maturity date and are non-callable for the first five years. From and after November 30, 2022, the original holders of the Preferred Shares may request and thus require, the Company (subject to customary blackout provisions) to remarket the Preferred Shares on their existing terms. If the remarketing is successful and the original holders elect to sell their preferred shares at the remarketed price and proceeds from such sale are less than the outstanding balance of the applicable shares (including dividends paid in kind and accumulated but unpaid dividends), the Company will be required to reimburse the sellers, up to a maximum of 10% of the par value of the originally issued preferred shares (including dividends paid in kind and accumulated but unpaid dividends) with such amount payable either in cash, ordinary shares, or any combination thereof, at the Company's option (the “Reimbursement Feature”). The Reimbursement Feature represents an embedded derivative that is not clearly and closely related to the preferred stock host and must be bifurcated. The Reimbursement Feature liability is reported at fair value within “Other liabilities” in the accompanying Consolidated Balance Sheets using a Black Derman Toy model incorporating among other things the paid in kind dividend coupon rate and the Company’s call option.

Funds withheld Receivable

FSRC and F&G Re have entered into various reinsurance agreements on a funds withheld basis, meaning that the funds are withheld by the ceding company from the coinsurance premium owed to FSRC and F&G Re as collateral for FSRC's and F&G Re's payment obligations. Accordingly, the collateral assets remain under the ultimate ownership of the ceding company. FSRC and F&G Re manage the assets supporting the reserves in accordance with the internal investments policies of the ceding companies and applicable law.

Limited Partnership Investments

Our investments in limited partnerships are included in other invested assets on our Consolidated Balance Sheets. We account for our investments in limited partnerships using the equity method and use net asset value ("NAV") as a practical expedient to determine the carrying value. Income from the limited partnership is included within "Net investment income" in the accompanying Consolidated Statements of Operations. Recognition of income is delayed due to the availability of the related financial statements, which are obtained from the partnership’s general partner generally on a one to three-month delay. Management meets quarterly with the general partner to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter valuation and investment income. In addition, the impact of audit adjustments related to completion of calendar-year financial statement audits of the limited partnership are typically received during the second quarter of each calendar year. Accordingly, our investment income from the limited partnership investment for any calendar-year period may not include the complete impact of the change in the underlying net assets for the partnership for that calendar-year period.

Intangible Assets

The Company’s intangible assets include an intangible asset reflecting the value of insurance and reinsurance contracts acquired (hereafter referred to as “the value of business acquired” or (“VOBA”), deferred acquisition costs (“DAC”), deferred sales inducements (“DSI”), and trademarks and state licenses.

VOBA is an intangible asset that reflects the amount recorded as insurance contract liabilities less the estimated fair value of in-force contracts in a life insurance company acquisition. It represents the portion of the purchase price allocated to the value of the rights to receive future cash flows from the business in force at the acquisition date. DAC consists principally of commissions that are related directly to the successful sale of new or recoverable insurance contracts, which may be deferred to the extent recoverable. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. DSI represents up front bonus credits and vesting bonuses to policyholder account values which may be deferred to the extent recoverable.

The methodology for determining the amortization of DAC, DSI and VOBA varies by product type. For all insurance contracts accounted for under long-duration contract deposit accounting, amortization is based on assumptions consistent with those used in the development of the underlying contract liabilities adjusted for emerging experience and expected trends. Amortization is reported within “Amortization of intangibles” in the accompanying Consolidated Statements of Operations.

For all of the insurance intangibles (DAC, DSI and VOBA), the balances are generally amortized over the lives of the policies in relation to the expected emergence of estimated gross profits (“EGPs”) from investment

income, surrender charges and other product fees, less policy benefits, maintenance expenses, mortality net of reinsurance ceded, and expense margins. Recognized gains (losses) on investments and changes in fair value of the funds withheld coinsurance embedded derivative are included in actual gross profits in the period realized as described further below.

Changes in assumptions, including the Company’s earned rate, (i.e., long term assumptions of the Company’s expected earnings on related investments), budgeted option costs (i.e., the expected cost to purchase call options in future periods to fund the equity indexed linked feature) and surrender rates can have a significant impact on VOBA, DAC and DSI balances and amortization rates. Due to the relative size and sensitivity to minor changes in underlying assumptions of those intangible balances, the Company performs quarterly and annual analysis of the VOBA, DAC and DSI balances for recoverability to ensure that the unamortized portion does not exceed the expected recoverable amounts. At each evaluation date, actual historical gross profits are reflected with the impact on the intangibles reported as “unlocking” as a component of amortization expense, and estimated future gross profits and related assumptions are evaluated for continued reasonableness. Any adjustment in estimated future gross profits requires that the amortization rate be revised (“unlocking”) retroactively to the date of the policy or contract issuance. The cumulative unlocking adjustment is recognized as a component of current period amortization.

The carrying amounts of VOBA, DAC and DSI are adjusted for the effects of unrealized gains and losses on fixed maturity securities classified as AFS. For investment-type products, the VOBA, DAC and DSI assets are adjusted for the impact of unrealized gains (losses) on investments as if these gains (losses) had been realized, with corresponding credits or charges included in AOCI.

Amortization expense of VOBA, DAC and DSI reflects an assumption for an expected level of credit-related investment losses. When actual credit-related investment losses are realized, the Company performs a retrospective unlocking of amortization for those intangibles as actual margins vary from expected margins. This unlocking is reflected in the accompanying Consolidated Statements of Operations.

Reinsurance

The Company’s insurance subsidiaries enter into reinsurance agreements with other companies in the normal course of business. The assets, liabilities, premiums and benefits of certain reinsurance contracts are presented on a net basis in the accompanying Consolidated Balance Sheets and Consolidated Statements of Operations, respectively, when there is a right of offset explicit in the reinsurance agreement. All other reinsurance agreements are reported on a gross basis in the Company’s Consolidated Balance Sheets as an asset for amounts recoverable from reinsurers or as a component of other liabilities for amounts, such as premiums, owed to the reinsurers, with the exception of amounts for which the right of offset also exists. Premiums and benefits are reported net of insurance ceded. The effects of certain reinsurance agreements are not accounted for as reinsurance as they do not satisfy the risk transfer requirements for GAAP. See "Note 13. Reinsurance" for details.

Income Taxes

The Company’s life insurance subsidiaries file a consolidated life insurance income tax return. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company assesses the recoverability of its deferred tax assets in each reporting period under the guidance outlined within Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes”. The guidance requires an assessment of both positive and negative evidence in determining the realizability of deferred tax assets. A valuation allowance is required to reduce the Company’s deferred tax asset to an amount that is more likely than not to be realized. In determining the net deferred tax asset and valuation allowance, management is required to make judgments and estimates related to projections of future profitability.  These judgments include the following: the timing and extent of the utilization of net operating loss carry-forwards, the reversals of temporary differences, and tax planning strategies.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company has the ability and intent to recover in a tax-free manner assets (or liabilities) with book/tax basis differences for which no deferred taxes have been provided, in accordance with ASC 740.

The Company applies the accounting guidance for uncertain tax positions which prescribes a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. The

guidance also provides information on de-recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Accrued interest expense and penalties related to uncertain tax positions are recorded in “Income tax (expense) benefit” in the Company’s Consolidated Statements of Operations. The Company had no unrecognized tax benefits related to uncertain tax positions as of December 31, 2019.

For discussion on the impact of tax reform and the 338(h)(10) election, see “Note 11. Income Taxes”.

Contractholder Funds

The liabilities for contractholder funds for deferred annuities, IUL and UL policies consist of contract account balances that accrue to the benefit of the contractholders. The liabilities for FIA policies consist of the value of the host contract plus the fair value of the embedded derivative. The embedded derivative is carried at fair value in “Contractholder funds” in the accompanying Consolidated Balance Sheets with changes in fair value reported in "Benefits and other changes in policy reserves" in the accompanying Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments". Liabilities for immediate annuities with life contingencies are recorded at the present value of future benefits.

Liabilities for the secondary guarantees on UL-type products or Investment-type contracts are calculated by multiplying the benefit ratio by the cumulative assessments recorded from contract inception through the balance sheet date less the cumulative secondary guarantee benefit payments plus interest. The benefit ratio is the ratio of the present value of future secondary guarantees to the present value of the assessments used to provide the secondary guarantees using the same assumptions as the Company uses for its intangible assets. If experience or assumption changes result in a new benefit ratio, the reserves are adjusted to reflect the changes in a manner similar to the unlocking of DAC, DSI and VOBA. The accounting for secondary guarantee benefits impact EGPs used to calculate amortization of DAC, DSI and VOBA.

Future Policy Benefits

The liabilities for future policy benefits and claim reserves for traditional life policies and life contingent pay-out annuity policies are computed using assumptions for investment yields, mortality and withdrawals based on generally accepted actuarial methods and assumptions at the time of contract issue. Investment yield assumption for traditional direct life reserves for all contracts is 5.7%. The investment yield assumptions for life contingent pay-out annuities range from 0.1% to 5.5%.

FSRC and F&G Re elected to apply the fair value option to account for its funds withheld receivables, non-funds withheld assets and insurance reserves related to its assumed third party reinsurance at the inception date of the reinsurance transactions. FSRC and F&G Re measure fair value of the funds withheld receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. The non-funds withheld assets held by FSRC, backing the insurance reserves, are measured at fair value.

FSRC and F&G Re use a discounted cash flows approach to measure the fair value of the insurance reserves. The cash flows associated with future policy premiums and benefits are generated using best estimate assumptions (plus a risk margin, where applicable). Risk margins are typically applied to non-observable, non-hedgeable market inputs such as mortality, morbidity, lapse, discount rate for non-performance risk, discount rate for risk margin, surrenders, etc. Mortality relates to the occurrence of death and morbidity relates to health risks. Mortality and morbidity assumptions are based upon the experience of the cedant as well as past and emerging industry experience, when available. Mortality and morbidity assumptions may be different by sex, underwriting class and policy type. Assumptions are also made for future mortality and morbidity improvements.

Policies are terminated through surrenders and maturities, where surrenders represent the voluntary terminations of policies by policyholders and maturities are determined by policy contract terms. Surrender assumptions are based upon cedant experience adjusted for expected future conditions. FSRC and F&G Re use market value weighting in the development of the discount rate. FSRC and F&G Re discount the liability cash flows using the market yields on the underlying assets backing the liabilities less a risk margin to reflect uncertainty and an adjustment to reflect the credit risk of FSRC and F&G Re, respectively. The Company adopted ASU 2016-01 effective January 1, 2018, which requires FSRC and F&G Re to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific

credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments. See "Note 13. Reinsurance" for further information.

Federal Home Loan Bank of Atlanta Agreements

Contractholder funds include funds related to funding agreements that have been issued by the Company to the Federal Home Loan Bank of Atlanta (“FHLB”) as a funding medium for single premium funding agreements. The funding agreements (i.e., immediate annuity contracts without life contingencies) provide a guaranteed stream of payments or provide for a bullet payment with renewal provisions. Single premiums were received at the initiation of the funding agreements and were in the form of advances from the FHLB. Payments under the funding agreements extend through 2022. The reserves for the funding agreements totaled $1,096 and $878 at December 31, 2019 and December 31, 2018, respectively, and are included in “Contractholder funds” in the accompanying Consolidated Balance Sheets.

In accordance with the agreements, the investments supporting the funding agreement liabilities are pledged as collateral to secure the FHLB funding agreement liabilities and are not available to settle the general obligations of the Company. The collateral investments had a fair value of $1,521 and $1,414 at December 31, 2019 and December 31, 2018, respectively.

Commitments and Contingencies

Contingencies arising from environmental remediation costs, regulatory judgments, claims, assessments, guarantees, litigation, recourse reserves, fines, penalties and other sources are recorded when deemed probable and reasonably estimable. The Company also has unfunded investment commitments based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. See "Note 12. Commitments and Contingencies" for further information.

Business Combinations

In accordance with ASC Topic 805, Business Combinations (“ASC 805”), the Company accounts for acquisitions by applying the acquisition method of accounting. The acquisition method of accounting requires, among other things, that the assets acquired and liabilities assumed in a business combination be measured at their fair values as of the closing date of the acquisition. The fair values assigned to the assets acquired and liabilities assumed are based on valuations using market participant assumptions and are preliminary pending the completion of the valuation analysis of selected assets and liabilities. During the measurement period (which is not to exceed one year from the acquisition date), the Company is required to retrospectively adjust the provisional assets or liabilities if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of those assets or liabilities as of that date. As of December 31, 2018, the measurement period is closed with respect to the Business Combination.

Reclassifications and Retrospective Adjustments

The Company identified an immaterial error, as described below, during the period ended September 30, 2018. Management has reviewed the impact of this error on prior periods in accordance with SEC Staff Accounting Bulletin No. 99, “Materiality,” (SAB 99) and determined this was not material to the prior periods impacted.

Effective December 1, 2017, the Company measured the identifiable assets acquired and liabilities assumed from the Business Combination at acquisition-date fair value in accordance with ASC 805. This required significant model changes for the re-bifurcation of the host contract and embedded derivative components of the fixed income annuity ("FIA") liability. During the quarter ended September 30, 2018, the Company identified an immaterial error resulting from the model code used in the calculation of the FIA embedded derivative liability. In issuing the September 30, 2018 Form 10-Q, the Company recorded an immaterial correction to the Consolidated Balance Sheet as of December 31, 2017 by decreasing the contractholder funds liability by $17 as well as a resulting decrease to the intangibles and deferred tax assets of $3 and $3, respectively. In addition, the Company recorded immaterial corrections to the Consolidated Statement of Operations for the one month ended December 31, 2017 by decreasing the benefits and other changes in policy reserves by $17, as well as increasing the amortization of intangibles by $3, and income tax expense by $3.

Certain prior year amounts have been reclassified or combined to conform to the current year presentation. These reclassifications and combinations had no effect on previously reported results of operations.

Adoption of New Accounting Pronouncements

Revenue from Contracts with Customers

In May 2014, the Financial Accounting Standards Board (FASB) issued new guidance on revenue recognition (ASU 2014-09, Revenue from Contracts with Customers (Topic 606)), effective for fiscal years beginning after December 15, 2016 and interim periods within those years. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606) - Deferral of the Effective Date, which deferred the effective date of ASU 2014-09 by one year. The FASB also issued the following ASUs which clarify the guidance in ASU 2014-09:

•ASU 2016-08 - Revenue from Contracts with Customers (Topic 606) - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) issued in March 2016

•ASU 2016-10 - Revenue from Contracts with Customers (Topic 606) - Identifying Performance Obligations and Licensing issued in April 2016

•ASU 2016-11 - Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815) - Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting issued in May 2016

•ASU 2016-12 - Revenue from Contracts with Customers (Topic 606) - Narrow-Scope Improvements and Practical Expedients issued in May 2016

The guidance in ASU 2014-09 and the related ASUs supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance unless the contracts are within the scope of other standards (for example, financial instruments, insurance contracts or lease contracts). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance establishes a five-step process to achieve this core principle.

The Company adopted these standards effective January 1, 2018. The adoption of these standards has had no impact on the Company's consolidated financial statements as the Company’s primary sources of revenue, insurance contracts and financial instruments, are excluded from the scope of these standards.

Statement of Cash Flows Classification of Certain Cash Receipts and Cash Payments

In August 2016, the FASB issued new guidance (ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments), effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years. Notable amendments in this update change the classification of certain cash receipts and cash payments in the Statement of Cash Flows in the following ways:

• cash payments for debt prepayment or debt extinguishment costs should be classified as cash outflows for financing activities

• the settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing should be classified as follows: the portion of the cash payment attributable to the accreted interest related to the debt discount as cash outflows for operating activities, and the portion of the cash payment attributable to the principal as cash outflows for financing activities

• a reporting entity must make an accounting policy election to classify distributions received from equity method investees using either:

◦ the cumulative earnings approach, which considers distributions received as returns on the investment and are classified as cash inflows from operating activities (with an exception when cumulative distributions received less distributions received in prior periods that were classified as returns of investment exceeds cumulative equity in earnings, in which case the current period distribution up to this excess amount will be considered a return of investment and classified as cash inflows from investing activities); or

◦ the nature of the distribution approach, which classifies distributions received based on the nature of the activity or activities of the investee that generated the distribution (would be considered

either a return on investment and classified as cash inflows from operating activities or a return of investment and classified as cash inflows from investing activities)

• in the absence of specific GAAP guidance, an entity should classify cash receipts and payments that have aspects of more than one class of cash flows by determining and appropriately classifying each separately identifiable source or use within the cash receipts and cash payments on the basis of the underlying cash flows. If cash receipts and payments have aspects of more than one class of cash flows and cannot be separated by source or use, the activity that is likely to be the predominant source or use of cash flows for the item will determine the classification.

The amendments in this ASU were adopted by the Company effective January 1, 2018 as required, using a retrospective transition method to each period presented (except where impracticable to apply retrospectively; those specific amendments will be applied prospectively as of the earliest date practicable). The Company has elected to use the nature of distribution approach to classify distributions received from equity method investees. The adoption of this standard had an immaterial impact on the Company's Consolidated Statements of Cash Flows.

Amendments to Recognition and Measurement of Financial Assets and Financial Liabilities

In March 2018, February 2018 and January 2016, the FASB issued amended guidance on the measurement of financial assets and financial liabilities (ASU 2018-04, Investments-Debt Securities (Topic 320) and Regulated Operations (Topic 980) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 117 and SEC Release No. 33-9273; ASU 2018-03, Technical Corrections and Improvements to Financial Instruments-Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities; and ASU 2016-01, Financial Instruments- Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities, respectively), effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Notable amendments in these updates:

• require all equity securities (other than equity investments accounted for under the equity method of accounting or requiring the consolidation of the investee) to be measured at fair value with changes in fair value recognized through net income. Equity securities that do not have readily determinable fair values may be measured at cost minus impairment

• require qualitative assessment for impairment of equity investments without readily determinable fair values at each reporting period and, if the qualitative assessment indicates that impairment exists, to measure the investment at fair value

• eliminate the requirement to disclose the methods and significant assumptions used to estimate fair value (which is currently required to be disclosed, for financial instruments measured at amortized cost on the balance sheet)

• require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments

The amendments in these ASUs were applied via a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption, and the amendments related to equity securities without readily determinable fair values were applied prospectively to equity investments that exist as of the date of adoption. The Company adopted ASUs 2016-01, 2018-03, and 2018-04 effective January 1, 2018, with a cumulative-effect adjustment to decrease retained earnings and increase AOCI by $4.

Premium Amortization on Purchased Callable Debt Securities

In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date. The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update were to be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its consolidated financial statements.

Amendments to Lease Accounting

In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842)), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update:

• require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less

• create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance

• not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02

• provide additional guidance on separating the lease components from the nonlease components of a contract

• require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases

• include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements

The amendments were required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its consolidated financial statements.

Derivatives and Hedging

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815), Targeted Improvements to the Accounting for Hedging Activities, effective for fiscal years beginning after December 15, 2018 including interim periods within those fiscal years. Under this update:

• removes previous limitations on designation of hedged risk in certain cash flow and fair value hedging relationships

• permits different measurements when accounting for hedged items in fair value hedges of interest rate risk

• the entity must present the hedging instrument earnings and hedged item earnings in the same income statement line

• in addition to exclusion of option premiums and forward points, also permits exclusion of the cross-currency basis spread portion of the change in fair value of a currency swap in assessment of hedge effectiveness

The Company adopted this standard effective January 1, 2019, as required, and it did not impact its consolidated financial statements.

Future Adoption of Accounting Pronouncements

New Credit Loss Standard

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Since its release, certain targeted improvements and transition relief amendments have been made to ASU 2016-13 and have been published in ASU 2018-19, ASU 2019-04, ASU 2019-05 and ASU 2019-11. Collectively, these ASUs will change the accounting for impairment of most financial assets and certain other instruments in the following ways:

• financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset. The measurement of expected credit losses is based on relevant information about past

events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount.

• credit losses relating to AFS fixed maturity securities generally will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses for AFS fixed maturity securities will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value

• the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount

• disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due

The Company has identified the material asset classes (e.g. available for sale securities, mortgage loans, reinsurance recoverable, other miscellaneous assets) affected by the new guidance. We will adopt this standard on January 1, 2020 and expect the total adoption date impact to be between $29 and $39 with $20 to $24 relating to our reinsurance recoverable, $7 to $14 related to mortgages and $1 related to other miscellaneous assets. The adoption of this guidance will significantly impact the operation of our existing processes around assessing the aforementioned asset classes for impairment.

Test for Goodwill Impairment

In January 2017, the FASB issued ASU 2017-04, Intangibles-Goodwill and Other (Topic 350), Simplifying the Test for Goodwill Impairment, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update:

• the subsequent measurement of goodwill is simplified by the elimination of step 2 from the goodwill impairment test, which required an entity to determine the implied fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of assets acquired and liabilities assumed in a business combination

• the entity should perform its goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount, recognizing an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, not to exceed the total amount of goodwill allocated to that reporting unit

• the entity is no longer required to perform a qualitative assessment for any reporting unit with a zero or negative carrying amount

The Company will adopt this standard on January 1, 2020, and does not expect this new accounting standard to have a significant impact on its consolidated financial statements.

Long-Duration Contracts

In August 2018, the FASB issued ASU 2018-12, Financial Services-Insurance (Topic 944), Targeted Improvements to the Accounting for Long-Duration Contracts, effective for fiscal years beginning after December 15, 2021 including interim periods within those fiscal years. Under this update:

• assumptions used to measure cash flows for traditional and limited-payment contracts must be reviewed at least annually with the effect of changes in those assumptions being recognized in the statement of operations

• the discount rate applied to measure the liability for future policy benefits and limited-payment contracts must be updated at each reporting date with the effect of changes in the rate being recognized in other comprehensive income

• market risk benefits associated with deposit contracts must be measured at fair value, with the effect of the change in the fair value attributable to a change in the instrument-specific credit risk being recognized in other comprehensive income

• deferred acquisition costs are required to be amortized in proportion to premiums, gross profits, or gross margins and those balances must be amortized on a constant level basis over the expected term of the related contracts

• deferred acquisition costs must be written off for unexpected contract terminations

• disaggregated rollforwards of beginning to ending balances of the liability for future policy benefits, policyholder account balances, market risk benefits, separate account liabilities and deferred acquisition costs, as well as information about significant inputs, judgments, assumptions, and methods used in measurement are required to be disclosed

The amendments in this ASU may be early adopted as of the beginning of an annual reporting period for which financial statements have not yet been issued, including interim financial statements. The Company does not currently expect to early adopt this standard. The Company has identified specific areas that will be impacted by the new guidance and is in the process of assessing the accounting, reporting and/or process changes that will be required to comply as well as the impact of the new guidance on its consolidated financial statements.

Fair Value Measurement

In August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820), Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update:

• for investments in certain entities that calculate net asset value, investors are required to disclose the timing of liquidation of an investee's assets and the date when restrictions from redemption might lapse if the investee has communicated timing to the entity or announced timing publicly

• entities should use the measurement uncertainty disclosure to communicate information about the uncertainty in measurement as of the reporting date

• entities must disclose changes in unrealized gains and losses included in other comprehensive income for recurring Level 3 fair value measurements, as well as the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, or other quantitative information in lieu of weighted average if the entity determines such information would be more reasonable and rational

• entities are no longer required to disclose the amounts and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation processes for Level 3 fair value measurements

The Company will adopt this standard on January 1, 2020, and does not expect this new accounting standard to have a significant impact on its consolidated financial statements.

Consolidation

In October 2018, the FASB issued ASU 2018-17, Consolidation (Topic 810), Targeted Improvements to Related Party Guidance for Variable Interest Entities, effective for fiscal years beginning after December 15, 2019 including interim periods within those fiscal years. Under this update, entities must consider indirect interests held through related parties under common control on a proportional basis to determine whether a decision-making fee is a variable interest.

The Company will adopt this standard on January 1, 2020, and does not expect this new accounting standard to have a significant impact on its consolidated financial statements.

XML

Fair Value of Financial Instruments

12 Months Ended

Dec. 31, 2019

Fair Value Disclosures [Abstract]

Fair Value of Financial Instruments

Fair Value of Financial Instruments

The Company’s measurement of fair value is based on assumptions used by market participants in pricing the asset or liability, which may include inherent risk, restrictions on the sale or use of an asset, or non-performance risk, which may include the Company’s own credit risk. The Company’s estimate of an exchange price is the price in an orderly transaction between market participants to sell the asset or transfer the liability (“exit price”) in the principal market, or the most advantageous market for that asset or liability in the absence of a principal market as opposed to the price that would be paid to acquire the asset or assume a liability (“entry price”). The Company categorizes financial instruments carried at fair value into a three-level fair value hierarchy, based on the priority of inputs to the respective valuation technique. The three-level hierarchy for fair value measurement is defined as follows:

Level 1 - Values are unadjusted quoted prices for identical assets and liabilities in active markets accessible at the measurement date.

Level 2 - Inputs include quoted prices for similar assets or liabilities in active markets, quoted prices from those willing to trade in markets that are not active, or other inputs that are observable or can be corroborated by market data for the term of the instrument. Such inputs include market interest rates and volatilities, spreads, and yield curves.

Level 3 - Certain inputs are unobservable (supported by little or no market activity) and significant to the fair value measurement. Unobservable inputs reflect the Company’s best estimate of what hypothetical market participants would use to determine a transaction price for the asset or liability at the reporting date based on the best information available in the circumstances.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, an investment’s level within the fair value hierarchy is based on the lowest level of input that is significant to the fair value measurement. The Company’s assessment of the significance of a particular input to the fair value measurement in its entirety requires judgment and considers factors specific to the investment.

When a determination is made to classify an asset or liability within Level 3 of the fair value hierarchy, the determination is based upon the significance of the unobservable inputs to the overall fair value measurement. Because certain securities trade in less liquid or illiquid markets with limited or no pricing information, the determination of fair value for these securities is inherently more difficult. In addition to the unobservable inputs, Level 3 fair value investments may include observable components, which are components that are actively quoted or can be validated to market-based sources.

The carrying amounts and estimated fair values of the Company’s financial instruments for which the disclosure of fair values is required, including financial assets and liabilities measured and carried at fair value on a recurring basis, with the exception of investment contracts, related party loans, portions of other invested assets and debt which are disclosed later within this footnote, was summarized according to the hierarchy previously described, as follows:

	December 31, 2019
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	969	$	—	$	—	$	969	$	969
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,866		828		5,694		5,694
Commercial mortgage-backed securities	—		2,895		27		2,922		2,922
Corporates	—		10,305		1,292		11,597		11,597
Hybrids	299		718		10		1,027		1,027
Municipals	—		1,301		42		1,343		1,343
Residential mortgage-backed securities	—		408		546		954		954
U.S. Government	28		6		—		34		34
Foreign Governments	—		137		18		155		155
Equity securities	387		614		1		1,002		1,002
Derivative investments	—		587		—		587		587
Other invested assets	—		—		46		46		46
Funds withheld for reinsurance receivables, at fair value	314		1,856		1		2,171		2,171
Total financial assets at fair value	$	1,997	$	23,693	$	2,811	$	28,501	$	28,501
Liabilities
Fair value of future policy benefits	—		—		1,953		1,953		1,953
Derivatives:
FIA embedded derivatives, included in contractholder funds	$	—	$	—	$	3,235	$	3,235	$	3,235
Reinsurance related embedded derivative, included in other liabilities	—		33		—		33		33
Preferred shares reimbursement feature embedded derivative	—		—		16		16		16
Total financial liabilities at fair value	$	—	$	33	$	5,204	$	5,237	$	5,237

	December 31, 2018
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	571	$	—	$	—	$	571	$	571
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,388		444		4,832		4,832
Commercial mortgage-backed securities	—		2,470		67		2,537		2,537
Corporates	—		9,150		1,231		10,381		10,381
Hybrids	265		626		10		901		901
Municipals	—		1,150		37		1,187		1,187
Residential mortgage-backed securities	—		417		614		1,031		1,031
U.S. Government	114		5		—		119		119
Foreign Governments	—		105		16		121		121
Equity securities	454		874		4		1,332		1,332
Derivative investments	—		97		—		97		97
Other invested assets	—		—		39		39		39
Funds withheld for reinsurance receivables, at fair value	177		576		4		757		757
Total financial assets at fair value	$	1,581	$	19,858	$	2,466	$	23,905	$	23,905
Liabilities
Fair value of future policy benefits	—		—		725		725		725
Derivatives:
FIA embedded derivatives, included in contractholder funds	—		—		2,476		2,476		2,476
Preferred shares reimbursement feature embedded derivative	—		—		29		29		29
Total financial liabilities at fair value	$	—	$	—	$	3,230	$	3,230	$	3,230

Valuation Methodologies

Fixed Maturity Securities & Equity Securities

The Company measures the fair value of its securities based on assumptions used by market participants in pricing the security. The most appropriate valuation methodology is selected based on the specific characteristics of the fixed maturity or equity security, and the Company will then consistently apply the valuation methodology to measure the security’s fair value. The Company's fair value measurement is based on a market approach, which utilizes prices and other relevant information generated by market transactions involving identical or comparable securities. Sources of inputs to the market approach include third-party pricing services, independent broker quotations, or pricing matrices. The Company uses observable and unobservable inputs in its valuation methodologies. Observable inputs include benchmark yields, reported trades, broker-dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers, and reference data. In addition, market indicators and industry and economic events are monitored and further market data will be acquired when certain thresholds are met.

For certain security types, additional inputs may be used, or some of the inputs described above may not be applicable. The significant input used in the fair value measurement of equity securities for which the market approach valuation technique is employed is yield for comparable securities. Increases or decreases in the yields would result in lower or higher, respectively, fair value measurements. To estimate the fair value of fixed maturity securities classified as level 3 in the fair value hierarchy the Company primarily uses prices from independent broker quotes. For broker-quoted only securities, quotes from market makers or broker-dealers are obtained from sources recognized to be market participants. Management believes the broker quotes are prices at which trades could be executed based on historical trades executed at broker-quoted or slightly higher prices. The Company does analyze the third-party valuation methodologies and related inputs to perform assessments and to determine the appropriate level within the fair value hierarchy. The Company did not adjust prices received from third parties as of December 31, 2019 or December 31, 2018.

The Company has an equity investment in a private business development company which is not traded on an exchange or valued by other sources such as analytics or brokers. The Company based the fair value of this investment on an estimated net asset value provided by the investee. Management did not make any adjustments to this valuation.

Derivative Financial Instruments

The fair value of call option assets represents what the Company would expect to receive or pay at the balance sheet date if it canceled the options, entered into offsetting positions, or exercised the options. Fair values for these instruments are determined internally, based on industry accepted valuation pricing models which use market-observable inputs, including interest rates, yield curve volatilities, and other factors.

The fair value of futures contracts represents the cumulative unsettled variation margin (open trade equity, net of cash settlements) which represents what the Company would expect to receive or pay at the balance sheet date if it canceled the contracts or entered into offsetting positions. These contracts are classified as Level 1.

The fair value measurement of the FIA embedded derivatives included in contractholder funds is determined through a combination of market observable information and significant unobservable inputs using the option budget method. The market observable inputs are the market value of option and interest swap rates. The significant unobservable inputs are the budgeted option cost (i.e., the expected cost to purchase call options in future periods to fund the equity indexed linked feature), surrender rates, mortality multiplier, and non-performance spread. The mortality multiplier at December 31, 2019 and December 31, 2018 was applied to the Annuity 2000 mortality tables. Increases or decreases in the market value of an option in isolation would result in a higher or lower, respectively, fair value measurement. Increases or decreases in interest swap rates, mortality multiplier, surrender rates, or non-performance spread in isolation would result in a lower or higher fair value measurement, respectively. Generally, a change in any one unobservable input would not directly result in a change in any other unobservable input.

The fair value of the reinsurance-related embedded derivative in the funds withheld reinsurance agreement with Kubera is estimated based upon the fair value of the assets supporting the funds withheld from reinsurance liabilities. The fair value of the assets is based on a quoted market price of similar assets (Level 2), and therfore the fair value of the embedded derivative is based on market-observable inputs and classified as Level 2.

The fair value of the Reimbursement Feature is determined using a Black Derman Toy model, incorporating the paid in kind dividend coupon, the Company's redemption option and the preferred shareholder's remarketing feature. The remarketing feature allows the shareholder to put the preferred shares to the Company for a value of par after five years and, if after a successful remarketing event the amount is less than 90% par, up to a maximum of 10% of liquidation price defined. Fair value of this derivative liability decreased $13 during the year ended December 31, 2019 and increased $6 during the year ended December 31, 2018, due primarily to changes in the credit spread applied in the discount rate.

Other Invested Assets

Fair value of the AnchorPath embedded derivative is based on an unobservable input, the net asset value of the AnchorPath fund at the balance sheet date.  The embedded derivative is similar to a call option on the net asset value of the AnchorPath fund with a strike price of zero since FGL Insurance will not be required to make any additional payments at maturity of the fund-linked note in order to receive the net asset value of the AnchorPath fund on the maturity date.  A Black-Scholes model determines the net asset value of the AnchorPath fund as the fair value of the call option regardless of the values used for the other inputs to the option pricing model.  The net asset value of the AnchorPath fund is provided by the fund manager at the end of each calendar month and represents the value an investor would receive if it withdrew its investment on the balance sheet date. Therefore, the key unobservable input used in the Black-Scholes model is the value of the AnchorPath fund. As the value of the AnchorPath fund increases or decreases, the fair value of the embedded derivative will increase or decrease.

FSRC and F&G Re Funds Withheld for Reinsurance Receivables and Future Policy Benefits

FSRC and F&G Re elected to apply the Fair Value Option to account for its funds withheld receivables and future policy benefits liability related to its assumed reinsurance. FSRC and F&G Re measures the fair value of the Funds Withheld for Reinsurance Receivables based on the fair values of the securities in the underlying funds withheld portfolio held by the cedant. FSRC and F&G Re use a discounted cash flows approach to measure the fair value of the Future Policy Benefits Reserve. The cash flows associated with future policy premiums and benefits are generated using best estimate assumptions. Included in the cash flows within the fair value for the reinsurance liabilities is a risk premium, which represents compensation a market participant would demand for uncertainty.

The significant unobservable inputs used in the fair value measurement of the FSRC and F&G Re future policy benefit liability are undiscounted cash flows (which are determined using actuarial assumptions related to lapses, surrenders, mortality, partial withdrawals and morbidity), non-performance risk spread and risk margin to reflect uncertainty. Undiscounted cash flows used in our December 31, 2019 and December 31, 2018 discounted cash flow models equaled $2,569 and $1,199, respectively. Increases or decreases in non-performance risk spread and risk margin to reflect uncertainty would result in a lower or higher fair value measurement, respectively.

Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of December 31, 2019 and December 31, 2018 are as follows: 

	Fair Value at				Range (Weighted average)
	December 31, 2019		Valuation Technique	Unobservable Input(s)	December 31, 2019
Assets
Asset-backed securities	$	801	Broker-quoted	Offered quotes	98.65% - 119.35% (102.02%)
Asset-backed securities	27		Third-Party Valuation	Offered quotes	0.00% - 99.43% (35.96%)
Commercial mortgage-backed securities	27		Broker-quoted	Offered quotes	100.15% - 127.60% (126.82%)
Corporates	346		Broker-quoted	Offered quotes	83.51% - 106.73% (99.56%)
Corporates	946		Third-Party Valuation	Offered quotes	98.58% - 119.44% (105.06%)
Hybrids	10		Third-Party Valuation	Offered quotes	104.72% - 104.72% (104.72%)
Municipals	42		Third-Party Valuation	Offered quotes	127.68% - 127.68% (127.68%)
Residential mortgage-backed securities	546		Broker-quoted	Offered quotes	0.00% - 106.50% (106.28%)
Foreign governments	18		Third-Party Valuation	Offered quotes	110.12% - 118.09% (112.61%)
Equity securities (Salus preferred equity)	1		Income-Approach	Yield	2.47%
Other invested assets:
Available-for-sale embedded derivative (AnchorPath)	21		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit linked note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables at fair value	1		Broker-quoted	Offered quotes	100.00%
Total	$	2,811
Liabilities
Future policy benefits	$	1,953	Discounted cash flow	Market value of option	0.00% - 11.20% (2.50%)
				Mortality multiplier	80.00% - 120.00% (95.46%)
				Surrender rates	0.00% - 55.00% (21.18%)
				Partial withdrawals	0.00% - 4.00% (2.28%)
				Non-performance spread	0.00% - 0.08% (0.03%)
				Option cost	0.00% - 5.02% (1.28%)
				Risk margin to reflect uncertainty	0.23% - 0.96% (0.34%)
				Morbidity risk margin	0.00% - 2.00% (0.07%)
Derivatives:
FIA embedded derivatives included in contractholder funds	3,235		Discounted cash flow	Market value of option	0.00% - 32.54% (3.64%)
				SWAP rates	1.73% - 1.90% (1.81%)
				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.64%)

				Partial withdrawals	2.00% - 3.50% (2.53%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.18% - 16.61% (2.12%)
Preferred shares reimbursement feature embedded derivative	16		Black Derman Toy model	Credit Spread	3.81%
				Yield Volatility	20.00%
Total liabilities at fair value	$	5,204

	Fair Value at				Range (Weighted average)
	December 31, 2018		Valuation Technique	Unobservable Input(s)	December 31, 2018
Assets
Asset-backed securities	$	405	Broker-quoted	Offered quotes	97.00% - 102.00% (99.77%)
Asset-backed securities	24		Matrix Pricing	Quoted prices	96.07% - 96.07% (96.07%)
Asset-backed securities	15		Third-Party Valuation	Offered quotes	0.00% - 99.29% (23.05%)
Commercial mortgage-backed securities	43		Broker-quoted	Offered quotes	77.12% - 100.08% (85.46%)
Commercial mortgage-backed securities	24		Matrix Pricing	Quoted prices	117.72% - 117.72% (117.72%)
Corporates	577		Broker-quoted	Offered quotes	74.63% - 104.62% (97.80%)
Corporates	654		Matrix Pricing	Quoted prices	91.74% - 113.25% (98.86%)
Hybrids	10		Matrix Pricing	Quoted prices	96.60% - 96.60% (96.60%)
Municipals	37		Broker-quoted	Offered quotes	111.23% - 111.23% (111.23%)
Residential mortgage-backed securities	614		Broker-quoted	Offered quotes	89.80% - 100.99% (100.73%)
Foreign governments	16		Broker-quoted	Offered quotes	98.38% - 99.01% (98.58%)
Equity securities (Salus preferred equity)	4		Income-Approach	Yield	7.15%
Other invested assets:
Available-for-sale embedded derivative (AnchorPath)	14		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit linked note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables, at fair value	4		Matrix pricing	Calculated prices	100.00%
Total	$	2,466
Liabilities
Future policy benefits	$	725	Discounted cash flow	Non-Performance risk spread	0.00% - 0.22% (0.18%)
				Risk margin to reflect uncertainty	0.35% - 0.71% (0.68%)
Derivatives:
FIA embedded derivatives included in contractholder funds	$	2,476	Discounted cash flow	Market value of option	0.00% - 31.06% (0.94%)
				SWAP rates	2.57% - 2.71% (2.63%)
				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.90%)
				Partial withdrawals	1.00% - 2.50% (2.00%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.11% - 16.61% (2.18%)
Preferred shares reimbursement feature embedded derivative	$	29	Black Derman Toy model	Credit Spread	5.14%
				Yield Volatility	20.00%
Total liabilities at fair value	$	3,230

The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, Predecessor period from October 1, 2017 to November 30, 3017, Predecessor period from October 1, 2016 to December 31, 2016, and the Predecessor year ended September 30, 2017, respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.

	Year ended December 31, 2019
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	444	$	—		$	19		$	675	$	—		$	(128	)	$	(182	)	$	828
Commercial mortgage-backed securities	67		—			5			1		—			(10		)	(36		)	27
Corporates	1,231		—			69			221		(106		)	(133		)	10			1,292
Hybrids	10		—			—			—		—			—			—			10
Municipals	37		—			5			—		—			—			—			42
Residential mortgage-backed securities	614		—			27			25		—			(91		)	(29		)	546
Foreign governments	16		—			2			—		—			—			—			18
Equity securities	4		(2		)	(1		)	—		—			—			—			1
Other invested assets:
Available-for-sale embedded derivative	14		7			—			—		—			—			—			21
Credit linked note	25		—			—			—		—			—			—			25
Funds withheld for reinsurance receivables, at fair value	4		—			—			20		(1		)	—			(22		)	1
Total assets at Level 3 fair value	$	2,466	$	5		$	126		$	942	$	(107	)	$	(362	)	$	(259	)	$	2,811
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,476	$	759		$	—		$	—	$	—		$	—		$	—		$	3,235
Future policy benefits (F&G Re and FSRC)	725		123			15			—		—			1,090			—			1,953
Preferred shares reimbursement feature embedded derivative	29		(13		)	—			—		—			—			—			16
Total liabilities at Level 3 fair value	$	3,230	$	869		$	15		$	—	$	—		$	1,090		$	—		$	5,204

(a) The net transfers out of Level 3 during the year ended December 31, 2019 were exclusively to Level 2.

	Year ended December 31, 2018
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	412	$	—		$	(4	)	$	476	$	—		$	(28	)	$	(412	)	$	444
Commercial mortgage-backed securities	49		—			(3		)	46		—			(6		)	(19		)	67
Corporates	1,169		—			(29		)	288		—			(126		)	(71		)	1,231
Hybrids	10		—			—			—		—			—			—			10
Municipals	38		—			(1		)	—		—			—			—			37
Residential mortgage-backed securities	66		—			5			560		(1		)	(15		)	(1		)	614
Foreign governments	17		—			(1		)	—		—			—			—			16
Equity securities	3		1			—			—		—			—			—			4
Other invested assets:
Available-for-sale embedded derivative	17		(3		)	—			—		—			—			—			14
Credit linked note	—		—			—			25		—			—			—			25
Funds withheld for reinsurance receivables, at fair value	4		—			—			6		—			(4		)	(2		)	4
Total assets at Level 3 fair value	$	1,785	$	(2	)	$	(33	)	$	1,401	$	(1	)	$	(179	)	$	(505	)	$	2,466
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,277	$	199		$	—		$	—	$	—		$	—		$	—		$	2,476
Future policy benefits (F&G Re and FSRC)	728		(45		)	(4		)	—		—			46			—			725
Preferred shares reimbursement feature embedded derivative	23		6			—			—		—			—			—			29
Total liabilities at Level 3 fair value	$	3,028	$	160		$	(4	)	$	—	$	—		$	46		$	—		$	3,230

(a) The net transfers out of Level 3 during the year ended December 31, 2018 were exclusively to Level 2.

	Period from December 1 to December 31, 2017
	Balance at Beginning of Period		Total Gains (Losses)					Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	225	$	—		$	—	$	143	$	—		$	(1	)	$	45		$	412
Commercial mortgage-backed securities	49		—			—		—		—			—			—			49
Corporates	1,163		—			2		30		(10		)	(16		)	—			1,169
Hybrids	10		—			—		—		—			—			—			10
Municipals	38		—			—		—		—			—			—			38
Residential mortgage-backed securities	67		—			—		—		—			(1		)	—			66
Foreign governments	17		—			—		—		—			—			—			17
Equity securities	38		—			—		—		—			—			(35		)	3
Other invested assets:
Available-for-sale embedded derivative	17		—			—		—		—			—			—			17
HGI Energy Note	20		—			—		—		(20		)	—			—			—
Funds withheld for reinsurance receivables, at fair value	4		—			—		—		—			—			—			4
Total assets at Level 3 fair value	$	1,648	$	—		$	2	$	173	$	(30	)	$	(18	)	$	10		$	1,785
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,331	$	(54	)	$	—	$	—	$	—		$	—		$	—		$	2,277
Future policy benefits (FSRC)	723		9			—		—		—			(4		)	—			728
Preferred shares reimbursement feature embedded derivative	23		—			—		—		—			—			—			23
Total liabilities at Level 3 fair value	$	3,077	$	(45	)	$	—	$	—	$	—		$	(4	)	$	—		$	3,028

(a) The net transfers out of Level 3 during the period from December 1 to December 31, 2017 were exclusively to Level 2.

	Period from October 1 to November 30, 2017
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales		Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	159	$	—		$	—		$	95	$	—	$	—		$	(29	)	$	225
Commercial mortgage-backed securities	95		—			(1		)	—		—		—			(45		)	49
Corporates	1,097		—			—			67		—		(19		)	18			1,163
Hybrids	10		—			—			—		—		—			—			10
Municipals	38		—			—			—		—		—			—			38
Residential mortgage-backed securities	15		—			1			51		—		—			—			67
Foreign governments	17		—			—			—		—		—			—			17
Equity securities	2		—			—			—		—		—			35			37
Other invested assets:
Available-for-sale embedded derivative	16		1			—			—		—		—			—			17
Total assets at Level 3 fair value	$	1,449	$	1		$	—		$	213	$	—	$	(19	)	$	(21	)	$	1,623
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,627	$	(296	)	$	—		$	—	$	—	$	—		$	—		$	2,331
Total liabilities at Level 3 fair value	$	2,627	$	(296	)	$	—		$	—	$	—	$	—		$	—		$	2,331

(a) The net transfers out of Level 3 during the Predecessor period from October 1 to November 30, 2017 were exclusively to Level 2.

	Period from October 1 to December 31, 2016 (Unaudited)
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	172	$	(1	)	$	(1	)	$	63	$	—		$	(7	)	$	(29	)	$	197
Commercial mortgage-backed securities	79		—			(2		)	8		—			—			—			85
Corporates	1,104		(1		)	(41		)	51		(5		)	(48		)	1			1,061
Hybrids	—		—			—			10		—			—			—			10
Municipals	41		—			(3		)	—		—			(1		)	—			37
Foreign governments	17		—			—			—		—			—			—			17
Equity securities	3		(2		)	—			—		—			—			—			1
Other invested assets:
Available-for-sale embedded derivative	13		—			—			—		—			—			—			13
Loan participations	21		(1		)	—			—		—			(14		)	—			6
Total assets at Level 3 fair value	$	1,450	$	(5	)	$	(47	)	$	132	$	(5	)	$	(70	)	$	(28	)	$	1,427
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,383	$	(133	)	$	—		$	—	$	—		$	—		$	—		$	2,250
Total liabilities at Level 3 fair value	$	2,383	$	(133	)	$	—		$	—	$	—		$	—		$	—		$	2,250

(a) The net transfers out of Level 3 during the Predecessor period from October 1 to December 30, 2016 (unaudited) were exclusively to Level 2.

	Year ended September 30, 2017
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	172	$	(2	)	$	2		$	152	$	—		$	(40	)	$	(125	)	$	159
Commercial mortgage-backed securities	79		—			1			18		—			(1		)	(2		)	95
Corporates	1,104		(1		)	(29		)	189		(20		)	(109		)	(37		)	1,097
Hybrids	—		—			—			10		—			—			—			10
Municipals	41		—			(2		)	—		—			(1		)	—			38
Residential mortgage-backed securities	—		—			1			—		—			—			14			15
Foreign governments	17		—			—			—		—			—			—			17
Equity securities	3		(2		)	1			—		—			—			—			2
Other invested assets:
Available-for-sale embedded derivative	13		3			—			—		—			—			—			16
Loan participations	21		(2		)	1			—		—			(20		)	—			—
Total assets at Level 3 fair value	$	1,450	$	(4	)	$	(25	)	$	369	$	(20	)	$	(171	)	$	(150	)	$	1,449
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,383	$	244		$	—		$	—	$	—		$	—		$	—		$	2,627
Total liabilities at Level 3 fair value	$	2,383	$	244		$	—		$	—	$	—		$	—		$	—		$	2,627

(a) The net transfers out of Level 3 during the Predecessor year ended September 30, 2017 were exclusively to Level 2.

Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value

The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value. Judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange.

FHLB Common Stock

The fair value of FHLB common stock is based on cost.

Mortgage Loans

The fair value of mortgage loans is established using a discounted cash flow method based on credit rating, maturity and contractual cash flows. This yield-based approach is sourced from our third-party vendor. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt service coverage, loan-to-value, quality of tenancy, borrower, and payment record. In the event of an impairment, the carrying value is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price, or the fair value of the collateral if the loan is collateral-dependent. The inputs used to measure the fair value of our mortgage loans are classified as Level 3 within the fair value hierarchy.

Policy Loans (included within Other Invested Assets)

Fair values for policy loans are estimated from a discounted cash flow analysis, using interest rates currently being offered for loans with similar credit risk.  Loans with similar characteristics are aggregated for purposes of the calculations.

Company Owned Life Insurance

Company owned life insurance (COLI) is a life insurance program used to finance certain employee benefit expenses. The fair value of COLI is based on net realizable value, which is generally cash surrender value.

Affiliated Bank Loan

The fair value of the affiliated bank loan is estimated using a discounted cash flow method based on the weighted average cost of capital ("WACC"). This yield-based approach is sourced from a third-party vendor and the WACC establishes a market participant discount rate by determining the hypothetical capital structure for the asset should it be underwritten as of each period end.

Investment Contracts

Investment contracts include deferred annuities, FIAs, indexed universal life policies ("IULs") and immediate annuities. The fair value of deferred annuity, FIA, and IUL contracts is based on their cash surrender value (i.e. the cost the Company would incur to extinguish the liability) as these contracts are generally issued without an annuitization date. The fair value of immediate annuities contracts is derived by calculating a new fair value interest rate using the updated yield curve and treasury spreads as of the respective reporting date. At December 31, 2019 and December 31, 2018, this resulted in lower fair value reserves relative to the carrying value. The Company is not required to, and has not, estimated the fair value of the liabilities under contracts that involve significant mortality or morbidity risks, as these liabilities fall within the definition of insurance contracts that are exceptions from financial instruments that require disclosures of fair value.

Debt

The fair value of debt is based on quoted market prices. The inputs used to measure the fair value of our outstanding debt are classified as Level 2 within the fair value hierarchy. Our revolving credit facility debt is classified as Level 3 within the fair value hierarchy, and the estimated fair value reflects the carrying value as the revolver has no maturity date.

The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described.

	December 31, 2019
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	62	$	—	$	62	$	62
Commercial mortgage loans	—		—		435		435		422
Residential mortgage loans	—		—		848		848		845
Policy loans, included in other invested assets	—		—		14		14		28
Company-owned life insurance	—		—		129		129		129
Affiliated bank loan	—		—		28		28		28
Funds withheld for reinsurance receivables, at fair value	—		—		1		1		1
Total	$	—	$	62	$	1,455	$	1,517	$	1,515
Liabilities
Investment contracts, included in contractholder funds	$	—	$	—	$	19,285	$	19,285	$	22,449
Debt	—		578		—		578		542
Total	$	—	$	578	$	19,285	$	19,863	$	22,991

	December 31, 2018
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	52	$	—	$	52	$	52
Commercial mortgage loans	—		—		483		483		482
Residential mortgage loans	—		—		187		187		185
Policy loans, included in other invested assets	—		—		11		11		22
Affiliated other invested assets	—		—		39		39		39
Total	$	—	$	52	$	720	$	772	$	780
Liabilities
Investment contracts, included in contractholder funds	$	—	$	—	$	18,358	$	18,358	$	20,911
Debt	—		520		—		520		541
Total	$	—	$	520	$	18,358	$	18,878	$	21,452

The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments is measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices”.

	Carrying Value After Measurement
	December 31, 2019		December 31, 2018
Equity securities available-for-sale	$	69	$	50
Limited partnership investment, included in other invested assets	1,010		510

For investments for which NAV is used as a practical expedient for fair value, the Company does not have any significant restrictions in their ability to liquidate their positions in these investments, other than obtaining general partner approval, nor does the Company believe it is probable a price less than NAV would be received in the event of a liquidation.

The Company reviews the fair value hierarchy classifications each reporting period. Changes in the observability of the valuation attributes may result in a reclassification of certain financial assets or liabilities. Such reclassifications are reported as transfers in and out of Level 3, or between other levels, at the beginning fair value for the reporting period in which the changes occur. The transfers into and out of Level 3 were related to changes in the primary pricing source and changes in the observability of external information used in determining the fair value.

The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, are as follows: 

	Transfers Between Fair Value Levels
	Level 1				Level 2				Level 3
	In		Out		In		Out		In		Out
Year ended December 31, 2019
Asset-backed securities	$	—	$	—	$	233	$	51	$	51	$	233
Commercial mortgage-backed securities	—		—		37		1		1		37
Corporates	—		—		1		11		11		1
Residential mortgage-backed securities	—		—		29		—		—		29
Equity securities	7		29		29		7		16		16
Funds withheld for reinsurance receivables	—		—		22		—		—		22
Total transfers	$	7	$	29	$	351	$	70	$	79	$	338
Year ended December 31, 2018
Asset-backed securities	$	—	$	—	$	425	$	13	$	13	$	425
Commercial mortgage-backed securities	—		—		28		9		9		28
Corporates	—		—		75		4		4		75
Hybrids	20		—		—		20		—		—
Residential mortgage-backed securities	—		—		36		35		35		36
Equity securities	25		30		30		25		—		—
Funds withheld for reinsurance receivables	—		—		2		—		—		2
Total transfers	$	45	$	30	$	596	$	106	$	61	$	566
Period from December 1 to December 31, 2017
Asset-backed securities	$	—	$	—	$	1	$	46	$	46	$	1
Commercial mortgage-backed securities	—		—		1		—		—		1
Hybrids	27		15		15		27		—		—
Equity securities	53		26		61		53		—		35
Total transfers	$	80	$	41	$	78	$	126	$	46	$	37
Predecessor
Period from October 1 to November 30, 2017
Asset-backed securities	$	—	$	—	$	29	$	—	$	—	$	29
Commercial mortgage-backed securities	—		—		46		1		1		46
Corporates	—		—		—		18		18		—
Hybrids	244		—		—		244		—		—
Equity securities	374		—		—		409		35		—
Total transfers	$	618	$	—	$	75	$	672	$	54	$	75
Predecessor
Period from October 1 to December 31, 2016 (Unaudited)
Asset-backed securities	$	—	$	—	$	68	$	39	$	39	$	68
Corporates	—		—		4		5		5		4
Total transfers	$	—	$	—	$	72	$	44	$	44	$	72
Predecessor
Year ended September 30, 2017
Asset-backed securities	$	—	$	—	$	222	$	112	$	112	$	222
Commercial mortgage-backed securities	—		—		7		6		6		7
Corporates	—		—		49		10		10		49
Total transfers	$	—	$	—	$	278	$	128	$	128	$	278

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended		15 Months Ended
	Dec. 31, 2017 USD ($)	Nov. 30, 2017 USD ($)	Dec. 31, 2016 USD ($)	Dec. 31, 2019 USD ($)	Sep. 30, 2017 USD ($)	Dec. 31, 2018 USD ($)
Cash flows from operating activities:
Net income (loss)	$ (91)	$ 28	$ 108	$ 507	$ 223	$ 13
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Stock based compensation	(1)	4	1	5	6	4
Amortization	6	(4)	(6)	39	(42)	43
Deferred income taxes	104	(7)	76	41	(4)	(30)
Interest credited/index credits to contractholder account balances	124	206	(13)	985	701	347
Net recognized losses (gains) on investments and derivatives	(42)	(137)	(51)	(682)	(305)	629
Charges assessed to contractholders for mortality and administration	(13)	(25)	(32)	(124)	(131)	(136)
Intangibles, net	(29)	(12)	23	(336)	(144)	(390)
Changes in operating assets and liabilities:
Reinsurance recoverable	17	3	(8)	13	(18)	24
Future policy benefits reflected in net income (loss)	4	(11)	(14)	1,079	(55)	(110)
Funds withheld for reinsurers	(2)	(16)	(26)	(1,220)	(105)	679
Collateral (returned) posted	17	56	40	387	158	(291)
Other assets and other liabilities	(9)	(6)	(26)	(19)	(47)	115
Net cash provided by (used in) operating activities	85	79	72	675	237	897
Cash flows from investing activities:
Proceeds from mortgage loans	1	2	13	100	48	65
Costs of mortgage loans	0	0	0	(701)	0	(185)
Capital expenditures	(1)	(1)	(2)	(11)	(4)	(7)
Payment for Contingent Consideration Liability, Investing Activities	0	0	0	0	0	(57)
Net cash provided by (used in) investing activities	(22)	(175)	(594)	(1,568)	(1,217)	(2,280)
Cash flows from financing activities:
Treasury stock	0	0	(1)	(65)	(1)	(4)
Payments of Debt Issuance Costs	0	0	0	0	0	(6)
Proceeds from (Repayments of) Debt	0	0	0	0	0	547
Retirement and paydown on debt and revolving credit facility	(105)	0	0	(27)	0	(440)
Draw on revolving credit facility	105	0	0	27	5	30
Common stock dividends paid	$ 0	$ (4)	$ (4)	$ (9)	$ (15)	$ 0
Warrants Tendered	0	0	0	0	0	(66)
Contractholder account deposits	$ 217	$ 443	$ 698	$ 4,124	$ 2,890	$ 3,352
Contractholder account withdrawals	(172)	(304)	(403)	(2,759)	(1,878)	(2,674)
Net cash provided by (used in) financing activities	45	135	290	1,291	1,001	739
Change in cash & cash equivalents	108	39	(232)	398	21	(644)
Cash & cash equivalents, beginning of period	924	885	864	571	864	885
Cash & cash equivalents, end of period	1,215	924	632	969	885	571
Supplemental disclosures:
Interest Paid, Excluding Capitalized Interest, Operating Activities	0	10	10	30	23	30
Income taxes (refunded) paid	(21)	0	0	(1)	114	41
Deferred sales inducements	10	3	0	130	20	138
Available-for-sale Securities
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	313	626	733	4,506	2,755	8,265
Cost of available-for-sale investments:	(348)	(874)	(1,355)	(4,733)	(4,123)	(10,079)
Derivative and other
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	169	117	71	338	458	499
Cost of available-for-sale investments:	$ (156)	$ (45)	$ (54)	$ (1,067)	$ (351)	$ (781)

XML

Stock Compensation

12 Months Ended

Dec. 31, 2019

Share-based Payment Arrangement [Abstract]

Stock Compensation

Stock Compensation

On August 8, 2017, the Company adopted a stock-based incentive plan (the “FGL Incentive Plan”) that permits the granting of awards in the form of qualified stock options, non-qualified stock options, restricted stock, restricted stock units, stock appreciation rights, unrestricted stock, performance-based awards, dividend equivalents, cash awards and any combination of the foregoing. The Company’s Compensation Committee is authorized to grant up to 15,006 thousand equity awards under the Incentive Plan. At December 31, 2019, 5,712 thousand equity awards are available for future issuance.

FGL Incentive Plan

The Company granted 7,749 thousand and 17,255 thousand stock options to certain officers during the twelve months ended December 31, 2019 and 2018 that vest based on continued service with the Company or a combination of continued service and Company performance (adjusted operating income return on equity or stock price performance). The total fair value of the awards granted during twelve months ended December 31, 2019 and 2018 was $12 and $32, respectively.

The fair value of the options is expensed over the requisite service period, which generally corresponds to the vesting period. To value the options granted with service and adjusted operating income return on equity performance vesting conditions, a Black Scholes valuation model was used. To value the options granted with stock price performance vesting conditions, a Monte Carlo simulation was used. A summary of the Company’s outstanding stock options as of December 31, 2019, and related activity during the twelve months ended December 31, 2019, is as follows (share amount in thousands):

Stock Option Awards	Options		Weighted Average Exercise Price
Stock options outstanding at December 31, 2018	13,007		$	9.68
Granted	7,749		9.18
Exercised	—		—
Forfeited or expired	(5,542	)	10.00
Stock options outstanding at December 31, 2019	15,214		9.30
Exercisable at December 31, 2019	1,009		9.16
Vested or projected to vest at December 31, 2019	15,214		$	9.30

The Company granted 147 thousand and 112 thousand restricted shares to directors in the twelve months ended December 31, 2019 and 2018, which vested on December 31, 2019 and 2018, respectively. The total fair value of the restricted shares granted in the twelve months ended December 31, 2019 and 2018 was $1 and $1, respectively.

A summary of the Company’s nonvested restricted shares outstanding as of December 31, 2019, and related activity during the twelve months ended, is as follows (share amount in thousands):

Restricted Stock Awards	Shares		Weighted Average Grant Date Fair Value
Restricted shares outstanding at December 31, 2018	—		$	—
Granted	147		6.82
Vested	(147	)	6.82
Vested or expected to vest at December 31, 2019	—		—

Management Incentive Plan

In the twelve months ended December 31, 2019 and 2018, the Company granted 541 thousand and 374 thousand phantom units to members of management under a management incentive plan (the "Management Incentive Plan"). The phantom units are settled in cash, and therefore the Management Incentive Plan is classified as a liability plan. The value of this plan is classified within "Other liabilities" on the Consolidated Balance Sheets and is adjusted each period, with a corresponding adjustment to “Acquisition and operating expenses, net of deferrals”, to reflect changes in the Company’s stock price. See "Note 2. Significant Accounting Policies and Practices" for a more detailed discussion of stock-based compensation. The total fair value of the phantom units granted in the twelve months ended December 31, 2019 and 2018 was $5 and $3, respectively.

One half of the phantom units vest in three equal installments on each March 15^th from 2019 to 2021, subject to awardees continued service with the Company. The other half will begin vesting on March 15, 2020 and cliff vest on March 15, 2021 based on continued service and attainment of a performance metric: adjusted operating income return on equity for the fiscal year 2020.

At December 31, 2019, the liability for phantom units of $1 was based on the number of units granted, the elapsed portion of the service period and the fair value of the Company’s common stock on that date which was $10.65.

A summary of the Management Incentive Plan nonvested phantom units outstanding as of December 31, 2019, and related activity during the twelve months ended is as follows (share amount in thousands):

Phantom units	Shares		Weighted Average Grant Date Fair Value
Phantom units outstanding at December 31, 2018	356		$	8.95
Granted	541		8.54
Vested	(59	)	10.00
Forfeited or expired	(93	)	9.33
Phantom units outstanding at December 31, 2019	745		$	9.02

The Company recognized total stock compensation expense related to the FGL Incentive Plan and Management Incentive Plan is as follows:

	Year ended
	December 31, 2019		December 31, 2018
Total stock compensation expense	5		4
Related tax benefit	1		1
Net stock compensation expense	$	4	$	3

The stock compensation expense is included in "Acquisition and operating expenses, net of deferrals" in the Company's Consolidated Statements of Operations.

Total compensation expense related to the FGL Incentive Plan and Management Incentive Plan not yet recognized as of December 31, 2019 and the weighted-average period over which this expense will be recognized are as follows:

	Unrecognized Compensation Expense		Weighted Average Recognition Period in Years
FGL Incentive Plan	$	18	3
Management Incentive Plan	4		2
Total unrecognized stock compensation expense	$	22	3

XML

Intangibles (Tables)

12 Months Ended

Dec. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Information Regarding Intangible Assets, VOBA and DAC

A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows:

	VOBA			DAC			DSI			Total
Balance at December 31, 2018	$	866		$	344		$	149		$	1,359
Deferrals	—			379			130			509
Amortization	(106		)	(30		)	(20		)	(156		)
Interest	18			13			4			35
Unlocking	(2		)	(2		)	(1		)	(5		)
Adjustment for net unrealized investment (gains) losses	(183		)	(74		)	(30		)	(287		)
Balance at December 31, 2019	$	593		$	630		$	232		$	1,455

	VOBA			DAC			DSI			Total
Balance at December 31, 2017	$	821		$	22		$	10		$	853
Deferrals	—			317			138			455
Amortization	(58		)	(4		)	(2		)	(64		)
Interest	19			4			1			24
Unlocking	(9		)	—			—			(9		)
Adjustment for net unrealized investment (gains) losses	93			5			2			100
Balance at December 31, 2018	$	866		$	344		$	149		$	1,359

	VOBA			DAC			DSI		Total
Balance at December 1, 2017	$	844		$	—		$	—	$	844
Deferrals	—			23			10		33
Amortization	(7		)	(1		)	—		(8		)
Interest	2			—			—		2
Unlocking	—			—			—		—
Adjustment for net unrealized investment (gains) losses	(18		)	—			—		(18		)
Balance at December 31, 2017	$	821		$	22		$	10	$	853

Predecessor	VOBA			DAC			DSI			Total
Balance at October 1, 2017	$	—		$	1,023		$	106		$	1,129
Deferrals	—			40			8			48
Amortization	(12		)	(39		)	(5		)	(56		)
Interest	2			7			1			10
Unlocking	7			4			(1		)	10
Adjustment for net unrealized investment (gains) losses	3			(4		)	—			(1		)
Balance at November 30, 2017	$	—		$	1,031		$	109		$	1,140

	VOBA			DAC			DSI			Total
Balance at October 1, 2016	$	19		$	921		$	86		$	1,026
Deferrals	—			88			12			100
Amortization	(31		)	(103		)	(2		)	(136		)
Interest	2			22			(11		)	13
Unlocking	6			(7		)	1			—
Adjustment for unrealized investment losses (gains)	122			103			—			225
Balance at December 31, 2016	$	118		$	1,024		$	86		$	1,228

Predecessor	VOBA			DAC			DSI			Total
Balance at September 30, 2016	$	19		$	921		$	86		$	1,026
Deferrals	—			293			43			336
Amortization	(65		)	(192		)	(23		)	(280		)
Interest	11			42			4			57
Unlocking	32			2			(4		)	30
Adjustment for net unrealized investment (gains) losses	3			(43		)	—			(40		)
Balance at September 30, 2017	$	—		$	1,023		$	106		$	1,129

Estimated Amortization Expense for VOBA in Future Fiscal Periods

Estimated amortization expense for VOBA in future fiscal periods is as follows:

	Estimated Amortization Expense
Fiscal Year
2020	62
2021	85
2022	80
2023	72
2024	65
Thereafter	337

XML

Basis of Presentation and Nature of Business (Tables)

12 Months Ended

Dec. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Premiums and Annuity Deposits, net of Coinsurance, Not Included as Revenue [Table Text Block]

Premiums and annuity deposits (net of reinsurance), which are not included as revenues (except for traditional premiums) in the accompanying Consolidated Statements of Operations, collected by product type were as follows:

 

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
Product Type							Predecessor		Predecessor		Predecessor
Fixed indexed annuities	$	2,800	$	2,253	$	178	$	288	$	556	$	1,892
Fixed rate annuities	539		61		45		116		99		556
Single premium immediate annuities	14		24		—		1		2		15
Life insurance (a)	203		182		16		29		50		176
Total	$	3,556	$	2,520	$	239	$	434	$	707	$	2,639

(a)

Life insurance includes Universal Life (“UL”) and traditional life insurance products for FGL Insurance and FGL NY Insurance.

XML

Investments - Available-for-Sale Securities Table (Details) $ in Millions	Dec. 31, 2019 USD ($) Security	Dec. 31, 2018 USD ($) Security
Available-for sale securities
Amortized cost	$ 22,914	$ 22,219
Gross Unrealized Gains	979	55
Gross Unrealized Losses	(167)	(1,165)
Fair Value	23,726	21,109
Carrying Value	23,726	21,109
Derivative investments
Amortized Cost	336	330
Gross Unrealized Gains	261	2
Gross Unrealized Losses	(10)	(235)
Fair Value	587	97
Carrying Value	587	97
Commercial mortgage loans
Carrying Value	1,267	667
Total investments
Amortized Cost	26,892	25,404
Gross Unrealized Gains	1,259	58
Gross Unrealized Losses	(197)	(1,545)
Fair Value	27,955	23,909
Carrying Value	27,954	23,917
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(44)	(1,045)
Available-for-sale securities, Fair Value, 12 months or longer	3,500	2,857
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(123)	(120)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	5,674	17,226
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	$ (167)	$ (1,165)
Total number of available-for-sale securities in an unrealized loss position less than twelve months | Security	290	1,551
Total number of available-for-sale securities in an unrealized loss position twelve months or longer | Security	446	556
Available-for-sale, Securities in Unrealized Loss Positions, Qualitative Disclosure, Number of Positions | Security	736	2,107
Equity Securities, Amortized Cost Basis	$ 1,069	$ 1,526
Equity Securities, Accumulated Gross Unrealized Gain, before Tax	19	1
Equity Securities, Accumulated Gross Unrealized Loss, before tax	17	145
Equity Securities, Fair Value	1,071	1,382
Equity Securities, Carrying Value	1,071	1,382
Asset-backed securities
Available-for sale securities
Amortized cost	5,720	4,954
Gross Unrealized Gains	51	15
Gross Unrealized Losses	(77)	(137)
Fair Value	5,694	4,832
Carrying Value	5,694	4,832
Total investments
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(12)	(116)
Available-for-sale securities, Fair Value, 12 months or longer	2,453	643
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(65)	(21)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	3,172	3,567
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(77)	(137)
Commercial mortgage-backed securities
Available-for sale securities
Amortized cost	2,788	2,568
Gross Unrealized Gains	140	9
Gross Unrealized Losses	(6)	(40)
Fair Value	2,922	2,537
Carrying Value	2,922	2,537
Total investments
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(4)	(34)
Available-for-sale securities, Fair Value, 12 months or longer	16	262
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(2)	(6)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	248	1,728
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(6)	(40)
Corporates
Available-for sale securities
Amortized cost	11,051	11,213
Gross Unrealized Gains	618	16
Gross Unrealized Losses	(72)	(848)
Fair Value	11,597	10,381
Carrying Value	11,597	10,381
Total investments
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(25)	(772)
Available-for-sale securities, Fair Value, 12 months or longer	804	1,465
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(47)	(76)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	1,834	9,481
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(72)	(848)
Hybrids
Available-for sale securities
Amortized cost	983	992
Gross Unrealized Gains	48	0
Gross Unrealized Losses	(4)	(91)
Fair Value	1,027	901
Carrying Value	1,027	901
Total investments
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months	(1)	(90)
Available-for-sale securities, Fair Value, 12 months or longer	60	7
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	(3)	(1)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	83	865
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	(4)	(91)
Municipals
Available-for sale securities
Amortized cost	1,284	1,216
Gross Unrealized Gains	64	3
Gross Unrealized Losses	(5)	(32)
Fair Value	1,343	1,187
Carrying Value	1,343	1,187
Residential mortgage-backed securities
Available-for sale securities
Amortized cost	917	1,027
Gross Unrealized Gains	40	12
Gross Unrealized Losses	(3)	(8)
Fair Value	954	1,031
Carrying Value	954	1,031
U.S. Government
Available-for sale securities
Amortized cost	33	120
Gross Unrealized Gains	1	0
Gross Unrealized Losses	0	(1)
Fair Value	34	119
Carrying Value	34	119
Total investments
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		0
Available-for-sale securities, Fair Value, 12 months or longer	0	50
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	0	(1)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value	6	119
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss	0	(1)
Debt Security, Government, Non-US
Available-for sale securities
Amortized cost	138	129
Available-for-sale Equity Securities, Accumulated Gross Unrealized Gain, before Tax	17	0
Gross Unrealized Losses	0	(8)
Fair Value	155	121
Carrying Value	155	121
Total investments
Available-for-sale securities, Gross Unrealized Losses, Less than 12 months		(3)
Available-for-sale securities, Fair Value, 12 months or longer		68
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss		(5)
Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value		115
Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss		(8)
Other invested assets
Available-for sale securities
Amortized cost	1,306	662
Gross Unrealized Gains	0	0
Gross Unrealized Losses	(3)	0
Fair Value	1,288	651
Carrying Value	1,303	662
Commercial Portfolio Segment
Commercial mortgage loans
Amortized Cost	422	482
Gross Unrealized Gains	0	0
Gross Unrealized Losses	0	0
Fair Value	435	483
Carrying Value	422	482
Residential Portfolio Segment
Commercial mortgage loans
Carrying Value	845	185
Investment, Residential Mortgage Loans, Amortized Cost	845	185
Investments, Residential Mortgage Loans, Accumulated Gross Unrealized Gain before Tax	0	0
Investments, Residential Mortgage Loans, Fair Value Disclosure	$ 848	$ 187

XML

Investments - Credit Impairment Loss Type (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Schedule of Investments [Line Items]
Credit impairment losses in operations	$ 0	$ 0	$ (1)	$ (21)	$ (24)	$ (22)
Change-of-intent losses in operations	0	0	0	(2)	0	0
Non-credit losses in other comprehensive income for investments which experienced OTTI	0	0	(1)	0	0	0
Asset Backed Securities and Corporate Securities [Member]
Schedule of Investments [Line Items]
Amortized cost	0	0	19	37	64	0
Fair value	$ 0	$ 0	$ 19	$ 37	$ 64	$ 0

XML

Intangibles - Summary of Changes in Carrying Amounts of Intangible Assets Including DAC, VOBA , and DSI (Detail) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
VOBA
VOBA at beginning of period	$ 0	$ 0	$ 19	$ 866	$ 821	$ 19
Deferrals	0	0	0	0	0	0
Amortization	(7)	(12)	(31)	(106)	(58)	(65)
Interest	2	2	2	18	19	11
Unlocking	0	7	6	(2)	(9)	32
Adjustment for net unrealized investment (gains) losses	(18)	3	122	(183)	93	3
VOBA at end of period	821	0	118	593	866	0
DAC
DAC at beginning of period	1,031	1,023	921	344	22	921
Deferrals	23	40	88	379	317	293
Amortization	(1)	(39)	(103)	(30)	(4)	(192)
Interest	0	7	22	13	4	42
Unlocking	0	4	(7)	(2)	0	2
Adjustment for net unrealized investment (gains) losses	0	(4)	103	(74)	5	(43)
DAC at end of period	22	1,031	1,024	630	344	1,023
Movement in Deferred Sales Inducements [Roll Forward]
DSI at beginning of period	109	106	86	149	10	86
Deferrals	10	8	12	130	138	43
Amortization	0	(5)	(2)	(20)	(2)	(23)
Interest	0	1	(11)	4	1	4
Unlocking	0	(1)	1	(1)	0	(4)
Adjustment for net unrealized investment (gains) losses	0	0	0	(30)	2	0
DSI at end of period	10	109	86	232	149	106
Total
Total VOBA, DAC and DSI at beginning of period	1,140	1,129	1,026	1,359	853	1,026
Deferrals	33	48	100	509	455	336
Amortization	(8)	(56)	(136)	(156)	(64)	(280)
Interest	2	10	13	35	24	57
Unlocking	0	10	0	(5)	(9)	30
Adjustment for net unrealized investment (gains) losses	(18)	(1)	225	(287)	100	(40)
Total VOBA, DAC and DSI at end of period	$ 853	$ 1,140	$ 1,228	$ 1,455	$ 1,359	$ 1,129

XML

Stock Compensation - Summary of Stock Options Outstanding and Related Activity (Details) - FGL Incentive Plan - $ / shares shares in Thousands		12 Months Ended
	Sep. 30, 2019	Dec. 31, 2019
Options (in shares):
Stock options outstanding at beginning of period (in shares)		13,007
Granted (in shares)		7,749
Exercised (in shares)		0
Forfeited or expired (in shares)		(5,542)
Stock options outstanding at end (in shares)		15,214
Vested and exercisable at end of period (in shares)	1,009
Vested or projected to vest (in shares)		15,214
Weighted Average Exercise Price (in dollars per share):
Stock options outstanding at beginning of period (in dollars per share)		$ 9.68
Granted (in dollars per share)		9.18
Exercised (in dollars per share)		0
Forfeited or expired (in dollars per share)		10.00
Stock options outstanding at end of period (in dollars per share)		9.30
Vested and exercisable at end of period (in dollars per share)	$ 9.16
Vested and projected to vest (in dollars per share)		$ 9.30

XML

Equity - Narrative (Details)												1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended			15 Months Ended
	Dec. 15, 2020	Feb. 26, 2020 $ / shares	Nov. 06, 2019 $ / shares	Aug. 07, 2019 $ / shares	May 07, 2019 $ / shares	Feb. 27, 2019 $ / shares	Oct. 09, 2018 USD ($) $ / shares shares	Oct. 04, 2018	Nov. 30, 2017 USD ($) $ / shares shares	Jun. 29, 2016 shares	May 25, 2016 $ / shares shares	Dec. 31, 2017 USD ($) $ / shares shares	Nov. 30, 2017 USD ($) $ / shares shares	Dec. 31, 2016 USD ($) shares	Dec. 31, 2019 USD ($) $ / shares shares	Dec. 31, 2018 USD ($) $ / shares shares	Sep. 30, 2017 USD ($) shares	Dec. 31, 2018 USD ($) $ / shares shares
Class of Stock [Line Items]
Authorized Share Capital | $															$ 90,000
Common stock, shares authorized (in shares) | shares															800,000,000	800,000,000		800,000,000
Sale of Stock, Number of Shares Issued in Transaction | shares									145,370,000	9,000,000	60,000,000
Sale of Stock, Price Per Share									$ 10.00		$ 10.00		$ 10.00
Preferred Stock, shares authorized (in shares) | shares															100,000,000	100,000,000		100,000,000
Preferred Stock, par value (in dollars per share)															$ 0.0001	$ 0.0001		$ 0.0001
Preferred Stock, shares issued (in shares) | shares															429,789	399,033		399,033
Payments of Stock Issuance Costs | $									$ 12,000,000
Preferred Stock, Call Features, Minimum Term									5 years
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares									19,083,000		34,500,000		19,083,000
Class of Warrant or Right, Exercise Price of Warrants or Rights												$ 11.50
Class Of Warrant Or Right, Redemption Price Of Warrants Or Rights																$ 0.01		$ 0.01
Warrants Tendered | $												0	0	0	0	(66,000,000)	0	66,000,000
Payments for Repurchase of Warrants | $							$ 64,000,000
Class of Warrant or Right, Outstanding | shares												70,883,000	0	0	5,510,000	55,838,000	0
Class Of Warrant Or Right, Redemption, Share Price Minimum Per Twenty Trading Days Within Thirty Trading Day Period																$ 18.00		$ 18.00
Common stock, par value (in dollars per share)															$ 0.0001	$ 0.0001		$ 0.0001
Shares repurchased (in shares) | shares															8,052,000	600,000
Treasury shares purchased | $														$ 1,000,000	$ 65,000,000	$ 4,000,000	$ 1,000,000
Shareholders' disclosure, ownership percentage															66.66667%
Cash dividend per common share (in dollars per share)			$ 0.01	$ 0.01	$ 0.01	$ 0.01
Stock Repurchase Program, Authorized Amount | $															$ 150,000,000
Total Stock Repurchased During Period, Shares | shares															8,652,000
Total Stock Repurchased During Period, Value | $															$ 69,000,000
Preferred Stock
Class of Stock [Line Items]
Preferred Stock, Call Features, Minimum Term									5 years
Preferred stock dividend rate									7.50%
Preferred Stock, Dividend Rate, Increase, Term									10 years
Preferred Stock, Dividend Rate, Percentage, Basis Spread On Variable Rate									5.50%
Preferred Stock, Conversion Term									10 years
Preferred Stock, Discount To Thirty Day Volume Weighted Average									5.00%
Preferred Stock, Floor Price During Year Eleven									$ 8.00
Preferred Stock, Floor Price During Year Twelve									7.00
Preferred Stock, Floor Price During Year Thirteen									$ 6.00
Subsequent Event [Member]
Class of Stock [Line Items]
Warrants Tendered								65,374,000
Ordinary Shares Exchanged for Outstanding Warrants | shares							7,191,000
Cash Exchanged per Warrant Outstanding | $							$ 0.98
Class of Warrant or Right, Outstanding | shares							5,510,000
Ordinary Shares Exchanged Per Outstanding Warrant							$ 0.11
Cash dividend per common share (in dollars per share)		$ 0.01
Stock Repurchase Program Expiration Date	Dec. 15, 2020
Subsidiaries
Class of Stock [Line Items]
Restricted net assets for consolidated subsidiaries | $															$ 2,501
Restricted net assets for consolidated subsidiaries, percentage of stockholder's equity															91.00%
Series A Cumulative Preferred Stock
Class of Stock [Line Items]
Preferred Stock, shares issued (in shares) | shares									275,000				275,000
Preferred Stock, Liquidation Preference Per Share									$ 1,000				$ 1,000
Preferred Stock, Liquidation Preference, Value | $									$ 275				$ 275
Series B Cumulative Preferred Stock
Class of Stock [Line Items]
Preferred Stock, shares issued (in shares) | shares									100,000				100,000
Preferred Stock, Liquidation Preference Per Share									$ 1,000				$ 1,000
Preferred Stock, Liquidation Preference, Value | $									$ 100				$ 100
Private Placement Warrant [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Exercise Price of Warrants or Rights											$ 1.00
CF Capital Growth, LLC 1 [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares											15,800,000
CF Capital Growth, LLC 2 [Member]
Class of Stock [Line Items]
Class of Warrant or Right, Number of Securities Called by Each Warrant or Right | shares											1,500,000

XML

Fair Value of Financial Instruments - Changes to Fair Value of Financial Instruments Level 3 (Detail) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				$ 2,811	$ 2,466
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	$ 1,623	$ 1,449		2,466	1,785
Assets, Total Gains (Losses) Included in Earnings	0	1	$ (5)	5	(2)	$ (4)
Assets, Total Gains (Losses) Included in AOCI	2	0	(47)	126	(33)	(25)
Assets, Purchases	173	213	132	942	1,401	369
Assets, Sales	(30)	0	(5)	(107)	(1)	(20)
Assets, Settlements	(18)	(19)	(70)	(362)	(179)	(171)
Assets, Net transfer In (Out) of Level 3	10	(21)	(28)	(259)	(505)	(150)
Balance at End of Period	1,785	1,623	1,427	2,811	2,466	1,449
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,331	2,627		3,230	3,028
Liabilities, Total Gains (Losses) Included in Earnings	(45)	(296)	(133)	869	160	244
Liabilities, Total Gains (Losses) Included in AOCI	0	0	0	15	(4)	0
Liabilities, Purchases	0	0	0	0	0	0
Liabilities, Sales	0	0	0	0	0	0
Liabilities, Settlements	(4)	0	0	(1,090)	(46)	0
Liabilities, Net transfer In (Out) of Level 3	0	0	0	0	0	0
Balance at End of Period	3,028	2,331	2,250	5,204	3,230	2,627
Future Policy Benefit					725
Liabilities, fair value				5,204	3,230
Other invested assets				1,303	662
Funds withheld for reinsurance receivables, at fair value				2,172	757
FIA embedded derivatives, included in contractholder funds
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	2,331	2,627		2,476	2,277
Liabilities, Total Gains (Losses) Included in Earnings	(54)	(296)	(133)	759	199	244
Liabilities, Total Gains (Losses) Included in AOCI	0	0	0	0	0	0
Liabilities, Purchases	0	0	0	0	0	0
Liabilities, Sales	0	0	0	0	0	0
Liabilities, Settlements	0	0	0	0	0	0
Liabilities, Net transfer In (Out) of Level 3	0	0	0	0	0	0
Balance at End of Period	2,277	2,331	2,250	3,235	2,476	2,627
Future Policy Benefits
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period				725	728
Liabilities, Total Gains (Losses) Included in Earnings	9			123	(45)
Liabilities, Total Gains (Losses) Included in AOCI	0			15	(4)
Liabilities, Purchases	0			0	0
Liabilities, Sales	0			0	0
Liabilities, Settlements	(4)			1,090	46
Liabilities, Net transfer In (Out) of Level 3	0			0	0
Balance at End of Period	728			1,953	725
Preferred Shares Reimbursement Feature Embedded Derivative [Member]
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period				29
Liabilities, Total Gains (Losses) Included in Earnings				(13)	6
Liabilities, Total Gains (Losses) Included in AOCI				0	0
Liabilities, Purchases				0	0
Liabilities, Sales				0	0
Liabilities, Settlements				0	0
Liabilities, Net transfer In (Out) of Level 3				0	0
Balance at End of Period				16	29
Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	225	159		444	412
Assets, Total Gains (Losses) Included in Earnings	0	0	(1)	0	0	(2)
Assets, Total Gains (Losses) Included in AOCI	0	0	(1)	19	(4)	2
Assets, Purchases	143	95	63	675	476	152
Assets, Sales	0	0	0	0	0	0
Assets, Settlements	(1)	0	(7)	(128)	(28)	(40)
Assets, Net transfer In (Out) of Level 3	45	(29)	(29)	(182)	(412)	(125)
Balance at End of Period	412	225	197	828	444	159
Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	49	95		67	49
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	0	(1)	(2)	5	(3)	1
Assets, Purchases	0	0	8	1	46	18
Assets, Sales	0	0	0	0	0	0
Assets, Settlements	0	0	0	(10)	(6)	(1)
Assets, Net transfer In (Out) of Level 3	0	(45)	0	(36)	(19)	(2)
Balance at End of Period	49	49	85	27	67	95
Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	1,163	1,097		1,231	1,169
Assets, Total Gains (Losses) Included in Earnings	0	0	(1)	0	0	(1)
Assets, Total Gains (Losses) Included in AOCI	2	0	(41)	69	(29)	(29)
Assets, Purchases	30	67	51	221	288	189
Assets, Sales	(10)	0	(5)	106	0	(20)
Assets, Settlements	(16)	(19)	(48)	(133)	(126)	(109)
Assets, Net transfer In (Out) of Level 3	0	18	1	10	(71)	(37)
Balance at End of Period	1,169	1,163	1,061	1,292	1,231	1,097
Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	10	10		10	10
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0	0	0	0	0
Assets, Purchases	0	0	10	0	0	10
Assets, Sales	0	0	0	0	0	0
Assets, Settlements	0	0	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	0	0	0
Balance at End of Period	10	10	10	10	10	10
Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	38	38		37	38
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0	(3)	5	(1)	(2)
Assets, Purchases	0	0	0	0	0	0
Assets, Sales	0	0	0	0	0	0
Assets, Settlements	0	0	(1)	0	0	(1)
Assets, Net transfer In (Out) of Level 3	0	0	0	0	0	0
Balance at End of Period	38	38	37	42	37	38
Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	37	2		4	3
Assets, Total Gains (Losses) Included in Earnings	0	0	(2)	(2)	1	(2)
Assets, Total Gains (Losses) Included in AOCI	0	0	0	(1)	0	1
Assets, Purchases	0	0	0	0	0	0
Assets, Sales	0	0	0	0	0	0
Assets, Settlements	0	0	0	0	0	0
Assets, Net transfer In (Out) of Level 3	(35)	35	0	0	0	0
Balance at End of Period	3	37	1	1	4	2
Available-for-sale embedded derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		16		14	17
Assets, Total Gains (Losses) Included in Earnings	0		0	7	(3)	3
Assets, Total Gains (Losses) Included in AOCI	0		0	0	0	0
Assets, Purchases	0		0	0	0	0
Assets, Sales	0		0	0	0	0
Assets, Settlements	0		0	0	0	0
Assets, Net transfer In (Out) of Level 3	0		0	0	0	0
Balance at End of Period	17		13	21	14	16
HIG Energy Notes
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period					0
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	(20)
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	0
Loan participations
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period		0
Assets, Total Gains (Losses) Included in Earnings			(1)			(2)
Assets, Total Gains (Losses) Included in AOCI			0			1
Assets, Purchases			0			0
Assets, Sales			0			0
Assets, Settlements			(14)			(20)
Assets, Net transfer In (Out) of Level 3			0			0
Balance at End of Period			6			0
Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	67	15		614	66
Assets, Total Gains (Losses) Included in Earnings	0	0		0	0	0
Assets, Total Gains (Losses) Included in AOCI	0	1		27	5	1
Assets, Purchases	0	51		25	560	0
Assets, Sales	0	0		0	(1)	0
Assets, Settlements	(1)	0		(91)	(15)	0
Assets, Net transfer In (Out) of Level 3	0	0		(29)	(1)	14
Balance at End of Period	66	67			614	15
Related party investment
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period				614
Balance at End of Period				546	614
Debt Security, Government, Non-US
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	17	17		16	17
Assets, Total Gains (Losses) Included in Earnings	0	0	0	0	0	0
Assets, Total Gains (Losses) Included in AOCI	0	0	0	2	(1)	0
Assets, Purchases	0	0	0	0	0	0
Assets, Sales	0	0	0	0	0	0
Assets, Settlements	0	0	0	0	0	0
Assets, Net transfer In (Out) of Level 3	0	0	0	0	0	0
Balance at End of Period	17	17	$ 17	18	16	$ 17
Reinsurance Receivables, Funds Withheld
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period				4
Assets, Total Gains (Losses) Included in Earnings				0	0
Assets, Total Gains (Losses) Included in AOCI				0	0
Assets, Purchases				20	6
Assets, Sales				(1)	0
Assets, Settlements				0	(4)
Assets, Net transfer In (Out) of Level 3				(22)	(2)
Balance at End of Period				1	4
HGI Energy Note
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period					4
Assets, Total Gains (Losses) Included in Earnings	0
Assets, Total Gains (Losses) Included in AOCI	0
Assets, Purchases	0
Assets, Sales	0
Assets, Settlements	0
Assets, Net transfer In (Out) of Level 3	0
Balance at End of Period	4
Fixed Maturity Security Embedded Derivative
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period	17
Assets, Total Gains (Losses) Included in Earnings		1
Assets, Total Gains (Losses) Included in AOCI		0
Assets, Purchases		0
Assets, Sales		0
Assets, Settlements		0
Assets, Net transfer In (Out) of Level 3		0
Balance at End of Period		$ 17
Market Approach | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				801	405
Market Approach | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				27	43
Market Approach | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				346	577
Market Approach | Municipals
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				42	37
Market Approach | Residential mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				546
Residential Mortage Backed securities					614
Market Approach | Debt Security, Government, Non-US
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				18	16
Market Approach | Credit Linked Note
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				25
Loan Recovery Value					25
Income Approach Valuation Technique | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure					654
Income Approach Valuation Technique | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure					10
Black Scholes Model | Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				21
Loan Recovery Valuation | Reinsurance Receivables, Funds Withheld
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				1
Matrix Pricing Valuation | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure					24
Matrix Pricing Valuation | Commercial mortgage-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure					24
Matrix Pricing Valuation | Corporates
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				946
Matrix Pricing Valuation | Hybrids
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				10
Third Parties | Asset-backed securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				27	15
Affiliated Entity | Bank Loan Obligations
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Balance at Beginning of Period				25
Assets, Total Gains (Losses) Included in Earnings				0	0
Assets, Total Gains (Losses) Included in AOCI				0	0
Assets, Purchases				0	25
Assets, Sales				0	0
Assets, Settlements				0	0
Assets, Net transfer In (Out) of Level 3				0	0
Balance at End of Period				25	25
Affiliated Entity | Market Approach | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure					4
Affiliated Entity | Income Approach Valuation Technique | Equity securities
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure				1
Affiliated Entity | Income Approach Valuation Technique | Other invested assets
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
Assets, Fair Value Disclosure					14
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, fair value				3,235	2,476
Preferred shares reimbursement feature embedded derivative | Income Approach Valuation Technique
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, fair value				16	29
Fair Value
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
FHLB Common Stock, Fair Value				62	52
Fair Value				435	483
Assets, Fair Value Disclosure				28,501	23,905
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Residential mortgage loans				14	187
Related party loans and investments					11
Other invested assets					39
Funds withheld for reinsurance receivables, at fair value				1
Assets, carried on Balance Sheet at amounts other than fair value				1,517	772
Liabilities Related to Investment Contracts, Fair Value Disclosure				19,285	18,358
Debt Instrument, Fair Value Disclosure				578	520
Liabilities, carried on Balance Sheet at amounts other than fair value				19,863	18,878
Fair Value | Preferred shares reimbursement feature embedded derivative
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, Total Gains (Losses) Included in Earnings	0
Liabilities, Total Gains (Losses) Included in AOCI	0
Liabilities, Purchases	0
Liabilities, Sales	0
Liabilities, Settlements	0
Liabilities, Net transfer In (Out) of Level 3	$ 0
Reported Value Measurement
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
FHLB Common Stock, Fair Value				62	52
Fair Value				422	482
Assets, Fair Value Disclosure				28,501	23,905
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Residential mortgage loans				28	185
Related party loans and investments					22
Other invested assets					39
Funds withheld for reinsurance receivables, at fair value				1
Assets, carried on Balance Sheet at amounts other than fair value				1,515	780
Liabilities Related to Investment Contracts, Fair Value Disclosure				22,449	20,911
Debt Instrument, Fair Value Disclosure				542	541
Liabilities, carried on Balance Sheet at amounts other than fair value				22,991	21,452
Fair Value, Inputs, Level 1
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
FHLB Common Stock, Fair Value				0	0
Fair Value				0	0
Assets, Fair Value Disclosure				1,997	1,581
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Residential mortgage loans				0	0
Related party loans and investments					0
Other invested assets					0
Funds withheld for reinsurance receivables, at fair value				0
Assets, carried on Balance Sheet at amounts other than fair value				0	0
Liabilities Related to Investment Contracts, Fair Value Disclosure				0	0
Debt Instrument, Fair Value Disclosure				0	0
Liabilities, carried on Balance Sheet at amounts other than fair value				0	0
Level 2
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
FHLB Common Stock, Fair Value				62	52
Fair Value				0	0
Assets, Fair Value Disclosure				23,693	19,858
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Residential mortgage loans				0	0
Related party loans and investments					0
Other invested assets					0
Funds withheld for reinsurance receivables, at fair value				0
Assets, carried on Balance Sheet at amounts other than fair value				62	52
Liabilities Related to Investment Contracts, Fair Value Disclosure				0	0
Debt Instrument, Fair Value Disclosure				578	520
Liabilities, carried on Balance Sheet at amounts other than fair value				578	520
Fair Value, Inputs, Level 3
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]
FHLB Common Stock, Fair Value				0	0
Fair Value				435	483
Assets, Fair Value Disclosure				2,811	2,466
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Residential mortgage loans				14	187
Related party loans and investments					11
Other invested assets					39
Funds withheld for reinsurance receivables, at fair value				1
Assets, carried on Balance Sheet at amounts other than fair value				1,455	720
Liabilities Related to Investment Contracts, Fair Value Disclosure				19,285	18,358
Debt Instrument, Fair Value Disclosure				0	0
Liabilities, carried on Balance Sheet at amounts other than fair value				19,285	18,358
FSRC
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Funds withheld for reinsurance receivables, at fair value				307	$ 275
FSRC | Income Approach Valuation Technique
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Liabilities, fair value				$ 1,953

XML

Stock Compensation - Summary of Unrecognized Stock Compensation Expense (Details) $ in Millions	12 Months Ended
	Dec. 31, 2019 USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 22
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	3 years
FGL Incentive Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 18
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	3 years
Management Incentive Plan | Phantom Share Units (PSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized Compensation Expense	$ 4
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition	2 years

XML

Debt - Narrative (Detail) - USD ($) $ in Millions			1 Months Ended	12 Months Ended
	Apr. 20, 2018	Nov. 30, 2017	Dec. 31, 2017	Dec. 31, 2019	Dec. 31, 2018
Debt Instrument [Line Items]
Debt Instrument, Face Amount				$ 542	$ 541
Revolving credit facility				0	$ 0
Gain on Extinguishment of Debt			$ 0	$ 0
Revolving Credit Facility
Debt Instrument [Line Items]
Revolving credit facility	$ 135
Interest rate if revolver drawn				4.55%	5.27%
Remaining borrowing capacity				$ 250
Senior Notes | 6.375% Senior Notes, Due April 1, 2021
Debt Instrument [Line Items]
Long-term debt, interest rate	6.375%
Debt	$ 300
Gain on Extinguishment of Debt	2
Senior Notes | Five Point Five Percent Senior Notes, Due 2025 [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 550
Long-term debt, interest rate	5.50%
Debt Instrument, Unamortized Discount Rate	99.50%
Debt	$ 547
Debt Issuance Costs, Net	$ 7
Royal Bank Of Canada | Revolving Credit Facility
Debt Instrument [Line Items]
senior unsecured revolving credit facility		$ 250
Debt term		3 years

XML

Basis of Presentation and Nature of Business

12 Months Ended

Dec. 31, 2019

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of Presentation and Nature of Business

Basis of Presentation and Nature of Business

FGL Holdings (the "Company"), formerly known as CF Corporation ("CF Corp"), a Cayman Islands exempted company, was originally incorporated in the Cayman Islands on February 26, 2016 as a Special Purpose Acquisition Company ("SPAC"). The Company’s primary business is the sale of individual life insurance products and annuities through independent agents, managing general agents, and specialty brokerage firms and in selected institutional markets. The Company’s principal products are deferred annuities (including fixed indexed annuity (“FIA”) contracts and fixed rate annuity contracts), immediate annuities and life insurance products. The Company markets products through its wholly-owned insurance subsidiaries, Fidelity & Guaranty Life Insurance Company (“FGL Insurance”) and Fidelity & Guaranty Life Insurance Company of New York (“FGL NY Insurance”), which together are licensed in all fifty states and the District of Columbia.

F&G Reinsurance Ltd (“F&G Re”), an exempted company incorporated in Bermuda with limited liability, provides a platform for non-affiliated reinsurance business. Front Street Re Cayman Ltd (“FSRC”), an exempted company incorporated in the Cayman Islands with limited liability, has a license to carry on business as an Unrestricted Class “B” Insurer that permits FSRC to conduct offshore direct and reinsurance business. F&G Re and FSRC (together herein referred to as the “F&G Reinsurance Companies”), are indirect wholly owned subsidiaries of the Company and parties to reinsurance transactions.

Prior to November 30, 2017, CF Corp. was a shell company with no operations. On November 30, 2017, CF Corp. consummated the acquisition of Fidelity & Guaranty Life ("FGL"), a Delaware corporation, and its subsidiaries, pursuant to the Agreement and Plan of Merger, dated as of May 24, 2017 (the “FGL Merger Agreement”). The transactions contemplated by the FGL Merger Agreement are referred to herein as the “Business Combination.” In addition to the Business Combination, on November 30, 2017, CF Corp bought all of the issued and outstanding shares of FSRC and F&G Re (formerly known as Front Street Re Ltd).

As a result of the Business Combination, for accounting purposes, FGL Holdings is the acquirer and FGL is the acquired party and accounting predecessor. Our financial statement presentation includes the financial statements of FGL and its subsidiaries as “Predecessor” for the periods prior to the completion of the Business Combination, and FGL Holdings, including the consolidation of FGL and its subsidiaries and the F&G Reinsurance Companies, for periods from and after the Closing Date. FGL Holdings is the surviving company organized and existing under the laws of the United States of America, any State of the United States, the District of Columbia or any territory thereof (and in the case of the Company, Bermuda or the Cayman Islands). Prior to the acquisition, FGL Holdings reported under a fiscal year end of December 31, and the Predecessor companies reported under a fiscal year end of September 30. Subsequent to the acquisition, FGL Holdings reports under a fiscal year end of December 31.

On February 7, 2020, FGL Holdings and Fidelity National Financial, Inc. (NYSE: FNF) (“FNF”) entered into a merger agreement pursuant to which FNF will acquire FGL Holdings for $12.50 per share, representing an equity value of approximately $2.7 billion. The transaction was approved by a Special Committee of FGL Holdings Directors, a Special Committee of FNF Directors and the FNF Board of Directors. FNF currently owns 7.9% of FGL Holdings outstanding ordinary shares and all of FGL Holdings Series B Preferred shares. In connection with and immediately prior to the closing of the proposed acquisition, FNF will acquire all outstanding FGL Holdings Series A preferred shares, with a face value of approximately $321 million as of December 31, 2019, and assume the $550 million of senior notes due 2025.

Under the terms of the merger agreement, holders of FGL Holdings' ordinary shares (other than FNF and its subsidiaries) may elect to receive either (i) $12.50 per share in cash or (ii) 0.2558 of a share of FNF common stock for each ordinary share of F&G they own. This is subject to an election and proration mechanism such that the aggregate consideration paid to such holders of FGL Holdings' ordinary shares will consist of approximately 60% cash and 40% FNF common stock.  

The transaction is expected to close in the second or third quarter of 2020, subject to the satisfaction of customary closing conditions, including the receipt of regulatory clearances and approval by FGL Holdings shareholders.

The accompanying financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“GAAP”). Dollar amounts in the accompanying sections are presented in millions, unless otherwise noted.

We have one reporting segment, which is consistent with and reflects the manner by which our chief operating decision maker views and manages the business. We currently distribute and service primarily fixed rate annuities, including FIAs. Premiums and annuity deposits (net of reinsurance), which are not included as revenues (except for traditional premiums) in the accompanying Consolidated Statements of Operations, collected by product type were as follows:

 

	Year ended										Year ended
	December 31, 2019		December 31, 2018		Period from December 1 to December 31, 2017		Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
Product Type							Predecessor		Predecessor		Predecessor
Fixed indexed annuities	$	2,800	$	2,253	$	178	$	288	$	556	$	1,892
Fixed rate annuities	539		61		45		116		99		556
Single premium immediate annuities	14		24		—		1		2		15
Life insurance (a)	203		182		16		29		50		176
Total	$	3,556	$	2,520	$	239	$	434	$	707	$	2,639

(a)

Life insurance includes Universal Life (“UL”) and traditional life insurance products for FGL Insurance and FGL NY Insurance.

XML

Income Taxes

12 Months Ended

Dec. 31, 2019

Income Tax Disclosure [Abstract]

Income Taxes

Income Taxes

The Company is a Cayman-domiciled corporation that has operations in Bermuda and the U.S. Neither the Cayman Islands nor Bermuda impose a corporate income tax. The Company’s U.S. non-life subsidiaries file a consolidated non-life U.S. Federal income tax return. For tax years prior to December 1, 2017, the non-life members were included in the consolidated U.S. Federal income tax return of HRG, the majority owner of FGL prior to the execution of the FGL Merger Agreement on November 30, 2017. The income tax liabilities of the Company as former members of the consolidated HRG return were calculated using the separate return method as prescribed in ASC 740. The Company’s US life insurance subsidiaries file a separate life subgroup consolidated U.S. Federal income tax return. The life insurance companies will be eligible to join in a consolidated filing with the U.S. non-life companies in 2022.

On May 24, 2017, the Company, HRG Group, Inc. ("HRG"), the majority owner of FGL prior to the execution of the FGL merger agreement on November 30, 2017, and CF Corp executed a letter agreement (the “side letter”)

which set forth the settlement provisions between the parties related to the Section 338(h)(10) transaction. The Section 338(h)(10) election treated the merger as an asset acquisition for U.S. tax purposes resulting in stub period tax yearends for both the life and non-life subsidiaries within the target group acquired as part of the acquisition. The side letter agreement between the parties specified that the purchase price would be adjusted for incremental tax costs attributable to the election. As such, the Company made two payments to HRG totaling $57 in March and May of 2018. The target 338(h)(10) group did not include FSRC, a 953(d) election U.S. tax payer. Any tax liability of the non-life entities’ arising from the deemed asset sale were reflected on HRG’s consolidated return, with the Companies’ non-life entities retaining successor liability. The life entities filed a separate final short-period return reflecting gain (or loss) from the deemed asset sale.

The Company’s U.S. subsidiaries are taxed at corporate rates on taxable income based on existing U.S. tax laws. Current income taxes are charged or credited to net income based upon amounts estimated to be payable or recoverable as a result of taxable operations for the current year.

Deferred income taxes are provided for the tax effect of temporary differences in the financial reporting and income tax bases of assets and liabilities, net operating loss carryforwards and tax credit carryforwards using enacted income tax rates and laws. The effect on deferred income tax assets and deferred income tax liabilities of a change in tax rates is recognized in net income in the period in which the change is enacted. A valuation allowance is required if it is more likely than not that a deferred tax asset will not be realized. In assessing the need for a valuation allowance, we considered the scheduled reversal of deferred tax liabilities, projected future taxable income, and taxable income from prior years available for recovery and tax planning strategies. Based on the available positive and negative evidence regarding future sources of taxable income, we have determined that the establishment of a valuation allowance was necessary for the U.S. non-life companies at December 31, 2019. The valuation allowance reflects a history of cumulative losses for the US nonlife subgroup. In addition, due to the debt structure of the US non-life entities, particularly at the holding company level, it is unlikely the US non-life subgroup will be in a net cumulative taxable income position in a near term projection window. During the quarter ended September 30, 2019, Management determined that a valuation allowance was no longer needed for the ordinary deferred tax assets of FSRC based on positive evidence including: cumulative three-year income, future projected earnings, and management’s ability to implement a future tax planning strategy if needed. Therefore, the valuation allowance against the FSRC deferred tax assets at that date was released and the Company recorded an $18 million gain in operating income during that quarter related to the release. The Company still maintains a valuation allowance against FSRC’s capital deferred tax assets due to lack of sufficient sources of income in which to recognize them. All other deferred tax assets were more likely than not to be realized based on expectations regarding future taxable income and considering all other available evidence, both positive and negative.

The Tax Cut and Jobs Act (“TCJA”) was enacted on December 22, 2017, and it amended many provisions of the Internal Revenue Code that have effects on the Company. Because the TCJA reduced the statutory tax rate from 35% to 21%, the Company was required to remeasure its deferred tax assets and liabilities using the lower rate at the December 22, 2017, date of enactment. This remeasurement resulted in a reduction of net deferred tax assets of $131, which includes a $0 benefit related to deferred taxes previously recognized in accumulated other comprehensive income. The Company evaluated whether or not to make a Section 953(d) election with respect to F&G Life Re Ltd. which would have resulted in F&G Life Re Ltd. being treated as if it were a US Tax Payer. Ultimately, the Company chose to be subject to the Base Erosion and Anti-Abuse Tax ("BEAT") through September 30, 2018 and then recapture the business that was subject to the Modco Agreement. The Modco Agreement was terminated effective September 30, 2018.

The SEC’s Staff Accounting Bulletin No. 118 (“SAB 118”) provides guidance on accounting for the effects of U.S. tax reform in circumstances in which an exact calculation cannot be made, but for which a reasonable estimate can be determined. December 22, 2018 marked the end of the measurement period for purposes of SAB 118. As such, we have completed our analysis based on the legislative updates relating to TCJA currently available. The only provision amount utilized in the preparation of the Company's December 31, 2017 financial statements was tax reserves. There are no provisional amounts utilized in the preparation of the Company’s December 31, 2018 or 2019 financial statements.

Income tax (expense) benefit is calculated based upon the following components of income before income taxes:

	Year ended												Year ended
	December 31, 2019		December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
									Predecessor		Predecessor		Predecessor
Pretax income (loss):
United States	$	467	$	(271	)	$	(55	)	$	44	$	163	$	333
Outside the United States	101		300			74			—		—		—
Total pretax income	$	568	$	29		$	19		$	44	$	163	$	333

The components of income tax (expense) benefit are as follows:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Current:
Federal	$	(22	)	$	(42	)	$	(5	)	$	(23	)	$	21		$	(114	)
State	—			—			—			—			—			—
Total current	$	(22	)	$	(42	)	$	(5	)	$	(23	)	$	21		$	(114	)
Deferred:
Federal	$	(39	)	$	26		$	(105	)	$	7		$	(76	)	$	4
State	—			—			—			—			—			—
Total deferred	$	(39	)	$	26		$	(105	)	$	7		$	(76	)	$	4
Income tax (expense)/benefit	$	(61	)	$	(16	)	$	(110	)	$	(16	)	$	(55	)	$	(110	)

The difference between income taxes expected at the U.S. Federal statutory income tax rate of 21% and reported income tax (expense) benefit is summarized as follows:

	Year ended															Year ended
	December 31, 2019			December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)			September 30, 2017
										Predecessor			Predecessor			Predecessor
Expected income tax (expense)/benefit at Federal statutory rate	$	(119	)	$	(6	)	$	(7	)	$	(15	)	$	(57	)	$	(117	)
Valuation allowance for deferred tax assets	39			(38		)	13			(2		)	—			1
Amortization of low income housing tax credits	(8		)	(4		)	(1		)	(1		)	—			(4		)
Benefit on LIHTC under proportional amortization method	9			5			—			1			—			5
Write off of expired capital loss carryforward	—			—			—			—			—			—
Remeasurement of deferred taxes under U.S. tax reform	—			—			(131		)	—			—			—
Dividends received deduction	4			5			—			1			—			4
Benefit on Outside of United States Income taxed at 0%	21			63			26			—			—			—
Withholding Tax on 0% Taxed Jurisdictions	(5		)	—			—			—			—			—
Write off of 382 Limited NOL	—			—			(12		)	—			—			—
Base Erosion & Antiabuse Tax "BEAT"	—			(44		)	—			—			—			—
Other	(2		)	3			2			—			2			1
Reported income tax (expense)/benefit	$	(61	)	$	(16	)	$	(110	)	$	(16	)	$	(55	)	$	(110	)
Effective tax rate	11		%	55		%	579		%	37		%	34		%	33		%

For the year ended December 31, 2019, the Company’s effective tax rate was 11%. The effective tax rate was positively impacted by the valuation allowance release on the US life companies’ prior year unrealized capital losses and the FSRC ordinary deferred tax assets, as well as the benefit of low taxed international income in excess of withholding taxes, and favorable permanent adjustments, including low income housing tax credits ("LIHTC") and the dividends received deduction ("DRD").

For the year ended December 31, 2018, the Company’s effective tax rate was 55%. The effective tax rate was negatively impacted by the valuation allowance expense on the US life companies’ unrealized capital losses and the FSRC and non-life insurance companies’ deferred tax assets. The negative impacts of the valuation allowance were partially offset by the benefit of low taxed international income in excess of the BEAT, and favorable permanent adjustments, including LIHTC and the DRD.

For the period December 1, 2017 to December 31, 2017, the Company’s effective tax rate includes the effects of rate change from 35% to 21% in connection with TCJA as well as certain reinsurance effects between the Companies' onshore and offshore insurance entities. Reversing out the effects of the tax reform rate change and impacts of FAS 133/DIGB36, (i.e. Embedded Derivatives impacts under Modified Coinsurance Arrangements) in regards to US/offshore reinsurance treatment of unrealized gains on funds withheld assets, results in an adjusted effective rate for the period of approximately 34% and is a more useful comparative to prior period rates reflected in the schedule above. The effective tax rate was impacted by tax expense recorded related to the remeasurement of deferred tax assets and liabilities as a result of tax reform. Additionally, the tax rate was positively impacted by income earned by foreign companies that is taxed at 0%.

For the Predecessor period October 1, 2017 to November 30, 2017, the Company’s effective tax rate was 37% (for Predecessor periods, references to “the Company” are to its predecessor). The negative impact of the valuation allowance expense of the non-life companies was partially offset by the net impact of positive permanent adjustments, including LIHTC and the DRD.

For the Predecessor period October 1, 2016 to December 31, 2016 (unaudited), the Company’s effective tax rate was 34%. The effective tax rate was impacted by favorable permanent adjustments, including LIHTC.

For the Predecessor year ended September 30, 2017, the Company’s effective tax rate was 33%. The effective tax rate was positively impacted by a valuation allowance release within the non-life companies and favorable permanent adjustments, including LIHTC and the DRD.

For the year ended December 31, 2019, the Company recorded a net valuation allowance release of $39 (comprised of a full year valuation allowance release of $14 related to the U.S. life insurance companies' unrealized capital losses on equity securities that are recorded through net income and $31 related to FSRC ordinary deferred tax assets, partially offset by a net increase to valuation allowance of $6 related to the Company's non-life companies).

For the year ended December 31, 2018, the company recorded a net valuation allowance expense of $38 (comprised of a net increase to valuation allowance of $3 related to the Company’s non-life companies, a net increase to valuation allowance of $21 related to FSRC, and a net increase to valuation allowance of $14 related to the US life insurance companies unrealized capital losses on equity securities that are recorded through net income).

For the period from December 1, 2017 to December 31, 2017, the Company recorded a net valuation allowance release of $13 primarily related to the DTA write off of the Net Operating Loss ("NOL") on FSRC that would not be able to be utilized as a result of the Section 382 limitation created by the merger with CF Corporation. For the Predecessor period from October 1, 2017 to November 30, 2017, the Company recorded a net valuation allowance expense of $2 related to the Company’s non-life companies. For the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), the Company recorded a net valuation allowance release of $0.

For the Predecessor year ended September 30, 2017, the Company recorded a net valuation allowance release of $1 related to the Company's non-life companies.

The Company records tax expense (benefit) that results from a change in Other Comprehensive Income (“OCI”) directly to OCI. Tax expense recorded directly to OCI includes deferred tax expense arising from a change in unrealized gain (loss) on available-for-sale securities and the tax-effects of other income items that are recorded to OCI. Changes in valuation allowance that are solely due to a deferred tax asset related to the unrealized gain on an available-for-sale security are allocated to other comprehensive income in accordance with ASC 740-10-45-20, "Income Taxes: Other Presentation Matters".

The Company recorded the following deferred tax expense to OCI:

	Year ended													Year ended
	December 31, 2019			December 31, 2018		Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017			Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
									Predecessor			Predecessor		Predecessor
Deferred Tax Expense in OCI	$	(242	)	$	132	$	(19	)	$	(7	)	$	154	$	(56	)

An excess tax benefit is the realized tax benefit related to the amount of deductible compensation cost reported on an employer’s tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes. The Company adopted ASU-2016-09 (Stock Compensation) effective October 1, 2015. ASU-2016-09 eliminates the requirement for excess tax benefits to be recorded as additional paid-in capital when realized. For the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, the Company recorded all excess tax benefits in the Consolidated Statements of Operations as a component of current income tax expense in accordance with the newly adopted guidance.

The following table is a summary of the components of deferred income tax assets and liabilities:

	December 31, 2019			December 31, 2018
Deferred tax assets:
Net operating loss, credit and capital loss carryforwards	$	35		$	94
Insurance reserves and claim related adjustments	716			620
Unrealized Investment Losses	—			201
Derivatives	—			36
Deferred acquisition costs	—			—
Funds held under Reinsurance Agreements	11			—
Other	37			30
Valuation allowance	(14		)	(154		)
Total deferred tax assets	$	785		$	827
Deferred tax liabilities:
Value of business acquired	$	(124	)	$	(181	)
Unrealized Investment Gains	(221		)	—
Investments	(121		)	(133		)
Derivatives	(45		)	—
Deferred acquisition costs	(139		)	(76		)
Transition reserve on new reserve method	(63		)	(75		)
Funds held under Reinsurance Agreements	—			(11		)
Other	(11		)	(8		)
Total deferred tax liabilities	$	(724	)	$	(484	)
Net deferred tax assets and (liabilities)	$	61		$	343

For the year ended December 31, 2019, the Company's valuation allowance of $14 consisted of a full valuation allowance on the Company's non-life insurance net deferred taxes, and a full valuation allowance on FSRC's capital net deferred taxes.

For the year ended December 31, 2018, the Company's valuation allowance of $154 consisted of a valuation allowance of $115 on US life company unrealized capital loss deferred tax assets, a full valuation allowance on the Company's non-life insurance net deferred taxes, and a full valuation allowance on FSRC's net deferred taxes.

For the period from December 1, 2017 to December 31, 2017, the Company’s valuation allowance of $15 consisted of a valuation allowance of $0 on US life company deferred tax assets, a full valuation allowance on the Company’s non-life insurance net deferred taxes, and a full valuation allowance on FSRC's net deferred taxes.

As of December 31, 2019, the Company has NOL carryforwards of $165, consisting of NOL carryforwards of $113 on the US life companies and $52 on FSRC. A portion of the FSRC losses existed prior to the November 30, 2017 acquisition and are therefore subject to Section 382 limitations. The FSRC NOL carryforwards that existed prior to January 1, 2018 of $31 will expire in years 2031 - 2032, if unused. The remaining NOLs are not subject to any limitation and have an indefinite carryforward period.

The U.S. Federal income tax returns of the Company for years prior to 2016 are no longer subject to examination by the taxing authorities. With limited exception, the Company is no longer subject to state and local income tax audits for years prior to 2014. The Company does not have any unrecognized tax benefits (“UTBs”) at December 31, 2019, December 31, 2018, December 31, 2017, and September 30, 2017 (Predecessor). In the event the Company has UTBs, interest and penalties related to uncertain tax positions would be recorded as part of income tax expense in the financial statements. The Company regularly assesses the likelihood of additional tax assessments by jurisdiction and, if necessary, adjusts its tax reserves based on new information or developments.

XML

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended		15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Sep. 30, 2017	Dec. 31, 2018
Revenues:
Premiums	$ 3	$ 7	$ 11	$ 40	$ 42	$ 54
Net investment income	92	174	240	1,229	1,005	1,107
Net investment gains (losses)	42	146	51	674	316	(629)
Insurance and investment product fees and other	28	35	38	170	167	179
Total revenues	165	362	340	2,113	1,530	711
Benefits and expenses:
Benefits and other changes in policy reserves	124	227	20	1,057	843	423
Acquisition and operating expenses, net of deferrals	16	51	28	330	137	181
Amortization of intangibles	4	36	123	126	193	49
Total operating expenses	144	314	171	1,513	1,173	653
Operating income	21	48	169	600	357	58
Interest expense	(2)	(4)	(6)	(32)	(24)	(29)
Income (loss) before income taxes	19	44	163	568	333	29
Income tax (expense) benefit	(110)	(16)	(55)	(61)	(110)	(16)
Net income (loss)	(91)	28	108	507	223	13
Less Preferred stock dividend	2	0	0	31	0	29
Net income (loss) available to common shareholders	$ (93)	$ 28	$ 108	$ 476	$ 223	$ (16)
Net income (loss) per common share
Basic (in USD per share)	$ (0.44)	$ 0.48	$ 1.85	$ 2.19	$ 3.83
Diluted (in USD per share)	$ (0.44)	$ 0.47	$ 1.85	$ 2.19	$ 3.83
Weighted average common shares used in computing net income (loss) per common share:
Basic (in shares)	214,370,000	58,341,112	58,280,532	216,591,908	58,319,517	216,018,629
Diluted (in shares)	214,370,000	58,494,043	58,366,009	216,737,602	58,415,187	216,018,629
Cash dividend per common share (in dollars per share)	$ 0	$ 0.07	$ 0.07	$ 0.04	$ 0.26	$ 0
Other-than-temporary impairments	$ 0	$ 0	$ (1)	$ (23)	$ (22)	$ (24)
Gains (losses) on derivatives and embedded derivatives	37	140	51	498	335	(295)
Other investment gains (losses)	5	6	1	199	3	(310)
Net investment gains (losses)	$ 42	$ 146	$ 51	$ 674	$ 316	$ (629)

XML

Significant Risks and Uncertainties

12 Months Ended

Dec. 31, 2019

Risks and Uncertainties [Abstract]

Significant Risks and Uncertainties

Significant Risks and Uncertainties

Best Interest Regulation    

In March 2018, the United States Fifth Circuit Court of Appeals formally vacated the U. S. Department Labor “Fiduciary Rule” which would have imposed fiduciary duties upon insurance agents selling Individual Retirement Account (IRA) annuities and would have potentially had a material impact on the Company, its products,

distribution, and business model. Since then, in June 2019, the U.S. Securities and Exchange Commission (SEC) adopted Regulation Best Interest imposing new sales practice standards on securities brokers, which does not directly impact the Company or its distributors, but gives impetus for the National Association of Insurance Commissioners (NAIC) and individual states to consider best interest proposals for insurance sales. The NAIC adopted an amended Suitability in Annuity Transactions Model Regulation in February 2020 incorporating a requirement that agents act in the best interest of consumers without putting their own financial interests or insurer’s interests ahead of consumer interests. It is expected individual states may soon begin to consider and adopt the NAIC model regulation. FGL NY Insurance already modified certain new business processes in response to the New York Department of Financial Services (NYDFS) best interest rule despite relatively low sales in New York. Management is following a legal challenge to nullify the NYDFS rule and will continue to monitor action by other state or federal agencies to implement sales practice rules affecting insurance agents selling fixed insurance or annuity products.

Use of Estimates and Assumptions

The preparation of the Company's consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and assumptions used.

The Company periodically, and at least annually, reviews the assumptions associated with reserves for policy benefits, product guarantees, and amortization of intangibles. As a result of the assumption review process that occurred in the year ended December 31, 2019, the surrender rates, guaranteed minimum withdrawal benefit (“GMWB”) utilization, IUL premium persistency, maintenance expenses, and earned rate assumptions were updated to reflect the Company's current and expected future experience. These changes in assumptions resulted in a net decrease in future expected margins and a corresponding increase in amortization expense reported as a component of “unlocking” for the period ended December 31, 2019. This resulted in a decrease to intangible assets of $3.  These assumptions are used in the SOP 03-1 liability for GMWB benefits and resulted in a decrease in liability of $13 for the period ended December 31, 2019.  The surrender rate assumptions are also used in the reserve calculation and resulted in an increase in embedded derivative liability of $1 for the period ended December 31, 2019. The change in assumptions as of December 31, 2018 resulted in a net increase in future expected margins and a corresponding decrease in amortization expense reported as a component of “unlocking”. This resulted in a decrease to intangible assets of $2.  These assumptions are also used in the reserve calculation and resulted in a decrease of $5 in the year ended December 31, 2018.

As a result of the assumption review process at FSRC that occurred in the year ended December 31, 2019, the premium rate, claim factor and IBNR assumptions were updated. This resulted in an increase to the future policy benefits of $10. F&G Re periodically, and at least annually, reviews the assumptions associated with reserves for future policy benefits. As a result of the assumption review process that occurred in the year ended December 31, 2019, the duration discount weighting and model demographics assumptions were updated to reflect the Company's current and expected future experience. This resulted in a decrease to future policy benefits of $14.

Concentrations of Financial Instruments

As of December 31, 2019 and December 31, 2018, the Company’s most significant investment in one industry, excluding United States ("U.S.") Government securities, was its investment securities in the Banking industry with a fair value of $2,414 or 9% and $2,491 or 10%, respectively, of the invested assets portfolio and an amortized cost of $2,325 and $2,691, respectively. As of December 31, 2019, the Company’s holdings in this industry include investments in 98 different issuers with the top ten investments accounting for 39% of the total holdings in this industry. As of December 31, 2019, the Company had no investments in issuers that exceeded 10% of shareholders' equity. As of December 31, 2018, the Company had sixteen investments in issuers that exceeded 10% of shareholders' equity, with a total fair value of $1,634 or 7% of the invested assets portfolio: JP Morgan Chase & Co, Metropolitan Transportation Authority (NY), AT&T Inc, HSBC Holdings, Wells Fargo & Company, General Motors Co, Nationwide Mutual Insurance Company, Goldman Sachs Group Inc, United Mexican States, Energy Transfer Partners, Prudential Financial Inc, Citigroup Inc, HP Enterprise Co, Viacom Inc, Kinder Morgan Energy Partners, and Fuel Trust. The Company's largest concentration in any single issuer as of December 31, 2019 and December 31, 2018 was HSBC Holdings with a total fair value of $132 or 1%, and JP Morgan Chase & Co, with a total fair value of $115 or 1% of the invested assets portfolio, respectively.

Concentrations of Financial and Capital Markets Risk

The Company is exposed to financial and capital markets risk, including changes in interest rates and credit spreads which can have an adverse effect on the Company’s results of operations, financial condition and liquidity. The Company’s exposure to such financial and capital markets risk relates primarily to the market price and cash flow variability associated with changes in interest rates. A rise in interest rates, in the absence of other countervailing changes, will increase the net unrealized loss position of the Company’s investment portfolio and, if long-term interest rates rise dramatically within a six to twelve month time period, certain of the Company’s products may be exposed to disintermediation risk. Disintermediation risk refers to the risk that policyholders surrender their contracts in a rising interest rate environment, requiring the Company to liquidate assets in an unrealized loss position. The Company attempts to mitigate the risk, including changes in interest rates by investing in less rate-sensitive investments, including senior tranches of collateralized loan obligations, non-agency residential mortgage-backed securities, and various types of asset backed securities. Management believes this risk is also mitigated to some extent by surrender charge protection provided by the Company’s products. The Company expects to continue to face these challenges and uncertainties that could adversely affect its results of operations and financial condition.

Concentration of Reinsurance Risk

The Company has a significant concentration of reinsurance risk with third party reinsurers, Wilton Reassurance Company (“Wilton Re”) and Kubera Insurance (SAC) Ltd. ("Kubera") that could have a material impact on the Company’s financial position in the event that either Wilton Re or Kubera fail to perform their obligations under the various reinsurance treaties. Wilton Re is a wholly-owned subsidiary of Canada Pension Plan Investment Board ("CPPIB"). CPPIB has an AAA issuer credit rating from Standard & Poor's Ratings Services ("S&P") as of December 31, 2019. Kubera is not rated, however, management has attempted to mitigate the risk of non-performance through the funds withheld arrangement. As of December 31, 2019, the net amount recoverable from Wilton Re was $1,496 and the net amount recoverable from Kubera was $842. The Company monitors both the financial condition of individual reinsurers and risk concentration arising from similar activities and economic characteristics of reinsurers to attempt to reduce the risk of default by such reinsurers. The Company believes that all amounts due from Wilton Re and Kubera for periodic treaty settlements are collectible as of December 31, 2019.

On March 6, 2019, Scottish Re (U.S.), Inc. (“SRUS”), a Delaware domestic life and health reinsurer of FGL Insurance, was ordered into receivership for purposes of rehabilitation. As of December 31, 2019, the net amount recoverable from SRUS was $47. The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business.

On July 9, 2019, Pavonia Life Insurance Company of Michigan ("Pavonia"), a Michigan domiciled life, accident, and health insurance company, was placed into rehabilitation.  While the court order indicated that Pavonia had a stable financial condition and lack of non-insurance affiliated investments, the Director of the Michigan Department of Insurance and Financial Services ("MDIFS") has concerns relating to Pavonia's parent company. To insulate Pavonia from its parent until a pending acquisition transaction could be consummated, MDIFS placed Pavonia under supervision and rehabilitation. As of December 31, 2019, the net amount recoverable from Pavonia was $85.  The financial exposure related to these ceded reserves are substantially mitigated via a reinsurance agreement whereby Wilton Re assumes treaty non-performance including credit risk for this business.

XML

Intangibles

12 Months Ended

Dec. 31, 2019

Goodwill and Intangible Assets Disclosure [Abstract]

Intangibles

Intangibles

A summary of the changes in the carrying amounts of the Company's VOBA, DAC and DSI intangible assets are as follows:

	VOBA			DAC			DSI			Total
Balance at December 31, 2018	$	866		$	344		$	149		$	1,359
Deferrals	—			379			130			509
Amortization	(106		)	(30		)	(20		)	(156		)
Interest	18			13			4			35
Unlocking	(2		)	(2		)	(1		)	(5		)
Adjustment for net unrealized investment (gains) losses	(183		)	(74		)	(30		)	(287		)
Balance at December 31, 2019	$	593		$	630		$	232		$	1,455

	VOBA			DAC			DSI			Total
Balance at December 31, 2017	$	821		$	22		$	10		$	853
Deferrals	—			317			138			455
Amortization	(58		)	(4		)	(2		)	(64		)
Interest	19			4			1			24
Unlocking	(9		)	—			—			(9		)
Adjustment for net unrealized investment (gains) losses	93			5			2			100
Balance at December 31, 2018	$	866		$	344		$	149		$	1,359

	VOBA			DAC			DSI		Total
Balance at December 1, 2017	$	844		$	—		$	—	$	844
Deferrals	—			23			10		33
Amortization	(7		)	(1		)	—		(8		)
Interest	2			—			—		2
Unlocking	—			—			—		—
Adjustment for net unrealized investment (gains) losses	(18		)	—			—		(18		)
Balance at December 31, 2017	$	821		$	22		$	10	$	853

Predecessor	VOBA			DAC			DSI			Total
Balance at October 1, 2017	$	—		$	1,023		$	106		$	1,129
Deferrals	—			40			8			48
Amortization	(12		)	(39		)	(5		)	(56		)
Interest	2			7			1			10
Unlocking	7			4			(1		)	10
Adjustment for net unrealized investment (gains) losses	3			(4		)	—			(1		)
Balance at November 30, 2017	$	—		$	1,031		$	109		$	1,140

	VOBA			DAC			DSI			Total
Balance at October 1, 2016	$	19		$	921		$	86		$	1,026
Deferrals	—			88			12			100
Amortization	(31		)	(103		)	(2		)	(136		)
Interest	2			22			(11		)	13
Unlocking	6			(7		)	1			—
Adjustment for unrealized investment losses (gains)	122			103			—			225
Balance at December 31, 2016	$	118		$	1,024		$	86		$	1,228

Predecessor	VOBA			DAC			DSI			Total
Balance at September 30, 2016	$	19		$	921		$	86		$	1,026
Deferrals	—			293			43			336
Amortization	(65		)	(192		)	(23		)	(280		)
Interest	11			42			4			57
Unlocking	32			2			(4		)	30
Adjustment for net unrealized investment (gains) losses	3			(43		)	—			(40		)
Balance at September 30, 2017	$	—		$	1,023		$	106		$	1,129

Amortization of VOBA, DAC, and DSI is based on the historical, current and future expected gross margins or profits recognized, including investment gains and losses. The interest accrual rate utilized to calculate the accretion of interest on VOBA ranged from 0.05% to 4.01%. The adjustment for net unrealized investment losses (gains) represents the amount of VOBA, DAC, and DSI that would have been amortized if such unrealized gains and losses had been recognized. This is referred to as the “shadow adjustments” as the additional amortization is reflected in AOCI rather than the Consolidated Statements of Operations. As of December 31, 2019 and 2018, the VOBA balances included cumulative adjustments for net unrealized investment (gains) losses of $(108), and $75, respectively, the DAC balances included cumulative adjustments for net unrealized investment (gains) losses of $(70) and $5, respectively, and the DSI balances included net unrealized investment (gains) losses of $(28) and $2 respectively.

Estimated amortization expense for VOBA in future fiscal periods is as follows:

	Estimated Amortization Expense
Fiscal Year
2020	62
2021	85
2022	80
2023	72
2024	65
Thereafter	337

The Company had an unearned revenue balance of $(43) as of December 31, 2019, including deferrals of $(41), amortization of $(4), interest of $(2), unlocking of $1, and adjustment for net unrealized investment gains (losses) of $44. The Company had an unearned revenue balance of $(41) as of December 31, 2018, including deferrals of $(37), amortization of $18, unlocking of $4, and adjustment for net unrealized investment gains (losses) of $(26).

Definite and Indefinite Lived Intangible Assets

On November 30, 2017, $467 of goodwill was recognized as a result of the FGL and FSR acquisitions. These transactions were accounted for separately using the acquisition method under which the Company recorded the identifiable assets acquired, including indefinite-lived and definite-lived intangible assets, and liabilities assumed, at their acquisition date fair values.

Other identifiable intangible assets as of December 31, 2019 consist of the following:

	December 31, 2019
	Cost		Accumulated amortization		Net carrying amount		Weighted average useful life (years)
Trade marks / trade names	$	16	$	4	$	12	10
State insurance licenses	6		N/A		6		Indefinite
Total					$	18

XML

Cover - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2019	Feb. 24, 2020	Jun. 30, 2019
Entity Information [Line Items]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2019
Document Transition Report	false
Entity File Number	001-37779
Entity Registrant Name	FGL HOLDINGS
Entity Incorporation, State or Country Code	E9
Entity Tax Identification Number	98-1354810
Entity Address, Address Line One	4th Floor
Entity Address, Address Line Two	Boundary Hall, Cricket Square
Entity Address, City or Town	Grand Cayman
Entity Address, Country	KY
Entity Address, Postal Zip Code	KY1-1102
City Area Code	800
Local Phone Number	445-6758
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 1,214
Entity Common Stock, Shares Outstanding		221,807,598
Amendment Flag	false
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	FY
Entity Central Index Key	0001668428
Current Fiscal Year End Date	--12-31
Ordinary shares, par value $.0001 per share
Entity Information [Line Items]
Title of 12(b) Security	Ordinary shares, par value $.0001 per share
Trading Symbol	FG
Warrants to purchase ordinary shares
Entity Information [Line Items]
Title of 12(b) Security	Warrants to purchase ordinary shares
Trading Symbol	FG WS

XML

Fair Value of Financial Instruments (Tables)

12 Months Ended

Dec. 31, 2019

Fair Value Disclosures [Abstract]

Assets and Liabilities Carrying at Fair Value on Recurring Basis

	December 31, 2019
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	969	$	—	$	—	$	969	$	969
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,866		828		5,694		5,694
Commercial mortgage-backed securities	—		2,895		27		2,922		2,922
Corporates	—		10,305		1,292		11,597		11,597
Hybrids	299		718		10		1,027		1,027
Municipals	—		1,301		42		1,343		1,343
Residential mortgage-backed securities	—		408		546		954		954
U.S. Government	28		6		—		34		34
Foreign Governments	—		137		18		155		155
Equity securities	387		614		1		1,002		1,002
Derivative investments	—		587		—		587		587
Other invested assets	—		—		46		46		46
Funds withheld for reinsurance receivables, at fair value	314		1,856		1		2,171		2,171
Total financial assets at fair value	$	1,997	$	23,693	$	2,811	$	28,501	$	28,501
Liabilities
Fair value of future policy benefits	—		—		1,953		1,953		1,953
Derivatives:
FIA embedded derivatives, included in contractholder funds	$	—	$	—	$	3,235	$	3,235	$	3,235
Reinsurance related embedded derivative, included in other liabilities	—		33		—		33		33
Preferred shares reimbursement feature embedded derivative	—		—		16		16		16
Total financial liabilities at fair value	$	—	$	33	$	5,204	$	5,237	$	5,237

	December 31, 2018
	Level 1		Level 2		Level 3		Fair Value		Carrying Amount
Assets
Cash and cash equivalents	$	571	$	—	$	—	$	571	$	571
Fixed maturity securities, available-for-sale:
Asset-backed securities	—		4,388		444		4,832		4,832
Commercial mortgage-backed securities	—		2,470		67		2,537		2,537
Corporates	—		9,150		1,231		10,381		10,381
Hybrids	265		626		10		901		901
Municipals	—		1,150		37		1,187		1,187
Residential mortgage-backed securities	—		417		614		1,031		1,031
U.S. Government	114		5		—		119		119
Foreign Governments	—		105		16		121		121
Equity securities	454		874		4		1,332		1,332
Derivative investments	—		97		—		97		97
Other invested assets	—		—		39		39		39
Funds withheld for reinsurance receivables, at fair value	177		576		4		757		757
Total financial assets at fair value	$	1,581	$	19,858	$	2,466	$	23,905	$	23,905
Liabilities
Fair value of future policy benefits	—		—		725		725		725
Derivatives:
FIA embedded derivatives, included in contractholder funds	—		—		2,476		2,476		2,476
Preferred shares reimbursement feature embedded derivative	—		—		29		29		29
Total financial liabilities at fair value	$	—	$	—	$	3,230	$	3,230	$	3,230

The following tables provide the carrying value and estimated fair value of our financial instruments that are carried on the Consolidated Balance Sheets at amounts other than fair value, summarized according to the fair value hierarchy previously described.

	December 31, 2019
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	62	$	—	$	62	$	62
Commercial mortgage loans	—		—		435		435		422
Residential mortgage loans	—		—		848		848		845
Policy loans, included in other invested assets	—		—		14		14		28
Company-owned life insurance	—		—		129		129		129
Affiliated bank loan	—		—		28		28		28
Funds withheld for reinsurance receivables, at fair value	—		—		1		1		1
Total	$	—	$	62	$	1,455	$	1,517	$	1,515
Liabilities
Investment contracts, included in contractholder funds	$	—	$	—	$	19,285	$	19,285	$	22,449
Debt	—		578		—		578		542
Total	$	—	$	578	$	19,285	$	19,863	$	22,991

	December 31, 2018
	Level 1		Level 2		Level 3		Total Estimated Fair Value		Carrying Amount
Assets
FHLB common stock	$	—	$	52	$	—	$	52	$	52
Commercial mortgage loans	—		—		483		483		482
Residential mortgage loans	—		—		187		187		185
Policy loans, included in other invested assets	—		—		11		11		22
Affiliated other invested assets	—		—		39		39		39
Total	$	—	$	52	$	720	$	772	$	780
Liabilities
Investment contracts, included in contractholder funds	$	—	$	—	$	18,358	$	18,358	$	20,911
Debt	—		520		—		520		541
Total	$	—	$	520	$	18,358	$	18,878	$	21,452

Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis

Quantitative information regarding significant unobservable inputs used for recurring Level 3 fair value measurements of financial instruments carried at fair value as of December 31, 2019 and December 31, 2018 are as follows: 

	Fair Value at				Range (Weighted average)
	December 31, 2019		Valuation Technique	Unobservable Input(s)	December 31, 2019
Assets
Asset-backed securities	$	801	Broker-quoted	Offered quotes	98.65% - 119.35% (102.02%)
Asset-backed securities	27		Third-Party Valuation	Offered quotes	0.00% - 99.43% (35.96%)
Commercial mortgage-backed securities	27		Broker-quoted	Offered quotes	100.15% - 127.60% (126.82%)
Corporates	346		Broker-quoted	Offered quotes	83.51% - 106.73% (99.56%)
Corporates	946		Third-Party Valuation	Offered quotes	98.58% - 119.44% (105.06%)
Hybrids	10		Third-Party Valuation	Offered quotes	104.72% - 104.72% (104.72%)
Municipals	42		Third-Party Valuation	Offered quotes	127.68% - 127.68% (127.68%)
Residential mortgage-backed securities	546		Broker-quoted	Offered quotes	0.00% - 106.50% (106.28%)
Foreign governments	18		Third-Party Valuation	Offered quotes	110.12% - 118.09% (112.61%)
Equity securities (Salus preferred equity)	1		Income-Approach	Yield	2.47%
Other invested assets:
Available-for-sale embedded derivative (AnchorPath)	21		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit linked note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables at fair value	1		Broker-quoted	Offered quotes	100.00%
Total	$	2,811
Liabilities
Future policy benefits	$	1,953	Discounted cash flow	Market value of option	0.00% - 11.20% (2.50%)
				Mortality multiplier	80.00% - 120.00% (95.46%)
				Surrender rates	0.00% - 55.00% (21.18%)
				Partial withdrawals	0.00% - 4.00% (2.28%)
				Non-performance spread	0.00% - 0.08% (0.03%)
				Option cost	0.00% - 5.02% (1.28%)
				Risk margin to reflect uncertainty	0.23% - 0.96% (0.34%)
				Morbidity risk margin	0.00% - 2.00% (0.07%)
Derivatives:
FIA embedded derivatives included in contractholder funds	3,235		Discounted cash flow	Market value of option	0.00% - 32.54% (3.64%)
				SWAP rates	1.73% - 1.90% (1.81%)
				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.64%)

				Partial withdrawals	2.00% - 3.50% (2.53%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.18% - 16.61% (2.12%)
Preferred shares reimbursement feature embedded derivative	16		Black Derman Toy model	Credit Spread	3.81%
				Yield Volatility	20.00%
Total liabilities at fair value	$	5,204

	Fair Value at				Range (Weighted average)
	December 31, 2018		Valuation Technique	Unobservable Input(s)	December 31, 2018
Assets
Asset-backed securities	$	405	Broker-quoted	Offered quotes	97.00% - 102.00% (99.77%)
Asset-backed securities	24		Matrix Pricing	Quoted prices	96.07% - 96.07% (96.07%)
Asset-backed securities	15		Third-Party Valuation	Offered quotes	0.00% - 99.29% (23.05%)
Commercial mortgage-backed securities	43		Broker-quoted	Offered quotes	77.12% - 100.08% (85.46%)
Commercial mortgage-backed securities	24		Matrix Pricing	Quoted prices	117.72% - 117.72% (117.72%)
Corporates	577		Broker-quoted	Offered quotes	74.63% - 104.62% (97.80%)
Corporates	654		Matrix Pricing	Quoted prices	91.74% - 113.25% (98.86%)
Hybrids	10		Matrix Pricing	Quoted prices	96.60% - 96.60% (96.60%)
Municipals	37		Broker-quoted	Offered quotes	111.23% - 111.23% (111.23%)
Residential mortgage-backed securities	614		Broker-quoted	Offered quotes	89.80% - 100.99% (100.73%)
Foreign governments	16		Broker-quoted	Offered quotes	98.38% - 99.01% (98.58%)
Equity securities (Salus preferred equity)	4		Income-Approach	Yield	7.15%
Other invested assets:
Available-for-sale embedded derivative (AnchorPath)	14		Black Scholes model	Market value of AnchorPath fund	100.00%
Credit linked note	25		Broker-quoted	Offered quotes	100.00%
Funds withheld for reinsurance receivables, at fair value	4		Matrix pricing	Calculated prices	100.00%
Total	$	2,466
Liabilities
Future policy benefits	$	725	Discounted cash flow	Non-Performance risk spread	0.00% - 0.22% (0.18%)
				Risk margin to reflect uncertainty	0.35% - 0.71% (0.68%)
Derivatives:
FIA embedded derivatives included in contractholder funds	$	2,476	Discounted cash flow	Market value of option	0.00% - 31.06% (0.94%)
				SWAP rates	2.57% - 2.71% (2.63%)
				Mortality multiplier	80.00% - 80.00% (80.00%)
				Surrender rates	0.50% - 75.00% (5.90%)
				Partial withdrawals	1.00% - 2.50% (2.00%)
				Non-performance spread	0.25% - 0.25% (0.25%)
				Option cost	0.11% - 16.61% (2.18%)
Preferred shares reimbursement feature embedded derivative	$	29	Black Derman Toy model	Credit Spread	5.14%
				Yield Volatility	20.00%
Total liabilities at fair value	$	3,230

Changes in Fair Value of Financial Instruments - Assets

The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, Predecessor period from October 1, 2017 to November 30, 3017, Predecessor period from October 1, 2016 to December 31, 2016, and the Predecessor year ended September 30, 2017, respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.

	Year ended December 31, 2019
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	444	$	—		$	19		$	675	$	—		$	(128	)	$	(182	)	$	828
Commercial mortgage-backed securities	67		—			5			1		—			(10		)	(36		)	27
Corporates	1,231		—			69			221		(106		)	(133		)	10			1,292
Hybrids	10		—			—			—		—			—			—			10
Municipals	37		—			5			—		—			—			—			42
Residential mortgage-backed securities	614		—			27			25		—			(91		)	(29		)	546
Foreign governments	16		—			2			—		—			—			—			18
Equity securities	4		(2		)	(1		)	—		—			—			—			1
Other invested assets:
Available-for-sale embedded derivative	14		7			—			—		—			—			—			21
Credit linked note	25		—			—			—		—			—			—			25
Funds withheld for reinsurance receivables, at fair value	4		—			—			20		(1		)	—			(22		)	1
Total assets at Level 3 fair value	$	2,466	$	5		$	126		$	942	$	(107	)	$	(362	)	$	(259	)	$	2,811
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,476	$	759		$	—		$	—	$	—		$	—		$	—		$	3,235
Future policy benefits (F&G Re and FSRC)	725		123			15			—		—			1,090			—			1,953
Preferred shares reimbursement feature embedded derivative	29		(13		)	—			—		—			—			—			16
Total liabilities at Level 3 fair value	$	3,230	$	869		$	15		$	—	$	—		$	1,090		$	—		$	5,204

(a) The net transfers out of Level 3 during the year ended December 31, 2019 were exclusively to Level 2.

	Year ended December 31, 2018
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	412	$	—		$	(4	)	$	476	$	—		$	(28	)	$	(412	)	$	444
Commercial mortgage-backed securities	49		—			(3		)	46		—			(6		)	(19		)	67
Corporates	1,169		—			(29		)	288		—			(126		)	(71		)	1,231
Hybrids	10		—			—			—		—			—			—			10
Municipals	38		—			(1		)	—		—			—			—			37
Residential mortgage-backed securities	66		—			5			560		(1		)	(15		)	(1		)	614
Foreign governments	17		—			(1		)	—		—			—			—			16
Equity securities	3		1			—			—		—			—			—			4
Other invested assets:
Available-for-sale embedded derivative	17		(3		)	—			—		—			—			—			14
Credit linked note	—		—			—			25		—			—			—			25
Funds withheld for reinsurance receivables, at fair value	4		—			—			6		—			(4		)	(2		)	4
Total assets at Level 3 fair value	$	1,785	$	(2	)	$	(33	)	$	1,401	$	(1	)	$	(179	)	$	(505	)	$	2,466
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,277	$	199		$	—		$	—	$	—		$	—		$	—		$	2,476
Future policy benefits (F&G Re and FSRC)	728		(45		)	(4		)	—		—			46			—			725
Preferred shares reimbursement feature embedded derivative	23		6			—			—		—			—			—			29
Total liabilities at Level 3 fair value	$	3,028	$	160		$	(4	)	$	—	$	—		$	46		$	—		$	3,230

(a) The net transfers out of Level 3 during the year ended December 31, 2018 were exclusively to Level 2.

	Period from December 1 to December 31, 2017
	Balance at Beginning of Period		Total Gains (Losses)					Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	225	$	—		$	—	$	143	$	—		$	(1	)	$	45		$	412
Commercial mortgage-backed securities	49		—			—		—		—			—			—			49
Corporates	1,163		—			2		30		(10		)	(16		)	—			1,169
Hybrids	10		—			—		—		—			—			—			10
Municipals	38		—			—		—		—			—			—			38
Residential mortgage-backed securities	67		—			—		—		—			(1		)	—			66
Foreign governments	17		—			—		—		—			—			—			17
Equity securities	38		—			—		—		—			—			(35		)	3
Other invested assets:
Available-for-sale embedded derivative	17		—			—		—		—			—			—			17
HGI Energy Note	20		—			—		—		(20		)	—			—			—
Funds withheld for reinsurance receivables, at fair value	4		—			—		—		—			—			—			4
Total assets at Level 3 fair value	$	1,648	$	—		$	2	$	173	$	(30	)	$	(18	)	$	10		$	1,785
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,331	$	(54	)	$	—	$	—	$	—		$	—		$	—		$	2,277
Future policy benefits (FSRC)	723		9			—		—		—			(4		)	—			728
Preferred shares reimbursement feature embedded derivative	23		—			—		—		—			—			—			23
Total liabilities at Level 3 fair value	$	3,077	$	(45	)	$	—	$	—	$	—		$	(4	)	$	—		$	3,028

(a) The net transfers out of Level 3 during the period from December 1 to December 31, 2017 were exclusively to Level 2.

	Period from October 1 to November 30, 2017
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales		Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	159	$	—		$	—		$	95	$	—	$	—		$	(29	)	$	225
Commercial mortgage-backed securities	95		—			(1		)	—		—		—			(45		)	49
Corporates	1,097		—			—			67		—		(19		)	18			1,163
Hybrids	10		—			—			—		—		—			—			10
Municipals	38		—			—			—		—		—			—			38
Residential mortgage-backed securities	15		—			1			51		—		—			—			67
Foreign governments	17		—			—			—		—		—			—			17
Equity securities	2		—			—			—		—		—			35			37
Other invested assets:
Available-for-sale embedded derivative	16		1			—			—		—		—			—			17
Total assets at Level 3 fair value	$	1,449	$	1		$	—		$	213	$	—	$	(19	)	$	(21	)	$	1,623
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,627	$	(296	)	$	—		$	—	$	—	$	—		$	—		$	2,331
Total liabilities at Level 3 fair value	$	2,627	$	(296	)	$	—		$	—	$	—	$	—		$	—		$	2,331

(a) The net transfers out of Level 3 during the Predecessor period from October 1 to November 30, 2017 were exclusively to Level 2.

	Period from October 1 to December 31, 2016 (Unaudited)
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	172	$	(1	)	$	(1	)	$	63	$	—		$	(7	)	$	(29	)	$	197
Commercial mortgage-backed securities	79		—			(2		)	8		—			—			—			85
Corporates	1,104		(1		)	(41		)	51		(5		)	(48		)	1			1,061
Hybrids	—		—			—			10		—			—			—			10
Municipals	41		—			(3		)	—		—			(1		)	—			37
Foreign governments	17		—			—			—		—			—			—			17
Equity securities	3		(2		)	—			—		—			—			—			1
Other invested assets:
Available-for-sale embedded derivative	13		—			—			—		—			—			—			13
Loan participations	21		(1		)	—			—		—			(14		)	—			6
Total assets at Level 3 fair value	$	1,450	$	(5	)	$	(47	)	$	132	$	(5	)	$	(70	)	$	(28	)	$	1,427
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,383	$	(133	)	$	—		$	—	$	—		$	—		$	—		$	2,250
Total liabilities at Level 3 fair value	$	2,383	$	(133	)	$	—		$	—	$	—		$	—		$	—		$	2,250

(a) The net transfers out of Level 3 during the Predecessor period from October 1 to December 30, 2016 (unaudited) were exclusively to Level 2.

	Year ended September 30, 2017
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	172	$	(2	)	$	2		$	152	$	—		$	(40	)	$	(125	)	$	159
Commercial mortgage-backed securities	79		—			1			18		—			(1		)	(2		)	95
Corporates	1,104		(1		)	(29		)	189		(20		)	(109		)	(37		)	1,097
Hybrids	—		—			—			10		—			—			—			10
Municipals	41		—			(2		)	—		—			(1		)	—			38
Residential mortgage-backed securities	—		—			1			—		—			—			14			15
Foreign governments	17		—			—			—		—			—			—			17
Equity securities	3		(2		)	1			—		—			—			—			2
Other invested assets:
Available-for-sale embedded derivative	13		3			—			—		—			—			—			16
Loan participations	21		(2		)	1			—		—			(20		)	—			—
Total assets at Level 3 fair value	$	1,450	$	(4	)	$	(25	)	$	369	$	(20	)	$	(171	)	$	(150	)	$	1,449
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,383	$	244		$	—		$	—	$	—		$	—		$	—		$	2,627
Total liabilities at Level 3 fair value	$	2,383	$	244		$	—		$	—	$	—		$	—		$	—		$	2,627

(a) The net transfers out of Level 3 during the Predecessor year ended September 30, 2017 were exclusively to Level 2.

Changes in Fair Value of Financial Instruments - Liabilities

The following tables summarize changes to the Company’s financial instruments carried at fair value and classified within Level 3 of the fair value hierarchy for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, Predecessor period from October 1, 2017 to November 30, 3017, Predecessor period from October 1, 2016 to December 31, 2016, and the Predecessor year ended September 30, 2017, respectively. This summary excludes any impact of amortization of VOBA and DAC. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.

	Year ended December 31, 2019
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	444	$	—		$	19		$	675	$	—		$	(128	)	$	(182	)	$	828
Commercial mortgage-backed securities	67		—			5			1		—			(10		)	(36		)	27
Corporates	1,231		—			69			221		(106		)	(133		)	10			1,292
Hybrids	10		—			—			—		—			—			—			10
Municipals	37		—			5			—		—			—			—			42
Residential mortgage-backed securities	614		—			27			25		—			(91		)	(29		)	546
Foreign governments	16		—			2			—		—			—			—			18
Equity securities	4		(2		)	(1		)	—		—			—			—			1
Other invested assets:
Available-for-sale embedded derivative	14		7			—			—		—			—			—			21
Credit linked note	25		—			—			—		—			—			—			25
Funds withheld for reinsurance receivables, at fair value	4		—			—			20		(1		)	—			(22		)	1
Total assets at Level 3 fair value	$	2,466	$	5		$	126		$	942	$	(107	)	$	(362	)	$	(259	)	$	2,811
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,476	$	759		$	—		$	—	$	—		$	—		$	—		$	3,235
Future policy benefits (F&G Re and FSRC)	725		123			15			—		—			1,090			—			1,953
Preferred shares reimbursement feature embedded derivative	29		(13		)	—			—		—			—			—			16
Total liabilities at Level 3 fair value	$	3,230	$	869		$	15		$	—	$	—		$	1,090		$	—		$	5,204

(a) The net transfers out of Level 3 during the year ended December 31, 2019 were exclusively to Level 2.

	Year ended December 31, 2018
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	412	$	—		$	(4	)	$	476	$	—		$	(28	)	$	(412	)	$	444
Commercial mortgage-backed securities	49		—			(3		)	46		—			(6		)	(19		)	67
Corporates	1,169		—			(29		)	288		—			(126		)	(71		)	1,231
Hybrids	10		—			—			—		—			—			—			10
Municipals	38		—			(1		)	—		—			—			—			37
Residential mortgage-backed securities	66		—			5			560		(1		)	(15		)	(1		)	614
Foreign governments	17		—			(1		)	—		—			—			—			16
Equity securities	3		1			—			—		—			—			—			4
Other invested assets:
Available-for-sale embedded derivative	17		(3		)	—			—		—			—			—			14
Credit linked note	—		—			—			25		—			—			—			25
Funds withheld for reinsurance receivables, at fair value	4		—			—			6		—			(4		)	(2		)	4
Total assets at Level 3 fair value	$	1,785	$	(2	)	$	(33	)	$	1,401	$	(1	)	$	(179	)	$	(505	)	$	2,466
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,277	$	199		$	—		$	—	$	—		$	—		$	—		$	2,476
Future policy benefits (F&G Re and FSRC)	728		(45		)	(4		)	—		—			46			—			725
Preferred shares reimbursement feature embedded derivative	23		6			—			—		—			—			—			29
Total liabilities at Level 3 fair value	$	3,028	$	160		$	(4	)	$	—	$	—		$	46		$	—		$	3,230

(a) The net transfers out of Level 3 during the year ended December 31, 2018 were exclusively to Level 2.

	Period from December 1 to December 31, 2017
	Balance at Beginning of Period		Total Gains (Losses)					Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	225	$	—		$	—	$	143	$	—		$	(1	)	$	45		$	412
Commercial mortgage-backed securities	49		—			—		—		—			—			—			49
Corporates	1,163		—			2		30		(10		)	(16		)	—			1,169
Hybrids	10		—			—		—		—			—			—			10
Municipals	38		—			—		—		—			—			—			38
Residential mortgage-backed securities	67		—			—		—		—			(1		)	—			66
Foreign governments	17		—			—		—		—			—			—			17
Equity securities	38		—			—		—		—			—			(35		)	3
Other invested assets:
Available-for-sale embedded derivative	17		—			—		—		—			—			—			17
HGI Energy Note	20		—			—		—		(20		)	—			—			—
Funds withheld for reinsurance receivables, at fair value	4		—			—		—		—			—			—			4
Total assets at Level 3 fair value	$	1,648	$	—		$	2	$	173	$	(30	)	$	(18	)	$	10		$	1,785
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,331	$	(54	)	$	—	$	—	$	—		$	—		$	—		$	2,277
Future policy benefits (FSRC)	723		9			—		—		—			(4		)	—			728
Preferred shares reimbursement feature embedded derivative	23		—			—		—		—			—			—			23
Total liabilities at Level 3 fair value	$	3,077	$	(45	)	$	—	$	—	$	—		$	(4	)	$	—		$	3,028

(a) The net transfers out of Level 3 during the period from December 1 to December 31, 2017 were exclusively to Level 2.

	Period from October 1 to November 30, 2017
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales		Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	159	$	—		$	—		$	95	$	—	$	—		$	(29	)	$	225
Commercial mortgage-backed securities	95		—			(1		)	—		—		—			(45		)	49
Corporates	1,097		—			—			67		—		(19		)	18			1,163
Hybrids	10		—			—			—		—		—			—			10
Municipals	38		—			—			—		—		—			—			38
Residential mortgage-backed securities	15		—			1			51		—		—			—			67
Foreign governments	17		—			—			—		—		—			—			17
Equity securities	2		—			—			—		—		—			35			37
Other invested assets:
Available-for-sale embedded derivative	16		1			—			—		—		—			—			17
Total assets at Level 3 fair value	$	1,449	$	1		$	—		$	213	$	—	$	(19	)	$	(21	)	$	1,623
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,627	$	(296	)	$	—		$	—	$	—	$	—		$	—		$	2,331
Total liabilities at Level 3 fair value	$	2,627	$	(296	)	$	—		$	—	$	—	$	—		$	—		$	2,331

(a) The net transfers out of Level 3 during the Predecessor period from October 1 to November 30, 2017 were exclusively to Level 2.

	Period from October 1 to December 31, 2016 (Unaudited)
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	172	$	(1	)	$	(1	)	$	63	$	—		$	(7	)	$	(29	)	$	197
Commercial mortgage-backed securities	79		—			(2		)	8		—			—			—			85
Corporates	1,104		(1		)	(41		)	51		(5		)	(48		)	1			1,061
Hybrids	—		—			—			10		—			—			—			10
Municipals	41		—			(3		)	—		—			(1		)	—			37
Foreign governments	17		—			—			—		—			—			—			17
Equity securities	3		(2		)	—			—		—			—			—			1
Other invested assets:
Available-for-sale embedded derivative	13		—			—			—		—			—			—			13
Loan participations	21		(1		)	—			—		—			(14		)	—			6
Total assets at Level 3 fair value	$	1,450	$	(5	)	$	(47	)	$	132	$	(5	)	$	(70	)	$	(28	)	$	1,427
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,383	$	(133	)	$	—		$	—	$	—		$	—		$	—		$	2,250
Total liabilities at Level 3 fair value	$	2,383	$	(133	)	$	—		$	—	$	—		$	—		$	—		$	2,250

(a) The net transfers out of Level 3 during the Predecessor period from October 1 to December 30, 2016 (unaudited) were exclusively to Level 2.

	Year ended September 30, 2017
	Predecessor
	Balance at Beginning of Period		Total Gains (Losses)						Purchases		Sales			Settlements			Net transfer In (Out) of Level 3 (a)			Balance at End of Period
			Included in Earnings			Included in AOCI
Assets
Fixed maturity securities available-for-sale:
Asset-backed securities	$	172	$	(2	)	$	2		$	152	$	—		$	(40	)	$	(125	)	$	159
Commercial mortgage-backed securities	79		—			1			18		—			(1		)	(2		)	95
Corporates	1,104		(1		)	(29		)	189		(20		)	(109		)	(37		)	1,097
Hybrids	—		—			—			10		—			—			—			10
Municipals	41		—			(2		)	—		—			(1		)	—			38
Residential mortgage-backed securities	—		—			1			—		—			—			14			15
Foreign governments	17		—			—			—		—			—			—			17
Equity securities	3		(2		)	1			—		—			—			—			2
Other invested assets:
Available-for-sale embedded derivative	13		3			—			—		—			—			—			16
Loan participations	21		(2		)	1			—		—			(20		)	—			—
Total assets at Level 3 fair value	$	1,450	$	(4	)	$	(25	)	$	369	$	(20	)	$	(171	)	$	(150	)	$	1,449
Liabilities
FIA embedded derivatives, included in contractholder funds	$	2,383	$	244		$	—		$	—	$	—		$	—		$	—		$	2,627
Total liabilities at Level 3 fair value	$	2,383	$	244		$	—		$	—	$	—		$	—		$	—		$	2,627

(a) The net transfers out of Level 3 during the Predecessor year ended September 30, 2017 were exclusively to Level 2.

Schedule of Net Asset Value

The following table includes assets that have not been classified in the fair value hierarchy as the fair value of these investments is measured using the net asset value per share practical expedient. For further discussion about this adoption see “Note 2. Significant Accounting Policies and Practices”.

	Carrying Value After Measurement
	December 31, 2019		December 31, 2018
Equity securities available-for-sale	$	69	$	50
Limited partnership investment, included in other invested assets	1,010		510

Gross Transfers Into and Out of Certain Fair Value Levels by Asset Class

The Company’s assessment resulted in gross transfers into and gross transfers out of certain fair value levels by asset class for the years ended December 31, 2019 and December 31, 2018, the period from December 1, 2017 to December 31, 2017, the Predecessor period from October 1, 2017 to November 30, 2017, the Predecessor period from October 1, 2016 to December 31, 2016 (unaudited), and the Predecessor year ended September 30, 2017, are as follows: 

	Transfers Between Fair Value Levels
	Level 1				Level 2				Level 3
	In		Out		In		Out		In		Out
Year ended December 31, 2019
Asset-backed securities	$	—	$	—	$	233	$	51	$	51	$	233
Commercial mortgage-backed securities	—		—		37		1		1		37
Corporates	—		—		1		11		11		1
Residential mortgage-backed securities	—		—		29		—		—		29
Equity securities	7		29		29		7		16		16
Funds withheld for reinsurance receivables	—		—		22		—		—		22
Total transfers	$	7	$	29	$	351	$	70	$	79	$	338
Year ended December 31, 2018
Asset-backed securities	$	—	$	—	$	425	$	13	$	13	$	425
Commercial mortgage-backed securities	—		—		28		9		9		28
Corporates	—		—		75		4		4		75
Hybrids	20		—		—		20		—		—
Residential mortgage-backed securities	—		—		36		35		35		36
Equity securities	25		30		30		25		—		—
Funds withheld for reinsurance receivables	—		—		2		—		—		2
Total transfers	$	45	$	30	$	596	$	106	$	61	$	566
Period from December 1 to December 31, 2017
Asset-backed securities	$	—	$	—	$	1	$	46	$	46	$	1
Commercial mortgage-backed securities	—		—		1		—		—		1
Hybrids	27		15		15		27		—		—
Equity securities	53		26		61		53		—		35
Total transfers	$	80	$	41	$	78	$	126	$	46	$	37
Predecessor
Period from October 1 to November 30, 2017
Asset-backed securities	$	—	$	—	$	29	$	—	$	—	$	29
Commercial mortgage-backed securities	—		—		46		1		1		46
Corporates	—		—		—		18		18		—
Hybrids	244		—		—		244		—		—
Equity securities	374		—		—		409		35		—
Total transfers	$	618	$	—	$	75	$	672	$	54	$	75
Predecessor
Period from October 1 to December 31, 2016 (Unaudited)
Asset-backed securities	$	—	$	—	$	68	$	39	$	39	$	68
Corporates	—		—		4		5		5		4
Total transfers	$	—	$	—	$	72	$	44	$	44	$	72
Predecessor
Year ended September 30, 2017
Asset-backed securities	$	—	$	—	$	222	$	112	$	112	$	222
Commercial mortgage-backed securities	—		—		7		6		6		7
Corporates	—		—		49		10		10		49
Total transfers	$	—	$	—	$	278	$	128	$	128	$	278

XML

Significant Accounting Policies and Practices (Policies)

12 Months Ended

Dec. 31, 2019

Accounting Policies [Abstract]

Principles of Consolidation

Principles of Consolidation

The accompanying audited consolidated financial statements include the accounts of the Company and all other entities in which the Company has a controlling financial interest. All intercompany accounts and transactions have been eliminated in consolidation.

VIE

We are involved in certain entities that are considered variable interest entities ("VIEs") as defined under U.S. GAAP. Our involvement with VIEs is primarily to invest in assets that allow us to gain exposure to a broadly diversified portfolio of asset classes. A VIE is an entity that does not have sufficient equity to finance its own activities without additional financial support or where investors lack certain characteristics of a controlling financial interest. We assess our relationships to determine if we have the ability to direct the activities, or otherwise exert control, to evaluate if we are the primary beneficiary of the VIE. If we determine we are the primary beneficiary of a VIE, we consolidate the assets and liabilities of the VIE in our audited consolidated financial statements. See "Note 4. Investments" for additional information on the Company’s investments in VIEs.

Revenue Recognition

Revenue Recognition

Insurance Premiums

The Company’s insurance premiums for traditional life insurance products are recognized as revenue when due from the contractholder. The Company’s traditional life insurance products include those products with fixed and guaranteed premiums and benefits and consist primarily of term life insurance and certain annuities with life contingencies, net of premiums ceded under reinsurance.

Premium collections for fixed indexed and fixed rate annuities, indexed universal life (“IUL”) policies and immediate annuities without life contingency are reported as an increase to deposit liabilities (i.e., contractholder funds) instead of as revenues. Similarly, cash payments to policyholders are reported as decreases in the liability for contractholder funds and not as expenses. Sources of revenues for products accounted for as deposit liabilities are net investment income, surrender and other charges deducted from contractholder funds, and net realized gains (losses) on investments. Surrender charges are earned when a policyholder withdraws funds from the contract early or cancels the contract. Other income related to riders is earned when elected by the policyholder.

See a description of FSRC’s and F&G Re's accounting policy for its assumed reinsurance contracts as described under "Reinsurance".

Net Investment Income

Dividends and interest income are recorded in “Net investment income” and recognized when earned. Income or losses upon call or prepayment of available-for-sale fixed maturity securities are recognized in "Net investment income". Amortization of premiums and accretion of discounts on investments in fixed maturity securities are reflected in “Net investment income” based on the earliest call date of the investments in a manner that produces a constant effective yield.

FSRC and F&G Re's dividends and interest income are recorded in "Net investment income" in the consolidated financial statements and are recognized on an accrual basis. Amortization of premiums and accretion of discounts on investment in debt securities are reflected in "Net investment income" over the contractual terms of the investments in a manner that produces a constant effective yield.

For mortgage-backed and asset-backed securities, included in the fixed maturity available-for-sale (“AFS”) securities portfolios, the Company recognizes income using a constant effective yield based on anticipated cash flows and the estimated economic life of the securities. When actual prepayments differ significantly from originally anticipated prepayments, the effective yield is generally recalculated prospectively to reflect actual payments to date plus anticipated future payments. Any adjustments resulting from changes in effective yield are reflected in “Net investment income’’.

"Net investment income" is presented net of earned investment management fees.

Net Investment Gains (Losses)

Net investment gains (losses) include realized gains and losses from the sale of investments, unrealized gains and losses on equity securities at fair value, write-downs for other-than-temporary impairments (“OTTI”) of AFS investments, and realized and unrealized gains and losses on derivatives and embedded derivatives. FSRC and F&G Re's net investment gains (losses) include realized losses and gains from the sale of investments, changes in

the fair value of funds withheld receivables and realized and unrealized gains and losses on derivative investments. Realized gains and losses on the sale of investments are determined using the specific identification method on the trade date.

Insurance and Investment Product Fees and Other

Product fee revenue from IUL products and annuities is comprised of policy and contract fees charged for the cost of insurance, policy administration and rider fees. Fees are assessed on a monthly basis and recognized as revenue when earned. Product fee revenue also includes surrender charges which are collected and recognized as revenue when the policy is surrendered.

Benefits and Other Changes in Policy Reserves

Benefits and Other Changes in Policy Reserves

Benefit expenses for deferred annuity, FIA and IUL policies include index credits and interest credited to contractholder account balances and benefit claims in excess of contract account balances, net of reinsurance recoveries, are charged to expense in the period that they are earned by the policyholder based on their selected strategy. Interest crediting rates associated with funds invested in the general account of our insurance subsidiaries during 2017 through 2019 ranged from 0.5% to 6.0% for deferred annuities and FIA's, combined, and 3.0% to 4.8% for IUL's. Other changes in policy reserves include the change in the fair value of the FIA embedded derivative and the change in the reserve for secondary guarantee benefit payments.

Other changes in policy reserves also include the change in reserves for life insurance products. For traditional life and immediate annuities, policy benefit claims are charged to expense in the period that the claims are incurred, net of reinsurance recoveries.

Stock-Based Compensation

Stock-Based Compensation

We expense the fair value of stock awards included in our incentive compensation plans. The Company issues stock options with three different types of vesting conditions. As of the date that there is a mutual understanding between the Company and the grantee of key terms of the awards, the fair value of stock options that vest based on service or non-market based performance conditions are determined using a Black-Scholes options valuation methodology. The Company uses a Monte Carlo simulation to determine the fair value of stock awards that vest based upon market conditions. The fair value of the awards is expensed over the performance or service period, which generally corresponds to the vesting period, and is recognized as an increase to “Additional paid-in capital” in “Shareholders’ equity”. We classify certain stock awards settled in cash as liabilities. For these awards, the fair value is classified as a liability on our Consolidated Balance Sheets, and the liability is marked-to-market through net income (loss) at the end of each reporting period. Stock-based compensation expense is reflected in “Acquisition and operating expenses, net of deferrals” on our Consolidated Statements of Operations.

Interest Expense

Interest Expense

Interest expense on our debt is recognized as due and any associated premiums, discounts, and issuance costs are amortized (accreted) over the term of the related borrowing utilizing the straight line method. Interest expense also includes non-use fees on the revolving line of credit facility

Earnings Per Share

Earnings Per Share

Basic earnings per share (“EPS”) is computed by dividing earnings available to common shareholders by the average common shares outstanding. Diluted EPS is computed assuming the conversion or exercise of nonvested stock, stock options, warrants and performance share units outstanding during the year. The effect of a potential conversion of outstanding preferred shares to common shares is not considered in the diluted EPS calculation as the preferred shareholders do not yet have the right to convert. Stock options and warrants are excluded from the computation of diluted EPS, based on the application of the treasury stock method, if they are anti-dilutive.

Cash and Cash Equivalents

Cash Equivalents

The Company considers money market funds and highly liquid debt instruments purchased with original maturities of three months or less to be cash equivalents. As of December 31, 2019 and December 31, 2018, the Company held cash equivalents of $38 and $84 respectively.

Investments

Investments

Investment Securities

The Company’s investments in fixed maturity securities have been designated as AFS and are carried at fair value with unrealized gains and losses included in “Accumulated other comprehensive income” (“AOCI”), net of associated intangible asset and unearned revenue ("UREV") “shadow adjustments” (discussed in "Note 7. Intangibles") and deferred income taxes. The Company's investments in equity securities are carried at fair value with unrealized gains and losses included in “Realized gains (losses)”. Prior to the adoption of ASU 2016-01, effective January 1, 2018, unrealized gains and losses on equity securities were included in AOCI.

Available-for-Sale Securities' Other-Than-Temporary Impairments

The Company regularly reviews AFS securities for declines in fair value that it determines to be other-than-temporary. Prior to the adoption of ASU 2016-01, for an equity security, if the Company did not have the ability and intent to hold the security for a sufficient and reasonable period of time to allow for a recovery in value, it concluded that an OTTI had occurred and the amortized cost of the security was written down to the current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. Following the adoption of ASU 2016-01, equity securities are no longer reviewed for OTTI. When assessing its ability and intent to hold a security to recovery, the Company considers, among other things, the severity and duration of the decline in fair value of the security as well as the cause of the decline, business prospects and the overall financial condition of the issuer. When evaluating redeemable preferred stocks for OTTI the Company applies the accounting policy described above for fixed maturity securities (including an anticipated recovery period), provided there has been no evidence of a deterioration in credit of the issuer.

For its fixed maturity AFS securities, the Company generally considers the following in determining whether its unrealized losses are other-than-temporary:

• The estimated period until recovery;

• The extent and the duration of the decline;

• The reasons for the decline in value (credit event, currency or interest-rate related, including general credit spread widening);

• The financial condition of and near-term prospects of the issuer (including issuer’s current credit rating and the probability of full recovery of principal based upon the issuer’s financial strength);

• Current delinquencies and nonperforming assets of underlying collateral;

• Expected future default rates;

• Collateral value by vintage, geographic region, industry concentration or property type;

• Subordination levels or other credit enhancements as of the balance sheet date as compared to origination; and

• Contractual and regulatory cash obligations and the issuer's plans to meet such obligations.

The Company recognizes OTTI on fixed maturity securities in an unrealized loss position when one of the following circumstances exists:

• The Company does not expect full recovery of its amortized cost based on the present value of cash flows expected to be collected;

• The Company intends to sell a security; or

• It is more likely than not that the Company will be required to sell a security prior to recovery.

If the Company intends to sell a fixed maturity AFS security or it is more likely than not the Company will be required to sell the security before recovery of its amortized cost basis and the fair value of the security is below amortized cost, the Company will conclude that an OTTI has occurred and the amortized cost is written down to current fair value, with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations. If the Company does not intend to sell a fixed maturity security or it is more likely than not the Company will not be required to sell a fixed maturity security before recovery of its amortized cost basis and the present value of the cash flows expected to be collected is less than the amortized cost of the security (referred to as the credit loss), an OTTI has occurred and the amortized cost is written down to the estimated recovery value with a corresponding charge to “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations, as this amount is deemed the credit loss portion of the OTTI. The remainder of the

decline to fair value is recorded in AOCI as an unrealized loss on AFS securities, as this amount is considered a non-credit impairment.

When assessing the Company’s intent to sell a fixed maturity security or if it is more likely than not the Company will be required to sell a fixed maturity security before recovery of its cost basis, the Company evaluates facts and circumstances at the individual security level based on facts and circumstances relevant to that security. Management also consider decisions to reposition the Company’s security portfolio, sale of securities to meet cash flow needs and sales of securities to capitalize on favorable pricing and tax planning strategies.

When evaluating mortgage-backed securities and asset-backed securities, the Company considers a number of pool-specific factors as well as market level factors when determining whether or not the impairment on the security is temporary or other-than-temporary. The most important factor is the performance of the underlying collateral in the security and the trends of that performance. The Company uses this information about the collateral to forecast the timing and rate of mortgage loan defaults, including making projections for loans that are already delinquent and for those loans that are currently performing but may become delinquent in the future. Other factors used in this analysis include type of underlying collateral (e.g., prime, Alternative A-paper (“Alt-A”), or subprime), geographic distribution of underlying loans and timing of liquidations by state. Once default rates and timing assumptions are determined, the Company then makes assumptions regarding the severity of a default if it were to occur. Factors that impact the severity assumption include expectations for future home price appreciation or depreciation, loan size, first lien versus second lien, existence of loan level private mortgage insurance, type of occupancy and geographic distribution of loans. Once default and severity assumptions are determined for the security in question, cash flows for the underlying collateral are projected, including expected defaults and prepayments. These cash flows on the collateral are then translated to cash flows on the Company’s tranche based on the cash flow waterfall of the entire capital security structure. If this analysis indicates the entire principal on a particular security will not be returned, the security is reviewed for OTTI by comparing the present value of expected future cash flows to amortized cost. To the extent that the security has already been impaired or was purchased at a discount, such that the amortized cost of the security is less than or equal to the present value of cash flows expected to be collected, no impairment is required. The Company also considers the ability of monoline insurers to meet their contractual guarantees on wrapped mortgage-backed securities. Otherwise, if the amortized cost of the security is greater than the present value of the cash flows expected to be collected, then an OTTI is recognized.

The Company includes the total OTTI recognized in "Net investment gains (losses)" in the Consolidated Statements of Operations, with an offset for the amount of non-credit impairments recognized in AOCI. See "Note 4. Investments"

Mortgage Loans on Real Estate

Mortgage Loans on Real Estate

The Company’s investment in mortgage loans consists of commercial and residential mortgage loans on real estate, which are reported at amortized cost, less impairment write-downs and allowance for losses. If a mortgage loan is determined to be impaired (i.e., when it is probable that the Company will be unable to collect all amounts due according to the contractual terms of the loan agreement or the loan is modified in a troubled debt restructuring), the carrying value of the mortgage loan is reduced to the lower of either the present value of expected cash flows from the loan, discounted at the loan’s original purchase yield, or fair value of the collateral. For those mortgages that are determined to require foreclosure, the carrying value is reduced to the fair value of the underlying collateral, net of estimated costs to obtain and sell at the point of foreclosure. The carrying value of the impaired loans is reduced by establishing an allowance with the offset recorded in "Net investment gains (losses)" in the Consolidated Statements of Operations.

Commercial mortgage loans are continuously monitored by reviewing appraisals, operating statements, rent revenues, annual inspection reports, loan specific credit quality, property characteristics, market trends and other factors.

Commercial mortgage loans are rated for the purpose of quantifying the level of risk. Loans are placed on a watch list when the debt service coverage ("DSC") ratio falls below and the loan-to-value ("LTV") ratios exceeds certain thresholds. Loans on the watchlist are closely monitored for collateral deficiency or other credit events that may lead to a potential loss of principal or interest. The Company defines delinquent mortgage loans as 30 days past due, consistent with industry practice.

Residential mortgage loans have a primary credit quality indicator of either a performing or nonperforming loan. The Company defines nonperforming residential mortgage loans as those that are 90 or more days past due

and/or in nonaccrual status which is assessed monthly. Generally, nonperforming residential mortgage loans have a higher risk of experiencing a credit loss.

Interest on loans is recognized on an accrual basis at the applicable interest rate on the principal amount outstanding. Loan origination fees and direct costs, as well as premiums and discounts, are amortized as level yield adjustments over the respective loan terms. Unamortized net fees or costs are recognized upon early repayment of the loans. Loan commitment fees are deferred and amortized on an effective yield basis over the term of the loan.

We establish mortgage loan valuation allowances both on a loan specific basis for those loans considered impaired where a property specific or market specific risk has been identified that could likely result in a future loss, as well as for pools of loans with similar risk characteristics where a property specific or market specific risk has not been identified, but for which we expect to incur a loss. Accordingly, a valuation allowance is provided to absorb these estimated probable credit losses. As of December 31, 2019 and 2018, the Company did not identify any specific loans that were impaired.

The determination of the amount of valuation allowances is based upon our periodic evaluation and assessment of inherent risks associated with our loan portfolios. Such evaluations and assessments are based upon several factors, including our experience for loan losses, defaults and loss severity, and loss expectations for loans with similar risk characteristics. We evaluate and monitor LTV ratios and DSC ratios of our loans as indicators of potential risk of default in establishing our valuation allowance.

Derivative Financial Instruments

Derivative Financial Instruments

The Company hedges certain portions of its exposure to product related equity market risk by entering into derivative transactions (primarily call options). All such derivative instruments are recognized as either assets or liabilities in the accompanying Consolidated Balance Sheets at fair value. The changes in fair value are reported within “Net investment gains (losses)” in the accompanying Consolidated Statements of Operations.

The Company purchases financial instruments and issues products that may contain embedded derivative instruments. If it is determined that the embedded derivative possesses economic characteristics that are not clearly and closely related to the economic characteristics of the host contract, and a separate instrument with the same terms would qualify as a derivative instrument, the embedded derivative is bifurcated from the host contract for measurement purposes. The embedded derivative is carried at fair value, which is determined through a combination of market observable inputs such as market value of option and interest swap rates and unobservable inputs such as the mortality multiplier, surrender and withdrawal rates and non-performance spread. The changes in fair value are reported within “Benefits and other changes in policy reserves” in the accompanying Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments".

Reinsurance Related Embedded Derivatives

As discussed in “Note 13. Reinsurance”, FGL Insurance entered into a reinsurance agreement with Kubera effective December 31, 2018, to cede certain MYGA and deferred annuity statutory reserve on a coinsurance funds withheld basis, net of applicable existing reinsurance. Funds withheld arrangements allow the Company to retain legal ownership of assets backing reinsurance arrangements until they are earned by the reinsurer while passing credit risk associated with the assets in the funds withheld account to the reinsurer. These arrangements create embedded derivatives considered total return swaps with contractual returns that are attributable to the assets and liabilities associated with the reinsurance arrangement. The fair value of the total return swap is based on the change in fair value of the underlying assets held in the funds withheld portfolio. Investment results for the assets that support the coinsurance with funds withheld reinsurance arrangement, including gains and losses from sales, are passed directly to the reinsurer pursuant to contractual terms of the reinsurance arrangement. These total return swaps are not clearly and closely related to the underlying reinsurance contract and thus require bifurcation. The reinsurance related embedded derivative is reported in “Other assets” if in a net gain position, or “Other liabilities”, if in a net loss position on the Consolidated Balance Sheets and the related gains or losses are reported in “Net investment gains (losses)” on the Consolidated Statements of Operations.

FGL Insurance has a funds withheld coinsurance arrangement with FSRC, which creates an embedded derivative similar to the embedded derivative described above related to the Kubera reinsurance agreement. Due to the acquisition of FSRC, the reinsurance related embedded derivative is eliminated in consolidation in the periods after December 1, 2017.

Limited Partnership Investment

Limited Partnership Investments

Our investments in limited partnerships are included in other invested assets on our Consolidated Balance Sheets. We account for our investments in limited partnerships using the equity method and use net asset value ("NAV") as a practical expedient to determine the carrying value. Income from the limited partnership is included within "Net investment income" in the accompanying Consolidated Statements of Operations. Recognition of income is delayed due to the availability of the related financial statements, which are obtained from the partnership’s general partner generally on a one to three-month delay. Management meets quarterly with the general partner to determine whether any credit or other market events have occurred since prior quarter financial statements to ensure any material events are properly included in current quarter valuation and investment income. In addition, the impact of audit adjustments related to completion of calendar-year financial statement audits of the limited partnership are typically received during the second quarter of each calendar year. Accordingly, our investment income from the limited partnership investment for any calendar-year period may not include the complete impact of the change in the underlying net assets for the partnership for that calendar-year period.

Intangible Assets

Intangible Assets

The Company’s intangible assets include an intangible asset reflecting the value of insurance and reinsurance contracts acquired (hereafter referred to as “the value of business acquired” or (“VOBA”), deferred acquisition costs (“DAC”), deferred sales inducements (“DSI”), and trademarks and state licenses.

VOBA is an intangible asset that reflects the amount recorded as insurance contract liabilities less the estimated fair value of in-force contracts in a life insurance company acquisition. It represents the portion of the purchase price allocated to the value of the rights to receive future cash flows from the business in force at the acquisition date. DAC consists principally of commissions that are related directly to the successful sale of new or recoverable insurance contracts, which may be deferred to the extent recoverable. Indirect or unsuccessful acquisition costs, maintenance, product development and overhead expenses are charged to expense as incurred. DSI represents up front bonus credits and vesting bonuses to policyholder account values which may be deferred to the extent recoverable.

The methodology for determining the amortization of DAC, DSI and VOBA varies by product type. For all insurance contracts accounted for under long-duration contract deposit accounting, amortization is based on assumptions consistent with those used in the development of the underlying contract liabilities adjusted for emerging experience and expected trends. Amortization is reported within “Amortization of intangibles” in the accompanying Consolidated Statements of Operations.

For all of the insurance intangibles (DAC, DSI and VOBA), the balances are generally amortized over the lives of the policies in relation to the expected emergence of estimated gross profits (“EGPs”) from investment

income, surrender charges and other product fees, less policy benefits, maintenance expenses, mortality net of reinsurance ceded, and expense margins. Recognized gains (losses) on investments and changes in fair value of the funds withheld coinsurance embedded derivative are included in actual gross profits in the period realized as described further below.

Changes in assumptions, including the Company’s earned rate, (i.e., long term assumptions of the Company’s expected earnings on related investments), budgeted option costs (i.e., the expected cost to purchase call options in future periods to fund the equity indexed linked feature) and surrender rates can have a significant impact on VOBA, DAC and DSI balances and amortization rates. Due to the relative size and sensitivity to minor changes in underlying assumptions of those intangible balances, the Company performs quarterly and annual analysis of the VOBA, DAC and DSI balances for recoverability to ensure that the unamortized portion does not exceed the expected recoverable amounts. At each evaluation date, actual historical gross profits are reflected with the impact on the intangibles reported as “unlocking” as a component of amortization expense, and estimated future gross profits and related assumptions are evaluated for continued reasonableness. Any adjustment in estimated future gross profits requires that the amortization rate be revised (“unlocking”) retroactively to the date of the policy or contract issuance. The cumulative unlocking adjustment is recognized as a component of current period amortization.

The carrying amounts of VOBA, DAC and DSI are adjusted for the effects of unrealized gains and losses on fixed maturity securities classified as AFS. For investment-type products, the VOBA, DAC and DSI assets are adjusted for the impact of unrealized gains (losses) on investments as if these gains (losses) had been realized, with corresponding credits or charges included in AOCI.

Amortization expense of VOBA, DAC and DSI reflects an assumption for an expected level of credit-related investment losses. When actual credit-related investment losses are realized, the Company performs a retrospective unlocking of amortization for those intangibles as actual margins vary from expected margins. This unlocking is reflected in the accompanying Consolidated Statements of Operations.

Reinsurance

Reinsurance

The Company’s insurance subsidiaries enter into reinsurance agreements with other companies in the normal course of business. The assets, liabilities, premiums and benefits of certain reinsurance contracts are presented on a net basis in the accompanying Consolidated Balance Sheets and Consolidated Statements of Operations, respectively, when there is a right of offset explicit in the reinsurance agreement. All other reinsurance agreements are reported on a gross basis in the Company’s Consolidated Balance Sheets as an asset for amounts recoverable from reinsurers or as a component of other liabilities for amounts, such as premiums, owed to the reinsurers, with the exception of amounts for which the right of offset also exists. Premiums and benefits are reported net of insurance ceded.

Income Taxes

Income Taxes

The Company’s life insurance subsidiaries file a consolidated life insurance income tax return. Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The Company assesses the recoverability of its deferred tax assets in each reporting period under the guidance outlined within Accounting Standards Codification (“ASC”) Topic 740, “Income Taxes”. The guidance requires an assessment of both positive and negative evidence in determining the realizability of deferred tax assets. A valuation allowance is required to reduce the Company’s deferred tax asset to an amount that is more likely than not to be realized. In determining the net deferred tax asset and valuation allowance, management is required to make judgments and estimates related to projections of future profitability.  These judgments include the following: the timing and extent of the utilization of net operating loss carry-forwards, the reversals of temporary differences, and tax planning strategies.  The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date. The Company has the ability and intent to recover in a tax-free manner assets (or liabilities) with book/tax basis differences for which no deferred taxes have been provided, in accordance with ASC 740.

The Company applies the accounting guidance for uncertain tax positions which prescribes a minimum recognition threshold a tax position is required to meet before being recognized in the financial statements. The

guidance also provides information on de-recognition, measurement, classification, interest and penalties, accounting in interim periods, disclosure and transition. The Company recognizes the effect of income tax positions only if those positions are more likely than not of being sustained. Recognized income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Accrued interest expense and penalties related to uncertain tax positions are recorded in “Income tax (expense) benefit” in the Company’s Consolidated Statements of Operations. The Company had no unrecognized tax benefits related to uncertain tax positions as of December 31, 2019.

Contractholder Funds

Contractholder Funds

The liabilities for contractholder funds for deferred annuities, IUL and UL policies consist of contract account balances that accrue to the benefit of the contractholders. The liabilities for FIA policies consist of the value of the host contract plus the fair value of the embedded derivative. The embedded derivative is carried at fair value in “Contractholder funds” in the accompanying Consolidated Balance Sheets with changes in fair value reported in "Benefits and other changes in policy reserves" in the accompanying Consolidated Statements of Operations. See a description of the fair value methodology used in "Note 6. Fair Value of Financial Instruments". Liabilities for immediate annuities with life contingencies are recorded at the present value of future benefits.

Liabilities for the secondary guarantees on UL-type products or Investment-type contracts are calculated by multiplying the benefit ratio by the cumulative assessments recorded from contract inception through the balance sheet date less the cumulative secondary guarantee benefit payments plus interest. The benefit ratio is the ratio of the present value of future secondary guarantees to the present value of the assessments used to provide the secondary guarantees using the same assumptions as the Company uses for its intangible assets. If experience or assumption changes result in a new benefit ratio, the reserves are adjusted to reflect the changes in a manner similar to the unlocking of DAC, DSI and VOBA. The accounting for secondary guarantee benefits impact EGPs used to calculate amortization of DAC, DSI and VOBA.

Future Policy Benefits

Future Policy Benefits

The liabilities for future policy benefits and claim reserves for traditional life policies and life contingent pay-out annuity policies are computed using assumptions for investment yields, mortality and withdrawals based on generally accepted actuarial methods and assumptions at the time of contract issue. Investment yield assumption for traditional direct life reserves for all contracts is 5.7%. The investment yield assumptions for life contingent pay-out annuities range from 0.1% to 5.5%.

Federal Home Loan Bank of Atlanta Agreements

Federal Home Loan Bank of Atlanta Agreements

Contractholder funds include funds related to funding agreements that have been issued by the Company to the Federal Home Loan Bank of Atlanta (“FHLB”) as a funding medium for single premium funding agreements.

Commitments and Contingencies

Commitments and Contingencies

Contingencies arising from environmental remediation costs, regulatory judgments, claims, assessments, guarantees, litigation, recourse reserves, fines, penalties and other sources are recorded when deemed probable and reasonably estimable.

Adoption of New Accounting Pronouncements

Adoption of New Accounting Pronouncements

Revenue from Contracts with Customers

In May 2014, the Financial Accounting Standards Board (FASB) issued new guidance on revenue recognition (ASU 2014-09, Revenue from Contracts with Customers (Topic 606)), effective for fiscal years beginning after December 15, 2016 and interim periods within those years. In August 2015, the FASB issued ASU 2015-14, Revenue from Contracts with Customers (Topic 606) - Deferral of the Effective Date, which deferred the effective date of ASU 2014-09 by one year. The FASB also issued the following ASUs which clarify the guidance in ASU 2014-09:

•ASU 2016-08 - Revenue from Contracts with Customers (Topic 606) - Principal versus Agent Considerations (Reporting Revenue Gross versus Net) issued in March 2016

•ASU 2016-10 - Revenue from Contracts with Customers (Topic 606) - Identifying Performance Obligations and Licensing issued in April 2016

•ASU 2016-11 - Revenue Recognition (Topic 605) and Derivatives and Hedging (Topic 815) - Rescission of SEC Guidance Because of Accounting Standards Updates 2014-09 and 2014-16 Pursuant to Staff Announcements at the March 3, 2016 EITF Meeting issued in May 2016

•ASU 2016-12 - Revenue from Contracts with Customers (Topic 606) - Narrow-Scope Improvements and Practical Expedients issued in May 2016

The guidance in ASU 2014-09 and the related ASUs supersedes the revenue recognition requirements in Topic 605, Revenue Recognition, and most industry-specific guidance unless the contracts are within the scope of other standards (for example, financial instruments, insurance contracts or lease contracts). The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance establishes a five-step process to achieve this core principle.

The Company adopted these standards effective January 1, 2018. The adoption of these standards has had no impact on the Company's consolidated financial statements as the Company’s primary sources of revenue, insurance contracts and financial instruments, are excluded from the scope of these standards.

Statement of Cash Flows Classification of Certain Cash Receipts and Cash Payments

In August 2016, the FASB issued new guidance (ASU 2016-15, Statement of Cash Flows (Topic 230), Classification of Certain Cash Receipts and Cash Payments), effective for fiscal years beginning after December 15, 2017 and interim periods within those fiscal years. Notable amendments in this update change the classification of certain cash receipts and cash payments in the Statement of Cash Flows in the following ways:

• cash payments for debt prepayment or debt extinguishment costs should be classified as cash outflows for financing activities

• the settlement of zero-coupon debt instruments or other debt instruments with coupon interest rates that are insignificant in relation to the effective interest rate of the borrowing should be classified as follows: the portion of the cash payment attributable to the accreted interest related to the debt discount as cash outflows for operating activities, and the portion of the cash payment attributable to the principal as cash outflows for financing activities

• a reporting entity must make an accounting policy election to classify distributions received from equity method investees using either:

◦ the cumulative earnings approach, which considers distributions received as returns on the investment and are classified as cash inflows from operating activities (with an exception when cumulative distributions received less distributions received in prior periods that were classified as returns of investment exceeds cumulative equity in earnings, in which case the current period distribution up to this excess amount will be considered a return of investment and classified as cash inflows from investing activities); or

◦ the nature of the distribution approach, which classifies distributions received based on the nature of the activity or activities of the investee that generated the distribution (would be considered

either a return on investment and classified as cash inflows from operating activities or a return of investment and classified as cash inflows from investing activities)

• in the absence of specific GAAP guidance, an entity should classify cash receipts and payments that have aspects of more than one class of cash flows by determining and appropriately classifying each separately identifiable source or use within the cash receipts and cash payments on the basis of the underlying cash flows. If cash receipts and payments have aspects of more than one class of cash flows and cannot be separated by source or use, the activity that is likely to be the predominant source or use of cash flows for the item will determine the classification.

The amendments in this ASU were adopted by the Company effective January 1, 2018 as required, using a retrospective transition method to each period presented (except where impracticable to apply retrospectively; those specific amendments will be applied prospectively as of the earliest date practicable). The Company has elected to use the nature of distribution approach to classify distributions received from equity method investees. The adoption of this standard had an immaterial impact on the Company's Consolidated Statements of Cash Flows.

Amendments to Recognition and Measurement of Financial Assets and Financial Liabilities

In March 2018, February 2018 and January 2016, the FASB issued amended guidance on the measurement of financial assets and financial liabilities (ASU 2018-04, Investments-Debt Securities (Topic 320) and Regulated Operations (Topic 980) - Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 117 and SEC Release No. 33-9273; ASU 2018-03, Technical Corrections and Improvements to Financial Instruments-Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities; and ASU 2016-01, Financial Instruments- Overall (Subtopic 825-10), Recognition and Measurement of Financial Assets and Financial Liabilities, respectively), effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. Notable amendments in these updates:

• require all equity securities (other than equity investments accounted for under the equity method of accounting or requiring the consolidation of the investee) to be measured at fair value with changes in fair value recognized through net income. Equity securities that do not have readily determinable fair values may be measured at cost minus impairment

• require qualitative assessment for impairment of equity investments without readily determinable fair values at each reporting period and, if the qualitative assessment indicates that impairment exists, to measure the investment at fair value

• eliminate the requirement to disclose the methods and significant assumptions used to estimate fair value (which is currently required to be disclosed, for financial instruments measured at amortized cost on the balance sheet)

• require an entity to present separately in other comprehensive income the portion of the total change in the fair value of a liability resulting from a change in the instrument-specific credit risk when the entity has elected to measure the liability at fair value in accordance with the fair value option for financial instruments

The amendments in these ASUs were applied via a cumulative-effect adjustment to the balance sheet as of the beginning of the fiscal year of adoption, and the amendments related to equity securities without readily determinable fair values were applied prospectively to equity investments that exist as of the date of adoption. The Company adopted ASUs 2016-01, 2018-03, and 2018-04 effective January 1, 2018, with a cumulative-effect adjustment to decrease retained earnings and increase AOCI by $4.

Premium Amortization on Purchased Callable Debt Securities

In March 2017, the FASB issued new guidance on the amortization of callable securities (ASU 2017-08, Receivables-Nonrefundable Fees and Other Costs (Subtopic 310-20), Premium Amortization on Purchased Callable Debt Securities), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The ASU requires premiums paid on purchased debt securities with an explicit call option to be amortized to the earliest call date, as opposed to the maturity date. The updated guidance is applicable to instruments that are callable based on explicit, non-contingent call features that are callable at fixed prices on preset dates. The amendments in this update were to be applied using the modified retrospective method through a cumulative effect adjustment directly to retained earnings as of the beginning of the period of adoption. The Company adopted this new accounting guidance effective January 1, 2019, as required, and it had an immaterial impact on its consolidated financial statements.

Amendments to Lease Accounting

In February 2016, the FASB issued amended guidance (ASU 2016-02, Leases (Topic 842)), effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. Notable amendments in this update:

• require entities to recognize the rights and obligations resulting from all leases or lease components of contracts, including operating leases, as lease assets and lease liabilities, with an exception allowed for leases with a term of 12 months or less

• create a distinction between finance leases and operating leases, with classification criteria substantially similar to that for distinguishing between capital leases and operating leases under previous guidance

• not retain the accounting model for leveraged leases under previous guidance for leases that commence after the effective date of ASU 2016-02

• provide additional guidance on separating the lease components from the nonlease components of a contract

• require qualitative disclosures along with specific quantitative disclosures to provide information regarding the amount, timing, and uncertainty of cash flows arising from leases

• include modifications to align lessor accounting with the changes to lessee accounting, as well as changes to the requirements of recognizing a transaction as a sale and leaseback transaction, however, these changes will have no impact on the Company's current lease arrangements

The amendments were required to be applied at the beginning of the earliest period presented using a modified retrospective approach (including several optional practical expedients related to leases commenced before the effective date). The Company adopted this standard effective January 1, 2019, as required, and it had an immaterial impact on its consolidated financial statements.

Derivatives and Hedging

In August 2017, the FASB issued ASU 2017-12, Derivatives and Hedging (Topic 815), Targeted Improvements to the Accounting for Hedging Activities, effective for fiscal years beginning after December 15, 2018 including interim periods within those fiscal years. Under this update:

• removes previous limitations on designation of hedged risk in certain cash flow and fair value hedging relationships

• permits different measurements when accounting for hedged items in fair value hedges of interest rate risk

• the entity must present the hedging instrument earnings and hedged item earnings in the same income statement line

• in addition to exclusion of option premiums and forward points, also permits exclusion of the cross-currency basis spread portion of the change in fair value of a currency swap in assessment of hedge effectiveness

The Company adopted this standard effective January 1, 2019, as required, and it did not impact its consolidated financial statements.

Future Adoption of Accounting Pronouncements

New Credit Loss Standard

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses (Topic 326), Measurement of Credit Losses on Financial Instruments, effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Since its release, certain targeted improvements and transition relief amendments have been made to ASU 2016-13 and have been published in ASU 2018-19, ASU 2019-04, ASU 2019-05 and ASU 2019-11. Collectively, these ASUs will change the accounting for impairment of most financial assets and certain other instruments in the following ways:

• financial assets (or a group of financial assets) measured at amortized cost will be required to be presented at the net amount expected to be collected, with an allowance for credit losses deducted from the amortized cost basis, resulting in a net carrying value that reflects the amount the entity expects to collect on the financial asset. The measurement of expected credit losses is based on relevant information about past

events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount.

• credit losses relating to AFS fixed maturity securities generally will be recorded through an allowance for credit losses, rather than reductions in the amortized cost of the securities. The allowance methodology recognizes that value may be realized either through collection of contractual cash flows or through the sale of the security. Therefore, the amount of the allowance for credit losses for AFS fixed maturity securities will be limited to the amount by which fair value is below amortized cost because the classification as available for sale is premised on an investment strategy that recognizes that the investment could be sold at fair value, if cash collection would result in the realization of an amount less than fair value

• the income statement will reflect the measurement of expected credit losses for newly recognized financial assets as well as the expected increases or decreases (including the reversal of previously recognized losses) of expected credit losses that have taken place during the period. The measurement of expected credit losses is based on relevant information about past events, including historical experience, current conditions, and reasonable and supportable forecasts that affect the collectability of the reported amount

• disclosures will be required to include information around how the credit loss allowance was developed, further details on information currently disclosed about credit quality of financing receivables and net investments in leases, and a rollforward of the allowance for credit losses for AFS fixed maturity securities as well as an aging analysis for securities that are past due

XML

Earnings Per Share

12 Months Ended

Dec. 31, 2019

Earnings Per Share [Abstract]

Earnings Per Share

Earnings Per Share

The following table sets forth the computation of basic and diluted earnings per share (share amounts in thousands):

	Year Ended												Year ended
	December 31, 2019		December 31, 2018			Period from December 1 to December 31, 2017			Period from October 1 to November 30, 2017		Period from October 1 to December 31, 2016 (Unaudited)		September 30, 2017
									Predecessor		Predecessor		Predecessor
Net income (loss)	$	507	$	13		$	(91	)	$	28	$	108	$	223
Less Preferred stock dividend	31		29			2			—		—		—
Net income (loss) available to common shares	476		(16		)	(93		)	28		108		223
Weighted-average common shares outstanding - basic	216,592		216,019			214,370			58,341		58,281		58,320
Dilutive effect of unvested restricted stock & PRSU	86		—			—			61		57		43
Dilutive effect of stock options	59		—			—			92		28		52
Weighted-average shares outstanding - diluted	216,738		216,019			214,370			58,494		58,366		58,415
Net income (loss) per common share:
Basic	$	2.19	$	(0.07	)	$	(0.44	)	$	0.48	$	1.85	$	3.83
Diluted	$	2.19	$	(0.07	)	$	(0.44	)	$	0.47	$	1.85	$	3.83

The number of shares of common stock outstanding used in calculating the weighted average thereof reflects the actual number of FGL Holdings shares of common stock outstanding, excluding unvested restricted stock and shares held in treasury.

The calculation of diluted earnings per share excludes the incremental effect of warrants, preferred shares and options due to their anti-dilutive effect for the following periods:

	Year Ended					Year ended
	December 31, 2019	December 31, 2018	Period from December 1 to December 31, 2017	Period from October 1 to November 30, 2017	Period from October 1 to December 31, 2016 (Unaudited)	September 30, 2017
(in thousands)				Predecessor	Predecessor	Predecessor
Warrants	5,510	55,838	70,883	—	—	—
Preferred shares	430	399	375	—	—	—
Options and restricted shares	1,346	863	—	—	31	—

Under applicable accounting guidance, companies in a loss position are required to use basic weighted average common shares outstanding in the calculation of diluted loss per share. Therefore, as a result of our net loss for the year ended December 31, 2018, we were required to use basic weighted-average common shares outstanding in the calculation of the year ended December 31, 2018 diluted loss per share, as the inclusion of shares for restricted stock of 35 thousand would have been antidilutive to the calculation. If we had not incurred a net loss in the year ended December 31, 2018, dilutive potential common shares would have been 216 million.

The preferred stock shares outstanding as of December 31, 2019 and December 31, 2018 are anti-dilutive as the contingency that would allow for the preferred shares to be converted to common shares has not yet been met.

XML

Subsequent Events (Notes)

2 Months Ended

Mar. 02, 2020

Subsequent Event [Line Items]

Subsequent Events [Text Block]

Note 19. Subsequent Events

The equity market volatility subsequent to December 31, 2019 has the potential to materially impact the fair value of the Company’s invested assets, including derivatives, and policyholder liabilities.  In addition, a disruption in the financial and credit markets increases the risk of credit defaults.  As of the date of this filing, the Company has not quantified the impact of such equity market volatility on its consolidated financial statements.

XML

Quarterly Results (Unaudited) - Schedule of Quarterly Financial Information (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended									12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Effect of Fourth Quarter Events [Line Items]
Premiums	$ 3	$ 7	$ 7	$ 9	$ 8	$ 16	$ 9	$ 12	$ 15	$ 18	$ 11	$ 40		$ 42	$ 54
Net investment income	92	174	324	301	315	289	295	267	282	263	240	1,229		1,005	1,107
Net investment gains (losses)	42	146	196	103	135	240	(555)	119	(2)	(191)	51	674	$ (629)	316	(629)
Insurance and investment product fees and other	28	35	36	42	37	55	40	46	45	48	38	170		167	179
Total revenues	165	362	563	455	495	600	(211)	444	340	138	340	2,113		1,530	711
Total operating expenses	144	314	282	391	428	412	(20)	365	280	28	171	1,513		1,173	653
Net income (loss)	$ (91)	$ 28	$ 225	$ 65	$ 46	$ 171	$ (148)	$ 56	$ 40	$ 65	$ 108	$ 507	$ 13	$ 223	$ 13
Net income (loss) per common share - basic (in USD per share)	$ (0.44)	$ 0.48	$ 1.02	$ 0.26	$ 0.17	$ 0.74	$ (0.70)	$ 0.23	$ 0.15	$ 0.27	$ 1.85	$ 2.19	$ (0.07)	$ 3.83
Net income (loss) per common share - diluted (in USD per share)	$ (0.44)	$ 0.47	$ 1.02	$ 0.26	$ 0.17	$ 0.74	$ (0.70)	$ 0.23	$ 0.15	$ 0.27	$ 1.85	$ 2.19	$ (0.07)	$ 3.83

XML

Earnings Per Share - Summary of Basic and Diluted EPS (Detail) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended									12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Earnings Per Share [Abstract]
Net income (loss)	$ (91)	$ 28	$ 225	$ 65	$ 46	$ 171	$ (148)	$ 56	$ 40	$ 65	$ 108	$ 507	$ 13	$ 223	$ 13
Less Preferred stock dividend	2	0									0	31	29	0	$ 29
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic	$ (93)	$ 28									$ 108	$ 476	$ (16)	$ 223
Weighted-average common shares outstanding - basic (in shares)	214,370,000	58,341,112									58,280,532	216,591,908	216,019,000	58,319,517	216,018,629
Dilutive effect of unvested restricted stock and unvested performance restricted stock (in shares)	0	61,000									57,000	86,000	0	43,000
Dilutive effect of stock options (in shares)	0	92,000									28,000	59,000	0	52,000
Weighted-average shares outstanding - diluted (in shares)	214,370,000	58,494,043									58,366,009	216,737,602	216,019,000	58,415,187	216,018,629
Net income (loss) per common share:
Basic (in USD per share)	$ (0.44)	$ 0.48	$ 1.02	$ 0.26	$ 0.17	$ 0.74	$ (0.70)	$ 0.23	$ 0.15	$ 0.27	$ 1.85	$ 2.19	$ (0.07)	$ 3.83
Diluted (in USD per share)	$ (0.44)	$ 0.47	$ 1.02	$ 0.26	$ 0.17	$ 0.74	$ (0.70)	$ 0.23	$ 0.15	$ 0.27	$ 1.85	$ 2.19	$ (0.07)	$ 3.83
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Common Stock Warrants Outstanding	70,883,000	0									0	5,510,000	55,838,000	0
Antidilutive securities excluded from computation of EPS, less than, amount (shares)													216,000,000
Restricted Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of EPS, less than, amount (shares)													35,000
Stock Option Awards
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	0	0									31,000	1,346,000	863,000	0
Preferred Stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of EPS, less than, amount (shares)	375,000	0									0	430,000	399,000,000	0

XML

Insurance Subsidiary Financial Information and Regulatory Matters (Tables)

12 Months Ended

Dec. 31, 2019

Insurance [Abstract]

Statutory Accounting Practices Disclosure

The Company’s principal insurance subsidiaries’ statutory (SAP and GAAP) financial statements are based on a December 31 year end. Statutory net income and statutory capital and surplus of the Company’s wholly-owned insurance subsidiaries were as follows:

	Subsidiary (state/country of domicile) (a)
	FGL Insurance (IA)			FGL NY Insurance (NY)			F&G Life Re (Bermuda)
Statutory Net Income (loss):
Year ended December 31, 2019	$	152		$	(1	)	$	3
Year ended December 31, 2018	(151		)	(3		)	319
Statutory Capital and Surplus:
December 31, 2019	$	1,513		$	95		$	2
December 31, 2018	1,545			85			2

(a) FGL NY Insurance is a subsidiary of FGL Insurance, and the columns should not be added together.

	Subsidiary (state/country of domicile)
	FSR (Cayman)			F&G Re (Bermuda)
Statutory Net Income (loss):
Year ended December 31, 2019	$	(29	)	$	69
Year ended December 31, 2018	(29		)	(14		)
Statutory Capital and Surplus:
December 31, 2019	$	73		$	295
December 31, 2018	73			38

XML

Schedule II - Condensed Financial Information - Condensed Statement of Cash Flow (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended									12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2019	Sep. 30, 2019	Jun. 30, 2019	Mar. 31, 2019	Dec. 31, 2018	Sep. 30, 2018	Jun. 30, 2018	Mar. 31, 2018	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Cash flows from operating activities:
Net income (loss)	$ (91)	$ 28	$ 225	$ 65	$ 46	$ 171	$ (148)	$ 56	$ 40	$ 65	$ 108	$ 507	$ 13	$ 223	$ 13
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Realized capital and other gains on investments	(42)	(137)									(51)	(682)		(305)	629
Stock based compensation	(1)	4									1	5		6	4
Other assets and other liabilities	(9)	(6)									(26)	(19)		(47)	115
Net cash provided by (used in) operating activities	85	79									72	675		237	897
Cash flows from investing activities:
Net cash provided by (used in) investing activities	(22)	(175)									(594)	(1,568)		(1,217)	(2,280)
Cash flows from financing activities:
Dividends payments	0	(4)									(4)	(9)		(15)	0
Treasury stock	0	0									(1)	(65)		(1)	(4)
Net cash provided by (used in) financing activities	45	135									290	1,291		1,001	739
Change in cash & cash equivalents	108	39									(232)	398		21	(644)
Cash & cash equivalents, beginning of period	924	885				571				1,215	864	571	1,215	864	885
Cash & cash equivalents, end of period	1,215	924	969				571				632	969	571	885	571
Parent Company
Cash flows from operating activities:
Net income (loss)	(91)	28									108	507	13	223
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Realized capital and other gains on investments	0	0									2	0	0	5
Equity in net income of subsidiaries	102	(29)									(109)	(459)	(17)	(227)
Stock based compensation	0	1									1	5	4	2
Other assets and other liabilities	1	2									0	(48)	4	3
Net cash provided by (used in) operating activities	12	2									2	5	4	6
Cash flows from investing activities:
Net cash provided by (used in) investing activities	0	0									5	41	(54)	12
Cash flows from financing activities:
Cash paid upon warrant tender and capitalized warrant tender costs	0	0									0	0	(66)	0
Dividends payments	0	(4)									(4)	(9)	0	(15)
Treasury stock	0	0									(1)	(65)	(4)	(1)
Distribution to CF Bermuda and subsidiaries	(97)	0									0	26	57	(2)
Net cash provided by (used in) financing activities	(97)	(4)									(5)	(48)	(13)	(18)
Change in cash & cash equivalents	(85)	(2)									2	(2)	(63)	0
Cash & cash equivalents, beginning of period	0	2				$ 7				$ 70	2	7	70	2	2
Cash & cash equivalents, end of period	70	0	$ 5				$ 7				4	5	7	2	$ 7
Equity securities | Parent Company
Cash flows from investing activities:
Proceeds from available-for-sale investments, sold, matured or repaid:	0	0									5	41	0	12
Cost of available-for-sale investments:	$ 0	$ 0									$ 0	$ 0	$ (54)	$ 0

XML

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2019

Commitments and Contingencies Disclosure [Abstract]

Summary of Unfunded Commitments

The Company has unfunded investment commitments as of December 31, 2019 based upon the timing of when investments are executed compared to when the actual investments are funded, as some investments require that funding occur over a period of months or years. A summary of unfunded commitments by invested asset class are included below:

	December 31, 2019
Asset Type
Other invested assets	$	1,202
Equity securities	14
Fixed maturity securities, available-for-sale	48
Other assets	78
Residential mortgage loans	16
Total	$	1,358

As of December 31, 2019, the Company had unfunded commitments in affiliated investments which are included in the table above. See "Note 14. Related Party Transactions" for further information.

XML

Fair Value of Financial Instruments - Schedule of Unobservable Inputs Used for Level Three Fair Value Measurements of Financial Instruments on Recurring Basis (Detail) - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017	Dec. 01, 2017
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 2,811,000,000	$ 2,466,000,000
Future Policy Benefit		725,000,000
Liabilities, fair value	5,204,000,000	3,230,000,000
Credit Spread	$ 0.0381
Yield Volatility	0.00%
Available-for-sale Securities	$ 23,726,000,000	21,109,000,000
Derivative investments	587,000,000	97,000,000
Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	5,694,000,000	4,832,000,000
Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	2,922,000,000	2,537,000,000
Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	11,597,000,000	10,381,000,000
Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,027,000,000	901,000,000
Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	954,000,000	1,031,000,000
U.S. Government
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	34,000,000	119,000,000
Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	155,000,000	121,000,000
Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	801,000,000	405,000,000
Market Approach | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	27,000,000	43,000,000
Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	346,000,000	577,000,000
Market Approach | States, municipalities and political subdivisions
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	42,000,000	37,000,000
Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 546,000,000
Market Approach | Equity securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Estimated recovery value percentage	2.47%
Market Approach | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.00%
Market Approach | Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 18,000,000	16,000,000
Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		654,000,000
Income Approach Valuation Technique | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		10,000,000
Income Approach Valuation Technique | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	100.00%
Matrix Pricing Valuation | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		24,000,000
Matrix Pricing Valuation | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		24,000,000
Matrix Pricing Valuation | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 946,000,000
Matrix Pricing Valuation | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 10,000,000
Matrix Pricing Valuation | Funds withheld for reinsurance liabilities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	100.00%
Loan Recovery Valuation | Reinsurance Receivables, Funds Withheld
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 1,000,000
Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	3,235,000,000	2,476,000,000
Preferred shares reimbursement feature embedded derivative | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Liabilities, fair value	16,000,000	$ 29,000,000
Minimum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Available-for-sale Securities	$ 29,000,000
Minimum | Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	98.65%	97.00%
Minimum | Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		74.63%
Minimum | Market Approach | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.60%
Minimum | Market Approach | States, municipalities and political subdivisions
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	127.68%	111.23%
Minimum | Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	89.80%
Minimum | Market Approach | Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	110.12%	98.38%
Minimum | Third Party Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	0.00%	0.00%
Minimum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Minimum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	100.15%	117.72%
Minimum | Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	83.51%	91.74%
Minimum | Income Approach Valuation Technique | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	104.72%
Minimum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.00%	0.00%
Minimum | Future Policy Benefits, Market Value of Option [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	0.00%
Minimum | Future Policy Benefits, Mortality Multiplier [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	80.00%
Minimum | Future Policy Benefits | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, swap rates	0.00%
Fair value inputs, mortality multiplier	0.00%
Fair value inputs, non performance spread	0.00%
Risk Margin To Reflect Uncertainty	0.23%
Mortality, Morbidity and Surrender Rate Assumption	0
Minimum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	0.00%	0.00%
Fair value inputs, swap rates	1.73%	2.57%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	0.50%	0.50%
Fair value inputs, non performance spread	0.25%	0.25%
Minimum | Fixed indexed annuities | Partial Withdrawls
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.00%	1.00%
Minimum | Fixed indexed annuities | Option Cost [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, non performance spread	0.18%	0.01%
Maximum
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Available-for-sale Securities	$ 39,000,000
Maximum | Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	119.35%	102.00%
Maximum | Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		104.62%
Maximum | Market Approach | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.60%
Maximum | Market Approach | States, municipalities and political subdivisions
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	127.68%	111.23%
Maximum | Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	106.50%	100.99%
Maximum | Market Approach | Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	118.09%	99.01%
Maximum | Third Party Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	99.43%	99.29%
Maximum | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Maximum | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	127.60%	117.72%
Maximum | Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	106.73%	113.25%
Maximum | Income Approach Valuation Technique | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	104.72%
Maximum | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.08%	0.22%
Maximum | Future Policy Benefits, Market Value of Option [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	11.20%
Maximum | Future Policy Benefits, Mortality Multiplier [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	120.00%
Maximum | Future Policy Benefits | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, swap rates	55.00%
Fair value inputs, mortality multiplier	4.00%
Fair value inputs, non performance spread	5.02%
Risk Margin To Reflect Uncertainty	0.96%
Mortality, Morbidity and Surrender Rate Assumption	0.02
Maximum | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	32.54%	31.06%
Fair value inputs, swap rates	1.90%	2.71%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	75.00%	75.00%
Fair value inputs, non performance spread	0.25%	0.25%
Maximum | Fixed indexed annuities | Partial Withdrawls
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, surrender rates	3.50%	2.50%
Maximum | Fixed indexed annuities | Option Cost [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, non performance spread	16.61%	16.61%
Weighted Average
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Risk Margin To Reflect Uncertainty		0.00%
Credit Spread		$ 0.0514
Yield Volatility		0.00%
Weighted Average | Market Approach | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	102.02%	99.77%
Weighted Average | Market Approach | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		97.80%
Weighted Average | Market Approach | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.60%
Weighted Average | Market Approach | States, municipalities and political subdivisions
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	127.68%	111.23%
Weighted Average | Market Approach | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	106.28%	100.73%
Weighted Average | Market Approach | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		100.00%
Estimated recovery value percentage		7.15%
Weighted Average | Market Approach | Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	112.61%	98.58%
Weighted Average | Third Party Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	35.96%	23.05%
Weighted Average | Third Party Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		85.46%
Weighted Average | Third Party Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	85.46%
Weighted Average | Income Approach Valuation Technique | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices		96.07%
Weighted Average | Income Approach Valuation Technique | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	126.82%	117.72%
Weighted Average | Income Approach Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	99.56%	98.86%
Weighted Average | Income Approach Valuation Technique | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, quoted prices	104.72%
Weighted Average | Income Approach Valuation Technique | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model		100.00%
Weighted Average | Income Approach Valuation Technique | Future Policy Benefits, Nonperformance Risk Spread
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model	0.03%	0.18%
Weighted Average | Matrix Pricing Valuation | Funds withheld for reinsurance liabilities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, black scholes model		100.00%
Weighted Average | Future Policy Benefits, Market Value of Option [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	2.50%
Weighted Average | Future Policy Benefits, Mortality Multiplier [Member] | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	95.46%
Weighted Average | Future Policy Benefits | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, swap rates	21.18%
Fair value inputs, mortality multiplier	2.28%
Fair value inputs, non performance spread	1.28%
Risk Margin To Reflect Uncertainty	0.34%
Mortality, Morbidity and Surrender Rate Assumption	0.0007
Weighted Average | Fixed indexed annuities | Income Approach Valuation Technique
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, market value of option	3.64%	94.00%
Fair value inputs, swap rates	1.81%	2.63%
Fair value inputs, mortality multiplier	80.00%	80.00%
Fair value inputs, surrender rates	5.64%	5.90%
Fair value inputs, non performance spread	0.25%	0.25%
Weighted Average | Fixed indexed annuities | Partial Withdrawls
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, surrender rates	2.53%	2.00%
Weighted Average | Fixed indexed annuities | Option Cost [Member]
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, non performance spread	2.12%	2.18%
Insurance Subsidiary | Market Approach | Equity securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 4,000,000
Insurance Subsidiary | Income Approach Valuation Technique | Equity securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value	$ 1,000,000
Insurance Subsidiary | Income Approach Valuation Technique | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Assets, fair value		$ 14,000,000
Insurance Subsidiary | Minimum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, other loan recoveries		77.12%
Insurance Subsidiary | Minimum | Third Party Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, other loan recoveries	98.58%
Insurance Subsidiary | Maximum | Market Approach | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, other loan recoveries		100.08%
Insurance Subsidiary | Maximum | Third Party Valuation Technique | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Fair value inputs, other loan recoveries	119.44%
Loan Participation - JSN Jewelry, Inc. | Market Approach | Funds withheld for reinsurance liabilities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Reinsurance Receivables, Funds Withheld		$ 4,000,000
Fair Value, Inputs, Level 1
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents	$ 969,000,000	571,000,000
Assets, fair value	1,997,000,000	1,581,000,000
Equity securities	387,000,000	454,000,000
Derivative investments	0	0
Other invested assets		0
Financial Liabilities Fair Value Disclosure	0	0
Fair Value, Inputs, Level 1 | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 1 | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 1 | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 1 | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	299,000,000	265,000,000
Fair Value, Inputs, Level 1 | States, municipalities and political subdivisions
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 1 | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 1 | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0
Fair Value, Inputs, Level 1 | U.S. Government
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	28,000,000	114,000,000
Fair Value, Inputs, Level 1 | Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 1 | Reinsurance Receivables, Funds Withheld
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	314,000,000	177,000,000
Fair Value, Inputs, Level 1 | Future Policy Benefits
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 1 | Embedded Derivatives in Reinsurance Contracts
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0
Fair Value, Inputs, Level 1 | Fixed indexed annuities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 1 | Preferred shares reimbursement feature embedded derivative
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Level 2
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents	0	0
Assets, fair value	23,693,000,000	19,858,000,000
Equity securities	614,000,000	874,000,000
Derivative investments	587,000,000	97,000,000
Other invested assets		0
Financial Liabilities Fair Value Disclosure	33,000,000	0
Level 2 | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	4,866,000,000	4,388,000,000
Level 2 | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	2,895,000,000	2,470,000,000
Level 2 | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	10,305,000,000	9,150,000,000
Level 2 | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	718,000,000	626,000,000
Level 2 | States, municipalities and political subdivisions
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,301,000,000	1,150,000,000
Level 2 | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	408,000,000	417,000,000
Level 2 | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0
Level 2 | U.S. Government
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	6,000,000	5,000,000
Level 2 | Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	137,000,000	105,000,000
Level 2 | Reinsurance Receivables, Funds Withheld
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,856,000,000	576,000,000
Level 2 | Future Policy Benefits
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Level 2 | Embedded Derivatives in Reinsurance Contracts
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	33,000,000
Level 2 | Fixed indexed annuities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Level 2 | Preferred shares reimbursement feature embedded derivative
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 3
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents	0	0
Assets, fair value	2,811,000,000	2,466,000,000
Equity securities	1,000,000	4,000,000
Derivative investments	0	0
Other invested assets		39,000,000
Financial Liabilities Fair Value Disclosure	5,204,000,000	3,230,000,000
Fair Value, Inputs, Level 3 | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	828,000,000	444,000,000
Fair Value, Inputs, Level 3 | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	27,000,000	67,000,000
Fair Value, Inputs, Level 3 | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,292,000,000	1,231,000,000
Fair Value, Inputs, Level 3 | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	10,000,000	10,000,000
Fair Value, Inputs, Level 3 | States, municipalities and political subdivisions
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	42,000,000	37,000,000
Fair Value, Inputs, Level 3 | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	546,000,000	614,000,000
Fair Value, Inputs, Level 3 | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	46,000,000
Fair Value, Inputs, Level 3 | U.S. Government
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0	0
Fair Value, Inputs, Level 3 | Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	18,000,000	16,000,000
Fair Value, Inputs, Level 3 | Reinsurance Receivables, Funds Withheld
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,000,000	4,000,000
Fair Value, Inputs, Level 3 | Future Policy Benefits
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,953,000,000	725,000,000
Fair Value, Inputs, Level 3 | Embedded Derivatives in Reinsurance Contracts
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	0
Fair Value, Inputs, Level 3 | Fixed indexed annuities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	3,235,000,000	2,476,000,000
Fair Value, Inputs, Level 3 | Preferred shares reimbursement feature embedded derivative
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	16,000,000	29,000,000
Reported Value Measurement
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents	969,000,000	571,000,000
Assets, fair value	28,501,000,000	23,905,000,000
Equity securities	1,002,000,000	1,332,000,000
Derivative investments	587,000,000	97,000,000
Other invested assets		39,000,000
Financial Liabilities Fair Value Disclosure	5,237,000,000	3,230,000,000
Reported Value Measurement | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	5,694,000,000	4,832,000,000
Reported Value Measurement | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	2,922,000,000	2,537,000,000
Reported Value Measurement | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	11,597,000,000	10,381,000,000
Reported Value Measurement | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,027,000,000	901,000,000
Reported Value Measurement | States, municipalities and political subdivisions
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,343,000,000	1,187,000,000
Reported Value Measurement | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	954,000,000	1,031,000,000
Reported Value Measurement | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	46,000,000
Reported Value Measurement | U.S. Government
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	34,000,000	119,000,000
Reported Value Measurement | Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	155,000,000	121,000,000
Reported Value Measurement | Reinsurance Receivables, Funds Withheld
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	2,171,000,000	757,000,000
Reported Value Measurement | Future Policy Benefits
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,953,000,000	725,000,000
Reported Value Measurement | Embedded Derivatives in Reinsurance Contracts
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	33,000,000
Reported Value Measurement | Fixed indexed annuities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	3,235,000,000	2,476,000,000
Reported Value Measurement | Preferred shares reimbursement feature embedded derivative
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	16,000,000	29,000,000
Fair Value
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Cash and cash equivalents	969,000,000	571,000,000
Assets, fair value	28,501,000,000	23,905,000,000
Equity securities	1,002,000,000	1,332,000,000
Derivative investments	587,000,000	97,000,000
Other invested assets		39,000,000
Financial Liabilities Fair Value Disclosure	5,237,000,000	3,230,000,000
Fair Value | Asset-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	5,694,000,000	4,832,000,000
Fair Value | Commercial mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	2,922,000,000	2,537,000,000
Fair Value | Corporates
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	11,597,000,000	10,381,000,000
Fair Value | Hybrids
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,027,000,000	901,000,000
Fair Value | States, municipalities and political subdivisions
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,343,000,000	1,187,000,000
Fair Value | Residential mortgage-backed securities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	954,000,000	1,031,000,000
Fair Value | Other invested assets
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	46,000,000
Fair Value | U.S. Government
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	34,000,000	119,000,000
Fair Value | Debt Security, Government, Non-US
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	155,000,000	121,000,000
Fair Value | Reinsurance Receivables, Funds Withheld
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	2,171,000,000	757,000,000
Fair Value | Future Policy Benefits
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	1,953,000,000	725,000,000
Fair Value | Embedded Derivatives in Reinsurance Contracts
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	33,000,000
Fair Value | Fixed indexed annuities
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	3,235,000,000	2,476,000,000
Fair Value | Preferred shares reimbursement feature embedded derivative
Fair Value Measurement Inputs and Valuation Techniques [Line Items]
Available-for-sale Securities	$ 16,000,000	$ 29,000,000	$ 23,000,000	$ 23,000,000

XML

Related Party Transactions - Narrative (Details) - USD ($)			1 Months Ended	12 Months Ended
	Dec. 31, 2018	Dec. 17, 2018	Dec. 31, 2017	Dec. 31, 2019	Dec. 31, 2018
Related Party Transaction [Line Items]
Management Fee, Description				$ 95,000,000
Management Fee Payable	$ 20,000,000			47,000,000	$ 20,000,000
Reimbursement Revenue (Deprecated 2018-01-31)				10,000,000	9,000,000
Related Party Transaction, Asset Carrying Value	1,461,000,000			2,001,000,000	1,461,000,000
Foreign Currency Transaction Gain (Loss), Unrealized	(2,000,000)			(3,000,000)
Other Commitment				83,000,000
Net investment income			$ 1,000,000	112,000,000	33,000,000
Related Party Transactions, Gain (Loss)			$ 0	0	0
Commitment to Invest
Related Party Transaction [Line Items]
Other Commitment				1,358,000,000
Commitment to Invest | Affiliated Entity
Related Party Transaction [Line Items]
Other Commitment	$ 990,000,000			993,000,000	$ 990,000,000
Residential Portfolio Segment
Related Party Transaction [Line Items]
Residential Mortgage Loans Purchased		$ 185,000,000		$ 89,000,000

XML

Investments - Net Investment Income (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Schedule of Investments [Line Items]
Gross investment income	$ 93	$ 178	$ 245	$ 1,345	$ 1,177	$ 1,027
Investment expense	(1)	(4)	(5)	(116)	(70)	(22)
Net investment income	92	174	240	1,229	1,107	1,005
Fixed maturity securities, available-for-sale
Schedule of Investments [Line Items]
Gross investment income	80	164	228	1,054	1,009	953
Equity securities
Schedule of Investments [Line Items]
Gross investment income	6	5	10	73	73	41
Mortgage loans
Schedule of Investments [Line Items]
Gross investment income	2	4	6	42	24	23
Invested cash and short-term investments
Schedule of Investments [Line Items]
Gross investment income	1	1		18	16	3
Funds withheld
Schedule of Investments [Line Items]
Gross investment income	2	0	0	65	28	0
Limited partnerships
Schedule of Investments [Line Items]
Gross investment income	1	3	1	81	17	5
Other investments
Schedule of Investments [Line Items]
Gross investment income	$ 1	$ 1	$ 0	$ 12	$ 10	$ 2

XML

Income Taxes - Components of Income Tax Expense (Benefit) (Details) - USD ($)	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended			15 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017	Dec. 31, 2018
Current:
Federal	$ (5,000,000)	$ (23,000,000)	$ 21,000,000	$ (22,000,000)	$ (42,000,000)	$ (114,000,000)
State	0	0	0	0	0	0
Total current	(5,000,000)	(23,000,000)	21,000,000	(22,000,000)	(42,000,000)	(114,000,000)
Deferred:
Federal	(105,000,000)	7,000,000	(76,000,000)	(39,000,000)	26,000,000	4,000,000
State	0	0	0	0	0	0
Total deferred	(105,000,000)	7,000,000	(76,000,000)	(39,000,000)	26,000,000	4,000,000
Income tax (expense)/benefit	$ (110,000,000)	$ (16,000,000)	$ (55,000,000)	$ (61,000,000)	$ (16,000,000)	$ (110,000,000)	$ (16,000,000)

XML

Commitments and Contingencies - Schedule of Investment Commitments (Details) $ in Millions	Dec. 31, 2019 USD ($)
Other Commitments [Line Items]
Unfunded investment commitment	$ 83
Commitment to Invest
Other Commitments [Line Items]
Unfunded investment commitment	1,358
Other invested assets | Commitment to Invest
Other Commitments [Line Items]
Unfunded investment commitment	1,202
Equity securities | Commitment to Invest
Other Commitments [Line Items]
Unfunded investment commitment	14
Fixed maturity securities, available-for-sale | Commitment to Invest
Other Commitments [Line Items]
Unfunded investment commitment	48
Other assets | Commitment to Invest
Other Commitments [Line Items]
Unfunded investment commitment	$ 78

XML

Derivative Financial Instruments - Schedule of Change in Fair Value of Derivative Instruments (Details) - USD ($) $ in Millions	1 Months Ended	2 Months Ended	3 Months Ended	12 Months Ended
	Dec. 31, 2017	Nov. 30, 2017	Dec. 31, 2016	Dec. 31, 2019	Dec. 31, 2018	Sep. 30, 2017
Derivative [Line Items]
Change in fair value of other derivatives and embedded derivatives	$ 0	$ 1	$ 12	$ 57	$ (42)	$ (16)
Net investment (losses) gains
Derivative [Line Items]
Change in fair value of other derivatives and embedded derivatives	37	140	51	498	(295)	335
Call options | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of other derivatives and embedded derivatives	34	129	39	404	(244)	338
Futures contracts | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of other derivatives and embedded derivatives	3	9	0	27	(8)	10
Currency Forward | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of other derivatives and embedded derivatives	0	0	0	3	2	0
Other derivatives and embedded derivatives | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of other derivatives and embedded derivatives	0	1	0	7	(3)	3
Reinsurance related embedded derivative | Net investment (losses) gains
Derivative [Line Items]
Change in fair value of other derivatives and embedded derivatives	0	1	12	57	(42)	(16)
FIA embedded derivative
Derivative [Line Items]
Change in fair value of other derivatives and embedded derivatives	(54)	123	(133)	759	199	244
Preferred shares reimbursement feature embedded derivative
Derivative [Line Items]
Change in fair value of other derivatives and embedded derivatives	$ 0	$ 0	$ 0	$ (13)	$ 6	$ 0